WO2024254346A1 - Engineered viral like particles (evlps) for the selective transduction of target cells - Google Patents
Engineered viral like particles (evlps) for the selective transduction of target cells Download PDFInfo
- Publication number
- WO2024254346A1 WO2024254346A1 PCT/US2024/032867 US2024032867W WO2024254346A1 WO 2024254346 A1 WO2024254346 A1 WO 2024254346A1 US 2024032867 W US2024032867 W US 2024032867W WO 2024254346 A1 WO2024254346 A1 WO 2024254346A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid sequence
- virus
- particle
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Definitions
- gene editing agents such as base editors and prime editors
- base editors and prime editors enable the precise manipulation of genomic DNA in living organisms and raise the possibility of treating the root cause of many genetic diseases.
- the broad therapeutic application of in vivo gene editing requires safe and efficient means for delivering gene editing agents to multiple tissues and organs.
- viruses such as adeno-associated viruses (AAVs) or lentiviruses (LV), to deliver DNA encoding a gene editing agent to target tissues.
- viruses such as adeno-associated viruses (AAVs) or lentiviruses (LV)
- viral delivery of DNA encoding editing agents leads to prolonged expression in transduced cells, which could increase the frequency of off-target editing.
- viral delivery of DNA raises the possibility of viral vector integration into the genome of transduced cells, both of which can potentially promote oncogenesis or other adverse effects.
- viral and nonviral delivery vectors e.g., AAV or LV
- the efficiency of these approaches can vary dramatically, especially in primary cells that are highly sensitive to changes in their environment and may be altered in response to transfection agents and/or vectors. This effect is further exacerbated in vivo when pharmacokinetics significantly limits the accessibility of certain cell types to circulating delivery vectors.
- VLPs virus-like particles
- Cas9 proteins for example, Cas9 proteins, base editors, and prime editors.
- RNPs ribonucleoproteins
- These VLPs utilize wild-type viral fusogen proteins, which have been optimized by natural evolution to transduce many different cell types. This property, which yields highly infectious VLPs, increases transduction of non-target cell types when used in vivo due to the wide natural tropism of the wild-type viral fusogen. This can be problematic when targeted gene editing (e.g., gene editing of a specific cell type) is desired. Thus, improvements are needed.
- the present disclosure provides compositions of engineered virus like particles (eVLPs) and eVLP complexes for the selective transduction and genome editing of human cells (e.g., hematopoietic stem and progenitor cells, HSPCs).
- eVLPs engineered virus like particles
- eVLP complexes for the selective transduction and genome editing of human cells (e.g., hematopoietic stem and progenitor cells, HSPCs).
- Polynucleotides encoding the proteins of the eVLP and eVLP complexes, vectors comprising said polynucleotides, cells comprising the polynucleotides and/or vectors, and kits useful for producing the eVLPs and eVLP complexes are also provided.
- methods of preparing eVLPs and eVLP complexes are also disclosed herein, as are methods for editing a nucleic acid molecule using said eVLPs and/or eVLP complexes.
- Other aspects relate to methods of delivering a cargo (e.g., a therapeutic) of interest to a target cell.
- the methods relate to using the eVLPs disclosed herein to deliver a base editor or a prime editor to a target cell to treat a disease or disorder.
- the eVLPs disclosed herein are formed via supra-molecular assembly and comprise (a) an envelope comprising (i) a lipid membrane (e.g., single-layer or bi-layer membrane) and a (ii) viral envelope glycoprotein; and (b) a multi-protein core region enclosed by the envelope and comprising (i) a Gag protein, (ii) a Gag-Pro-Pol protein, and (iii) a Gag-cargo fusion protein (e.g., a second fusion protein) comprising a Gag protein fused to a cargo protein (e.g., a napDNAbp, base editor, or prime editor, or therapeutic protein) via a cleavable linker (e.g., a protease-cleavable linker).
- a transmembrane domain is conjugated to a targeting domain.
- a transmembrane domain is conjugated to a targeting domain.
- a transmembrane domain is conjugated to a
- eVLP compositions comprising fusion proteins comprising a targeting moiety.
- the fusion proteins comprise a cytokine conjugated to a transmembrane protein and/or an envelope glycoprotein of the eVLP.
- the fusion proteins comprise a targeting moiety domain, a stalk protein domain, and a transmembrane domain, and/or optionally, an envelope glycoprotein domain.
- Targeted-eVLP architectures comprising various combinations of targeting domains (e.g., facilitates targeted binding of the eVLP to a target cell), stalk domains (e.g., inert domains that act as spacer sequences), transmembrane domains (e.g., a peptide that spans across the lipid membrane domain of the eVLP), and/or envelope glycoproteins (e.g., proteins that facilitate binding of the eVLP to multiple cell targets).
- Other aspects of the disclosure provide eVLP compositions comprising envelope glycoproteins comprising non-natural moieties and methods of conjugating said eVLPs to various targeting moieties using chemistry, e.g., bio-orthogonal click chemistry.
- eVLP compositions comprising targeting moieties on their surfaces (e.g., as fusion proteins comprising the viral envelope glycoprotein and/or transmembrane proteins) are capable of delivering payloads to specific cell types, both in vitro and in vivo, with higher transduction efficiencies than eVLPs lacking said targeting moieties.
- the present disclosure relates to eVLPs comprising one or more fusion proteins capable of displaying a targeting domain on the surface of eVLP.
- the fusion protein comprises a transmembrane domain and a targeting domain.
- the fusion protein comprises a transmembrane domain, a stalk domain, and a targeting domain.
- the fusion protein comprises a viral envelope domain and a targeting domain.
- the fusion protein comprises a viral envelope domain, a stalk domain, and a targeting domain.
- any two domains within the fusion protein may be optionally linked together using one or more linkers (e.g., cleavable linkers), according to some embodiments.
- a first linker e.g., cleavable linker
- the first linker e.g., cleavable linker
- the stalk domain e.g., a targeting domain.
- a second linker e.g., cleavable linker
- the one or more linkers comprises a stalk domain.
- a stalk domain connects the transmembrane domain and the targeting domain.
- a first linker (e.g., linker) connects a viral envelope glycoprotein domain and the targeting domain.
- the first linker e.g., linker
- the first linker connects the viral envelope glycoprotein domain and the stalk domain.
- the first linker e.g., linker
- a second linker e.g., linker
- the fusion protein comprises a transmembrane domain, an optional linker (e.g., linker), and a targeting domain (e.g., any domain capable of binding a target receptor on a target cell).
- exemplary receptortargeting domains contemplated herein include, but are not limited to, CD110:Thrombopoientin (TPO), c-kit:Stem Cell Factor (SCF), CXCR4:CXCL12, CD46:Adenovirus F35 (AdF35), CD201:Protein C, CD150:SH2DlA/EAT-2, CD45:CMV ULll/PP14/adenovirus E3, CD54:LFA-1, CD55:CD97, CD58:CD2, CD59:CD2, CD100:Plexin-B2, CD120:TNFa/b, CD124:IL-4, and Flk2:Flt3 ligand.
- the fusion protein comprises a transmembrane domain, a stalk domain, an optional linker (e.g., linker), and a targeting domain.
- the fusion protein comprises a viral envelope glycoprotein, an optional linker (e.g., a linker), and a targeting domain.
- Additional embodiments include fusion proteins comprising the viral transmembrane domain, a stalk domain, an optional linker (e.g., linker), and a targeting domain.
- one or more domains of a fusion protein comprises a mutation.
- the mutation reduces the affinity of an envelope glycoprotein for its target receptor while preserving its fusogenic capabilities.
- a transmembrane domain comprises a mutation.
- a viral envelope glycoprotein domain comprises a mutation.
- a targeting domain comprises a mutation.
- a stalk domain comprises a mutation.
- eVEPs comprising any combination of the fusion proteins disclosed herein are also possible, according to some embodiments.
- eVEPs may comprise a first fusion protein comprising a transmembrane domain and a targeting domain and a second fusion protein comprising a viral envelope domain and a targeting domain.
- the person of ordinary skill in the art will understand that the eVEPs disclosed herein may comprise any suitable number of fusion proteins.
- eVLPs may comprises a first fusion protein, a second fusion protein, a third fusion protein, a fourth fusion protein, a fifth fusion protein, and so on.
- the eVLPs comprise at least 2 fusion proteins.
- the eVLP complexes comprise an eVLP and a small molecule, an antibody, a (poly)nucleic acid, a protein, a peptide, or the like.
- the protein or peptide is a recombinant protein or a recombinant peptide.
- the eVLP comprises a fusion protein comprising a targeting domain configured to bind to the small molecule, antibody, (poly)nucleic acid, protein, or peptide.
- the eVLP comprising the fusion protein comprising the targeting domain binds to the small molecule, an antibody, a (poly)nucleic acid, a protein, a peptide, thus forming an eVLP complex.
- the small molecule, antibody, (poly)nucleic acid, protein, or peptide facilitates binding of the eVLP complex to a target cell.
- the eVLP complex comprises an antibody bound to thetargeting domain of the fusion protein.
- the targeting domain is configured to bind to one or more domains of the antibody.
- the antibody facilitates binding of the eVLP to the target cell.
- the antibody is any antibody capable of binding to a cell surface (e.g., via a cell surface receptor).
- any known targeting domain- antibody domain complex known in the art may be used to form the eVLP complexes disclosed herein.
- the antibody domain is an IgG antibody
- the targeting domain is a Z-peptide, which is known in the art to bind IgG antibodies.
- Other antibodies can also be used as described herein (e.g., IgA, IgM, IgE, etc.). Other non-limiting examples are provided in the Detailed Description. Accordingly, in some embodiments, the targeting domain and/or antibody domain may be naturally occurring or non-naturally occurring.
- eVLP complexes contemplated herein may be formed in vitro or in vivo.
- eVLP complexes are formed in vitro by mixing a desired antibody domain (e.g., IgG antibody) with eVLPs comprising fusion proteins comprising targeting domains (e.g., Z-peptide) capable of binding the desired antibody domain.
- eVLP complexes may be formed in vivo, for example, by administering eVLPs comprising fusion proteins comprising a targeting domain (e.g., Z- peptide) capable of binding to a desired antibody domain to a subject in need thereof, wherein antibody domain is also present within the subject in need.
- the subject in need may produce the antibody domain naturally or may be administered the antibody domain prior to or following administration of the eVLPs.
- Other aspects of the present disclosure relate to enhancing the selective tropism of eVLPs by chemically conjugating a desired targeting domain to the surface of the eVLP (e.g., using chemical methods as opposed to genetic methods).
- the eVLPs disclosed herein comprise at least one conjugation domain capable of forming a bond with a desired targeting domain.
- the conjugation domain is a subdomain of a transmembrane domain.
- the conjugation domain is a subdomain of a viral envelope glycoprotein domain.
- the conjugation domain is a subdomain of a stalk domain.
- multiple conjugation subdomains are possible within the eVLPs (e.g., the conjugation domain is a subdomain of the transmembrane domain and the envelope glycoprotein domain).
- the reactive group is a chemical group that is naturally occurring in biological systems (e.g., -SH, -NH2, -COOH groups, etc.).
- eVLPs comprising a viral envelope protein comprising N-azidoacetylmannosamine (ManNAz) may be reacted with a targeting domain comprising a strained alkyne group (e.g., dibenzocyclooctyne, DIBO).
- a targeting domain comprising a strained alkyne group (e.g., dibenzocyclooctyne, DIBO).
- the one or more polynucleotides comprises a first nucleic acid encoding a first fusion protein.
- the fusion protein be any fusion protein disclosed herein.
- the fusion protein comprises a transmembrane domain, a targeting domain, and optionally, a stalk domain.
- the one or more polynucleotides further comprises a second nucleic acid sequence encoding a viral envelope glycoprotein.
- the one or more polynucleotides further comprise a third nucleic acid sequence encoding a group-specific antigen (gag) protease (pro) polyprotein.
- the one or more polynucleotides further comprises a fourth nucleic acid sequence encoding a second fusion protein encoding a base editor, a prime editor, or other protein(e.g., a therapeutic protein).
- Other aspects of the present disclosure relate to one or more methods. In some embodiments, the methods relate to methods of producing the eVLPs disclosed herein.
- the methods comprise transfecting a cell (e.g., a producer cell) with one or more polynucleotides that encode for said eVLPs.
- Other methods are directed to methods of editing a nucleic acid molecule in a target cell using any of the eVLPs disclosed herein.
- the methods comprise contacting the target cell with any of the eVLPs, polynucleotides, vectors, and/or cells disclosed herein, wherein the eVLPs encapsulate a gene editor (e.g., base editor or prime editor, a therapeutic, etc.), and wherein upon transduction the gene editor installs one or more modifications to the nucleic acid molecule at a target site.
- a gene editor e.g., base editor or prime editor, a therapeutic, etc.
- the methods comprise methods for treating a disease using the eVLPs disclosed herein.
- the methods comprise contacting a target cell (e.g., hematopoietic stem and progenitor cells, HSPCs) with any of the eVLPs, polynucleotides, vectors, and/or cells or compositions thereof disclosed herein, wherein the eVLPs encapsulate a therapeutic (e.g., base editor or prime editor, RNA therapy, peptide therapy, etc.), and wherein upon transduction the gene editor installs one or more modifications to the nucleic acid molecule at a target site, and wherein the one or more modifications are associated with reducing, relieving, treating, curing, or preventing the symptoms of a disease or disorder.
- a target cell e.g., hematopoietic stem and progenitor cells, HSPCs
- a therapeutic e.g., base editor or prime editor, RNA therapy, peptide therapy, etc.
- compositions comprising any of the eVLPs, polynucleotides, vectors, and/or cells disclosed herein, and a pharmaceutical excipient.
- FIG. 1 shows a schematic drawing of various surface receptors with high- specificity for hematopoietic stem and progenitor cell (e.g., HSPCs) and their cognate ligand including (1) thrombonoietin receptor (e.g., CD110)/Thrombopoietin (TPO), (2) proto- oncogene c-Kit (e.g., c-Kit)/Stem Cell Factor (SCF), C-X-C chemokine receptor type 4 (e.g., CXCR-4)/stromal-derived factor 1 (e.g., CXCL-12 or SDF-1), and CD46 complement regulatory protein (e.g., CD46)/Adenovirus Finger Protein 35 (e.g., AdF35).
- thrombonoietin receptor e.g., CD110
- TPO Thrombopoietin
- TPO Thrombopoietin
- SCF Ste Cell Factor
- FIG. 2 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
- FIG. 3 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain and a wild-type VSVG transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
- FIG. 4 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain, a CD8 alpha stalk domain, and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
- FIG. 5 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain, an IgG alpha stalk domain, and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
- FIG. 6 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
- the targeting domain is configured to bind to an antibody, which in turn, binds a protein on a target cell.
- FIG. 7 shows an exemplary eVLP comprising a wild-type envelope glycoprotein comprising one or more non-natural moieties.
- FIG. 8 shows a schematic drawing of a version 4 virus-like particle (e.g., v4 eVLP) architecture as published in Banskota, Raguram et al., Cell 185, 250-265 (2022).
- Vesicular stomatitis virus G protein e.g., VSVG
- LDLR ubiquitously expressed LDL receptor protein
- FIG. 9 shows exemplary embodiments wherein genome editing agents were selectively delivered to hematopoietic stem cells using eVLPs comprising a targeting protein conjugated to a VSVGmut, a mutated version of the fusogen VSVG (K47Q, R354A) with impaired binding affinity for its natural receptor but with retained fusogenic activity.
- This fusogen is displayed on v4 eVLP architecture in its binding active form.
- the targeting protein corresponds to a ligand that binds a surface receptor on HSPCs.
- Exemplary targeting proteins tested include TPO, SCF, CXCL12, and F35.
- FIG. 10 shows a plot of the percentage of reads with the desired A>G edit at position 7 in the BCE11A +58kb enhancer in hCD34+ cells as a function of eVEPs with 50 different targeting architectures.
- eVEPs were engineered to contain an adenine base editor (e.g., ABE8e) and a sgRNA (e.g., A>G edits at position 7 of BCE11A protospacer) as cargo.
- adenine base editor e.g., ABE8e
- sgRNA e.g., A>G edits at position 7 of BCE11A protospacer
- FIG.l 1 shows additional eVEP architectures to display the targeting protein on the eVEP surface, as contemplated herein.
- targeting proteins may be displayed on eVEP surfaces through various transmembrane domains fused to an inert stalk domain which serves as a spacer separating the transmembrane domain from the targeting domain thus allowing access to bind membrane proximal receptors on target cells.
- Exemplary inert stalks include CD8alpha and IgG.
- FIG. 12A shows the use of wild type (WT) VSVG in a fusion with the targeting proteins (e.g., as opposed to the VSVGmut).
- Constructs comprising the pCMV-TPO-VSVG and pCMV-SCF-VSVG exhibited 15% and 10% of the editing efficiency of WT VSVG v4 eVLPs in human CD34+ cells, respectively, with no statistically significant loss in cell viability compared to VSVG-eVLPs.
- Constructs comprising an adenine base editor were validated by observing A>G editing at position 7 of BCL11 A protospacer.
- FIG. 12B shows the viability of CD34+ cells following treatment with targeted- eVLPs as described in FIG. 7.
- FIG. 13A shows an illustration of an exemplary barcoded lentivirus platform for testing viral targeting proteins in a high-throughput, pooled manner.
- HIV 1 lentivirus is produced in an arrayed format (typically 96 w format) by transfecting HEK17 producer cells with pCMV- VSVGmut, psPAX2 (lentiviral packaging plasmid), a barcoded lentiviral genome containing a predefined NNNNNNNNNNNNNNNNNN barcode in addition to pCMV-EGFP-P2A-PuroR.
- FIG. 13B shows an illustration of an exemplary assay used to validate the ability of targets identified from the lentiviral screen to delivery eVEPs to target cells.
- FIG. 14A shows the sequence of exemplary construct pJAQ218 identified during the lentiviral screen.
- Two barcodes are assigned to each targeting ligand or combination of ligands involved in the screen.
- FIG. 14B shows the results from an exemplary lentiviral screen using CD34+ cells. The reads assigned to each barcode are plotted in a scatterplot with the hits defined in the upper right quadrant. The soundness of the screen can be ascertained from both the separation of the positive and negative controls (VSV-G and VSV- Gmut here) and the correlation between degenerate barcodes (distinct barcode sequences corresponding to the same targeting ligand).
- FIGs. 14C and 14D show a plot of the reads assigned to each barcode normalized to the cDNA and gDNA, respectively.
- FIG. 14D shows a plot of the reads assigned to each barcode normalized to the ratio of the gDNA/cDNA. The color of the dot represents the sum of the cDNA reads between the two barcodes assigned to a single construct. This gives information on production titer achievable for a given construct.
- FIG. 15 shows the results from an exemplary validation study performed using Base-editing eVLPs bearing one or more exemplary candidate targeting proteins identified using the lentiviral screen shown in FIG. 13.
- BE-eVLPs were screened for their ability to induce an A «T to G*C base edit in the BCL11A gene in CD34+ cells in vitro.
- FIG. 16 shows the results from an exemplary validation study performed using Prime editing eVLPs (PE-eVLPs) bearing pJAQ218, which is a targeting protein identified using the lentiviral screen shown in FIG. 13.
- PE-eVLP constructs used the V3 and V3b prime editor architectures. PE-eVLPs were screened for their ability to recode a 5bp substitution in the HEK gene in CD34+ cells.
- FIG. 17 shows an exemplary eVLP construct comprising (i) a first fusion protein comprising a first targeting domain, a stalk domain, and a transmembrane domain, (ii) a second fusion protein comprising a second targeting domain, a stalk domain, and a transmembrane domain, and (iii) a mutated Cocal envelope glycoprotein domain.
- the first targeting domain is different than the second targeting domain.
- FIG.18A shows a scatter plot of the reads assigned to each barcode plotted with the hits defined in the upper right quadrant. The screen was performed using lentiviruses comprisng a mutant cocal glycoenvelope protein.
- FIG. 18B shows a plot of the reads, normalized to the cDNA, for the data provided in FIG. 18 A.
- FIGs. 19A and 19B shows the results from another exemplary lentiviral screen testing a different array of targeting proteins and VSV-Gmut against CD34+ cells.
- FIG. 19A shows the reads assigned to each barcode from gDNA; whereas FIG. 19B shows the reads assigned to each barcode from gDNA normalized to the cDNA.
- base editor refers to an agent comprising a polypeptide that is capable of making a modification to a base (e.g., A, T, C, G, or U) within a nucleic acid sequence (e.g., DNA or RNA) that converts one base to another (e.g., A to G, A to C, A to T, C to T, C to G, C to A, G to A, G to C, G to T, T to A, T to C, or T to G).
- the base editor is capable of deaminating a base within a nucleic acid such as a base within a DNA molecule.
- the base editor is capable of deaminating an adenine (A) in DNA.
- Such base editors may include a nucleic acid programmable DNA binding protein (napDNAbp) fused to an adenosine deaminase.
- Some base editors include CRISPR-mediated fusion proteins that are utilized in the base editing methods described herein.
- the base editor comprises a nucleaseinactive Cas9 (dCas9) fused to a deaminase which binds a nucleic acid in a guide RNA- programmed manner via the formation of an R-loop, but does not cleave the nucleic acid.
- dCas9 nucleaseinactive Cas9
- the dCas9 domain of the fusion protein may include a D10A and a H840A mutations described in PCT/US2016/058344, which published as WO 2017/070632 on April 27, 2017, and is incorporated herein by reference.
- the DNA cleavage domain of S. pyogenes Cas9 includes two subdomains, the HNH nuclease subdomain and the RuvCl subdomain.
- the HNH subdomain cleaves the strand complementary to the gRNA (the “targeted strand,” or the strand in which editing or deamination occurs), whereas the RuvCl subdomain cleaves the non-complementary strand containing the PAM sequence (the “non-edited strand”).
- a base editor comprises a Cas9 nickase (nCas9) that comprises only one of the D10A or the H840A mutations.
- a base editor is a macromolecule or macromolecular complex that results primarily (e.g., more than 80%, more than 85%, more than 90%, more than 95%, more than 99%, more than 99.9%, or 100%) in the conversion of a base in a polynucleotide sequence into another base (i.e., a transition or transversion) using a combination of 1) a nucleotide-, nucleoside-, or base-modifying enzyme and 2) a nucleic acid binding protein that can be programmed to bind to a specific nucleic acid sequence.
- the base editor comprises a DNA binding domain (e.g., a programmable DNA binding domain, such as a dCas9 or nCas9) that directs it to a target sequence.
- the base editor comprises a base modification domain fused to a programmable DNA binding domain (e.g., dCas9 or nCas9).
- base modifying enzyme and “base modification domain,” which are used interchangeably herein, refer to an enzyme that can modify a base and convert one base to another (e.g., a deaminase, such as a cytidine deaminase or an adenosine deaminase).
- the base modifying enzyme of the base editor may target cytosine (C) bases in a nucleic acid sequence and convert the C to a thymine (T) base.
- C to T editing is carried out by a deaminase, e.g., a cytidine deaminase.
- a to G editing is carried out by a deaminase, e.g., an adenosine deaminase.
- Base editors that can carry out other types of base conversions are also contemplated.
- a base editor converts a C to a T.
- the base editor comprises a cytosine deaminase.
- a “cytosine deaminase”, or “cytidine deaminase,” refers to an enzyme that catalyzes the chemical reaction “cytosine + H2O uracil + NH3” or “5-methyl-cytosine + H2O thymine + NH3.” As may be apparent from the reaction formula, such chemical reactions result in a C to U/T base change.
- the C to T base editor comprises a dCas9 or nCas9 fused to a cytidine deaminase.
- the cytidine deaminase domain is fused to the N-terminus of the dCas9 or nCas9.
- the base editor further comprises a domain that inhibits uracil glycosylase, and/or a nuclear localization signal.
- PCT/US2019/47996 PCT Application No. PCT/US2019/049793
- PCT Application No. PCT/US2020/028568 PCT Application No. PCT/US2019/61685, PCT Application No. PCT/US2019/57956, and PCT Application No. PCT/US2019/58678, each of which is incorporated herein by reference.
- a base editor converts an A to a G.
- the base editor comprises an adenosine deaminase.
- An “adenosine deaminase” is an enzyme involved in purine metabolism. An adenosine deaminase catalyzes hydrolytic deamination of adenosine (forming inosine, which base pairs as G) in the context of DNA. There are no known natural adenosine deaminases that act on DNA. Instead, known adenosine deaminase enzymes only act on RNA (tRNA or mRNA).
- Exemplary adenosine and cytidine base editors are also described in Rees & Liu, Base editing: precision chemistry on the genome and transcriptome of living cells, Nat. Rev. Genet. 2018;19(12):770-788; as well as U.S. Patent Publication No. 2018/0073012, U.S. Patent Publication No. 2017/0121693, PCT Publication No. WO 2017/070633, U.S. Patent Publication No. 2015/0166980, U.S. Patent No. 9,840,699, and U.S. Patent No. 10,077,453, each of which is incorporated herein by reference.
- Cas9 or “Cas9 nuclease” refers to an RNA-guided nuclease comprising a Cas9 domain, or a fragment thereof (e.g., a protein comprising an active or inactive DNA cleavage domain of Cas9, and/or the gRNA binding domain of Cas9).
- a “Cas9 domain,” as used herein, is a protein fragment comprising an active or inactive cleavage domain of Cas9 and/or the gRNA binding domain of Cas9.
- a “Cas9 protein” is a full length Cas9 protein.
- a Cas9 nuclease is also referred to sometimes as a casnl nuclease or a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat)-associated nuclease.
- CRISPR is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements, and conjugative plasmids).
- CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids.
- CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA).
- tracrRNA trans-encoded small RNA
- me endogenous ribonuclease 3
- Cas9 domain The tracrRNA serves as a guide for ribonuclease 3-aided processing of pre-crRNA.
- Cas9/crRNA/tracrRNA endo-nucleolytically cleaves a linear or circular dsDNA target complementary to the spacer.
- the target strand not complementary to crRNA is first cut endonucleolytically, then trimmed 3'-5' exonucleolytically.
- DNA-binding and cleavage typically requires protein and both RNAs.
- single guide RNAs (“sgRNA”, or simply “gRNA”) can be engineered so as to incorporate aspects of both the crRNA and tracrRNA into a single RNA species. See, e.g., Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. Science 337:816-821(2012), which is incorporated herein by reference.
- Cas9 recognizes a short motif in the CRISPR repeat sequences (the PAM or protospacer adjacent motif) to help distinguish self versus non-self.
- Cas9 nuclease sequences and structures are well known to those of skill in the art (see, e.g., “Complete genome sequence of an Ml strain of Streptococcus pyogenes.” Ferretti et al., J.J., McShan W.M., Ajdic D.J., Savic D.J., Savic G., Lyon K., Primeaux C., Sezate S., Suvorov A.N., Kenton S., Lai H.S., Lin S.P., Qian Y., Jia H.G., Najar E.Z., Ren Q., Zhu H., Song L., White J., Yuan X., Clifton S.W., Roe B.A., McLaughlin R.E., Proc.
- Cas9 orthologs have been described in various species, including, but not limited to, S. pyogenes and 5. thermophilus. Additional suitable Cas9 nucleases and sequences will be apparent to those of skill in the art based on this disclosure, and such Cas9 nucleases and sequences include Cas9 sequences from the organisms and loci disclosed in Chylinski, Rhun, and Charpentier, “The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems” (2013) RNA Biology 10:5, 726-737; which is incorporated herein by reference.
- a Cas9 nuclease comprises one or more mutations that partially impair or inactivate the DNA cleavage domain.
- a nuclease-inactivated Cas9 domain may interchangeably be referred to as a “dCas9” protein (for nuclease-“dead” Cas9).
- Methods for generating a Cas9 domain (or a fragment thereof) having an inactive DNA cleavage domain are known (see, e.g., Jinek et al., Science. 337:816-821(2012); Qi et al., “Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression” (2013) Cell.
- the DNA cleavage domain of Cas9 is known to include two subdomains, the HNH nuclease subdomain and the RuvCl subdomain.
- the HNH subdomain cleaves the strand complementary to the gRNA, whereas the RuvCl subdomain cleaves the non-complementary strand. Mutations within these subdomains can silence the nuclease activity of Cas9.
- the mutations D10A and H840A completely inactivate the nuclease activity of S. pyogenes Cas9 (Jinek et al., Science.
- proteins comprising Cas9 or fragments thereof are referred to as “Cas9 variants.”
- a Cas9 variant shares homology to Cas9, or a fragment thereof.
- a Cas9 variant is at least about 70% identical, at least about 80% identical, at least about 90% identical, at least about 95% identical, at least about 96% identical, at least about 97% identical, at least about 98% identical, at least about 99% identical, at least about 99.5% identical, at least about 99.8% identical, at least about 99.9% or 100% identical to a wild type Cas9.
- the Cas9 variant may have 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 21, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, or more amino acid changes compared to wild type Cas9. Fusion protein
- fusion protein refers to a hybrid polypeptide that comprises protein domains from at least two different proteins.
- One protein may be located at the amino-terminal (N-terminal) portion of the fusion protein or at the carboxy-terminal (C- terminal) protein thus forming an “amino-terminal fusion protein” or a “carboxy-terminal fusion protein,” respectively.
- a protein may comprise different domains, for example, a nucleic acid binding domain (e.g., the gRNA binding domain of Cas9 that directs the binding of the protein to a target site) and a nucleic acid cleavage domain or a catalytic domain of a nucleic-acid editing protein.
- fusion proteins include fusion of a Cas9 or equivalent thereof to a deaminase (as in a base editor) or to a polymerase, such as a reverse transcriptase (as in a prime editor).
- Any of the fusion proteins provided herein may be produced by any method known in the art.
- the fusion proteins provided herein may be produced via recombinant protein expression and purification, which is especially suited for fusion proteins comprising a peptide linker. Methods for recombinant protein expression and purification are well known, and include those described by Green and Sambrook, Molecular Cloning: A Laboratory Manual (4th ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (2012)), which is incorporated herein by reference.
- Gag is the primary structural protein responsible for orchestrating the majority of steps in viral assembly, including budding out of fully-formed enveloped virions having an (i) envelope (comprising a lipid membrane formed from cell membrane during budding out, and one or more glycoproteins inserted therein), and (ii) a capsid, which is the internal protein shell. Most of these assembly steps occur via interactions with three Gag subdomains - matrix (MA), capsid (CA), and nucleocapsid. These three regions have a low level of sequence conservation among the different retroviral genera, which belies the observed high level of structural conservation. Outside of these three domains, Gag proteins can vary widely.
- MA subdomains - matrix
- CA capsid
- nucleocapsid nucleocapsid
- HIV-1 Gag additionally codes for a C-terminal p6 protein as well as two spacer proteins, SP1 and SP2, which demarcate the CA-NC and NC-p6 junctions, but HTLV-1 contains no additional sequences outside of MA, CA, and NC (Oroszlan and Copeland, 1985; Henderson et al., 1992).
- Gag is also referred to as a “viral structural protein.”
- the term “viral structural protein” refers to viral proteins that contribute to the overall structure of the capsid protein or of the protein core of a virus.
- the term “viral structural protein” further includes functional fragments or derivatives of such viral protein contributing to the structure of a capsid protein or of the protein core of a virus.
- An example of viral structural protein is MMLV Gag.
- the viral membrane fusion proteins are not considered as viral structural proteins. Typically, said viral structural proteins are localized inside the core of the virus.
- the gag protein used in the eVLPs described herein comprises the sequence of SEQ ID NO: 405, or a sequence at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% identical to the sequence of SEQ ID NO: 405:
- gag nuclcocapsid protein refers to a protein that makes up the core structural component of the inner shell of many viruses, including retroviruses.
- the gag nuclcocapsid proteins used in the VEPs of the present disclosure may be an MMLV gag nuclcocapsid protein, an FMLV gag nuclcocapsid protein, or a nuclcocapsid protein from any other virus that produces such proteins.
- Group-specific antigen gag
- protease pro
- a “group-specific antigen (gag) protease (pro) polyprotein” or “gag-pro polyprotein” refers to a gag nuclcocapsid protein further comprising a viral protease linked thereto. Gag -pro polyproteins mediate proteolytic cleavage of gag and gag-pol polyproteins or nuclcocapsid proteins during or shortly after the release of a virion from the plasma membrane.
- the protease of a gag-pro polyprotein is responsible for cleaving a cleavable linker in the fusion protein to release a cargo protein (such as a base editor or prime editor) following delivery of the VLP to a target cell.
- a gag-pro polyprotein is an MMLV gag-pro polyprotein or an FMLV gag-pro polyprotein.
- gRNA Guide RNA
- guide RNA is a particular type of guide nucleic acid which is mostly commonly associated with a Cas protein of a CRISPR-Cas9 and which associates with Cas9, directing the Cas9 protein to a specific sequence in a DNA molecule that includes complementarity to the protospacer sequence of the guide RNA.
- this term also embraces the equivalent guide nucleic acid molecules that associate with Cas9 equivalents, homologs, orthologs, or paralogs, whether naturally occurring or non-naturally occurring (e.g., engineered or recombinant), and which otherwise program the Cas9 equivalent to localize to a specific target nucleotide sequence.
- the Cas9 equivalents may include other napDNAbp from any type of CRISPR system (e.g., type II, V, VI), including Cpfl (a type-V CRISPR-Cas system), C2cl (a type V CRISPR-Cas system), C2c2 (a type VI CRISPR-Cas system), and C2c3 (a type V CRISPR-Cas system).
- Cpfl a type-V CRISPR-Cas system
- C2cl a type V CRISPR-Cas system
- C2c2 a type VI CRISPR-Cas system
- C2c3 a type V CRISPR-Cas system
- a guide RNA is a particular type of guide nucleic acid that is most commonly associated with a Cas protein of a CRISPR-Cas9 and which associates with Cas9, directing the Cas9 protein to a specific sequence in a DNA molecule that includes complementarity to the protospacer sequence for the guide RNA.
- guide RNAs associate with Cas9, directing (or programming) the Cas9 protein to a specific sequence in a DNA molecule that includes a sequence complementary to the protospacer sequence for the guide RNA.
- a gRNA is a component of the CRISPR/Cas system.
- a guide RNA comprises a fusion of a CRISPR-targeting RNA (crRNA) and a trans-activation crRNA (tracrRNA), providing both targeting specificity and scaffolding/binding ability for Cas9 nuclease.
- crRNA CRISPR-targeting RNA
- tracrRNA trans-activation crRNA
- a “crRNA” is a bacterial RNA that confers target specificity and requires tracrRNA to bind to Cas9.
- a “tracrRNA” is a bacterial RNA that links the crRNA to the Cas9 nuclease and typically can bind any crRNA.
- the sequence specificity of a Cas DNA-binding protein is determined by gRNAs, which have nucleotide base-pairing complementarity to target DNA sequences.
- the native gRNA comprises a 20 nucleotide (nt) Specificity Determining Sequence (SDS), or spacer, which specifies the DNA sequence to be targeted, and is immediately followed by an 80 nt scaffold sequence, which associates the gRNA with Cas9.
- the 80nt scaffold sequence comprises any one of the following sequences:
- eNme2 121 GTTGTAGCTCCCTTTCTCATTTCGGAAACGAAATGAGAACCGTTGCTACAATAAG GCCGTCTGAAAAGATGTGCCGCAACGCTCTGCCCCTTAAAGCTTCTGCTTTAAGG GGCATCGTTTA (SEQ ID NO: 393)
- eNme279 GTTGTAGCTCCCGAAACGTTGCTACAATAAGGCCGTCTGAAAAGACGTGCCGCA ACGCTCTGCCTTCTGGCATCGTTTA (SEQ ID NO: 394)
- the 80 nt scaffold sequence comprises a nucleic acid sequence that is at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5%, at least 99.8%, or 100% identical to any one of the nucleic acid sequences of SEQ ID NO:s: 388-394.
- an SDS spacer of the present disclosure has a length of 15 to 100 nucleotides, or more.
- an SDS spacer may have a length of 15 to 90, 15 to 85, 15 to 80, 15 to 75, 15 to 70, 15 to 65, 15 to 60, 15 to 55, 15 to 50, 15 to 45, 15 to 40, 15 to 35, 15 to 30, or 15 to 20 nucleotides.
- the SDS is 20 nucleotides long.
- the SDS may be 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 nucleotides long.
- At least a portion of the target DNA sequence is complementary to the SDS of the gRNA.
- a region of the target sequence is complementary to the SDS of the gRNA sequence and is immediately followed by the correct protospacer adjacent motif (PAM) sequence (e.g., NGG for Cas9 and TTN, TTTN, or YTN for Cpfl).
- PAM protospacer adjacent motif
- an SDS is 100% complementary to its target sequence.
- the SDS sequence is less than 100% complementary to its target sequence and is, thus, considered to be partially complementary to its target sequence.
- a targeting sequence may be 99%, 98%, 97%, 96%, 95%, 94%, 93%, 92%, 91%, or 90% complementary to its target sequence.
- the SDS of template DNA or target DNA may differ from a complementary region of a gRNA by 1, 2, 3, 4, or 5 nucleotides.
- the guide RNA is about 15-120 nucleotides long and comprises a sequence of at least 10 contiguous nucleotides that is complementary to a target sequence. In some embodiments, the guide RNA is 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,
- the guide RNA comprises a sequence of 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or more contiguous nucleotides that is complementary to a target sequence. Sequence complementarity refers to distinct interactions between adenine and thymine (DNA) or uracil (RNA), and between guanine and cytosine.
- the terms “prime editing guide RNA” or “PEgRNA” or “extended guide RNA” refer to a specialized form of a guide RNA that has been modified to include one or more additional sequences for implementing the prime editing methods and compositions described herein.
- the prime editing guide RNAs comprise one or more “extended regions” of nucleic acid sequence.
- the extended regions may comprise, but are not limited to, single- stranded RNA or DNA. Further, the extended regions may occur at the 3' end of a traditional guide RNA. In other arrangements, the extended regions may occur at the 5' end of a traditional guide RNA.
- the extended region may occur at an intramolecular region of the traditional guide RNA, for example, in the gRNA core region which associates and/or binds to the napDNAbp.
- the extended region comprises a “DNA synthesis template” which encodes (by the polymerase of the prime editor) a single- stranded DNA which, in turn, has been designed to be (a) homologous with the endogenous target DNA to be edited, and (b) which comprises at least one desired nucleotide change (e.g., a transition, a transversion, a deletion, or an insertion) to be introduced or integrated into the endogenous target DNA.
- a desired nucleotide change e.g., a transition, a transversion, a deletion, or an insertion
- the extended region may also comprise other functional sequence elements, such as, but not limited to, a “primer binding site” and a “spacer or linker” sequence, or other structural elements, such as, but not limited to, aptamers, stem loops, hairpins, toe loops (e.g., a 3' toeloop), or an RNA-protein recruitment domain (e.g., MS2 hairpin).
- the “primer binding site” comprises a sequence that hybridizes to a single-strand DNA sequence having a 3 end generated from the nicked DNA of the R-loop.
- the PEgRNAs have a 5' extension arm, a spacer, and a gRNA core.
- the 5' extension further comprises in the 5' to 3' direction a reverse transcriptase template, a primer binding site, and a linker.
- the reverse transcriptase template may also be referred to more broadly as the “DNA synthesis template” where the polymerase of a prime editor described herein is not an RT, but another type of polymerase.
- the PEgRNAs have a 5' extension arm, a spacer, and a gRNA core.
- the 5' extension further comprises in the 5' to 3' direction a reverse transcriptase template, a primer binding site, and a linker.
- the reverse transcriptase template may also be referred to more broadly as the “DNA synthesis template” where the polymerase of a prime editor described herein is not an RT, but another type of polymerase.
- the PEgRNAs have in the 5' to 3' direction a spacer (1), a gRNA core (2), and an extension arm (3).
- the extension arm (3) is at the 3' end of the PEgRNA.
- the extension arm (3) further comprises in the 5' to 3' direction a “primer binding site” (A), an “edit template” (B), and a “homology arm” (C).
- the extension arm (3) may also comprise an optional modifier region at the 3' and 5' ends, which may be the same sequences or different sequences.
- the 3' end of the PEgRNA may comprise a transcriptional terminator sequence.
- the PEgRNAs have in the 5' to 3' direction an extension arm (3), a spacer (1), and a gRNA core (2).
- the extension arm (3) is at the 5' end of the PEgRNA.
- the extension arm (3) further comprises in the 3' to 5' direction a “primer binding site” (A), an “edit template” (B), and a “homology arm” (C).
- the extension arm (3) may also comprise an optional modifier region at the 3' and 5' ends, which may be the same sequences or different sequences.
- the PEgRNAs may also comprise a transcriptional terminator sequence at the 3' end.
- linker refers to a molecule linking two other molecules or moieties.
- the linker can be an amino acid sequence in the case of a linker joining two fusion proteins.
- a Cas9 can be fused to a deaminase (e.g., an adenosine deaminase or a cytosine deaminase) by an amino acid linker sequence.
- a Cas9 can be fused to a reverse transcriptase by an amino acid linker sequence.
- the linker can also be a nucleotide sequence in the case of joining two nucleotide sequences together (e.g., in a gRNA).
- the linker is an organic molecule, group, polymer, or chemical moiety.
- the linker is 5-200 amino acids in length, for example, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 30-35, 35-40, 40-45, 45-50, 50-60, 60-70, 70-80, 80-90, 90-100, 100-150, or 150-200 amino acids in length. Longer or shorter linkers are also contemplated.
- the protease cleavage site may be any known in the art, or any sequence yet to be discovered, so long as the corresponding protease may be co-packaged in the VLPs to allow for post-maturation cleavage within the mature VLP particles.
- Such cleavage sites and their corresponding proteases include but are not limited to: (a) granzyme A, which recognizes and cleaves a sequence comprising ASPRAGGK (SEQ ID NO: 339), (b) granzyme B, which recognizes and cleaves a sequence comprising YEADSLEE (SEQ ID NO: 340), (c) granzyme K, which recognizes and cleaves a sequence comprising YQYRAL (SEQ ID NO: 341), or (d) Cathepsin D, which recognizes and cleaves a sequence comprising LGVLIV (SEQ ID NO: 342).
- proteases can include, without limitation, Arg-C proteinase, Asp- N Endopeptidase, Caspase 1, Caspase 2, Caspase 3, Caspase 4, Caspase 5, Caspase 7, Caspase 8, Caspase 9, Caspase 10, Chymotrypsin, Clostripain, Enterokinase, Factor Xa, Glutamyl endopeptidase, Granzyme B, Neutrophil elastase, Pepsin, Prolyl-endopeptidase, Proteinase K, Staphylococcal peptidase I, Thermolysin, Thrombin, and Trypsin.
- proteasesensitive linkers including any serine protease, cysteine protease, aspartic protease, threonine protease, glutamic protease, metalloprotease, or asparagine peptide lyase (which constitute major classifications of known proteases).
- the specific protease cleavage sites for said enzymes are well-known in the art and may be utilized in the linkers herein to provide protease-susceptible linkers.
- nucleic acid programmable DNA binding protein or “napDNAbp,” of which Cas9 is an example, refers to a protein that uses RNA:DNA hybridization to target and bind to specific sequences in a DNA molecule.
- Each napDNAbp is associated with at least one guide nucleic acid (e.g., guide RNA), which localizes the napDNAbp to a DNA sequence that comprises a DNA strand (i.e., a target strand) that is complementary to the guide nucleic acid, or a portion thereof (e.g., the protospacer of a guide RNA).
- the guide nucleic-acid “programs” the napDNAbp (e.g., Cas9 or equivalent) to localize and bind to a complementary sequence.
- the binding mechanism of a napDNAbp - guide RNA complex includes the step of forming an R-loop whereby the napDNAbp induces the unwinding of a double-strand DNA target, thereby separating the strands in the region bound by the napDNAbp.
- the guide RNA protospacer then hybridizes to the “target strand.” This displaces a “non-target strand” that is complementary to the target strand, which forms the single strand region of the R-loop.
- the napDNAbp includes one or more nuclease activities, which then cut the DNA, leaving various types of lesions.
- the napDNAbp may comprise a nuclease activity that cuts the non-target strand at a first location, and/or cuts the target strand at a second location.
- the target DNA can be cut to form a “double- stranded break” whereby both strands are cut.
- the target DNA can be cut at only a single site, i.e., the DNA is “nicked” on one strand.
- Exemplary napDNAbp with different nuclease activities include “Cas9 nickase” (“nCas9”) and a deactivated Cas9 having no nuclease activities (“dead Cas9” or “dCas9”). Exemplary sequences for these and other napDNAbp are provided herein.
- nuclear export sequence refers to an amino acid sequence that promotes transport of a protein out of the cell nucleus to the cytoplasm, for example, through the nuclear pore complex by nuclear transport.
- Nuclear export sequences are known in the art and would be apparent to the skilled artisan.
- NES sequences are described in Xu, D. et al. Sequence and structural analyses of nuclear export signals in the NESdb database. Mol Biol. Cell. 2012, 23(18) 3677-3693, the contents of which are incorporated herein by reference.
- Exemplary NES include, but are not limited to, the following:
- DHAEKVAEKLEALSV SEQ ID NO: 410
- ATRELDELMASLSDF SEQ ID NO: 444 [00125] YQNIELITFINALKL SEQ ID NO: 445
- the NES examples above are not limiting.
- the fusion proteins delivered by the presently described VLPs may comprise any known NES sequence, including any of those described in Xu, D. et al. Sequence and structural analyses of nuclear export signals in the NESdb database. Mol. Biol. Cell. 2012, 23(18), 3677-3693; Fung, H. Y. J. et al. Structural determinants of nuclear export signal orientation in binding to exportin CRM1. eLife. 2015, 4:el0034; and Kosugi, S. et al. Nuclear Export Signal Consensus Sequences Defined Using a Localization-based Yeast Selection System. Traffic. 2008, 9(12), 2053-2062, each of which are incorporated herein by reference.
- the fusion proteins, constructs encoding the fusion proteins, and VLPs disclosed herein further comprise one or more, preferably, at least three nuclear export sequences.
- the fusion proteins comprise at least three NESs.
- the NESs can be the same NESs or they can be different NESs.
- the fusion proteins, constructs encoding the fusion proteins, and VLPs may comprise at least one, at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least ten, or more NESs.
- the one or more NESs are of sufficient strength to drive accumulation of the VLP proteins (e.g., the Gag-cargo) in a detectable amount respectively in the cytoplasm of a producer cell.
- the location of the NES fusion can be at the N-terminus, the C-terminus, or within a sequence of a fusion protein (e.g., inserted between the encoded napDNAbp component (e.g., Cas9) and the gag nucleocapsid protein).
- the NES or multiple NESs, e.g., three NESs) are positioned between the napDNAbp and the gag nucleocapsid protein such that they can be cleaved from the napDNAbp upon delivery of the fusion protein to a target cell.
- NES sequences may preferably be joined to a fusion protein via a cleavable linker, such as protease-cleavable linker (e.g., the Gag-Pro-Pol).
- a cleavable linker such as protease-cleavable linker (e.g., the Gag-Pro-Pol).
- the NES may be removed from the cargo protein after VLP maturation so that the cargo may be free to translocate to the nucleus once delivered to a recipient cell.
- the NESs may be any known NES sequence in the art.
- the NESs may also be any future-discovered NESs for nuclear export.
- the NESs also may be any naturally-occurring NES, or any non-naturally occurring NES (e.g., an NES with one or more desired mutations).
- the term “nuclear export sequence” or “NES” refers to an amino acid sequence that promotes export of a protein from the cell nucleus, for example, by nuclear transport. Nuclear export sequences are known in the art and would be apparent to the skilled artisan.
- a base editor or other fusion protein may be modified with one or more nuclear export sequences (NES), preferably at least three NESs.
- the fusion proteins are modified with two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, or ten or more NESs.
- the disclosure contemplates the use of any nuclear export sequence known in the art at the time of the disclosure, or any nuclear export sequence that is identified or otherwise made available in the state of the art after the time of the instant filing.
- a representative nuclear export sequence is a peptide sequence that directs the protein out of the nucleus of the cell in which the sequence is expressed.
- NESs commonly contain hydrophobic amino acid residues in the sequence LXXXLXXLXL, where L is a hydrophobic residue (frequently leucine), and X represents any amino acid.
- Nuclear export sequences often comprise leucine residues.
- the fusion proteins delivered by the VLPs described herein may also comprise nuclear export sequences that are linked through one or more linkers, e.g., a polymeric, amino acid, nucleic acid, polysaccharide, chemical, or nucleic acid linker element.
- linkers within the contemplated scope of the disclosure are not intended to have any limitations and can be any suitable type of molecule (e.g., polymer, amino acid, polysaccharide, nucleic acid, lipid, or any synthetic chemical linker domain) and can be joined to the base editor by any suitable strategy that effectuates forming a bond (e.g., covalent linkage, hydrogen bonding) between the cargo protein and the one or more NESs.
- the linker joining one or more NES and a cargo protein is a cleavable linker, as described further herein, such the one or more NES can be cleaved from the cargo protein, e.g., upon delivery of the cargo protein to a target cell.
- Nuclear localization sequence [00171]
- the term “nuclear localization sequence” or “NLS” refers to an amino acid sequence that promotes import of a protein into the cell nucleus, for example, by nuclear transport.
- Nuclear localization sequences are known in the art and would be apparent to the skilled artisan. For example, NLS sequences are described in Plank et al., International PCT Application, PCT/EP2000/011690, filed November 23, 2000, published as WO/2001/038547 on May 31, 2001, the contents of which are incorporated herein by reference for its disclosure of exemplary nuclear localization sequences.
- an NLS comprises the amino acid sequence PKKKRKV (SEQ ID NO: 484), MDSLLMNRRKFLYQFKNVRWAKGRRETYLC (SEQ ID NO: 485), KRTADGSEFESPKKKRKV (SEQ ID NO: 486), or KRTADGSEFEPKKKRKV (SEQ ID NO: 487).
- NLS comprises the amino acid sequences NLSKRPAAIKKAGQAKKKK (SEQ ID NO: 488), PAAKRVKLD (SEQ ID NO: 489), RQRRNELKRSF (SEQ ID NO: 490), or NQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGY (SEQ ID NO: 491).
- a base editor, prime editor, or other fusion protein may be modified with one or more nuclear localization sequences (NLS), preferably at least two NLSs.
- the fusion proteins are modified with two or more NLSs.
- the disclosure contemplates the use of any nuclear localization sequence known in the art at the time of the disclosure, or any nuclear localization sequence that is identified or otherwise made available in the state of the art after the time of the instant filing.
- a representative nuclear localization sequence is a peptide sequence that directs the protein to the nucleus of the cell in which the sequence is expressed.
- a nuclear localization signal is predominantly basic, can be positioned almost anywhere in a protein’s amino acid sequence, generally comprises a short sequence of four amino acids (Autieri & Agrawal, (1998) J. Biol. Chem. 273: 14731-37, incorporated herein by reference) to eight amino acids, and is typically rich in lysine and arginine residues (Magin et al., (2000) Virology 274: 11-16, incorporated herein by reference).
- Nuclear localization sequences often comprise proline residues.
- a variety of nuclear localization sequences have been identified and have been used to effect transport of biological molecules from the cytoplasm to the nucleus of a cell. See, e.g., Tinland et al., (1992) Proc.
- NLSs can be classified in three general groups: (i) a monopartite NLS exemplified by the SV40 large T antigen NLS (PKKKRKV (SEQ ID NO: 484)); (ii) a bipartite motif consisting of two basic domains separated by a variable number of spacer amino acids and exemplified by the Xenopus nucleoplasmin NLS (KRXXXXXXXXXKKKL (SEQ ID NO: 492)); and (iii) noncanonical sequences such as M9 of the hnRNP Al protein, the influenza virus nucleoprotein NLS, and the yeast Gal4 protein NLS (Dingwall and Laskey 1991).
- Nuclear localization sequences appear at various points in the amino acid sequences of proteins. NLS have been identified at the N-terminus, the C-terminus, and in the central region of proteins. Thus, the disclosure provides fusion proteins that may be modified with one or more NLSs at the C-terminus and/or the N-terminus, as well as at internal regions of the fusion protein. The residues of a longer sequence that do not function as component NLS residues should be selected so as not to interfere, for example, tonically or sterically, with the nuclear localization signal itself. Therefore, although there are no strict limits on the composition of an NLS-comprising sequence, in practice, such a sequence can be functionally limited in length and composition.
- the present disclosure contemplates any suitable means by which to modify a fusion protein to include one or more NLSs.
- the fusion proteins may be engineered to express a fusion protein that is translationally fused at its N-terminus or its C- terminus (or both) to one or more NLSs, i.e., to form a base editor or prime editor-NLS fusion construct.
- a fusion protein-encoding nucleotide sequence may be genetically modified to incorporate a reading frame that encodes one or more NLSs in an internal region of the encoded base editor or prime editor.
- the NLSs may include various amino acid linkers or spacer regions encoded between the base editor and the N- terminally, C-terminally, or internally-attached NLS amino acid sequence, e.g., and in the central region of proteins.
- the present disclosure also provides for nucleotide constructs, vectors, and host cells for expressing fusion proteins that comprise a base editor or prime editor and one or more NLSs, among other components.
- the fusion proteins delivered by the VLPs described herein may also comprise nuclear localization sequences that are linked to the fusion protein through one or more linkers, e.g., a polymeric, amino acid, nucleic acid, polysaccharide, chemical, or nucleic acid linker element.
- linkers within the contemplated scope of the disclosure are not intended to have any limitations and can be any suitable type of molecule (e.g., polymer, amino acid, polysaccharide, nucleic acid, lipid, or any synthetic chemical linker domain) and can be joined to the fusion protein by any suitable strategy that effectuates forming a bond (e.g., covalent linkage, hydrogen bonding) between the fusion protein and the one or more NLSs.
- nucleic acid refers to a polymer of nucleotides.
- the polymer may include natural nucleosides (i.e., adenosine, thymidine, guanosine, cytidine, uridine, deoxyadenosine, deoxythymidine, deoxyguanosine, and deoxy cytidine), nucleoside analogs (e.g., 2-aminoadenosine, 2-thiothymidine, inosine, pyrrolo-pyrimidine, 3-methyl adenosine, 5-methylcytidine, C5 bromouridine, C5 fluorouridine, C5 iodouridine, C5 propynyl uridine, C5 propynyl cytidine, C5 methylcytidine, 7 deazaadenosine, 7 deazaguanosine, 8 oxoadenosine, 8 oxoadenosine, 8
- nucleocapsid protein refers to a protein that makes up the core structural component of the inner shell of many viruses, including retroviruses.
- a nucleocapsid protein makes up part of the gag protein.
- the nucleocapsid proteins used in the VLPs of the present disclosure may be an MMLV gag nucleocapsid protein, an FMLV gag nucleocapsid protein, or a nucleocapsid protein from any other virus that produces such proteins.
- the term “prime editor” refers to fusion constructs comprising a napDNAbp (e.g., Cas9 nickase) and a reverse transcriptase that are capable of carrying out prime editing on a target nucleotide sequence in the presence of a PEgRNA (or “extended guide RNA”).
- the term “prime editor” may refer to the fusion protein or to the fusion protein complexed with a PEgRNA, and/or further complexed with a second-strand nicking sgRNA.
- the prime editor may also refer to the complex comprising a fusion protein (reverse transcriptase fused to a napDNAbp) and a PEgRNA.
- Prime editors may be used to carry out prime editing, which is an approach for gene editing using napDNAbps, a polymerase (e.g., a reverse transcriptase), and specialized guide RNAs that include a primer binding site and a DNA synthesis template for encoding desired new genetic information (or deleting genetic information) that is then incorporated into a target DNA sequence.
- Prime editing is described in Anzalone, A. V. et al., Search- and- replace genome editing without double-strand breaks or donor DNA. Nature 576, 149-157 (2019), which is incorporated herein by reference. See also International PCT Application, PCT/US2020/023721, filed March 19, 2020, and published as WO 2020/191239, which is incorporated herein by reference.
- Prime editing represents a platform for genome editing that is a versatile and precise method to directly write new genetic information into a specified DNA site using a nucleic acid programmable DNA binding protein (“napDNAbp”) working in association with a polymerase (i.e., in the form of a fusion protein or otherwise provided in trans with the napDNAbp), wherein the prime editing system is programmed with a prime editing (PE) guide RNA (“PEgRNA”) that both specifies the target site and templates the synthesis of the desired edit in the form of a replacement DNA strand by way of an extension (either DNA or RNA) engineered onto a guide RNA (e.g., at the 5' or 3' end, or at an internal portion of a guide RNA).
- PE prime editing
- PEgRNA prime editing guide RNA
- the replacement strand containing the desired edit (e.g., a single nucleobase substitution) shares the same sequence as the endogenous strand (or is homologous to it) immediately downstream of the nick site of the target site to be edited (with the exception that it includes the desired edit).
- the endogenous strand downstream of the nick site is replaced by the newly synthesized replacement strand containing the desired edit.
- Cas protein-reverse transcriptase fusions or related systems are used to target a specific DNA sequence with a guide RNA, generate a single strand nick at the target site, and use the nicked DNA as a primer for reverse transcription of an engineered DNA synthesis template that is integrated with the guide RNA.
- prime editors that use reverse transcriptase as the DNA polymerase component
- the prime editors described herein are not limited to reverse transcriptase but may include the use of virtually any DNA polymerase.
- the application throughout may refer to prime editors with “reverse transcriptase,” it is set forth here that reverse transcriptase are only one type of DNA polymerase that may work with prime editing.
- reverse transcriptase the person having ordinary skill in the art should appreciate that any suitable DNA polymerase may be used in place of the reverse transcriptase.
- the prime editors may comprise Cas9 (or an equivalent napDNAbp), which is programmed to target a DNA sequence by associating it with a specialized guide RNA (i.e., PEgRNA) containing a spacer sequence that anneals to a complementary sequence (the complementary sequence to an endogenous protospacer sequence) in the target DNA.
- PEgRNA also contains new genetic information in the form of an extension that encodes a replacement strand of DNA containing a desired nucleotide change which is used to replace a corresponding endogenous DNA strand at the target site.
- the mechanism of prime editing involves nicking the target site in one strand of the DNA to expose a 3 '-hydroxyl group.
- the extension — which provides the template for polymerization of the replacement strand containing the edit — can be formed from RNA or DNA.
- the polymerase of the prime editor can be an RNA-dependent DNA polymerase (such as a reverse transcriptase).
- the polymerase of the prime editor may be a DNA-dependent DNA polymerase.
- the newly synthesized strand i.e., the replacement DNA strand containing the desired nucleotide edit
- the newly synthesized (or replacement) strand of DNA may also be referred to as a single strand DNA flap, which would compete for hybridization with the complementary homologous endogenous DNA strand, thereby displacing the corresponding endogenous strand.
- Resolution of the hybridized intermediate (also referred to as a heteroduplex, comprising the single strand DNA flap synthesized by the reverse transcriptase hybridized to the endogenous DNA strand with the exception of mismatches at positions where desired nucleotide edits are installed in the edit strand) can include removal of the resulting displaced flap of endogenous DNA (e.g., with a 5' end DNA flap endonuclease, FEN1), ligation of the synthesized single strand DNA flap to the target DNA, and assimilation of the desired nucleotide changes as a result of cellular DNA repair and/or replication processes.
- endogenous DNA e.g., with a 5' end DNA flap endonuclease, FEN1
- FEN1 5' end DNA flap endonuclease
- the term “producer cell” refers to any cell type that can be used to make the VLPs described herein.
- One or more polynucleotides encoding the components of a VLP are transfected, transduced, electroporated, or otherwise inserted into a producer cell.
- a single vector comprises polynucleotides encoding all components of the VLP, and in other embodiments, polynucleotides encoding each component of the VLP are split over two, three, or four different vectors. Once the producer cell expresses the polynucleotides, the various components of the VLPs self-assemble spontaneously within the producer cells.
- gag polyproteins encoded on the polynucleotides as described above.
- the gag polyproteins (some of which are fused to a cargo molecule such as a protein) multimerize at the cell membrane of a producer cell and are subsequently released into the producer cell supernatant spontaneously.
- Producer cell lines include, but are not limited to, Gesicle 293T cells, HEK 293T, 293G, 293SF, 293FT, 293TN, Eent-X 293T, and inducible custom cell lines with lentivirally integrated VEP genes.
- protease cleavage site refers to an amino acid sequence that is recognized and cleaved by a protease, i.e., an enzyme that catalyzes proteolysis and breaks down proteins into smaller polypeptides, or single amino acids.
- a protease cleavage site is included in a cleavable linker in a fusion protein, as described herein.
- a protease cleavage site is cleaved by the protease of a gag-pro polyprotein.
- a protease cleavage site comprises an MMLV protease cleavage site or an FMLV protease cleavage site.
- a protease cleavage site comprises one of the amino acid sequences TSTLLMENSS (SEQ ID NO: 334), PRSSLYPALTP (SEQ ID NO: 335), VQALVLTQ (SEQ ID NO: 336), PLQVLTLNIERR (SEQ ID NO: 337), or an amino acid sequence at least 90% identical to any one of SEQ ID NO:s: 1-4.
- a protease cleavage site comprises an amino acid sequence of any one of SEQ ID NO:s: 1-8, or an amino acid sequence at least 90% identical to any one of SEQ ID NO:s: 1-8.
- Protein peptide, and polypeptide
- protein refers to a polymer of amino acid residues linked together by peptide (amide) bonds.
- the terms refer to a protein, peptide, or polypeptide of any size, structure, or function. Typically, a protein, peptide, or polypeptide will be at least three amino acids long.
- a protein, peptide, or polypeptide may refer to an individual protein or a collection of proteins.
- One or more of the amino acids in a protein, peptide, or polypeptide may be modified, for example, by the addition of a chemical entity such as a carbohydrate group, a hydroxyl group, a phosphate group, a famesyl group, an isofamesyl group, a fatty acid group, a linker for conjugation, functionalization, or other modification, etc.
- a protein, peptide, or polypeptide may also be a single molecule or may be a multi-molecular complex.
- a protein, peptide, or polypeptide may be just a fragment of a naturally occurring protein or peptide.
- a protein, peptide, or polypeptide may be naturally occurring, recombinant, or synthetic, or any combination thereof.
- any of the proteins provided herein may be produced by any method known in the art.
- the proteins provided herein may be produced via recombinant protein expression and purification, which is especially suited for fusion proteins comprising a peptide linker.
- Methods for recombinant protein expression and purification are well known, and include those described by Green and Sambrook, Molecular Cloning: A Laboratory Manual (4th ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (2012)), the contents of which are incorporated herein by reference.
- the term “subject,” as used herein, refers to an individual organism, for example, an individual mammal.
- the subject is a human.
- the subject is a non-human mammal.
- the subject is a non-human primate.
- the subject is a rodent.
- the subject is a sheep, a goat, a cattle, a cat, or a dog.
- the subject is a vertebrate, an amphibian, a reptile, a fish, an insect, a fly, or a nematode.
- the subject is a research animal.
- the subject is genetically engineered, e.g., a genetically engineered non-human subject. The subject may be of either sex and at any stage of development.
- substitution refers to replacement of a residue within a sequence, e.g., a nucleic acid or amino acid sequence, with another residue, or a deletion or insertion of one or more residues within a sequence.
- mutation may also be used throughout the present disclosure to refer to a substitution (i.e., a “nucleic acid mutation” or an “amino acid mutation”). Substitutions are typically described herein by identifying the original residue followed by the position of the residue within the sequence and the identity of the newly mutated/substituted residue.
- a substitution is in a viral nucleocapsid protein, which may be part of a VLP as described herein.
- a “target cell” refers to any cell type to which a VLP is delivered.
- a VLP is used to deliver a particular cargo to a target cell.
- a VLP may be used to deliver a gene editing agent such as a napDNAbp (e.g., a Cas9 protein), a base editor, or a prime editor to a target cell.
- a napDNAbp e.g., a Cas9 protein
- the cargo is released and may perform its function, for example, by editing the genome of the target cell.
- Target cell types include any cell to which a person of ordinary skill in the art may want to deliver a VLP as described herein.
- VLPs are delivered into human embryonic kidney (HEK) cells (e.g., HEK 293 or HEK 293T cells).
- HEK human embryonic kidney
- VLPs are delivered into stem cells (e.g., human stem cells) such as, for example, pluripotent stem cells (e.g., human pluripotent stem cells including human induced pluripotent stem cells (hiPSCs)).
- stem cells e.g., human stem cells
- pluripotent stem cells e.g., human pluripotent stem cells including human induced pluripotent stem cells (hiPSCs)
- Target cell types contemplated by the present disclosure include, but are not limited to, stem and progenitor cells (e.g., embryonic stem cells, hematopoietic stem cells, mesenchymal stem cells, neural crest cells, etc.), endothelial cells, muscle cells, myocardial cells, smooth and skeletal muscle cells, mesenchymal cells, epithelial cells, hematopoietic cells, lymphocytes such as T-cells (e.g., Thl T cells, Th2 T cells, ThO T cells, cytotoxic T cells) and B cells (e.g., pre-B cells), monocytes, dendritic cells, neutrophils, macrophages, natural killer cells, mast cells, adipocytes, immune cells, neurons, hepatocytes, and cells involved with particular organs (e.g., thymus, endocrine glands, pancreas, brain, neurons, glia, astrocytes, dendrocytes, osteoblasts, etc
- VLPs are delivered into a cell line, such as, but not limited to, 293-T, 3T3, 4T1, 721, 9L, A-549, A172, A20, A253, A2780, A2780ADR, A2780cis, A431, ALC, B16, B35, BCP-1, BEAS-2B, bEnd.3, BHK-21, BR 293, BxPC3, C2C12, C3H- 10T1/2, C6, C6/36, Cal-27, CGR8, CHO, CML Tl, CMT, COR-L23, COR-L23/5010, COR- L23/CPR, COR-L23/R23, COS-7, COV-434, CT26, D17, DH82, DU145, DuCaP, E14Tg2a, EL4, EM2, EM3, EMT6/AR1, EMT6/AR10.0, FM3, H1299, H69, HB54,
- treatment refers to a clinical intervention aimed to reverse, alleviate, delay the onset of, or inhibit the progress of a disease or disorder, or one or more symptoms thereof, as described herein.
- treatment refers to a clinical intervention aimed to reverse, alleviate, delay the onset of, or inhibit the progress of a disease or disorder, or one or more symptoms thereof, as described herein.
- treatment may be administered after one or more symptoms have developed and/or after a disease has been diagnosed.
- treatment may be administered in the absence of symptoms, e.g., to prevent or delay onset of a symptom or inhibit onset or progression of a disease.
- treatment may be administered to a susceptible individual prior to the onset of symptoms (e.g., in light of a history of symptoms and/or in light of genetic or other susceptibility factors). Treatment may also be continued after symptoms have resolved, for example, to prevent or delay their recurrence.
- variant nucleocapsid protein is a nucleocapsid protein comprising one or more changes in amino acid residues as compared to a wild type nucleocapsid protein amino acid sequence.
- variant nucleocapsid protein encompasses homologous proteins having at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99% or 100% identity with a reference sequence and having the same or substantially the same functional activity or activities as the reference sequence.
- mutants, truncations, or domains of a reference sequence that display the same or substantially the same functional activity or activities as the reference sequence.
- vector refers to a nucleic acid that can be modified to encode a gene of interest and that is able to enter a host cell and replicate within the host cell, and then transfer a replicated form of the vector into another host cell.
- exemplary suitable vectors include viral vectors, such as retroviral vectors or bacteriophages and filamentous phage, and conjugative plasmids. Additional suitable vectors will be apparent to those of skill in the art based on the instant disclosure.
- viral envelope glycoprotein refers to oligo saccharide-containing proteins that form a part of the viral envelope, i.e., the outermost layer of many types of viruses that protects the viral genetic materials when traveling between host cells. Glycoproteins may assist with identification and binding to receptors on a target cell membrane so that the viral envelope fuses with the membrane, allowing the contents of the viral particle (which may be, e.g., a VLP as described herein) to enter the host cell. This property may also be referred to as “tropism.”
- the viral envelope glycoproteins used in the VLPs of the present disclosure may comprise any glycoprotein from an enveloped virus.
- a viral envelope glycoprotein is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein.
- a viral envelope glycoprotein is a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein, or a mutant form thereof.
- VLPs Virus-like particles
- a “virus-like particle (VLP)” (or “engineered virus-like particle (eVLP),” which is used interchangeably with the term “VLP” herein) consists of a supra- molecular assembly comprising (a) an envelope comprising (i) a lipid membrane (e.g., singlelayer or bi-layer membrane) and a (ii) viral envelope glycoprotein, and (b) a multi-protein core region comprising (ii) a Gag protein, (ii) a first fusion protein comprising a Gag protein and Pro-Pol, and (iii) a second fusion protein comprising a Gag protein fused to a cargo protein via a protease-cleavable linker.
- VLP virus-like particle
- the gag protein comprises a nucleocapsid protein variant as described herein.
- the cargo protein is a napDNAbp (e.g., Cas9).
- the cargo protein is a base editor.
- the cargo protein is a prime editor.
- the multiprotein core region of the VLPs further comprises one or more guide RNA molecules which are complexed with a napDNAbp, base editor, or prime editor to form a ribonucleoprotein (RNP).
- the guide RNA molecule comprises a barcode sequence as described herein (e.g., a barcode sequence associated with a nucleocapsid protein variant that forms part of the gag protein).
- the VLPs are prepared in a producer cell that is transiently transformed with plasmid DNA that encodes that various protein and nucleic acid (sgRNA) components of the VLPs.
- the components self-assemble at the cell membrane and bud out in accordance with the naturally occurring mechanism of retroviral budding in order to release from the cell fully-matured VLPs.
- the Pol-Pro cleaves the protease- sensitive linker joining the Gag-cargo linker (e.g., the linker joining a Gag to a napDNAbp RNP) to release the cargo within the VLP.
- the VLP is administered to a recipient target cell and taken up by said target cell, the contents of the VLP are released, including free cargo (e.g., a napDNAbp, base editor, or prime editor).
- free cargo e.g., a napDNAbp, base editor, or prime editor.
- the cargo may translocate to the nuclease of the cell (in particular, where NLSs are included on an RNP cargo), where DNA editing may occur at target sites specified by the guide RNA.
- the protease-cleavable linker is optimized to improve cleavage efficiency after VLP maturation.
- the Gag-cargo fusion e.g., Gag::BE
- the Gag-cargo fusion further comprises one or more nuclear export signals at one or more locations along the length of the fusion polypeptide protein which may be joined by a cleavable linker such that during VLP assembly in the producer cell, the Gag-cargo fusions (due to presence of competing NLS signals) do not accumulate in the nucleus of the producer cells but instead are available in the cytoplasm to undergo the VLP assembly process at the cell membrane.
- the NES may be cleaved by Pro-Pol, thereby separating the cargo (e.g., napDNAbp, base editor, or prime editor) from the NES.
- the cargo e.g., napDNAbp, base editor, or prime editor, typically flanked with one or more NLS elements
- the cargo will not comprise an NES element, which may otherwise prohibit the transport of the cargo into the nucleus and hinder gene editing activity.
- an optimized stoichiometry ratio of Gag-cargo fusion to Gag-Pro-Pol fusion protein is used, which balances the amount of Gag-cargo available to be packaged into VLPs with the amount of retrovirus protease (the “Pro” in the Gag-Pro-Pol fusion) required for VLP maturation.
- the optimized ratio of Gag-cargo fusion to Gag-Pro-Pol fusion protein is achieved by the appropriate ratio of plasmids encoding each component which are transiently delivered to the producer cells.
- the optimal gag-cargo:gag-pro-pol stoichiometry is 25% gag-cargo:75% gag- pro-pol.
- a VLP comprises additional agents for targeting the VLP for delivery to particular cell types.
- additional targeting agents may be incorporated into the outer lipid membrane encapsulation layer of the VLP.
- the additional targeting agent is a protein.
- the additional targeting agent is an antibody.
- a virus-derived particle comprises a virus-like particle formed by one or more virus-derived protein(s), which virus-derived particle is substantially devoid of a viral genome such that the VLP is replication-incompetent when delivered to a recipient cell.
- wild type is a term of the art understood by skilled persons and means the typical form of an organism, strain, gene or characteristic as it occurs in nature as distinguished from mutant or variant forms.
- click chemistry refers to a chemical synthesis technique introduced by K. Barry Sharpless of The Scripps Research Institute, describing chemistry tailored to generate covalent bonds quickly and reliably by joining small units comprising reactive groups together. See, e.g., Kolb, Finn and Sharpless Angewandte Chemie International Edition (2001) 40: 2004-2021; Evans, Australian Journal of Chemistry (2007) 60: 384-395).
- Exemplary coupling reactions include, but are not limited to, formation of esters, thioesters, amides (e.g., such as peptide coupling) from activated acids or acyl halides; nucleophilic displacement reactions (e.g., such as nucleophilic displacement of a halide or ring opening of strained ring systems); azidealkyne Huisgen cycloaddition; thiol-yne addition; imine formation; Michael additions (e.g., maleimide addition); and Diels- Alder reactions (e.g., tetrazine [4 + 2] cycloaddition).
- nucleophilic displacement reactions e.g., such as nucleophilic displacement of a halide or ring opening of strained ring systems
- azidealkyne Huisgen cycloaddition thiol-yne addition
- imine formation Michael additions (e.g., maleimide addition)
- Diels- Alder reactions
- click chemistry reactions include, but are not limited to, azide-alkyne Huisgen cycloaddition; and Diels-Alder reactions (e.g., tetrazine [4 + 2] cycloaddition).
- click chemistry reactions are modular, wide in scope, give high chemical yields, generate inoffensive byproducts, are stereospecific, exhibit a large thermodynamic driving force > 84 kJ/mol to favor a reaction with a single reaction product, and/or can be carried out under physiological conditions.
- a click chemistry reaction exhibits high atom economy, can be carried out under simple reaction conditions, use readily available starting materials and reagents, uses no toxic solvents or use a solvent that is benign or easily removed (preferably water), and/or provides simple product isolation by non- chromatographic methods (crystallization or distillation).
- click chemistry handle refers to a reactant, or a reactive group, that can partake in a click chemistry reaction.
- a strained alkyne e.g., a cyclooctyne
- click chemistry reactions require at least two molecules comprising click chemistry handles that can react with each other.
- click chemistry handle pairs that are reactive with each other are sometimes referred to herein as partner click chemistry handles.
- an azide is a partner click chemistry handle to a cyclooctyne or any other alkyne.
- exemplary click chemistry handles suitable for use according to some aspects of this invention are described herein, for example, in Tables 1 and 2.
- click chemistry handles are used that can react to form covalent bonds in the presence of a metal catalyst, e.g., copper (II).
- click chemistry handles are used that can react to form covalent bonds in the absence of a metal catalyst.
- click chemistry handles include, but are not limited to, the click chemistry reaction partners, groups, and handles described in Becer, Hoogenboom, and Schubert, Click Chemistry beyond Metal-Catalyzed Cycloaddition, Angewandte Chemie International Edition (2009) 48: 4900 - 4908 and PCT/US2012/044584 and references therein, which references are incorporated herein by reference for click chemistry handles and methodology.
- Table 1 Exemplary click chemistry handles and reactions.
- the present disclosure provides articles and methods for the selective transduction and genome editing of human cells (e.g., hematopoietic stem and progenitors cells, HSPCs) using engineered viral like particles (e.g., eVLPs).
- eVLPs comprising fusion proteins comprising a targeting moiety.
- the fusion proteins comprise a cytokine conjugated to a transmembrane protein and/or an envelope glycoprotein.
- the fusion proteins comprise a targeting moiety domain, a stalk protein domain, a transmembrane domain and/or envelope glycoprotein domain.
- Targeted-eVLP architectures comprising fusion proteins comprising various targeting domains, stalk domains, transmembrane domains, and envelope glycoproteins are also provided herein.
- the eVLP comprise a second fusion protein comprising various targeting domains, stalk domains, and transmembrane domains or envelope glycoprotein domain.
- the first fusion protein and second fusion protein comprise the same targeting domains, stalk domains, and transmembrane or envelope glycoprotein domains.
- the first fusion protein and second fusion protein comprise different targeting domains, stalk domains, and transmembrane or envelope glycoprotein domains.
- the different targeting domains are configured to bind the same, or different, target (e.g., receptor) on a target cell (e.g., they both target the same cell type, such as HSPC or immune cells).
- eVLP compositions comprising envelope glycoproteins comprising non-natural sugars and methods of conjugating various targeting moieties to said eVLPs using bio-orthogonal click chemistry.
- Polynucleotides, vectors, cells, and kits useful for producing the articles, and performing the methods, described herein are also provided.
- eVLP architectures use VSVG as the standard envelope glycoprotein.
- VSVG initiates receptor- mediated endocytosis through the ubiquitously expressed LDL receptor protein (LDLR).
- LDLR ubiquitously expressed LDL receptor protein
- the wide expression distribution of LDLR means that v4 eVLPs have the potential to transduce many cell types. While this has obvious benefits especially in an ex vivo context, this property increases transduction in off-target cell types, especially in the liver. Therefore, the effective dose reaching the target cell population for a given disease is much lower than the administered dose since off-target cells act as a sink for the high-activity eVLPs.
- eVLP architectures comprising a targeting domain increases the effective dose of a therapeutic (e.g., genome editors) reaching a target cell.
- a therapeutic e.g., genome editors
- eVLPs carrying genome editors permit delivery of gene editors to correct disease-associated alleles only in the cell types where they exert the most substantial phenotypic effect.
- non- viral targeting domains e.g., cytokines
- aspects of the present disclosure are generally directed toward compositions of eVLPs comprising one or more targeting domains and methods of making the same, both in vitro and in vivo.
- compositions of eVLPs comprising one or more targeting domains and methods of making the same, both in vitro and in vivo.
- the following is a description of various elements that permit the targeted delivery of eVLPs as contemplated herein.
- FIG. 2 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain, a targeting domain, and a linker.
- TM transmembrane
- FIG 2 also shows other eVLP components including the (i) lipid membrane e.g., single-layer or bi-layer membrane), a mutant viral envelope glycoprotein (e.g., VSVG-mut) and a multi-protein core region enclosed by the envelope and comprising a Gag protein, a Gag-Pro-Pol protein, and a Gag-cargo fusion protein.
- the fusion protein is conjugated to a transmembrane domain
- the envelope glycoprotein is a mutant envelope glycoprotein (e.g., VSVG-mutant, Cocal-mutant, Nipah virus mutant).
- envelope glycoproteins and/or mutant envelope glycoproteins are also contemplated.
- the envelope glycoprotein is derived from the vesicular stomatitis virus G (e.g., VSVG), the Cocal, virus and/or Nipah virus.
- the mutant envelope protein comprises an envelope glycoprotein derived from the vesicular stomatitis virus (e.g., VSVG), Cocal virus, and/or Nipah virus.
- the fusion protein may comprise other domains (e.g., stalk domain) and/or combinations of domains (e.g., targeting domains) according to other embodiments.
- FIG. 3 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a wild type envelope glycoprotein domain, a targeting domain, and a linker.
- the eVLP construct in FIG. 3 also comprises a mutant envelope glycoprotein, e.g., VSVG-mutant that possesses impaired binding affinity to the LDLR but retains its fusogenic activity.
- a mutant envelope glycoprotein e.g., VSVG-mutant that possesses impaired binding affinity to the LDLR but retains its fusogenic activity.
- Such embodiments may be useful, for example, for increasing the transduction efficiency of the eVLPs into in a target cell type.
- the fusion protein may comprise other domains (e.g., stalk domain) and/or combinations of domains (e.g., targeting domains) according to other embodiments.
- FIGs. 4 and 5 show exemplary embodiments of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain, a stalk domain, and a targeting domain.
- the eVLP construct in FIGs. 4 and 5 also comprises a mutant envelope glycoprotein, e.g., VSVG-mutant that possesses impaired binding affinity to the LDLR but retains its fusogenic activity.
- the stalk domains are inert and serve as linkers (or spacers) to separate the transmembrane domain, which incorporates into the eVLP capsid, from the targeting protein.
- the stalk domain comprises CD8-alpha or a fragment thereof (e.g., FIG. 4).
- the stalk domain comprises IgG, or a fragment thereof (e.g., FIG. 5). Again, such embodiments, are useful for increasing the transduction efficiency of the eVLPs.
- the fusion protein may comprise other domains and/or combinations of domains (e.g., targeting domains) according to other embodiments.
- FIG. 6 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain, a targeting domain, and a linker.
- the targeting domain binds to a second targeting domain, which in turn binds to a target receptor on a target cell (e.g., HSBC cell).
- the targeting domain comprises an IgG binding peptide configured to bind to an IgG antibody (e.g., an anti-CDl 10 IgG antibody).
- the fusion protein may comprise other domains (e.g., stalk domain) and/or combinations of domains (e.g., targeting domains) according to other embodiments.
- FIG. 7 shows an exemplary eVLP comprising a non-natural moiety (e.g., an azido (-N3) functionality) and an exemplary method of producing the same.
- a non-natural moiety e.g., an azido (-N3) functionality
- general methods are known in the art for incorporating non-natural moieties (e.g., N-(4- pentynoyl mannosamine, N-azidoacetylmannosamine, etc.) into cell surface glycoproteins (e.g., such as VSVG).
- eVLPs of the present disclosure comprise an envelope glycoprotein with one or more azido functionalities.
- the eVLPs comprises an envelope glycoprotein with one or more alkyne or strained alkyne functionalities.
- FIG. 17 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain (e.g., ICAM1), a stalk domain (e.g., CD8a), and two different targeting domains (e.g., a-CD4 scFV and a-CD8 scFV).
- TM transmembrane
- the eVLP construct comprises a mutant envelope glycoprotein, e.g., Cocal mut that possesses impaired binding affinity that reduces its broad tropism but retains its fusogenic activity.
- the stalk domains are inert and serve as linkers (or spacers) to separate the transmembrane domain, which incorporates into the eVLP capsid, from the targeting protein.
- the stalk domain is CD8-alpha.
- the stalk domain is IgG. Again, such embodiments, are useful for increasing the transduction efficiency of the eVLPs.
- the fusion protein may comprise other domains and/or combinations of domains (e.g., targeting domains) according to other embodiments.
- a virus-like particle comprises a fusion protein comprising a transmembrane domain, a stalk domain, and a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
- a virus-like particle comprises a fusion protein comprising a transmembrane domain, a stalk domain, and two or more targeting domains, wherein the targeting domains are not a viral envelope glycoprotein, an antibody, or an antibody fragment.
- a virus-like particle comprises a fusion protein comprising a transmembrane domain and a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
- a virus-like particle comprises (a) a fusion protein comprising (i) a transmembrane domain and (ii) a targeting domain, and (b) an antibody domain, wherein the targeting domain of the fusion protein binds to the antibody domain to form a virus-like particle-antibody complex, and wherein, the targeting domain is not an envelope glycoprotein, an antibody, or a fragment of an antibody.
- a virus-like particle comprises (a) a fusion protein comprising (i) a transmembrane domain, (ii) a stalk domain, and (iii) a targeting domain, and (b) an antibody domain, wherein the targeting domain of the fusion protein binds to the antibody domain to form a virus-like particle-antibody complex, and wherein, the targeting domain is not an envelope glycoprotein, an antibody, or a fragment of an antibody.
- the virus-like particle comprises at least one conjugation domain.
- eVLPs of the present disclosure comprise a fusion protein comprising a targeting domain.
- the fusion protein comprises a transmembrane domain and a targeting domain.
- the eVLP comprises a fusion protein comprising a transmembrane domain, a stalk domain, and a targeting domain.
- the fusion protein may further, optionally comprise one or more linkers (e.g., linkers), for example, between the transmembrane domain and the targeting domain, between the transmembrane domain and the stalk domain, between the stalk domain and the targeting domain, and/or between the targeting domain and a signaling peptide.
- the one or more linkers is a first linker, a second linker, a third linker, and so on.
- the one or more linkers may be used to link any two domains.
- an optional first linker e.g., flexible
- an optional second linker e.g., flexible
- a fusion protein may comprise a targeting domain and an envelope glycoprotein domain (e.g., VSVG).
- an eVLP may comprise more than one fusion protein comprising any one of the domains described above.
- the domains of the more than one fusion proteins are the same; in other embodiments, the domains of the more than one fusion proteins are different.
- an eVLP comprises a first fusion protein comprising an ICAM1 transmembrane domain, a CD8a stalk domain, and a aCD4 scFv targeting domain and a second fusion protein comprising comprising an ICAM1 transmembrane domain, a CD8a stalk domain, and a aCD8-scFv targeting domain (FIG. 17).
- the eVLP targets HSC cells.
- the eVLPs target immune cells, such as CD4+ or CD8+ T cells.
- the fusion protein may have any suitable structure and/or orientation known in the art.
- the fusion proteins comprise the following structures:
- N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[Stalk domain] -[Targeting domain] -[optional signal peptide] -C-terminus.
- N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Stalk domain] -[Targeting domain]-[ optional signal peptide] -C-terminus.
- N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[Stalk domain] -[optional linker] -[Targeting domain]- [optional signal peptide] -C-terminus.
- the eVLPs comprise a fusion protein comprising a transmembrane domain.
- Any suitable transmembrane domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein.
- the transmembrane domain is selected from the group consisting of CD28, CD43, CD49d, CD62L, CD162, HLA-A2, HLA-DRA, ICAM1, LFA-1, mCD3z, mCD4, mCD8a, hCD8a, hCD8a, and VSVG-TM.
- Non-limiting exemplary embodiments of possible transmembrane domains for use in any of the fusion proteins disclosed herein include: [00231] CD28 FWVLVVVGGVLACYSLLVTVAFIIFWV (SEQ ID NO: 363)
- IWAPLAGTCGVLLLSLVITLY (SEQ ID NO: 375)
- the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 363-376 or 493.
- the eVLPs comprise a fusion protein comprising a viral envelope glycoprotein domain.
- a viral envelope glycoprotein domain Any suitable viral envelope glycoprotein domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein.
- the viral envelope glycoprotein comprises one or more mutations, for example, a mutation that decreases the glycoproteins binding affinity for its native target receptor. In some embodiment, the mutation does not substantially reduce the fugsionic properties (e.g., the ability to induce endocytic transduction).
- Non-limiting exemplary embodiments of possible viral envelope glycoprotein domains for use in any of the fusion proteins disclosed herein include:
- VSV-Gmut amino acid sequence (K47Q/R354A, del 1-16, VSVGTM ASP )
- VSV-Gmut amino acid sequence (K47Q/R354A):
- Nipah-G MPAENKKVRFENTTSDKGKIPSKVIKSYYGTMDIKKINEGLLDSKILSAFNTVIALLGS
- Nipah-F Nipah-F
- the viral envelope glycoprotein domain comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 377-379 or 494- 501.
- Stalk domain amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 377-379 or 494- 501.
- the eVLPs comprise a fusion protein comprising a stalk domain.
- Any suitable stalk domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein.
- the stalk domain is selected from the group consisting of hCD8a-l, hCD8a-2, hIgG4-CH3, mCD3z, mCD4, mCD8a-l, mCD8a-2, hCD8a’, mCD28, hCD8, CD8 hinge region, Siglec-4:12, Siglec-1, Siglec-2, Siglec-3, Siglec- 7, IgGl-CH3, IgG4-CH2CH3, IgGl-CH2CH3, IgGl-1, IgGl-2, IgG2, IgG3, and IgG4.
- the stalk domain is selected from the group consisting of hCD8a-l, hCD8a-2, hIgG4-CH3, mCD3z, mCD4, mCD8a-l, mCD8a-2, hCD8a’, mCD28, hCD8, Siglec-4:12, IgGl-CH3, IgG4-CH2CH3, IgGl-CH2CH3, IgGl-1, IgGl-2, IgG2, IgG3, and IgG4.
- the stalk domain is selected from the group consisting of mmIgG2_l, mmIgG2_2, and mmIgG2_3.
- the stalk domain is selected from the group consisting of IgG3_l, IgG3_2, IgG3_3, IgG3_4, IgG3_5, IgG3_6, IgGl_3, IgGl_4, IgG3_7, IgG2_l, and IgGl_3.
- stalk domain is selected from the group consisting of IgAl_l, IgAl_2, IgAl_3, IgAl_4, IgA2_l, IgA2_2, IgA2_3, and IgA2_4.
- the stalk domain is selected from the group consisting of IgD_l, IgD_2, IgD_3, IgD_4, IgE, IgM_l, IgM_2, IgM_3, and IgGl_4.
- Non-limiting exemplary embodiments of possible stalk domains for use in any of the fusion proteins disclosed herein include:
- CD 8 a trunc
- TTTPAPRPPTPAPTIASQPLSLRPEAC SEQ ID NO: 503
- TTTKPVLRTPSPVHPTGTSQPQRPEDCRPRGSVKGTGLDFACD SEQ ID. NO. 35
- EPKSPDKTHTCPPCP SEQ ID. NO. 43
- IgG2 ERKCCVEVPPCP (SEQ ID. NO. 45)
- KPCPPCKCP (SEQ ID. NO. 58)
- KPCPPCKCPAP (SEQ ID. NO. 59)
- EPKSCDTPPPCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAP (SEQ ID. NO. 63)
- EPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAP SEQ ID. NO. 64
- EPKSCDKTHTCPPCPAP (SEQ ID. NO. 67)
- PKSCDKTHTCPPCPAP (SEQ ID. NO. 68)
- PCPRCPAP (SEQ ID. NO. 69)
- PCPAPPVAG PS (SEQ ID. NO. 70)
- PPKPKDT (SEQ ID. NO. 71)
- TPSPSCCHP (SEQ ID. NO. 75)
- PPPCCHP (SEQ ID. NO. 78)
- PCPVPPPPPCCHP (SEQ ID. NO. 79)
- ETKTPE CP5HTQPLGVYLLTP SEQ ID. NO. 80
- KTPECPSHTQPLGVYLLTP (SEQ ID. NO. 81)
- PECPSHTQPLGVYLLTP (SEQ ID. NO. 82)
- RWPESPKAQASSVP (SEQ ID. NO. 83)
- PLPVIAELPP (SEQ ID. NO. 86)
- ELPPKVSVFVPP (SEQ ID. NO. 87)
- IgGl_4 AEPKSPDKTHTCPPCPKDPK (SEQ ID. NO. 88)
- the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 29-88, 404, 502-503, 894, or 896-899.
- the eVLPs comprise a fusion protein comprising a targeting domain.
- Any suitable targeting domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein.
- the targeting domain is a cytokine.
- the targeting domain is a protein.
- Other targeting domains are possible in other embodiments.
- the targeting domain is a (poly)nucleic acid, a glycoprotein, a protein, a peptide, or a small molecule.
- the targeting domain comprises an antibody or an aptamer.
- the targeting domain is not a viral envelope glycoprotein. In other embodiments the targeting domain is not a fragment of an antibody domain.
- the targeting domain is configured to bind to a specific target, e.g., a receptor on a specific cell type.
- the target domain preferentially binds to human hematopoietic stem and progenitor cell (e.g., HSPCs).
- HSPCs comprise a plurality of cell types.
- the target cell type within the family of HSPC cells is the long term HSCs (LT-HSCs) which have both self-renewal and multi-lineage potential.
- target cells within the HSPC family of cells include short term HSCs (ST-HSCs), Multi-Potent Progenitor cells (MPPs), Common Myeloid Progenitor cells (CMPs), Common Lymphoid Progenitor cells (CLPs), Megakaryocyte-erythroid progenitor cells (MEPs), granulocyte-monocyte progenitor cells (GMPs), neutrophils, megakaryocytes, platelets, erythrocytes, monocytes, macrophages, basophils, lymphocytes, dendritic cells, T cells, B cells, according to other embodiments.
- ST-HSCs Short term HSCs
- MPPs Multi-Potent Progenitor cells
- CMPs Common Myeloid Progenitor cells
- CLPs Common Lymphoid Progenitor cells
- MEPs Megakaryocyte-erythroid progenitor cells
- GMPs granulocyte-monocyte progenitor cells
- the cells within the HSPC family may be identified by various surface markers.
- cells expressing CD201 + CD150 + CD48- Lin‘ c-Kit + Sca-l + or CD34-Flk2 _ Lin-c-Kit + Sca-l + are considered in the art to be LT-HSC cells, according to some embodiments.
- LT-HSC cells can be further differentiated into ST-HSC cells which express CD34 + Flk2-Lin-c-Kit + Sca-l + , in other embodiments.
- ST-HSC cells may then differentiate into MPP cells expressing CD34 + Flk2 + Lin-c-Kit + Sca-l + or CD150-CD48-Lin _ c-Kit + Sca-l + , according to certain embodiments.
- MPP cells may then either differentiate into CMP cells (e.g., expressing CD34 + FcyRIVIII low Lin _ c-Kit + Sca-l-) or CLP cells (e.g., expressing Lin-c-Kit low Sca- l low IL7Ra + Flk2 + ), according to another set of embodiments.
- CMP cells may further differentiate into MEP cells (e.g., expressing CD34+FcyRIFIIl-Lin-c-Kit+Sca-l-) or GMP cells (e.g., expressing CD34+FcyRIFIII+Lin-c-Kit+Sca-l-); whereas CLP cells further differentiate into dendritic cells, T-cells, NK cells, and B-cells.
- MEP cells are known to further differentiate into megakaryocytes and erythrocytes; whereas GMP cells may differentiate into basophils, neutrophils, eosinophils, monocytes, and dendritic cells.
- Monocytes may also further differentiate into macrophages and monocyte derived dendritic cells.
- the targeting domain binds to target proteins on T cells and/or B cells.
- Exemplary targeting domains and their target receptor on T cells are shown below:
- Exemplary targeting domains and their target receptor on B cells are shown below:
- the targeting domain may bind to any known “receptor” on a target cell surface.
- receptor any known “receptor” on a target cell surface.
- the term “receptor” as used herein does not require any signaling event to occur upon binding of the targeting domain to the target receptor, although such a signaling event is not precluded from occurring.
- the receptor may be any moiety present on the cell surface, including but not limited to glycoproteins, proteins (e.g., globular proteins, lipid anchored proteins, peripheral proteins), carbohydrates, glycolipids, lipids, and/or complexes formed therefrom.
- Exemplary receptor: targeting domains contemplated herein include, but are not limited to, CD110:Thrombopoientin (TPO), c-kit:Stem Cell Factor (SCF), CXCR4:CXCL12, CD46:Adenovirus F35 (AdF35), CD201:Protein C, CD150:SH2DlA/EAT-2, CD45:CMV ULll/PP14/adenovirus E3, CD54:LFA-1, CD55:CD97, CD58:CD2, CD59:CD2, CD100:Plexin-B2, CD120:TNFa/b, CD124:IL-4, and Flk2:Flt3.
- Non-limiting exemplary embodiments of possible targeting domains for use in any of the fusion proteins disclosed herein include:
- MDLGQKLLEAAWAGQLDEVRILLKAGADVNAKNSRGWTPLHTAAQTGHLEIFEVL LKAGADVNAKTNKRVTPLHLAAALGHLEIVEVLLKAGADVNARDTWGTTPADLAA KYGHRDIAEVLQKAA (SEQ ID NO: 912).
- Sana CD8 scFv form 4 QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGRINPK SGRTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTVVYYCARLTEGIPDYWGQG TTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAW YQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYST PQTFGPGTKVDIKRFGGGTKVEIK (SEQ ID NO: 935).
- CD117 scFv AHI QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGVIYSGN GDTSYNQKFKGKATLTADKSSSTAYMQINSLTSEDSAVYYCARERDTRFGNWGQGT LVTVSAGGGGSGGGGSGGGGSNIVLTQSPASLAVSLGLRATISCRASESVDIYGNSFM HWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQ NNEDPYTFGGGTKLEIK(SEQ ID NO: 504).
- CD 117 scFv AH2 [00407] CD 117 scFv AH2:
- CD 117 scFv 2Dl [00408] CD 117 scFv 2Dl:
- CD 117 scFv 2D2 [00409] CD 117 scFv 2D2:
- CD117 scFv 4Fl [00410] CD117 scFv 4Fl:
- CD 117 scFv 4F2 YINYSGSTYYNPSLKSQISITRDTSKNQYYLQLNSVTTEDAATYYCARGGNYFAMDY WGQGTSVTVSS (SEQ ID NO: 508).
- CD 117 scFv 4k94 [00412] CD 117 scFv 4k94:
- CD117 scFv 54 [00413] CD117 scFv 54:
- CD117 scFv 56 [00415] CD117 scFv 56:
- CD117 scFv 57 [00416] CD117 scFv 57:
- CD117 scFv 61 [00418] CD117 scFv 61:
- CD117 scFv 66 [00419] CD117 scFv 66:
- CD117 scFv 67 EVQLVESGGGLVQPGRSLRLSCTASGFTFSDHDMNWVRQAPGKGLEWVGRTRNAA GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 518).
- CD117 scFv 68 [00421] CD117 scFv 68:
- CD117 scFv 69 [00422] CD117 scFv 69:
- CD117 scFv 70 [00423] CD117 scFv 70:
- CD 117 SRI scFv [00424] CD 117 SRI scFv:
- CD 133 scFv 1 [00429] CD 133 scFv 1:
- CD 133 scFv 2 [00430] CD 133 scFv 2:
- the targeting domain comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 343-362, 387, 900-944, 504-522, or 527- 533.
- the targeting domain is selected from the group consisting of CALR-del52, CALR-ins5, CXCL12, AdF35, mSCF soluble, SCF, SCF mutant (V49L/F63L/K91E/I98R), SCF mutant (V49L/F63L/K91E), SCF mutant (V49L/F63L), SCF soluble, SCF soluble mutant (V49L/F63L/K91E/I98R), SCF soluble mutant (V49L/F63L/K91E), SCF soluble mutant (V49L/F63L), TPO-157, TPO-163, TPO-171, TPO, CXCL1 1, CXCL4, and CXCL14
- the eVLPs comprising a fusion protein may further comprise an optional signaling peptide.
- Any suitable signaling peptide known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein.
- signaling peptides also referred to as signal sequence, targeting signal, localization signal, localization sequence, transit peptide, leader sequence, or leader peptide
- signaling peptides is a short peptide (e.g., typically between 16-30 amino acids long) present at the N-terminus (or occasionally non-classically at the C-terminus or internally within the peptide sequence) of most newly synthesized proteins that are destined toward the secretory pathway.
- signaling peptides prompt a cell to translocate the protein to a desired location (e.g., to the cell membrane).
- the signaling peptide is cleaved from the fusion protein following translocation; however, in other embodiments, the signaling peptide is not cleaved from the fusion protein following translocation.
- MKCLLYLAFLFIGVNC (SEQ ID. NO. 6)
- MNRGVPFRHLLLVLQLALLPAATQG (SEQ ID. NO. 7)
- MYLWLKLLAFGFAFLDTEVFVTG (SEQ ID. NO. 8)
- MSLPVTALLLPLALLLHAARP (SEQ ID. NO. 9)
- MALPVTALLLPLALLLHAARP (SEQ ID. NO. 10)
- MAGPPRLLLLPLLLALARGLPGALA SEQ ID. NO. 14
- MSAPKLLSLGCIFFPLLLFQQARA SEQ ID. NO. 15
- MAWAPLLLTLLAHCTDCWA SEQ ID. NO. 24
- hIL2RG MLKPSLPFTSLLFLQLPLLGVG (SEQ ID. NO. 25)
- the signaling peptide comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 6-28.
- the fusion proteins comprise at least one of the following non-limiting structures:
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present disclosure provides compositions and methods for the selective transduction and genome editing of human cells (e.g., hematopoietic stem and progenitors cells, HSPCs) using engineered viral like particles (eVLPs). Aspects of the disclosure provide eVLP compositions comprising fusion proteins comprising a targeting moiety. In some embodiments, the fusion proteins comprise a cytokine conjugated to a transmembrane protein and/or an envelope glycoprotein. In other embodiments, the fusion proteins comprise a targeting moiety domain, a stalk protein domain, a transmembrane and/or envelope glycoprotein domain. Targeted-eVLP architectures comprising various targeting domains, stalk domains, transmembrane domains, and envelope glycoproteins are also provided herein. Other aspects of the disclosure provide eVLP compositions comprising envelope glycoproteins comprising non-natural sugars and methods of conjugating said eVLPs to various targeting moieties using bio-orthogonal click chemistry. Polynucleotides, vectors, cells, and kits useful for producing the articles, and performing the methods, described herein are also provided.
Description
ENGINEERED VIRAL LIKE PARTICLES (EVLPS) FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS
GOVERNMENT SUPPORT
[001] This invention was made with government support under Grant Nos. UG3AI150551, U01AI142756, R35GM118062, RM1HG009490, and R01EY009339 awarded by the National Institutes of Health. The government has certain rights in the invention.
BACKGROUND OF INVENTION
[002] Recently developed gene editing agents, such as base editors and prime editors, enable the precise manipulation of genomic DNA in living organisms and raise the possibility of treating the root cause of many genetic diseases. The broad therapeutic application of in vivo gene editing requires safe and efficient means for delivering gene editing agents to multiple tissues and organs. Many of the most robust approaches for delivering gene editing agents in vivo reported to date involve the use of viruses, such as adeno-associated viruses (AAVs) or lentiviruses (LV), to deliver DNA encoding a gene editing agent to target tissues. However, viral delivery of DNA encoding editing agents leads to prolonged expression in transduced cells, which could increase the frequency of off-target editing. In addition, viral delivery of DNA raises the possibility of viral vector integration into the genome of transduced cells, both of which can potentially promote oncogenesis or other adverse effects. Further, despite the constant development of transfection methods and the optimization of viral and nonviral delivery vectors (e.g., AAV or LV), the efficiency of these approaches can vary dramatically, especially in primary cells that are highly sensitive to changes in their environment and may be altered in response to transfection agents and/or vectors. This effect is further exacerbated in vivo when pharmacokinetics significantly limits the accessibility of certain cell types to circulating delivery vectors.
[003] More recently, virus-like particles (VLPs) have been engineered to deliver, for example, Cas9 proteins, base editors, and prime editors. These VLPs allow the delivery of ribonucleoproteins (RNPs) (e.g., a gene editing protein agent complexed with a guide RNA) instead of DNA to target cells. The short half-life of RNPs in cells limits the opportunity for off-target editing. These VLPs, however, utilize wild-type viral fusogen proteins, which have
been optimized by natural evolution to transduce many different cell types. This property, which yields highly infectious VLPs, increases transduction of non-target cell types when used in vivo due to the wide natural tropism of the wild-type viral fusogen. This can be problematic when targeted gene editing (e.g., gene editing of a specific cell type) is desired. Thus, improvements are needed.
SUMMARY OF INVENTION
[004] The present disclosure provides compositions of engineered virus like particles (eVLPs) and eVLP complexes for the selective transduction and genome editing of human cells (e.g., hematopoietic stem and progenitor cells, HSPCs). Polynucleotides encoding the proteins of the eVLP and eVLP complexes, vectors comprising said polynucleotides, cells comprising the polynucleotides and/or vectors, and kits useful for producing the eVLPs and eVLP complexes are also provided. Additionally, methods of preparing eVLPs and eVLP complexes are also disclosed herein, as are methods for editing a nucleic acid molecule using said eVLPs and/or eVLP complexes. Other aspects relate to methods of delivering a cargo (e.g., a therapeutic) of interest to a target cell. For example, in some embodiments, the methods relate to using the eVLPs disclosed herein to deliver a base editor or a prime editor to a target cell to treat a disease or disorder.
[005] Aspects of the disclosure relate to eVLPs. In some embodiments, the eVLPs disclosed herein are formed via supra-molecular assembly and comprise (a) an envelope comprising (i) a lipid membrane (e.g., single-layer or bi-layer membrane) and a (ii) viral envelope glycoprotein; and (b) a multi-protein core region enclosed by the envelope and comprising (i) a Gag protein, (ii) a Gag-Pro-Pol protein, and (iii) a Gag-cargo fusion protein (e.g., a second fusion protein) comprising a Gag protein fused to a cargo protein (e.g., a napDNAbp, base editor, or prime editor, or therapeutic protein) via a cleavable linker (e.g., a protease-cleavable linker). As described in more detail below, in some embodiments, a transmembrane domain is conjugated to a targeting domain. In other embodiments, the envelope glycoprotein is conjugated to the targeting domain.
[006] Some aspects of the disclosure relate to eVLP compositions comprising fusion proteins comprising a targeting moiety. In some embodiments, the fusion proteins comprise a cytokine conjugated to a transmembrane protein and/or an envelope glycoprotein of the eVLP. In other embodiments, the fusion proteins comprise a targeting moiety domain, a stalk protein domain, and a transmembrane domain, and/or optionally, an envelope glycoprotein domain. Targeted-eVLP architectures comprising various combinations of targeting domains
(e.g., facilitates targeted binding of the eVLP to a target cell), stalk domains (e.g., inert domains that act as spacer sequences), transmembrane domains (e.g., a peptide that spans across the lipid membrane domain of the eVLP), and/or envelope glycoproteins (e.g., proteins that facilitate binding of the eVLP to multiple cell targets). Other aspects of the disclosure provide eVLP compositions comprising envelope glycoproteins comprising non-natural moieties and methods of conjugating said eVLPs to various targeting moieties using chemistry, e.g., bio-orthogonal click chemistry.
[007] As described herein, the inventors have discovered that eVLP compositions comprising targeting moieties on their surfaces (e.g., as fusion proteins comprising the viral envelope glycoprotein and/or transmembrane proteins) are capable of delivering payloads to specific cell types, both in vitro and in vivo, with higher transduction efficiencies than eVLPs lacking said targeting moieties.
[008] Thus, in certain aspects, the present disclosure relates to eVLPs comprising one or more fusion proteins capable of displaying a targeting domain on the surface of eVLP. In some embodiments, the fusion protein comprises a transmembrane domain and a targeting domain. In some embodiments, the fusion protein comprises a transmembrane domain, a stalk domain, and a targeting domain. In other embodiments, the fusion protein comprises a viral envelope domain and a targeting domain. Alternatively, or additionally, the fusion protein comprises a viral envelope domain, a stalk domain, and a targeting domain.
[009] Any two domains within the fusion protein may be optionally linked together using one or more linkers (e.g., cleavable linkers), according to some embodiments. For example, in one set of embodiments, a first linker (e.g., cleavable linker) connects the transmembrane domain and the targeting domain. In another set of embodiments, the first linker (e.g., cleavable linker) connects the transmembrane domain and the stalk domain. In a third set of embodiments, the first linker (e.g., cleavable linker) connects the stalk domain to a targeting domain. In yet another set of embodiments, a second linker (e.g., cleavable linker) connects the stalk domain to a targeting domain.
[0010] In some embodiments, the one or more linkers comprises a stalk domain. For example, in some cases, a stalk domain connects the transmembrane domain and the targeting domain.
[0011] In some embodiments, a first linker (e.g., linker) connects a viral envelope glycoprotein domain and the targeting domain. In another set of embodiments, the first linker (e.g., linker) connects the viral envelope glycoprotein domain and the stalk domain. In a
third set of embodiments, the first linker (e.g., linker) connects the stalk domain to a targeting domain. In yet another set of embodiments, a second linker (e.g., linker) connects the stalk domain to a targeting domain.
[0012] In certain embodiments, the fusion protein comprises a transmembrane domain, an optional linker (e.g., linker), and a targeting domain (e.g., any domain capable of binding a target receptor on a target cell). Exemplary receptortargeting domains contemplated herein include, but are not limited to, CD110:Thrombopoientin (TPO), c-kit:Stem Cell Factor (SCF), CXCR4:CXCL12, CD46:Adenovirus F35 (AdF35), CD201:Protein C, CD150:SH2DlA/EAT-2, CD45:CMV ULll/PP14/adenovirus E3, CD54:LFA-1, CD55:CD97, CD58:CD2, CD59:CD2, CD100:Plexin-B2, CD120:TNFa/b, CD124:IL-4, and Flk2:Flt3 ligand.
[0013] In other embodiments, the fusion protein comprises a transmembrane domain, a stalk domain, an optional linker (e.g., linker), and a targeting domain. In some embodiments, the fusion protein comprises a viral envelope glycoprotein, an optional linker (e.g., a linker), and a targeting domain. Additional embodiments include fusion proteins comprising the viral transmembrane domain, a stalk domain, an optional linker (e.g., linker), and a targeting domain.
[0014] In some embodiments, one or more domains of a fusion protein comprises a mutation. In some embodiments, the mutation reduces the affinity of an envelope glycoprotein for its target receptor while preserving its fusogenic capabilities. For example, in some embodiments, a transmembrane domain comprises a mutation. In some embodiments, a viral envelope glycoprotein domain comprises a mutation. In other embodiments, a targeting domain comprises a mutation. In other embodiments still, a stalk domain comprises a mutation.
[0015] eVEPs comprising any combination of the fusion proteins disclosed herein are also possible, according to some embodiments. For example, in some embodiments, eVEPs may comprise a first fusion protein comprising a transmembrane domain and a targeting domain and a second fusion protein comprising a viral envelope domain and a targeting domain. The person of ordinary skill in the art will understand that the eVEPs disclosed herein may comprise any suitable number of fusion proteins. Thus, in some embodiments, eVLPs may comprises a first fusion protein, a second fusion protein, a third fusion protein, a fourth fusion protein, a fifth fusion protein, and so on. In some embodiments, the eVLPs comprise at least 2 fusion proteins.
[0016] Other aspects of the disclosure relate to eVLP complexes. In some embodiments, the eVLP complexes comprise an eVLP and a small molecule, an antibody, a (poly)nucleic acid, a protein, a peptide, or the like. In some embodiments, the protein or peptide is a recombinant protein or a recombinant peptide. In some embodiments, the eVLP comprises a fusion protein comprising a targeting domain configured to bind to the small molecule, antibody, (poly)nucleic acid, protein, or peptide. In some embodiments, the eVLP comprising the fusion protein comprising the targeting domain binds to the small molecule, an antibody, a (poly)nucleic acid, a protein, a peptide, thus forming an eVLP complex. In some embodiments, the small molecule, antibody, (poly)nucleic acid, protein, or peptide facilitates binding of the eVLP complex to a target cell. In some embodiments, the eVLP complex comprises an antibody bound to thetargeting domain of the fusion protein. In some embodiments, the targeting domain is configured to bind to one or more domains of the antibody. In some embodiments, the antibody facilitates binding of the eVLP to the target cell. In some embodiments, the antibody is any antibody capable of binding to a cell surface (e.g., via a cell surface receptor).
[0017] Any known targeting domain- antibody domain complex known in the art may be used to form the eVLP complexes disclosed herein. For example, in some embodiments, the antibody domain is an IgG antibody, and the targeting domain is a Z-peptide, which is known in the art to bind IgG antibodies. Other antibodies can also be used as described herein (e.g., IgA, IgM, IgE, etc.). Other non-limiting examples are provided in the Detailed Description. Accordingly, in some embodiments, the targeting domain and/or antibody domain may be naturally occurring or non-naturally occurring.
[0018] Any of the eVLP complexes contemplated herein may be formed in vitro or in vivo. For example, in some embodiments, eVLP complexes are formed in vitro by mixing a desired antibody domain (e.g., IgG antibody) with eVLPs comprising fusion proteins comprising targeting domains (e.g., Z-peptide) capable of binding the desired antibody domain. Alternatively, eVLP complexes may be formed in vivo, for example, by administering eVLPs comprising fusion proteins comprising a targeting domain (e.g., Z- peptide) capable of binding to a desired antibody domain to a subject in need thereof, wherein antibody domain is also present within the subject in need. Notably, the subject in need may produce the antibody domain naturally or may be administered the antibody domain prior to or following administration of the eVLPs.
[0019] Other aspects of the present disclosure relate to enhancing the selective tropism of eVLPs by chemically conjugating a desired targeting domain to the surface of the eVLP (e.g., using chemical methods as opposed to genetic methods). As such, in some embodiments, the eVLPs disclosed herein comprise at least one conjugation domain capable of forming a bond with a desired targeting domain. In a first set of embodiments, the conjugation domain is a subdomain of a transmembrane domain. In a second set of embodiments, the conjugation domain is a subdomain of a viral envelope glycoprotein domain. In third set of embodiments, the conjugation domain is a subdomain of a stalk domain. In other embodiments, multiple conjugation subdomains are possible within the eVLPs (e.g., the conjugation domain is a subdomain of the transmembrane domain and the envelope glycoprotein domain).
[0020] In some embodiments, the eVLPs comprise one least one conjugation domain comprising at least one reactive group capable of forming a bond with a desired targeting domain comprising a second reactive group (e.g., -COOH + -NH2 or -N3 +-C=C-, etc.) In some embodiments, the reactive group is a chemical group that is naturally occurring in biological systems (e.g., -SH, -NH2, -COOH groups, etc.). In other embodiments, the chemical group is a chemical group that is not naturally occurring in biological systems (e.g., -N3, -C=C-, etc.). For example, in some embodiments, eVLPs comprising a viral envelope protein comprising N-azidoacetylmannosamine (ManNAz) may be reacted with a targeting domain comprising a strained alkyne group (e.g., dibenzocyclooctyne, DIBO). Such embodiments produce eVLPs comprising a viral envelope glycoprotein comprising one or more targeted domains via a 1,2,3-triazole ring linkage.
[0021] Additional aspects of the present disclosure relate to one or more polynucleotides that, collectively, encode for any one of the proteins of the eVLPs disclosed herein. In some embodiments, the one or more polynucleotides comprises a first nucleic acid encoding a first fusion protein. The fusion protein be any fusion protein disclosed herein. For example, in some embodiments the fusion protein comprises a transmembrane domain, a targeting domain, and optionally, a stalk domain. In other embodiments, the one or more polynucleotides further comprises a second nucleic acid sequence encoding a viral envelope glycoprotein. In another embodiment, the one or more polynucleotides further comprise a third nucleic acid sequence encoding a group-specific antigen (gag) protease (pro) polyprotein. In some embodiments, the one or more polynucleotides further comprises a fourth nucleic acid sequence encoding a second fusion protein encoding a base editor, a prime editor, or other protein(e.g., a therapeutic protein).
[0022] Other aspects of the present disclosure relate to one or more methods. In some embodiments, the methods relate to methods of producing the eVLPs disclosed herein. For example, in some embodiments, the methods comprise transfecting a cell (e.g., a producer cell) with one or more polynucleotides that encode for said eVLPs. Other methods are directed to methods of editing a nucleic acid molecule in a target cell using any of the eVLPs disclosed herein. In some embodiments, the methods comprise contacting the target cell with any of the eVLPs, polynucleotides, vectors, and/or cells disclosed herein, wherein the eVLPs encapsulate a gene editor (e.g., base editor or prime editor, a therapeutic, etc.), and wherein upon transduction the gene editor installs one or more modifications to the nucleic acid molecule at a target site.
[0023] In other embodiments, the methods comprise methods for treating a disease using the eVLPs disclosed herein. In some embodiments, the methods comprise contacting a target cell (e.g., hematopoietic stem and progenitor cells, HSPCs) with any of the eVLPs, polynucleotides, vectors, and/or cells or compositions thereof disclosed herein, wherein the eVLPs encapsulate a therapeutic (e.g., base editor or prime editor, RNA therapy, peptide therapy, etc.), and wherein upon transduction the gene editor installs one or more modifications to the nucleic acid molecule at a target site, and wherein the one or more modifications are associated with reducing, relieving, treating, curing, or preventing the symptoms of a disease or disorder.
[0024] Other aspects relate to pharmaceutical compositions comprising any of the eVLPs, polynucleotides, vectors, and/or cells disclosed herein, and a pharmaceutical excipient.
[0025] It should be appreciated that the foregoing concepts, and additional concepts discussed below, may be arranged in any suitable combination, as the present disclosure is not limited in this respect. Further, other advantages and novel features of the present disclosure will become apparent from the following detailed description of various nonlimiting embodiments when considered in conjunction with the accompanying Figures.
[0026] International Patent Application Nos. PCT/US2022/080834, PCT/US2022/080836, and PCT/US2022/080856, each of which was filed on December 2, 2022, and each of which is incorporated herein by reference.
BRIEF DESCRIPTION OF THE DRAWINGS
[0027] FIG. 1 shows a schematic drawing of various surface receptors with high- specificity for hematopoietic stem and progenitor cell (e.g., HSPCs) and their cognate ligand including (1) thrombonoietin receptor (e.g., CD110)/Thrombopoietin (TPO), (2) proto-
oncogene c-Kit (e.g., c-Kit)/Stem Cell Factor (SCF), C-X-C chemokine receptor type 4 (e.g., CXCR-4)/stromal-derived factor 1 (e.g., CXCL-12 or SDF-1), and CD46 complement regulatory protein (e.g., CD46)/Adenovirus Finger Protein 35 (e.g., AdF35).
[0028] FIG. 2 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
[0029] FIG. 3 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain and a wild-type VSVG transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
[0030] FIG. 4 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain, a CD8 alpha stalk domain, and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
[0031] FIG. 5 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain, an IgG alpha stalk domain, and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain.
[0032] FIG. 6 shows exemplary eVLP constructs comprising (i) a fusion protein comprising a targeting domain and a transmembrane domain, and (ii) a mutated VSVG envelope glycoprotein domain. The targeting domain is configured to bind to an antibody, which in turn, binds a protein on a target cell.
[0033] FIG. 7 shows an exemplary eVLP comprising a wild-type envelope glycoprotein comprising one or more non-natural moieties.
[0034] FIG. 8 shows a schematic drawing of a version 4 virus-like particle (e.g., v4 eVLP) architecture as published in Banskota, Raguram et al., Cell 185, 250-265 (2022). Vesicular stomatitis virus G protein (e.g., VSVG) is the standard envelope glycoprotein which initiates receptor-mediated endocytosis through the ubiquitously expressed LDL receptor protein (LDLR). The wide expression distribution of LDLR means that v4 eVLPs have the potential to transduce many different cell types, which often results in significant off-target effects.
[0035] FIG. 9 shows exemplary embodiments wherein genome editing agents were selectively delivered to hematopoietic stem cells using eVLPs comprising a targeting protein conjugated to a VSVGmut, a mutated version of the fusogen VSVG (K47Q, R354A) with impaired binding affinity for its natural receptor but with retained fusogenic activity. This fusogen is displayed on v4 eVLP architecture in its binding active form. Here the targeting
protein corresponds to a ligand that binds a surface receptor on HSPCs. Exemplary targeting proteins tested include TPO, SCF, CXCL12, and F35.
[0036] FIG. 10 shows a plot of the percentage of reads with the desired A>G edit at position 7 in the BCE11A +58kb enhancer in hCD34+ cells as a function of eVEPs with 50 different targeting architectures. To measure the editing efficiency, eVEPs were engineered to contain an adenine base editor (e.g., ABE8e) and a sgRNA (e.g., A>G edits at position 7 of BCE11A protospacer) as cargo.
[0037] FIG.l 1 shows additional eVEP architectures to display the targeting protein on the eVEP surface, as contemplated herein. As shown in the figure, targeting proteins may be displayed on eVEP surfaces through various transmembrane domains fused to an inert stalk domain which serves as a spacer separating the transmembrane domain from the targeting domain thus allowing access to bind membrane proximal receptors on target cells.
Exemplary inert stalks, as shown, include CD8alpha and IgG.
[0038] FIG. 12A shows the use of wild type (WT) VSVG in a fusion with the targeting proteins (e.g., as opposed to the VSVGmut). Constructs comprising the pCMV-TPO-VSVG and pCMV-SCF-VSVG exhibited 15% and 10% of the editing efficiency of WT VSVG v4 eVLPs in human CD34+ cells, respectively, with no statistically significant loss in cell viability compared to VSVG-eVLPs. Constructs comprising an adenine base editor were validated by observing A>G editing at position 7 of BCL11 A protospacer.
[0039] FIG. 12B shows the viability of CD34+ cells following treatment with targeted- eVLPs as described in FIG. 7.
[0040] FIG. 13A shows an illustration of an exemplary barcoded lentivirus platform for testing viral targeting proteins in a high-throughput, pooled manner. In this screen, HIV 1 lentivirus is produced in an arrayed format (typically 96 w format) by transfecting HEK17 producer cells with pCMV- VSVGmut, psPAX2 (lentiviral packaging plasmid), a barcoded lentiviral genome containing a predefined NNNNNNNNNNNNNNNNNNNN barcode in addition to pCMV-EGFP-P2A-PuroR. FIG. 13B shows an illustration of an exemplary assay used to validate the ability of targets identified from the lentiviral screen to delivery eVEPs to target cells.
[0041] FIG. 14A shows the sequence of exemplary construct pJAQ218 identified during the lentiviral screen. Two barcodes are assigned to each targeting ligand or combination of ligands involved in the screen. FIG. 14B shows the results from an exemplary lentiviral screen using CD34+ cells. The reads assigned to each barcode are plotted in a scatterplot
with the hits defined in the upper right quadrant. The soundness of the screen can be ascertained from both the separation of the positive and negative controls (VSV-G and VSV- Gmut here) and the correlation between degenerate barcodes (distinct barcode sequences corresponding to the same targeting ligand). gDNA reads per targeting construct plotted in a scatterplot with the hits defined in the upper right quadrant. .FIGs. 14C and 14D show a plot of the reads assigned to each barcode normalized to the cDNA and gDNA, respectively. FIG. 14D shows a plot of the reads assigned to each barcode normalized to the ratio of the gDNA/cDNA. The color of the dot represents the sum of the cDNA reads between the two barcodes assigned to a single construct. This gives information on production titer achievable for a given construct.
[0042] FIG. 15 shows the results from an exemplary validation study performed using Base-editing eVLPs bearing one or more exemplary candidate targeting proteins identified using the lentiviral screen shown in FIG. 13. BE-eVLPs were screened for their ability to induce an A«T to G*C base edit in the BCL11A gene in CD34+ cells in vitro.
[0043] FIG. 16 shows the results from an exemplary validation study performed using Prime editing eVLPs (PE-eVLPs) bearing pJAQ218, which is a targeting protein identified using the lentiviral screen shown in FIG. 13. eVLP constructs used the V3 and V3b prime editor architectures. PE-eVLPs were screened for their ability to recode a 5bp substitution in the HEK gene in CD34+ cells.
[0044] FIG. 17 shows an exemplary eVLP construct comprising (i) a first fusion protein comprising a first targeting domain, a stalk domain, and a transmembrane domain, (ii) a second fusion protein comprising a second targeting domain, a stalk domain, and a transmembrane domain, and (iii) a mutated Cocal envelope glycoprotein domain. The first targeting domain is different than the second targeting domain.
[0045] FIG.18A shows a scatter plot of the reads assigned to each barcode plotted with the hits defined in the upper right quadrant. The screen was performed using lentiviruses comprisng a mutant cocal glycoenvelope protein. FIG. 18B shows a plot of the reads, normalized to the cDNA, for the data provided in FIG. 18 A.
[0046] FIGs. 19A and 19B shows the results from another exemplary lentiviral screen testing a different array of targeting proteins and VSV-Gmut against CD34+ cells. FIG. 19A shows the reads assigned to each barcode from gDNA; whereas FIG. 19B shows the reads assigned to each barcode from gDNA normalized to the cDNA.
DEFINITIONS
[0047] Unless defined otherwise, all technical and scientific terms used herein have the meaning commonly understood by a person skilled in the art to which this invention belongs. The following references provide one of skill with a general definition of many of the terms used in this invention: Singleton et al., Dictionary of Microbiology and Molecular Biology (2nd ed. 1994); The Cambridge Dictionary of Science and Technology (Walker ed., 1988); The Glossary of Genetics, 5th Ed., R. Rieger et al. (eds.), Springer Verlag (1991); and Hale & Marham, The Harper Collins Dictionary of Biology (1991). As used herein, the following terms have the meanings ascribed to them unless specified otherwise.
Base editors
[0048] The term “base editor (BE)” refers to an agent comprising a polypeptide that is capable of making a modification to a base (e.g., A, T, C, G, or U) within a nucleic acid sequence (e.g., DNA or RNA) that converts one base to another (e.g., A to G, A to C, A to T, C to T, C to G, C to A, G to A, G to C, G to T, T to A, T to C, or T to G). In some embodiments, the base editor is capable of deaminating a base within a nucleic acid such as a base within a DNA molecule. In the case of an adenosine base editor, the base editor is capable of deaminating an adenine (A) in DNA. Such base editors may include a nucleic acid programmable DNA binding protein (napDNAbp) fused to an adenosine deaminase. Some base editors include CRISPR-mediated fusion proteins that are utilized in the base editing methods described herein. In some embodiments, the base editor comprises a nucleaseinactive Cas9 (dCas9) fused to a deaminase which binds a nucleic acid in a guide RNA- programmed manner via the formation of an R-loop, but does not cleave the nucleic acid. For example, the dCas9 domain of the fusion protein may include a D10A and a H840A mutations described in PCT/US2016/058344, which published as WO 2017/070632 on April 27, 2017, and is incorporated herein by reference. The DNA cleavage domain of S. pyogenes Cas9 includes two subdomains, the HNH nuclease subdomain and the RuvCl subdomain. The HNH subdomain cleaves the strand complementary to the gRNA (the “targeted strand,” or the strand in which editing or deamination occurs), whereas the RuvCl subdomain cleaves the non-complementary strand containing the PAM sequence (the “non-edited strand”). The RuvCl mutant D10A generates a nick in the targeted strand, while the HNH mutant H840A generates a nick on the non-edited strand (see Jinek et al., Science, 337:816-821(2012); Qi et al., Cell. 28; 152(5): 1173-83 (2013)). In some embodiments, a base editor comprises a Cas9 nickase (nCas9) that comprises only one of the D10A or the H840A mutations.
[0049] In some embodiments, a base editor is a macromolecule or macromolecular complex that results primarily (e.g., more than 80%, more than 85%, more than 90%, more than 95%, more than 99%, more than 99.9%, or 100%) in the conversion of a base in a polynucleotide sequence into another base (i.e., a transition or transversion) using a combination of 1) a nucleotide-, nucleoside-, or base-modifying enzyme and 2) a nucleic acid binding protein that can be programmed to bind to a specific nucleic acid sequence.
[0050] In some embodiments, the base editor comprises a DNA binding domain (e.g., a programmable DNA binding domain, such as a dCas9 or nCas9) that directs it to a target sequence. In some embodiments, the base editor comprises a base modification domain fused to a programmable DNA binding domain (e.g., dCas9 or nCas9). The terms “base modifying enzyme” and “base modification domain,” which are used interchangeably herein, refer to an enzyme that can modify a base and convert one base to another (e.g., a deaminase, such as a cytidine deaminase or an adenosine deaminase). The base modifying enzyme of the base editor may target cytosine (C) bases in a nucleic acid sequence and convert the C to a thymine (T) base. In some embodiments, C to T editing is carried out by a deaminase, e.g., a cytidine deaminase. In some embodiments, A to G editing is carried out by a deaminase, e.g., an adenosine deaminase. Base editors that can carry out other types of base conversions (e.g., C to G) are also contemplated.
[0051] In some embodiments, a base editor converts a C to a T. In some embodiments, the base editor comprises a cytosine deaminase. A “cytosine deaminase”, or “cytidine deaminase,” refers to an enzyme that catalyzes the chemical reaction “cytosine + H2O
uracil + NH3” or “5-methyl-cytosine + H2O
thymine + NH3.” As may be apparent from the reaction formula, such chemical reactions result in a C to U/T base change. In the context of a gene, such a nucleotide change, or mutation, may in turn lead to an amino acid change in the protein, which may affect the protein’s function, e.g., loss-of-function or gain-of-function. In some embodiments, the C to T base editor comprises a dCas9 or nCas9 fused to a cytidine deaminase. In some embodiments, the cytidine deaminase domain is fused to the N-terminus of the dCas9 or nCas9. In some embodiments, the base editor further comprises a domain that inhibits uracil glycosylase, and/or a nuclear localization signal. Such base editors have been described in the art, e.g., in Rees & Liu, Nat. Rev. Genet. 2018;19(12):770-788 and Koblan et al., Nat. Biotechnol. 2018;36(9):843-846; as well as U.S. Patent Publication No.
2018/0073012, U.S. Patent Publication No. 2017/0121693, PCT Publication No. WO 2017/070633, U.S. Patent Publication No. 2015/0166980, U.S. Patent No. 9,840,699, U.S.
Patent No. 10,077,453, PCT Publication No. WO 2019/023680, PCT Publication No. WO 2018/0176009, PCT Application No PCT/US2019/033848, PCT Application No.
PCT/US2019/47996, PCT Application No. PCT/US2019/049793, PCT Application No. PCT/US2020/028568, PCT Application No. PCT/US2019/61685, PCT Application No. PCT/US2019/57956, and PCT Application No. PCT/US2019/58678, each of which is incorporated herein by reference.
[0052] In some embodiments, a base editor converts an A to a G. In some embodiments, the base editor comprises an adenosine deaminase. An “adenosine deaminase” is an enzyme involved in purine metabolism. An adenosine deaminase catalyzes hydrolytic deamination of adenosine (forming inosine, which base pairs as G) in the context of DNA. There are no known natural adenosine deaminases that act on DNA. Instead, known adenosine deaminase enzymes only act on RNA (tRNA or mRNA). Evolved deoxyadenosine deaminase enzymes that accept DNA substrates and deaminate dA to deoxyinosine have been described, e.g., in PCT Application PCT/US2017/045381, filed August 3, 2017, which published as WO 2018/027078, PCT Application No. PCT/US2019/033848, which published as WO 2019/226953, PCT Application No PCT/US2019/033848, filed May 23, 2019, and PCT Patent Application No. PCT/US2020/028568, filed April 17, 2020; each of which is incorporated herein by reference.
[0053] Exemplary adenosine and cytidine base editors are also described in Rees & Liu, Base editing: precision chemistry on the genome and transcriptome of living cells, Nat. Rev. Genet. 2018;19(12):770-788; as well as U.S. Patent Publication No. 2018/0073012, U.S. Patent Publication No. 2017/0121693, PCT Publication No. WO 2017/070633, U.S. Patent Publication No. 2015/0166980, U.S. Patent No. 9,840,699, and U.S. Patent No. 10,077,453, each of which is incorporated herein by reference.
Cas9
[0054] The term “Cas9” or “Cas9 nuclease” refers to an RNA-guided nuclease comprising a Cas9 domain, or a fragment thereof (e.g., a protein comprising an active or inactive DNA cleavage domain of Cas9, and/or the gRNA binding domain of Cas9). A “Cas9 domain,” as used herein, is a protein fragment comprising an active or inactive cleavage domain of Cas9 and/or the gRNA binding domain of Cas9. A “Cas9 protein” is a full length Cas9 protein. A Cas9 nuclease is also referred to sometimes as a casnl nuclease or a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat)-associated nuclease. CRISPR is an adaptive immune system that provides protection against mobile genetic elements (viruses,
transposable elements, and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems, correct processing of pre-crRNA requires a trans-encoded small RNA (tracrRNA), endogenous ribonuclease 3 (me), and a Cas9 domain. The tracrRNA serves as a guide for ribonuclease 3-aided processing of pre-crRNA. Subsequently, Cas9/crRNA/tracrRNA endo-nucleolytically cleaves a linear or circular dsDNA target complementary to the spacer. The target strand not complementary to crRNA is first cut endonucleolytically, then trimmed 3'-5' exonucleolytically. In nature, DNA-binding and cleavage typically requires protein and both RNAs. However, single guide RNAs (“sgRNA”, or simply “gRNA”) can be engineered so as to incorporate aspects of both the crRNA and tracrRNA into a single RNA species. See, e.g., Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. Science 337:816-821(2012), which is incorporated herein by reference. Cas9 recognizes a short motif in the CRISPR repeat sequences (the PAM or protospacer adjacent motif) to help distinguish self versus non-self. Cas9 nuclease sequences and structures are well known to those of skill in the art (see, e.g., “Complete genome sequence of an Ml strain of Streptococcus pyogenes.” Ferretti et al., J.J., McShan W.M., Ajdic D.J., Savic D.J., Savic G., Lyon K., Primeaux C., Sezate S., Suvorov A.N., Kenton S., Lai H.S., Lin S.P., Qian Y., Jia H.G., Najar E.Z., Ren Q., Zhu H., Song L., White J., Yuan X., Clifton S.W., Roe B.A., McLaughlin R.E., Proc. Natl. Acad. Sci. U.S.A. 98:4658- 4663(2001); “CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.” Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E., Nature 471:602-607(2011); and “A programmable dual- RNA-guided DNA endonuclease in adaptive bacterial immunity.” Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. Science 337:816-821(2012), each of which is incorporated herein by reference). Cas9 orthologs have been described in various species, including, but not limited to, S. pyogenes and 5. thermophilus. Additional suitable Cas9 nucleases and sequences will be apparent to those of skill in the art based on this disclosure, and such Cas9 nucleases and sequences include Cas9 sequences from the organisms and loci disclosed in Chylinski, Rhun, and Charpentier, “The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems” (2013) RNA Biology 10:5, 726-737; which is incorporated herein by reference. In some embodiments, a Cas9 nuclease comprises one or more mutations that partially impair or inactivate the DNA cleavage domain.
[0055] A nuclease-inactivated Cas9 domain may interchangeably be referred to as a “dCas9” protein (for nuclease-“dead” Cas9). Methods for generating a Cas9 domain (or a fragment thereof) having an inactive DNA cleavage domain are known (see, e.g., Jinek et al., Science. 337:816-821(2012); Qi et al., “Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression” (2013) Cell. 28; 152(5): 1173-83, the entire contents of each of which are incorporated herein by reference). For example, the DNA cleavage domain of Cas9 is known to include two subdomains, the HNH nuclease subdomain and the RuvCl subdomain. The HNH subdomain cleaves the strand complementary to the gRNA, whereas the RuvCl subdomain cleaves the non-complementary strand. Mutations within these subdomains can silence the nuclease activity of Cas9. For example, the mutations D10A and H840A completely inactivate the nuclease activity of S. pyogenes Cas9 (Jinek et al., Science. 337:816-821(2012); Qi et al., Cell. 28; 152(5): 1173-83 (2013)). In some embodiments, proteins comprising Cas9 or fragments thereof are referred to as “Cas9 variants.” A Cas9 variant shares homology to Cas9, or a fragment thereof. For example, a Cas9 variant is at least about 70% identical, at least about 80% identical, at least about 90% identical, at least about 95% identical, at least about 96% identical, at least about 97% identical, at least about 98% identical, at least about 99% identical, at least about 99.5% identical, at least about 99.8% identical, at least about 99.9% or 100% identical to a wild type Cas9. In some embodiments, the Cas9 variant may have 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 21, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, or more amino acid changes compared to wild type Cas9. Fusion protein
[0056] The term “fusion protein,” as used herein, refers to a hybrid polypeptide that comprises protein domains from at least two different proteins. One protein may be located at the amino-terminal (N-terminal) portion of the fusion protein or at the carboxy-terminal (C- terminal) protein thus forming an “amino-terminal fusion protein” or a “carboxy-terminal fusion protein,” respectively. A protein may comprise different domains, for example, a nucleic acid binding domain (e.g., the gRNA binding domain of Cas9 that directs the binding of the protein to a target site) and a nucleic acid cleavage domain or a catalytic domain of a nucleic-acid editing protein. Other examples include fusion of a Cas9 or equivalent thereof to a deaminase (as in a base editor) or to a polymerase, such as a reverse transcriptase (as in a prime editor). Any of the fusion proteins provided herein may be produced by any method known in the art. For example, the fusion proteins provided herein may be produced via
recombinant protein expression and purification, which is especially suited for fusion proteins comprising a peptide linker. Methods for recombinant protein expression and purification are well known, and include those described by Green and Sambrook, Molecular Cloning: A Laboratory Manual (4th ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (2012)), which is incorporated herein by reference.
Group- specific antigen (gag)
[0057] Without being limited by theory, and in the context of typical envelope virus lifecycle, Gag is the primary structural protein responsible for orchestrating the majority of steps in viral assembly, including budding out of fully-formed enveloped virions having an (i) envelope (comprising a lipid membrane formed from cell membrane during budding out, and one or more glycoproteins inserted therein), and (ii) a capsid, which is the internal protein shell. Most of these assembly steps occur via interactions with three Gag subdomains - matrix (MA), capsid (CA), and nucleocapsid. These three regions have a low level of sequence conservation among the different retroviral genera, which belies the observed high level of structural conservation. Outside of these three domains, Gag proteins can vary widely. For example, HIV-1 Gag additionally codes for a C-terminal p6 protein as well as two spacer proteins, SP1 and SP2, which demarcate the CA-NC and NC-p6 junctions, but HTLV-1 contains no additional sequences outside of MA, CA, and NC (Oroszlan and Copeland, 1985; Henderson et al., 1992).
[0058] Gag is also referred to as a “viral structural protein.” As used herein, the term “viral structural protein” refers to viral proteins that contribute to the overall structure of the capsid protein or of the protein core of a virus. The term “viral structural protein” further includes functional fragments or derivatives of such viral protein contributing to the structure of a capsid protein or of the protein core of a virus. An example of viral structural protein is MMLV Gag. The viral membrane fusion proteins are not considered as viral structural proteins. Typically, said viral structural proteins are localized inside the core of the virus. [0059] In some embodiments, the gag protein used in the eVLPs described herein (including the viral nucleocapsid portion) comprises the sequence of SEQ ID NO: 405, or a sequence at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% identical to the sequence of SEQ ID NO: 405:
[0060] MGQTVTTPLSLTLGHWKDVERIAHNQSVDVKKRRWVTFCSAEWPTFNV GWPRDGTFNRDLITQVKIKVFSPGPHGHPDQVPYIVTWEALAFDPPPWVKPFVHPKP
PPPLPPSAPSLPLEPPRSTPPRSSLYPALTPSLGAKPKPQVLSDSGGPLIDLLTEDPPPYR DPRPPPSDRDGNGGEATPAGEAPDPSPMASRLRGRREPPVADSTTSQAFPLRAGGNG QLQYWPFSSSDLYNWKNNNPSFSEDPGKLTALIESVLITHQPTWDDCQQLLGTLLTG EEKQRVEEEARKAVRGDDGRPTQEPNEVDAAFPEERPDWDYTTQAGRNHEVHYRQ EEEAGEQNAGRSPTNEAKVKGITQGPNESPSAFEEREKEAYRRYTPYDPEDPGQETN VSMSFIWQSAPDIGRKEEREEDEKNKTEGDEVREAEKIFNKRETPEEREERIRRETEE KEERRRTEDEQKEKERDRRRHREMSKEEATVVSGQKQDRQGGERRRSQEDRDQCA YCKEKGHWAKDCPKKPRGPRGPRPQTSEETEDD (SEQ ID NO: 405)
Group- specific antigen (gag) nuclcocapsid protein
[0061] The term “group -specific antigen nuclcocapsid protein” or “gag nuclcocapsid protein” refers to a protein that makes up the core structural component of the inner shell of many viruses, including retroviruses. The gag nuclcocapsid proteins used in the VEPs of the present disclosure may be an MMLV gag nuclcocapsid protein, an FMLV gag nuclcocapsid protein, or a nuclcocapsid protein from any other virus that produces such proteins.
Group- specific antigen (gag) protease (pro) polyprotein
[0062] A “group-specific antigen (gag) protease (pro) polyprotein” or “gag-pro polyprotein” refers to a gag nuclcocapsid protein further comprising a viral protease linked thereto. Gag -pro polyproteins mediate proteolytic cleavage of gag and gag-pol polyproteins or nuclcocapsid proteins during or shortly after the release of a virion from the plasma membrane. In the VLPs described herein, the protease of a gag-pro polyprotein is responsible for cleaving a cleavable linker in the fusion protein to release a cargo protein (such as a base editor or prime editor) following delivery of the VLP to a target cell. In some embodiments, a gag-pro polyprotein is an MMLV gag-pro polyprotein or an FMLV gag-pro polyprotein.
Guide RNA (“gRNA”)
[0063] As used herein, the term “guide RNA” is a particular type of guide nucleic acid which is mostly commonly associated with a Cas protein of a CRISPR-Cas9 and which associates with Cas9, directing the Cas9 protein to a specific sequence in a DNA molecule that includes complementarity to the protospacer sequence of the guide RNA. However, this term also embraces the equivalent guide nucleic acid molecules that associate with Cas9 equivalents, homologs, orthologs, or paralogs, whether naturally occurring or non-naturally occurring (e.g., engineered or recombinant), and which otherwise program the Cas9 equivalent to localize to a specific target nucleotide sequence. The Cas9 equivalents may
include other napDNAbp from any type of CRISPR system (e.g., type II, V, VI), including Cpfl (a type-V CRISPR-Cas system), C2cl (a type V CRISPR-Cas system), C2c2 (a type VI CRISPR-Cas system), and C2c3 (a type V CRISPR-Cas system). Further Cas-equivalents are described in Makarova et al., “C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector,” Science 2016; 353(6299), which is incorporated herein by reference.
[0064] A guide RNA is a particular type of guide nucleic acid that is most commonly associated with a Cas protein of a CRISPR-Cas9 and which associates with Cas9, directing the Cas9 protein to a specific sequence in a DNA molecule that includes complementarity to the protospacer sequence for the guide RNA. Functionally, guide RNAs associate with Cas9, directing (or programming) the Cas9 protein to a specific sequence in a DNA molecule that includes a sequence complementary to the protospacer sequence for the guide RNA. A gRNA is a component of the CRISPR/Cas system. Typically, a guide RNA comprises a fusion of a CRISPR-targeting RNA (crRNA) and a trans-activation crRNA (tracrRNA), providing both targeting specificity and scaffolding/binding ability for Cas9 nuclease. A “crRNA” is a bacterial RNA that confers target specificity and requires tracrRNA to bind to Cas9. A “tracrRNA” is a bacterial RNA that links the crRNA to the Cas9 nuclease and typically can bind any crRNA. The sequence specificity of a Cas DNA-binding protein is determined by gRNAs, which have nucleotide base-pairing complementarity to target DNA sequences. The native gRNA comprises a 20 nucleotide (nt) Specificity Determining Sequence (SDS), or spacer, which specifies the DNA sequence to be targeted, and is immediately followed by an 80 nt scaffold sequence, which associates the gRNA with Cas9. In some embodiments, the 80nt scaffold sequence comprises any one of the following sequences:
[0065] Sp Flipped:
GTTTAAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA AAAAGTGGCACCGAGTCGGTGC (SEQ ID NO: 388)
[0066] Sp Extended:
GTTTTAGAGCTATGCTGGAAACAGCATAGCAAGTTTAAATAAGGCTAGTCCGTTA TCAACTTGAAAAAGTGGCACCGAGTCGGTGC (SEQ ID NO: 389)
[0067] Sp F&E:
GTTTAAGAGCTATGCTGGAAACAGCATAGCAAGTTTAAATAAGGCTAGTCCGTTA TCAACTTGAAAAAGTGGCACCGAGTCGGTGC (SEQ ID NO: 390)
[0068] Sauri 76:
GTTTTAGTACTCTGGAAACAGAATCTACTAAAACAAGGCAAAATGCCGTGTTTAT CTCGTCAACTTGTTGGCGAGA (SEQ ID NO: 391) [0069] Sauri 84:
GTTTTAGTACTCTGTAATGAAAATTACAGAATCTACTAAAACAAGGCAAAATGCC GTGTTTATCTCGTCAACTTGTTGGCGAGA (SEQ ID NO: 392) [0070] eNme2 121: GTTGTAGCTCCCTTTCTCATTTCGGAAACGAAATGAGAACCGTTGCTACAATAAG GCCGTCTGAAAAGATGTGCCGCAACGCTCTGCCCCTTAAAGCTTCTGCTTTAAGG GGCATCGTTTA (SEQ ID NO: 393) [0071] eNme279: GTTGTAGCTCCCGAAACGTTGCTACAATAAGGCCGTCTGAAAAGACGTGCCGCA ACGCTCTGCCTTCTGGCATCGTTTA (SEQ ID NO: 394)
[0072] In some embodiments, the 80 nt scaffold sequence comprises a nucleic acid sequence that is at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5%, at least 99.8%, or 100% identical to any one of the nucleic acid sequences of SEQ ID NO:s: 388-394. [0073] In some embodiments, an SDS spacer of the present disclosure has a length of 15 to 100 nucleotides, or more. For example, an SDS spacer may have a length of 15 to 90, 15 to 85, 15 to 80, 15 to 75, 15 to 70, 15 to 65, 15 to 60, 15 to 55, 15 to 50, 15 to 45, 15 to 40, 15 to 35, 15 to 30, or 15 to 20 nucleotides. In some embodiments, the SDS is 20 nucleotides long. For example, the SDS may be 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25 nucleotides long.
At least a portion of the target DNA sequence is complementary to the SDS of the gRNA. For Cas9 to successfully bind to the DNA target sequence, a region of the target sequence is complementary to the SDS of the gRNA sequence and is immediately followed by the correct protospacer adjacent motif (PAM) sequence (e.g., NGG for Cas9 and TTN, TTTN, or YTN for Cpfl). In some embodiments, an SDS is 100% complementary to its target sequence. In some embodiments, the SDS sequence is less than 100% complementary to its target sequence and is, thus, considered to be partially complementary to its target sequence. For example, a targeting sequence may be 99%, 98%, 97%, 96%, 95%, 94%, 93%, 92%, 91%, or 90% complementary to its target sequence. In some embodiments, the SDS of template DNA or target DNA may differ from a complementary region of a gRNA by 1, 2, 3, 4, or 5 nucleotides.
[0074] In some embodiments, the guide RNA is about 15-120 nucleotides long and comprises a sequence of at least 10 contiguous nucleotides that is complementary to a target sequence. In some embodiments, the guide RNA is 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,
26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50,
51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75,
76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 97, 98, 99, 100,
101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, or 120 nucleotides long. In some embodiments, the guide RNA comprises a sequence of 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, or more contiguous nucleotides that is complementary to a target sequence. Sequence complementarity refers to distinct interactions between adenine and thymine (DNA) or uracil (RNA), and between guanine and cytosine. [0075] As used herein, the terms “prime editing guide RNA” or “PEgRNA” or “extended guide RNA” refer to a specialized form of a guide RNA that has been modified to include one or more additional sequences for implementing the prime editing methods and compositions described herein. As described herein, the prime editing guide RNAs comprise one or more “extended regions” of nucleic acid sequence. The extended regions may comprise, but are not limited to, single- stranded RNA or DNA. Further, the extended regions may occur at the 3' end of a traditional guide RNA. In other arrangements, the extended regions may occur at the 5' end of a traditional guide RNA. In still other arrangements, the extended region may occur at an intramolecular region of the traditional guide RNA, for example, in the gRNA core region which associates and/or binds to the napDNAbp. The extended region comprises a “DNA synthesis template” which encodes (by the polymerase of the prime editor) a single- stranded DNA which, in turn, has been designed to be (a) homologous with the endogenous target DNA to be edited, and (b) which comprises at least one desired nucleotide change (e.g., a transition, a transversion, a deletion, or an insertion) to be introduced or integrated into the endogenous target DNA. The extended region may also comprise other functional sequence elements, such as, but not limited to, a “primer binding site” and a “spacer or linker” sequence, or other structural elements, such as, but not limited to, aptamers, stem loops, hairpins, toe loops (e.g., a 3' toeloop), or an RNA-protein recruitment domain (e.g., MS2 hairpin). As used herein, the “primer binding site” comprises a sequence that hybridizes to a single-strand DNA sequence having a 3 end generated from the nicked DNA of the R-loop.
[0076] In certain embodiments, the PEgRNAs have a 5' extension arm, a spacer, and a gRNA core. The 5' extension further comprises in the 5' to 3' direction a reverse transcriptase template, a primer binding site, and a linker. The reverse transcriptase template may also be referred to more broadly as the “DNA synthesis template” where the polymerase of a prime editor described herein is not an RT, but another type of polymerase.
[0077] In certain other embodiments, the PEgRNAs have a 5' extension arm, a spacer, and a gRNA core. The 5' extension further comprises in the 5' to 3' direction a reverse transcriptase template, a primer binding site, and a linker. The reverse transcriptase template may also be referred to more broadly as the “DNA synthesis template” where the polymerase of a prime editor described herein is not an RT, but another type of polymerase.
[0078] In still other embodiments, the PEgRNAs have in the 5' to 3' direction a spacer (1), a gRNA core (2), and an extension arm (3). The extension arm (3) is at the 3' end of the PEgRNA. The extension arm (3) further comprises in the 5' to 3' direction a “primer binding site” (A), an “edit template” (B), and a “homology arm” (C). The extension arm (3) may also comprise an optional modifier region at the 3' and 5' ends, which may be the same sequences or different sequences. In addition, the 3' end of the PEgRNA may comprise a transcriptional terminator sequence. These sequence elements of the PEgRNAs are further described and defined herein.
[0079] In still other embodiments, the PEgRNAs have in the 5' to 3' direction an extension arm (3), a spacer (1), and a gRNA core (2). The extension arm (3) is at the 5' end of the PEgRNA. The extension arm (3) further comprises in the 3' to 5' direction a “primer binding site” (A), an “edit template” (B), and a “homology arm” (C). The extension arm (3) may also comprise an optional modifier region at the 3' and 5' ends, which may be the same sequences or different sequences. The PEgRNAs may also comprise a transcriptional terminator sequence at the 3' end. These sequence elements of the PEgRNAs are further described and defined herein.
Linkers
[0080] The term “linker,” as used herein, refers to a molecule linking two other molecules or moieties. The linker can be an amino acid sequence in the case of a linker joining two fusion proteins. For example, a Cas9 can be fused to a deaminase (e.g., an adenosine deaminase or a cytosine deaminase) by an amino acid linker sequence. A Cas9 can be fused to a reverse transcriptase by an amino acid linker sequence. The linker can also be a nucleotide sequence in the case of joining two nucleotide sequences together (e.g., in a
gRNA). In other embodiments, the linker is an organic molecule, group, polymer, or chemical moiety. In some embodiments, the linker is 5-200 amino acids in length, for example, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 30-35, 35-40, 40-45, 45-50, 50-60, 60-70, 70-80, 80-90, 90-100, 100-150, or 150-200 amino acids in length. Longer or shorter linkers are also contemplated.
[0081] The protease cleavage site may be any known in the art, or any sequence yet to be discovered, so long as the corresponding protease may be co-packaged in the VLPs to allow for post-maturation cleavage within the mature VLP particles. Such cleavage sites and their corresponding proteases include but are not limited to: (a) granzyme A, which recognizes and cleaves a sequence comprising ASPRAGGK (SEQ ID NO: 339), (b) granzyme B, which recognizes and cleaves a sequence comprising YEADSLEE (SEQ ID NO: 340), (c) granzyme K, which recognizes and cleaves a sequence comprising YQYRAL (SEQ ID NO: 341), or (d) Cathepsin D, which recognizes and cleaves a sequence comprising LGVLIV (SEQ ID NO: 342). Many other combinations of specific proteases and protease cleavage sites may be used in connection with the present disclosure by co-packing a specific protease during the VLP manufacture process. Such proteases can include, without limitation, Arg-C proteinase, Asp- N Endopeptidase, Caspase 1, Caspase 2, Caspase 3, Caspase 4, Caspase 5, Caspase 7, Caspase 8, Caspase 9, Caspase 10, Chymotrypsin, Clostripain, Enterokinase, Factor Xa, Glutamyl endopeptidase, Granzyme B, Neutrophil elastase, Pepsin, Prolyl-endopeptidase, Proteinase K, Staphylococcal peptidase I, Thermolysin, Thrombin, and Trypsin. Any protease paired with its cognate recognition sequence may be used in the present disclosure proteasesensitive linkers, including any serine protease, cysteine protease, aspartic protease, threonine protease, glutamic protease, metalloprotease, or asparagine peptide lyase (which constitute major classifications of known proteases). The specific protease cleavage sites for said enzymes are well-known in the art and may be utilized in the linkers herein to provide protease-susceptible linkers. napDNAbp
[0082] As used herein, the term “nucleic acid programmable DNA binding protein” or “napDNAbp,” of which Cas9 is an example, refers to a protein that uses RNA:DNA hybridization to target and bind to specific sequences in a DNA molecule. Each napDNAbp is associated with at least one guide nucleic acid (e.g., guide RNA), which localizes the napDNAbp to a DNA sequence that comprises a DNA strand (i.e., a target strand) that is complementary to the guide nucleic acid, or a portion thereof (e.g., the protospacer of a guide
RNA). In other words, the guide nucleic-acid “programs” the napDNAbp (e.g., Cas9 or equivalent) to localize and bind to a complementary sequence.
[0083] Without being bound by theory, the binding mechanism of a napDNAbp - guide RNA complex, in general, includes the step of forming an R-loop whereby the napDNAbp induces the unwinding of a double-strand DNA target, thereby separating the strands in the region bound by the napDNAbp. The guide RNA protospacer then hybridizes to the “target strand.” This displaces a “non-target strand” that is complementary to the target strand, which forms the single strand region of the R-loop. In some embodiments, the napDNAbp includes one or more nuclease activities, which then cut the DNA, leaving various types of lesions.
For example, the napDNAbp may comprise a nuclease activity that cuts the non-target strand at a first location, and/or cuts the target strand at a second location. Depending on the nuclease activity, the target DNA can be cut to form a “double- stranded break” whereby both strands are cut. In other embodiments, the target DNA can be cut at only a single site, i.e., the DNA is “nicked” on one strand. Exemplary napDNAbp with different nuclease activities include “Cas9 nickase” (“nCas9”) and a deactivated Cas9 having no nuclease activities (“dead Cas9” or “dCas9”). Exemplary sequences for these and other napDNAbp are provided herein.
Nuclear export sequence (NES)
[0084] The term “nuclear export sequence” or “NES” refers to an amino acid sequence that promotes transport of a protein out of the cell nucleus to the cytoplasm, for example, through the nuclear pore complex by nuclear transport. Nuclear export sequences are known in the art and would be apparent to the skilled artisan. For example, NES sequences are described in Xu, D. et al. Sequence and structural analyses of nuclear export signals in the NESdb database. Mol Biol. Cell. 2012, 23(18) 3677-3693, the contents of which are incorporated herein by reference. Exemplary NES include, but are not limited to, the following:
[0085] MEELSQALASSFSV SEQ ID NO: 406
[0086] PLQLPPLERLTL SEQ ID NO: 407
[0087] NELALKLAGLDI SEQ ID NO: 408
[0088] ERFEMFRELNEALEL SEQ ID NO: 409
[0089] DHAEKVAEKLEALSV SEQ ID NO: 410
[0090] QLVEELLKIICAFQL SEQ ID NO: 411
[0091] TNLEALQKKLEELEL SEQ ID NO: 412
[0092] DVKEEMTSALATMRV SEQ ID NO: 413
[0093] STNGSLAAEFRHLQL SEQ ID NO: 414
[0094] PSVQELTEQIHRLLM SEQ ID NO: 415
[0095] MNFKELKDFLKELNI SEQ ID NO: 416
[0096] ENFEILMKLKESLEL SEQ ID NO: 417
[0097] FETVYELTKMCTIR SEQ ID NO: 418
[0098] SGKASSSLGLQDFDL SEQ ID NO: 419
[0099] PKYSDIDVDGLCSEL SEQ ID NO: 420
[00100] VDLACTPTDVRDVDI SEQ ID NO: 893
[00101] YGEKTTQRDLTELEI SEQ ID NO: 421
[00102] RRIYDITNVLEGIGL SEQ ID NO: 422
[00103] AKIIPYSGLLLVITV SEQ ID NO: 423
[00104] LRSEEVHWLHVDMGV SEQ ID NO: 424
[00105] LQSEEVHWLHLDMGV SEQ ID NO: 425
[00106] LQVRKYSLDLASLIL SEQ ID NO: 426
[00107] AGVEAIIRILQQLLF SEQ ID NO: 427
[00108] TGVEALIRILQQLLF SEQ ID NO: 428
[00109] IVLNQLCVRFFGLDL SEQ ID NO: 429
[00110] SLGGFEITPPVVLRL SEQ ID NO: 430
[00111] EAIQDLCLAVEEVSL SEQ ID NO: 431
[00112] DELLQVLRMMVGVNI SEQ ID NO: 432
[00113] SVMLAVQEGIDLLTF SEQ ID NO: 433
[00114] LSSHFQELSI SEQ ID NO: 434
[00115] QSTHVDIRTLEDLLM SEQ ID NO: 435
[00116] ESSAEDLRTLQQLFL SEQ ID NO: 436
[00117] EFSLPTHHTVRLIRV SEQ ID NO: 437
[00118] MSSGYYLGEILRLAL SEQ ID NO: 438
[00119] DTVLDILRDFFELRL SEQ ID NO: 439
[00120] NSVNEILSEFYYVRL SEQ ID NO: 440
[00121] CAFLSVKKQFEELTL SEQ ID NO: 441
[00122] ISPEHVIQALESLGF SEQ ID NO: 442
[00123] AHWMRQLVSFQKLKL SEQ ID NO: 443
[00124] ATRELDELMASLSDF SEQ ID NO: 444
[00125] YQNIELITFINALKL SEQ ID NO: 445
[00126] FNATAVVRHMRKLQL SEQ ID NO: 446
[00127] SGIFGLVTNLEELEV SEQ ID NO: 447
[00128] EESYTLNSDLARLGV SEQ ID NO: 448
[00129] EESYDLTSHLARLGV SEQ ID NO: 449
[00130] GIQQAHAEQLANMRI SEQ ID NO: 450
[00131] DVKEEMTSALATMRV SEQ ID NO: 451
[00132] AAEPVILDLRDLFQL SEQ ID NO: 452
[00133] MEGCVSNLMV SEQ ID NO: 453
[00134] EGCVSNLMV SEQ ID NO: 454
[00135] DMDFLRNLFSQTLSL SEQ ID NO: 455
[00136] EQLLEIVHDLENLSL SEQ ID NO: 456
[00137] NVMKYFTDLFDYLPL SEQ ID NO: 457
[00138] KVYPIILRLGSNLSL SEQ ID NO: 458
[00139] YAGFSLPHAILRIDL SEQ ID NO: 459
[00140] EIVRDIKEKLCYVAL SEQ ID NO: 460
[00141] EAINKLESNLRELQI SEQ ID NO: 461
[00142] EAINKLENNLRELQI SEQ ID NO: 462
[00143] SDQKQEQLLLKKMYL SEQ ID NO: 463
[00144] KQVLWDRTFSLFQQL SEQ ID NO: 464
[00145] AQLQNLTKRIDSLPL SEQ ID NO: 465
[00146] NDENEHQLSLRTVSL SEQ ID NO: 466
[00147] ISFTEFVKVLEKVDV SEQ ID NO: 467
[00148] MESAITLWQFLLQL SEQ ID NO: 468
[00149] VPKELMQQIENFEKI SEQ ID NO: 469
[00150] QARFILEKIDGKIII SEQ ID NO: 470
[00151] QVKFIKMIIEKELTV SEQ ID NO: 471
[00152] NHRMKNLREISQLGI SEQ ID NO: 472
[00153] NHRVKKLNEISKLGI SEQ ID NO: 473
[00154] TEKHLQKYLRQDLRL SEQ ID NO: 474
[00155] RQERKRPLLDLHIEL SEQ ID NO: 475
[00156] ANMRIQDLKVSLKPL SEQ ID NO: 476
[00157] ATMRVDYEQIKIKKI SEQ ID NO: 477
[00158] LQGEEFVCLKSIILL SEQ ID NO: 478
[00159] THYGQKAILFLPLPV SEQ ID NO: 479
[00160] PSAHEITGLADSLQL SEQ ID NO: 480
[00161] VRLHDVLHSDKKLTL SEQ ID NO: 481
[00162] LINRNGELKLANFGL SEQ ID NO: 482
[00163] LEPLKKLECLKSLDL SEQ ID NO: 483
[00164] The NES examples above are not limiting. The fusion proteins delivered by the presently described VLPs may comprise any known NES sequence, including any of those described in Xu, D. et al. Sequence and structural analyses of nuclear export signals in the NESdb database. Mol. Biol. Cell. 2012, 23(18), 3677-3693; Fung, H. Y. J. et al. Structural determinants of nuclear export signal orientation in binding to exportin CRM1. eLife. 2015, 4:el0034; and Kosugi, S. et al. Nuclear Export Signal Consensus Sequences Defined Using a Localization-based Yeast Selection System. Traffic. 2008, 9(12), 2053-2062, each of which are incorporated herein by reference.
[00165] In various embodiments, the fusion proteins, constructs encoding the fusion proteins, and VLPs disclosed herein further comprise one or more, preferably, at least three nuclear export sequences. In certain embodiments, the fusion proteins comprise at least three NESs. In embodiments with at least three NESs, the NESs can be the same NESs or they can be different NESs. In certain other embodiments, the fusion proteins, constructs encoding the fusion proteins, and VLPs may comprise at least one, at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, at least ten, or more NESs. In general, the one or more NESs are of sufficient strength to drive accumulation of the VLP proteins (e.g., the Gag-cargo) in a detectable amount respectively in the cytoplasm of a producer cell.
[00166] The location of the NES fusion can be at the N-terminus, the C-terminus, or within a sequence of a fusion protein (e.g., inserted between the encoded napDNAbp component (e.g., Cas9) and the gag nucleocapsid protein). In certain embodiments, the NES (or multiple NESs, e.g., three NESs) are positioned between the napDNAbp and the gag nucleocapsid protein such that they can be cleaved from the napDNAbp upon delivery of the fusion protein to a target cell. NES sequences may preferably be joined to a fusion protein via a cleavable linker, such as protease-cleavable linker (e.g., the Gag-Pro-Pol). In this way, the
NES may be removed from the cargo protein after VLP maturation so that the cargo may be free to translocate to the nucleus once delivered to a recipient cell.
[00167] The NESs may be any known NES sequence in the art. The NESs may also be any future-discovered NESs for nuclear export. The NESs also may be any naturally-occurring NES, or any non-naturally occurring NES (e.g., an NES with one or more desired mutations). [00168] The term “nuclear export sequence” or “NES” refers to an amino acid sequence that promotes export of a protein from the cell nucleus, for example, by nuclear transport. Nuclear export sequences are known in the art and would be apparent to the skilled artisan. [00169] In one aspect of the disclosure, a base editor or other fusion protein may be modified with one or more nuclear export sequences (NES), preferably at least three NESs. In certain embodiments, the fusion proteins are modified with two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, or ten or more NESs. The disclosure contemplates the use of any nuclear export sequence known in the art at the time of the disclosure, or any nuclear export sequence that is identified or otherwise made available in the state of the art after the time of the instant filing. A representative nuclear export sequence is a peptide sequence that directs the protein out of the nucleus of the cell in which the sequence is expressed. NESs commonly contain hydrophobic amino acid residues in the sequence LXXXLXXLXL, where L is a hydrophobic residue (frequently leucine), and X represents any amino acid. Nuclear export sequences often comprise leucine residues.
[00170] The fusion proteins delivered by the VLPs described herein may also comprise nuclear export sequences that are linked through one or more linkers, e.g., a polymeric, amino acid, nucleic acid, polysaccharide, chemical, or nucleic acid linker element. The linkers within the contemplated scope of the disclosure are not intended to have any limitations and can be any suitable type of molecule (e.g., polymer, amino acid, polysaccharide, nucleic acid, lipid, or any synthetic chemical linker domain) and can be joined to the base editor by any suitable strategy that effectuates forming a bond (e.g., covalent linkage, hydrogen bonding) between the cargo protein and the one or more NESs. In some embodiments, the linker joining one or more NES and a cargo protein is a cleavable linker, as described further herein, such the one or more NES can be cleaved from the cargo protein, e.g., upon delivery of the cargo protein to a target cell.
Nuclear localization sequence (NLS)
[00171] The term “nuclear localization sequence” or “NLS” refers to an amino acid sequence that promotes import of a protein into the cell nucleus, for example, by nuclear transport. Nuclear localization sequences are known in the art and would be apparent to the skilled artisan. For example, NLS sequences are described in Plank et al., International PCT Application, PCT/EP2000/011690, filed November 23, 2000, published as WO/2001/038547 on May 31, 2001, the contents of which are incorporated herein by reference for its disclosure of exemplary nuclear localization sequences. In some embodiments, an NLS comprises the amino acid sequence PKKKRKV (SEQ ID NO: 484), MDSLLMNRRKFLYQFKNVRWAKGRRETYLC (SEQ ID NO: 485), KRTADGSEFESPKKKRKV (SEQ ID NO: 486), or KRTADGSEFEPKKKRKV (SEQ ID NO: 487). In other embodiments, NLS comprises the amino acid sequences NLSKRPAAIKKAGQAKKKK (SEQ ID NO: 488), PAAKRVKLD (SEQ ID NO: 489), RQRRNELKRSF (SEQ ID NO: 490), or NQSSNFGPMKGGNFGGRSSGPYGGGGQYFAKPRNQGGY (SEQ ID NO: 491).
[00172] In one aspect of the disclosure, a base editor, prime editor, or other fusion protein may be modified with one or more nuclear localization sequences (NLS), preferably at least two NLSs. In certain embodiments, the fusion proteins are modified with two or more NLSs. The disclosure contemplates the use of any nuclear localization sequence known in the art at the time of the disclosure, or any nuclear localization sequence that is identified or otherwise made available in the state of the art after the time of the instant filing. A representative nuclear localization sequence is a peptide sequence that directs the protein to the nucleus of the cell in which the sequence is expressed. A nuclear localization signal is predominantly basic, can be positioned almost anywhere in a protein’s amino acid sequence, generally comprises a short sequence of four amino acids (Autieri & Agrawal, (1998) J. Biol. Chem. 273: 14731-37, incorporated herein by reference) to eight amino acids, and is typically rich in lysine and arginine residues (Magin et al., (2000) Virology 274: 11-16, incorporated herein by reference). Nuclear localization sequences often comprise proline residues. A variety of nuclear localization sequences have been identified and have been used to effect transport of biological molecules from the cytoplasm to the nucleus of a cell. See, e.g., Tinland et al., (1992) Proc. Natl. Acad. Sci. U.S.A. 89:7442-46; Moede et al., (1999) FEBS Lett. 461:229- 34, which is incorporated herein by reference. Translocation is currently thought to involve nuclear pore proteins.
[00173] Most NLSs can be classified in three general groups: (i) a monopartite NLS exemplified by the SV40 large T antigen NLS (PKKKRKV (SEQ ID NO: 484)); (ii) a bipartite motif consisting of two basic domains separated by a variable number of spacer amino acids and exemplified by the Xenopus nucleoplasmin NLS (KRXXXXXXXXXXKKKL (SEQ ID NO: 492)); and (iii) noncanonical sequences such as M9 of the hnRNP Al protein, the influenza virus nucleoprotein NLS, and the yeast Gal4 protein NLS (Dingwall and Laskey 1991).
[00174] Nuclear localization sequences appear at various points in the amino acid sequences of proteins. NLS have been identified at the N-terminus, the C-terminus, and in the central region of proteins. Thus, the disclosure provides fusion proteins that may be modified with one or more NLSs at the C-terminus and/or the N-terminus, as well as at internal regions of the fusion protein. The residues of a longer sequence that do not function as component NLS residues should be selected so as not to interfere, for example, tonically or sterically, with the nuclear localization signal itself. Therefore, although there are no strict limits on the composition of an NLS-comprising sequence, in practice, such a sequence can be functionally limited in length and composition.
[00175] The present disclosure contemplates any suitable means by which to modify a fusion protein to include one or more NLSs. In one aspect, the fusion proteins may be engineered to express a fusion protein that is translationally fused at its N-terminus or its C- terminus (or both) to one or more NLSs, i.e., to form a base editor or prime editor-NLS fusion construct. In other embodiments, a fusion protein-encoding nucleotide sequence may be genetically modified to incorporate a reading frame that encodes one or more NLSs in an internal region of the encoded base editor or prime editor. In addition, the NLSs may include various amino acid linkers or spacer regions encoded between the base editor and the N- terminally, C-terminally, or internally-attached NLS amino acid sequence, e.g., and in the central region of proteins. Thus, the present disclosure also provides for nucleotide constructs, vectors, and host cells for expressing fusion proteins that comprise a base editor or prime editor and one or more NLSs, among other components.
[00176] The fusion proteins delivered by the VLPs described herein may also comprise nuclear localization sequences that are linked to the fusion protein through one or more linkers, e.g., a polymeric, amino acid, nucleic acid, polysaccharide, chemical, or nucleic acid linker element. The linkers within the contemplated scope of the disclosure are not intended to have any limitations and can be any suitable type of molecule (e.g., polymer, amino acid,
polysaccharide, nucleic acid, lipid, or any synthetic chemical linker domain) and can be joined to the fusion protein by any suitable strategy that effectuates forming a bond (e.g., covalent linkage, hydrogen bonding) between the fusion protein and the one or more NLSs.
Nucleic acid molecule
[00177] The term “nucleic acid,” as used herein, refers to a polymer of nucleotides. The polymer may include natural nucleosides (i.e., adenosine, thymidine, guanosine, cytidine, uridine, deoxyadenosine, deoxythymidine, deoxyguanosine, and deoxy cytidine), nucleoside analogs (e.g., 2-aminoadenosine, 2-thiothymidine, inosine, pyrrolo-pyrimidine, 3-methyl adenosine, 5-methylcytidine, C5 bromouridine, C5 fluorouridine, C5 iodouridine, C5 propynyl uridine, C5 propynyl cytidine, C5 methylcytidine, 7 deazaadenosine, 7 deazaguanosine, 8 oxoadenosine, 8 oxoguanosine, 0(6) methylguanine, 4-acetylcytidine, 5- (carboxyhydroxymethyl)uridine, dihydrouridine, methylpseudouridine, 1 -methyl adenosine, 1-methyl guanosine, N6-methyl adenosine, and 2-thiocytidine), chemically modified bases, biologically modified bases (e.g., methylated bases), intercalated bases, modified sugars (e.g., 2'-fluororibose, ribose, 2'-deoxyribose, 2'-O-methylcytidine, arabinose, and hexose), or modified phosphate groups (e.g., phosphorothioates and 5' N phosphoramidite linkages).
Nucleocapsid protein
[00178] The term “nucleocapsid protein” refers to a protein that makes up the core structural component of the inner shell of many viruses, including retroviruses. A nucleocapsid protein makes up part of the gag protein. The nucleocapsid proteins used in the VLPs of the present disclosure may be an MMLV gag nucleocapsid protein, an FMLV gag nucleocapsid protein, or a nucleocapsid protein from any other virus that produces such proteins.
Prime editor
[00179] The term “prime editor” refers to fusion constructs comprising a napDNAbp (e.g., Cas9 nickase) and a reverse transcriptase that are capable of carrying out prime editing on a target nucleotide sequence in the presence of a PEgRNA (or “extended guide RNA”). The term “prime editor” may refer to the fusion protein or to the fusion protein complexed with a PEgRNA, and/or further complexed with a second-strand nicking sgRNA. In some embodiments, the prime editor may also refer to the complex comprising a fusion protein (reverse transcriptase fused to a napDNAbp) and a PEgRNA.
[00180] Prime editors may be used to carry out prime editing, which is an approach for gene editing using napDNAbps, a polymerase (e.g., a reverse transcriptase), and specialized guide RNAs that include a primer binding site and a DNA synthesis template for encoding desired new genetic information (or deleting genetic information) that is then incorporated into a target DNA sequence. Prime editing is described in Anzalone, A. V. et al., Search- and- replace genome editing without double-strand breaks or donor DNA. Nature 576, 149-157 (2019), which is incorporated herein by reference. See also International PCT Application, PCT/US2020/023721, filed March 19, 2020, and published as WO 2020/191239, which is incorporated herein by reference.
[00181] Prime editing represents a platform for genome editing that is a versatile and precise method to directly write new genetic information into a specified DNA site using a nucleic acid programmable DNA binding protein (“napDNAbp”) working in association with a polymerase (i.e., in the form of a fusion protein or otherwise provided in trans with the napDNAbp), wherein the prime editing system is programmed with a prime editing (PE) guide RNA (“PEgRNA”) that both specifies the target site and templates the synthesis of the desired edit in the form of a replacement DNA strand by way of an extension (either DNA or RNA) engineered onto a guide RNA (e.g., at the 5' or 3' end, or at an internal portion of a guide RNA). The replacement strand containing the desired edit (e.g., a single nucleobase substitution) shares the same sequence as the endogenous strand (or is homologous to it) immediately downstream of the nick site of the target site to be edited (with the exception that it includes the desired edit). Through DNA repair and/or replication machinery, the endogenous strand downstream of the nick site is replaced by the newly synthesized replacement strand containing the desired edit. Cas protein-reverse transcriptase fusions or related systems are used to target a specific DNA sequence with a guide RNA, generate a single strand nick at the target site, and use the nicked DNA as a primer for reverse transcription of an engineered DNA synthesis template that is integrated with the guide RNA. However, while the concept begins with prime editors that use reverse transcriptase as the DNA polymerase component, the prime editors described herein are not limited to reverse transcriptase but may include the use of virtually any DNA polymerase. Indeed, while the application throughout may refer to prime editors with “reverse transcriptase,” it is set forth here that reverse transcriptase are only one type of DNA polymerase that may work with prime editing. Thus, wherever the specification mentions a “reverse transcriptase,” the person having ordinary skill in the art should appreciate that any suitable DNA polymerase may be
used in place of the reverse transcriptase. Thus, in one aspect, the prime editors may comprise Cas9 (or an equivalent napDNAbp), which is programmed to target a DNA sequence by associating it with a specialized guide RNA (i.e., PEgRNA) containing a spacer sequence that anneals to a complementary sequence (the complementary sequence to an endogenous protospacer sequence) in the target DNA. The PEgRNA also contains new genetic information in the form of an extension that encodes a replacement strand of DNA containing a desired nucleotide change which is used to replace a corresponding endogenous DNA strand at the target site. To transfer information from the PEgRNA to the target DNA, the mechanism of prime editing involves nicking the target site in one strand of the DNA to expose a 3 '-hydroxyl group. The exposed 3 '-hydroxyl group can then be used to prime the DNA polymerization of the edit-encoding extension on PEgRNA directly into the target site. In various embodiments, the extension — which provides the template for polymerization of the replacement strand containing the edit — can be formed from RNA or DNA. In the case of an RNA extension, the polymerase of the prime editor can be an RNA-dependent DNA polymerase (such as a reverse transcriptase). In the case of a DNA extension, the polymerase of the prime editor may be a DNA-dependent DNA polymerase. The newly synthesized strand (i.e., the replacement DNA strand containing the desired nucleotide edit) that is formed by the prime editor would be homologous to the genomic target sequence (i.e., have the same sequence as), except for the inclusion of one or more desired nucleotide changes (e.g., a single nucleotide substitution, a deletion, or an insertion, or a combination thereof). The newly synthesized (or replacement) strand of DNA may also be referred to as a single strand DNA flap, which would compete for hybridization with the complementary homologous endogenous DNA strand, thereby displacing the corresponding endogenous strand. Resolution of the hybridized intermediate (also referred to as a heteroduplex, comprising the single strand DNA flap synthesized by the reverse transcriptase hybridized to the endogenous DNA strand with the exception of mismatches at positions where desired nucleotide edits are installed in the edit strand) can include removal of the resulting displaced flap of endogenous DNA (e.g., with a 5' end DNA flap endonuclease, FEN1), ligation of the synthesized single strand DNA flap to the target DNA, and assimilation of the desired nucleotide changes as a result of cellular DNA repair and/or replication processes.
Producer cell
[00182] The term “producer cell” refers to any cell type that can be used to make the VLPs described herein. One or more polynucleotides encoding the components of a VLP are
transfected, transduced, electroporated, or otherwise inserted into a producer cell. In some embodiments, a single vector comprises polynucleotides encoding all components of the VLP, and in other embodiments, polynucleotides encoding each component of the VLP are split over two, three, or four different vectors. Once the producer cell expresses the polynucleotides, the various components of the VLPs self-assemble spontaneously within the producer cells. Assembly of the VLPs relies on multimerization of the gag polyproteins encoded on the polynucleotides as described above. The gag polyproteins (some of which are fused to a cargo molecule such as a protein) multimerize at the cell membrane of a producer cell and are subsequently released into the producer cell supernatant spontaneously. Producer cell lines include, but are not limited to, Gesicle 293T cells, HEK 293T, 293G, 293SF, 293FT, 293TN, Eent-X 293T, and inducible custom cell lines with lentivirally integrated VEP genes.
Protease cleavage site
[00183] The term “protease cleavage site,” as used herein, refers to an amino acid sequence that is recognized and cleaved by a protease, i.e., an enzyme that catalyzes proteolysis and breaks down proteins into smaller polypeptides, or single amino acids. In some embodiments, a protease cleavage site is included in a cleavable linker in a fusion protein, as described herein. In certain embodiments, a protease cleavage site is cleaved by the protease of a gag-pro polyprotein. In some embodiments, a protease cleavage site comprises an MMLV protease cleavage site or an FMLV protease cleavage site. In certain embodiments, a protease cleavage site comprises one of the amino acid sequences TSTLLMENSS (SEQ ID NO: 334), PRSSLYPALTP (SEQ ID NO: 335), VQALVLTQ (SEQ ID NO: 336), PLQVLTLNIERR (SEQ ID NO: 337), or an amino acid sequence at least 90% identical to any one of SEQ ID NO:s: 1-4. In some embodiments, a protease cleavage site comprises an amino acid sequence of any one of SEQ ID NO:s: 1-8, or an amino acid sequence at least 90% identical to any one of SEQ ID NO:s: 1-8.
Protein, peptide, and polypeptide
[00184] The terms “protein,” “peptide,” and “polypeptide” are used interchangeably herein and refer to a polymer of amino acid residues linked together by peptide (amide) bonds. The terms refer to a protein, peptide, or polypeptide of any size, structure, or function. Typically, a protein, peptide, or polypeptide will be at least three amino acids long. A protein, peptide, or polypeptide may refer to an individual protein or a collection of proteins. One or more of the amino acids in a protein, peptide, or polypeptide may be modified, for example, by the
addition of a chemical entity such as a carbohydrate group, a hydroxyl group, a phosphate group, a famesyl group, an isofamesyl group, a fatty acid group, a linker for conjugation, functionalization, or other modification, etc. A protein, peptide, or polypeptide may also be a single molecule or may be a multi-molecular complex. A protein, peptide, or polypeptide may be just a fragment of a naturally occurring protein or peptide. A protein, peptide, or polypeptide may be naturally occurring, recombinant, or synthetic, or any combination thereof. Any of the proteins provided herein may be produced by any method known in the art. For example, the proteins provided herein may be produced via recombinant protein expression and purification, which is especially suited for fusion proteins comprising a peptide linker. Methods for recombinant protein expression and purification are well known, and include those described by Green and Sambrook, Molecular Cloning: A Laboratory Manual (4th ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (2012)), the contents of which are incorporated herein by reference.
Subject
[00185] The term “subject,” as used herein, refers to an individual organism, for example, an individual mammal. In some embodiments, the subject is a human. In some embodiments, the subject is a non-human mammal. In some embodiments, the subject is a non-human primate. In some embodiments, the subject is a rodent. In some embodiments, the subject is a sheep, a goat, a cattle, a cat, or a dog. In some embodiments, the subject is a vertebrate, an amphibian, a reptile, a fish, an insect, a fly, or a nematode. In some embodiments, the subject is a research animal. In some embodiments, the subject is genetically engineered, e.g., a genetically engineered non-human subject. The subject may be of either sex and at any stage of development.
Substitution
[00186] The term “substitution,” as used herein, refers to replacement of a residue within a sequence, e.g., a nucleic acid or amino acid sequence, with another residue, or a deletion or insertion of one or more residues within a sequence. The term “mutation” may also be used throughout the present disclosure to refer to a substitution (i.e., a “nucleic acid mutation” or an “amino acid mutation”). Substitutions are typically described herein by identifying the original residue followed by the position of the residue within the sequence and the identity of the newly mutated/substituted residue. Various methods for making the amino acid substitutions provided herein are well known in the art, and are provided by, for example, Green and Sambrook, Molecular Cloning: A Laboratory Manual (4th ed., Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, N.Y. (2012)). In some embodiments, a substitution is in a viral nucleocapsid protein, which may be part of a VLP as described herein.
Target cell
[00187] A “target cell” refers to any cell type to which a VLP is delivered. In some embodiments, a VLP is used to deliver a particular cargo to a target cell. For example, a VLP may be used to deliver a gene editing agent such as a napDNAbp (e.g., a Cas9 protein), a base editor, or a prime editor to a target cell. Once the VLP enters the target cell, the cargo is released and may perform its function, for example, by editing the genome of the target cell. Target cell types include any cell to which a person of ordinary skill in the art may want to deliver a VLP as described herein. In some embodiments, VLPs are delivered into human embryonic kidney (HEK) cells (e.g., HEK 293 or HEK 293T cells). In some embodiments, VLPs are delivered into stem cells (e.g., human stem cells) such as, for example, pluripotent stem cells (e.g., human pluripotent stem cells including human induced pluripotent stem cells (hiPSCs)).
[00188] Target cell types contemplated by the present disclosure include, but are not limited to, stem and progenitor cells (e.g., embryonic stem cells, hematopoietic stem cells, mesenchymal stem cells, neural crest cells, etc.), endothelial cells, muscle cells, myocardial cells, smooth and skeletal muscle cells, mesenchymal cells, epithelial cells, hematopoietic cells, lymphocytes such as T-cells (e.g., Thl T cells, Th2 T cells, ThO T cells, cytotoxic T cells) and B cells (e.g., pre-B cells), monocytes, dendritic cells, neutrophils, macrophages, natural killer cells, mast cells, adipocytes, immune cells, neurons, hepatocytes, and cells involved with particular organs (e.g., thymus, endocrine glands, pancreas, brain, neurons, glia, astrocytes, dendrocytes, osteoblasts, osteoclasts, gametes, fat cells, and genetically modified cells thereof).
[00189] In some embodiments, VLPs are delivered into a cell line, such as, but not limited to, 293-T, 3T3, 4T1, 721, 9L, A-549, A172, A20, A253, A2780, A2780ADR, A2780cis, A431, ALC, B16, B35, BCP-1, BEAS-2B, bEnd.3, BHK-21, BR 293, BxPC3, C2C12, C3H- 10T1/2, C6, C6/36, Cal-27, CGR8, CHO, CML Tl, CMT, COR-L23, COR-L23/5010, COR- L23/CPR, COR-L23/R23, COS-7, COV-434, CT26, D17, DH82, DU145, DuCaP, E14Tg2a, EL4, EM2, EM3, EMT6/AR1, EMT6/AR10.0, FM3, H1299, H69, HB54, HB55, HCA2, Hepalclc7, High Five cells, HL-60, HMEC, HT-29, HUVEC, J558L cells, Jurkat, JY cells, K562 cells, KCL22, KG1, Ku812, KY01, LNCap, Ma-Mel 1, 2, 3....48, MC-38, MCF-10A, MCF-7, MDA-MB-231, MDA-MB-435, MDA-MB-468, MDCK II, MG63, MONO-MAC 6,
MOR/0.2R, MRC5, MTD-1A, MyEnd, NAEM-1, NCI-H69/CPR, NCI-H69/LX10, NCI- H69/LX20, NCI-H69/LX4, NIH-3T3, NW- 145, OPCN/OPCT Peer, PNT-1A/PNT 2, PTK2, Raji, RBL cells, RenCa, RIN-5F, RMA/RMAS, S2, Saos-2 cells, Sf21, Sf9, SiHa, SKBR3, SKOV-3, T-47D, T2, T84, THP1, U373, U87, U937, VCaP, WM39, WT-49, X63, YAC-1, or YAR cells.
Treatment
[00190] The terms “treatment,” “treat,” and “treating,” refer to a clinical intervention aimed to reverse, alleviate, delay the onset of, or inhibit the progress of a disease or disorder, or one or more symptoms thereof, as described herein. As used herein, the terms “treatment,” “treat,” and “treating” refer to a clinical intervention aimed to reverse, alleviate, delay the onset of, or inhibit the progress of a disease or disorder, or one or more symptoms thereof, as described herein. In some embodiments, treatment may be administered after one or more symptoms have developed and/or after a disease has been diagnosed. In other embodiments, treatment may be administered in the absence of symptoms, e.g., to prevent or delay onset of a symptom or inhibit onset or progression of a disease. For example, treatment may be administered to a susceptible individual prior to the onset of symptoms (e.g., in light of a history of symptoms and/or in light of genetic or other susceptibility factors). Treatment may also be continued after symptoms have resolved, for example, to prevent or delay their recurrence.
Variant
[00191] As used herein, the term “variant” should be taken to mean the exhibition of qualities that have a pattern that deviates from what occurs in nature, e.g., a variant nucleocapsid protein is a nucleocapsid protein comprising one or more changes in amino acid residues as compared to a wild type nucleocapsid protein amino acid sequence. The term “variant” encompasses homologous proteins having at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99% or 100% identity with a reference sequence and having the same or substantially the same functional activity or activities as the reference sequence. The term also encompasses mutants, truncations, or domains of a reference sequence that display the same or substantially the same functional activity or activities as the reference sequence.
Vector
[00192] The term “vector,” as used herein, refers to a nucleic acid that can be modified to encode a gene of interest and that is able to enter a host cell and replicate within the host cell, and then transfer a replicated form of the vector into another host cell. Exemplary suitable vectors include viral vectors, such as retroviral vectors or bacteriophages and filamentous phage, and conjugative plasmids. Additional suitable vectors will be apparent to those of skill in the art based on the instant disclosure.
Viral envelope glycoprotein
[00193] The term “viral envelope glycoprotein” refers to oligo saccharide-containing proteins that form a part of the viral envelope, i.e., the outermost layer of many types of viruses that protects the viral genetic materials when traveling between host cells. Glycoproteins may assist with identification and binding to receptors on a target cell membrane so that the viral envelope fuses with the membrane, allowing the contents of the viral particle (which may be, e.g., a VLP as described herein) to enter the host cell. This property may also be referred to as “tropism.” The viral envelope glycoproteins used in the VLPs of the present disclosure may comprise any glycoprotein from an enveloped virus. In some embodiments, a viral envelope glycoprotein is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein. In certain embodiments, a viral envelope glycoprotein is a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein, or a mutant form thereof.
Virus-like particles (VLPs)
[00194] As used herein, a “virus-like particle (VLP)” (or “engineered virus-like particle (eVLP),” which is used interchangeably with the term “VLP” herein) consists of a supra- molecular assembly comprising (a) an envelope comprising (i) a lipid membrane (e.g., singlelayer or bi-layer membrane) and a (ii) viral envelope glycoprotein, and (b) a multi-protein core region comprising (ii) a Gag protein, (ii) a first fusion protein comprising a Gag protein and Pro-Pol, and (iii) a second fusion protein comprising a Gag protein fused to a cargo protein via a protease-cleavable linker. In some embodiments, the gag protein comprises a nucleocapsid protein variant as described herein. In various embodiments, the cargo protein is a napDNAbp (e.g., Cas9). In other embodiments, the cargo protein is a base editor. In other embodiments, the cargo protein is a prime editor. In various other embodiments, the multiprotein core region of the VLPs further comprises one or more guide RNA molecules which
are complexed with a napDNAbp, base editor, or prime editor to form a ribonucleoprotein (RNP). In some embodiments, the guide RNA molecule comprises a barcode sequence as described herein (e.g., a barcode sequence associated with a nucleocapsid protein variant that forms part of the gag protein). In various embodiments, the VLPs are prepared in a producer cell that is transiently transformed with plasmid DNA that encodes that various protein and nucleic acid (sgRNA) components of the VLPs. The components self-assemble at the cell membrane and bud out in accordance with the naturally occurring mechanism of retroviral budding in order to release from the cell fully-matured VLPs. Once formed, the Pol-Pro cleaves the protease- sensitive linker joining the Gag-cargo linker (e.g., the linker joining a Gag to a napDNAbp RNP) to release the cargo within the VLP. Once the VLP is administered to a recipient target cell and taken up by said target cell, the contents of the VLP are released, including free cargo (e.g., a napDNAbp, base editor, or prime editor). Once in the cell, the cargo may translocate to the nuclease of the cell (in particular, where NLSs are included on an RNP cargo), where DNA editing may occur at target sites specified by the guide RNA.
[00195] In some embodiments, the protease-cleavable linker is optimized to improve cleavage efficiency after VLP maturation. In some embodiments, the Gag-cargo fusion (e.g., Gag::BE) further comprises one or more nuclear export signals at one or more locations along the length of the fusion polypeptide protein which may be joined by a cleavable linker such that during VLP assembly in the producer cell, the Gag-cargo fusions (due to presence of competing NLS signals) do not accumulate in the nucleus of the producer cells but instead are available in the cytoplasm to undergo the VLP assembly process at the cell membrane. Once inside the matured VLPs following release from the producer cell, the NES may be cleaved by Pro-Pol, thereby separating the cargo (e.g., napDNAbp, base editor, or prime editor) from the NES. Upon delivery to a recipient cell, therefore, the cargo (e.g., napDNAbp, base editor, or prime editor, typically flanked with one or more NLS elements) will not comprise an NES element, which may otherwise prohibit the transport of the cargo into the nucleus and hinder gene editing activity.
[00196] In some embodiments, an optimized stoichiometry ratio of Gag-cargo fusion to Gag-Pro-Pol fusion protein is used, which balances the amount of Gag-cargo available to be packaged into VLPs with the amount of retrovirus protease (the “Pro” in the Gag-Pro-Pol fusion) required for VLP maturation. In some embodiments, the optimized ratio of Gag-cargo fusion to Gag-Pro-Pol fusion protein is achieved by the appropriate ratio of plasmids
encoding each component which are transiently delivered to the producer cells. In some embodiments, the optimal gag-cargo:gag-pro-pol stoichiometry is 25% gag-cargo:75% gag- pro-pol.
[00197] In some embodiments, a VLP comprises additional agents for targeting the VLP for delivery to particular cell types. For example, such additional targeting agents may be incorporated into the outer lipid membrane encapsulation layer of the VLP. In some embodiments, the additional targeting agent is a protein. In certain embodiments, the additional targeting agent is an antibody.
[00198] Thus, as used herein, a virus-derived particle comprises a virus-like particle formed by one or more virus-derived protein(s), which virus-derived particle is substantially devoid of a viral genome such that the VLP is replication-incompetent when delivered to a recipient cell.
Wild type
[00199] As used herein the term “wild type” is a term of the art understood by skilled persons and means the typical form of an organism, strain, gene or characteristic as it occurs in nature as distinguished from mutant or variant forms.
Click Chemistry
[0105] The term “click chemistry” refers to a chemical synthesis technique introduced by K. Barry Sharpless of The Scripps Research Institute, describing chemistry tailored to generate covalent bonds quickly and reliably by joining small units comprising reactive groups together. See, e.g., Kolb, Finn and Sharpless Angewandte Chemie International Edition (2001) 40: 2004-2021; Evans, Australian Journal of Chemistry (2007) 60: 384-395).
Exemplary coupling reactions (some of which may be classified as “click chemistry”) include, but are not limited to, formation of esters, thioesters, amides (e.g., such as peptide coupling) from activated acids or acyl halides; nucleophilic displacement reactions (e.g., such as nucleophilic displacement of a halide or ring opening of strained ring systems); azidealkyne Huisgen cycloaddition; thiol-yne addition; imine formation; Michael additions (e.g., maleimide addition); and Diels- Alder reactions (e.g., tetrazine [4 + 2] cycloaddition).
Exemplary click chemistry reactions include, but are not limited to, azide-alkyne Huisgen cycloaddition; and Diels-Alder reactions (e.g., tetrazine [4 + 2] cycloaddition). In some embodiments, click chemistry reactions are modular, wide in scope, give high chemical yields, generate inoffensive byproducts, are stereospecific, exhibit a large thermodynamic driving force > 84 kJ/mol to favor a reaction with a single reaction product, and/or can be
carried out under physiological conditions. In some embodiments, a click chemistry reaction exhibits high atom economy, can be carried out under simple reaction conditions, use readily available starting materials and reagents, uses no toxic solvents or use a solvent that is benign or easily removed (preferably water), and/or provides simple product isolation by non- chromatographic methods (crystallization or distillation).
[0106] The term “click chemistry handle,” as used herein, refers to a reactant, or a reactive group, that can partake in a click chemistry reaction. For example, a strained alkyne, e.g., a cyclooctyne, is a click chemistry handle, since it can partake in a strain-promoted cycloaddition (see, e.g., Table 1). In general, click chemistry reactions require at least two molecules comprising click chemistry handles that can react with each other. Such click chemistry handle pairs that are reactive with each other are sometimes referred to herein as partner click chemistry handles. For example, an azide is a partner click chemistry handle to a cyclooctyne or any other alkyne. Exemplary click chemistry handles suitable for use according to some aspects of this invention are described herein, for example, in Tables 1 and 2. In some embodiments, click chemistry handles are used that can react to form covalent bonds in the presence of a metal catalyst, e.g., copper (II). In some embodiments, click chemistry handles are used that can react to form covalent bonds in the absence of a metal catalyst. Additional suitable click chemistry handles are well known to those of skill in the art, and such click chemistry handles include, but are not limited to, the click chemistry reaction partners, groups, and handles described in Becer, Hoogenboom, and Schubert, Click Chemistry beyond Metal-Catalyzed Cycloaddition, Angewandte Chemie International Edition (2009) 48: 4900 - 4908 and PCT/US2012/044584 and references therein, which references are incorporated herein by reference for click chemistry handles and methodology.
Table 2: Exemplary click chemistry handles and reactions (from Becer, Hoogenboom, and
Schubert, Click Chemistry Beyond Metal-Catalyzed Cycloaddition, Angewandte Chemie
DETAILED DESCRIPTION
[00200] The present disclosure provides articles and methods for the selective transduction and genome editing of human cells (e.g., hematopoietic stem and progenitors cells, HSPCs) using engineered viral like particles (e.g., eVLPs). Aspects of the disclosure provide eVLPs comprising fusion proteins comprising a targeting moiety. In some embodiments, the fusion proteins comprise a cytokine conjugated to a transmembrane protein and/or an envelope glycoprotein. In other embodiments, the fusion proteins comprise a targeting moiety domain, a stalk protein domain, a transmembrane domain and/or envelope glycoprotein domain. Targeted-eVLP architectures comprising fusion proteins comprising various targeting domains, stalk domains, transmembrane domains, and envelope glycoproteins are also provided herein. In some embodiments, the eVLP comprise a second fusion protein comprising various targeting domains, stalk domains, and transmembrane domains or envelope glycoprotein domain. In some embodiments, the first fusion protein and second fusion protein comprise the same targeting domains, stalk domains, and transmembrane or envelope glycoprotein domains. In some embodiments, the first fusion protein and second fusion protein comprise different targeting domains, stalk domains, and transmembrane or envelope glycoprotein domains. In some embodiments, the different targeting domains are configured to bind the same, or different, target (e.g., receptor) on a target cell (e.g., they both target the same cell type, such as HSPC or immune cells).
[00201] Other aspects of the disclosure provide eVLP compositions comprising envelope glycoproteins comprising non-natural sugars and methods of conjugating various targeting moieties to said eVLPs using bio-orthogonal click chemistry. Polynucleotides, vectors, cells, and kits useful for producing the articles, and performing the methods, described herein are also provided.
[00202] As described elsewhere herein, current eVLP architectures (e.g., v4 eVLPs) use VSVG as the standard envelope glycoprotein. VSVG initiates receptor- mediated endocytosis through the ubiquitously expressed LDL receptor protein (LDLR). The wide expression distribution of LDLR means that v4 eVLPs have the potential to transduce many cell types. While this has obvious benefits especially in an ex vivo context, this property increases transduction in off-target cell types, especially in the liver. Therefore, the effective dose reaching the target cell population for a given disease is much lower than the administered dose since off-target cells act as a sink for the high-activity eVLPs.
[00203] The inventors of the present disclosure have now discovered that eVLP architectures comprising a targeting domain increases the effective dose of a therapeutic (e.g.,
genome editors) reaching a target cell. For example, eVLPs carrying genome editors permit delivery of gene editors to correct disease-associated alleles only in the cell types where they exert the most substantial phenotypic effect. Importantly, the inventors have surprisingly shown that non- viral targeting domains (e.g., cytokines) may be incorporated into eVLP architectures thus greatly enhancing the specificity of transduction both in vitro and in vivo. As such, aspects of the present disclosure are generally directed toward compositions of eVLPs comprising one or more targeting domains and methods of making the same, both in vitro and in vivo. The following is a description of various elements that permit the targeted delivery of eVLPs as contemplated herein. eVLP Constructs
[00204] The core components used to assemble the eVLPs of the present disclosure are discussed elsewhere herein, but in general include one or more retrovirus-derived structural protein(s) and optionally one or more virus-derived envelope protein(s) or mutated variants thereof. FIG. 2 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain, a targeting domain, and a linker. FIG 2 also shows other eVLP components including the (i) lipid membrane e.g., single-layer or bi-layer membrane), a mutant viral envelope glycoprotein (e.g., VSVG-mut) and a multi-protein core region enclosed by the envelope and comprising a Gag protein, a Gag-Pro-Pol protein, and a Gag-cargo fusion protein. Thus, in some embodiments, the fusion protein is conjugated to a transmembrane domain, and the envelope glycoprotein is a mutant envelope glycoprotein (e.g., VSVG-mutant, Cocal-mutant, Nipah virus mutant). Such embodiments may be useful, for example, for ablating the native cellular tropism associated with the VSVG glycoprotein while retaining fusogenic activity and enhancing selective tropism toward a specific cell type. Other envelope glycoproteins and/or mutant envelope glycoproteins are also contemplated. For example, in some embodiments, the envelope glycoprotein is derived from the vesicular stomatitis virus G (e.g., VSVG), the Cocal, virus and/or Nipah virus. In some embodiments, the mutant envelope protein comprises an envelope glycoprotein derived from the vesicular stomatitis virus (e.g., VSVG), Cocal virus, and/or Nipah virus. The fusion protein may comprise other domains (e.g., stalk domain) and/or combinations of domains (e.g., targeting domains) according to other embodiments.
[00205] FIG. 3 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a wild type envelope glycoprotein domain, a targeting domain, and a linker. The eVLP construct in FIG. 3 also comprises a mutant envelope glycoprotein, e.g., VSVG-mutant
that possesses impaired binding affinity to the LDLR but retains its fusogenic activity. Such embodiments may be useful, for example, for increasing the transduction efficiency of the eVLPs into in a target cell type. The fusion protein may comprise other domains (e.g., stalk domain) and/or combinations of domains (e.g., targeting domains) according to other embodiments.
[00206] FIGs. 4 and 5 show exemplary embodiments of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain, a stalk domain, and a targeting domain. Again, the eVLP construct in FIGs. 4 and 5 also comprises a mutant envelope glycoprotein, e.g., VSVG-mutant that possesses impaired binding affinity to the LDLR but retains its fusogenic activity. In some embodiments, the stalk domains are inert and serve as linkers (or spacers) to separate the transmembrane domain, which incorporates into the eVLP capsid, from the targeting protein. In some embodiments, the stalk domain comprises CD8-alpha or a fragment thereof (e.g., FIG. 4). In other embodiments, the stalk domain comprises IgG, or a fragment thereof (e.g., FIG. 5). Again, such embodiments, are useful for increasing the transduction efficiency of the eVLPs. The fusion protein may comprise other domains and/or combinations of domains (e.g., targeting domains) according to other embodiments.
[00207] FIG. 6 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain, a targeting domain, and a linker. In this set of embodiments, however, the targeting domain binds to a second targeting domain, which in turn binds to a target receptor on a target cell (e.g., HSBC cell). For example, in certain embodiments, the targeting domain comprises an IgG binding peptide configured to bind to an IgG antibody (e.g., an anti-CDl 10 IgG antibody). Such embodiments are useful, for example, to enhance the targeting specificity of the eVLP construct. The fusion protein may comprise other domains (e.g., stalk domain) and/or combinations of domains (e.g., targeting domains) according to other embodiments.
[00208] FIG. 7 shows an exemplary eVLP comprising a non-natural moiety (e.g., an azido (-N3) functionality) and an exemplary method of producing the same. It will be appreciated that general methods are known in the art for incorporating non-natural moieties (e.g., N-(4- pentynoyl mannosamine, N-azidoacetylmannosamine, etc.) into cell surface glycoproteins (e.g., such as VSVG). Thus, in some embodiments, eVLPs of the present disclosure comprise an envelope glycoprotein with one or more azido functionalities. In other embodiments, the eVLPs comprises an envelope glycoprotein with one or more alkyne or strained alkyne functionalities.
[00209] FIG. 17 shows an exemplary embodiment of an eVLP comprising a fusion protein comprising a transmembrane (TM) domain (e.g., ICAM1), a stalk domain (e.g., CD8a), and two different targeting domains (e.g., a-CD4 scFV and a-CD8 scFV). The eVLP construct comprises a mutant envelope glycoprotein, e.g., Cocal mut that possesses impaired binding affinity that reduces its broad tropism but retains its fusogenic activity. In some embodiments, the stalk domains are inert and serve as linkers (or spacers) to separate the transmembrane domain, which incorporates into the eVLP capsid, from the targeting protein. In some embodiments, the stalk domain is CD8-alpha. In other embodiments, the stalk domain is IgG. Again, such embodiments, are useful for increasing the transduction efficiency of the eVLPs. The fusion protein may comprise other domains and/or combinations of domains (e.g., targeting domains) according to other embodiments.
[00210] In some embodiments, a virus-like particle comprises a fusion protein comprising a transmembrane domain, a stalk domain, and a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
[00211] In some embodiments, a virus-like particle comprises a fusion protein comprising a transmembrane domain, a stalk domain, and two or more targeting domains, wherein the targeting domains are not a viral envelope glycoprotein, an antibody, or an antibody fragment.
[00212]
[00213] In some embodiments, a virus-like particle comprises a fusion protein comprising a transmembrane domain and a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
[00214] In some embodiments, a virus-like particle comprises (a) a fusion protein comprising (i) a transmembrane domain and (ii) a targeting domain, and (b) an antibody domain, wherein the targeting domain of the fusion protein binds to the antibody domain to form a virus-like particle-antibody complex, and wherein, the targeting domain is not an envelope glycoprotein, an antibody, or a fragment of an antibody.
[00215] In some embodiments, a virus-like particle comprises (a) a fusion protein comprising (i) a transmembrane domain, (ii) a stalk domain, and (iii) a targeting domain, and (b) an antibody domain, wherein the targeting domain of the fusion protein binds to the antibody domain to form a virus-like particle-antibody complex, and wherein, the targeting domain is not an envelope glycoprotein, an antibody, or a fragment of an antibody.
[00216] In some embodiments, the virus-like particle comprises at least one conjugation domain.
Fusion proteins
[00217] One strategy, contemplated herein, for enhancing the selective tropism of eVLPs is to genetically engineer the eVLP to display a targeting domain on the surface of the viral capsid. As such, in some embodiments, eVLPs of the present disclosure comprise a fusion protein comprising a targeting domain. In some embodiments, the fusion protein comprises a transmembrane domain and a targeting domain. In some embodiments, the eVLP comprises a fusion protein comprising a transmembrane domain, a stalk domain, and a targeting domain. Additionally, the fusion protein may further, optionally comprise one or more linkers (e.g., linkers), for example, between the transmembrane domain and the targeting domain, between the transmembrane domain and the stalk domain, between the stalk domain and the targeting domain, and/or between the targeting domain and a signaling peptide. In some embodiments, the one or more linkers is a first linker, a second linker, a third linker, and so on. In some embodiments, the one or more linkers may be used to link any two domains. For example, in some embodiments, an optional first linker (e.g., flexible) connects the transmembrane domain and the targeting domain and an optional second linker (e.g., flexible) connects the stalk domain to targeting domain. Other compositions are also possible in other embodiments, for example, a fusion protein may comprise a targeting domain and an envelope glycoprotein domain (e.g., VSVG). In some embodiments, an eVLP may comprise more than one fusion protein comprising any one of the domains described above. In some embodiments, the domains of the more than one fusion proteins are the same; in other embodiments, the domains of the more than one fusion proteins are different. For example, in some embodiments, an eVLP comprises a first fusion protein comprising an ICAM1 transmembrane domain, a CD8a stalk domain, and a aCD4 scFv targeting domain and a second fusion protein comprising comprising an ICAM1 transmembrane domain, a CD8a stalk domain, and a aCD8-scFv targeting domain (FIG. 17). In some embodiments, the eVLP targets HSC cells. In other embodiments, the eVLPs target immune cells, such as CD4+ or CD8+ T cells. The fusion protein may have any suitable structure and/or orientation known in the art. For example, in some embodiments, the fusion proteins comprise the following structures:
[00218] N-terminus- [Transmembrane domain or envelope glycoprotein domain]- [Targeting domain] -[optional signal peptide] -C-terminus.
[00219] C-terminus-[Transmembrane domain or envelope glycoprotein domain]- [Targeting domain] -[optional signal peptide]-N-terminus.
[00220] N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Targeting domain] -[optional signal peptide] -C-terminus.
[00221] C-terminus-[Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Targeting domain] -[optional signal peptide]-N-terminus.
[00222] N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[Stalk domain] -[Targeting domain] -[optional signal peptide] -C-terminus.
[00223] C-terminus-[Transmembrane domain or envelope glycoprotein domain] -[Stalk domain] -[Targeting domain] -[optional signal peptide]-N-terminus.
[00224] N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Stalk domain] -[Targeting domain]-[ optional signal peptide] -C-terminus.
[00225] C-terminus-[Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Stalk domain] -[Targeting domain]- [optional signal peptide] -N-terminus.
[00226] N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[Stalk domain] -[optional linker] -[Targeting domain]- [optional signal peptide] -C-terminus.
[00227] C-terminus-[Transmembrane domain or envelope glycoprotein domain] -[Stalk domain] -[optional linker] -[Targeting domain] -[optional signal peptide]-N-terminus.
[00228] N-terminus- [Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Stalk domain] -[optional linker] -[Targeting domain] -[optional signal peptide] -C- terminus.
[00229] C-terminus-[Transmembrane domain or envelope glycoprotein domain] -[optional linker] -[Stalk domain] -[optional linker] -[Targeting domain] -[optional signal peptide]-N- terminus.
Transmembrane domain
[00230] In some embodiments, the eVLPs comprise a fusion protein comprising a transmembrane domain. Any suitable transmembrane domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein. In some embodiments, the transmembrane domain is selected from the group consisting of CD28, CD43, CD49d, CD62L, CD162, HLA-A2, HLA-DRA, ICAM1, LFA-1, mCD3z, mCD4, mCD8a, hCD8a, hCD8a, and VSVG-TM. Non-limiting exemplary embodiments of possible transmembrane domains for use in any of the fusion proteins disclosed herein include: [00231] CD28
FWVLVVVGGVLACYSLLVTVAFIIFWV (SEQ ID NO: 363)
[00232] CD43
GMLPVAVLVALLAVIVLVALLLLWRRRQKRRT (SEQ ID NO: 364)
[00233] CD49d
IVIISSSLLLGLIVLLLISYVMWKAGFFKRQYKS (SEQ ID NO: 365)
[00234] CD62L
PLFIPVAVMVTAFSGLAFIIWLARRLKKGKKSKR (SEQ ID NO: 366)
[00235] CD 162
LLAILILALVATIFFVCTVVLAVRLSRKGHMYPVRN (SEQ ID NO: 367)
[00236] HLA-A2
IVGIIAGLVLFGAVITGAVVAAVMWRRKSSDRKG (SEQ ID NO: 368)
[00237] HLA-DRA
NVVCALGLTVGLVGIIIGTIFIIKGLRKSNAAERRGPL (SEQ ID NO: 369)
[00238] ICAM1
IVIITVVAAAVIMGTAGLSTYLYNRQRKIKKYRL (SEQ ID NO: 370)
[00239] LFA-1
YLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLK (SEQ ID NO: 371)
[00240] mCD3z
LCYLLDGILFIYGVIITALYL (SEQ ID NO: 372)
[00241] mCD4
VFLACVLGGSFGFLGFLGLCILC (SEQ ID NO: 373)
[00242] mCD8a
IWAPLAGICVALLLSLIITLI (SEQ ID NO: 374)
[00243] hCD8a
IWAPLAGTCGVLLLSLVITLY (SEQ ID NO: 375)
[00244] VSVG-TM
IASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ ID NO: 376)
[00245] VSVGss-TM:
GTNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMN RLGKV (SEQ ID NO: 493)
[00246] In some embodiments, the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 363-376 or 493.
Viral envelope glycoprotein domain
[00247] In some embodiments, the eVLPs comprise a fusion protein comprising a viral envelope glycoprotein domain. Any suitable viral envelope glycoprotein domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein. In some embodiments, the viral envelope glycoprotein comprises one or more mutations, for example, a mutation that decreases the glycoproteins binding affinity for its native target receptor. In some embodiment, the mutation does not substantially reduce the fugsionic properties (e.g., the ability to induce endocytic transduction). Non-limiting exemplary embodiments of possible viral envelope glycoprotein domains for use in any of the fusion proteins disclosed herein include:
[00248] VSV-Gmut amino acid sequence (K47Q/R354A, del 1-16, VSVGTM ASP)
KFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTALQVKMPQSHKAIQADG WMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESIEQTKQGTWLNPGFPPQS CGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGKCSNYICPTVHNSTTWHS DYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYFAYETGGKACKMQYCK HWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTSVDVSLIQDVERILDYSL CQETWSKIRAGLPISPVDLSYLAPKNPGTGPAFTIINGTLKYFETRYIRVDIAAPILSRM
VGMISGTTTEAELWDDWAPYEDVEIGPNGVLRTSSGYKFPLYMIGHGMLDSDLHLS
SKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLII
GLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ ID NO: 377)
[00249] VSV-Gmut amino acid sequence (K47Q/R354A):
MKCLLYLAFLFIGVNCKFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTA
LQVKMPQSHKAIQADGWMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESI
EQTKQGTWLNPGFPPQSCGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGK
CSNYICPTVHNSTTWHSDYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYF
AYETGGKACKMQYCKHWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTS
VDVSLIQDVERILDYSLCQETWSKIRAGLPISPVDLSYLAPKNPGTGPAFTIINGTLKY
FETRYIRVDIAAPILSRMVGMISGTTTEAELWDDWAPYEDVEIGPNGVLRTSSGYKFP
LYMIGHGMLDSDLHLSSKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEG
WFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ
ID NO: 378)
[00250] VSVG amino acid sequence:
MKCLLYLAFLFIGVNCKFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTA
LQVKMPKSHKAIQADGWMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESI
EQTKQGTWLNPGFPPQSCGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGK
CSNYICPTVHNSTTWHSDYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYF
AYETGGKACKMQYCKHWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTS
VDVSLIQDVERILDYSLCQETWSKIRAGLPISPVDLSYLAPKNPGTGPAFTIINGTLKY
FETRYIRVDIAAPILSRMVGMISGTTTERELWDDWAPYEDVEIGPNGVLRTSSGYKFP
LYMIGHGMLDSDLHLSSKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEG
WFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ
ID NO: 379)
[00251] VSVGmut2 (K47Q, R354Q):
MKCLLYLAFLFIGVNCKFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTA
LQVKMPQSHKAIQADGWMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESI
EQTKQGTWLNPGFPPQSCGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGK
CSNYICPTVHNSTTWHSDYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYF
AYETGGKACKMQYCKHWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTS VDVSLIQDVERILDYSLCQETWSKIRAGLPISPVDLSYLAPKNPGTGPAFTIINGTLKY FETRYIRVDIAAPILSRMVGMISGTTTEQELWDDWAPYEDVEIGPNGVLRTSSGYKFP LYMIGHGMLDSDLHLSSKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEG WFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ ID NO: 494)
[00252] Cocal:
MNFLLLTFIVLPLCSHAKFSIVFPQSQKGNWKNVPSSYHYCPSSSDQNWHNDLLGIT MKVKMPKTHKAIQADGWMCHAAKWITTCDFRWYGPKYITHSIHSIQPTSEQCKESI KQTKQGTWMSPGFPPQNCGYATVTDSVAVVVQATPHHVLVDEYTGEWIDSQFPNG KCETEECETVHNSTVWYSDYKVTGLCDATLVDTEITFFSEDGKKESIGKPNTGYRSN
YFAYEKGDKVCKMNYCKHAGVRLPSGVWFEFVDQDVYAAAKLPECPVGATISAPT QTSVDVSLILDVERILDYSLCQETWSKIRSKQPVSPVDLSYLAPKNPGTGPAFTIINGT LKYFETRYIRIDIDNPIISKMVGKISGSQTERELWTEWFPYEGVEIGPNGILKTPTGYKF PLFMIGHGMLDSDLHKTSQAEVFEHPHLAEAPKQLPEEETLFFGDTGISKNPVELIEG WFSSWKSTVVTFFFAIGVFILLYVVARIVIAVRYRYQGSNNKRIYNDIEMSRFRK (SEQ ID NO: 495)
[00253] Cocalmut:
MNFLLLTFIVLPLCSHAKFSIVFPQSQKGNWKNVPSSYHYCPSSSDQNWHNDLLGIT MKVKMPQTHKAIQADGWMCHAAKWITTCDFRWYGPKYITHSIHSIQPTSEQCKESI KQTKQGTWMSPGFPPQNCGYATVTDSVAVVVQATPHHVLVDEYTGEWIDSQFPNG KCETEECETVHNSTVWYSDYKVTGLCDATLVDTEITFFSEDGKKESIGKPNTGYRSN
YFAYEKGDKVCKMNYCKHAGVRLPSGVWFEFVDQDVYAAAKLPECPVGATISAPT QTSVDVSLILDVERILDYSLCQETWSKIRSKQPVSPVDLSYLAPKNPGTGPAFTIINGT LKYFETRYIRIDIDNPIISKMVGKISGSQTEAELWTEWFPYEGVEIGPNGILKTPTGYKF PLFMIGHGMLDSDLHKTSQAEVFEHPHLAEAPKQLPEEETLFFGDTGISKNPVELIEG WFSSWKSTVVTFFFAIGVFILLYVVARIVIAVRYRYQGSNNKRIYNDIEMSRFRK (SEQ ID NO: 496)
[00254] Nipah-G:
MPAENKKVRFENTTSDKGKIPSKVIKSYYGTMDIKKINEGLLDSKILSAFNTVIALLGS
IVIIVMNIMIIQNYTRSTDNQAVIKDALQGIQQQIKGLADKIGTEIGPKVSLIDTSSTITIP
ANIGLLGSKISQSTASINENVNEKCKFTLPPLKIHECNISCPNPLPFREYRPQTEGVSNL
VGLPNNICLQKTSNQILKPKLISYTLPVVGQSGTCITDPLLAMDEGYFAYSHLERIGSC
SRGVSKQRIIGVGEVLDRGDEVPSLFMTNVWTPPNPNTVYHCSAVYNNEFYYVLCA
VSTVGDPILNSTYWSGSLMMTRLAVKPKSNGGGYNQHQLALRSIEKGRYDKVMPY
GPSGIKQGDTLYFPAVGFLVRTEFKYNDSNCPITKCQYSKPENCRLSMGIRPNSHYIL
RSGLLKYNLSDGENPKVVFIEISDQRLSIGSPSKIYDSLGQPVFYQASFSWDTMIKFGD
VLTVNPLVVNWRNNTVISRPGQSQCPRFNTCPEICWEGVYNDAFLIDRINWISAGVFL
DSNQTAENPVFTVFKDNEILYRAQLASEDTNAQKTITNCFLLKNKIWCISLVEIYDTG
DNVIRPKLFAVKIPEQCT (SEQ ID NO: 497)
[00255] Nipah-Gmut:
MPAENKKVRFENTTSDKGKIPSKVIKSYYGTMDIKKINEGLLDSKILSAFNTVIALLGS
IVIIVMNIMIIQNYTRSTDNQAVIKDALQGIQQQIKGLADKIGTEIGPKVSLIDTSSTITIP
ANIGLLGSKISQSTASINENVNEKCKFTLPPLKIHECNISCPNPLPFREYRPQTEGVSNL
VGLPNNICLQKTSNQILKPKLISYTLPVVGQSGTCITDPLLAMDEGYFAYSHLERIGSC
SRGVSKQRIIGVGEVLDRGDEVPSLFMTNVWTPPNPNTVYHCSAVYNNEFYYVLCA
VSTVGDPILNSTYWSGSLMMTRLAVKPKSNGGGYNQHQLALRSIEKGRYDKVMPY
GPSGIKQGDTLYFPAVGFLVRTEFKYNDSNCPITKCQYSKPENCRLSMGIRPNSHYIL
RSGLLKYNLSDGENPKVVFIEISDQRLSIGSPSKIYDSLGQPVFYQASFSWDTMIKFGD
VLTVNPLVVNWRNNTVISRPGQSQCPRFNTCPAICAEGVYNDAFLIDRINWISAGVFL
DSNATAANPVFTVFKDNEILYRAQLASEDTNAQKTITNCFLLKNKIWCISLVEIYDTG
DNVIRPKLFAVKIPEQCT (SEQ ID NO: 498)
[00256] Nipah-Gmut trunc:
MKKINEGLLDSKILSAFNTVIALLGSIVIIVMNIMIIQNYTRSTDNQAVIKDALQGIQQQ
IKGLADKIGTEIGPKVSLIDTSSTITIPANIGLLGSKISQSTASINENVNEKCKFTLPPLKI
HECNISCPNPLPFREYRPQTEGVSNLVGLPNNICLQKTSNQILKPKLISYTLPVVGQSG
TCITDPLLAMDEGYFAYSHLERIGSCSRGVSKQRIIGVGEVLDRGDEVPSLFMTNVW
TPPNPNTVYHCSAVYNNEFYYVLCAVSTVGDPILNSTYWSGSLMMTRLAVKPKSNG
GGYNQHQLALRSIEKGRYDKVMPYGPSGIKQGDTLYFPAVGFLVRTEFKYNDSNCPI
TKCQYSKPENCRLSMGIRPNSHYILRSGLLKYNLSDGENPKVVFIEISDQRLSIGSPSKI
YDSLGQPVFYQASFSWDTMIKFGDVLTVNPLVVNWRNNTVISRPGQSQCPRFNTCP
AICAEGVYNDAFLIDRINWISAGVFLDSNATAANPVFTVFKDNEILYRAQLASEDTNA
QKTITNCFLLKNKIWCISLVEIYDTGDNVIRPKLFAVKIPEQCT (SEQ ID NO: 499)
[00257] Nipah-F:
MVVILDKRCYCNLLILILMISECSVGILHYEKLSKIGLVKGVTRKYKIKSNPLTKDIVI KMIPNVSNMSQCTGSVMENYKTRLNGILTPIKGALEIYKNNTHDLVGDVRLAGVIM AGVAIGIATAAQITAGVALYEAMKNADNINKLKSSIESTNEAVVKLQETAEKTVYVL TALQDYINTNLVPTIDKISCKQTELSLDLALSKYLSDLLFVFGPNLQDPVSNSMTIQAI SQAFGGNYETLLRTLGYATEDFDDLLESDSITGQIIYVDLSSYYIIVRVYFPILTEIQQA YIQELLPVSFNNDNSEWISIVPNFILVRNTLISNIEIGFCLITKRSVICNQDYATPMTNN MRECLTGSTEKCPRELVVSSHVPRFALSNGVLFANCISVTCQCQTTGRAISQSGEQTL LMIDNTTCPTAVLGNVIISLGKYLGSVNYNSEGIAIGPPVFTDKVDISSQISSMNQSLQ QSKDYIKEAQRLLDTVNPSLISMLSMIILYVLSIASLCIGLITFISFIIVEKKRNTYSRLED RRVRPTSSGDLYYIGT (SEQ ID NO: 500)
[00258] BaEVRLess:
MGFTTKIIFLYNLVLVYAGFDDPRKAIELVQKRYGRPCDCSGGQVSEPPSDRVSQVT CSGKTAYLMPDQRWKCKSIPKDTSPSGPLQECPCNSYQSSVHSSCYTSYQQCRSGNK TYYTATLLKTQTGGTSDVQVLGSTNKLIQSPCNGIKGQSICWSTTAPIHVSDGGGPLD TTRIKSVQRKLEEIHKALYPELQYHPLAIPKVRDNLMVDAQTLNILNATYNLLLMSN TSLVDDCWLCLKLGPPTPLAIPNFLLSYVTRSSDNISCLIIPPLLVQPMQFSNSSCLFSPS YNSTEEIDLGHVAFSNCTSITNVTGPICAVNGSVFLCGNNMAYTYLPTNWTGLCVLA TLLPDIDIIPGDEPVPIPAIDHFIYRPKRAIQFIPLLAGLGITAAFTTGATGLGVSVTQYT KLSNQLISDVQILSSTIQDLQDQVDSLAEVVLQNRRGLDLLTAEQGGICLALQEKCCF YVNKSGIVRDKIKTLQEELERRRKDLASNPLWTGLQGLLPYLLPFLGPLLTLLLLLTIG PCIFNRLTAFINDKLNIIHAM (SEQ ID NO: 501)
[00259] In some embodiments, the viral envelope glycoprotein domain comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 377-379 or 494- 501.
Stalk domain
In some embodiments, the eVLPs comprise a fusion protein comprising a stalk domain. Any suitable stalk domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein. In some embodiments, the stalk domain is selected from the group consisting of hCD8a-l, hCD8a-2, hIgG4-CH3, mCD3z, mCD4, mCD8a-l, mCD8a-2, hCD8a’, mCD28, hCD8, CD8 hinge region, Siglec-4:12, Siglec-1, Siglec-2, Siglec-3, Siglec- 7, IgGl-CH3, IgG4-CH2CH3, IgGl-CH2CH3, IgGl-1, IgGl-2, IgG2, IgG3, and IgG4. In some embodiments, the stalk domain is selected from the group consisting of hCD8a-l, hCD8a-2, hIgG4-CH3, mCD3z, mCD4, mCD8a-l, mCD8a-2, hCD8a’, mCD28, hCD8, Siglec-4:12, IgGl-CH3, IgG4-CH2CH3, IgGl-CH2CH3, IgGl-1, IgGl-2, IgG2, IgG3, and IgG4. In some embodiments, the stalk domain is selected from the group consisting of mmIgG2_l, mmIgG2_2, and mmIgG2_3. In some embodiments, the stalk domain is selected from the group consisting of IgG3_l, IgG3_2, IgG3_3, IgG3_4, IgG3_5, IgG3_6, IgGl_3, IgGl_4, IgG3_7, IgG2_l, and IgGl_3. In some embodiments, stalk domain is selected from the group consisting of IgAl_l, IgAl_2, IgAl_3, IgAl_4, IgA2_l, IgA2_2, IgA2_3, and IgA2_4. In some embodiments, the stalk domain is selected from the group consisting of IgD_l, IgD_2, IgD_3, IgD_4, IgE, IgM_l, IgM_2, IgM_3, and IgGl_4.
[00260] Non-limiting exemplary embodiments of possible stalk domains for use in any of the fusion proteins disclosed herein include:
[00261] COMP:
GQSPLGSDLGPQMLRELQETNAALQDVRELLRQQVREITFLKNTVMECDACGMQQS VRTGLPSVR (SEQ ID NO: 502)
[00262] CD 8 a trunc:
TTTPAPRPPTPAPTIASQPLSLRPEAC (SEQ ID NO: 503)
[00263] CD8 hinge region
(TTTPAPRPPTPAPTIASQPLSLRPEAC) (SEQ ID NO: 894)
[00264] hCD8a-l
TTTPAPRPPTPAPTIASQPLSLRPEACRPAAAVHTRGLDFACDIYIWAPLAGTCGVLLL
SLVITLYCS (SEQ ID. NO. 29)
[00265] hCD8a-2
TTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDI (SEQ ID. NO. 30)
[00266] hIgG4 CH3
PGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPP
VLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGKS (SEQ
ID. NO. 31)
[00267] mCD3z
QSFGLLDPK (SEQ ID. NO. 32)
[00268] mCD4
LSEGDKVKMDSRIQVLSRGVNQT (SEQ ID. NO. 33)
[00269] mCD8a-l
NISNSVMYFSSVVPVLQKVNSTTTKPVLRTPSPVHPTGTSQPQRPEDCRPRGSVKGTG
LDFACDIY (SEQ ID. NO. 34)
[00270] mCD8a-2
TTTKPVLRTPSPVHPTGTSQPQRPEDCRPRGSVKGTGLDFACD (SEQ ID. NO. 35)
[00271] hCD8a’
KPTTTPAPRPPTPAPTIASQPLSLRPEACRPAAGGAVHTRGLDFACDIY (SEQ ID. NO.
36)
[00272] mCD28
IEFMYPPPYLDNERSNGTIIHIKEKHLCHTQSSPKL (SEQ ID. NO. 37)
[00273] hCD8
IEVMYPPPYLDNERSNGTIIHVKGKHLCPSPLFPGPSKP (SEQ ID. NO. 38)
[00274] Siglec-4:12
PPVIVEMNSSVEAIEGSHVSLLCGADSNPPPLLTWMRDGTVLREAVAESLLLELEEVT
PAEDGVYACLAENAYGQDNRTVGLSVMYAPWKPTVNGTMVAVEGETVSILCSTQS
NPDPILTIFKEKQILSTVIYESELQLELPAVSPEDDGEYWCVAENQYGQRATAFNLSV
EFAPVLLLESHCAAARDTVQCLCVVKSNPEPSVAFELPSRNVTVNESEREFVYSERSG
LVLTSILTLRGQAQAPPRVICTARNLYGAKSLELPFQGAHRLMWAKIGPVGAV (SEQ
ID. NO. 39)
[00275] Siglec 1
MGFLPKLLLLASFFPAGQASWGVSSPQDVQGVKGSCLLIPCIFSFPADVEVPDGITAI
WYYDYSGQRQVVSHSADPKLVEARFRGRTEFMGNPEHRVCNLLLKDLQPEDSGSY
NFRFEISEVNRWSDVKGTLVTVTEEPRVPTIASPVELLEGTEVDFNCSTPYVCLQEQV
RLQWQGQDPARSVTFNSQKFEPTGVGHLETLHMAMSWQDHGRILRCQLSVANHRA
QSEIHLQVKYAPKGVKILLSPSGRNILPGELVTLTCQVNSSYPAVSSIKWLKDGVRLQ TKTGVLHLPQAAWSDAGVYTCQAENGVGSLVSPPISLHIFM (SEQ ID NO: 896).
[00276] Siglec 2
MHLLGPWLLLLVLEYLAFSDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESF
ILFHNPEYNKNTSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLND
SGQLGLRMESKTEKWMERIHLNVSERPFPLHIQLPPEIQESQEVTLTCLLNFSCYGYPI
QLQWLLEGVPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFL
SNDTVQLNVKHTPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSL
KKQNTFTLNLREVTKDQSGKYCCQVSNDVGPGRSEEVFLQVQYA (SEQ ID NO: 897).
[00277] Siglec 3
MPLLLLLPLLWAGALAMDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPV
HGYWFREGAIISRDSPVATNKLDQEVQEETQGRFRLLGDPSRNNCSLSIVDARRRDN
GSYFFRMERGSTKYSYKSPQLSVHVTDLTHRPKILIPGTLEPGHSKNLTCSVSWACEQ
GTPPIFSWLSAAPTSLGPRTTHSSVLIITPRPQDHGTNLTCQVKFAGAGVTTERTIQLN (SEQ ID NO: 898)
[00278] Siglec 7
MLPLQLPPLLWGRERVEGQKSNRKDYSLTMQSSVTVQEGMCVHVRCSFSYPVDSQT
DSDPVHGYWFRAGNDISWKAPVATNNPAWAVQEETRDRFHLLGDPQTKNCTLSIRD ARMSDAGRYFFRMEKGNIKWNYKYDQLSVNVTALTHRPNILIPGTLESGCFQNLTCS VPWACEQGTPPMISWMGTSVSPLHPSTTRSSVLTLIPQPQHHGTSLTCQVTLPGAGVT TNRTIQLNVSYPPQNLTVTVFQGEGTASTALGNSSSLSVLEGQSLRLVCAVDSNPPAR LSWTWRSLTLYPSQPSNPLVLELQVHLGDEGEFTCRAQNSLGSQHVSLNLSL (SEQ ID NO: 899).
[00279] IgGl-CH3
GQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPV LDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK (SEQ ID.
NO. 40)
[00280] IgG4-CH2CH3
FLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKT KPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREP QVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGS FFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK (SEQ ID. NO. 41)
[00281] IgGl-CH2CH3
GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKP REEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQ VYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFF LYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK (SEQ ID. NO. 42)
[00282] IgGl-1
EPKSPDKTHTCPPCP (SEQ ID. NO. 43)
[00283] IgGl-2
YVTVSSQDPAEPKSPDKTHTCPPCP (SEQ ID. NO. 44)
[00284] IgG2
ERKCCVEVPPCP (SEQ ID. NO. 45)
[00285] IgG3
ELKTPLGDTHTCPRCP (SEQ ID. NO. 46)
[00286] IgG4
ESKYGPPCPPCP (SEQ ID. NO. 47)
[00287] Linker C2
ETIRESKYGPPCPPCPGGGGSVP (SEQ ID. NO. 48)
[00288] CAR Spacer XS
YVTVSSQDPAEPKSPDKTHTCPPCPKGKHLCPSPLFPGPSKP (SEQ ID. NO. 49)
[00289] CAR Spacer IS
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSAKPSAPWSGPAARATPQ
HTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHST
AKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLS (SEQ ID. NO. 50)
[00290] CAR Spacer 2S
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSVPPTLEVTQQPVRAENQ
VNVTCQVRKFYPQRLQL TWLENGNVSRTETASTVTENKDGTYNWMS
WLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVS (SEQ ID. NO. 51)
[00291] CAR spacer XIS
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSAKPSAPWSGPAARATPQ
HTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHST
AKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSGGGGSKGKHLCPS PLFPGPSKP (SEQ ID. NO. 52)
[00292] CAR spacer X2S
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSVPPTLEVTQQPVRAENQ
VNVTCQVRKFYPQRLQL TWLENGNVSRTETASTVTENKDGTYNWMS
WLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVSKGKHLCPSPLFP GPSKP
(SEQ ID. NO. 53)
[00293] CAR spacer M
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSAKPSAPWSGPAARATPQ HTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHST AKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQ PVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDG TYNWMSWLLVNVSAHRDDVKLTCQVEHDGQPAVSKSHDLKVS (SEQ ID. NO. 54)
[00294] CAR spacer XM
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSAKPSAPWSGPAARATPQ HTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVDPVGESVSYSIHST AKVVLTREDVHSQVICEVAHVTLQGDPLRGTANLSETIRVPPTLEVTQQ PVRAENQVNVTCQVRKFYPQRLQLTWLENGNVSRTETASTVTENKDG TYNWMSWLLVNVSAH RDDVKL TCQVEHDGQPAVSKSHDLKVSKGKH LCPSPLFPG PSKP (SEQ ID. NO. 55)
[00295] CAR spacer L
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSVPPTLEVTQQPVRAENQ VNVTCQVRKFYPQRLQL TWLENGNVSRTETASTVTENKDGTYNWMS WLLVNVSAH RDDVKL TCQVEHDGQPAVSKSH DLKVSGGGGSAKPSAP WSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVD PVGESVSYSIHSTAKWLTREDVHSQVICEVAHVTLQGDPLRGTANLSE TIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQL TWLENGNVSR TET ASTVTENKDGTYNWMSWLLVNVSAHRDDVKL TCQVEH DGQPAV SKSHDLKVS (SEQ ID. NO. 56)
[00296] CAR spacer XL
YVTVSSQDPAEPKSPDKTHTCPPCPGGGGSVPPTLEVTQQPVRAENQ VNVTCQVRKFYPQRLQL TWLENGNVSRTETASTVTENKDGTYNWMS WLLVNVSAH RDDVKL TCQVEHDGQPAVSKSH DLKVSGGGGSAKPSAP WSGPAARATPQHTVSFTCESHGFSPRDITLKWFKNGNELSDFQTNVD
PVGESVSYSIHSTAKWLTREDVHSQVICEVAHVTLQGDPLRGTANLSE
TIRVPPTLEVTQQPVRAENQVNVTCQVRKFYPQRLQL TWLENGNVSR TET ASTVTENKDGTYNWMSWLLVNVSAHRDDVKL TCQVEH DGQPAV SKSHDLKVSKGKHLCPSPLFPGPSKP (SEQ ID. NO. 57)
[00297] mmIgG2_l
KPCPPCKCP (SEQ ID. NO. 58)
[00298] mmIgG2_2
KPCPPCKCPAP (SEQ ID. NO. 59)
[00299] mmIgG2_3
GPTIKPCPPCKCPAP (SEQ ID. NO. 60)
[00300] IgG3_l
ELKTPLGDTTHTCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPR
CPAP (SEQ ID. NO. 61)
[00301] IgG3_2
CPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAP (SEQ ID.
NO. 62)
[00302] IgG3_3
EPKSCDTPPPCPRCPEPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAP (SEQ ID. NO. 63)
[00303] IgG3_4
EPKSCDTPPPCPRCPEPKSCDTPPPCPRCPAP (SEQ ID. NO. 64)
[00304] IgG3_5
CPRCPEPKSCDTPPPCPRCPAP (SEQ ID. NO. 65)
[00305] IgG3_6
EPKSCDTPPPCPRCPAP (SEQ ID. NO. 66)
[00306] IgGl_3
EPKSCDKTHTCPPCPAP (SEQ ID. NO. 67)
[00307] IgGl_4
PKSCDKTHTCPPCPAP (SEQ ID. NO. 68)
[00308] IgG3_7
PCPRCPAP (SEQ ID. NO. 69)
[00309] IgG2_l
PCPAPPVAG PS (SEQ ID. NO. 70)
[00310] IgGl_3
PPKPKDT (SEQ ID. NO. 71)
[00311] IgAl_l
TVPCPVPSTPPTPSPSTPPTPSPSCCHP (SEQ ID. NO. 72)
[00312] IgA 1_2
TVPCPVPSTP (SEQ ID. NO. 73)
[00313] IgA 1_3
TPSPSTPPTP (SEQ ID. NO. 74)
[00314] IgA 1_4
TPSPSCCHP (SEQ ID. NO. 75)
[00315] IgA2_l
VPCPVPPPPPCCHPR (SEQ ID. NO. 76)
[00316] IgA2_2
VPCPVPP (SEQ ID. NO. 77)
[00317] IgA2_3
PPPCCHP (SEQ ID. NO. 78)
[00318] IgA2_4
PCPVPPPPPCCHP (SEQ ID. NO. 79)
[00319] IgD_l
RWPESPKAQASSVPTAQPQAEGSLAKATTAPATTRNTGRGGEEKKKEKEKEEQEER
ETKTPE CP5HTQPLGVYLLTP (SEQ ID. NO. 80)
[00320] IgD_2
KTPECPSHTQPLGVYLLTP (SEQ ID. NO. 81)
[00321] IgD_3
PECPSHTQPLGVYLLTP (SEQ ID. NO. 82)
[00322] IgD_4
RWPESPKAQASSVP (SEQ ID. NO. 83)
[00323] IgE
SVCSRDFTPP (SEQ ID. NO. 84)
[00324] IgM_l
PLPVIAELPPKVSVFVPPRDGFFGNP (SEQ ID. NO. 85)
[00325] IgM_2
PLPVIAELPP (SEQ ID. NO. 86)
[00326] IgM_3
ELPPKVSVFVPP (SEQ ID. NO. 87)
[00327] IgGl_4
AEPKSPDKTHTCPPCPKDPK (SEQ ID. NO. 88)
[00328] PDGFR
WSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLR (SEQ ID NO: 404)
[00329] In some embodiments, the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 29-88, 404, 502-503, 894, or 896-899.
Targeting domain
[00330] In some embodiments, the eVLPs comprise a fusion protein comprising a targeting domain. Any suitable targeting domain known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein. In some embodiments, the targeting domain is a cytokine. In some embodiments, the targeting domain is a protein. Other targeting domains are possible in other embodiments. For example, in certain embodiments, the targeting domain is a (poly)nucleic acid, a glycoprotein, a protein, a peptide, or a small molecule. In some embodiments, the targeting domain comprises an antibody or an aptamer.
[00331] In some embodiments, the targeting domain is not a viral envelope glycoprotein. In other embodiments the targeting domain is not a fragment of an antibody domain.
[00332] In some embodiments, the targeting domain is configured to bind to a specific target, e.g., a receptor on a specific cell type. The target domain, according to some embodiments, preferentially binds to human hematopoietic stem and progenitor cell (e.g., HSPCs). Without wishing to be bound by any particular theory, it is believed that HSPCs comprise a plurality of cell types. In some embodiments, the target cell type within the family of HSPC cells is the long term HSCs (LT-HSCs) which have both self-renewal and multi-lineage potential. Other target cells within the HSPC family of cells include short term HSCs (ST-HSCs), Multi-Potent Progenitor cells (MPPs), Common Myeloid Progenitor cells (CMPs), Common Lymphoid Progenitor cells (CLPs), Megakaryocyte-erythroid progenitor cells (MEPs), granulocyte-monocyte progenitor cells (GMPs), neutrophils, megakaryocytes,
platelets, erythrocytes, monocytes, macrophages, basophils, lymphocytes, dendritic cells, T cells, B cells, according to other embodiments.
[00333] Again, without wishing to be bound by any particular theory, it is believed that the cells within the HSPC family may be identified by various surface markers. For example, cells expressing CD201+CD150+CD48- Lin‘ c-Kit+Sca-l+ or CD34-Flk2_Lin-c-Kit+Sca-l+ are considered in the art to be LT-HSC cells, according to some embodiments. LT-HSC cells can be further differentiated into ST-HSC cells which express CD34+Flk2-Lin-c-Kit+ Sca-l+, in other embodiments. ST-HSC cells may then differentiate into MPP cells expressing CD34+Flk2+Lin-c-Kit+Sca-l+ or CD150-CD48-Lin_c-Kit+Sca-l+, according to certain embodiments. MPP cells may then either differentiate into CMP cells (e.g., expressing CD34+FcyRIVIIIlowLin_c-Kit+Sca-l-) or CLP cells (e.g., expressing Lin-c-KitlowSca- llowIL7Ra+Flk2+), according to another set of embodiments. CMP cells may further differentiate into MEP cells (e.g., expressing CD34+FcyRIFIIl-Lin-c-Kit+Sca-l-) or GMP cells (e.g., expressing CD34+FcyRIFIII+Lin-c-Kit+Sca-l-); whereas CLP cells further differentiate into dendritic cells, T-cells, NK cells, and B-cells. MEP cells are known to further differentiate into megakaryocytes and erythrocytes; whereas GMP cells may differentiate into basophils, neutrophils, eosinophils, monocytes, and dendritic cells.
Monocytes may also further differentiate into macrophages and monocyte derived dendritic cells.
[00334] In some embodiments, the targeting domain binds to target proteins on T cells and/or B cells. Exemplary targeting domains and their target receptor on T cells are shown below:
[00335] In some embodiments, the targeting domain may bind to any known “receptor” on a target cell surface. Those of skill in the art will understand that the term “receptor” as used herein does not require any signaling event to occur upon binding of the targeting domain to the target receptor, although such a signaling event is not precluded from occurring. As such, the receptor may be any moiety present on the cell surface, including but not limited to glycoproteins, proteins (e.g., globular proteins, lipid anchored proteins, peripheral proteins), carbohydrates, glycolipids, lipids, and/or complexes formed therefrom. Exemplary receptor: targeting domains contemplated herein include, but are not limited to, CD110:Thrombopoientin (TPO), c-kit:Stem Cell Factor (SCF), CXCR4:CXCL12, CD46:Adenovirus F35 (AdF35), CD201:Protein C, CD150:SH2DlA/EAT-2, CD45:CMV ULll/PP14/adenovirus E3, CD54:LFA-1, CD55:CD97, CD58:CD2, CD59:CD2, CD100:Plexin-B2, CD120:TNFa/b, CD124:IL-4, and Flk2:Flt3.
[00336] Non-limiting exemplary embodiments of possible targeting domains for use in any of the fusion proteins disclosed herein include:
[00337] CALR-del52
[00338] LLSVPLLLGLLGLAVAEPAVYFKEQFLDGDGWTSRWIESKHKSDFGKFVL SSGKFYGDEEKDKGLQTSQDARFYALSASFEPFSNKGQTLVVQFTVKHEQNIDCGGG YVKLFPNSLDQTDMHGDSEYNIMFGPDICGPGTKKVHVIFNYKGKNVLINKDIRCKD DEFTHLYTLIVRPDNTYEVKIDNSQVESGSLEDDWDFLPPKKIKDPDASKPEDWDER AKIDDPTDSKPEDWDKPEHIPDPDAKKPEDWDEEMDGEWEPPVIQNPEYKGEWKPR QIDNPDYKGTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVKSGTIFDNFLITNDE AYAEEFGNETWGVTKAAEKQMKDKQDEEQRTRRMMRTKMRMRRMRRTRRKMRR KMSPARPRTSCREACLQGWTEA (SEQ ID NO: 343)
[00339] CALR-ins5
[00340] LLSVPLLLGLLGLAVAEPAVYFKEQFLDGDGWTSRWIESKHKSDFGKFVL SSGKFYGDEEKDKGLQTSQDARFYALSASFEPFSNKGQTLVVQFTVKHEQNIDCGGG YVKLFPNSLDQTDMHGDSEYNIMFGPDICGPGTKKVHVIFNYKGKNVLINKDIRCKD DEFTHLYTLIVRPDNTYEVKIDNSQVESGSLEDDWDFLPPKKIKDPDASKPEDWDER AKIDDPTDSKPEDWDKPEHIPDPDAKKPEDWDEEMDGEWEPPVIQNPEYKGEWKPR QIDNPDYKGTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVKSGTIFDNFLITNDE
AYAEEFGNETWGVTKAAEKQMKDKQDEEQRLKEEEEDKKRKEEEEAEDNCRRMM
RTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQGWTEA (SEQ ID NO: 344)
[00341] CXCL12
[00342] NAKVVVVLVLVLTALCLSDGKPVSLSYRCPCRFFESHVARANVKHLKILN
TPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK (SEQ ID NO: 345)
[00343] AdF35
TKRVRLSDSFNPVYPYEDESTSQHPFYNPGFISPNGFTQSPDGVLTLKCLTPLTTTGGS
LQLKVGGGLTVDDTDGTLQENIRATAPITKNNHSVELSIGNGLETQNNKLCAKLGNG
LKFNNGDICIKDSINTLWTGINPPPNCQIVENTNTNDGKLTLVLVKNGGLVNGYVSLV GVSDTVNQMFTQKTANIQLRLYFDSSGNLLTEESDLKIPLKNKSSTATSETVASSKAF MPSTTAYPFNTTTRDSENYIHGICYYMTSYDRSLFPLNISIMLNSRMISSNVAYAIQFE
WNLNASESPESNIATLTTSPFFFSYITEDDN (SEQ ID NO: 346)
[00344] mSCF soluble
EICGDPVTDNVKDITKLVANLPNDYMITLNYVAGMDVLPSHCWLRDMLIQLSLSLTT
LLDKLSNISEGLSNYSIIHKLGIIVDDLFFCMEENAPKNRKEFPKRPETRSFTPEEFFSIF
NRSIDAFKDFMVASDTSDCVLSSTLGPEKDSRVSVTKPFMLPPVAAS (SEQ ID NO: 347)
[00345] mSCF soluble (V49L/F63L)
EICGDPVTDNVKDITKLVANLPNDYMITLNYVAGMDVLPSHCWLRDMLIQLSLSLTT
LLDKLSNISEGLSNYSIIHKLGIIVDDLFFCMEENAPKNIKEFPKRPETRSFTPEEFFSIFN RSIDAFKDFMVASDTSDCVLSSTLGPEKDSRVSVTKPFMLPPVAAS (SEQ ID NO: 387)
[00346] SCF
KKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYV
PGMDVLPSHCWISEMVVQLSDSLTDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVK ENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSR VSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGA LYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV (SEQ ID NO: 348)
[00347] SCF mutant (V49L/F63L/K91E/I98R)
KKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYV PGMDVLPSHCWISEMLVQLSDSLTDLLDKLSNISEGLSNYSIIDKLVNIVDDLVECVE ENSSKDRKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSR VSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGA
LYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV (SEQ ID NO: 349)
[00348] SCF mutant (V49L/F63L/K9 IE)
KKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYV PGMDVLPSHCWISEMLVQLSDSLTDLLDKLSNISEGLSNYSIIDKLVNIVDDLVECVE ENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSR VSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGA
LYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV (SEQ ID NO: 350)
[00349] SCF mutant (V49L/F63L)
KKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYV PGMDVLPSHCWISEMLVQLSDSLTDLLDKLSNISEGLSNYSIIDKLVNIVDDLVECVK ENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSR VSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGA
LYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV (SEQ ID NO: 351)
[00350] SCF soluble
EGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMVVQLSDSL TDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFF RIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAA (SEQ ID NO:
352)
[00351] SCF soluble mutant (V49L/F63L/K91E/I98R)
EGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMLVQLSDSL TDLLDKLSNISEGLSNYSIIDKLVNIVDDLVECVEENSSKDRKKSFKSPEPRLFTPEEFF RIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAA (SEQ ID NO:
353)
[00352] SCF soluble mutant (V49L/F63L/K9 IE)
EGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMLVQLSDSL
TDLLDKLSNISEGLSNYSIIDKLVNIVDDLVECVEENSSKDLKKSFKSPEPRLFTPEEFF
RIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAA (SEQ ID NO:
354)
[00353] SCF soluble mutant (V49L/F63L)
EGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMLVQLSDSL
TDLLDKLSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFF
RIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAA (SEQ ID NO:
355)
[00354] TPO-157
ELTELLLVVMLLLTARLTLSSPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTP
VLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLS
GQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLR (SEQ ID NO: 356)
[00355] TPO-163
ELTELLLVVMLLLTARLTLSSPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTP
VLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLS
GQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFL (SEQ ID NO: 357)
[00356] TPO-171
ELTELLLVVMLLLTARLTLSSPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTP
VLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLS
GQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFLMLVGGSTL
(SEQ ID NO: 358)
[00357] TPO
ELTELLLVVMLLLTARLTLSSPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTP
VLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLS
GQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFLMLVGGSTLC VRRAPPTTAVPSRTSLVLTLNELPNRTSGLLETNFTASARTTGSGLLKWQQGFRAKIP GLLNQTSRSLDQIPGYLNRIHELLNGTRGLFPGPSRRTLGAPDISSGTSDTGSLPPNLQ PGYSPSPTHPPTGQYTLFPLPPTLPTPVVQLHPLLPDPSAPTPTPTSPLLNTSYTHSQNL SQEG (SEQ ID NO: 359)
[00358] CXCL11
MSVKGMAIALAVILCATVVQGFPMFKRGRCLCIGPGVKAVKVADIEKASIMYPSNN DKIEVIITLKENKGQRCLNPKSKQARLIIKKVERKNF(SEQ ID NO: 360)
[00359] CXCL4
MSSAAGFCASRPGLLFLGLLLLPLVVAFASAEAEEDGDLQCLCVKTTSQVRPRHITSL EVIKAGPHCPTAQLIATLKNGRKICLDLQAPLYKKIIKKLLES (SEQ ID NO: 361)
[00360] CXCL14 (SEQ ID NO: 362)
MRLLAAALLLLLLALYTARVDGSKCKCSRKGPKIRYSDVKKLEMKPKYPHCEEKM VIITTKSVSRYRGQEHCLHPKLQSTKRFIKWYNAWNEKRRVYEE (SEQ ID NO: 362)
[00361] 53E11 a-hCD8 DARPin
MDLGKKLLEAARAGQDDEVRILMTNGADVNALDQAGSTPLHLAAWHGHLEIVEVL LKYGADVNASDIIGQTPLHLAALNGHLEIVEVLLKNGADVNARDRLGETPLHLAAFD GHLEIVEVLLKYDADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA (SEQ ID NO: 900).
[00362] CD8 51.1-Xencor-H1L1 scFv
MQIQLVQSGAEVKKPGASVKVSCKASGYSFTNFGMIWRQAPGQGLEWMGWINTYT GEPTYADGFTGRFVFSLQTSVNTAYLQISSLKAEDTAVYFCARKQYAGFFDYWGQG TLVTVSSGGGGSGGGGSGGGGSDILMTQSPSSLSASVGDRVTITCQASQDIGSNMGW LQQKPGKSFKALIYHGINLEYGVPSRFSGSGSGADYTLTISSLQPEDFATYYCVQFAQ FPYTFGGGTKVEIK (SEQ ID NO: 901).
[00363] 53F6 a-hCD8 DARPin
DLGKKLLEASRAGQDDEVRILMANGADVNAQDRYGTTPLHLAAWHGHLEIVEVLL KHGADVNANDVKGNTPLHLAANVGHLEIVEVLLKYGADVNAADNWGHTPLHLAA FWGHLEIVEVLLKYGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA (SEQ ID NO: 902).
[00364] 53F6 a-hCD8 DARPin
DLGKKLLEASRAGQDDEVRILMANGADVNAQDRYGTTPLHLAAWHGHLEIVEVLL KHGADVNANDVKGNTPLHLAANVGHLEIVEVLLKYGADVNAADNWGHTPLHLAA FWGHLEIVEVLLKYGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA (SEQ ID NO: 903).
[00365] 63A4 a-hCD8 DARPin
MDLGKKLLEAVRAGKDDEVRILMANGADVNAEDTQGNTPLHLVAWHGHLEIVEVL LKYGADVNASDIIGQTPLHLAALNGHLEIVEVLLKYGADVNAWDRHGHTPLHLAAY FGHLEIVEVLLKNGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA (SEQ ID NO: 904).
[00366] Acapatamab
CDQVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMYWVRQAPGKCLEWVAIISDG GYYTYYSDIIKGRFTISRDNAKNSLYLQMNSLKAEDTAVYYCARGFPLLRHGAMDY WGQGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCKASQNVD TNVAWYQQKPGQAPCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATY YADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISYWAYWG QGTLVTVSSGGGGSGGGGSGGGGSQTVVTQEPSLTVSPGGTVTLTCGSSTGAVTSGN YPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPEDEAEYY CVLWY (SEQ ID NO: 905).
[00367] Acapatamab Vh-Vk
QVQLVESGGGLVKPGESLRLSCAASGFTFSDYYMYWVRQAPGKCLEWVAIISDGGY YTYYSDIIKGRFTISRDNAKNSLYLQMNSLKAEDTAVYYCARGFPLLRHGAMDYWG QGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCKASQNVDTNV
AWYQQKPGQAPCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKYNNYATYYA
DSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVR (SEQ ID NO: 906).
[00368] Acapatamab Vh-Vl
EVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSKY
NNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYISY WAYWGQGTLVTVSSGGGGSGGGGSGGGGSQTVVTQEPSLTVSPGGTVTLTCGSSTG AVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQPE DEAEYYCVLWYSNRWVFGGGTKLTVL (SEQ ID NO: 907).
[00369] CD3 DARPin-C7vl4
MDLGQKLLEAAWAGQDDEVRILLAAGADVNAKNSRGWTPLHTAAQTGHLEIFEVL LKAGADVNAKNDKRVTPLHLAAALGHLEIVEVLLKAGADVNARDSWGTTPADLAA KYGHGDIAEVLQKAA (SEQ ID NO: 908).
[00370] CD3 DARPin-C7v 118
MDLGQKLLEAAWAGQDDEVRELLKAGADVNAKDSQGWTPLHTAAQTGHLEIFEVL LKAGADVNAKDDKGVTPLHLAAALGHLEIVEVLLKAGADVNAQDSWGTTPADLAA KYGHEDIAEVLQKAA (SEQ ID NO: 909).
[00371] CD3 DARPin-C7vll9
MDLGQKLLEAAWAGQDDEVRELLKAGADVNAKNSRGWTPLHTAAQTGHLEIFEVL LKAGADVNAKDDKGVTPLHLAAALGHLEIVEVLLKAGADVNAQDSWGTTPADLAA KYGHEDIAEVLQKAA (SEQ ID NO: 910).
[00372] CD3 DARPin-C7vl22
MDLGQKLLEAAWAGQDDEVRELLKAGADVNAKNSRGWTPLHTAAQTGHLEIFEVL LKAGADVNAKNDKRVTPLHLAAALGHLEIVEVLLKAGADVNARDSWGTTPADLAA KYGHQDIAEVLQKAA (SEQ ID NO: 911).
[00373] CD3 DARPin-C7vl27
MDLGQKLLEAAWAGQLDEVRILLKAGADVNAKNSRGWTPLHTAAQTGHLEIFEVL LKAGADVNAKTNKRVTPLHLAAALGHLEIVEVLLKAGADVNARDTWGTTPADLAA KYGHRDIAEVLQKAA (SEQ ID NO: 912).
[00374] scFv-CD3-l
MEVQLQQSGPELVKPGASMKISCKASGYSFTGYTMNWVKQSHGKNLEWMGLINPY KGVSTYNQKFKDKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSGYYGDSDWYF DVWGAGTTVTVSSGGGGSGGGGSGGGGSDIQMTQTTSSLSASLGDRVTISCRASQDI RNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSKFSGSGSGTDYSLTISNLEQEDIATYF CQQGNTLPWTFAGGTKLEIK (SEQ ID NO: 913).
[00375] scFv-CD3-2
DIQMTQTTSSLSASLGDRVTISCRASQDIRNYLNWYQQKPDGTVKLLIYYTSRLHSG VPSKFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFAGGTKLEIKGGGGSGGG GSGGGGSEVQLQQSGPELVKPGASMKISCKASGYSFTGYTMNWVKQSHGKNLEWM GLINPYKGVSTYNQKFKDKATLTVDKSSSTAYMELLSLTSEDSAVYYCARSGYYGD SDWYFDVWGAGTTVTVSS (SEQ ID NO: 914).
[00376] scFv-CD3-3
MQVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPS RGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYW GQGTTLTVSSGGGGSGGGGSGGGGSQIVLTQSPAIMSASPGEKVTMTCSASSSVSYM NWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQ QWSSNPFTFGSGTKLEIN (SEQ ID NO: 915).
[00377] scFv-CD3-4
MEVQLVESGGGLVQPGGSLKLSCAASGFTFNKYAMNWVRQAPGKGLEWVARIRSK YNNYATYYADSVKDRFTISRDDSKNTAYLQMNNLKTEDTAVYYCVRHGNFGNSYIS YWAYWGQGTLVTVSSGGGGSGGGGSGGGGSQTVVTQEPSLTVSPGGTVTLTCGSST GAVTSGNYPNWVQQKPGQAPRGLIGGTKFLAPGTPARFSGSLLGGKAALTLSGVQP EDEAEYYCVLWY (SEQ ID NO: 916).
[00378] scFv-CD4-l
QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYND GTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAY WGQGTLVTVSSGGGGSGGGGSGGGGSDIVMTQSPDSLAVSLGERVTMNCKSSQSLL YSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAE DVAVYYCQQYYSYRTFGGGTKLEIK (SEQ ID NO: 917).
[00379] scFv-CD4-2
MDIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIY WASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK GGGGSGGGGSGGGGSQVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQK PGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYC AREKDNYATGAWFAYWGQGTLVTVSS (SEQ ID NO: 918).
[00380] Sana CD 19 scFv FMC63 G4S linker
DIQMTQTTSSLSASLGDRVTISCRASQDISKYLNWYQQKPDGTVKLLIYHTSRLHSGV PSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPYTFGGGTKLEITGGGGSGGGG SGGGGSEVKLQESGPGLVAPSQSLSVTCTVSGVSLPDYGVSWIRQPPRKGLEWLGVI WGSETTYYNSALKSRLTIIKDNSKSQVFLKMNSLQTDDTAIYYCAKHYYYGGSYAM DYWGQGTSVTVSS (SEQ ID NO: 919).
[00381] Sana CD22 scFv m971-L7
QVQLQQSGPGMVKPSQTLSLTCAISGDSVSSNSVAWNWIRQSPSRGLEWLGRTYYR STWYNDYAVSMKSRITINPDTNKNQFSLQLNSVTPEDTAVYYCAREVTGDLEDAFDI WGQGTMVTVSSGGGGSGGGGSGGGGSDIQMIQSPSSLSASVGDRVTITCRASQTIWS YLNWYRQRPGEAPNLLIYAASSLQSGVPSRFSGRGSGTDFTLTISSLQAEDFATYYCQ
QSYSIPQTFGQGTKLEIK (SEQ ID NO: 920).
[00382] CD28 scFv
DIQMNQSPSSLSASLGDTITITCHASQNIYVWLNWYQQKPGNIPKLLIYKASNLHTGV PSRFSGSGSGTGFTLTISSLQPEDIATYYCQQGQTYPYTFGGGTKLEIKRADAAPTVSI FPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYS MSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRNGGGGSGGGGSGGGGSSQVQ
LQQSGPELVKPGTSVRISCEASGYTFTSYYIHWVKQRPGQGLEWIGCIYPGNVNTNY NEKFKDKATLIVDTSSNTAYMQLSRMTSEDSAVYFCTRSHYGLDWNFDVWGAGTT VTVSSAKTTPPSVYPLAPGSAAQTNSMVTLGCLVKGYFPEPVTVTWNSGSLSSGVHT FPAVLQSDLYTLSSSVTVPSSTWPSETVTCNVAHPASSTKVDKKIVPRDC (SEQ ID NO: 921).
[00383] hCDl 17 scFv Ab54 CA3079215A1
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGT ANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRGT LVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWY QQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVSDI TFGGGTKVEIK (SEQ ID NO: 922).
[00384] hCDl 17 scFv Ab55 CA3079215A1
QVQLVQSGAEVKKPGSSVKVSCKASGGTFRIYAISWVRQAPGQGLEWMGGIIPDFG VANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRG TLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNW YQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVS DITFGGGTKVEIK (SEQ ID NO: 923).
[00385] hCDl 17 scFv Ab56 CA3079215A1
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSLYAISWVRQAPGQGLEWMGGIIPAFG TANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRG TLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNW YQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVS DITFGGGTKVEIK (SEQ ID NO: 924).
[00386] hCDl 17 scFv Ab57 CA3079215A1
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSLYAISWVRQAPGQGLEWMGGIIPHFG LANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRG TLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNW YQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVS DITFGGGTKVEIK (SEQ ID NO: 925).
[00387] hCD117 scFv Ab61 CA3079215A1
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYVMIWVRQAPGKGLEWVSSISGDSVT TYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGPPTYHTNYYYMDV WGKGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSVSASVGDRVTITCRASQGISS WLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQ QTNSFPYTFGGGTKVEIK (SEQ ID NO: 926).
[00388] hCDl 17 scFv Ab66 CA3079215A1
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKA SSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 927).
[00389] hCDl 17 scFv Ab67 CA3079215A1
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDADMDWVRQAPGKGLEWVGRTRNKA GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 928).
[00390] hCDl 17 scFv Ab68 CA3079215A1
EVQLVESGGGLVQPGRSLRLSCTASGFTFSDHDMNWVRQAPGKGLEWVGRTRNAA GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 929).
[00391] hCDl 17 scFv Ab69 CA3079215A1
EVQLVESGGGLVQPGGSLRLSCAASGFTFVDHDMDWVRQAPGKGLEWVGRTRNKL GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL
NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS
YIAPYTFGGGTKVEIK (SEQ ID NO: 930).
[00392] USPTO 6,054,297 genentech hCDl 17 scFv
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYAMSWVRQAPGKGLEWVAVISENGS DTYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARDRGGAVSYFDVWG QGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQDVSSYL AWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQY NSLPYTFGQGTKVEIKRT (SEQ ID NO: 931).
[00393] Sana CD8 scFv form 1
QVQLVQSGAEVKKPGASVKVSCKASSYYIHMHWVRQAPGQGLEWMGRRINPKSGR TYYAQNFQGNYAQKFQGRVTSTRDTSISTAYMELSRLRSDDTVVYYCLTEGIPDYW GQGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQNIGTW LAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQ
SYSTPQTFGPGTKVDIKRFGGGTKVEIK (SEQ ID NO: 932).
[00394] Sana CD8 scFv form 2
QVQLVQSGAEVKKPGASVKVSCKASSYYIHMHWVRQAPGQGLEWMGRRINPKSGR TYYAQNFQGNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTVVYYCLTEGIPDYW GQGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQNIGTW LAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQ SYSTPQTFGPGTKVDIKRFGGGTKVEIK (SEQ ID NO: 933).
[00395] Sana CD8 scFv form 3
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIRINPK SGRTYYAQNFQGSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCLTEGIP DYWGQGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQNI GTWLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYY CQQSYSTPQTFGPGTKVDIKRFGGGTKVEIK (SEQ ID NO: 934).
[00396] Sana CD8 scFv form 4
QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGRINPK SGRTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTVVYYCARLTEGIPDYWGQG TTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAW YQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYST PQTFGPGTKVDIKRFGGGTKVEIK (SEQ ID NO: 935).
[00397] Sana CD8 scFv form 5
QVQEVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGEEWMGIINPKS GRTSYAQKFQGRVTMTRDTSTSTVYMEESSERSEDTAVYYCARETEGIPDYWGQGT TVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSESASVGDRVTITCRASQNIGTWEAWY QQKPGKAPKEEIYAASTEQSGVPSRFSGSGSGTDFTETISSEQPEDFATYYCQQSYSTP QTFGPGTKVDIKRFGGGTKVEIK (SEQ ID NO: 936).
[00398] Sana CD8 scFv form 6
DIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAWYQQKPGKAPKLLIYAASTLQSG VPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGPGTKVDIKRFGGGTKVE IKGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASSYYIHMHWVRQAP GQGLEWMGRRINPKSGRTYYAQNFQGNYAQKFQGRVTSTRDTSISTAYMELSRLRS DDTVVYYCARLTEGIPDYWGQGTTVTVSS (SEQ ID NO: 937).
[00399] Sana CD8 scFv form 7
DIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAWYQQKPGKAPKLLIYAASTLQSG VPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGPGTKVDIKRFGGGTKVE IKGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASSYYIHMHWVRQAP GQGLEWMGRRINPKSGRTYYAQNFQGNYAQKFQGRVTMTRDTSISTAYMELSRLRS DDTVVYYCARLTEGIPDYWGQGTTVTVSS (SEQ ID NO: 938).
[00400] Sana CD8 scFv form 8
DIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAWYQQKPGKAPKLLIYAASTLQSG VPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGPGTKVDIKRFGGGTKVE IKGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVR
QAPGQGLEWMGIRINPKSGRTYYAQNFQGSYAQKFQGRVTMTRDTSTSTVYMELSS
LRSEDTAVYYCARLTEGIPDYWGQGTTVTVSS (SEQ ID NO: 939).
[00401] Sana CD8 scFv form 9
DIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAWYQQKPGKAPKLLIYAASTLQSG
VPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGPGTKVDIKRFGGGTKVE
IKGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVR QAPGQGLEWMGRINPKSGRTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTVVY YCARLTEGIPDYWGQGTTVTVSS (SEQ ID NO: 940).
[00402] Sana CD8 scFv form 10
DIQMTQSPSSLSASVGDRVTITCRASQNIGTWLAWYQQKPGKAPKLLIYAASTLQSG
VPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPQTFGPGTKVDIKRFGGGTKVE
IKGGGGSGGGGSGGGGSQVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVR QAPGQGLEWMGIINPKSGRTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVY YCARLTEGIPDYWGQGTTVTVSS (SEQ ID NO: 941).
[00403] Sana CD8 VHH form 1
QVQLVESGGGLVQPGGSLRLSCSASGYVMGMHWVRQAPGKGLEYVSAAISRGGLS TSYADSVKGYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCDRSDLYEIT AASNIDSWGQGTTVTVSS (SEQ ID NO: 942).
[00404] Sana CD8 VHH form 2
QVQLQQWGAGLLKPSETLSLTCAVYGRTFSGYVWSWIRQPPGKGLEWIGEISRGGLS TNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAADRSDLYEITAASNIDSW GQGTTVTVSS (SEQ ID NO: 943).
[00405] Sana CD8 VHH form 3
QVQLVESGGGLVQPGGSLRLSCSASGRTFSGYMHWVRQAPGKGLEYVSAVISRGGL STAAYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCDRSDLYEITAASNID SWGQGTTVTVSS (SEQ ID NO: 944).
[00406] CD117 scFv AHI:
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGVIYSGN GDTSYNQKFKGKATLTADKSSSTAYMQINSLTSEDSAVYYCARERDTRFGNWGQGT LVTVSAGGGGSGGGGSGGGGSNIVLTQSPASLAVSLGLRATISCRASESVDIYGNSFM HWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQ NNEDPYTFGGGTKLEIK(SEQ ID NO: 504).
[00407] CD 117 scFv AH2:
NIVLTQSPASLAVSLGLRATISCRASESVDIYGNSFMHWYQQKPGQPPKLLIYLASNL ESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPYTFGGGTKLEIKGGGG SGGGGSGGGGSQVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQ
GLEWIGVIYSGNGDTSYNQKFKGKATLTADKSSSTAYMQINSLTSEDSAVYYCARER DTRFGNWGQGTLVTVSA (SEQ ID NO: 505).
[00408] CD 117 scFv 2Dl:
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTTVAWYQQKPGQSPKLLIYSASYRYTG VPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPPTFGGGTKLEIKGGGGSGG GGSGGGGSQVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWVKQRPEQGLEWI GCISPGNGDIKYNEKFKGKATLSADKSSSTAYMQLNSLTSEDSAVYFCKRWDYFDY WGQGTTLTVSS (SEQ ID NO: 506).
[00409] CD 117 scFv 2D2:
QVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWVKQRPEQGLEWIGCISPGNGD
IKYNEKFKGKATLSADKSSSTAYMQLNSLTSEDSAVYFCKRWDYFDYWGQGTTLTV SSGGGGSGGGGSGGGGSDIVMTQSHKFMSTSVGDRVSITCKASQDVSTTVAWYQQK PGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPPT FGGGTKLEIK (SEQ ID NO: 507).
[00410] CD117 scFv 4Fl:
DIVMTQSHKFMSTSVGDRVSITCKASQDVSTTVAWYQQKPGQSPKLLIYSASYRYTG VPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTPPTFGGGTKLEIKGGGGSGG GGSGGGGSEVQLQESGPSLVKPSQTLSLTCSVTGDSITSGYWNWIRKFPGNKLEYMG
YINYSGSTYYNPSLKSQISITRDTSKNQYYLQLNSVTTEDAATYYCARGGNYFAMDY WGQGTSVTVSS (SEQ ID NO: 508).
[00411] CD 117 scFv 4F2:
EVQLQESGPSLVKPSQTLSLTCSVTGDSITSGYWNWIRKFPGNKLEYMGYINYSGST
YYNPSLKSQISITRDTSKNQYYLQLNSVTTEDAATYYCARGGNYFAMDYWGQGTSV TVSSGGGGSGGGGSGGGGSDIVMTQSHKFMSTSVGDRVSITCKASQDVSTTVAWYQ QKPGQSPKLLIYSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQQHYSTP PTFGGGTKLEIK (SEQ ID NO: 509).
[00412] CD 117 scFv 4k94:
EVQLVESGGGLVQPGGSLRLSCAASGFNISSYSMHWVRQAPGKGLEWVASIYPYSG
YTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARYVYHALDYWGQGT LVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWY QQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQWAVH SLITFGQGTKVEIK (SEQ ID NO: 510).
[00413] CD117 scFv 54:
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGT ANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRGT LVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWY
QQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVSDI TFGGGTKVEIK (SEQ ID NO: 511).
[00414] CD117 scFv 55:
QVQLVQSGAEVKKPGSSVKVSCKASGGTFRIYAISWVRQAPGQGLEWMGGIIPDFG VANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRG TLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNW YQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVS DITFGGGTKVEIK (SEQ ID NO: 512).
[00415] CD117 scFv 56:
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSLYAISWVRQAPGQGLEWMGGIIPAFG TANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRG TLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNW
YQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVS
DITFGGGTKVEIK (SEQ ID NO: 513).
[00416] CD117 scFv 57:
QVQLVQSGAEVKKPGSSVKVSCKASGGTFSLYAISWVRQAPGQGLEWMGGIIPHFG LANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARGGLDTDEFDLWGRG TLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSINSYLNW YQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGVS DITFGGGTKVEIK (SEQ ID NO: 514).
[00417] CD117 scFv 58
EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVSAISGSGG STYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGPPTYHTNYYYMD VWGKGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSVSASVGDRVTITCRASQGIS SWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYC QQTNSFPYTFGGGTKVEIK (SEQ ID NO: 515).
[00418] CD117 scFv 61:
EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYVMIWVRQAPGKGLEWVSSISGDSVT TYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGPPTYHTNYYYMDV WGKGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSVSASVGDRVTITCRASQGISS WLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQ QTNSFPYTFGGGTKVEIK (SEQ ID NO: 516).
[00419] CD117 scFv 66:
EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKA SSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 517).
[00420] CD117 scFv 67:
EVQLVESGGGLVQPGRSLRLSCTASGFTFSDHDMNWVRQAPGKGLEWVGRTRNAA GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 518).
[00421] CD117 scFv 68:
EVQLVESGGGLVQPGRSLRLSCTASGFTFSDHDMNWVRQAPGKGLEWVGRTRNAA GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 519).
[00422] CD117 scFv 69:
EVQLVESGGGLVQPGGSLRLSCAASGFTFVDHDMDWVRQAPGKGLEWVGRTRNKL GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 520).
[00423] CD117 scFv 70:
EVQLVESGGGLVQPGGSLRLSCAASGFTFVDHDMDWVRQAPGKGLEWVGRTRNKL GSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCAREPKYWIDFDLW GRGTLVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQSISSYL NWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQS YIAPYTFGGGTKVEIK (SEQ ID NO: 521).
[00424] CD 117 SRI scFv:
QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGQGLEWIGVIYSGN GDTSYNQKFKGKATLTADKSSSTAYMQINSLTSEDSAVYYCARERDTRFGNWGQGT LVTVSAAKTTGGGGSGGGGSGGGGSIVLTQSPASLAVSLGLRATISCRASESVDIYGN SFMHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYY CQQNNEDPYTFGGGTKLEIK (SEQ ID NO: 522).
[00425] CXCR4 scFv 1:
EVQLVESGGGLVQPGGSLRLSCAAAGFTFSSYSMNWVRQAPGKGLEWVSYISSRSR
TIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARDYGGQPPYYYYYG MDVWGQGTTVTVSSGGGGSGGGGSGGGGSDIQMTQSPSSLSASVGDRVTITCRASQ GISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFVTY YCQQYNSYPRTFGQGTKVEIK (SEQ ID NO: 527).
[00426] CXCR4 scFv 2:
DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGV PSRFSGSGSGTDFTLTISSLQPEDFVTYYCQQYNSYPRTFGQGTKVEIKGGGGSGGGG SGGGGSEVQLVESGGGLVQPGGSLRLSCAAAGFTFSSYSMNWVRQAPGKGLEWVS YISSRSRTIYYADSVKGRFTISRDNAKNSLYLQMNSLRDEDTAVYYCARDYGGQPPY YYYYGMDVWGQGTTVTVSS (SEQ ID NO: 528).
[00427] CD90 scFv 1:
QVQLLQPGAELVRPGASVRLSCKTSGYTFTSYWINWVKQRPGQGLEWIGKIFPSDSH TNYNQKFKDKATLTVDKSSSTAYMQLISPTSEDSAVYYCTRDFDTQFYAMEYWGQ GTSVTVSSGSDSNAGHASAGNTSQIVLTQSPTIMSASPGQKVTINCSAISSVNYMHWY QQKPGSSPKLWIYATSKLTLGVPARFSGSGSGTSYSLTVNSMVTEDATSYFCHQWSS YPPTFGAGTKLELK (SEQ ID NO: 529).
[00428] CD90 scFv 2:
QVQLLQPGAELVRPGASVRLSCKTSGYTFTSYWINWVKQRPGQGLEWIGKIFPSDSH
TNYNQKFKDKATLTVDKSSSTAYMQLISPTSEDSAVYYCTRDFDTQFYAMEYWGQ GTSVTVSSGGGGSGGGGSGGGGSDIQMTQTTSSLSASLGDRVTISCRASQDISNYLN WYQQKPDGTFKLLIYYTSRLHSGVPSRFSGGGSGTDYSLTISNLEKEDIATYFCQQGN TLPRTFGGGTRLEVK (SEQ ID NO: 530).
[00429] CD 133 scFv 1:
AEVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISRTG
GVTRYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRTRRFDYWCQGT
LVTVSSSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYSASDLQSGVP
SRFSGSGSGTDFTLTISSLQPEDFATYYCQQTANSPSTFGQGTKVEI (SEQ ID NO: 531).
[00430] CD 133 scFv 2:
DIVLSQSPAIMSASPGEKVTISCSASSSVSYMYWYQQKPGSSPKPWIYRTSNLASGVP ARFSGSGSGTSYSLTISSMEAEDAATYYCQQYHSYPPTFGAGTKLELKSSGGGGSGG GGGGSSRSSLEVKLVESGPELKKPGETVKISCKASGYTFTDYSMKWVNQAPGKGLK WMGWINTETGEPSYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCATDYGD YFDYWGQGTTLTVSS (SEQ ID NO: 532).
[00431] FLT3L:
DCSFQHSPISSDFAVKIRELSDYLLQDYPVTVASNLQDEELCGGLWRLVLAQRWMER LKTVAGSKMQGLLERVNTEIHFVTKCAFQPPPSCLRFVQTNISRLLQETSEQLVALKP WITRQNFSRCLELQCAAAIEVMYPPPYLDNEKSNGTIIHVKGKHLCPSPLFPGPSKP (SEQ ID NO: 533).
[00432] In some embodiments, the targeting domain comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 343-362, 387, 900-944, 504-522, or 527- 533.
[00433] In some embodiments, the targeting domain is selected from the group consisting of CALR-del52, CALR-ins5, CXCL12, AdF35, mSCF soluble, SCF, SCF mutant (V49L/F63L/K91E/I98R), SCF mutant (V49L/F63L/K91E), SCF mutant (V49L/F63L), SCF soluble, SCF soluble mutant (V49L/F63L/K91E/I98R), SCF soluble mutant (V49L/F63L/K91E), SCF soluble mutant (V49L/F63L), TPO-157, TPO-163, TPO-171, TPO, CXCL1 1, CXCL4, and CXCL14
Signaling peptides
[00434] In some embodiments, the eVLPs comprising a fusion protein may further comprise an optional signaling peptide. Any suitable signaling peptide known to one of ordinary skill in the art may be used to make the fusion proteins contemplated herein. Without wishing to be bound by any particular theory, it is believed that signaling peptides
(also referred to as signal sequence, targeting signal, localization signal, localization sequence, transit peptide, leader sequence, or leader peptide) is a short peptide (e.g., typically between 16-30 amino acids long) present at the N-terminus (or occasionally non-classically at the C-terminus or internally within the peptide sequence) of most newly synthesized proteins that are destined toward the secretory pathway. Functionally, signaling peptides prompt a cell to translocate the protein to a desired location (e.g., to the cell membrane). In some embodiments, the signaling peptide is cleaved from the fusion protein following translocation; however, in other embodiments, the signaling peptide is not cleaved from the fusion protein following translocation.
[00435] VSVG:
MKCLLYLAFLFIGVNC (SEQ ID. NO. 6)
[00436] hCD4:
MNRGVPFRHLLLVLQLALLPAATQG (SEQ ID. NO. 7)
[00437] hCD45:
MYLWLKLLAFGFAFLDTEVFVTG (SEQ ID. NO. 8)
[00438] hCD8a:
MSLPVTALLLPLALLLHAARP (SEQ ID. NO. 9)
[00439] hCD8a-l
MALPVTALLLPLALLLHAARP (SEQ ID. NO. 10)
[00440] hCD8b:
MRPRLWLLLAAQLTVLHGNSV (SEQ ID. NO. 11)
[00441] hCD2:
MSFPCKFVASFLLIFNVSSKGAVS (SEQ ID. NO. 12)
[00442] hCD5:
MPMGSLQPLATLYLLGMLVASCLG (SEQ ID. NO. 13)
[00443] hCD7:
MAGPPRLLLLPLLLALARGLPGALA (SEQ ID. NO. 14)
[00444] hTYRPl:
MSAPKLLSLGCIFFPLLLFQQARA (SEQ ID. NO. 15)
[00445] hLALBa:
MRFFVPLFLVGILFPAILA (SEQ ID. NO. 16)
[00446] hBGAL:
MPGFLVRILPLLLVLLLLGPTRG (SEQ ID. NO. 17)
[00447] hCD52:
MKRFLFLLLTISLLVMVQIQTGLS (SEQ ID. NO. 18)
[00448] hCD109:
MQGPPLLTAAHLLCVCTAALA (SEQ ID. NO. 19)
[00449] hCO3:
MGPTSGPSLLLLLLTHLPLALG (SEQ ID. NO. 20)
[00450] hGRAB:
MQPILLLLAFLLLPRADA (SEQ ID. NO. 21)
[00451] hKV310:
MEAPAQLLFLLLLWLPDTTR (SEQ ID. NO. 22)
[00452] hKV401:
MVLQTQVFISLLLWISGAYG (SEQ ID. NO. 23)
[00453] hLV605:
MAWAPLLLTLLAHCTDCWA (SEQ ID. NO. 24)
[00454] hIL2RG:
MLKPSLPFTSLLFLQLPLLGVG (SEQ ID. NO. 25)
[00455] hBPILl:
MAWASRLGLLLALLLPVVGA (SEQ ID. NO. 26)
[00456] hFCGRN:
MGVPRPQPWALGLLLFLLPGSLG (SEQ ID. NO. 27)
[00457] mlgK:
MAVPTQVLGLLLLWLTOA (SEQ ID. NO. 28)
[00458] B2M signal peptide
MSRSVALAVLALLSLSGLEA (SEQ ID NO: 395
[00459] In some embodiments, the signaling peptide comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 6-28.
Fusion protein sequences
[00460] In some embodiments the fusion proteins comprise at least one of the following non-limiting structures:
(1) [Signaling peptide] -[TPO]- [optional linker] -[VS VGTM];
(2) [Signaling peptide]- [SCFK9iEmono]- [optional linker] -[ VS VGmut];
(3) [Signaling peptide]- [ADF35]-[optional linker] -[VS VGTM];
(4) [Signaling peptide] -[SCF]- [optional linker] -[ VS VG];
(5) [Signaling peptide] -[SCF] -[optional linker] -[IgG4]- [optional linker] -[CD62];
(6) [Signaling peptide] -[SCF] -[optional linker] -[CD8]- [optional linker] -[CD43];
(7) [Signaling peptide] -[SCF] -[optional linker] -[CD8]- [optional linker]- [CD62];
(8) [Signaling peptide] -[SCF] -[optional linker] -[CD8]- [optional linker] -[HL A- A2];
(9) [Signaling peptide] -[SCF] -[optional linker] -[CD8]- [optional linker]-[HLA-DRA];
(10) [Signaling peptide] -[SCF] -[optional linker] -[CD8]- [optional linker] -[LFA-1].
(11) [TPO] -[optional linker] -[VS VGTM] ;
(12) [SCFK9iEmono]- [optional linker] -[VS VGmut];
(13) [ADF35]-[optional linker] -[ VS VG™];
(14) [SCF]- [optional linker] -[ VS VG];
(15) [SCF] -[optional linker] -[IgG4]- [optional linker] -[CD62];
(16) [SCF] -[optional linker] -[CD8]- [optional linker] -[CD43];
(17) [SCF] -[optional linker] -[CD8]- [optional linker]- [CD62];
(18) [SCF] -[optional linker] -[CD8]- [optional linker] -[HLA-A2];
(19) [SCF] -[optional linker] -[CD8]- [optional linker]-[HLA-DRA];
(20) [SCF] -[optional linker] -[CD8]- [optional linker] -[LFA-1]
(21) [SCF(V49L/F63L)]- [optional linker] -[ VS VG™]
(22). [SCF (V49L/F63L/K91E)]-[optional linker] -[ VS VGMUTASP].
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCT
CTGCCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATT
CTTCGAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACT
CCAAACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTG
TGCATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAAC
AAGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCATGAAGTGCCTTTTGTACTTA
GCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCA
AAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCA
GATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCC
AGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGG
TCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCG
ATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACA
AGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTG
ACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATG
AATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATT
ACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAA
AGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGAC
GGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTT
GCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGA
GTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTG
CAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGAC
CTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTC
TGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGAT
CTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCA
ATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCC
AATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACT
GTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCT
GAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTC
AAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGG
GCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAG
CTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCT
CCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATT
TATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACA
GATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCA
ATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTC
GAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTG
GTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCT
CTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTA
ATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCAC
TCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGG
TTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCT
ATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCAT
AGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTT
TCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTC
TCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGG
ATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCG
CTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGT
GCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCC
AGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGA
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGAAGCCA
TCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCG
ACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTT
CGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTT
AGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTT
TCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGT
AACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGT
TTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGG
GTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATG
ATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATT
GGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAAT
GATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTC
TGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGG
TTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGA
ATTCTGACACTATGACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTA
CCCCTACGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATC
AGCCCTAATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGA
CCCCTCTCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGA
CCGTGGACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTA
TCACCAAGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCC
AGAACAACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAG
ATATCTGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACC
TAATTGCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGT
GCTGGTTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCC
GATACAGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTG
TATTTCGACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCC
TGAAAAACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCT
TCATGCCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAA
CTACATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCC
CTGAACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTAC
GCCATCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATC
GCCACACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACA
GCGGTGGGAGCGGCGGGAGCGGCGGTAGCAAGTGCCTTTTGTACTTAGCCTTTTT
ATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGA
AACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAA
ATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTC
ACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTAC
TTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTC
ACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACT
TGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATG
CCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACAC
AGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATG
CCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTA
TGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGC
TATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATC
CGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID.
NO. 90)
[00463] Construct 114
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGC
CAGGCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGC
AAGCTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGG
TGCACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGA
GTGGAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGA
CCCTGCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCT
GTCCAGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCT
GCAGAGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAA
GGACCCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGG
TTTCTGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCA
CCGCCGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAG
AACGAGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTC
TGGTCTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAA
CCAGACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGA
GCTGCTGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGG
AGCTCCTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCT
GCAACCTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTG
TTTCCTCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCC
TGACCCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTAC
ACACACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGG
CGGTAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCA
AGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTC
TAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATA
GGCACAGCCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGAC
GGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATG
GACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATG
CAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCC
TCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAG
GTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCAC
AGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTAC
AACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCC
ATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAG
GGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGC
AAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTC
GAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAG
GGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGA
CGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAG
AGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCA
GGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCA
GATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGAT
CAGTGGAACTACCACAGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGA
CGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCT
TTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGG
CTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGA
TGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTA
GAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGG
GTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAAT
TAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTG
GAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTT
GTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAA
AAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCA
GGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCA
CAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAG
CCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGT
GTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCAT
TTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGC
TGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGC
CCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTT
TTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACAT
GTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCC
TCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATA
GCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCC
GGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTA
ATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGC
ATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID. NO. 91)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCAC
CATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTAC
CATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAG
CCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGA
TGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAA
GTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAA
AGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAA
AGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACT
CCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCA
TCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTG
GCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGAC
ATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCCGGGAAAGGAGGGCACA
GGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATG
CAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATG
GCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAA
GTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGA
GAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGG
TCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACC
GGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACA
TCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGG
AACTACCACAGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGA
AATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATAC
ATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGG
TGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAG
TTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGT
TGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAAT
CATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGC
ACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGT
AACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATA
CCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAA
AAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGC
AGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAAT
ACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCT
TGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTT
GGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAA
ACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCT
GCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCT
GCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTAT
ATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTT
CCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAA
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGT
TGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACG
CTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATAC
CTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAG
GTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCC
CCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACC
CGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACG
GCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTT
CGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGG
TGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAA
GATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTT
AAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAA
TTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGAC
AGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTC
ATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTA
CCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAG
ATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTG
CAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAG
TAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTG
GTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAA
GGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCC
TCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCA
GCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGG
TGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCT
TGCCCGGCG (SEQ ID. NO. 92)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGAAGCCA
TCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCG
ACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTT
CGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTT
AGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTT
TCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGT
AACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGT
TTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGG
GTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATG
ATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATT
GGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAAT
GATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTC
TGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGG
TTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGA
ATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCA
ACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTG
ACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTAC
ATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGA
TCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTT
CAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAA
CATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAA
AAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGA
ATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACAT
CTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGT
GACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGC
AGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGG
GCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCG
CTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCC
AGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAA
TTTCAGGAGGTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAA
TCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTT
TATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID. NO. 93)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCT
GCACGCCGCTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCT
CCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGG
GTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGAC
TACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTT
GGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACA
AGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGG
TCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACC
TGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTT
CAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAG
ACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTG
TCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACG
ACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGC
ACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTC
GGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAAC
ATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACG
GGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGT
GCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTT
TTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATT
GCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACA
AGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCA
TGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATA
ACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTG
AACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTG
GATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACC
ATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGG
AAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCT
GACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCT
TCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCA
GAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACT
GCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATA
AGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTC
TGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATC
TTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAA
TCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGC
TTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTC
GATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCA
CAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGAC
CCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGG
ACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAA
CATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTT
TGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGT
AGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACT
ATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAG
AAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAA
TCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTC
AAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAA
ACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCT
ATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAG
ATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCT
GACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTT
TGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGA
ATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAA
CAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCAT
TCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTT
GTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGA
TTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAG
ATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTG
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCC
AACGCGCGGGGA (SEQ ID. NO. 94)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCT
GCACGCCGCTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCT
CCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGG
GTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGAC
TACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTT
GGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACA
AGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGG
TCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACC
GGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTT
CAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAG
ACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTG
TCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACG
ACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGC
ACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTC
GGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAAC
ATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACG
GGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGT
GCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTT
TTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATT
GCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACA
AGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCA
TGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATA
ACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTG
AACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTG
GATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACC
ATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGG
AAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCT
GACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCT
TCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCA
GAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACT
GCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATA
AGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTC
TGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATC
TTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAA
TCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGC
TTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTC
GATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCA
CAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGAC
CCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGG
ACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAA
CATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTT
TGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGT
AGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACT
ATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAG
AAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAA
TCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTC
AAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAA
ACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCT
ATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAG
ATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCT
GACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTT
TGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGA
ATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAA
CAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCAT
TCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTT
GTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGA
TTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAG
ATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTG
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCC
AACGCGCGGGGA (SEQ ID. NO. 95)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACG
TGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACG
TGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGC
AGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGG
CCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGC
CTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTT
TCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAG
TCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATG
CTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAAC
ACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAA
CAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGA
TATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATG
TGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAA
AATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGA
CTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTC
TTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGA
AGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGC
AAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAG
GATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTG
CTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTT
GGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATC
TCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTT
TCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGA
TATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACA
GAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCC
AATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGAC
ATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACA
TCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTG
GTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAG
TTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATC
CTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAA
AGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAAC
GGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTAT
CAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGAT
CTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGA
CTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTG
TGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAAT
GAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACA
AAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTC
CTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGA (SEQ ID. NO. 96)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCT
GCACGCCGCTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAA
GGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAA
GTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGT
GGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCT
GAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGAC
CTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAG
AGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGA
GTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGT
CAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATT
CATGCTGCCTCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAT
GAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCA
TAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCA
TTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCC
TTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATG
TGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAG
CATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAG
TTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCT
CACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCA
ACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCA
TTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATC
ACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGG
TTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAA
TACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTG
ATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTAT
CTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGG
ATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTC
CAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCC
TGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGA
GTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTA
CCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTG
GACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGAT
TGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTC
GAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTAT
TTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTT
CAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTG
GACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACC
AAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTC
AAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATG
CTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAA
AAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCT
GCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGA (SEQ ID. NO. 97)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
GGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCG
CCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACCTAACTCAAATCCT
GCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAG
AGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGG
AATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCA
GAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATACCACTGAGATCT
TTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACT
TCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTG
TCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGA
GTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAA
GGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCT
TATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTG
TTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTT
TTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATC
CCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAA
TTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAA
AGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAAC
GCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGA
CTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCG
GTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCA
AAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTC
CATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGG
TGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCC
CTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCT
CCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCG
GTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCG
ACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGA
CTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGT
AGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAG
AACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTT
GGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTT
GCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCT
TTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGT
CATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGT
TTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCT
TAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCC
TGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCA
GTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAAT
AAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGC
CTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTT
AATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGT
CGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATG
ATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTC
AGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATT
CTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACC
AAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCG (SEQ
ID. NO. 98)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
ATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCA
GCTACGTGATGTGGAAGGCCGGCTTCTTCAAAAGACAGTACAAGTCCTAACTCA
AATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGC
TCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAA
AAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTG
CCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTT
GATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATT
TTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAAT
GAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCA
ATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAG
TTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGG
CCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCA
GCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTA
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGC
CAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACG
CTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTT
ACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCG
TTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCA
TAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACT
CAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGC
G (SEQ ID. NO. 99)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
CCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTAT
CATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGTAACTCAA
ATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCT
CAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAA
AACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGC
CTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATACCACTG
AGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCAT
CTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTT
TTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAG
AATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGA
ACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCC
ATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGT
TTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCC
AGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTT
GATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATT
TTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAAT
GAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCA
ATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAG
TTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGG
CCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCA
GCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTA
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGC
CAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACG
CTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTT
ACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCG
TTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCA
TAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACT
CAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGC
G (SEQ ID. NO. 100)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
CTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGT
GGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAACTA
ACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATAC
CATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAA
AAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCA
GGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATA
CCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTT
GAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTT
GGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAA
ACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCT
GCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCT
GCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTAT
ATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTT
CCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAA
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGT
TGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACG
CTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATAC
CTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAG
GTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCC
CCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACC
CGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACG
GCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTT
CGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGG
TGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAA
GATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTT
AAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAA
TTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGAC
AGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTC
ATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTA
CCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAG
ATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTG
CAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAG
TAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTG
GTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAA
GGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCC
TCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCA
GCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGG
TGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCT
TGCCCGGCG (SEQ ID NO: 101)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
ATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTG
TGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGCTAACTCA
AATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGC
TCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAA
AAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTG
CCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTT
GATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATT
TTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAAT
GAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCA
ATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAG
TTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGG
CCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCA
GCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTA
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGC
CAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACG
CTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTT
ACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCG
TTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCA
TAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACT
CAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGC
G (SEQ ID NO: 102)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
AACGTGGTGTGCGCCCTGGGCCTGACCGTGGGCCTGGTCGGCATCATCATTGGAA
CAATCTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCC
CTCTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTT
GTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAA
AAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCA
GGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCA
CAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAG
CCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGT
GTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCAT
TTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGC
TGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGC
CCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTT
TTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACAT
GTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCC
TCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATA
GCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCC
GGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTA
ATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGC
ATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTT
CCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGT
ATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGC
AGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGG
CCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAA
TCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGC
GTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCG
GATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGC
TGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACG
AACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTC
CAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGAT
TAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAA
CTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTT
ACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGT
AGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTC
AAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTC
ACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTT
TTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGT
CTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATT
TCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAG
GGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGG
CTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTG
GTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAG
AGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGC
ATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACG
ATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTC
GGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTA
TGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTG
ACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTT
GCTCTTGCCCGGCG (SEQ ID NO: 103)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
ATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGA
GCACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTGTAACTCA
AATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGC
TCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAA
AAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTG
CCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTT
GATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATT
TTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAAT
GAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCA
ATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAG
TTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGG
CCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCA
GCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTA
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGC
CAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACG
CTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTT
ACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCG
TTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCA
TAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACT
CAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGC
G (SEQ ID NO: 104)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
TACCTGTACGTGCTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCA
TCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAGTAACTCAAATCCTG
CACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGA
GGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGA
ATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAG
AAGGTGGTGGCTGGTGTGGCCAATGCCCCGGCTCACAAATACCACTGAGATCTTT
TTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTC
TGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTC
TCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGT
ATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGG
TTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTA
TTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTT
ATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTT
CCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCC
TCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATT
GTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAG
CCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCC
CGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGC
GCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACT
CGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGT
AATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAA
AAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCC
ATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGT
GGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCC
TCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTC
CCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGG
TGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGA
CCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGAC
TTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTA
GGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGA
ACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTG
GTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTG
CAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTT
TTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTC
ATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTT
TTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTT
AATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCT
GACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAG
TGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATA
AACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCC
TCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTA
ATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTC
GTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGA
TCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCA
GAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTC
TCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCA
AGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCG (SEQ
ID NO: 105)
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACT
GCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACC
AACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATG
ATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCA
GCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCA
GCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACA
TCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAA
AGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAAT
CTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCT
GATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTG
ACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCA
GCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGG
CCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCT
CTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAG
ATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATT
TCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTT
GTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCAC
ACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTC
AAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAA
AATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCC
AAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATT
CCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAA
CGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGC
AACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTG
GTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGC
AGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATA
AGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTC
AGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTA
ACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGC
ATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCT
CTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCA
TCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATT
ATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCC
AGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACC
ATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTG
CTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAG
CGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATG
GAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGG
TATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGA
TACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGG
AAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGC
ACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAG
GCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAA
TTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGA
AGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTT
TCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCT
GGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCT
CTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTA
TTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGT
TGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTAT
TCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTA
TTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTC
CTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCT
CGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTG
TTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGC
CTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCC
GCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCG
CGGGGA (SEQ ID NO: 106)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAACGCCAAGGTCGTGGT
CGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCGTCAGC
CTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGCCAACG
TCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTAGCCCG
GCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGGATTCA
GGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGTGGGAGCATTGC
CTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGG
TATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCC
GTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAGGATCTCAA (SEQ ID NO: 107)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGACCAAAAGAGTGCGGCT
GTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCCAGCAC
CCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCCAGATG
GCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCCCTGCA
ACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTGCAGG
AGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAACTGA
GCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTGGGCA
ATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAACACCCT
GTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACCAATAC
CAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTCAACGG
CTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACACAGAAG
ACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCTGACAG
AGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCACATCTG
AGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCTTTTAA
CACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTACATGAC
CAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACAGCAG
GATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGAACGC
CAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTTCTTC
AGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGTGGGAGCATTGCCTCT
TTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATG
TTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGA
GTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGT
CGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGT
GGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAAT
TATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAAT
TTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACA
TATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGG
CAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTC
ATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTT
GACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATC
CCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACT
CCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCA
ATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAG
TGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCC
AGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGA
CTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA
AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGG
TAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCA
GCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAGGATCTCAA (SEQ ID NO: 108)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGAACTTACAGAACTGCT
GCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGGCTCCT
CCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACGTGCTG
CACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGTGCTGCT
CCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGAGACAAA
GGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGATGGCCGC
TCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTGAGTGG
ACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAACTCCC
ACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTGAGCTT
CCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCTCCACC
CTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATCTCTGG
TTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACCAACTT
CACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAGGGCTT
CAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATCAGAT
CCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCCTCTT
CCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCACAAG
CGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCCCACT
CACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCAACAC
CCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAACCCC
CACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCAGGAG
GGCAGCGGTGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAA
TCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAG
CACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
TAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGAT
ACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAA
AAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGC
AGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAAT
ACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCT
TGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTT
GGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAA
ACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCT
GCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCT
GCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTAT
ATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTT
CCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAA
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGT
TGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACG
CTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATAC
CTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAG
GTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCC
CCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACC
CGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACG
GCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTT
CGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGG
TGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
(SEQ ID NO: 109)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAAAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAAAAAACCCAGACCT
GGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGAC
CGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCT
GGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATG
GACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGAT
TCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATT
ACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGA
AAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGAC
TGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAA
GGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCC
CCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGG
CCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACC
CCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAG
CCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGC
CTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGC
ATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGG
GAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATC
CTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAA
AGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAAC
GGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTAT
CAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGAT
CTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGA
CTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTG
TGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAAT
GAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACA
AAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTC
CTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 110)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGATGAAGTGCCTTTTGTA
CTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTG
ACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCA
TCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTA
ATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCT
GCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGAC
AGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATC
ATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAAC
AGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACC
CCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCG
TGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAA
GGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGC
TCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGA
GATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCA
TCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAG
GGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCA
GGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTG
GGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACA
ACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCC
TCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCC
TCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGG
TGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCC
CTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGC
TAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTC
ACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTT
GGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGG
CTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCC
ATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTT
TTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCC
TCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGAC
GGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATC
CGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGG
GTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTT
CCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGG
GAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTG
CGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATA
CGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGG
CCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAG
GCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCG
AAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGT
GCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTT
CGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTA
GGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTAT
CGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCG
GTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAG
TATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAG
CTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAG
CAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 111)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATC
TGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTATT
CATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAA
CTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATT
GGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACA
AGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTG
TGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACT
CCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGG
CTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCG
AAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGG
AGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCC
CACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGT
GATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTAT
CATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAA
CTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCC
CATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATT
CCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGAT
GTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAA
CCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCT
TGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTA
AAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAA
GAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACT
GGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTT
CAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTT
CATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTT
CGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAA
TCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCT
TTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATG
TTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGA
GTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCG
AGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGG
CCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTA
TGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTT
ATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATA
TGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCA
ACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCAT
CAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGA
CTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCT
AAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCC
CAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAAT
TCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCA
CACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTG
AGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACC
TGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGC
GTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGG
CTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAA
TCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAG
GAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGAC
GAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTA
TAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGA
CCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTT
TCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGC
TGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAA
CTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCC
ACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTG
AAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTC
TGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAAC
AAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAG
AAAAAAAAGGATCTCAA (SEQ ID NO: 112)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCT
CCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTG
CTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCC
TCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGC
AGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGA
TCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACCT
AACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATA
CCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAA
AAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCA
GGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATA
CCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTT
GAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTT
GGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAA
ACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCT
GCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCT
GCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTAT
ATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTT
CCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAA
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGT
TGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACG
CTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATAC
CTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAG
GTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCC
CCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACC
CGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACG
GCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTT
CGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGG
TGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
(SEQ ID NO: 113)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCT
CCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTG
CTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCC
TCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGC
AGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGC
TGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACA
AGTCCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTT
GTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAA
AAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTC
AGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTC
ACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAA
GCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATA
GTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATC
ATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATAT
GCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACA
GCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTT
TTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACA
TGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCC
CTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCAT
AGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGC
CGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATT
AATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTG
CATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCT
TCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGG
TATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACG
CAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAG
GCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAA
ATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGG
CGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACC
GGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCAC
GCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCA
CGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAG
TCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGG
ATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCT
AACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAG
TTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTG
GTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATC
TCAA (SEQ ID NO: 114)
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTT
GATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATT
TTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAAT
GAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCA
ATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAG
TTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGG
CCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCA
GCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTA
TCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGC
CAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACG
CTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTT
ACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCG
TTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCA
TAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACT
CAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGC
GTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATT
GGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCA
GTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACC
AGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAAT
AAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGA
AGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGA
AAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAAT
TGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCAT
TTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGA
CCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAA
CGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACT
ACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTA
AATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCG
AACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCT
GGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGC
GCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGG
GCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGC
TGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGG
CCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAGACCTGGATCCTGACAT
GCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTG
CAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCT
GCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCTC
TGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATC
TGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGTAACTCAAATCC
TGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAA
GAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGA
ATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAG
AAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTT
TTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTC
TGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTC
TCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGT
ATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGG
TTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTA
TTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTT
ATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTT
CCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCC
TCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATT
GTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAG
CCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCC
CGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGC
GCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACT
CGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGT
AATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAA
AAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCC
ATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGT
GGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG (SEQ ID
NO: 115)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCT
CCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTG
CTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCC
TCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGC
AGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCT
TCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACC
CTGTGCGGAACTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAAT
CAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTT
ATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGC
GCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGA
GCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGAT
AACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA
AAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCAC
AAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC
CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCT
TACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCT
CACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGT
GCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTT
GAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAAC
AGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGG
CCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCG
CTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGG
ATCTCAA (SEQ ID NO: 116)
GCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATC
ATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGAT
CCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTC
ACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGG
AATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTAT
TGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTT
AGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTA
AATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCT
CATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATA
GACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAG
AACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCA
CTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCAC
TAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGG
CGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGC
GCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAA
TGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAA
GGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGT
GCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTA
AAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGC
TCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCC
ATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGAC
ATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAG
CCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGA
CCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAA
CGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGC
CCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTC
AATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACT
TTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCG
GTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCA
AGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGG
ACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGC
GTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCG
CCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATC
CAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGAT
TGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTT
CAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGA
TAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTC
TTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTT
AAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTT
CAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTG
TTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGG
AAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTT
TATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAA
ACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGG
GCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGG
ATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCC
CCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAGACCTGGATCCTG
ACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCA
TCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTA
ATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCT
GCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGAC
AGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATC
ATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAAC
AGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACC
CCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCG
TGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAA
GGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGC
TCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGA
GATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCA
TCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAG
GGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCA
GGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCG
GTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAG
CCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACA
AGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCT
GCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCAT
CGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTG
GTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGCTAACTCAAA
TCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTC
AAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAC
GGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTAT
CAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGAT
CTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGA
CTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTG
TGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAAT
GAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACA
AAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTC
CTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATC
TTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGG
TCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAG
TTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGC
TTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGC
CTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCC
AGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCA
ATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCC
GCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAG
TTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTC
GTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACA
TGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTG
TCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAA
TTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAA
CCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCG (SEQ
ID NO: 117)
TTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCC
GATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAG
AAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCG
CGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCG
CCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTAT
TACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGC
CAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAAT
ACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAG
AGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATGTACATTTATATTGGC
TCATGTCCAACATTACCGCCATGTTGACATTGATTATTGACTAGTTATTAATAGTA
ATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAA
CTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGT
CAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCA
ATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCAT
ATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATT
ATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATT
AGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGA
TAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGA
GTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGC
CCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAG
AGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGAC
CTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAAC
TTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATT
CATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGT
CCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGT
TGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAAC
TTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGT
AAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTAC
TTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTT
CTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACA
CCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAG
ATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATG
CCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCAT
CATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCC
CTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGAC
CTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTT
TAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGT
GAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCT
GAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGAT
GGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATT
TCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGAC
GACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTC
AAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACC
GGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGT
GGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCC
ATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCT
AATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATG
GCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTG
GAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACG
AGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAG
GTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGA
CCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGG
CCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACAT
CTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTG
ATCACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACC
GTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAA
AGAGCAACGCCGCTGAGCGGAGAGGCCCTCTGTAACTCAAATCCTGCACAACAG
ATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAA
TTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAG
GGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTG
GCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTG
CCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATA
AAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCG
GAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTT
AGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATA
AAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGA
AAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCT
TTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCC
TGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATC
GGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTC
ACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCC
TAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGT
CGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAG
GCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCG
GTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTAT
CCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAA
AAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGC
CCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCG
ACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTC
CTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGC
GTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTC
GCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTT
ATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTG
GCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACA
GAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTA
TCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATC
CGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATT
ACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTG
ACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAA
AAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTA
AAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCA
CCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGT
GTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGAT
ACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGC
CGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCT
ATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCA
ACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGC
TTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTG
TGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGG
CCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATG
CCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAG
AATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATAC
CGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGG
CGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTC
GTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCA
AAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATG
TTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATT
GTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGG
TTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAATATTTTG
TTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGA
AATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGT
TGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAA
AGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTA
ATCAAGTT (SEQ ID NO: 118)
AGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCAC
ATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAG
CTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGC
TCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGC
GGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAA
CGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAA
AGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAA
AAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCA
GGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTA
CCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCA
CGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGC
ACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGA
GTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAG
GATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCC
TAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCA
GTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCT
GGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGA
TCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAA
ACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGAT
CCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACT
TGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTC
TATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACG
GGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTC
ACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAG
AAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAA
GCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTA
CAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCC
CAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGC
TCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCA
TGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTT
TCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGAC
CGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAA
CTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGAT
CTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCT
TCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCT
TCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATAC
ATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCC
GAAAAGTGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAAT
TTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTT
ATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACA
AGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCT
ATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTC
GAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGC
TTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAG
GAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCA
CACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCT
GCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTG
GCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCC
CAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTA
TAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCA
TTGCATACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAAC
ATTACCGCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACG
GGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAA
ATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGAC
GTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAG
TATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTA
CGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTA
CATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTA
TTACCATGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGA
CTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGG
CACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGC
AAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAG
TGAACCGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAG
ACACCGGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAG
TTTGGGGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGG
AGGGGGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCAC
CATGGACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATT
GTCTCCTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCA
TTTGTAACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCT
CTAATCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGT
TTTAGAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAA
TTCTGGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATC
ATCCTGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAA
ATACTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTT
TCCTACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAA
GAATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACC
GCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCC
AGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGT
GAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGC
CAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGC
CCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGA
CAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAAC
GAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGG
GAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACC
TGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCC
GCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGG
CCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTA
CTGCAGCGGTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATG
GGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCAAGAA
ATACCGGCTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATC
AACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTA
TGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCC
TCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCT
CACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGA
AGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAAT
AGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAAT
CATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATA
TGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAAC
AGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGAT
TTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTA
CATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGT
CCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTC
ATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACG
(SEQ ID NO: 119)
CGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGC
AAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAAT
GTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGG
GTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAATATTTT
GTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCG
AAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTG
TTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAA
AGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTA
ATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGG
GAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGG
AAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTC
ACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCG
TCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCT
CTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTT
GGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGC
GCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGGCGGCC
GCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATGTACAT
TTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGACTAGTT
ATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCG
CGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGC
CCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCC
ATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCA
AGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCC
GCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACA
TCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATCAAT
GGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACG
TCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAA
CAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTA
TATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCATCCACG
CTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGACCGAT
CCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTCGCTAT
TGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTAGAATG
GGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTTCACTT
TCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTAACTTT
TTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTTTATTT
GTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGGTATAT
TATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGATAAGG
TAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGGTAGA
AACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGATATAC
ACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGCTAAC
CATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTGTTGT
GCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATTCTGA
CACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCAC
GCCGCTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAA
CTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGA
CCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACA
TGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGAT
CAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTT
CAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAA
CATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAA
AAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGA
ATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACAT
CTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGT
GACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGC
AGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGG
GCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCG
CTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCC
AGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAA
TTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCT
GCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGC
GGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCG
CCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCT
CTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCTACCTGTACGTGTTGAGC
GGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGG
GCTTTTTCAAAAGAAACCTGAAGTAACTCAAATCCTGCACAACAGATTCTTCATG
TTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGA
GTTTTTAATTTTTATGAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGA
GGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCC
AATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATG
GGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTAT
TTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATG
GGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAAC
ATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCA
GTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACT
TGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTA
AAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCC
AGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATT
CGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCAC
ACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGA
GCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCT
GTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCG
TATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGC
TGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAAT
CAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGG
AACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACG
AGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTAT
AAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGAC
CCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCT
GGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAAC
TATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCA
CTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGA
AGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCT
GCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACA
AACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGA
AAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGT
GGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCT
TCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATA
TGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCA
GCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAAC
TACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGA
CCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGC
CGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGT
TGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTG
CCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAG
CTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAA
GCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGT
TATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTA
AGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTA
TGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCAC
ATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAAC
TCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACT (SEQ ID
NO: 120)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCT
CGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAG
ACGGACCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAAC
TTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGA
AAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTC
AGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTC
ACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAA
GCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATA
GTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATC
ATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATAT
GCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACA
GCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTT
TTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACA
TGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCC
CTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCAT
AGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGC
CGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATT
AATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTG
CATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCT
TCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGG
TATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACG
CAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAG
GCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAA
ATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGG
CGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACC
GGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCAC
GCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCA
CGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAG
TCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGG
ATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCT
AACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAG
TTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTG
GTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATC
TCAA (SEQ ID NO: 121)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCT
GATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCTTCTTCAAAAGA
CAGTACAAGTCCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAA
TCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTT
TATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGC
GCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGA
GCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGAT
AACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA
AAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCAC
AAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC
CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCT
TACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCT
CACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGT
GCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTT
GAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAAC
AGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGG
CCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCG
CTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGG
ATCTCAA (SEQ ID NO: 122)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGC
CTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAA
GAAATCTAAGCGGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAA
ATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTT
TTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTC
ACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCC
TGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACAT
CATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATT
GCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGG
CAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGC
CCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATAT
GAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGT
TAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTT
CCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATA
GCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATC
ATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACAT
ACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACT
CACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGC
CAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGG
CGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCG
AGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGA
TAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTA
AAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCA
CAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATA
CCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGC
TTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGC
TCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTG
TGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCT
TGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAA
CAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTG
GCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAG
CCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACC
GCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAG
GATCTCAA (SEQ ID NO: 123)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCAC
AATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCA
CATGTACCCTGTGCGGAACTAACTCAAATCCTGCACAACAGATTCTTCATGTTTG
GACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTT
TTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGA
GGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCC
AATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATG
GGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTAT
TTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATG
GGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAAC
ATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCA
GTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACT
TGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTA
AAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCC
AGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATT
CGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCAC
ACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGA
GCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCT
GTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCG
TATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGC
TGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAAT
CAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGG
AACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACG
AGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTAT
AAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGAC
CCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCT
GGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAAC
TATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCA
CTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGA
AGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCT
GCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACA
AACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGA
AAAAAAGGATCTCAA (SEQ ID NO: 124)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGG
CGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAG
CGACAGAAAGGGCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCA
AATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATT
TTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATT
CACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCC
CTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACA
TCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATT
GCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGG
CAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGC
CCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATAT
GAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGT
TAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTT
CCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATA
GCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATC
ATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACAT
ACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACT
CACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGC
CAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGG
CGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCG
AGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGA
TAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTA
AAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCA
CAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATA
CCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGC
TTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGC
TCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTG
TGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCT
TGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAA
CAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTG
GCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAG
CCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACC
GCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAG
GATCTCAA (SEQ ID NO: 125)
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACCGTGGGCCT
GGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAAGAGCAA
CGCCGCTGAGCGGAGAGGCCCTCTGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATC
CGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAGGATCTCAA (SEQ ID NO: 126)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGC
CAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTC
TACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAAC
TACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCA
GACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCG
TGATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCT
GGGCAAGAGCGGTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGAT
CATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCAA
GAAATACCGGCTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAA
ATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTT
TTATGAAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATT
CACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCC
CTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACA
TCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATT
GCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGG
CAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGC
CCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATAT
GAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGT
TAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTT
CCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATA
GCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATC
ATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACAT
ACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACT
CACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGC
CAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGG
CGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCG
AGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGA
TAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTA
AAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCA
CAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATA
CCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGC
TTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGC
TCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTG
TGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCT
TGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAA
CAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTG
GCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAG
CCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACC
GCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAG
GATCTCAA (SEQ ID NO: 127)
TCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCT
GGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCA
TAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTA
AACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATT
GACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTAT
GGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGT
GATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGG
ATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAAT
CAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGC
GGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGT
CAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGG
GACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGG
ACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGG
CAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGA
CCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCT
CTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAA
CGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCA
CTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAG
AACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGC
TGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGC
CTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCT
GAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACA
GCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTC
CTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGCCCTG
CTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAGACCT
GGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGAC
CGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCT
GGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATG
GACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGAT
TCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATT
ACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGA
AAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGAC
TGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAA
GGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCC
CCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGG
CCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACC
CCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAG
CCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGC
CTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGC
ATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGG
TAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGCCAGGA
GGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTCTACCC
CAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAACTACA
AGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCAGACT
GACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCGTGAT
GCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCTGGGC
AAGAGCGGTGGGAGCTACCTGTACGTGCTGAGCGGCATCGGCGGACTGCTGCTG
CTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGA
AGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTG
ATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAA
AAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGT
GCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAA
ATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCC
CTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGT
GTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTT
AAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTG
GCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCC
CCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTT
TATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGT
TTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTC
TTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGC
TGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGG
AAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAAT
TGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGT
TTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACT
ACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTAC
CTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGT (SEQ ID NO: 128)
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTGACA
TGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCT
GCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATC
TGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGG
AGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGG
TCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACCTAACTCAAAT
CCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCA
AAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAA
CGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTA
TCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGA
TCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTG
ACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTT
GTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAA
TGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAAC
AAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATT
CCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTT
GTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGA
TTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAG
ATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTG
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCC
AACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCAC
TGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAG
GCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGA
GCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTT
TTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAG
AGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGC
TCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTT
CGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCC
CGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTAT
GTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGA
AGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAG
TTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGT
TTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 129)
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTGACA
TGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCT
GCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATC
TGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGG
AGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTT
TTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGTAAC
TCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCA
TGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAA
AAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGG
CTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCA
CTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAG
CATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGA
ATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACA
TCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCC
ATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCT
GTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATT
TTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACT
AGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCT
TATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTC
CTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCAT
AAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTG
CGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAA
TCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTC
GCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCAC
TCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAAC
ATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCT
GGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGT
CCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTAT
CTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCG
TTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGT
AAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTA
CACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGA
AAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGT
TTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEG ID
NO: 130)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTGACA
TGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCT
GCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATC
TGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGG
AGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCAC
CGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAA
CTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGA
TACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAA
AAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGT
GCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAA
ATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCC
CTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGT
GTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTT
AAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTG
GCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCC
CCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTT
TATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGT
TTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTC
TTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGC
TGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGG
AAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAAT
TGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGT
TTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTAGCCTAACT
ACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTAC
CTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
(SEQ ID NO: 131)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTGACA
TGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCT
GCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATC
TGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCCTGCTGGCTATCCTGA
TCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAG
ACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAACTAACTCAAATCCTGCAC
AACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGC
CTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTC
CTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAG
GTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTC
CCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGG
CTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCT
CACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATT
TGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTG
GCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTC
CATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTT
TTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTC
CTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGA
CGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTAT
CCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGG
GGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTT
TCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGG
GGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCT
GCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAAT
ACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAG
GCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATA
GGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGC
GAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCG
TGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCT
TCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGT
AGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCG
CTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTA
TCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGC
GGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACA
GTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTA
GCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAA
GCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 132)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCACCAAAAGAGTGCGGCTGTCTGATAGC
TTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCCAGCACCCCTTCTACA
ACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCCAGATGGCGTGCTGAC
CCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCCCTGCAACTGAAGGTG
GGCGGAGGACTGACCGTGGACGACACCGACGGCACACTGCAGGAGAACATCAG
AGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAACTGAGCATCGGCAA
CGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAA
GTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAACACCCTGTGGACCGG
AATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACCAATACCAACGACGG
CAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTCAACGGCTACGTGTC
CCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACACAGAAGACCGCTAA
TATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCTGACAGAGGAATCT
GACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCACATCTGAGACAGTG
GCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCTTTTAACACCACCA
CACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTACATGACCAGCTACG
ACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACAGCAGGATGATCA
GCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGAACGCCAGCGAGA
GCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTTCTTCAGCTACATC
ACCGAAGATGACAACAGCGGTGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTA
TCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGC
ATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAAC
CGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAA
TCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTT
TATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGC
GCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGA
GCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGAT
AACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA
AAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCAC
AAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC
CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCT
TACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCT
CACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGT
GCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTT
GAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAAC
AGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGG
CCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCG
CTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGG
ATCTCAA (SEQ ID NO: 133)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTGACA
TGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCT
GCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATC
TGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGG
AGCATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTT
CACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAAT
TACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCA
CAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTT
GGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACC
GAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAG
GAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCT
CAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTG
ACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGT
TCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAAC
CTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATG
GACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGC
ACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAA
ATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAG
ATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGT
CAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGT
TGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGC
GGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGA
ACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGAT
ACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAG
TGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGT
GGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTA
TACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTC
AGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGA
GAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAA
GGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTT
AATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAA
AGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAA
AGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTG
ATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAA
AAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGT
GCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAA
ATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCC
CTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGT
GTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTT
AAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTG
GCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCC
CCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTT
TATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGT
TTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTC
TTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGC
TGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGG
AAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAAT
TGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGT
TTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACT
ACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTAC
CTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
(SEQ ID NO: 134)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTG
GGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGA
AAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCAT
AATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCT
ATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATT
TCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATC
TGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGA
ATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGC
AGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAA
TGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTG
TCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTC
TAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCC
CTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGA
GGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCA
GGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAG
TCTAATTCAGGACGTTGAGAGGATCCTGGATTATTCCCTCTGCCAAGAAACCTGG
AGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTC
CTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATA
CTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATG
GTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATGACTGGGCA
CCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGA
TATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCT
TAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAA
CTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAAT
CGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCT
TTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTT
TGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATG
AACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACC
AAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAA
TTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAA
TTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATG
CCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGA
CATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTC
ATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGA
GGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATA
TGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTAT
ATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAG
GTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATT
TTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCAT
AGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAAT
CATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAAC
ATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAA
CTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGT
GCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTG
GGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGG
CGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGG
GATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCG
TAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCAT
CACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAG
ATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGC
CGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAT
AGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCT
GTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCG
TCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGT
AACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGG
TGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGA
AGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCA
CCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAA
AGGATCTCAA (SEQ ID NO: 135)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTG
GGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGA
AAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCAT
AATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCT
ATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATT
TCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATC
TGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGA
ATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGC
AGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAA
TGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTG
TCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTC
TAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCC
CTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGA
GGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCA
GGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAG
TCTAATTCAGGACGTTGAGAGGATTCTGGATTATTCCCTCTGCCAAGAAACCTGG
AGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTC
CTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATA
CTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATG
GTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATGACTGGGCA
CCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGA
TATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCT
TAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAA
CTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAAT
CGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCT
TTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTT
TGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATG
AACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACC
AAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAA
TTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAAT
TCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGC
CCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGAC
ATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCA
TTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAG
GGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATAT
GCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTAT
ATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAG
GTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATT
TTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCAT
AGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAAT
CATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAAC
ATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAA
CTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGT
GCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTG
GGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGG
CGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGG
GATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCG
TAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCAT
CACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAG
ATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGC
CGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCAT
AGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCT
GTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCG
TCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGT
AACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGG
TGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGA
AGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCA
CCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAA
AGGATCTCAA (SEQ ID NO: 136)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTGGGAG
CGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATT
GGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGG
AAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGC
ATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTCACAAGG
CTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGA
TTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCA
TCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTG
AATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAG
CAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGA
ATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACT
GTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATT
CTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATC
CCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGG
AGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATC
AGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCT
GAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAA
GTCTAATTCAGGACGTTGAGAGGATCCTGGATTATTCCCTCTGCCAAGAAACCTG
GAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCT
CCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAAT
ACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAAT
GGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATGACTGGGC
ACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGG
ATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATC
TTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCA
ACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCA
ATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTT
CTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATC
TTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGA
TGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGA
CCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTT
AATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGA
ATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAAT
GCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGG
ACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTT
CATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGG
AGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACAT
ATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGT
ATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTG
AGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAA
ATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGT
CATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGT
AATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACA
ACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCT
AACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTC
GTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTAT
TGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGC
GGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAG
GGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAAC
CGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGC
ATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAA
GATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCT
GCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTC
ATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGG
CTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTAT
CGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTG
GTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCT
GAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAAC
CACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAA
AAAGGATCTCAA (SEQ ID NO: 137)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCGAACTTACAGAACTGCTGCTGGTCGTG
ATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCG
ACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACGTGCTGCACTCCAGAC
TGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTG
GACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGAGACAAAGGCCCAGGA
CATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCA
GCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTGAGTGGACAGGTGCG
CCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAACTCCCACCTCAGGGC
AGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTGAGCTTCCAGCACCTGC
TGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCG
GAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATCTCTGGTTCTCACCCTG
AACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACCAACTTCACCGCCAGC
GCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAA
ATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATCAGATCCCTGGCTACC
TGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCCTCTTCCCCGGACCCT
CTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCACAAGCGACACCGGCA
GCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCCCACTCACCCCCCCAC
AGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCAACACCCGTGGTCCAG
CTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCT
GCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGG
GAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATC
CTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAA
AGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACG
GAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATC
AGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATC
TTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGAC
TTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGT
GTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATG
AGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAA
AGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCC
TTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 138)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGC
GAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCT
GGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATG
GACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGAT
TCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATT
ACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGA
AAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGAC
TGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAA
GGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCC
CCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGG
CCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTAT
CATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCA
TTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACC
GACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAAT
CAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTT
ATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 139)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGC
GAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCT
GGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATG
GACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGAT
TCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATT
ACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGA
AAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGAC
TGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAA
GGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCC
CCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGG
CCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTAT
CATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCA
TTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACC
GACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAAT
CAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTT
ATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 140)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGC
GAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCT
GGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATG
GACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGAT
TCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATT
ACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGG
AGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGAC
TGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAA
GGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCC
CCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGG
CCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTAT
CATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCA
TTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACC
GACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAAT
CAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTT
ATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 141)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGC
GAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCT
GGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATG
GACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGAT
TCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATT
ACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGG
AGGAGAACAGCTCCAAGGACCGGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGA
CTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTA
AGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTC
CCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTG
GCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTA
TCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGC
ATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAAC
CGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAA
TCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTT
TATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 142)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGA
AACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAA
ATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTC
ACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTAC
TTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTC
ACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACT
TGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATG
CCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACAC
AGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATG
CCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTA
TGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGC
TATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCCTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATC
CGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAGGATCTCAA (SEQ ID NO: 143)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAAAAAAACCCAG
ACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGA
AGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACA
AAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTG
GCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGA
GCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAG
CAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTG
CGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCC
AAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCC
TTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCC
TGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCC
TGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAA
GAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTG
TTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGC
CTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGA
TCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGC
GGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGA
AACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAA
ATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTC
ACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTAC
TTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTC
ACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACT
TGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATG
CCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACAC
AGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATG
CCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTA
TGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGC
TATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCCTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATC
CGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAGGATCTCAA (SEQ ID NO: 144)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCT
GCACGCCGCTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCT
CCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGG
GTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGAC
TACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTT
GGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACA
AGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGG
TCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACC
GGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTT
CAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAG
ACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTG
TCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACG
ACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGC
ACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTC
GGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAAC
ATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACG
GGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCA
CCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTA
CCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACA
GCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGG
ATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGA
AGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGA
AAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCA
AAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGAC
TCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTC
ATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCT
GGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGA
CATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCAC
AGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAAT
GCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGAT
GGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCA
AGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTG
AGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGG
GTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAAC
CGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATAC
ATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTG
GAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGG
AAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATA
CATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAG
GTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGA
GTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGG
TTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAA
TCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAG
CACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
TAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGAT
ACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAA
AAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTG
CAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAA
TACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCC
TTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGT
TGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAA
AACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGC
TGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCC
TGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTA
TATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 145)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCT
CTGCCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATT
CTTCGAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACT
CCAAACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTG
TGCATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAAC
AAGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCA
CACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGT
CAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAA
AATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCC
AAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATT
CCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAA
CGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGC
AACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTG
GTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGC
AGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATA
AGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTC
AGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTA
ACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGC
ATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCT
CTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCA
TCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATT
ATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCC
AGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACC
ATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTG
CTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAG
CGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATG
GAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGG
TATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGA
TACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGG
AAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGC
ACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAG
GCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAA
TTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGA
AGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTT
TCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCT
GGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCT
CTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTA
TTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGT
TGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTAT
TCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTA
TTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTC
CTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCT
CGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTG
TTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGC
CTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCC
GCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCG
CGGGGA (SEQ ID NO: 146)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACG
TGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACG
TGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGC
AGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGG
CCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACC
ATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACC
ATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGC
CTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGAT
GTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAG
TATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAA
GCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAA
GTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCC
TCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATC
AACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGC
ATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACAT
CACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGG
GTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCA
ATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCT
GATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTA
TCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAG
GATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTT
CCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTC
CTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAG
AGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACT
ACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATT
GGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGA
TTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTT
CGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTA
TTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGT
TCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATT
GGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACAC
CAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACT
CAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCAT
GCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAA
AAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGC
TGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCAC
TGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGC
ATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAA
TTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACAT
CAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCA
TGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTG
TCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTT
TGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTA
GCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTT
ATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCC
TGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATA
AAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGC
GCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAAT
CGGCCAACGCGCGGGGA (SEQ ID NO: 147)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCC
CTACGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGC
CCTAATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCC
CTCTCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCG
TGGACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCA
CCAAGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAG
AACAACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGAT
ATCTGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTA
ATTGCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGC
TGGTTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCG
ATACAGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGT
ATTTCGACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCT
GAAAAACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTT
CATGCCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAA
CTACATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCC
CTGAACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTAC
GCCATCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATC
GCCACACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACA
GCGGTGGGAGCGGCGGGAGCGGCGGTAGCAAGTTCACCATAGTTTTTCCACACA
ACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAG
CTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATG
CCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAAT
GGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCAT
CCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAA
ACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACT
GTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTG
ATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCA
ATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGT
CAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAG
GACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTAC
TTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGG
GGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTG
CTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCA
GACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCC
CTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTG
GATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAA
TCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGC
TCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGA
ACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGT
TCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATG
TTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACA
TTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACT
GGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACA
ACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCC
TCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTC
CTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAG
GTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTC
CCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGG
CTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCT
CACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATT
TGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTG
GCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTC
CATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTT
TTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTC
CTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGA
CGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTAT
CCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGG
GGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTT
TCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGG
GGA (SEQ ID NO: 148)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGC
CAGGCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGC
AAGCTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGG
TGCACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGA
GTGGAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGA
CCCTGCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCT
GTCCAGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCT
GCAGAGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAA
GGACCCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGG
TTTCTGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCA
CCGCCGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAG
AACGAGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTC
TGGTCTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAA
CCAGACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGA
GCTGCTGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGG
AGCTCCTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCT
GCAACCTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTG
TTTCCTCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCC
TGACCCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTAC
ACACACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGG
CGGTAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAA
TGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATG
ACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTC
AAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCG
CTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTA
GAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCC
AGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTG
ATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGG
TTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCA
TAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAAC
CTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGG
GAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCA
AGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTG
TCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATG
CCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTA
ATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCA
AAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAA
AAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTT
GAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCG
GAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCAT
ATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATA
AGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGC
TCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTC
CTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGA
GCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTA
TCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGC
ATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAAC
CGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAA
TCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTT
TATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 149)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACT
GCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACC
AACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATG
ATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCA
GCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCA
GCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACA
TCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAA
AGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAAT
CTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCT
GATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTG
ACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCA
GCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGG
CCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCT
CTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAG
ATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATT
TCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAG
TTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTA
TTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTA
CAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGT
CATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATA
TAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCAT
TGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTG
TGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCAC
CATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACG
GAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTC
TGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACC
TTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTC
AGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATAC
TGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATA
AGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTC
TGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATC
TTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAA
TCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGC
TTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTC
GATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCA
CAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGAC
CCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGG
ACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAA
CATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTT
TGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGT
AGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACT
ATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAG
AAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTCAAA
TCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTC
AAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAA
ACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCT
ATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAG
ATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCT
GACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTT
TGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGA
ATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAA
CAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCAT
TCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTT
GTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGA
TTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAG
ATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTG
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCC
AACGCGCGGGGA (SEQ ID NO: 150)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATC
TGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAA
AAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGA
TTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAG
AGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCA
CTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATC
CTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGG
AACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACG
GATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAAT
ACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACA
TATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGG
GCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGA
GAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCT
TATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTC
AGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAG
CCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTC
AGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGC
CAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTC
AGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATG
GTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAAT
CCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTG
GGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAG
GACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGAC
TCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAG
ACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTA
TCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTA
TTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAG
TTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATAC
AGACATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTC
TTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTAT
ATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGA
TCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTG
GTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAA
AAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGG
AAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAG
GACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAG
TTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGA
GGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAG
CCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAAC
ATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACT
ACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCC
GCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAAT
GAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGG
AAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGG
TTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCG
TTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAAGGATCTCAA (SEQ ID NO: 151)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAACCCAGACCTGGATCCTGACA
TGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCT
GCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATC
TGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCC
CAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGA
TCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATC
GACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGC
TCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCC
CTTAGAAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGAT
AGCAGCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCG
GCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGG
CCGTGGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGG
AGAAGGAACGGGAATTTCAGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGG
AGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTT
CCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTT
AATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGC
AGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGG
TATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAAC
AATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCT
TCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGT
CCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGAT
TCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACT
CTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCAT
TTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAG
GAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCC
TGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGG
TTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAG
AAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCA
GGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAAT
CAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAAC
CCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGA
CCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAAT
GATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGA
AGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTT
TCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAA
AGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGA
TGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTT
GTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAA
CTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATG
AAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCT
CAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCT
CACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGA
AGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAAT
AGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAAT
CATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATA
TGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAAC
AGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGAT
TTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTA
CATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGT
CCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTC
ATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGA
GCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACA
TTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGC
TGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCT
CTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGC
GGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAA
CGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAA
AGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAA
AAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCA
GGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTA
CCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCA
CGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGC
ACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGA
GTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAG
GATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCC
TAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCA
GTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCT
GGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGA
TCTCAA (SEQ ID NO: 152)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTGGGAG
CGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGG
AAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTA
AATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGT
CACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTA
CTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTT
CACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAAC
TTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGAT
GCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACA
CAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATAT
GCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCT
ATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAG
CTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGT
CGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGT
GGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAAT
TATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAAT
TTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACA
TATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGG
CAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTC
ATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTT
GACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATC
CCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACT
CCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCA
ATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAG
TGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCC
AGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGA
CTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA
AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGG
TAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCA
GCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAAGGATCTCAA (SEQ ID NO: 153)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCGGC
ATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCC
TGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACCTAACTCAAATCCTGCA
CAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGG
CCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATT
CCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAA
GGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTT
CCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTG
GCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTC
TCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTAT
TTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTT
GGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATT
CCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTAT
TTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCC
TCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTC
GACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGT
TATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCC
TGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCG
CTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGC
GGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCG
CTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTA
ATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAA
AGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCA
TAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTG
GCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCT
CGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCC
CTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGT
GTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGAC
CGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACT
TATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAG
GCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAA
CAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGG
TAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGC
AAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 154)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATC
GTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCT
ACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCCTAACTCAAAT
CCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCA
AAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAA
ACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCT
ATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAG
ATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCT
GACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTT
TGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGA
ATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAA
CAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCAT
TCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTT
GTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGA
TTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAG
ATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTG
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCC
AACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCAC
TGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAG
GCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGA
GCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTT
TTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAG
AGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGC
TCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTT
CGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCC
CGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTAT
GTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGA
AGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAG
TTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGT
TTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 155)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCT
CTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCAT
CTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGTAACTCAAATC
CTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAA
AGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACG
GAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATC
AGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATC
TTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGAC
TTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGT
GTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATG
AGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAA
AGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCC
TTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 156)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCTG
CTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGT
GCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAACTAACT
CAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCAT
GCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAA
AAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGC
TGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCAC
TGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGC
ATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAA
TTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACAT
CAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCA
TGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTG
TCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTT
TGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTA
GCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTT
ATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCC
TGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATA
AAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGC
GCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAAT
CGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCG
CTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACT
CAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAAC
ATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCT
GGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGT
CCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTAT
CTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCG
TTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGT
AAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTA
CACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGA
AAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGT
TTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEG ID
NO: 157)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATC
GTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGG
TGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGCTAACTCAAAT
CCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCA
AAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAC
GGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTAT
CAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGAT
CTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGA
CTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTG
TGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAAT
GAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACA
AAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTC
CTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGTGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 158)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCAAC
GTGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAA
TCTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTC
TGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTG
ATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAA
AAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTG
CAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAA
TACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCC
TTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGT
TGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAA
AACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGC
TGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCC
TGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTA
TATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTT
CCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGC
TCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAA
GAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGT
TGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACG
CTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATAC
CTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAG
GTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCC
CCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACC
CGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA
GAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACG
GCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTT
CGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGG
TGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 159)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTACCAAAAGAGTG
CGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACCTCCC
AGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAAGCCC
AGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCGGCTCC
CTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCACACTG
CAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCGTGGAA
CTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTG
GGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTATCAAC
ACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAAACACC
AATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTC
AACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTTCACAC
AGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCT
GACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACCGCCAC
ATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCT
TTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCTACTAC
ATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCTGAACA
GCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGA
ACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCTTTTTT
CTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGCGGGAGCGGCGG
TAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGC
CAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAA
GAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTG
CGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATC
GTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGC
ACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTGTAACTCAAA
TCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTC
AAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAC
GGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTAT
CAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGAT
CTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGA
CTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTG
TGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAAT
GAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACA
AAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTC
CTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 160)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGG
TCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACCTAACTCAAAT
CCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCA
AAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAC
GGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTAT
CAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGAT
CTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGA
CTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTG
TGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAAT
GAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACA
AAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTC
CTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 161)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGA
TCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCCTAAC
TCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCA
TGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAA
AAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAG
GCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACC
ACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGA
GCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGG
AATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAAC
ATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGC
CATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGC
TGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATAT
TTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACT
AGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCT
TATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTC
CTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCAT
AAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTG
CGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAA
TCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTC
GCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCAC
TCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAAC
ATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCT
GGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGT
CCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTAT
CTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCG
TTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGT
AAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTA
CACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGA
AAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGT
TTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 162)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTT
TTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGTAAC
TCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCA
TGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAA
AAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCT
GCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 163)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCAC
CGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAA
CTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGA
TACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAA
AAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGT
GCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAA
ATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCC
CTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGT
GTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTT
AAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTG
GCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCC
CCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTT
TATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGT
TTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTC
TTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGC
TGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGG
AAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAAT
TGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGT
TTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACT
ACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTAC
CTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
(SEQ ID NO: 164)
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCT
GGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGA
AGACAGAAGAGACGGACCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTG
GACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTT
TTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAG
GAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCA
ATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGG
GGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATT
TTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGG
GAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACA
TATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGT
ATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTG
AGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAA
ATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGT
CATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGT
AATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACA
ACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCT
AACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTC
GTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTAT
TGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGC
GGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAG
GGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAAC
CGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGC
ATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAA
GATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCT
GCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTC
ATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGG
CTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTAT
CGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTG
GTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCT
GAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAAC
CACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAA
AAAGGATCTCAA (SEQ ID NO: 165)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCT
GCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGC
CTCTTCAAAAAACAGTACAAGTCCTAACTCAAATCCTGCACAACAGATTCTTCAT
GTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTG
AGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATC
CGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAGGATCTCAA (SEQ ID NO: 166)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGT
GATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTG
AAGAAGGGCAAGAAATCTAAGCGGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCC
GTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAAGGATCTCAA (SEQ ID NO: 167)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGC
CCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGC
AGAAAGGGCCACATGTACCCTGTGCGGAACTAACTCAAATCCTGCACAACAGAT
TCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATT
ATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAG
GGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTG
GCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTG
CCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATA
AAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCG
GAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTT
AGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATA
AAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGA
AAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCT
TTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCC
TGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATC
GGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTC
ACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCC
TAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGT
CGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAG
GCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCG
GTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTAT
CCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAA
AAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGC
CCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCG
ACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTC
CTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGC
GTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTC
GCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTT
ATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTG
GCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACA
GAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTA
TCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATC
CGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATT
ACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 168)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGGGCATCATCGCCGGACT
GGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGG
AGAAAGTCTAGCGACAGAAAGGGCTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCC
GTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGT
GTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAA
ATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAA
ATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGA
CATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTT
GGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGG
TCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCC
TTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACAT
CCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTA
CTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCG
CAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAAT
TCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATG
AGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGA
AACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGT
TTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGT
TCGGCTGCGGTGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGG
CCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCC
TGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGG
ACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTT
CCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGG
CGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCG
GTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGC
AGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGC
GCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCG
CAGAAAAAAAAGGATCTCAA (SEQ ID NO: 169)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCT
GACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTG
AGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTGTAACTCAAATCCTGCACA
ACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCC
TCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCT
CGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGT
GGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCC
TCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCT
AATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCA
CTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTG
GTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGC
TATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCA
TAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTT
TTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCT
CTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACG
GATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCC
GCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGG
TGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTC
CAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGG
AGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGC
GCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATAC
GGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGC
CAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGG
CTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGA
AACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGC
GCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCG
GGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGG
TCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTG
CGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCG
CCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGT
GCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTA
TTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCT
CTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCA
GCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 170)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCACCGTGGTCGC
CGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACA
GAGAAAGATCAAGAAATACCGGCTGTAACTCAAATCCTGCACAACAGATTCTTC
ATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATT
TGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCG
TCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGT
GGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAAT
TATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAAT
TTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACA
TATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGG
CAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTC
ATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTT
GACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATC
CCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACT
CCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCA
ATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAG
TGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCC
AGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGA
CTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA
AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGG
TAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCA
GCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAAGGATCTCAA (SEQ ID NO: 171)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGCGGCT
CCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGACATC
TCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGAAACC
AACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCAGCAG
GGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCTTGATC
AGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAGAGGCC
TCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGCGGCAC
AAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCCAGCCC
CACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACACTGCCA
ACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTACCCCAA
CCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTGTCTCA
GGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCGGTGGGAGCTACCTGTACGTGCTGAGCGGCAT
CGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTT
TTCAAAAGAAACCTGAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGG
ACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTT
TAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGA
ATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAAT
GCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGG
ACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTT
CATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGG
AGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACAT
ATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGT
ATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTG
AGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAA
ATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGT
CATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGT
AATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACA
ACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCT
AACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTC
GTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTAT
TGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGC
GGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAG
GGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAAC
CGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGC
ATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAA
GATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCT
GCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTC
ATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGG
CTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTAT
CGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTG
GTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCT
GAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAAC
CACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAA
AAAAGGATCTCAA (SEQ ID NO: 172)
[00545] Construct 252
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCGGCATGCTGC
CTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCT
GCTGTGGCGGAGAAGACAGAAGAGACGGACCTAACTCAAATCCTGCACAACAG
ATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAA
TTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCCTCGA
GGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGT
GGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCT
GCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAAT
AAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTC
GGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTT
TAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTAT
AAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAG
AAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTC
TTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTC
CTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGAT
CGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCT
CACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGC
CTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAG
TCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGA
GGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTC
GGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTT
ATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGC
AAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCC
GCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACC
CGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTC
TCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAA
GCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGT
TCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCC
TTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCAC
TGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTA
CAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTG
GTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTG
ATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAG
ATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 173)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCA
TCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGAT
GTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCCTAACTCAAATCCTGCAC
AACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGC
CTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAAACGGAAT
TCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAA
GGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTT
CCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTG
GCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTC
TCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTAT
TTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTT
GGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATT
CCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTAT
TTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCC
TCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTC
GACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGT
TATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCC
TGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCG
CTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGC
GGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCG
CTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTA
ATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAA
AGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCA
TAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTG
GCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCT
CGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCC
CTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGT
GTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGAC
CGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACT
TATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAG
GCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAA
CAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGG
TAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGC
AAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA (SEQ ID NO: 174)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCTGCTGGCTA
TCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCC
GTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAACTAACTCAAATCC
TGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAA
GAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAACG
GAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATC
AGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATC
TTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGAC
TTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGT
GTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATG
AGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAA
AGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCC
TTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGT
GTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATT
TTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGAT
CCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAA
ATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTA
AAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACT
GCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAA
CGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTG
ACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGC
GGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGC
AAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTT
CCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAG
GTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTC
CCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTC
TCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTC
GGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCC
GACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACG
ACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATG
TAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGT
TGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTT
TGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 175)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCTCTGTTCAT
CCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTG
GCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGTAACTCAAATCCTGCACA
ACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCC
TCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTCC
TCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGG
TGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCC
CTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGC
TAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTC
ACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTT
GGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGG
CTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCC
ATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTT
TTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCC
TCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGAC
GGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATC
CGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGG
GTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTT
CCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGG
GAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTG
CGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATA
CGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGG
CCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAG
GCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCG
AAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGT
GCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTT
CGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTA
GGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTAT
CGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCG
GTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAG
TATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAG
CTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAG
CAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 176)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGGGCA
TCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGC
CGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGCTAACTCAAATCCTGCAC
AACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGC
CTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAACGGAATTC
CTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAG
GTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTC
CCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGG
CTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCT
CACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATT
TGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTG
GCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTC
CATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTT
TTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTC
CTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGA
CGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTAT
CCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGG
GGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTT
TCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGG
GGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCT
GCGCTCGGTCGTTCGGCTGCGGTGAGCGGTATCAGCTCACTCAAAGGCGGTAAT
ACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAG
GCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATA
GGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGC
GAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCG
TGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCT
TCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGT
AGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCG
CTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTA
TCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGC
GGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACA
GTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTA
GCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAA
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGT
GCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCAT
CATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTGTAACT
CAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCAT
GCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAA
AAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTG
CCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTG
AGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCAT
CTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTT
TTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAG
AATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGA
ACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCC
ATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGT
TTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCC
AGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
TGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO:
178)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCA
TCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCT
GTACAACAGACAGAGAAAGATCAAGAAATACCGGCTGTAACTCAAATCCTGCAC
AACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGC
CTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCC
TCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGG
TGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCC
CTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGC
TAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTC
ACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTT
GGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGG
CTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCC
ATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTT
TTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCC
TCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGAC
GGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATC
CGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGG
GTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTT
CCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGG
GAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTG
CGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATA
CGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGG
CCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAG
GCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCG
AAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGT
GCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTT
CGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTA
GGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTAT
CGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCG
GTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAG
TATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAG
CTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAG
CAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 179)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAACTTACAGAA
CTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGCCCGG
CTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGCCACG
TGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCCCTGT
GCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGGAAGA
GACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCGTGAT
GGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACAGCTG
AGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGACCCAA
CTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTTCCTG
AGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACC
ACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTC
TGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCT
GGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTG
CTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCTACCTGTACG
TGCTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTA
CAAGGTGGGCTTTTTCAAAAGAAACCTGAAGTAACTCAAATCCTGCACAACAGA
TTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAAT
TATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGG
GATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGG
CTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGC
CAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAA
AGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGG
AAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTA
GAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAA
AGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAA
AAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTT
TAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCT
GACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATC
GGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTC
ACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCC
TAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGT
CGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAG
GCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCG
GTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTAT
CCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAA
AAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGC
CCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCG
ACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTC
CTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGC
GTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTC
GCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTT
ATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTG
GCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACA
GAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTA
TCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATC
CGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATT
ACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID NO: 180)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCG
CTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGCTAAC
TCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCA
TGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAA
AAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGC
TGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCAC
TGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGC
ATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAA
TTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACAT
CAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCA
TGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTG
TCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTT
TGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTA
GCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTT
ATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCC
TGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATA
AAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGC
GCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAAT
CGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCG
CTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGTGAGCGGTATCAGCTCACT
CAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAAC
ATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCT
GGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA
AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCT
GGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGT
CCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTAT
CTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCG
TTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGT
AAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTA
CACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGA
AAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGT
TTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCAA (SEQ ID
NO: 181)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCAACGTGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATCATCATTG
GAACAATCTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAG
GCCCTCTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAA
CTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATG
AAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTC
AGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTC
ACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAA
GCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATA
GTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATC
ATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATAT
GCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACA
GCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTT
TTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACA
TGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCC
CTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCAT
AGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGC
CGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATT
AATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTG
CATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCT
TCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGG
TATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACG
CAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAG
GCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAA
ATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGG
CGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACC
GGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCAC
GCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCA
CGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAG
TCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGG
ATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCT
AACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAG
TTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTG
GTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGA
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCC
TGAGCACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTGTAAC
TCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCA
TGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAA
AAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCT
GCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCT
CACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCA
AAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACAT
GTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGG
CGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAG
TCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGG
AAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCG
CCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTC
AGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAG
GTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACT
AGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAA
GAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTT
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTAACGCCAAGGTC
GTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGACGGGAAGCCCG
TCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCATGTTGCCAGAGC
CAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCCTTCAGATTGTA
GCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGAAGCTAAAGTGG
ATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGAGCGGCGGGAG
CGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATC
GCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGC
ACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGG
CACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGG
AGCTACCTGTACGTGCTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCT
TCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAGTAACTCAAATC
CTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAA
AGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGG
AATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCA
GAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTT
TTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTT
CTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGT
CTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAG
TATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAG
GTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTT
ATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGT
TATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTT
TCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCC
CTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAAT
TGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAA
GCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGC
CCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACG
CGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGAC
TCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGG
TAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAA
AAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCC
ATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGT
GGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCC
TCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTC
CCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGG
TGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGA
CCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGAC
TTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTA
GGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGA
ACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTG
GTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTG
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTGGGAG
CGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGG
AAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTA
AATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGT
CACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTA
CTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTT
CACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAAC
TTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGAT
GCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACA
CAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATAT
GCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCT
ATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAG
CTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGT
CGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGT
GGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAAT
TATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAAT
TTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACA
TATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGG
CAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTC
ATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTT
GACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATC
CCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACT
CCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCA
ATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAG
TGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCC
AGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGA
CTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA
AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGG
TAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCA
GCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAAGGATCTCAA (SEQ ID NO: 185)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTGGGAG
CGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGG
AAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTA
AATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGT
CACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTA
CTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTT
CACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAAC
TTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGAT
GCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACA
CAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATAT
GCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCT
ATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAG
CTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGT
CGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGT
GGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAAT
TATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAAT
TTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACA
TATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGG
CAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTC
ATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTT
GACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATC
CCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACT
CCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCA
ATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAG
TGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCC
AGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGA
CTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA
AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGG
TAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCA
GCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAAGGATCTCAA (SEQ ID NO: 186)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAA
GGACCGGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTGGGAG
CGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGG
AAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTA
AATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGT
CACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTA
CTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTT
CACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAAC
TTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGAT
GCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACA
CAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATAT
GCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCT
ATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAG
CTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGTAACTCAAATCCTGCACAACAGATTCTTCA
TGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTT
GAGTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGT
CGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGT
GGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAAT
TATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAAT
TTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACA
TATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGG
CAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTC
ATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTT
GACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATC
CCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACT
CCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCA
ATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTC
CACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAG
TGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAA
CCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTT
GCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTC
GGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCC
AGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTG
ACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGA
CTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTC
CGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCA
AGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGG
TAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCA
GCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTC
TTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAAGGATCTCAA (SEQ ID NO: 187)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGC
CGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACG
GACCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTG
TGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAA
AAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGG
TGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACA
AATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCC
CCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGT
GTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTT
AAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTG
GCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCC
CCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTT
TATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGT
TTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTC
TTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGC
TGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGG
AAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAAT
TGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGT
TTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACT
ACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTAC
CTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
(SEQ ID NO: 188)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTT
CAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAA
ATCTAAGCGGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATC
AACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTA
TGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTC
CTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGG
CTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCAT
GAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCA
ATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAA
ATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCA
TATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAA
ACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAG
ATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCT
TACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCT
GTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATG
TCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATAC
GAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCA
CATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCA
GCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAG
CGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATA
ACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAA
AAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACA
AAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACC
AGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTT
ACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTC
ACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTG
CACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTG
AGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACA
GGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGC
CTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCC
AGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGC
TGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAG
GATCTCAA (SEQ ID NO: 189)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGAT
CGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACA
GTACAAGTCCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATC
AACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTA
TGAAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCA
CTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCT
GGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATC
ATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTG
CAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGC
AAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCC
CATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATG
AAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTT
AGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTC
CTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAG
CTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGC
GCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGA
GCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGAT
AACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA
AAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCAC
AAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC
CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCT
TACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCT
CACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGT
GCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTT
GAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAAC
AGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGG
CCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCG
CTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGG
ATCTCAA (SEQ ID NO: 190)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCG
CCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCG
ACAGAAAGGGCTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAAT
CAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTT
ATGAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACT
CCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTG
GCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCA
TGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGC
AATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCA
AATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCC
ATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGA
AACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTA
GATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCC
TTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGC
TGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCAT
GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATA
CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTC
ACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCC
AGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGC
GCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGTGA
GCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGAT
AACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA
AAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCAC
AAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC
CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCT
TACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCT
CACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGT
GCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTT
GAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAAC
AGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGG
CCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGC
CAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCG
CTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAG
GATCTCAA (SEQ ID NO: 191)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGG
TCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAAGAGCAACG
CCGCTGAGCGGAGAGGCCCTCTGTAACTCAAATCCTGCACAACAGATTCTTCATG
TTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGA
GTTTTTAATTTTTATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCG
AGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGG
CCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTA
TGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTT
ATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATA
TGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCA
ACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCAT
CAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGA
CTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCT
AAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCC
CAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAAT
TCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCA
CACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTG
AGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACC
TGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGC
GTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGG
CTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAA
TCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAG
GAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGAC
GAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTA
TAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGA
CCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTT
TCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGC
TGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAA
CTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCC
ACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTG
AAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTC
TGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAAC
AAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAG
AAAAAAAAGGATCTCAA (SEQ ID NO: 192)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCAT
GGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCAAGA
AATACCGGCTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAAT
CAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTT
ATGAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTC
CTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGG
CTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCAT
GAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCA
ATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAA
ATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCA
TATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAA
ACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAG
ATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCT
TACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCT
GTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATG
TCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATAC
GAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCA
CATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCA
GCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCG
CTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAG
CGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATA
ACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAA
AAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACA
AAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACC
AGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTT
ACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTC
ACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTG
CACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTG
AGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACA
GGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGC
CTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCC
AGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGC
TGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAG
GATCTCAA (SEQ ID NO: 193)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCTACCTGTACGTGCTGAGCGGCATCGGCGGACTGCTGC
TGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCT
GAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTG
TGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAA
AAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGT
GCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAA
ATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCC
CTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGT
GTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTT
AAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTG
GCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCC
CCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTT
TATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGT
TTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTC
TTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGC
TGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGG
AAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAAT
TGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCAT
TAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTAT
CAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAG
GAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCC
GCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGT
TTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGA
TACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTG
TAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAA
CCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCA
ACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTA
GCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACT
ACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTAC
CTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAG
CGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAAGGATCTCA
A (SEQ ID NO: 194)
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCAC
GTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCT
GACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTC
GTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGG
CTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCT
CCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGT
CCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAG
TAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCAT
CGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGG
TCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATG
GCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGAC
TGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGC
TCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAA
GTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGC
TGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATC
TTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGC
AAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTT
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTG
AATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAG
TGCCACCTAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTT
AAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATC
AAAAGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCC
ACTATTAAAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGG
CGATGGCCCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGC
CGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGG
GGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGG
GCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCG
CCGCGCTTAATGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAA
CTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAA
AGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTC
ACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGG
CGAATTGGAGCTCCACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCAT
ACGTTGTATCCATATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACC
GCCATGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCA
TTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCC
CGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGT
TCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTA
CGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCC
CTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGAC
CTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCA
TGGTGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACG
GGGATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAA
AATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATG
GGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAAC
CGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACC
GGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGG
GGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGG
GGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATG
GACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTC
CTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGC
CCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCGCTAGACCTGAGGGCATCTGC
AGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTG
CCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCC
AGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGAT
CTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCG
ACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCT
CCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTG
AGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGT
GGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGAT
AGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGTG
GGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACAC
CTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACC
CGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGG
GCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGT
ACTGCAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAAT
CTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACAT
GTACCCTGTGCGGAACTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGAC
CAAATCAACTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTA
ATTTTTATGAAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGA
ATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAAT
GCCCTGGCTCACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGG
ACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTT
CATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGG
AGGGCAAATCATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACAT
ATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGT
ATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTG
AGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAA
ATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGT
CATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGT
AATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACA
ACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCT
AACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTC
GTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTAT
TGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGC
GGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAG
GGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAAC
CGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGC
ATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAA
GATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCT
GCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTC
ATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGG
CTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTAT
CGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTG
GTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGT
GGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCT
GAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAAC
CACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAA
AAAAGGATCTCAA (SEQ ID NO: 195)
TCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTG
GAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAG
TTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCA
GCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATA
AGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAA
GCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAA
AAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATT
GTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATT
TTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGAC
CGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCC
TCGAGGAATTCTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGG
CCCTGCTGCTGCACGCCGCTAGACCTATGTTCAACATGCAGTGTCAGCGGAGATT
CTACGAGGCCCTGCACGACCCTAATCTGAACGAGGAACAGAGAAACGCCAAGAT
CAAGAGCATCAGAGATGACTGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCA
CCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCC
TCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGC
CTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCG
TGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCTTCTGGGTCCTGGTTGTG
GTGGGCGGAGTGCTGGCCTGCTACAGCCTGCTGGTGACCGTGGCCTTTATCATTT
TCTGGGTGTGACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAA
CTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATG
AAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCC
TCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCT
CACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGA
AGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAAT
AGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAAT
CATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATA
TGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAAC
AGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGAT
TTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTA
CATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGT
CCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTC
ATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGA
GCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACA
TTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGC
TGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCT
CTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGC
GGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAA
CGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAA
AGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAA
AAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCA
GGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTA
CCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCA
CGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGC
ACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGA
GTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAG
GATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCC
TAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCA
GTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCT
GGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGA
TCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAA
ACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGAT
CCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACT
TGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTC
TATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACG
GGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTC
ACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAG
AAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAA
GCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTA
CAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCC
CAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGC
TCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCA
TGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTT
TCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGAC
CGAGTTGCTCTTGCCCGGCG (SEQ ID NO: 196)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGAAGCCA
TCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCG
ACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTT
CGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTT
AGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTT
TCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGT
AACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGT
TTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGG
GTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATG
ATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATT
GGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAAT
GATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTC
TGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGG
TTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGA
ATTCTGACACTATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTG
CTGCACGCCGCTAGACCTATGTTCAACATGCAGTGTCAGCGGAGATTCTACGAGG
CCCTGCACGACCCTAATCTGAACGAGGAACAGAGAAACGCCAAGATCAAGAGCA
TCAGAGATGACTGCAGCGGTGGGAGCGGCGGGAGCCCCGGCCAACCTCGGGAAC
CCCAGGTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGT
CCCTCACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGG
AGAGCAACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACA
GCGATGGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCA
GGAGGGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTA
CACACAGAAATCTCTGAGCCTGTCTCTGGGCAAGTCTTTTTGGGTCCTGGTCGTG
GTGGGCGGAGTTCTGGCCTGCTACAGCCTGCTGGTGACAGTGGCCTTCATCATCT
TCTGGGTGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAA
CTTGTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATG
AAAAAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCC
TCAGGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCT
CACAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGA
AGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAAT
AGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAAT
CATTTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATA
TGCTGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAAC
AGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGAT
TTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTA
CATGTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGT
CCCTCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTC
ATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGA
GCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACA
TTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGC
TGCATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 197)
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGAAGCCA
TCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCG
ACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTT
CGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTT
AGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTT
TCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGT
AACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGT
TTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGG
GTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATG
ATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATT
GGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAAT
GATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTC
TGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGG
TTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGA
ATTCTGACACTATGTTCAACATGCAGTGTCAGCGGAGATTCTACGAGGCCCTGCA
CGACCCTAATCTGAACGAGGAACAGAGAAACGCCAAGATCAAGAGCATCAGAG
ATGACTGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCC
CCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCC
CGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGC
GACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTC
TGGTGATCACCCTGTACTGCAGCTTCTGGGTCCTGGTTGTGGTGGGCGGAGTGCT
GGCCTGCTACAGCCTGCTGGTGACCGTGGCCTTTATCATTTTCTGGGTGTGACTC
AAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATG
CTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAA
AAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCT
GCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGA (SEQ ID NO: 198)
AAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAA
TGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGA
ACCGTCAGATCGCCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACA
CCGGGACCGATCCAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTG
GGGACCCTTGATTGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGG
GGGCAAAGTTTTCAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCAT
GGACCCTCATGATAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCT
CCTCTTATTTTCTTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGT
AACGAATTTTTAAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAA
TCACTTTTTTTTCAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTA
GAGAACAATTGTTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCT
GGCTGGCGTGGAAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCC
TGCCTTTCTCTTTATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATA
CTCTGAGTCCAAACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCC
TACAGCTCCTGGGCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGA
ATTCCTCGACGGATCCCTCGAGGAATTCTGACACTATGTTCAACATGCAGTGTCA
GCGGAGATTCTACGAGGCCCTGCACGACCCTAATCTGAACGAGGAACAGAGAAA
CGCCAAGATCAAGAGCATCAGAGATGACTGCAGCGGTGGGAGCGGCGGGAGCG
GCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGTGTACACCCTGCCTCCTAGCC
AGGAGGAAATGACCAAGAACCAGGTGTCCCTCACATGTCTGGTGAAGGGATTCT
ACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACGGCCAGCCTGAGAACAACT
ACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCAGCTTCTTTCTGTATAGCAG
ACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCAATGTGTTCAGCTGCAGCGT
GATGCACGAGGCTCTGCACAACCACTACACACAGAAATCTCTGAGCCTGTCTCTG
GGCAAGTCTTTTTGGGTCCTGGTCGTGGTGGGCGGAGTTCTGGCCTGCTACAGCC
TGCTGGTGACAGTGGCCTTCATCATCTTCTGGGTGTGACTCAAATCCTGCACAAC
AGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATGCTCAAAGAGGCCTC
AATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAAAAAAACGGAATTCC
TCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCTGCCTATCAGAAGG
TGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTTCC
CTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGC
TAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTC
ACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAATGAGTATTT
GGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGG
CTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCC
ATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTTGTGTTATTTT
TTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGATTTTTCCTCC
TCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGAC
GGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGTGTGAAATTGTTATC
CGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGG
GTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTT
CCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGG
GAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTG
CGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATA
CGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGG
CCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAG
GCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCG
AAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGT
GCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTT
CGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTA
GGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTAT
CGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCG
GTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAG
TATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAG
CTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAG
CAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTA
CGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGA
GATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAA
ATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATC
AGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACT
CCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCT
GCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAAC
CAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCC
ATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATA
GTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTT
GGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCC
CCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAG
TAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTT
ACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGT
CATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACG
GGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACG
TTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATG
TAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTC
TGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGA
CACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTAT
CAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAAC
AAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTT
AATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCA
ATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGG
GTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCC
AACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCA
TCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACC
CTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGA
GAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTA
GCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAG
GGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTG
CGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCA
GTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTG
GCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATAT
GTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGA
CTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGA
GTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGAC
CCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGA
CTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGT
ACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAA
TGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGC
AGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTA
CATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCC
ATTGACGTCAATGGGAGTTTGTTTTGGCACC (SEQ ID NO: 199)
AATGTAGTCTTATGCAATACTCTTGTAGTCTTGCAACATGGTAACGATGAGTTAG
CAACATGCCTTACAAGGAGAGAAAAAGCACCGTGCATGCCGATTGGTGGAAGTA
AGGTGGTACGATCGTGCCTTATTAGGAAGGCAACAGACGGGTCTGACATGGATT
GGACGAACCACTGAATTCCGCATTGCAGAGATATTGTATTTAAGTGCCTAGCTCG
ATACAATAAACGCCATTTGACCATTCACCACATTGGTGTGCACCGGGTCTCTCTG
GTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTAACTAGGGAACCCACTGCTT
AAGCCTCAATAAAGCTTGCCTTGAGTGCTTCAAGTAGTGTGTGCCCGTCTGTTGT
GTGACTCTGGTAACTAGAGATCCCTCAGACCCTTTTAGTCAGTGTGGAAAATCTC
TAGCAGTGGCGCCCGAACAGGGACTTGAAAGCGAAAGGGAAACCAGAGGAGCT
CTCTCGACGCAGGACTCGGCTTGCTGAAGCGCGCACGGCAAGAGGCGAGGGGCG
GCGACTGGTGAGTACGCCAAAAATTTTGACTAGCGGAGGCTAGAAGGAGAGAGA
TGGGTGCGAGAGCGTCAGTATTAAGCGGGGGAGAATTAGATCGCGATGGGAAAA
AATTCGGTTAAGGCCAGGGGGAAAGAAAAAATATAAATTAAAACATATAGTATG
GGCAAGCAGGGAGCTAGAACGATTCGCAGTTAATCCTGGCCTGTTAGAAACATC
AGAAGGCTGTAGACAAATACTGGGACAGCTACAACCATCCCTTCAGACAGGATC
AGAAGAACTTAGATCATTATATAATACAGTAGCAACCCTCTATTGTGTGCATCAA
AGGATAGAGATAAAAGACACCAAGGAAGCTTTAGACAAGATAGAGGAAGAGCA
AAACAAAAGTAAGACCACCGCACAGCAAGCGGCCGCTGATCTTCAGACCTGGAG
GAGGAGATATGAGGGACAATTGGAGAAGTGAATTATATAAATATAAAGTAGTAA
AAATTGAACCATTAGGAGTAGCACCCACCAAGGCAAAGAGAAGAGTGGTGCAG
AGAGAAAAAAGAGCAGTGGGAATAGGAGCTTTGTTCCTTGGGTTCTTGGGAGCA
GCAGGAAGCACTATGGGCGCAGCGTCAATGACGCTGACGGTACAGGCCAGACAA
TTATTGTCTGGTATAGTGCAGCAGCAGAACAATTTGCTGAGGGCTATTGAGGCGC
AACAGCATCTGTTGCAACTCACAGTCTGGGGCATCAAGCAGCTCCAGGCAAGAA
TCCTGGCTGTGGAAAGATACCTAAAGGATCAACAGCTCCTGGGGATTTGGGGTT
GCTCTGGAAAACTCATTTGCACCACTGCTGTGCCTTGGAATGCTAGTTGGAGTAA
TAAATCTCTGGAACAGATTTGGAATCACACGACCTGGATGGAGTGGGACAGAGA
AATTAACAATTACACAAGCTTAATACACTCCTTAATTGAAGAATCGCAAAACCA
GCAAGAAAAGAATGAACAAGAATTATTGGAATTAGATAAATGGGCAAGTTTGTG
GAATTGGTTTAACATAACAAATTGGCTGTGGTATATAAAATTATTCATAATGATA
GTAGGAGGCTTGGTAGGTTTAAGAATAGTTTTTGCTGTACTTTCTATAGTGAATA
GAGTTAGGCAGGGATATTCACCATTATCGTTTCAGACCCACCTCCCAACCCCGAG
GGGACCCGACAGGCCCGAAGGAATAGAAGAAGAAGGTGGAGAGAGAGACAGA
GACAGATCCATTCGATTAGTGAACGGATCGGCACTGCGTGCGCCAATTCTGCAG
ACAAATGGCAGTATTCATCCACAATTTTAAAAGAAAAGGGGGGATTGGGGGGTA
CAGTGCAGGGGAAAGAATAGTAGACATAATAGCAACAGACATACAAACTAAAG
AATTACAAAAACAAATTACAAAAATTCAAAATTTTCGGGTTTATTACAGGGACA
GCAGAGATCCANNNNNNNNNNNNNNNNNNNNGTTTGGTTAATTAAGGTACCGA
CATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATA
GCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTG
ACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTA
ACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTG
CCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGT
CAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGAC
TTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCG
GTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCA
AGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGG
ACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGC
GTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCG
CCTGGAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATC
CAGCCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGAT
TGTTCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTT
CAGGGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGA
TAATTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTC
TTTTCATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTT
AAATTCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTT
CAAGGCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTG
TTATAATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGG
AAATATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTT
TATGGTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAA
ACCGGGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGG
GCAACGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGAGGG
CCGGATCCGAATTCCTGTATTTGTCTGAAAACATGGTGAGCAAGGGCGAGGAGC
TGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCC
ACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGA
CCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGT
GACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAA
GCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCAC
CATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGA
GGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGA
CGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTA
TATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCA
CAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCC
CATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCC
GCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTC
GTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGGGATCCGGC
GCAACAAACTTCTCTCTGCTGAAACAAGCCGGAGATGTCGAAGAGAATCCTGGA
CCGACCGAGTACAAGCCCACGGTGCGCCTCGCCACCCGCGACGACGTCCCCAGG
GCCGTACGCACCCTCGCCGCCGCGTTCGCCGACTACCCCGCCACGCGCCACACCG
TCGATCCGGACCGCCACATCGAGCGGGTCACCGAGCTGCAAGAACTCTTCCTCAC
GCGCGTCGGGCTCGACATCGGCAAGGTGTGGGTCGCGGACGACGGCGCCGCGGT
GGCGGTCTGGACCACGCCGGAGAGCGTCGAAGCGGGGGCGGTGTTCGCCGAGAT
CGGCCCGCGCATGGCCGAGTTGAGCGGTTCCCGGCTGGCCGCGCAGCAACAGAT
GGAAGGCCTCCTGGCGCCGCACCGGCCCAAGGAGCCCGCGTGGTTCCTGGCCAC
CGTCGGAGTCTCGCCCGACCACCAGGGCAAGGGTCTGGGCAGCGCCGTCGTGCT
CCCCGGAGTGGAGGCGGCCGAGCGCGCCGGGGTGCCCGCCTTCCTGGAGACCTC
CGCGCCCCGCAACCTCCCCTTCTACGAGCGGCTCGGCTTCACCGTCACCGCCGAC
GTCGAGGTGCCCGAAGGACCGCGCACCTGGTGCATGACCCGCAAGCCCGGTGCC
TGAACGCGTTAAGTCGACAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGA
CTGGTATTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATG
CCTTTGTATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAA
TCCTGGTTGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGCG
TGGTGTGCACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCACCAC
CTGTCAGCTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGCGGAAC
TCATCGCCGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTGGGCACTGA
CAATTCCGTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCTGCTCGCCTGTG
TTGCCACCTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCCCTTCGGCCCTCAAT
CCAGCGGACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTGCGGCCTCTTCCGCGTCT
TCGCCTTCGCCCTCAGACGAGTCGGATCTCCCTTTGGGCCGCCTCCCCGCGTCGA
CTTTAAGACCAATGACTTACAAGGCAGCTGTAGATCTTAGCCACTTTTTAAAAGA
AAAGGGGGGACTGGAAGGGCTAATTCACTCCCAACGAAGACAAGATCTGCTTTT
TGCTTGTACTGGGTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGC
TAACTAGGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCTTCAAG
TAGTGTGTGCCCGTCTGTTGTGTGACTCTGGTAACTAGAGATCCCTCAGACCCTTT
TAGTCAGTGTGGAAAATCTCTAGCAGGGCCCGTTTAAACCCGCTGATCAGCCTCG
ACTGTGCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCCTCCCCCGTGCCTTCCTT
GACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTGCA
TCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACA
GCAAGGGGGAGGATTGGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGC
TCTATGGCTTCTGAGGCGGAAAGAACCAGCTGGGGCTCTAGGGGGTATCCCCAC
GCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTG
ACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTT
TCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTA
GGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTG
ATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTT
GGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAAC
CCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTG
GTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATG
TGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGC
AAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCC
CAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCC
CGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCG
CCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTC
TGAGCTATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAA
AAGCTCCCGGGAGCTTGTATATCCATTTTCGGATCTGATCAGCACGTGTTGACAA
TTAATCATCGGCATAGTATATCGGCATAGTATAATACGACAAGGTGAGGAACTA
AACCATGGCCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCGCGCGACGTCGCC
GGAGCGGTCGAGTTCTGGACCGACCGGCTCGGGTTCTCCCGGGACTTCGTGGAG
GACGACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCC
AGGACCAGGTGGTGCCGGACAACACCCTGGCCTGGGTGTGGGTGCGCGGCCTGG
ACGAGCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACGCCT
CCGGGCCGGCCATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCC
TGCGCGACCCGGCCGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGAC
ACGTGCTACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGG
AATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTG
GAGTTCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAA
GCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGT
GGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCTAG
CTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGC
TCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTG
CCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCA
GTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAG
AGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCT
CGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGT
TATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAG
CAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTC
CGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAAC
CCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCT
CTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGA
AGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCG
TTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGC
CTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCA
CTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCT
ACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTT
GGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTT
GATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCA
GATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGG
GTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTA
TCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAA
TCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGA
GGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCG
TCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAAT
GATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCC
AGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCA
GTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTG
CGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTA
TGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCAT
GTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAG
TTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGT
CATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTC
TGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGAT
AATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTT
CGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACC
CACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGT
GAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGG
AAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGG
TTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATA
GGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCGACGGATCGGGA
GATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATA
GTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCG
AGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAATTGCATGAAGAAT
CTGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCGATGTACGGGCCAGATATACGC
GTT SEQ ID NO: 534
CGACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCT
CTGATGCCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGC
TGAGTAGTGCGCGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACCGACAA
TTGCATGAAGAATCTGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCGATGTACGG
GCCAGATATACGCGTTAATGTAGTCTTATGCAATACTCTTGTAGTCTTGCAACAT
GGTAACGATGAGTTAGCAACATGCCTTACAAGGAGAGAAAAAGCACCGTGCATG
CCGATTGGTGGAAGTAAGGTGGTACGATCGTGCCTTATTAGGAAGGCAACAGAC
GGGTCTGACATGGATTGGACGAACCACTGAATTCCGCATTGCAGAGATATTGTAT
TTAAGTGCCTAGCTCGATACAATAAACGCCATTTGACCATTCACCACATTGGTGT
GCACCGGGTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTAACT
AGGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCTTCAAGTAGTG
TGTGCCCGTCTGTTGTGTGACTCTGGTAACTAGAGATCCCTCAGACCCTTTTAGTC
AGTGTGGAAAATCTCTAGCAGTGGCGCCCGAACAGGGACTTGAAAGCGAAAGGG
AAACCAGAGGAGCTCTCTCGACGCAGGACTCGGCTTGCTGAAGCGCGCACGGCA
AGAGGCGAGGGGCGGCGACTGGTGAGTACGCCAAAAATTTTGACTAGCGGAGGC
TAGAAGGAGAGAGATGGGTGCGAGAGCGTCAGTATTAAGCGGGGGAGAATTAG
ATCGCGATGGGAAAAAATTCGGTTAAGGCCAGGGGGAAAGAAAAAATATAAATT
AAAACATATAGTATGGGCAAGCAGGGAGCTAGAACGATTCGCAGTTAATCCTGG
CCTGTTAGAAACATCAGAAGGCTGTAGACAAATACTGGGACAGCTACAACCATC
CCTTCAGACAGGATCAGAAGAACTTAGATCATTATATAATACAGTAGCAACCCTC
TATTGTGTGCATCAAAGGATAGAGATAAAAGACACCAAGGAAGCTTTAGACAAG
ATAGAGGAAGAGCAAAACAAAAGTAAGACCACCGCACAGCAAGCGGCCGCTGA
TCTTCAGACCTGGAGGAGGAGATATGAGGGACAATTGGAGAAGTGAATTATATA
AATATAAAGTAGTAAAAATTGAACCATTAGGAGTAGCACCCACCAAGGCAAAGA
GAAGAGTGGTGCAGAGAGAAAAAAGAGCAGTGGGAATAGGAGCTTTGTTCCTTG
GGTTCTTGGGAGCAGCAGGAAGCACTATGGGCGCAGCGTCAATGACGCTGACGG
TACAGGCCAGACAATTATTGTCTGGTATAGTGCAGCAGCAGAACAATTTGCTGA
GGGCTATTGAGGCGCAACAGCATCTGTTGCAACTCACAGTCTGGGGCATCAAGC
AGCTCCAGGCAAGAATCCTGGCTGTGGAAAGATACCTAAAGGATCAACAGCTCC
TGGGGATTTGGGGTTGCTCTGGAAAACTCATTTGCACCACTGCTGTGCCTTGGAA
TGCTAGTTGGAGTAATAAATCTCTGGAACAGATTTGGAATCACACGACCTGGATG
GAGTGGGACAGAGAAATTAACAATTACACAAGCTTAATACACTCCTTAATTGAA
GAATCGCAAAACCAGCAAGAAAAGAATGAACAAGAATTATTGGAATTAGATAA
ATGGGCAAGTTTGTGGAATTGGTTTAACATAACAAATTGGCTGTGGTATATAAAA
TTATTCATAATGATAGTAGGAGGCTTGGTAGGTTTAAGAATAGTTTTTGCTGTAC
TTTCTATAGTGAATAGAGTTAGGCAGGGATATTCACCATTATCGTTTCAGACCCA
CCTCCCAACCCCGAGGGGACCCGACAGGCCCGAAGGAATAGAAGAAGAAGGTG
GAGAGAGAGACAGAGACAGATCCATTCGATTAGTGAACGGATCGGCACTGCGTG
CGCCAATTCTGCAGACAAATGGCAGTATTCATCCACAATTTTAAAAGAAAAGGG
GGGATTGGGGGGTACAGTGCAGGGGAAAGAATAGTAGACATAATAGCAACAGA
CATACAAACTAAAGAATTACAAAAACAAATTACAAAAATTCAAAATTTTCGGGT
TTATTACAGGGACAGCAGAGATCCAGCAGGTGTTAAGCACCGGTGGAGTGACGA
CCTTCAGCACGTTCGTACTGTTCAACGATGGTGTAGTCTTCGTTGTGGGAGGTGA
TGTCCAGTTTGATGTCGGTTTTGTAAGCACCCGGCAGCTGAACCGGTTTTTTAGC
CATGTAGGTGGTTTTAACTTCAGCGTCGTAGTGACCACCGTCTTTCAGTTTCAGA
CGCATTTTGATTTCACCTTTCAGAGCACCGTCTTCCGGGTACATACGTTCGGTGG
AAGCTTCCCAACCCATGGTTTTTTTCTGCATAACCGGACCGTCGGACGGGAAGTT
GGTACCACGCAGTTTAACTTTGTAGATGAACTCACCGTCTTGCAGGGAGGAGTCC
TGGGTAACGGTAACAACACCACCGTCTTCGAAGTTCATAACACGTTCCCATTTGA
AACCTTCCGGGAAGGACAGTTTCAGGTAGTCCGGGATGTCAGCCGGGTGTTTAA
CGTAAGCTTTGGAACCGTACTGGAACTGCGGGGACAGGATGTCCCAAGCGAACG
GCAGCGGACCACCTTTGGTAACTTTCAGTTTAGCGGTCTGGGTACCTTCGTACGG
ACGACCTTCACCTTCACCTTCGATTTCGAACTCGTGACCGTTAACGGAACCTTCC
ATACGAACTTTGAAACGCATGAACTCTTTGATAACGTCTTCGCTACTCGCCATAG
ATCCTTTCTCCTCTTTCAGATCCGTGCTCAGTATCTCTATCACTGATAGGGATGTC
AATCTCTATCACTGATAGGGACACCTGCGTTTGGTTAATTAAGGTACCGACATTG
ATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCA
TATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGC
CCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCC
AATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCAC
TTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATG
ACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCC
TACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTT
GGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCT
CCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTT
CCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTA
CGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGG
AGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGC
CTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTT
CTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGG
GTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAAT
TTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTC
ATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATT
CACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGG
CAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATA
ATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATA
TTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGG
TTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGG
GCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAAC
GTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGAGGGCCGGA
TCCGAATTCCTGTATTTGTCTGAAAACATGGTGAGCAAGGGCGAGGAGCTGTTCA
CCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGT
TCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGA
AGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCAC
CCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCA
CGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTC
TTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGAC
ACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATG
GCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATC
GAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGC
GACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGA
GCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCG
CCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGGGATCCGGCGCAACAA
ACTTCTCTCTGCTGAAACAAGCCGGAGATGTCGAAGAGAATCCTGGACCGACCG
AGTACAAGCCCACGGTGCGCCTCGCCACCCGCGACGACGTCCCCAGGGCCGTAC
GCACCCTCGCCGCCGCGTTCGCCGACTACCCCGCCACGCGCCACACCGTCGATCC
GGACCGCCACATCGAGCGGGTCACCGAGCTGCAAGAACTCTTCCTCACGCGCGT
CGGGCTCGACATCGGCAAGGTGTGGGTCGCGGACGACGGCGCCGCGGTGGCGGT
CTGGACCACGCCGGAGAGCGTCGAAGCGGGGGCGGTGTTCGCCGAGATCGGCCC
GCGCATGGCCGAGTTGAGCGGTTCCCGGCTGGCCGCGCAGCAACAGATGGAAGG
CCTCCTGGCGCCGCACCGGCCCAAGGAGCCCGCGTGGTTCCTGGCCACCGTCGG
AGTCTCGCCCGACCACCAGGGCAAGGGTCTGGGCAGCGCCGTCGTGCTCCCCGG
AGTGGAGGCGGCCGAGCGCGCCGGGGTGCCCGCCTTCCTGGAGACCTCCGCGCC
CCGCAACCTCCCCTTCTACGAGCGGCTCGGCTTCACCGTCACCGCCGACGTCGAG
GTGCCCGAAGGACCGCGCACCTGGTGCATGACCCGCAAGCCCGGTGCCTGAACG
CGTTAAGTCGACAATCAACCTCTGGATTACAAAATTTGTGAAAGATTGACTGGTA
TTCTTAACTATGTTGCTCCTTTTACGCTATGTGGATACGCTGCTTTAATGCCTTTGT
ATCATGCTATTGCTTCCCGTATGGCTTTCATTTTCTCCTCCTTGTATAAATCCTGGT
TGCTGTCTCTTTATGAGGAGTTGTGGCCCGTTGTCAGGCAACGTGGCGTGGTGTG
CACTGTGTTTGCTGACGCAACCCCCACTGGTTGGGGCATTGCCACCACCTGTCAG
CTCCTTTCCGGGACTTTCGCTTTCCCCCTCCCTATTGCCACGGCGGAACTCATCGC
CGCCTGCCTTGCCCGCTGCTGGACAGGGGCTCGGCTGTTGGGCACTGACAATTCC
GTGGTGTTGTCGGGGAAATCATCGTCCTTTCCTTGGCTGCTCGCCTGTGTTGCCAC
CTGGATTCTGCGCGGGACGTCCTTCTGCTACGTCCCTTCGGCCCTCAATCCAGCG
GACCTTCCTTCCCGCGGCCTGCTGCCGGCTCTGCGGCCTCTTCCGCGTCTTCGCCT
TCGCCCTCAGACGAGTCGGATCTCCCTTTGGGCCGCCTCCCCGCGTCGACTTTAA
GACCAATGACTTACAAGGCAGCTGTAGATCTTAGCCACTTTTTAAAAGAAAAGG
GGGGACTGGAAGGGCTAATTCACTCCCAACGAAGACAAGATCTGCTTTTTGCTTG
TACTGGGTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTAACTA
GGGAACCCACTGCTTAAGCCTCAATAAAGCTTGCCTTGAGTGCTTCAAGTAGTGT
GTGCCCGTCTGTTGTGTGACTCTGGTAACTAGAGATCCCTCAGACCCTTTTAGTC
AGTGTGGAAAATCTCTAGCAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGT
GCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCCTCCCCCGTGCCTTCCTTGACCC
TGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTGCATCGCA
TTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGCAA
GGGGGAGGATTGGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTAT
GGCTTCTGAGGCGGAAAGAACCAGCTGGGGCTCTAGGGGGTATCCCCACGCGCC
CTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGC
TACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCG
CCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTT
CCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGT
TCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGT
CCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTAT
CTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAA
AAAATGAGCTGATTTAACAAAAATTTAACGCGAATTAATTCTGTGGAATGTGTGT
CAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGC
ATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCA
GGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCC
CTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCA
TGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCTGCCTCTGAGC
TATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCT
CCCGGGAGCTTGTATATCCATTTTCGGATCTGATCAGCACGTGTTGACAATTAAT
CATCGGCATAGTATATCGGCATAGTATAATACGACAAGGTGAGGAACTAAACCA
TGGCCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCGCGCGACGTCGCCGGAG
CGGTCGAGTTCTGGACCGACCGGCTCGGGTTCTCCCGGGACTTCGTGGAGGACG
ACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGA
CCAGGTGGTGCCGGACAACACCCTGGCCTGGGTGTGGGTGCGCGGCCTGGACGA
GCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACGCCTCCGG
GCCGGCCATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCCTGCG
CGACCCGGCCGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGACACGT
GCTACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATC
GTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGT
TCTTCGCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAA
TAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTT
TGTCCAAACTCATCAATGTATCTTATCATGTCTGTATACCGTCGACCTCTAGCTAG
AGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCAC
AATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTA
ATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCG
GGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGC
GGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGT
CGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCC
ACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAA
GGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCC
CCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACA
GGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTG
TTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTG
GCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTC
CAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCC
GGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAG
CAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGT
TCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTG
CGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGC
AAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGC
GCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGC TCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAG GATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGT ATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTA
TCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAG ATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCG CGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGA
AGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTA ATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGT TGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCAT TCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAA AAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCA GTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATC CGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAG TGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGC CACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAA AACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGC
ACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAA ACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTG AATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTC TCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCC
GCGCACATTTCCCCGAAAAGTGCCACCTGACCACATTTCCCCGAAAAGTGCCACC TGACGTCGACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAA TCTGCTCTGATGCCGCATAGTTAAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAG GTCGCTGAGTAGTGCGCGAGCAAAATTTAAGCTACAACAAGGCAAGGCTTGACC
GACAATTGCATGAAGAATCTGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCGATG TACGGGCCAGATATACGCGTT SEQ ID NO: 535
[00574] The following examples contemplate fusion proteins that have been cloned into a plasmid with the structure: [front half]-[insert]-[back half] . In other words, the plasmid has been split into a [front half] sequence and a [back half] sequence, which are joined by an
[insert] sequence. The [front half] and [back half] sequences are the same but the [insert] sequence changes.
[00575] The [Front half] sequence comprises the following sequence:
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACT SEQ ID NO: 536
[00576] The [Back half] sequence comprises the following sequence:
TAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGAT
ACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAA
AAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTG
CAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAA
TACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCC
TTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGT
TGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAA
AACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGC
TGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCC
TGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTA
TATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTT
ACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTC
TCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGT
TTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAG
CATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAA
TGAATCGGCCAACGCGCGGGGA-3’ SEQ ID NO: 537
[00577] Contemplated [insert] sequences include, but are not limited to, the following:
ATGAACTTCCTGCTGCTGACATTCATCGTTCTGCCTCTGTGCAGCCACGCCAAGTT
CAGCATCGTGTTTCCACAGAGCCAGAAGGGCAACTGGAAGAACGTGCCCAGCAG
CTACCACTACTGTCCTTCTAGCTCCGACCAGAATTGGCACAATGATCTGTTGGGC
ATCACCATGAAAGTAAAGATGCCTAAGACCCATAAGGCCATCCAGGCCGACGGC
TGGATGTGCCACGCCGCTAAATGGATCACGACCTGCGACTTCAGATGGTACGGC
CCCAAATACATCACCCACAGCATCCACTCTATCCAACCTACAAGCGAGCAGTGTA
AAGAATCTATCAAGCAGACCAAGCAGGGAACCTGGATGAGCCCCGGCTTCCCCC
CCCAGAACTGCGGATATGCCACCGTGACAGACAGCGTGGCTGTGGTGGTGCAGG
CCACCCCTCATCACGTGCTGGTGGACGAGTACACCGGCGAGTGGATCGACAGCC
AGTTCCCTAACGGCAAGTGCGAGACAGAAGAGTGCGAAACCGTGCACAACAGCA
CAGTGTGGTATAGCGACTACAAGGTTACAGGACTGTGTGATGCCACCCTGGTCG
ATACCGAGATCACCTTCTTCTCCGAAGATGGCAAAAAGGAAAGCATCGGCAAAC
CTAATACCGGCTACCGGTCCAACTACTTCGCCTACGAGAAGGGCGATAAGGTGT
GCAAGATGAACTACTGCAAGCACGCCGGCGTCCGGCTGCCTAGCGGCGTGTGGT
TCGAGTTCGTGGATCAGGACGTGTACGCCGCAGCTAAGCTGCCTGAATGTCCTGT
TGGCGCTACAATCAGCGCCCCTACACAGACCTCTGTGGACGTGTCCCTTATCCTG
GATGTGGAACGCATTCTGGACTACAGCCTGTGCCAGGAGACATGGTCCAAGATC
CGGAGCAAGCAGCCTGTGTCTCCTGTGGACCTGAGCTACCTGGCCCCAAAGAAT
CCCGGCACCGGCCCTGCCTTCACCATCATCAACGGCACCCTGAAGTACTTCGAGA
CAAGATATATCAGAATTGACATCGACAACCCTATCATCAGCAAGATGGTGGGCA
AGATCTCCGGATCTCAAACTGAGAGAGAGCTGTGGACCGAGTGGTTTCCTTACG
AGGGCGTGGAAATCGGACCTAACGGGATCCTCAAGACCCCTACCGGCTACAAAT
TCCCCCTGTTTATGATCGGTCACGGCATGCTGGACTCTGATCTGCACAAGACCAG
CCAGGCTGAAGTGTTCGAGCACCCCCACCTGGCCGAGGCCCCAAAGCAACTGCC
AGAGGAAGAAACCCTGTTCTTCGGCGACACCGGAATTTCTAAAAACCCCGTGGA
ACTGATCGAGGGCTGGTTCAGCAGCTGGAAAAGCACCGTGGTCACATTCTTTTTT
GCCATCGGCGTGTTCATCCTGCTGTACGTGGTGGCCAGAATCGTGATCGCCGTGC
GGTACAGATACCAGGGCAGCAACAACAAGAGAATCTACAACGACATCGAGATG
AGCAGATTCCGGAAG SEQ ID NO: 538
ATGAACTTCCTGCTGCTGACATTCATCGTTCTGCCTCTGTGCAGCCACGCCAAGTT
CAGCATCGTGTTTCCACAGAGCCAGAAGGGCAACTGGAAGAACGTGCCCAGCAG
CTACCACTACTGTCCTTCTAGCTCCGACCAGAATTGGCACAATGATCTGTTGGGC
ATCACCATGAAAGTAAAGATGCCTCAGACCCATAAGGCCATCCAGGCCGACGGC
TGGATGTGCCACGCCGCTAAATGGATCACGACCTGCGACTTCAGATGGTACGGC
CCCAAATACATCACCCACAGCATCCACTCTATCCAACCTACAAGCGAGCAGTGTA
AAGAATCTATCAAGCAGACCAAGCAGGGAACCTGGATGAGCCCCGGCTTCCCCC
CCCAGAACTGCGGATATGCCACCGTGACAGACAGCGTGGCTGTGGTGGTGCAGG
CCACCCCTCATCACGTGCTGGTGGACGAGTACACCGGCGAGTGGATCGACAGCC
AGTTCCCTAACGGCAAGTGCGAGACAGAAGAGTGCGAAACCGTGCACAACAGCA
CAGTGTGGTATAGCGACTACAAGGTTACAGGACTGTGTGATGCCACCCTGGTCG
ATACCGAGATCACCTTCTTCTCCGAAGATGGCAAAAAGGAAAGCATCGGCAAAC
CTAATACCGGCTACCGGTCCAACTACTTCGCCTACGAGAAGGGCGATAAGGTGT
GCAAGATGAACTACTGCAAGCACGCCGGCGTCCGGCTGCCTAGCGGCGTGTGGT
TCGAGTTCGTGGATCAGGACGTGTACGCCGCAGCTAAGCTGCCTGAATGTCCTGT
TGGCGCTACAATCAGCGCCCCTACACAGACCTCTGTGGACGTGTCCCTTATCCTG
GATGTGGAACGCATTCTGGACTACAGCCTGTGCCAGGAGACATGGTCCAAGATC
CGGAGCAAGCAGCCTGTGTCTCCTGTGGACCTGAGCTACCTGGCCCCAAAGAAT
CCCGGCACCGGCCCTGCCTTCACCATCATCAACGGCACCCTGAAGTACTTCGAGA
CAAGATATATCAGAATTGACATCGACAACCCTATCATCAGCAAGATGGTGGGCA
AGATCTCCGGATCTCAAACTGAGGCCGAGCTGTGGACCGAGTGGTTTCCTTACGA
GGGCGTGGAAATCGGACCTAACGGGATCCTCAAGACCCCTACCGGCTACAAATT
CCCCCTGTTTATGATCGGTCACGGCATGCTGGACTCTGATCTGCACAAGACCAGC
CAGGCTGAAGTGTTCGAGCACCCCCACCTGGCCGAGGCCCCAAAGCAACTGCCA
GAGGAAGAAACCCTGTTCTTCGGCGACACCGGAATTTCTAAAAACCCCGTGGAA
CTGATCGAGGGCTGGTTCAGCAGCTGGAAAAGCACCGTGGTCACATTCTTTTTTG
CCATCGGCGTGTTCATCCTGCTGTACGTGGTGGCCAGAATCGTGATCGCCGTGCG
GTACAGATACCAGGGCAGCAACAACAAGAGAATCTACAACGACATCGAGATGA
GCAGATTCCGGAAG SEQ ID NO: 539
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACC SEQ ID NO: 540
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACC SEQ ID NO: 541
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCAC
CATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTAC
CATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAG
CCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGA
TGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAA
GTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAA
AGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAA
AGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACT
CCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCA
TCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTG
GCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGAC
ATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACA
GGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATG
CAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATG
GCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAA
GTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGA
GAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGG
TCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACC
GGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACA
TCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGG
AACTACCACAGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGA
AATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATAC
ATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGG
TGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAG
TTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGT
TGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAAT
CATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGC
ACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
SEQ ID NO: 542
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCAC
CATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTAC
CATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAG
CCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGA
TGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAA
GTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAA
AGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAA
AGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACT
CCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCA
TCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTG
GCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGAC
ATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACA
GGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATG
CAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATG
GCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAA
GTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGA
GAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGG
TCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACC
GGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACA
TCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGG
AACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGA
AATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATAC
ATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGG
TGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAG
TTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGT
TGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAAT
CATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGC
ACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
SEQ ID NO: 543
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCAC
CATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTAC
CATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAG
CCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGA
TGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAA
GTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAA
AGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAA
AGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACT
CCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCA
TCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTG
GCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGAC
ATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACA
GGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATG
CAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATG
GCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAA
GTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGA
GAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGG
TCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACC
GGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACA
TCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGG
AACTACCACAGAACAGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGA
AATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATAC
ATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGG
TGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAG
TTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGT
TGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAAT
CATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGC
ACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGT
AA SEQ ID NO: 544
ATGAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCA
GCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAA
GCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTG
TGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGA
CCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTA
TTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAA
ACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAA
TTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCA
CAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACT
TGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCA
CTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTT
GGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGC
CGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACA
GGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGC
CCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTAT
GTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCT
ATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGA
AACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACT
CCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGA
TTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGG
ATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGA
AACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTAT
CTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCC
TAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTC
AAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGA
CTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAG
TTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATC
TTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGC
TTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAA
ATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTC
TTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAG SEQ ID NO: 545
[00586] Construct pJAQl 13 [AdF35 Genscript Codon Optimized Targeting
ATGACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGG
ACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGG
CTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACC
ACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGAC
ACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAAC
AACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAA
GCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTAT
CAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAG
ATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAG
AACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTG
AACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACT
CCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACA
AGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTA
GCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTACATCC
ACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACAT
TAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCA
GTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACT
GACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGGTGGG
AGCGGCGGGAGCGGCGGTAGCAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTG
GGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGA
AAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCAT
AATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCT
ATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATT
TCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATC
TGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGA
ATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGC
AGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAA
TGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTG
TCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTC
TAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCC
CTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGA
GGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCA
GGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTG
AATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAG
TCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGG
AGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTC
CTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATA
CTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATG
GTCGGAATGATCAGTGGAACTACCACAGAAAGGGAACTGTGGGATGACTGGGCA
CCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGA
TATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCT
TAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAA
CTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAAT
CGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCT
TTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTT
TGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATG
AACCGACTTGGAAAG SEQ ID NO: 546
[00587] Construct pJAQl 14 [TPO Genscript Optimized Targeting Domain]- [SGGSx3.1 Linker]-[VSV-G TM]
ATGGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGA
CCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCT
GAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCT
CTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGA
CCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGC
TTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCT
GCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCT
GCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAA
CGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATG
CTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGC
CCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCG
GCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCT
GAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATC
TAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAA
CGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGAT
ATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGA
TATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGC
CTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAG
CGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGC
CAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCAT
GAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCA
TAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCA
TTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCC
TTACAAGTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATG
TGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGT
ATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAG
CATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAG
TTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCT
CACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCA
ACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCA
TTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATC
ACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGG
TTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAA
TACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTG
ATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTAT
CTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGG
ATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTC
CAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCC
TGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGA
GTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTA
CCACAGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTG
GACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGAT
TGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTC
GAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTAT
TTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTT
CAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTG
GACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACC
AAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAACTC
AAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTTGTGATACCATG
CTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAAAAAAAAAAAA
AAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCAGGTGCAGGCT
GCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACT
GAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCA
TCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATT
TTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCA
GAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATG
AACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTC
CATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTG
TTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGC
CAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATG
GAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATAGCTGTTTCCTGT
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAA
GTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGC
TCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG
GCCAACGCGCGGGGA SEQ ID NO: 547
[00588] Construct pJAQl 15 [SCF full Targeting Domain]-[SGGSx3.2 Linker]- [VSV-G TM]
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACC
AAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTC
AGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCC
AAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGG
GTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCC
GATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAAC
AAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGT
GACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGAT
GAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAAT
TACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCA
AAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGA
CGGAGAGCTATCATCCCCGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTT
TGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGG
AGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCT
GCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGA
CCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCT
CTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGA
TCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATC
AATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTC
CAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAAC
TGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTC
TGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTT
GGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATT
CAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTG
GGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAA
GCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTC
TCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGAT
TTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 548
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTG SEQ ID NO: 549
[00589] Construct pJAQ129 [CD8a Signal Peptide]-[SCF mutant (V49L/F63L)
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGT
ACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 550
[00590] Construct pJAQ 130 [CD8a Signal Peptide]-[SCF mutant
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGT
ACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 551
[00591] Construct pJAQ131 [CD8a Signal Peptide]-[SCF mutant
(V49L/F63L/K91E/I98R) Targeting Domain]-[SGGSx3.2 Einker] -[ VS V-G mut TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCGGAAAAA
GTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATC
TTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTG
ATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGA
CCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAG
CAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGC
CGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTC
TGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGA
TTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGT
ACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 552
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAG
ACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTT
AAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGT
CCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGT
GGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTA
CTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACA
ACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAG
CTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATG
CCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAAT
GGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCAT
CCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAA
ACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACT
GTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTG
ATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCA
ATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGT
CAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAG
GACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTAC
TTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGG
GGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTG
CTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCA
GACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCC
CTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTG
GATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAA
TCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGC
TCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGA
ACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGT
TCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATG
TTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACA
TTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACT
GGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 553
[00593] Construct pJAQ 133 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCT
TTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTC
CACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCC
GTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTC
AAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCT
TCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACAC
ATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACA
AACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATAT
GCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGC
TGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAAT
GCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTA
TAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCT
CAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGT
AACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAG
CATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATC
TCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCC
ATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGAT
TATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTC
CAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCAC
CATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATT
GCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAA
GCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAAT
GGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATG
GTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCC
TCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTG
ATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTG
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCT
TGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAG
ACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 554
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGT
GCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGG
AGAAGACAGAAGAGACGGACCSEQ ID NO: 555
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATCGTGATCATCTCTAGCAG
CCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCC
GGCTTCTTCAAAAGACAGTACAAGTCC SEQ ID NO: 556
[00596] Construct pJAQ138 [SCF full Targeting Domain]-[SGGSx3.2 Linker]- [CD62L TM]
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGC
CGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGA
CTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 557
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCCTGCTGGCTATCCTGATCCT
GGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTG
AGCAGAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 558
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATCGTGGGCATCATCGCCG
GACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTG
GCGGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 559
[00599] Construct pJAQ 144 [SCF full Targeting Domain]-[SGGSx3.2 Linker]-
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAACGTGGTGTGCGCCCTGG
GCCTGACCGTGGGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGG
CCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 560
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATCGTGATCATCACCGTGGT
CGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAG
ACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 561
[00601] Construct pJAQ148 [SCF full Targeting Domain]-[SGGSx3.2 Linker]-
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCTACCTGTACGTGCTGAGCGG
CATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGC
TTTTTCAAAAGAAACCTGAAG SEQ ID NO: 562
[00602] Construct pJAQ153 [SCF full Targeting Domain]-[SGGSx3.2 Linker]-
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTT
AGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACC
AAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTC
AGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCC
CAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGG
GTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCC
GATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAAC
AAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGT
GACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGAT
GAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAAT
TACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCA
AAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGA
CGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTT
TGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGG
AGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCT
GCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGA
CCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCT
CTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGA
TCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATC
AATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTC
CAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAAC
TGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTC
TGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTT
GGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATT
CAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTG
GGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAA
GCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTC
TCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGAT
TTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 563
ATGAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCA
GCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAA
GCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTG
TGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGA
CCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGG
TGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGAC
TATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAG
AAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID
NO: 564
[00604] Construct pJAQ155 [AdF35 Genscript Codon Optimized Targeting
ATGACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGG
ACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGG
CTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACC
ACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGAC
ACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAAC
AACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAA
GCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTAT
CAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAG
ATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAG
AACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTG
AACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACT
CCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACA
AGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTA
GCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTACATCC
ACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACAT
TAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCA
GTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACT
GACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGGTGGG
AGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAA
AGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 565
[00605] Construct pJAQ156 [TPO Genscript Optimized Targeting Domain]-
ATGGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGA
CCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCT
GAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCT
CTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGA
CCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGC
TTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCT
GCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCT
GCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAA
CGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATG
CTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGC
CCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCG
GCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCT
GAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATC
TAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAA
CGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGAT
ATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGA
TATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGC
CTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAG
CGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGC
CAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGTGGGAGCATTGCCTCTTTT
TTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCA
TCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGA
GATGAACCGACTTGGAAAG SEQ ID NO: 566
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATC
ATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCAT
TAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCG
ACTTGGAAAG SEQ ID NO: 567
[00607] Construct pJAQ158 [VSV-G Signal Peptide]-[SCF full Targeting Domain]-
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAA
TCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAG
CACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
SEQ ID NO: 568
[00608] Construct pJAQ 159 [CD8a Signal Peptide]-[SCF soluble mutant
(V49L/F63L/K91E) Targeting Domain]-[SGGSx3.2 Einker] -[ VS V-G mut TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCT
GAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTG
AGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAG
TGCGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAG
CCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACG
CCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCAC
CCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCT
CCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTT
TTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCG
TCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCA
AAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTC
CAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACAT
TCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAA
CGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGC
AACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTG
GTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGC
AGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATA
AGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTC
AGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTA
ACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGC
ATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCT
CTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCA
TCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATT
ATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCC
AGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACC
ATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTG
CTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAG
CGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATG
GAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGG
TATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGA
TACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGG
AAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGSEQ ID NO: 569
[00609] Construct pJAQ160 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]-[CD43 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGC
TGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAG
AAGACAGAAGAGACGGACC SEQ ID NO: 570
[00610] Construct pJAQ161 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]-[CD49d.2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCC
TGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGG
CCTCTTCAAAAAACAGTACAAGTCC SEQ ID NO: 571
[00611] Construct pJAQ162 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] -[CD62L TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCG
TGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACT
GAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 572
[00612] Construct pJAQ163 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] - [CD 162 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGG
CCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAG
CAGAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 573
[00613] Construct pJAQ164 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] - [HLA-A2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGGGCATCATCGCCGGA
CTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGC
GGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 574
[00614] Construct pJAQ165 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] -[HLA-DRA TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGC
CTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCC
TGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 575
[00615] Construct pJAQ166 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] -[IC AMI TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCACCGTGGTCG
CCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGAC
AGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 576
[00616] Construct pJAQ167 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] -[LF A- 1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTG
CGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCT
CTGGTGATCACCCTGTACTGCAGCGGTGGGAGCTACCTGTACGTGTTGAGCGGCA
TCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTT
TTTCAAAAGAAACCTGAAG
[00617] Construct pJAQ168 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Linker]-[CD43 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCGGCATGCTGCCT
GTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGC
TGTGGCGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 577
[00618] Construct pJAQ169 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Einker] -[CD49d TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCATCGTGATCATCT
CTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTG
GAAGGCCGGCTTCTTCAAAAGACAGTACAAGTCC SEQ ID NO: 578
[00619] Construct pJAQ170 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Linker] -[CD62L TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCCCTCTGTTCATCC
CCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGC
CAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGSEQ ID NO: 579
[00620] Construct pJAQ171 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Linker] -[CD 162 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCCTGCTGGCTATCC
TGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGT
GAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 580
[00621] Construct pJAQ172 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Einker] -[HEA-A2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCATCGTGGGCATC
ATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCG
TGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 581
[00622] Construct pJAQ173 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Linker] -[HLA-DRA TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCAACGTGGTGTGC
GCCCTGGGCCTGACCGTGGGCCTGGTCGGCATCATCATTGGAACAATCTTCATCA
TCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 582
[00623] Construct pJAQ174 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Linker] -[IC AMI TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCATCGTGATCATC
ACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGT
ACAACAGACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 583
[00624] Construct pJAQ175 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx2.1 Linker]-[IgG4 Fc CH3 Hinge]-[SGGSxl Linker] -[LF A- 1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAG
GTGTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTC
ACATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGC
AACGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGAT
GGCAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAG
GGCAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACA
CAGAAATCTCTGAGCCTGTCTCTGGGCAAGAGCGGTGGGAGCTACCTGTACGTG
CTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACA
AGGTGGGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 584
[00625] Construct pJAQ176 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.2 Linker]-[CD43 TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAA
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCC
CTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGA
AGAGACGGACC SEQ ID NO: 585
[00626] Construct pJAQ180 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.2 Linker]- [CD 62L TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAA
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTG
ACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGG
GCAAGAAATCTAAGCGGSEQ ID NO: 586
[00627] Construct pJAQ182 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.2 Linker] -[CD 162 TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAA
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTC
GCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAG
GGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 587
[00628] Construct pJAQ183 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSxl Linker] -[CD 162 TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAA
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGT
GCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGC
GGAAC SEQ ID NO: 588
[00629] Construct pJAQ 193 [VSV-G Signal Peptide] -[AdF35 Genscript Codon
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCACCAAAAG
AGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGAGAGCACC
TCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTTACCCAAA
GCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCACAGGCG
GCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCGACGGCA
CACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACCACAGCG
TGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGTGCGCCA
AGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGGACTCTA
TCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGTGGAAA
ACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGGAGGCC
TGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCAGATGTT
CACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGTGGCAAC
CTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGCAGCACC
GCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACCACAGCT
TATCCTTTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGCATCTGCT
ACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCATCATGCT
GAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCGAGTGGAA
CCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCACATCTCCT
TTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGGTGGGAGC
ATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGA
GTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATA
CAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 589
[00630] Construct pJAQ195 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.2 Linker]-[VSV-G Signal Peptide]-[VSV-G mut del SP TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAA
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACTTAGCCTTTTTAT
TCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAA
CTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATT
GGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACA
AGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTG
TGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACT
CCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGG
CTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCG
AAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGG
AGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCC
CACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGT
GATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTAT
CATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAA
CTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCC
CATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATT
CCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGAT
GTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAA
CCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCT
TGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTA
AAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAA
GAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACT
GGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTT
CAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTT
CATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTT
CGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAA
TCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCT
TTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAG SEQ ID NO: 590
[00631] Construct pJAQ211 [CD8a Signal Peptide]-[SCF mutant (V49L/F63L)
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGT
ACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCCTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 591
[00632] Construct pJAQ212 [CD8a Signal Peptide]-[SCF mutant (V49L/F63L/K91E) Targeting Domain]-[SGGSx3.2 Einker] -[ VS V-G TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGT
ACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATTCTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 592
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAG
ACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTT
AAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGT
CCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGT
GGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTA
CTTAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACA
ACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAG
CTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATG
CCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAAT
GGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCAT
CCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAA
ACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACT
GTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTG
ATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCA
ATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGT
CAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAG
GACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTAC
TTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGG
GGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTG
CTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCA
GACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCCTGGATTATTCC
CTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTG
GATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAA
TCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGC
TCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGA
ACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGT
TCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATG
TTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACA
TTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACT
GGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 593
[00634] Construct pJAQ214 [VSV-G Signal Peptide]-[TPO Genscript Optimized
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGAACTTAC
AGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGACCCTGTCCAGC
CCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCTGAGAGATAGC
CACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCTCTGCCTACCC
CTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAGATGG
AAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTTGAGGGCG
TGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCTGCTCGGACA
GCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCTGCTGGGGAC
CCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAACGCCATTTT
CCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATGCTGGTGGGC
GGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGCCCAGCCGGA
CATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCGGCCTGCTGGA
AACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCTGAAATGGCA
GCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATCTAGAAGCCT
TGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAACGGCACCAG
AGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGATATCAGCAGC
GGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGATATAGCCCC
AGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGCCTCCTACAC
TGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAGCGCCCCTAC
CCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGCCAGAACCTG
TCTCAGGAGGGCAGCGGTGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCA
TAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATT
AAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCG
ACTTGGAAAG SEQ ID NO: 594
[00635] Construct pJAQ215 [VSV-G Signal Peptide]-[SCF soluble Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGAGGGCAT
CTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAA
TCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTG
CCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACA
GATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCA
TCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACA
GCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCC
CTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGT
GGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAG
GATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCG
GTGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTT
AATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAA
AGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAA
AG SEQ ID NO: 595
[00636] Construct pJAQ216 [VSV-G Signal Peptide]-[SCF soluble mutant
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGAGGGCAT
CTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAA
TCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTG
CCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAG
ATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCAT
CGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAG
CTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAA
TCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAG
CACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
SEQ ID NO: 596
[00637] Construct pJAQ217 [VSV-G Signal Peptide]-[SCF soluble mutant (V49L/F63L/K91E) Targeting Domain]-[SGGSx3.2 Linker]-[VSVG TM tail TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGAGGGCAT
CTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAA
TCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTG
CCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAG
ATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCAT
CGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAG
CTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCT
GAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGG
TGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGA
TAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTAA
TCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAG
CACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
SEQ ID NO: 597
[00638] Construct pJAQ218 [VSV-G Signal Peptide]-[SCF soluble mutant (V49L/F63L/K91E/I98R) Targeting Domain]-[SGGSx3.2 Einker]-[VSVG TM tail TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGAGGGCAT
CTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAA
TCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTG
CCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCTCTGACAG
ATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCAT
CGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAG
CTCCAAGGACCGGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCC
TGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTG
GTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGG
ATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCGG
TGGGAGCGGCGGGAGCGGTGGGAGCATTGCCTCTTTTTTCTTTATCATAGGGTTA
ATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAA
GCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAA
G SEQ ID NO: 598
[00639] Construct pJAQ219 [CD8a Signal Peptide]-[SCF mutant (V49L/F63L)
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTT
TTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTG
CCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAA
GTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCAT
GCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAA
CACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGA
ACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGG
ATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCAT
GTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGA
AAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTG
ACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTT
CTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAG
AAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTG
CAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAA
GGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCT
GCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCC
TGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAAT
CTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCT
TTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCG
ATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCAC
AGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACC
CAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGA
CATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAAC
ATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTT
GGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTA
GTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTA
TTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID
NO: 599
[00640] Construct pJAQ220 [CD8a Signal Peptide]-[SCF mutant
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTT
TTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTG
CCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAA
GTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCAT
GCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAA
CACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGA
ACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGG
ATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCAT
GTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGA
AAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTG
ACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTT
CTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAG
AAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTG
CAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAA
GGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCT
GCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCC
TGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAAT
CTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCT
TTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCG
ATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCAC
AGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACC
CAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGA
CATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAAC
ATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTT
GGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTA
GTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTA
TTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID
NO: 600
[00641] Construct pJAQ221 [CD8a Signal Peptide]-[SCF mutant
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCGGAAAAA
GTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATC
TTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTG
ATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGA
CCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAG
CAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGC
CGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTC
TGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGA
TTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTT
TTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTG
CCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAA
GTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCAT
GCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAA
CACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGA
ACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGG
ATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCAT
GTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGA
AAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTG
ACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTT
CTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAG
AAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTG
CAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAA
GGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCT
GCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCT
TGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAAT
CTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCT
TTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCG
ATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCAC
AGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACC
CAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGA
CATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAAC
ATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTT
GGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTA
GTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTA
TTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAA SEQ ID NO: 601
[00642] Construct pJAQ222 [CXCL12 Targeting Domain]-[SGGSx3.2 Linker]- [VSV-G mut del SP TM]
ATGAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCA
GCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAA
GCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTG
TGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGA
CCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGG
TGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCA
AAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCA
GATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCC
AGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGG
TCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCG
ATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACA
AGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTG
ACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATG
AATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATT
ACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAA
AGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGAC
GGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTT
GCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGA
GTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTG
CAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGAC
CTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTC
TGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGAT
CTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCA
ATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCC
AATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACT
GTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCT
GAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTG
GACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTC
AAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGG
GCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAG
CTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCT
CCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATT
TATACAGACATAGAGATGAACCGACTTGGAAAGTAA SEQ ID NO: 602
[00643] Construct pJAQ223 [SCF soluble Targeting Domain]-[SGGSx3.2 Linker]-
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAG
ACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTT
AAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGT
CCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGT
GGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTT
TCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAG
TCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATG
CTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAAC
ACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAA
CAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGA
TATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATG
TGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAA
AATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGA
CTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTC
TTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGA
AGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGC
AAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAG
GATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTG
CTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTT
GGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATC
TCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTT
TCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGA
TATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACA
GAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCC
AATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGAC
ATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACA
TCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTG
GTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAG
TTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGTAA SEQ ID NO: 603
[00644] Construct pJAQ225 [AdF35 Genscript Codon Optimized Targeting
ATGACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGG
ACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGG
CTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACC
ACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGAC
ACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAAC
AACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAA
GCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTAT
CAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAG
ATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAG
AACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTG
AACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACT
CCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACA
AGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTA
GCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTACATCC
ACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACAT
TAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCA
GTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACT
GACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGGTGGG
AGCGGCGGGAGCGGCGGTAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAA
GGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATT
TAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGA
GTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCAC
TACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCC
TTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGA
ACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGG
ATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATA
CACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACAT
ATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGG
CTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAG
AGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTT
ATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCA
GACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGC
CAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCA
GTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCC
AAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCA
GCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGG
TACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATC
CTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGG
GATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGG
ACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACT
CCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGA
CGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTAT
CCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTAT
TGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGT
TGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACA
GACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 604
[00645] Construct pJAQ226 [TPO Genscript Optimized Targeting Domain]- [SGGSx3.1 Linker]-[VSV-G mut del SP TM]
ATGGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAGGCTGA
CCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAGCTGCT
GAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGCACCCT
CTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTGGAAGA
CCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGC
TTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCCAGCCT
GCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAGAGCCT
GCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGACCCCAA
CGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTCTGATG
CTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGCCGTGC
CCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACGAGCG
GCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGTCTGCT
GAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAGACATC
TAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGCTGAA
CGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTCCTGAT
ATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAACCTGGA
TATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCCTCTGC
CTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGACCCTAG
CGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACACACAGC
CAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCAA
GTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCT
AATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAG
GCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACG
GTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGG
ACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGC
AAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCT
CCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAG
GTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCAC
AGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTAC
AACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCC
ATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAG
GGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGC
AAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTC
GAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAG
GGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGA
CGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAG
AGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCA
GGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCA
GATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGAT
CAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGA
CGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCT
TTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGG
CTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGA
TGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTA
GAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGG
GTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAAT
TAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTG
GAAAG SEQ ID NO: 605
ATGAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGT
TTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACG
TGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCC
TGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGA
TGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACAT
TTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGA
CGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTT
CAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAAC
CGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCG
TGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGC
CATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTC
TAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTAT
GGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATT
GGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAAC
GAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGA
GGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCG
TCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCA
AAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTC
CAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACAT
TCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAA
CGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGC
AACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTG
GTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGC
AGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATA
AGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTC
AGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTA
ACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGC
ATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCT
CTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCA
TCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATT
ATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCC
AGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACC
ATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTG
CTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAG
CGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATG
GAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGG
TATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGA
TACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGG
AAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGSEQ ID NO: 606
[00647] Construct pJAQ228 [CD8a Signal Peptide]-[SCF soluble mutant
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCT
GAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTG
AGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAG
TGCGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAG
CCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACG
CCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCAC
CCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCT
CCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATA
GTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATT
ATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTT
ACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTG
TCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTAT
ATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCA
TTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTT
GTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTC
ACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAA
CGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCAT
TCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCA
CCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGT
TCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAAT
ACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTG
ATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTAT
CTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGG
ATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTC
CAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCC
TGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGA
GTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTA
CCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTG
GACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGAT
TGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTC
GAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTAT
TTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTT
CAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTG
GACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACC
AAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
SEQ ID NO: 607
[00648] Construct pJAQ229 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.2 Linker]-[VSV-G mut del SP TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCAAAAAAA
CCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAACCCTCTG
GTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGT
GACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGT
GCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCA
GCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGC
CTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTT
GAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCC
GAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCG
ACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAG
CACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTG
CCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAGAAAG
GCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCTGCCT
GCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAGAAAA
GACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGAAGATA
ACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTTTCCACACAACCAA
AAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAG
ATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCA
GAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTC
ACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGAT
CCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAG
GAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGAC
GGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAA
TACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTAC
ATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAG
GGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGG
AGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGC
TTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGT
CAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCA
GCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCT
CAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTG
CCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCT
CAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAAT
GGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAA
TCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGT
GGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGA
GGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGA
CTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAA
GACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCT
ATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCT
ATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGA
GTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATA
CAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 608
[00649] Construct pJAQ230 [SCF soluble Targeting Domain]-[SGGSx3.2 Linker]-
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAG
ACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTT
AAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGT
CCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGT
GGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTT
TCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAG
TCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATG
CTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAAC
ACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAA
CAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGA
TATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATG
TGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAA
AATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGA
CTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTC
TTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGA
AGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGC
AAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAG
GATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTG
CTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTT
GGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATC
TCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTT
TCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGA
TATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACA
GAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCC
AATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGAC
ATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACA
TCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTG
GTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAG
TTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 609
[00650] Construct pJAQ232 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTC
GCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGA
CGGACC SEQ ID NO: 610
[00651] Construct pJAQ233 [CD8a Signal Peptide] -[AdF35 Genscript Codon Optimized Targeting Domain]-[SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]- [CD49d.2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTG
ATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAAC
AGTACAAGTCC SEQ ID NO: 611
[00652] Construct pJAQ234 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCC
TTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAG
AAATCTAAGCGG SEQ ID NO: 612
[00653] Construct pJAQ235 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACA
ATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCAC
ATGTACCCTGTGCGGAAC SEQ ID NO: 613
[00654] Construct pJAQ236 [CD8a Signal Peptide] -[AdF35 Genscript Codon
Optimized Targeting Domain]-[SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]-[HLA-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGG
CGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAG
CGACAGAAAGGGC SEQ ID NO: 614
[00655] Construct pJAQ237 [CD8a Signal Peptide] -[AdF35 Genscript Codon
Optimized Targeting Domain]-[SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]-[HLA- DRA TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACCGTGAGCCT
GGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAAGAGCAA
CGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 615
[00656] Construct pJAQ238 [CD8a Signal Peptide] -[AdF35 Genscript Codon Optimized Targeting Domain]-[SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]- [ICAM1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGA
CCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCT
GGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCT
GTACTGCAGCGGTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATC
ATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCAAG
AAATACCGGCTG SEQ ID NO: 616
[00657] Construct pJAQ240 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCC
TGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAA
GAGACGGACC SEQ ID NO: 617
[00658] Construct pJAQ241 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGG
GCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAA
AAAACAGTACAAGTCC SEQ ID NO: 618
[00659] Construct pJAQ242 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGA
CCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGG
CAAGAAATCTAAGCGG SEQ ID NO: 619
[00660] Construct pJAQ243 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCG
CCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGG
GCCACATGTACCCTGTGCGGAAC SEQ ID NO: 620
[00661] Construct pJAQ244 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCGGCA
TGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCT
GCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 621
[00662] Construct pJAQ245 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCG
TGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTA
CGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCC SEQ ID NO: 622
[00663] Construct pJAQ246 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCTC
TGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATC
TGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 623
[00664] Construct pJAQ247 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCTGC
TGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTG
CTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC
SEQ ID NO: 624
[00665] Construct pJAQ248 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCG
TGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGT
GGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID
NO: 625
[00666] Construct pJAQ249 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCAACG
TGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAAT
CTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCT G SEQ ID NO: 626
[00667] Construct pJAQ250 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCG
TGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCAC
CTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 627
[00668] Construct pJAQ251 [CD8a Signal Peptide]-[TPO Genscript Optimized
Targeting Domain] -[SGGSx3.1 Linker]-[CD8a Hinge]-[SGGSxl Linker] -[LFA-1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAG
AGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGC
GGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCTACC
TGTACGTGCTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGT
GCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 628
[00669] Construct pJAQ252 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGT
GCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACC
SEQ ID NO: 629
[00670] Construct pJAQ253 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCT
GCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTC
C SEQ ID NO: 630
[00671] Construct pJAQ254 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
Domain]-[SGGSx3.1 Linker]-[CD8a Hinge]-[SGGSxl Linker] -[CD 162 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGT
GTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGT
GCGGAAC SEQ ID NO: 631
[00672] Construct pJAQ255 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCT
GGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCG
G SEQ ID NO: 632
[00673] Construct pJAQ256 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCAC
CGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGG
C SEQ ID NO: 633
[00674] Construct pJAQ257 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATCA
TCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGC
GGAGAGGCCCTCTG SEQ ID NO: 634
[00675] Construct pJAQ258 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAG
CCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGC
TG SEQ ID NO: 635
[00676] Construct pJAQ259 [CD8a Signal Peptide]-[TPO trunc 157 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGAGCGGTGGGAGCGGCG
GGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTA
CCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTGC
CGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCTG
GCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGCG
GTGGGAGCTACCTGTACGTGCTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCT
GATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG
SEQ ID NO: 636
[00677] Construct pJAQ260 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCATCGTGGGCATCATCGCCGGACTGGTGCTGT
TCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGT
CTAGCGACAGAAAGGGCSEQ ID NO: 637
[00678] Construct pJAQ261 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACCGTG
AGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAAG
AGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 638
[00679] Construct pJAQ262 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTG
TGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGA
TCAAGAAATACCGGCTG SEQ ID NO: 639
[00680] Construct pJAQ263 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTA
CATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATC
ACCCTGTACTGCAGCGGTGGGAGCTACCTGTACGTGCTGAGCGGCATCGGCGGA
CTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAG
AAACCTGAAG SEQ ID NO: 640
[00681] Construct pJAQ264 [SCF soluble mutant (V49L/F63L) Targeting Domain]- [SGGSx3.2 Linker]-[VSV-G mut del SP TM]
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAG
ACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTT
AAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGT
CCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGT
GGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTT
TCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAG
TCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATG
CTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAAC
ACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAA
CAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGA
TATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATG
TGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAA
AATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGA
CTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTC
TTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGA
AGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGC
AAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAG
GATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTG
CTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTT
GGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATC
TCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTT
TCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGA
TATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACA
GAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCC
AATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGAC
ATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACA
TCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTG
GTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAG
TTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 641
[00682] Construct pJAQ265 [SCF soluble mutant (V49L/F63L/K9 IE) Targeting
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GGAGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAG
ACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTT
AAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGT
CCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGT
GGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTTT
TCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGC
CCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAG
TCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATG
CTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAAC
ACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAA
CAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGA
TATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATG
TGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAA
AATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGA
CTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTC
TTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGA
AGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGC
AAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAG
GATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTG
CTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTT
GGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATC
TCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTT
TCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGA
TATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACA
GAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCC
AATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGAC
ATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACA
TCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTG
GTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAG
TTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTAT
TCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAA
AAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 642
[00683] Construct pJAQ266 [SCF soluble mutant (V49L/F63L/K91E/I98R)
ATGGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAA
GCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGC
ATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGC
GATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCA
ATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGT
GGAGGAGAACAGCTCCAAGGACCGGAAAAAGTCTTTCAAGAGCCCCGAGCCAA
GACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTT
TAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTG
TCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTG
TGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCAAGTTCACCATAGTTT
TTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTG
CCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAA
GTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCAT
GCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAA
CACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGA
ACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGG
ATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCAT
GTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGA
AAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTG
ACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTT
CTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAG
AAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTG
CAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAA
GGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCT
GCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCT
TGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAAT
CTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCT
TTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCG
ATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCAC
AGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACC
CAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGA
CATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAAC
ATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTT
GGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTA
GTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTA
TTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID
NO: 643
[00684] Construct pJAQ267 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCGGCATGCTGCCTGTGGC
TGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGG
CGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 644
[00685] Construct pJAQ268 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGT
GGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGA
AGACTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 645
[00686] Construct pJAQ269 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCTCTAG
CAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAG
GCCGGCCTCTTCAAAAAACAGTACAAGTCC SEQ ID NO: 646
[00687] Construct pJAQ270 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGGGCATCATCGC
CGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATG
TGGCGGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 647
[00688] Construct pJAQ271 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCT
GGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAG
GGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 648
[00689] Construct pJAQ272 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCACCGT
GGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAA
CAGACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 649
[00690] Construct pJAQ273 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCTACCTGTACGTGCTGAG
CGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTG
GGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 650
[00691] Construct pJAQ274 [CD8a Signal Peptide]-[SCF soluble Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGA
CAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGC
CTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGC
TGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCT
GAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGA
GTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGA
GCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGAC
GCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCA
CCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCC
TCCTGTGGCCGCCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCC
TGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTG
CGGCCCGAGGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTC
GCCTGCGACATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGC
TCTCTCTGGTGATCACCCTGTACTGCAGCGGTGGGAGCCTGCTGGCTATCCTGAT
CCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGA
CTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 651
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTAACGTGGTGTGCGCCCTGGGCCTGACC
GTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAA
AGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 652
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGT
GGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTG
GCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 653
[00694] Construct pJAQ282 [CD133 scFv 2 Targeting Domain]-[CD8 trunc Hinge]-
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTTACCT
GTACGTGTTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTG
CTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 654
[00695] Construct pJAQ283 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTGGCATGCTGCCTGTGGCTGTGCTGGTGGC
CCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAG
AAGAGACGGACC SEQ ID NO: 655
[00696] Construct pJAQ284 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATGGT
GACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAG
GGCAAGAAATCTAAGCGG SEQ ID NO: 656
[00697] Construct pJAQ285 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [CD8 trunc Hinge] -[HLA-A2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTATCGTGGGCATCATCGCCGGACTGGTGCT
GTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAA
GTCTAGCGACAGAAAGGGC SEQ ID NO: 657
[00698] Construct pJAQ286 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [CD8 trunc Hinge] -[LFA-1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTTACCTGTACGTGTTGAGCGGCATCGGCGG
ACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAA
GAAACCTGAAG SEQ ID NO: 658
[00699] Construct pJAQ287 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCT
GCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTG
GTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC
SEQ ID NO: 659
[00700] Construct pJAQ288 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTGG
CATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCC
CTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 660
[00701] Construct pJAQ289 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAT
CGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGC
TACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCC SEQ ID
NO: 661
[00702] Construct pJAQ290 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAT
CGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTG
GTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 662
[00703] Construct pJAQ291 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[CD49d.2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGC
AAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCTCTAGCAGC
CTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCG
GCCTCTTCAAAAAACAGTACAAGTCC SEQ ID NO: 663
[00704] Construct pJAQ292 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACACTAC
AACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTG
TCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCG
CCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCA
AGAAATCTAAGCGG SEQ ID NO: 664
[00705] Construct pJAQ293 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACACTAC
AACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTG
TCACTGCGCCCTGAAGCCTGTATCGTGATCATCACCGTGGTCGCCGCCGCTGTGA
TCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCA
AGAAATACCGGCTG SEQ ID NO: 665
[00706] Construct pJAQ294 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTGGCATGCTGCCTGTGGCTGTGCTGGTGGC
CCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAG
AAGAGACGGACC SEQ ID NO: 666
[00707] Construct pJAQ295 [B2M Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[CD 162 TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCCTGATCCTGGCC
CTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCA
GAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 667
[00708] Construct pJAQ296 [B2M Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[CD49d.2 TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCTCTAGCAGCCTG CTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCC
TCTTCAAAAAACAGTACAAGTCC SEQ ID NO: 668
[00709] Construct pJAQ297 [B2M Signal Peptide]-[SCF full Targeting Domain]-
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTG
ATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGA
AGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 669
[00710] Construct pJAQ298 [B2M Signal Peptide]-[SCF full Targeting Domain]-
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAACGTGGTGTGCGCCCTGGGCCTG
ACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGA
GAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 670
[00711] Construct pJAQ299 [B2M Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[ICAM1 TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCACCGTGGTCGCC
GCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAG
AGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 671
[00712] Construct pJAQ300 [B2M Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[LFA-1 TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTTACCTGTACGTGTTGAGCGGCATC
GGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTT
CAAAAGAAACCTGAAG SEQ ID NO: 672
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTGGCATGCTGCCTG
TGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCT
GTGGCGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 673
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCT
CTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTG
GAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCC SEQ ID NO: 674
ATGGGATTTCTGCCTAAGCTGCTGCTGCTGGCCTCTTTTTTCCCCGCCGGTCAAGC
TAGCTGGGGCGTGTCTTCTCCACAAGATGTGCAGGGCGTGAAGGGCAGCTGCCT
GCTCATCCCTTGCATCTTCAGCTTCCCTGCTGATGTCGAAGTGCCTGATGGCATCA
CAGCCATCTGGTACTACGACTACAGCGGCCAGAGACAGGTGGTGTCCCACAGCG
CCGACCCCAAACTGGTCGAGGCCAGATTTAGGGGCCGCACCGAGTTCATGGGCA
ACCCCGAGCACAGAGTGTGCAACCTGCTGCTTAAAGACCTGCAACCTGAGGACA
GCGGATCTTATAACTTCAGATTCGAAATTTCTGAGGTGAACCGGTGGAGCGACGT
GAAAGGCACCCTGGTTACCGTGACCGAGGAACCTAGAGTGCCCACCATCGCCTC
CCCTGTGGAACTGCTGGAAGGCACAGAAGTGGACTTCAACTGCAGCACCCCTTA
CGTGTGTCTGCAGGAGCAGGTGCGGCTGCAGTGGCAGGGCCAGGATCCTGCCAG
AAGCGTGACCTTCAATTCACAGAAGTTCGAGCCTACAGGCGTGGGACACCTGGA
AACACTGCACATGGCCATGAGCTGGCAGGACCACGGCAGAATCCTGAGATGCCA
GCTGAGCGTGGCCAACCACCGGGCCCAGAGCGAGATCCACCTGCAGGTGAAGTA
CGCCCCTAAGGGCGTGAAGATCCTGCTGAGTCCTAGCGGCCGGAACATCCTGCC
AGGCGAGCTGGTGACCCTGACATGCCAGGTTAATAGCAGCTACCCTGCTGTATCC
AGCATCAAGTGGCTGAAGGACGGCGTCAGACTGCAGACCAAGACCGGCGTGCTG
CACCTCCCACAGGCCGCTTGGTCCGACGCCGGAGTGTACACCTGTCAGGCCGAG
AACGGCGTGGGCAGCCTGGTGAGCCCCCCCATCAGCCTGCATATCTTCATGAGCG
GTGGTAGCGGAGGTAGTGGAGGTAGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTTA
CCTGTACGTGTTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATC
GTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 675
ATGCACCTGCTTGGACCTTGGCTGCTGCTGCTGGTGCTGGAATACCTGGCCTTTA
GCGATAGCTCTAAATGGGTCTTTGAGCACCCTGAAACCCTGTATGCTTGGGAGGG
CGCCTGCGTGTGGATCCCCTGCACCTACAGGGCCCTGGACGGCGACCTGGAAAG
CTTCATTCTGTTCCACAACCCCGAGTACAACAAGAACACCAGCAAGTTCGACGGC
ACCAGACTGTACGAGTCTACAAAGGACGGCAAGGTGCCATCTGAGCAGAAAAGA
GTGCAGTTCCTGGGAGATAAGAACAAAAACTGCACCCTGAGCATCCACCCCGTG
CACCTGAATGATTCTGGCCAGCTGGGCCTGCGGATGGAATCCAAGACCGAGAAG
TGGATGGAAAGAATCCATCTGAACGTGTCCGAGAGACCTTTCCCCCTCCACATCC
AGCTGCCTCCAGAGATCCAGGAGAGCCAGGAGGTTACACTCACCTGTCTGCTGA
ACTTCTCATGCTACGGCTACCCTATCCAACTGCAATGGCTGCTGGAAGGCGTGCC
CATGCGGCAGGCCGCCGTGACTAGCACATCTCTGACCATCAAGTCCGTGTTTACA
CGCAGCGAGCTGAAGTTCAGCCCTCAGTGGAGCCACCACGGCAAGATCGTGACA
TGTCAGCTGCAGGACGCCGACGGCAAATTCCTGAGCAACGACACCGTGCAGCTG
AACGTGAAGCACACACCTAAGCTGGAAATCAAGGTGACCCCTAGCGACGCTATC
GTGCGGGAAGGCGACAGCGTGACAATGACCTGCGAGGTCAGCAGCAGCAATCCT
GAGTACACCACCGTGTCCTGGCTGAAAGATGGAACAAGCCTGAAGAAGCAGAAC
ACCTTCACCCTGAACCTGAGAGAGGTGACCAAGGATCAGAGCGGCAAGTACTGC
TGTCAGGTGTCTAATGACGTGGGACCTGGCAGAAGCGAGGAAGTGTTCCTTCAA
GTGCAGTACGCCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTA
TCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCCTGAT
CCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGA
CTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 676
[00717] Construct pJAQ305 [Siglec 2 Targeting Domain]-[CD8 trunc Hinge]- [CD62L TM]
ATGCACCTGCTTGGACCTTGGCTGCTGCTGCTGGTGCTGGAATACCTGGCCTTTA
GCGATAGCTCTAAATGGGTCTTTGAGCACCCTGAAACCCTGTATGCTTGGGAGGG
CGCCTGCGTGTGGATCCCCTGCACCTACAGGGCCCTGGACGGCGACCTGGAAAG
CTTCATTCTGTTCCACAACCCCGAGTACAACAAGAACACCAGCAAGTTCGACGGC
ACCAGACTGTACGAGTCTACAAAGGACGGCAAGGTGCCATCTGAGCAGAAAAGA
GTGCAGTTCCTGGGAGATAAGAACAAAAACTGCACCCTGAGCATCCACCCCGTG
CACCTGAATGATTCTGGCCAGCTGGGCCTGCGGATGGAATCCAAGACCGAGAAG
TGGATGGAAAGAATCCATCTGAACGTGTCCGAGAGACCTTTCCCCCTCCACATCC
AGCTGCCTCCAGAGATCCAGGAGAGCCAGGAGGTTACACTCACCTGTCTGCTGA
ACTTCTCATGCTACGGCTACCCTATCCAACTGCAATGGCTGCTGGAAGGCGTGCC
CATGCGGCAGGCCGCCGTGACTAGCACATCTCTGACCATCAAGTCCGTGTTTACA
CGCAGCGAGCTGAAGTTCAGCCCTCAGTGGAGCCACCACGGCAAGATCGTGACA
TGTCAGCTGCAGGACGCCGACGGCAAATTCCTGAGCAACGACACCGTGCAGCTG
AACGTGAAGCACACACCTAAGCTGGAAATCAAGGTGACCCCTAGCGACGCTATC
GTGCGGGAAGGCGACAGCGTGACAATGACCTGCGAGGTCAGCAGCAGCAATCCT
GAGTACACCACCGTGTCCTGGCTGAAAGATGGAACAAGCCTGAAGAAGCAGAAC
ACCTTCACCCTGAACCTGAGAGAGGTGACCAAGGATCAGAGCGGCAAGTACTGC
TGTCAGGTGTCTAATGACGTGGGACCTGGCAGAAGCGAGGAAGTGTTCCTTCAA
GTGCAGTACGCCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTA
TCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGT
GGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGA
AGACTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 677
[00718] Construct pJAQ306 [Siglec 2 Targeting Domain]-[CD8 trunc Hinge]-[HLA-
ATGCACCTGCTTGGACCTTGGCTGCTGCTGCTGGTGCTGGAATACCTGGCCTTTA
GCGATAGCTCTAAATGGGTCTTTGAGCACCCTGAAACCCTGTATGCTTGGGAGGG
CGCCTGCGTGTGGATCCCCTGCACCTACAGGGCCCTGGACGGCGACCTGGAAAG
CTTCATTCTGTTCCACAACCCCGAGTACAACAAGAACACCAGCAAGTTCGACGGC
ACCAGACTGTACGAGTCTACAAAGGACGGCAAGGTGCCATCTGAGCAGAAAAGA
GTGCAGTTCCTGGGAGATAAGAACAAAAACTGCACCCTGAGCATCCACCCCGTG
CACCTGAATGATTCTGGCCAGCTGGGCCTGCGGATGGAATCCAAGACCGAGAAG
TGGATGGAAAGAATCCATCTGAACGTGTCCGAGAGACCTTTCCCCCTCCACATCC
AGCTGCCTCCAGAGATCCAGGAGAGCCAGGAGGTTACACTCACCTGTCTGCTGA
ACTTCTCATGCTACGGCTACCCTATCCAACTGCAATGGCTGCTGGAAGGCGTGCC
CATGCGGCAGGCCGCCGTGACTAGCACATCTCTGACCATCAAGTCCGTGTTTACA
CGCAGCGAGCTGAAGTTCAGCCCTCAGTGGAGCCACCACGGCAAGATCGTGACA
TGTCAGCTGCAGGACGCCGACGGCAAATTCCTGAGCAACGACACCGTGCAGCTG
AACGTGAAGCACACACCTAAGCTGGAAATCAAGGTGACCCCTAGCGACGCTATC
GTGCGGGAAGGCGACAGCGTGACAATGACCTGCGAGGTCAGCAGCAGCAATCCT
GAGTACACCACCGTGTCCTGGCTGAAAGATGGAACAAGCCTGAAGAAGCAGAAC
ACCTTCACCCTGAACCTGAGAGAGGTGACCAAGGATCAGAGCGGCAAGTACTGC
TGTCAGGTGTCTAATGACGTGGGACCTGGCAGAAGCGAGGAAGTGTTCCTTCAA
GTGCAGTACGCCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTA
TCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAACGTGGTGTGCGCCCT
GGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAG
GGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 678
Construct pJAQ307 [Siglec 3 Targeting Domain]-[CD8 trunc Hinge]-[CD43 TM] [00719] Domain Name Domain Type Start End
ATGCCTCTGCTGCTCCTGCTGCCTCTCCTGTGGGCTGGCGCCCTGGCCATGGACC
CCAATTTCTGGCTGCAGGTGCAAGAGAGCGTCACCGTGCAGGAGGGCCTGTGCG
TGCTGGTGCCATGTACATTTTTCCACCCCATCCCCTACTACGACAAGAACAGCCC
TGTTCATGGCTACTGGTTCCGGGAAGGCGCTATCATCAGCAGAGATAGCCCCGTG
GCCACCAACAAGCTGGATCAGGAGGTGCAGGAGGAAACCCAGGGCAGATTCAG
ACTGCTGGGCGATCCTAGCCGGAACAACTGCAGCCTGAGCATCGTGGACGCCAG
AAGAAGGGACAACGGCTCTTATTTCTTTCGGATGGAACGGGGCAGCACCAAGTA
CAGCTACAAGTCCCCACAACTGAGCGTGCACGTGACAGACCTGACACACAGACC
TAAGATCCTGATCCCTGGAACCCTGGAACCCGGCCACTCTAAAAATCTGACCTGT
TCTGTCTCCTGGGCCTGCGAGCAGGGCACACCTCCTATCTTCAGCTGGCTGTCCG
CCGCCCCTACAAGCCTGGGACCTAGAACAACCCACAGCTCTGTGCTGATTATCAC
CCCTAGACCCCAGGACCACGGCACAAACCTGACCTGCCAGGTGAAATTCGCCGG
AGCCGGCGTGACCACCGAGAGAACCATCCAGCTGAACACTACAACTCCAGCACC
CAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCT
GAAGCCTGTGGCATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCG
TGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACC
SEQ ID NO: 679
ATGCTGCCGCTGCAGCTGCCGCCCCTGCTGTGGGGCAGAGAGAGAGTGGAAGGC
CAGAAAAGCAATAGAAAGGATTACAGCCTGACCATGCAGAGCAGCGTGACCGTG
CAGGAGGGCATGTGCGTGCACGTGCGGTGCAGCTTCAGCTACCCCGTGGATTCTC
AGACCGACAGCGACCCCGTGCATGGCTACTGGTTCCGGGCCGGCAACGACATCT
CCTGGAAGGCCCCTGTGGCCACAAACAACCCTGCTTGGGCTGTGCAGGAGGAAA
CACGCGACAGATTCCACCTGCTGGGCGACCCTCAGACAAAGAACTGCACCCTGT
CCATCCGGGACGCCAGAATGAGCGATGCCGGAAGATACTTCTTCCGGATGGAAA
AAGGTAATATTAAGTGGAACTACAAGTACGACCAGCTGTCTGTTAACGTGACCG
CCCTGACCCACAGGCCTAACATCCTGATCCCCGGCACCCTGGAGTCTGGATGTTT
TCAGAATCTGACCTGCAGCGTCCCCTGGGCCTGTGAACAGGGCACCCCTCCAATG
ATCAGCTGGATGGGCACCAGCGTGTCCCCTCTGCACCCTAGCACCACCAGAAGCT
CCGTGCTGACCCTGATCCCTCAACCCCAACACCACGGCACAAGCCTGACATGCCA
GGTGACCCTGCCTGGCGCCGGCGTGACTACAAACAGAACAATCCAGCTGAACGT
TTCCTACCCTCCTCAAAACCTGACAGTGACCGTCTTTCAGGGCGAGGGCACAGCT
TCTACCGCCCTGGGAAACAGCAGCTCTCTGAGCGTGCTGGAAGGCCAGAGCCTG
AGACTGGTGTGCGCCGTGGACAGCAACCCACCTGCCAGACTGAGCTGGACCTGG
CGGAGCCTGACCCTTTATCCAAGCCAGCCTTCTAACCCCCTGGTGCTCGAGCTGC
AGGTCCACCTGGGAGATGAGGGCGAGTTCACCTGTAGAGCCCAGAATTCTCTGG
GCAGCCAGCACGTGTCCCTCAACCTGAGCTTGACTACAACTCCAGCACCCAGACC
CCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCC
TGTATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGCTGCTGA
TCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGTCC
SEQ ID NO: 680
ATGCTGCCGCTGCAGCTGCCGCCCCTGCTGTGGGGCAGAGAGAGAGTGGAAGGC
CAGAAAAGCAATAGAAAGGATTACAGCCTGACCATGCAGAGCAGCGTGACCGTG
CAGGAGGGCATGTGCGTGCACGTGCGGTGCAGCTTCAGCTACCCCGTGGATTCTC
AGACCGACAGCGACCCCGTGCATGGCTACTGGTTCCGGGCCGGCAACGACATCT
CCTGGAAGGCCCCTGTGGCCACAAACAACCCTGCTTGGGCTGTGCAGGAGGAAA
CACGCGACAGATTCCACCTGCTGGGCGACCCTCAGACAAAGAACTGCACCCTGT
CCATCCGGGACGCCAGAATGAGCGATGCCGGAAGATACTTCTTCCGGATGGAAA
AAGGTAATATTAAGTGGAACTACAAGTACGACCAGCTGTCTGTTAACGTGACCG
CCCTGACCCACAGGCCTAACATCCTGATCCCCGGCACCCTGGAGTCTGGATGTTT
TCAGAATCTGACCTGCAGCGTCCCCTGGGCCTGTGAACAGGGCACCCCTCCAATG
ATCAGCTGGATGGGCACCAGCGTGTCCCCTCTGCACCCTAGCACCACCAGAAGCT
CCGTGCTGACCCTGATCCCTCAACCCCAACACCACGGCACAAGCCTGACATGCCA
GGTGACCCTGCCTGGCGCCGGCGTGACTACAAACAGAACAATCCAGCTGAACGT
TTCCTACCCTCCTCAAAACCTGACAGTGACCGTCTTTCAGGGCGAGGGCACAGCT
TCTACCGCCCTGGGAAACAGCAGCTCTCTGAGCGTGCTGGAAGGCCAGAGCCTG
AGACTGGTGTGCGCCGTGGACAGCAACCCACCTGCCAGACTGAGCTGGACCTGG
CGGAGCCTGACCCTTTATCCAAGCCAGCCTTCTAACCCCCTGGTGCTCGAGCTGC
AGGTCCACCTGGGAGATGAGGGCGAGTTCACCTGTAGAGCCCAGAATTCTCTGG
GCAGCCAGCACGTGTCCCTCAACCTGAGCTTGACTACAACTCCAGCACCCAGACC
CCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCC
TGTCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTT
TATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGG
SEQ ID NO: 681
ATGCTGCCGCTGCAGCTGCCGCCCCTGCTGTGGGGCAGAGAGAGAGTGGAAGGC
CAGAAAAGCAATAGAAAGGATTACAGCCTGACCATGCAGAGCAGCGTGACCGTG
CAGGAGGGCATGTGCGTGCACGTGCGGTGCAGCTTCAGCTACCCCGTGGATTCTC
AGACCGACAGCGACCCCGTGCATGGCTACTGGTTCCGGGCCGGCAACGACATCT
CCTGGAAGGCCCCTGTGGCCACAAACAACCCTGCTTGGGCTGTGCAGGAGGAAA
CACGCGACAGATTCCACCTGCTGGGCGACCCTCAGACAAAGAACTGCACCCTGT
CCATCCGGGACGCCAGAATGAGCGATGCCGGAAGATACTTCTTCCGGATGGAAA
AAGGTAATATTAAGTGGAACTACAAGTACGACCAGCTGTCTGTTAACGTGACCG
CCCTGACCCACAGGCCTAACATCCTGATCCCCGGCACCCTGGAGTCTGGATGTTT
TCAGAATCTGACCTGCAGCGTCCCCTGGGCCTGTGAACAGGGCACCCCTCCAATG
ATCAGCTGGATGGGCACCAGCGTGTCCCCTCTGCACCCTAGCACCACCAGAAGCT
CCGTGCTGACCCTGATCCCTCAACCCCAACACCACGGCACAAGCCTGACATGCCA
GGTGACCCTGCCTGGCGCCGGCGTGACTACAAACAGAACAATCCAGCTGAACGT
TTCCTACCCTCCTCAAAACCTGACAGTGACCGTCTTTCAGGGCGAGGGCACAGCT
TCTACCGCCCTGGGAAACAGCAGCTCTCTGAGCGTGCTGGAAGGCCAGAGCCTG
AGACTGGTGTGCGCCGTGGACAGCAACCCACCTGCCAGACTGAGCTGGACCTGG
CGGAGCCTGACCCTTTATCCAAGCCAGCCTTCTAACCCCCTGGTGCTCGAGCTGC
AGGTCCACCTGGGAGATGAGGGCGAGTTCACCTGTAGAGCCCAGAATTCTCTGG
GCAGCCAGCACGTGTCCCTCAACCTGAGCTTGACTACAACTCCAGCACCCAGACC
CCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCC
TGTTACCTGTACGTGTTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCT
TCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAGSEQ ID NO: 682
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATG
GTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGA
AGGGCAAGAAATCTAAGCGG SEQ ID NO: 683
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCCTGATCCTGGCCCTG
GTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAA
AGGGCCACATGTACCCTGTGCGGAACSEQ ID NO: 684
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCACCGTGGTCGCCGCC
GCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGA
AAGATCAAGAAATACCGGCTG SEQ ID NO: 685
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCTGCT
GGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTG
CTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC
SEQ ID NO: 686
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGT
GATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCAC
CTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 687
[00728] Construct pJAQ316 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [CD8 trunc Hinge] -[CD49d.2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCTCTAGCAGCCTGCTGCT
GGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTC
AAAAAACAGTACAAGTCC SEQ ID NO: 688
[00729] Construct pJAQ317 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [CD8 trunc Hinge] -[CD 162 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCCTGATCCTGGCCCTGGTC
GCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAG
GGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 689
[00730] Construct pJAQ318 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCACCGTGGTCGCCGCCGC
TGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAA
GATCAAGAAATACCGGCTG SEQ ID NO: 690
[00731] Construct pJAQ319 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCC
TCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCA
TCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID
NO: 691
[00732] Construct pJAQ320 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAT
CGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGC
ACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 692
[00733] Construct pJAQ321 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTTA
CCTGTACGTGTTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATC
GTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 693
[00734] Construct pJAQ322 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[CD62L TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGC
AAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCC
GTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGAC
TGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 694
[00735] Construct pJAQ323 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[ICAM1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGC
AAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCACCGTGGTC
GCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGA
CAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 695
[00736] Construct pJAQ324 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACACTAC
AACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTG
TCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCA
CAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCC
ACATGTACCCTGTGCGGAAC SEQ ID NO: 696
[00737] Construct pJAQ325 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACACTAC
AACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTG
TCACTGCGCCCTGAAGCCTGTTACCTGTACGTGTTGAGCGGCATCGGCGGACTGC
TGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAA
CCTGAAG SEQ ID NO: 697
[00738] Construct pJAQ326 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATGGT
GACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAG
GGCAAGAAATCTAAGCGG SEQ ID NO: 698
[00739] Construct pJAQ327 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [CD8 trunc Hinge] -[HLA-A2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTATCGTGGGCATCATCGCCGGACTGGTGCT
GTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAA
GTCTAGCGACAGAAAGGGC SEQ ID NO: 699
[00740] Construct pJAQ328 [CD90 scFvl Targeting Domain]-[CD8 trunc Hinge]-
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAACGTGGTGTGCG
CCCTGGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCAT
CAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 700
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCA
CCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTA
CAACAGACAGAGAAAGATCAAGAAATACCGGCTGSEQ ID NO: 701
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTGGCATGCTGCCTGTGGCTGTGCTGGTG
GCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAAGAC
AGAAGAGACGGACC SEQ ID NO: 702
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGGGCATCATCGCCGGACTGGTG
CTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGA
AAGTCTAGCGACAGAAAGGGC SEQ ID NO: 703
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCCTCT
GTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCT
GGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID NO: 704
[00745] Construct pJAQ333 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTAACGTGGTGTGCGCCCTGGGCCTGACCGT
GAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAA
GAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 705
[00746] Construct pJAQ334 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCACTACAACTCCAGCACCCAGACCCCCTA
CACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCT
GCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTG
GTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC
SEQ ID NO: 706
[00747] Construct pJAQ335 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[CD43 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGC
AAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTGGCATGCTGCCTGTGGCTGTG
CTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGA
GAAGACAGAAGAGACGGACC SEQ ID NO: 707
[00748] Construct pJAQ336 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[HLA-A2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGC
AAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGGGCATCATCGCCGGA
CTGGTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGC
GGAGAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 708
[00749] Construct pJAQ337 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[HLA-DRA TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGC
AAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTAACGTGGTGTGCGCCCTGGGC
CTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCC
TGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 709
[00750] Construct pJAQ338 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACACTAC
AACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTG
TCACTGCGCCCTGAAGCCTGTATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCC
TGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAA
ACAGTACAAGTCCSEQ ID NO: 710
[00751] Construct pJAQ339 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACACTAC
AACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTG
TCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCG
CCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCA
AGAAATCTAAGCGG SEQ ID NO: 711
[00752] Construct pJAQ340 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [CD8 trunc Hinge] -[CD49d.2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCTCTAGCAGCCTGCTGCT
GGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTC
AAAAAACAGTACAAGTCC SEQ ID NO: 712
[00753] Construct pJAQ341 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCCTGATCCTGGCCCTGGTC
GCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAG
GGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 713
[00754] Construct pJAQ342 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
ACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGC
CCCTGTCACTGCGCCCTGAAGCCTGTTACCTGTACGTGTTGAGCGGCATCGGCGG
ACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAA
GAAACCTGAAG SEQ ID NO: 714
[00755] Construct pJAQ343 [B2M Signal Peptide]-[SCF full Targeting Domain]- [CD8 trunc Hinge] -[CD43 TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTGGCATGCTGCCTGTGGCTGTGCTG
GTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCTGTGGCGGAGAA
GACAGAAGAGACGGACC SEQ ID NO: 715
[00756] Construct pJAQ344 [B2M Signal Peptide]-[SCF full Targeting Domain]-
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGGGCATCATCGCCGGACTG
GTGCTGTTCGGCGCCGTCATCACCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGA
GAAAGTCTAGCGACAGAAAGGGC SEQ ID NO: 716
[00757] Construct pJAQ345 [CD90 scFvl Targeting Domain]-[CD8 trunc Hinge]-
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCCTCTGTTCATCC
CCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGC
CAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGGSEQ ID NO: 717
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTCTGCTGGCTATCC
TGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGT
GAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 718
[00759] Construct pJAQ347 [CD90 scFvl Targeting Domain]-[CD8 trunc Hinge]-
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCA
ACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTTACCTGTACGTGT
TGAGCGGCATCGGCGGACTGCTGCTGCTGCTCCTGATCTTCATCGTGCTGTACAA
GGTGGGCTTTTTCAAAAGAAACCTGAAG SEQ ID NO: 719
[00760] Construct pJAQ358 [CD8a Signal Peptide]-[TPO-157 Targeting Domain]- [CD8 trunc Hinge] -[CD62L TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACCGCCAG
ACTGACCCTGAGCAGCCCCGCCCCTCCTGCCTGCGATCTGCGGGTGCTGTCTAAA
CTGCTGCGGGACAGCCACGTGCTGCATTCTAGACTGAGCCAGTGTCCTGAGGTGC
ACCCCCTGCCCACCCCTGTGCTGCTGCCCGCTGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAAATGGAAGAGACAAAGGCCCAAGACATCCTGGGCGCCGTGACCCT
GCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGCCCTACATGCCTGTC
CAGCCTCCTGGGACAGCTGTCCGGCCAGGTGCGGCTGCTGCTTGGAGCCCTGCAG
AGCCTGCTGGGCACACAGCTGCCACCTCAGGGCAGAACCACAGCCCACAAGGAT
CCTAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGAGAACTACAACTCCAGCAC
CCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCC
TGAAGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGC
CTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAG
CGG SEQ ID NO: 720
[00761] Construct pJAQ359 [CD8a Signal Peptide]-[TPO-157 Targeting Domain]-
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACCGCCAG
ACTGACCCTGAGCAGCCCCGCCCCTCCTGCCTGCGATCTGCGGGTGCTGTCTAAA
CTGCTGCGGGACAGCCACGTGCTGCATTCTAGACTGAGCCAGTGTCCTGAGGTGC
ACCCCCTGCCCACCCCTGTGCTGCTGCCCGCTGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAAATGGAAGAGACAAAGGCCCAAGACATCCTGGGCGCCGTGACCCT
GCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGCCCTACATGCCTGTC
CAGCCTCCTGGGACAGCTGTCCGGCCAGGTGCGGCTGCTGCTTGGAGCCCTGCAG
AGCCTGCTGGGCACACAGCTGCCACCTCAGGGCAGAACCACAGCCCACAAGGAT
CCTAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGAGAACTACAACTCCAGCAC
CCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCC
TGAAGCCTGTTACCTGTACGTGTTGAGCGGCATCGGCGGACTGCTGCTGCTGCTC
CTGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG
SEQ ID NO: 721
[00762] Construct pJAQ360 [CD8a Signal Peptide] -[CALR-ins5 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTATGCTGCTTAGCGTGCCTCTGCTGCTGGGCCTGCTGGGCCTGGCCGT
GGCCGAACCCGCCGTGTACTTCAAGGAACAGTTCCTCGACGGCGATGGATGGAC
ATCTAGATGGATCGAGTCTAAGCATAAGAGCGATTTCGGCAAGTTTGTGCTGAGC
TCCGGCAAGTTCTACGGCGACGAGGAAAAAGATAAGGGCCTGCAGACCAGCCAA
GACGCCAGATTCTACGCTCTGAGCGCCAGCTTCGAGCCCTTCTCCAACAAGGGCC
AGACCCTGGTCGTGCAGTTTACAGTGAAGCACGAGCAGAACATCGATTGCGGCG
GAGGCTACGTGAAGCTGTTCCCCAACTCTCTGGATCAGACAGATATGCACGGCG
ACAGCGAGTACAACATCATGTTCGGCCCTGACATCTGTGGCCCCGGCACAAAGA
AAGTGCACGTGATCTTTAACTACAAAGGAAAAAACGTGCTGATCAACAAAGACA
TCAGATGCAAGGACGACGAGTTCACCCACCTGTACACCCTGATTGTGCGGCCTGA
TAATACCTACGAGGTGAAGATCGATAACAGCCAGGTCGAGAGCGGCAGCCTGGA
AGACGACTGGGATTTCCTGCCTCCTAAGAAGATCAAGGACCCCGATGCTAGCAA
GCCCGAGGACTGGGACGAGAGAGCCAAGATTGACGACCCTACAGACTCCAAGCC
TGAGGACTGGGACAAGCCCGAGCACATCCCTGATCCTGATGCTAAAAAGCCTGA
GGACTGGGACGAGGAAATGGACGGCGAATGGGAGCCTCCAGTGATCCAGAATCC
TGAATACAAGGGCGAATGGAAGCCTAGGCAGATCGACAACCCAGACTACAAGG
GCACCTGGATCCACCCTGAGATCGACAATCCTGAGTATTCTCCCGACCCCAGCAT
CTACGCCTATGATAACTTTGGAGTTCTGGGACTGGACCTGTGGCAGGTGAAGTCT
GGAACCATCTTCGACAACTTCCTGATCACTAACGACGAGGCCTACGCCGAGGAA
TTCGGCAACGAGACCTGGGGCGTGACCAAGGCCGCCGAGAAACAGATGAAAGA
CAAGCAGGACGAAGAACAGCGGCTGAAGGAAGAAGAGGAAGATAAGAAAAGA
AAGGAAGAAGAGGAGGCTGAGGATAATTGTAGACGGATGATGAGAACCAAGAT
GCGCATGCGGAGAATGAGAAGAACCAGAAGAAAGATGCGGCGGAAGATGAGCC
CTGCCAGACCGCGGACAAGCTGCCGGGAAGCCTGCCTGCAAGGCTGGACCGAGG
CCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCATCACCGTGGTGGCGGCT
GCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATCTGTACAACCGCCAGCGTA
AAATCAAGAAGTACCGCCTG SEQ ID NO: 722
[00763] Construct pJAQ361 [CD8a Signal Peptide]-[CALR-del52 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTATGCTGCTGTCCGTGCCTCTGCTGCTGGGCCTGCTGGGACTGGCCGT
GGCCGAGCCAGCCGTTTACTTCAAGGAACAGTTTCTGGACGGCGACGGCTGGAC
AAGCAGATGGATCGAGTCTAAGCATAAGTCCGACTTCGGCAAGTTCGTGCTGTCT
AGCGGAAAATTCTACGGCGATGAAGAGAAGGACAAGGGCCTGCAGACCTCCCA
GGACGCTAGATTCTACGCCCTGAGCGCCTCTTTCGAACCCTTCAGCAACAAGGGA
CAGACCCTGGTGGTGCAATTCACCGTGAAACACGAGCAGAATATCGACTGCGGT
GGCGGCTACGTCAAGCTGTTCCCCAACAGCCTGGACCAGACAGACATGCACGGC
GACAGCGAGTACAACATCATGTTCGGCCCTGATATCTGCGGCCCCGGCACAAAG
AAGGTGCACGTGATCTTTAACTACAAGGGCAAGAACGTGCTGATTAACAAAGAC
ATCCGGTGCAAGGACGACGAGTTCACACACCTGTACACCCTGATCGTGCGGCCT
GACAACACCTACGAGGTGAAGATCGACAATTCTCAGGTCGAGAGCGGCAGCCTC
GAGGACGATTGGGATTTCCTTCCTCCTAAGAAAATCAAAGACCCCGATGCCAGC
AAACCTGAAGACTGGGATGAGAGAGCCAAGATCGACGACCCCACCGACAGCAA
GCCTGAAGATTGGGACAAACCTGAGCACATCCCTGACCCCGATGCCAAAAAGCC
TGAGGATTGGGATGAAGAGATGGACGGAGAATGGGAGCCTCCAGTGATTCAGAA
CCCTGAATATAAGGGCGAGTGGAAGCCTAGACAGATCGATAATCCTGATTACAA
GGGCACCTGGATCCACCCTGAAATCGACAATCCCGAGTATAGCCCAGACCCAAG
CATCTACGCCTACGACAACTTTGGAGTGCTGGGCCTGGATCTGTGGCAGGTGAAG
TCTGGCACCATCTTTGACAACTTCCTGATCACCAACGACGAGGCTTACGCTGAGG
AATTCGGCAACGAGACATGGGGGGTGACCAAGGCCGCTGAAAAGCAGATGAAA
GACAAGCAAGACGAAGAACAAAGAACCAGACGCATGATGCGGACAAAGATGCG
GATGCGGCGGATGAGAAGAACAAGAAGGAAGATGAGACGGAAGATGAGCCCTG
CCAGACCCAGAACCAGCTGCAGAGAGGCCTGTCTGCAGGGCTGGACCGAGGCCA
CTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCC
CCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCC
GTGATCATGGGCACCGCCGGTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAA
TCAAGAAGTACCGCCTG SEQ ID NO: 723
[00764] Construct pJAQ362 [CD8a Signal Peptide]-[TPO-157 Targeting Domain]- [CD8 trunc Hinge] -[ICAM1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACCGCCAG
ACTGACCCTGAGCAGCCCCGCCCCTCCTGCCTGCGATCTGCGGGTGCTGTCTAAA
CTGCTGCGGGACAGCCACGTGCTGCATTCTAGACTGAGCCAGTGTCCTGAGGTGC
ACCCCCTGCCCACCCCTGTGCTGCTGCCCGCTGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAAATGGAAGAGACAAAGGCCCAAGACATCCTGGGCGCCGTGACCCT
GCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGCCCTACATGCCTGTC
CAGCCTCCTGGGACAGCTGTCCGGCCAGGTGCGGCTGCTGCTTGGAGCCCTGCAG
AGCCTGCTGGGCACACAGCTGCCACCTCAGGGCAGAACCACAGCCCACAAGGAT
CCTAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGAGAACTACAACTCCAGCAC
CCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCC
TGAAGCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACC
GCCGGTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCC
TG SEQ ID NO: 724
[00765] Construct pJAQ363 [CD8a Signal Peptide] -[TPO- 163 Targeting Domain]- [CD8 trunc Hinge] -[ICAM1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACAGCCCG
CCTGACACTGAGCAGCCCTGCCCCTCCAGCCTGCGATCTGAGAGTGCTGAGCAA
ACTGCTGAGAGATAGCCACGTGCTGCACAGCAGACTGTCTCAGTGCCCCGAGGT
GCACCCCCTGCCCACCCCTGTGCTGCTGCCTGCCGTGGACTTCAGCCTGGGAGAG
TGGAAGACCCAAATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGAC
CCTGCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGACCTACCTGTCT
GTCCAGCCTGCTTGGCCAGCTCTCCGGCCAAGTGCGGCTGCTGCTGGGAGCTCTG
CAGAGCCTGCTGGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCATAAG
GACCCCAACGCCATCTTCCTGTCTTTTCAGCACCTGCTGCGGGGCAAGGTGCGGT
TCCTGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAG
TCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCATCACCGTGGTGGCG
GCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATCTGTACAACCGCCAGC
GTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 725
[00766] Construct pJAQ364 [CD8a Signal Peptide] -[TPO- 171 Targeting Domain] -
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGCTGACCGAGCTGCTGCTGGTCGTTATGCTGCTGCTTACAGCCAG
ACTGACACTGTCCAGCCCTGCCCCTCCAGCATGCGACCTGAGGGTGCTGAGCAA
GCTGCTGAGAGATAGCCACGTGCTGCACTCTAGACTGTCTCAGTGCCCCGAGGTG
CACCCTCTGCCCACCCCTGTGCTGCTCCCCGCCGTGGACTTCAGCCTGGGCGAGT
GGAAGACCCAGATGGAAGAAACCAAGGCCCAGGATATCCTGGGCGCTGTGACCC
TGCTGCTGGAAGGCGTGATGGCCGCTAGAGGACAACTGGGACCTACCTGTCTGA
GCAGCCTGCTGGGCCAGCTGTCCGGCCAAGTGCGGCTGCTGCTGGGCGCCCTGC
AGAGCCTGCTCGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCATAAGG
ACCCCAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGCGGGGCAAAGTGCGGTT
CCTGATGCTGGTGGGCGGATCTACACTGACTACAACTCCAGCACCCAGACCCCCT
ACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTA
TTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTC
CACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 726
[00767] Construct pJAQ365 [CD8a Signal Peptide]-[CD117 scFv 2D 1 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGATATTGTGATGACCCAGAGCCATAAGTTCATGAGCACCAGCGTGG
GCGATAGAGTGTCCATCACCTGCAAGGCCTCTCAGGACGTGTCTACAACCGTGGC
CTGGTACCAGCAGAAACCTGGCCAGAGCCCTAAGCTGCTGATCTACTCTGCCAGC
TACAGATATACCGGCGTGCCCGACAGATTCACAGGCAGCGGCTCCGGCACAGAC
TTCACCTTCACCATCAGCAGCGTGCAGGCCGAAGATCTGGCCGTTTACTACTGCC
AGCAACACTACAGCACACCTCCAACATTCGGCGGCGGCACCAAGCTGGAAATCA
AAGGCGGTGGAGGCAGCGGAGGCGGAGGCTCTGGCGGCGGCGGCAGCCAAGTG
CAACTCCAGCAGAGTGATGCCGAGCTGGTGAAGCCTGGAGCTTCTGTGAAGATC
AGCTGCAAAGCTTCTGGCTACACCTTTACCGACCACGCCATCCACTGGGTCAAGC
AGCGGCCCGAGCAGGGCCTGGAATGGATCGGCTGTATCTCCCCTGGAAATGGCG
ACATCAAGTACAACGAGAAGTTTAAGGGCAAGGCTACACTGAGCGCCGACAAAA
GCTCTAGCACCGCCTACATGCAGCTGAACAGCCTGACAAGCGAGGACAGCGCCG
TGTATTTCTGCAAGCGGTGGGACTACTTCGACTACTGGGGCCAGGGAACCACCCT
GACCGTGTCCAGCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACT
ATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCATCACCG
TGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATCTGTACAA
CCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 727
[00768] Construct pJAQ366 [CD8a Signal Peptide]- [CD 117 scFv 2D2 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAGAGCGACGCCGAGCTGGTGAAGCCCGGAG
CCTCCGTGAAGATCTCCTGCAAGGCTAGCGGCTACACCTTCACCGACCATGCCAT
CCACTGGGTGAAACAGCGGCCTGAGCAGGGCCTGGAATGGATCGGATGTATCAG
CCCCGGCAACGGCGACATCAAATACAATGAGAAGTTCAAGGGCAAGGCTACACT
GTCTGCCGACAAGAGCAGCAGCACCGCCTACATGCAGCTGAACAGCCTCACCAG
CGAGGACAGCGCCGTTTACTTCTGCAAGCGGTGGGACTACTTTGATTATTGGGGA
CAAGGCACCACCCTGACAGTGAGCTCTGGCGGAGGTGGCTCTGGAGGCGGTGGA
TCTGGTGGTGGCGGATCAGATATTGTGATGACCCAGAGCCACAAGTTCATGAGC
ACAAGCGTCGGAGATAGAGTGTCTATCACATGCAAAGCTTCTCAGGACGTGTCC
ACCACCGTGGCCTGGTATCAGCAGAAACCTGGCCAGTCTCCTAAGCTGCTGATCT
ACAGCGCCAGCTACAGATACACAGGCGTGCCAGACAGATTCACCGGCTCTGGTA
GCGGCACAGACTTCACCTTCACCATCTCTAGCGTGCAGGCCGAAGATCTGGCCGT
GTACTACTGCCAGCAACACTACAGCACCCCTCCTACCTTTGGCGGAGGCACAAA
GCTGGAAATCAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACT
ATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCATCACCG
TGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATCTGTACAA
CCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 728
[00769] Construct pJAQ367 [CD8a Signal Peptide]-[CD117 scFv 4F1 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGACATCGTGATGACCCAGAGCCACAAGTTCATGAGCACCAGCGTGG
GCGATAGAGTGTCCATCACATGCAAGGCCAGCCAGGACGTGTCTACAACCGTGG
CCTGGTACCAGCAGAAACCTGGCCAAAGCCCCAAGCTGCTGATCTACTCCGCCTC
TTACCGGTACACCGGCGTGCCTGACCGGTTCACCGGCAGCGGCTCTGGCACCGAC
TTCACCTTCACCATCAGCAGCGTCCAGGCCGAGGACCTGGCCGTGTACTACTGCC
AGCAGCACTACTCTACCCCTCCAACCTTTGGCGGAGGAACAAAGCTGGAAATCA
AGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGAGGTGC
AGCTGCAGGAGAGCGGTCCTAGCCTCGTGAAGCCTTCTCAGACCCTGAGCCTGA
CCTGTAGCGTGACCGGCGACAGCATCACCAGCGGATATTGGAATTGGATCAGAA
AGTTCCCCGGCAACAAGCTGGAATACATGGGCTACATCAACTACAGCGGCAGCA
CGTACTACAACCCCAGCCTGAAAAGCCAGATCAGCATTACCAGAGATACATCTA
AGAACCAGTACTATCTGCAACTGAACAGCGTTACAACAGAGGATGCTGCTACAT
ACTATTGCGCCAGAGGCGGAAATTACTTTGCCATGGACTACTGGGGCCAGGGCA
CCTCCGTGACAGTGTCCAGCACTACAACTCCAGCACCCAGACCCCCTACACCTGC
TCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATC
ATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATC
TGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 729
[00770] Construct pJAQ368 [CD8a Signal Peptide]- [CD 117 scFv 4F2 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAAGTGCAGCTGCAGGAGAGCGGACCTAGCCTGGTGAAGCCTAGCC
AGACCCTGAGCCTGACCTGCAGCGTCACAGGCGACAGCATCACCAGCGGCTACT
GGAACTGGATCAGAAAGTTCCCTGGCAACAAGCTCGAGTACATGGGCTACATCA
ACTACAGCGGCTCCACCTACTACAACCCCAGCCTGAAGTCCCAAATCAGCATTAC
CAGAGATACCAGCAAGAATCAGTACTATCTGCAACTGAACAGCGTGACAACCGA
GGACGCCGCTACATACTATTGCGCCAGAGGCGGCAATTACTTCGCCATGGACTAC
TGGGGCCAGGGCACCAGCGTGACAGTGTCTAGCGGCGGCGGCGGCTCTGGCGGT
GGCGGAAGCGGCGGCGGAGGAAGTGATATCGTGATGACCCAGAGCCACAAGTTT
ATGAGCACATCTGTGGGCGACAGAGTGTCCATCACATGTAAAGCTTCTCAGGAC
GTGTCCACCACCGTGGCCTGGTACCAGCAGAAACCTGGCCAGTCCCCAAAGCTG
CTGATCTACAGCGCCAGCTACCGGTACACCGGCGTTCCTGACCGGTTCACAGGAT
CTGGATCTGGCACAGATTTCACCTTTACCATCAGCAGCGTGCAGGCCGAGGACCT
GGCCGTGTACTATTGCCAGCAGCACTACTCTACACCCCCCACCTTCGGCGGAGGC
ACCAAGCTGGAAATCAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCT
CCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCA
TCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATCT
GTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 730
[00771] Construct pJAQ375 [CD8a Signal Peptide]-[CD117 scFv AHI Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAACCTGGCGCTGAACTGGTCAAGCCCGGCG
CCAGCGTGAAAATGAGCTGCAAGGCCAGCGGCTACACATTTACCAGCTATAATA
TGCACTGGGTGAAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGTGATCT
ACAGCGGCAACGGCGACACCAGCTACAACCAGAAATTCAAGGGCAAGGCCACA
CTGACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATTAACAGCCTGACC
TCTGAGGATAGCGCCGTTTACTACTGCGCCCGGGAAAGAGATACAAGATTTGGA
AACTGGGGACAGGGAACACTGGTGACCGTGTCTGCCGGCGGAGGTGGCTCTGGA
GGCGGTGGATCTGGTGGTGGCGGATCAAACATCGTGCTGACCCAGAGCCCCGCT
TCTCTGGCCGTGTCCCTGGGCCTGCGGGCTACAATCAGCTGCAGAGCCAGCGAG
AGCGTGGACATCTACGGCAATTCCTTCATGCACTGGTACCAGCAGAAGCCTGGA
CAGCCTCCAAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGAGTGCCT
GCCAGGTTCAGCGGCTCTGGCTCTAGAACAGACTTCACCCTGACCATCGACCCCG
TGGAGGCCGACGACGCCGCCACCTACTATTGTCAGCAGAACAACGAGGACCCTT
ACACCTTCGGCGGCGGAACCAAGCTGGAGATCAAGACTACAACTCCAGCACCCA
GACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGA
AGCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCC
GGTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 731
[00772] Construct pJAQ376 [CD8a Signal Peptide]- [CD 117 scFv AH2 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAATATCGTGCTGACACAGAGCCCAGCTAGCCTGGCTGTGTCTCTGGG
CCTGAGAGCCACAATCAGCTGTAGAGCTTCTGAGTCCGTGGACATCTACGGCAAT
AGCTTCATGCACTGGTACCAGCAGAAGCCTGGACAGCCCCCCAAGCTGCTGATCT
ATCTGGCCTCCAACCTGGAAAGCGGAGTGCCTGCCCGGTTCAGCGGCTCCGGCTC
TAGAACCGACTTCACCCTGACCATTGACCCCGTGGAAGCCGACGACGCCGCCAC
CTACTACTGCCAGCAGAACAACGAGGATCCTTACACCTTTGGCGGAGGGACCAA
GCTGGAAATCAAGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGG
ATCACAGGTGCAGCTGCAGCAACCTGGCGCCGAGCTGGTTAAACCTGGTGCTAG
CGTGAAGATGAGCTGCAAGGCCAGCGGCTACACCTTCACCAGCTACAACATGCA
CTGGGTCAAACAGACACCTGGCCAGGGCCTGGAGTGGATCGGCGTGATCTACAG
CGGCAACGGCGATACCTCTTATAACCAGAAATTTAAGGGCAAGGCCACACTCAC
AGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATCAACAGCCTGACAAGCGA
GGACAGCGCCGTGTACTACTGCGCCAGGGAGCGGGACACCAGATTCGGCAACTG
GGGACAAGGCACCCTGGTGACCGTGTCTGCCACTACAACTCCAGCACCCAGACC
CCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCC
TGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTC
TCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 732
[00773] Construct pJAQ378 [CD8a Signal Peptide]-[CD117 scFv 58 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGCTCGAGTCCGGCGGCGGACTGGTGCAGCCCGGCG
GATCTCTGAGACTGTCTTGCGCCGCTAGCGGCTTCACCTTTAGCAACTACGCCAT
GAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCAGCGCTATCTC
CGGCAGCGGAGGCTCAACATACTACGCCGACAGCGTTAAGGGAAGATTCACCAT
CAGCCGGGACAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGC
CGAGGACACCGCCGTGTACTATTGTGCCAAGGGCCCTCCTACATACCACACCAAT
TACTATTACATGGACGTGTGGGGCAAAGGCACAACAGTGACCGTGAGCAGCGGC
GGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATG
ACCCAGAGCCCTAGCTCTGTGTCCGCCTCTGTGGGAGATAGAGTGACAATCACCT
GCAGAGCCAGCCAGGGCATCAGCAGCTGGCTGGCCTGGTACCAGCAAAAGCCCG
GCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGCGTGCC
CAGCAGATTCAGCGGTAGCGGCAGCGGCACCGACTTCACACTGACCATTAGCTC
CCTGCAGCCTGAGGATTTCGCCACATACTACTGCCAGCAGACCAACTCTTTTCCA
TACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAGACTACAACTCCAGCACCC
AGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTG
AAGCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGC
CGGTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 733
[00774] Construct pJAQ379 [CD8a Signal Peptide]-[CD117 scFv 61 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGCTGGAAAGCGGAGGCGGCCTGGTGCAGCCTGGCG
GCTCTCTGCGGCTGTCTTGCGCCGCTAGCGGCTTCACATTTAGCAGCTACGTGAT
GATCTGGGTTAGACAGGCCCCTGGAAAAGGACTGGAGTGGGTCTCCTCTATCAG
CGGCGATAGCGTCACCACCTACTATGCCGACAGCGTGAAGGGCAGATTTACAAT
TAGCAGAGATAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGC
CGAGGACACCGCCGTGTACTACTGCGCCAAGGGCCCTCCAACCTACCACACAAA
CTACTACTACATGGACGTGTGGGGCAAAGGCACCACAGTGACCGTGTCCAGCGG
CGGCGGAGGCTCTGGAGGCGGCGGCAGCGGCGGAGGAGGCAGCGACATCCAGA
TGACCCAGAGCCCTAGCTCCGTGTCCGCCTCTGTGGGCGACAGAGTGACAATCAC
CTGCAGAGCCAGCCAGGGTATCAGCTCTTGGCTGGCCTGGTACCAGCAAAAGCC
TGGCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGAGTG
CCCAGCCGGTTCAGCGGCAGCGGCAGCGGCACTGATTTCACCCTGACAATCTCTT
CCCTCCAGCCCGAGGACTTCGCCACCTACTATTGTCAGCAGACCAATAGCTTCCC
CTACACCTTCGGCGGCGGCACAAAGGTGGAAATCAAGACTACAACTCCAGCACC
CAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCT
GAAGCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCG
CCGGTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCT G SEQ ID NO: 734
[00775] Construct pJAQ380 [CD8a Signal Peptide]-[CD117 scFv 66 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGCCTGGTGCAGCCTGGAG
GCAGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTTTCTGATCACTACAT
GGATTGGGTGCGGCAGGCCCCAGGAAAAGGCCTGGAATGGGTCGGACGGACCA
GAAACAAGGCCTCTTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGGTT
CACAATTAGCCGGGACGACAGCAAGAACAGCCTGTACCTGCAGATGAACAGCCT
GAAGACCGAGGATACCGCCGTGTACTATTGCGCCAGAGAGCCTAAATACTGGAT
CGACTTCGACCTGTGGGGCAGAGGCACCCTGGTTACAGTGTCCAGCGGCGGTGG
CGGCAGCGGCGGCGGAGGCAGCGGAGGCGGAGGCAGCGACATCCAGATGACAC
AGAGCCCTAGCAGCCTCTCCGCCAGCGTGGGAGATAGAGTGACAATCACATGTA
GAGCCTCCCAGTCTATCAGCTCTTACCTGAATTGGTACCAGCAAAAGCCCGGCAA
GGCCCCTAAGCTGCTGATCTACGCCGCCAGCAGCCTGCAAAGCGGCGTGCCCAG
CAGATTCTCCGGCTCCGGCTCTGGCACCGACTTCACCCTGACCATCAGCTCCCTG
CAGCCCGAGGACTTTGCCACCTACTACTGCCAGCAGAGCTACATCGCCCCTTACA
CCTTCGGCGGCGGCACCAAGGTGGAAATCAAGACTACAACTCCAGCACCCAGAC
CCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGC
CTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGT
CTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 735
[00776] Construct pJAQ381 [CD8a Signal Peptide]-[CD117 scFv 67 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTTCAGCCCGGCG
GAAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACGCCGACA
TGGACTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGGCCGCACCA
GAAACAAGGCCGGCTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGAT
TCACAATTTCTAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAATTCCCT
GAAGACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTACTGGAT
CGACTTCGACCTGTGGGGCAGAGGCACACTGGTGACAGTGTCCTCCGGCGGAGG
TGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATGACCCA
GAGCCCCAGCAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCACATGCAG
AGCCTCCCAGTCTATCAGCAGCTACCTGAACTGGTACCAGCAGAAGCCCGGCAA
AGCCCCTAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCGGCGTGCCTAGC
CGGTTCAGCGGCAGCGGCAGCGGTACAGACTTTACCCTGACCATCAGCTCCCTGC
AGCCTGAGGATTTCGCCACCTACTATTGTCAGCAAAGCTACATCGCCCCATACAC
CTTTGGCGGCGGAACCAAGGTGGAAATCAAGACTACAACTCCAGCACCCAGACC
CCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCC
TGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTC
TCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 736
[00777] Construct pJAQ382 [CD8a Signal Peptide]-[CD117 scFv 68 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCC
GGAGCCTGCGGCTGAGCTGCACCGCCAGCGGCTTCACCTTCAGCGACCACGACA
TGAATTGGGTTAGACAGGCCCCTGGCAAAGGCCTGGAATGGGTGGGCCGCACCA
GAAACGCCGCCGGATCTTATACAACAGAGTACGCTGCTTCTGTGAAGGGCCGGT
TCACAATTAGCAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAACAGCC
TGAAGACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCCAAGTACTGGA
TCGACTTCGACCTGTGGGGCCGGGGCACCCTGGTCACCGTGTCCAGCGGCGGAG
GTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGACATCCAGATGACCC
AGTCTCCTAGCAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCACCTGTA
GAGCCAGCCAGAGCATCAGCTCATATCTGAACTGGTACCAGCAGAAACCCGGCA
AGGCCCCTAAGCTGCTGATCTACGCCGCTAGCTCTCTGCAGTCCGGGGTGCCATC
TAGATTCTCCGGCAGCGGCTCTGGAACTGATTTTACACTGACAATCAGCTCCCTT
CAACCCGAGGATTTCGCCACCTACTACTGCCAGCAGAGCTACATCGCCCCTTACA
CCTTTGGCGGCGGCACAAAGGTGGAAATCAAGACTACAACTCCAGCACCCAGAC
CCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGC
CTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGT
CTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 737
[00778] Construct pJAQ383 [CD8a Signal Peptide]-[CD117 scFv 69 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTGCAGCCCGGCG
GCTCCCTGAGACTGAGCTGCGCCGCTTCTGGCTTCACCTTTGTGGACCACGATAT
GGACTGGGTGCGGCAGGCCCCAGGCAAGGGCCTGGAATGGGTCGGAAGAACCA
GAAACAAGCTGGGCTCTTATACAACCGAGTACGCCGCTAGCGTTAAGGGCAGAT
TCACAATCAGCCGCGACGACAGCAAGAATAGCCTGTACCTGCAGATGAACAGCC
TTAAAACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTACTGGA
TCGACTTCGACCTGTGGGGCCGGGGCACCCTGGTGACAGTGTCCAGCGGAGGCG
GCGGCAGCGGCGGAGGAGGCTCAGGAGGAGGCGGCAGCGATATCCAGATGACA
CAGTCTCCTAGCAGCCTCTCCGCCAGCGTGGGCGATAGAGTGACAATCACCTGCA
GAGCCAGCCAGAGCATCTCCAGCTACCTGAACTGGTACCAGCAAAAGCCTGGAA
AAGCCCCCAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAATCTGGCGTGCCCAG
CCGGTTCAGCGGCTCTGGTAGCGGCACCGACTTCACCCTGACAATTAGCTCCCTG
CAGCCTGAGGATTTTGCCACCTACTATTGTCAGCAGAGCTACATCGCCCCTTACA
CCTTCGGCGGCGGCACCAAGGTGGAAATCAAGACTACAACTCCAGCACCCAGAC
CCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGC
CTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGT
CTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 738
[00779] Construct pJAQ384 [CD8a Signal Peptide]- [CD 117 scFv 70 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGGCTGGTGCAGCCTGGCG
GCAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACTACGCCAT
GAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGCCGTGATCAG
CGAGAACGGCTCCGATACCTACTACGCCGATTCTGTTAAGGGCAGATTCACCATT
AGCCGCGACGACAGCAAGAACACCCTGTACCTGCAAATGAACAGCCTGAGGGCC
GAGGACACCGCCGTGTACTATTGCGCCAGAGATAGAGGCGGCGCCGTGTCCTAC
TTCGACGTGTGGGGACAGGGCACACTGGTCACCGTGTCTTCTGGCGGAGGCGGC
AGCGGCGGCGGCGGCTCTGGCGGCGGCGGATCTGACATCCAGATGACACAGTCC
CCTAGCAGCCTGTCTGCCAGCGTGGGAGATAGAGTGACCATCACCTGTAGAGCC
AGCCAGGACGTGTCCTCTTATCTGGCCTGGTACCAGCAAAAGCCCGGCAAAGCC
CCTAAGCTGCTGATCTACGCTGCTTCTAGCCTCGAGAGCGGCGTGCCCAGCAGAT
TCAGCGGAAGCGGCAGCGGAACAGACTTTACCCTGACAATCAGCTCCCTGCAGC
CAGAGGACTTCGCTACATACTACTGCCAGCAGTACAATAGCCTGCCTTACACATT
TGGCCAGGGCACCAAGGTGGAAATCAAGCGGACCACTACAACTCCAGCACCCAG
ACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAA
GCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCG
GTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG
SEQ ID NO: 739
[00780] Construct pJAQ385 [CD8a Signal Peptide]-[CD117 SRI scFv Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAGCCTGGAGCCGAGCTGGTGAAACCTGGCG
CCAGCGTGAAGATGAGCTGCAAGGCCTCCGGTTATACATTCACCTCCTACAACAT
GCACTGGGTCAAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGTGATCTA
CAGCGGCAACGGAGATACCAGCTACAACCAGAAATTCAAGGGCAAGGCCACCCT
GACCGCCGACAAGTCCAGCAGCACCGCCTACATGCAGATCAACAGCCTGACCAG
CGAGGATAGCGCCGTGTACTATTGCGCCAGAGAGCGGGACACCAGATTTGGAAA
TTGGGGCCAAGGCACCCTGGTTACAGTGTCTGCCGCTAAGACCACCGGCGGAGG
TGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAATCGTGCTGACACAGAG
CCCTGCTTCTCTGGCCGTGTCCCTGGGCCTGCGGGCCACAATTAGCTGTAGAGCC
TCTGAGAGCGTGGACATCTACGGCAATAGCTTCATGCACTGGTACCAGCAAAAG
CCTGGCCAGCCCCCCAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGC
GTGCCAGCTAGGTTCAGCGGAAGCGGCTCTAGAACCGACTTCACACTGACCATC
GACCCTGTGGAAGCCGATGACGCCGCCACATACTACTGCCAGCAGAACAACGAG
GACCCCTACACCTTTGGCGGCGGAACAAAGCTGGAAATCAAGACTACAACTCCA
GCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGC
GCCCTGAAGCCTGTATTGTCATCATCACCGTGGTGGCGGCTGCCGTGATCATGGG
CACCGCCGGTCTCTCCACTTATCTGTACAACCGCCAGCGTAAAATCAAGAAGTAC
CGCCTG SEQ ID NO: 740
[00781] Construct pJAQ402 [CD8a Signal Peptide]- [CD 117 scFv 54 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTCCAGCTGGTGCAAAGTGGAGCAGAAGTCAAGAAACCCGGAA
GCTCAGTCAAAGTGTCTTGCAAAGCTAGCGGAGGCACGTTCTCAAGTTATGCCAT
ATCCTGGGTGCGCCAAGCGCCCGGCCAAGGCTTGGAATGGATGGGTGGTATAAT
ACCGATTTTTGGGACAGCGAATTATGCACAGAAGTTTCAAGGTAGAGTGACGATT
ACGGCGGATGAAAGTACATCCACGGCGTACATGGAGCTGTCCAGTCTGCGGTCA
GAAGACACAGCCGTATATTACTGCGCGCGAGGAGGGCTCGATACGGACGAATTT
GATCTGTGGGGGCGGGGGACCTTGGTCACAGTAAGTAGCGGGGGAGGAGGCTCT
GGCGGTGGCGGTTCAGGTGGAGGAGGATCCGACATTCAGATGACTCAATCCCCT
TCCTCCCTGAGTGCCTCCGTCGGGGACAGAGTAACGATTACCTGTAGGGCCAGCC
AAAGTATTAACAGCTACCTGAATTGGTATCAGCAGAAGCCCGGCAAAGCCCCGA
AGCTCTTGATATACGCCGCGTCCTCCTTGCAAAGTGGGGTGCCGTCTAGATTCAG
CGGTAGCGGTAGTGGAACGGATTTTACGCTTACTATATCTAGTCTTCAACCGGAG
GATTTTGCTACTTATTATTGTCAACAAGGAGTGTCCGATATCACGTTTGGCGGTG
GGACAAAGGTGGAAATTAAAACTACAACTCCAGCACCCAGACCCCCTACACCTG
CTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCAT
CATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTAT
CTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTGSEQ ID NO: 741
[00782] Construct pJAQ403 [CD8a Signal Peptide]-[CD117 scFv 55 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTTCAGTTGGTTCAGTCCGGCGCTGAAGTTAAAAAGCCCGGAA
GCAGTGTAAAGGTCTCCTGCAAGGCCAGTGGCGGGACATTCCGAATTTACGCCA
TCTCATGGGTCCGACAGGCTCCAGGACAAGGACTTGAGTGGATGGGTGGTATTA
TACCAGACTTCGGGGTTGCCAATTACGCACAAAAATTCCAGGGACGAGTAACTA
TAACTGCGGATGAATCAACCTCTACGGCTTATATGGAGCTCTCATCCTTGCGGTC
AGAAGACACGGCCGTGTATTATTGTGCAAGGGGCGGACTCGACACCGATGAGTT
TGATCTTTGGGGCAGAGGTACTCTGGTGACTGTTAGTAGCGGGGGTGGAGGCTCT
GGCGGAGGGGGAAGTGGCGGAGGAGGGAGCGACATCCAAATGACTCAATCACC
TAGCTCACTTAGCGCAAGCGTTGGCGACCGCGTCACTATTACCTGTCGCGCGTCA
CAATCTATCAACTCATATCTGAATTGGTATCAACAAAAGCCTGGTAAGGCCCCTA
AGCTTCTTATTTATGCAGCCAGTAGCCTTCAATCCGGCGTCCCAAGTCGATTCTCC
GGGAGTGGAAGTGGTACAGATTTTACCCTGACCATAAGCAGTTTGCAGCCGGAA
GACTTTGCTACCTATTATTGCCAACAGGGGGTCTCCGATATTACTTTCGGGGGAG
GCACCAAAGTGGAAATCAAGACTACAACTCCAGCACCCAGACCCCCTACACCTG
CTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCAT
CATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTAT
CTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTGSEQ ID NO: 742
[00783] Construct pJAQ404 [CD8a Signal Peptide]-[CD117 scFv 56 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAGGTGCAGTTGGTGCAGAGTGGTGCAGAGGTAAAGAAACCAGGCA
GCAGTGTAAAGGTCTCCTGCAAAGCTAGTGGAGGGACTTTCTCTCTCTATGCCAT
AAGTTGGGTTCGCCAGGCGCCGGGACAAGGACTCGAATGGATGGGAGGAATCAT
TCCGGCGTTCGGGACAGCCAATTATGCACAGAAATTCCAAGGTAGGGTAACTAT
TACTGCCGATGAGTCAACGTCTACCGCCTATATGGAACTCTCATCCCTTCGAAGC
GAGGACACCGCTGTATACTACTGTGCACGCGGAGGATTGGATACCGATGAATTC
GATCTCTGGGGAAGAGGAACGCTTGTCACGGTAAGCAGTGGCGGTGGCGGGTCT
GGAGGCGGAGGAAGCGGCGGCGGGGGGTCAGACATACAAATGACCCAGAGTCC
ATCAAGTCTGAGTGCTAGTGTAGGAGATCGCGTAACCATTACATGCCGCGCCTCT
CAATCTATCAACTCCTACTTGAACTGGTATCAGCAGAAACCAGGAAAGGCTCCA
AAGTTGTTGATTTATGCAGCTTCTAGTCTCCAGTCAGGAGTACCTTCTCGGTTCTC
CGGATCTGGTAGCGGAACAGACTTCACATTGACCATAAGTAGCTTGCAGCCAGA
AGACTTTGCAACGTATTACTGCCAACAAGGCGTGAGTGACATCACGTTCGGCGG
CGGAACAAAGGTAGAGATTAAAACTACAACTCCAGCACCCAGACCCCCTACACC
TGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTC
ATCATCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTT
ATCTGTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 743
[00784] Construct pJAQ405 [CD8a Signal Peptide]-[CD117 scFv 57 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTCCAACTTGTACAATCTGGTGCGGAGGTCAAGAAACCGGGTA
GCTCCGTTAAGGTCTCATGCAAAGCAAGCGGTGGCACTTTCAGTTTGTATGCGAT
CTCTTGGGTGCGGCAAGCGCCAGGACAAGGTCTGGAATGGATGGGTGGGATAAT
ACCTCATTTTGGACTCGCGAATTATGCACAAAAGTTTCAAGGTAGAGTTACAATA
ACCGCGGATGAAAGTACCTCCACCGCATACATGGAGTTGTCAAGCCTTAGGAGT
GAGGACACAGCCGTTTATTACTGTGCCCGAGGCGGATTGGACACTGATGAATTTG
ACTTGTGGGGGAGAGGCACACTCGTAACAGTCAGTAGTGGGGGAGGCGGCTCCG
GAGGCGGCGGTTCTGGCGGCGGAGGTTCCGATATTCAAATGACCCAGAGTCCAA
GTAGTCTTTCCGCATCCGTAGGTGACAGAGTGACTATAACATGCAGGGCATCACA
ATCCATCAACTCTTATCTGAACTGGTACCAACAAAAACCAGGTAAAGCTCCTAAG
CTGCTCATATATGCAGCAAGTTCCCTCCAGAGCGGAGTCCCCTCTCGGTTTTCTG
GTTCCGGAAGCGGAACAGATTTTACGCTCACTATAAGTAGCCTTCAACCTGAGGA
CTTCGCAACATATTACTGTCAACAAGGCGTTTCTGACATCACCTTCGGGGGCGGC
ACCAAGGTCGAGATAAAAACTACAACTCCAGCACCCAGACCCCCTACACCTGCT
CCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGTCATCA
TCACCGTGGTGGCGGCTGCCGTGATCATGGGCACCGCCGGTCTCTCCACTTATCT
GTACAACCGCCAGCGTAAAATCAAGAAGTACCGCCTG SEQ ID NO: 744
[00785] Construct pJAQ436 [Nipah-Gmut TM]-[CD90 scFvl Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCC
CGGCGCAAGCGTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTAC
TGGATCAACTGGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAG
ATTTTCCCCAGTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTA
CGTTGACGGTCGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGAC
CAGTGAGGATTCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTAC
GCTATGGAATACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGAT
AGCAACGCGGGCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAA
AGCCCTACAATAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCT
GCGATTAGTAGCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCAC
CTAAACTTTGGATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTT
TAGTGGAAGTGGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACA
GAAGATGCTACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGG
GGCTGGAACTAAATTGGAGTTGAAG SEQ ID NO: 745
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCA
GCCTGGCGGCAGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCC
TACGCCATGAGCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGC
GCCATCAGCAGAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAG
ATTCACCATCAGCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAG
CCTGCGGGCCGAGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTT
CGACTACTGGTGCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTG
TCTGCTTCTGTGGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATC
AGCAGCTACCTGAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTG
ATCTACAGCGCTTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCG
GATCTGGAACCGATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGC
CACCTACTATTGTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACA
AAGGTGGAAATC SEQ ID NO: 746
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAG
CCCTGGCGAGAAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATG
TACTGGTACCAGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCT
CTAATCTGGCCTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAG
CTACAGCCTGACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTG
CCAGCAGTACCACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACT
GAAAAGCTCCGGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAA
GCAGCCTGGAAGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGA
GAAACCGTGAAGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGC
ATGAAGTGGGTCAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATT
AACACCGAGACCGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCC
TTCAGCCTCGAGACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGA
ACGAGGACACCGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTA
CTGGGGCCAGGGAACAACACTGACCGTGTCCTCC SEQ ID NO: 747
[00788] Construct pJAQ439 [Nipah-Gmut TM]-[CXCL12 Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCG
CTCTGCCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGA
TTCTTCGAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACA
CTCCAAACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAG
TGTGCATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAA
ACAAG SEQ ID NO: 748
[00789] Construct pJAQ440 [Nipah-Gmut TM]-[TPO Genscript Optimized
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACC
GCCAGGCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGA
GCAAGCTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGA
GGTGCACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGC
GAGTGGAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGT
GACCCTGCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTG
CCTGTCCAGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCC
CTGCAGAGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACAT
AAGGACCCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGC
GGTTTCTGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTAC
CACCGCCGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAAT
AGAACGAGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGC
TCTGGTCTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGA
ACCAGACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACG
AGCTGCTGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGG
GAGCTCCTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACC
TGCAACCTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCT
GTTTCCTCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGC
CTGACCCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTA
CACACACAGCCAGAACCTGTCTCAGGAGGGC SEQ ID NO: 749
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCA
ACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTG
ACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTAC
ATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGA
TCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTT
CAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAA
CATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAA
AAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGA
ATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACAT
CTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGT
GACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGC
AGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGG
GCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCG
CTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCC
AGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAA
TTTCAGGAGGTG SEQ ID NO: 750
[00791] Construct pJAQ442 [Nipah-Gmut TM]-[SCF soluble Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGA
CGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTA
CGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGT
GCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAA
GGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTG
GTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGC
CCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTA
TCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAG
CAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCAT
GCTGCCTCCTGTGGCCGCC SEQ ID NO: 751
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTCTGCTTAGCGTGCCTCTGCTGCTGGGCCTGCTGGGCCTGGCC
GTGGCCGAACCCGCCGTGTACTTCAAGGAACAGTTCCTCGACGGCGATGGATGG
ACATCTAGATGGATCGAGTCTAAGCATAAGAGCGATTTCGGCAAGTTTGTGCTGA
GCTCCGGCAAGTTCTACGGCGACGAGGAAAAAGATAAGGGCCTGCAGACCAGCC
AAGACGCCAGATTCTACGCTCTGAGCGCCAGCTTCGAGCCCTTCTCCAACAAGGG
CCAGACCCTGGTCGTGCAGTTTACAGTGAAGCACGAGCAGAACATCGATTGCGG
CGGAGGCTACGTGAAGCTGTTCCCCAACTCTCTGGATCAGACAGATATGCACGG
CGACAGCGAGTACAACATCATGTTCGGCCCTGACATCTGTGGCCCCGGCACAAA
GAAAGTGCACGTGATCTTTAACTACAAAGGAAAAAACGTGCTGATCAACAAAGA
CATCAGATGCAAGGACGACGAGTTCACCCACCTGTACACCCTGATTGTGCGGCCT
GATAATACCTACGAGGTGAAGATCGATAACAGCCAGGTCGAGAGCGGCAGCCTG
GAAGACGACTGGGATTTCCTGCCTCCTAAGAAGATCAAGGACCCCGATGCTAGC
AAGCCCGAGGACTGGGACGAGAGAGCCAAGATTGACGACCCTACAGACTCCAA
GCCTGAGGACTGGGACAAGCCCGAGCACATCCCTGATCCTGATGCTAAAAAGCC
TGAGGACTGGGACGAGGAAATGGACGGCGAATGGGAGCCTCCAGTGATCCAGA
ATCCTGAATACAAGGGCGAATGGAAGCCTAGGCAGATCGACAACCCAGACTACA
AGGGCACCTGGATCCACCCTGAGATCGACAATCCTGAGTATTCTCCCGACCCCAG
CATCTACGCCTATGATAACTTTGGAGTTCTGGGACTGGACCTGTGGCAGGTGAAG
TCTGGAACCATCTTCGACAACTTCCTGATCACTAACGACGAGGCCTACGCCGAGG
AATTCGGCAACGAGACCTGGGGCGTGACCAAGGCCGCCGAGAAACAGATGAAA
GACAAGCAGGACGAAGAACAGCGGCTGAAGGAAGAAGAGGAAGATAAGAAAA
GAAAGGAAGAAGAGGAGGCTGAGGATAATTGTAGACGGATGATGAGAACCAAG
ATGCGCATGCGGAGAATGAGAAGAACCAGAAGAAAGATGCGGCGGAAGATGAG
CCCTGCCAGACCGCGGACAAGCTGCCGGGAAGCCTGCCTGCAAGGCTGGACCGA
GGCC SEQ ID NO: 752
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACC
GCCAGACTGACCCTGAGCAGCCCCGCCCCTCCTGCCTGCGATCTGCGGGTGCTGT
CTAAACTGCTGCGGGACAGCCACGTGCTGCATTCTAGACTGAGCCAGTGTCCTGA
GGTGCACCCCCTGCCCACCCCTGTGCTGCTGCCCGCTGTGGACTTCAGCCTGGGC
GAGTGGAAGACCCAAATGGAAGAGACAAAGGCCCAAGACATCCTGGGCGCCGT
GACCCTGCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGCCCTACATG
CCTGTCCAGCCTCCTGGGACAGCTGTCCGGCCAGGTGCGGCTGCTGCTTGGAGCC
CTGCAGAGCCTGCTGGGCACACAGCTGCCACCTCAGGGCAGAACCACAGCCCAC
AAGGATCCTAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGAGA SEQ ID
NO: 753
[00794] Construct pJAQ446 [Nipah-Gmut TM]-[TPO- 171 Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGCTGACCGAGCTGCTGCTGGTCGTTATGCTGCTGCTTACA
GCCAGACTGACACTGTCCAGCCCTGCCCCTCCAGCATGCGACCTGAGGGTGCTGA
GCAAGCTGCTGAGAGATAGCCACGTGCTGCACTCTAGACTGTCTCAGTGCCCCGA
GGTGCACCCTCTGCCCACCCCTGTGCTGCTCCCCGCCGTGGACTTCAGCCTGGGC
GAGTGGAAGACCCAGATGGAAGAAACCAAGGCCCAGGATATCCTGGGCGCTGTG
ACCCTGCTGCTGGAAGGCGTGATGGCCGCTAGAGGACAACTGGGACCTACCTGT
CTGAGCAGCCTGCTGGGCCAGCTGTCCGGCCAAGTGCGGCTGCTGCTGGGCGCC
CTGCAGAGCCTGCTCGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCAT
AAGGACCCCAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGCGGGGCAAAGTGC
GGTTCCTGATGCTGGTGGGCGGATCTACACTG SEQ ID NO: 754
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGATATTGTGATGACCCAGAGCCATAAGTTCATGAGCACCAG
CGTGGGCGATAGAGTGTCCATCACCTGCAAGGCCTCTCAGGACGTGTCTACAACC
GTGGCCTGGTACCAGCAGAAACCTGGCCAGAGCCCTAAGCTGCTGATCTACTCTG
CCAGCTACAGATATACCGGCGTGCCCGACAGATTCACAGGCAGCGGCTCCGGCA
CAGACTTCACCTTCACCATCAGCAGCGTGCAGGCCGAAGATCTGGCCGTTTACTA
CTGCCAGCAACACTACAGCACACCTCCAACATTCGGCGGCGGCACCAAGCTGGA
AATCAAAGGCGGTGGAGGCAGCGGAGGCGGAGGCTCTGGCGGCGGCGGCAGCC
AAGTGCAACTCCAGCAGAGTGATGCCGAGCTGGTGAAGCCTGGAGCTTCTGTGA
AGATCAGCTGCAAAGCTTCTGGCTACACCTTTACCGACCACGCCATCCACTGGGT
CAAGCAGCGGCCCGAGCAGGGCCTGGAATGGATCGGCTGTATCTCCCCTGGAAA
TGGCGACATCAAGTACAACGAGAAGTTTAAGGGCAAGGCTACACTGAGCGCCGA
CAAAAGCTCTAGCACCGCCTACATGCAGCTGAACAGCCTGACAAGCGAGGACAG
CGCCGTGTATTTCTGCAAGCGGTGGGACTACTTCGACTACTGGGGCCAGGGAACC
ACCCTGACCGTGTCCAGC SEQ ID NO: 755
[00796] Construct pJAQ448 [Nipah-Gmut TM]-[CD117 scFv 4F1 Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGACATCGTGATGACCCAGAGCCACAAGTTCATGAGCACCAG
CGTGGGCGATAGAGTGTCCATCACATGCAAGGCCAGCCAGGACGTGTCTACAAC
CGTGGCCTGGTACCAGCAGAAACCTGGCCAAAGCCCCAAGCTGCTGATCTACTC
CGCCTCTTACCGGTACACCGGCGTGCCTGACCGGTTCACCGGCAGCGGCTCTGGC
ACCGACTTCACCTTCACCATCAGCAGCGTCCAGGCCGAGGACCTGGCCGTGTACT
ACTGCCAGCAGCACTACTCTACCCCTCCAACCTTTGGCGGAGGAACAAAGCTGG
AAATCAAGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAG
AGGTGCAGCTGCAGGAGAGCGGTCCTAGCCTCGTGAAGCCTTCTCAGACCCTGA
GCCTGACCTGTAGCGTGACCGGCGACAGCATCACCAGCGGATATTGGAATTGGA
TCAGAAAGTTCCCCGGCAACAAGCTGGAATACATGGGCTACATCAACTACAGCG
GCAGCACGTACTACAACCCCAGCCTGAAAAGCCAGATCAGCATTACCAGAGATA
CATCTAAGAACCAGTACTATCTGCAACTGAACAGCGTTACAACAGAGGATGCTG
CTACATACTATTGCGCCAGAGGCGGAAATTACTTTGCCATGGACTACTGGGGCCA
GGGCACCTCCGTGACAGTGTCCAGC SEQ ID NO: 756
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTAATATCGTGCTGACACAGAGCCCAGCTAGCCTGGCTGTGTCT
CTGGGCCTGAGAGCCACAATCAGCTGTAGAGCTTCTGAGTCCGTGGACATCTACG
GCAATAGCTTCATGCACTGGTACCAGCAGAAGCCTGGACAGCCCCCCAAGCTGC
TGATCTATCTGGCCTCCAACCTGGAAAGCGGAGTGCCTGCCCGGTTCAGCGGCTC
CGGCTCTAGAACCGACTTCACCCTGACCATTGACCCCGTGGAAGCCGACGACGC
CGCCACCTACTACTGCCAGCAGAACAACGAGGATCCTTACACCTTTGGCGGAGG
GACCAAGCTGGAAATCAAGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGG
TGGCGGATCACAGGTGCAGCTGCAGCAACCTGGCGCCGAGCTGGTTAAACCTGG
TGCTAGCGTGAAGATGAGCTGCAAGGCCAGCGGCTACACCTTCACCAGCTACAA
CATGCACTGGGTCAAACAGACACCTGGCCAGGGCCTGGAGTGGATCGGCGTGAT
CTACAGCGGCAACGGCGATACCTCTTATAACCAGAAATTTAAGGGCAAGGCCAC
ACTCACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATCAACAGCCTGAC
AAGCGAGGACAGCGCCGTGTACTACTGCGCCAGGGAGCGGGACACCAGATTCGG
CAACTGGGGACAAGGCACCCTGGTGACCGTGTCTGCC SEQ ID NO: 757
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGTGCAGCTGCTCGAGTCCGGCGGCGGACTGGTGCAGCC
CGGCGGATCTCTGAGACTGTCTTGCGCCGCTAGCGGCTTCACCTTTAGCAACTAC
GCCATGAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCAGCGCT
ATCTCCGGCAGCGGAGGCTCAACATACTACGCCGACAGCGTTAAGGGAAGATTC
ACCATCAGCCGGGACAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTG
CGGGCCGAGGACACCGCCGTGTACTATTGTGCCAAGGGCCCTCCTACATACCAC
ACCAATTACTATTACATGGACGTGTGGGGCAAAGGCACAACAGTGACCGTGAGC
AGCGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATC
CAGATGACCCAGAGCCCTAGCTCTGTGTCCGCCTCTGTGGGAGATAGAGTGACA
ATCACCTGCAGAGCCAGCCAGGGCATCAGCAGCTGGCTGGCCTGGTACCAGCAA
AAGCCCGGCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCG
GCGTGCCCAGCAGATTCAGCGGTAGCGGCAGCGGCACCGACTTCACACTGACCA
TTAGCTCCCTGCAGCCTGAGGATTTCGCCACATACTACTGCCAGCAGACCAACTC
TTTTCCATACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAG SEQ ID NO: 758
[00799] Construct pJAQ457 [Nipah-Gmut TM]-[CD117 scFv 61 Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGTGCAGCTGCTGGAAAGCGGAGGCGGCCTGGTGCAGCC
TGGCGGCTCTCTGCGGCTGTCTTGCGCCGCTAGCGGCTTCACATTTAGCAGCTAC
GTGATGATCTGGGTTAGACAGGCCCCTGGAAAAGGACTGGAGTGGGTCTCCTCT
ATCAGCGGCGATAGCGTCACCACCTACTATGCCGACAGCGTGAAGGGCAGATTT
ACAATTAGCAGAGATAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTG
CGGGCCGAGGACACCGCCGTGTACTACTGCGCCAAGGGCCCTCCAACCTACCAC
ACAAACTACTACTACATGGACGTGTGGGGCAAAGGCACCACAGTGACCGTGTCC
AGCGGCGGCGGAGGCTCTGGAGGCGGCGGCAGCGGCGGAGGAGGCAGCGACAT
CCAGATGACCCAGAGCCCTAGCTCCGTGTCCGCCTCTGTGGGCGACAGAGTGAC
AATCACCTGCAGAGCCAGCCAGGGTATCAGCTCTTGGCTGGCCTGGTACCAGCA
AAAGCCTGGCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGC
GGAGTGCCCAGCCGGTTCAGCGGCAGCGGCAGCGGCACTGATTTCACCCTGACA
ATCTCTTCCCTCCAGCCCGAGGACTTCGCCACCTACTATTGTCAGCAGACCAATA
GCTTCCCCTACACCTTCGGCGGCGGCACAAAGGTGGAAATCAAG SEQ ID
NO: 759
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTCAAGTTCAGTTGGTTCAGTCCGGCGCTGAAGTTAAAAAGCC
CGGAAGCAGTGTAAAGGTCTCCTGCAAGGCCAGTGGCGGGACATTCCGAATTTA
CGCCATCTCATGGGTCCGACAGGCTCCAGGACAAGGACTTGAGTGGATGGGTGG
TATTATACCAGACTTCGGGGTTGCCAATTACGCACAAAAATTCCAGGGACGAGT
AACTATAACTGCGGATGAATCAACCTCTACGGCTTATATGGAGCTCTCATCCTTG
CGGTCAGAAGACACGGCCGTGTATTATTGTGCAAGGGGCGGACTCGACACCGAT
GAGTTTGATCTTTGGGGCAGAGGTACTCTGGTGACTGTTAGTAGCGGGGGTGGAG
GCTCTGGCGGAGGGGGAAGTGGCGGAGGAGGGAGCGACATCCAAATGACTCAA
TCACCTAGCTCACTTAGCGCAAGCGTTGGCGACCGCGTCACTATTACCTGTCGCG
CGTCACAATCTATCAACTCATATCTGAATTGGTATCAACAAAAGCCTGGTAAGGC
CCCTAAGCTTCTTATTTATGCAGCCAGTAGCCTTCAATCCGGCGTCCCAAGTCGA
TTCTCCGGGAGTGGAAGTGGTACAGATTTTACCCTGACCATAAGCAGTTTGCAGC
CGGAAGACTTTGCTACCTATTATTGCCAACAGGGGGTCTCCGATATTACTTTCGG
GGGAGGCACCAAAGTGGAAATCAAG SEQ ID NO: 760
[00801] Construct pJAQ474 [Nipah-Gmut TM]-[AdF35 Genscript Codon Optimized
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTAC
CCCTACGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCA
GCCCTAATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGAC
CCCTCTCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGAC
CGTGGACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTAT
CACCAAGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCA
GAACAACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGA
TATCTGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCT
AATTGCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTG
CTGGTTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCG
ATACAGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGT
ATTTCGACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCT
GAAAAACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTT
CATGCCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAA
CTACATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCC
CTGAACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTAC
GCCATCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATC
GCCACACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAAC
SEQ ID NO: 761
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACA
GCCCGCCTGACACTGAGCAGCCCTGCCCCTCCAGCCTGCGATCTGAGAGTGCTGA
GCAAACTGCTGAGAGATAGCCACGTGCTGCACAGCAGACTGTCTCAGTGCCCCG
AGGTGCACCCCCTGCCCACCCCTGTGCTGCTGCCTGCCGTGGACTTCAGCCTGGG
AGAGTGGAAGACCCAAATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCG
TGACCCTGCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGACCTACCT
GTCTGTCCAGCCTGCTTGGCCAGCTCTCCGGCCAAGTGCGGCTGCTGCTGGGAGC
TCTGCAGAGCCTGCTGGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCA
TAAGGACCCCAACGCCATCTTCCTGTCTTTTCAGCACCTGCTGCGGGGCAAGGTG
CGGTTCCTG SEQ ID NO: 762
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTCAAGTGCAGCTGCAGCAGAGCGACGCCGAGCTGGTGAAGCC
CGGAGCCTCCGTGAAGATCTCCTGCAAGGCTAGCGGCTACACCTTCACCGACCAT
GCCATCCACTGGGTGAAACAGCGGCCTGAGCAGGGCCTGGAATGGATCGGATGT
ATCAGCCCCGGCAACGGCGACATCAAATACAATGAGAAGTTCAAGGGCAAGGCT
ACACTGTCTGCCGACAAGAGCAGCAGCACCGCCTACATGCAGCTGAACAGCCTC
ACCAGCGAGGACAGCGCCGTTTACTTCTGCAAGCGGTGGGACTACTTTGATTATT
GGGGACAAGGCACCACCCTGACAGTGAGCTCTGGCGGAGGTGGCTCTGGAGGCG
GTGGATCTGGTGGTGGCGGATCAGATATTGTGATGACCCAGAGCCACAAGTTCA
TGAGCACAAGCGTCGGAGATAGAGTGTCTATCACATGCAAAGCTTCTCAGGACG
TGTCCACCACCGTGGCCTGGTATCAGCAGAAACCTGGCCAGTCTCCTAAGCTGCT
GATCTACAGCGCCAGCTACAGATACACAGGCGTGCCAGACAGATTCACCGGCTC
TGGTAGCGGCACAGACTTCACCTTCACCATCTCTAGCGTGCAGGCCGAAGATCTG
GCCGTGTACTACTGCCAGCAACACTACAGCACCCCTCCTACCTTTGGCGGAGGCA
CAAAGCTGGAAATCAAGSEQ ID NO: 763
[00804] Construct pJAQ477 [Nipah-Gmut TM]-[CD117 scFv 4F2 Targeting
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAAGTGCAGCTGCAGGAGAGCGGACCTAGCCTGGTGAAGCC
TAGCCAGACCCTGAGCCTGACCTGCAGCGTCACAGGCGACAGCATCACCAGCGG
CTACTGGAACTGGATCAGAAAGTTCCCTGGCAACAAGCTCGAGTACATGGGCTA
CATCAACTACAGCGGCTCCACCTACTACAACCCCAGCCTGAAGTCCCAAATCAGC
ATTACCAGAGATACCAGCAAGAATCAGTACTATCTGCAACTGAACAGCGTGACA
ACCGAGGACGCCGCTACATACTATTGCGCCAGAGGCGGCAATTACTTCGCCATG
GACTACTGGGGCCAGGGCACCAGCGTGACAGTGTCTAGCGGCGGCGGCGGCTCT
GGCGGTGGCGGAAGCGGCGGCGGAGGAAGTGATATCGTGATGACCCAGAGCCA
CAAGTTTATGAGCACATCTGTGGGCGACAGAGTGTCCATCACATGTAAAGCTTCT
CAGGACGTGTCCACCACCGTGGCCTGGTACCAGCAGAAACCTGGCCAGTCCCCA
AAGCTGCTGATCTACAGCGCCAGCTACCGGTACACCGGCGTTCCTGACCGGTTCA
CAGGATCTGGATCTGGCACAGATTTCACCTTTACCATCAGCAGCGTGCAGGCCGA
GGACCTGGCCGTGTACTATTGCCAGCAGCACTACTCTACACCCCCCACCTTCGGC
GGAGGCACCAAGCTGGAAATCAAG SEQ ID NO: 764
[00805] Construct pJAQ479 [Nipah-Gmut TM]-[CD117 scFv AHI Targeting
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTCAAGTGCAGCTGCAGCAACCTGGCGCTGAACTGGTCAAGCC
CGGCGCCAGCGTGAAAATGAGCTGCAAGGCCAGCGGCTACACATTTACCAGCTA
TAATATGCACTGGGTGAAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGT
GATCTACAGCGGCAACGGCGACACCAGCTACAACCAGAAATTCAAGGGCAAGGC
CACACTGACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATTAACAGCCT
GACCTCTGAGGATAGCGCCGTTTACTACTGCGCCCGGGAAAGAGATACAAGATT
TGGAAACTGGGGACAGGGAACACTGGTGACCGTGTCTGCCGGCGGAGGTGGCTC
TGGAGGCGGTGGATCTGGTGGTGGCGGATCAAACATCGTGCTGACCCAGAGCCC
CGCTTCTCTGGCCGTGTCCCTGGGCCTGCGGGCTACAATCAGCTGCAGAGCCAGC
GAGAGCGTGGACATCTACGGCAATTCCTTCATGCACTGGTACCAGCAGAAGCCT
GGACAGCCTCCAAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGAGTG
CCTGCCAGGTTCAGCGGCTCTGGCTCTAGAACAGACTTCACCCTGACCATCGACC
CCGTGGAGGCCGACGACGCCGCCACCTACTATTGTCAGCAGAACAACGAGGACC
CTTACACCTTCGGCGGCGGAACCAAGCTGGAGATCAAG SEQ ID NO: 765
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGCCTGGTGCAGCC
TGGAGGCAGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTTTCTGATCAC
TACATGGATTGGGTGCGGCAGGCCCCAGGAAAAGGCCTGGAATGGGTCGGACGG
ACCAGAAACAAGGCCTCTTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCA
GGTTCACAATTAGCCGGGACGACAGCAAGAACAGCCTGTACCTGCAGATGAACA
GCCTGAAGACCGAGGATACCGCCGTGTACTATTGCGCCAGAGAGCCTAAATACT
GGATCGACTTCGACCTGTGGGGCAGAGGCACCCTGGTTACAGTGTCCAGCGGCG
GTGGCGGCAGCGGCGGCGGAGGCAGCGGAGGCGGAGGCAGCGACATCCAGATG
ACACAGAGCCCTAGCAGCCTCTCCGCCAGCGTGGGAGATAGAGTGACAATCACA
TGTAGAGCCTCCCAGTCTATCAGCTCTTACCTGAATTGGTACCAGCAAAAGCCCG
GCAAGGCCCCTAAGCTGCTGATCTACGCCGCCAGCAGCCTGCAAAGCGGCGTGC
CCAGCAGATTCTCCGGCTCCGGCTCTGGCACCGACTTCACCCTGACCATCAGCTC
CCTGCAGCCCGAGGACTTTGCCACCTACTACTGCCAGCAGAGCTACATCGCCCCT
TACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAG SEQ ID NO: 766
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTTCAGCC
CGGCGGAAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACGC
CGACATGGACTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGGCCG
CACCAGAAACAAGGCCGGCTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGG
CAGATTCACAATTTCTAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAA
TTCCCTGAAGACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTA
CTGGATCGACTTCGACCTGTGGGGCAGAGGCACACTGGTGACAGTGTCCTCCGG
CGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGAT
GACCCAGAGCCCCAGCAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCAC
ATGCAGAGCCTCCCAGTCTATCAGCAGCTACCTGAACTGGTACCAGCAGAAGCC
CGGCAAAGCCCCTAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCGGCGTG
CCTAGCCGGTTCAGCGGCAGCGGCAGCGGTACAGACTTTACCCTGACCATCAGCT
CCCTGCAGCCTGAGGATTTCGCCACCTACTATTGTCAGCAAAGCTACATCGCCCC
ATACACCTTTGGCGGCGGAACCAAGGTGGAAATCAAG SEQ ID NO: 767
[00808] Construct pJAQ482 [Nipah-Gmut TM]-[CD117 scFv 69 Targeting Domain]
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTGCAGCC
CGGCGGCTCCCTGAGACTGAGCTGCGCCGCTTCTGGCTTCACCTTTGTGGACCAC
GATATGGACTGGGTGCGGCAGGCCCCAGGCAAGGGCCTGGAATGGGTCGGAAG
AACCAGAAACAAGCTGGGCTCTTATACAACCGAGTACGCCGCTAGCGTTAAGGG
CAGATTCACAATCAGCCGCGACGACAGCAAGAATAGCCTGTACCTGCAGATGAA
CAGCCTTAAAACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTA
CTGGATCGACTTCGACCTGTGGGGCCGGGGCACCCTGGTGACAGTGTCCAGCGG
AGGCGGCGGCAGCGGCGGAGGAGGCTCAGGAGGAGGCGGCAGCGATATCCAGA
TGACACAGTCTCCTAGCAGCCTCTCCGCCAGCGTGGGCGATAGAGTGACAATCA
CCTGCAGAGCCAGCCAGAGCATCTCCAGCTACCTGAACTGGTACCAGCAAAAGC
CTGGAAAAGCCCCCAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAATCTGGCGT
GCCCAGCCGGTTCAGCGGCTCTGGTAGCGGCACCGACTTCACCCTGACAATTAGC
TCCCTGCAGCCTGAGGATTTTGCCACCTACTATTGTCAGCAGAGCTACATCGCCC
CTTACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAG SEQ ID NO: 768
ATGCCTGCTGAAAACAAGAAGGTGCGGTTCGAGAATACCACCTCTGATAAGGGC
AAGATCCCTAGCAAGGTGATCAAGAGCTACTACGGCACCATGGACATCAAGAAA
ATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAACACCGTGATCG
CCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCATCCAGAACTA
CACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGCAGGGCATTCA
GCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCGGTCCAAAGGT
GTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACATCGGACTCCTG
GGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGTGAACGAAAA
GTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACATCAGCTGCCCT
AATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTCTCCAACCTG
GTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAGATCCTGAAA
CCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCACCTGCATCA
CCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCATCTGGAACG
AATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGGCGTGGGCGA
AGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAACGTGTGGAC
CCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAACAACGAGTTC
TACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGAACAGCACCT
ACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCAAAAGCAACG
GCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGAAGGGCAGAT
ATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAGACACACTGT
ACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAACGACAGCA
ACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAGACTGAGCA
TGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTCAAATACA
ACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCTGACCAGA
GGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAACCTGTGTT
TTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACGTGCTGACC
GTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAGACCCGGCC
AATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAGGGCGTGTA
CAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCGTGTTCCTG
GACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGATAATGAAA
TCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAAAACCATCA
CCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTCGAGATCTA
CGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAGATTCCAGA
GCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGGCTGGTGCAGCC
TGGCGGCAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACTAC
GCCATGAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGCCGTG
ATCAGCGAGAACGGCTCCGATACCTACTACGCCGATTCTGTTAAGGGCAGATTCA
CCATTAGCCGCGACGACAGCAAGAACACCCTGTACCTGCAAATGAACAGCCTGA
GGGCCGAGGACACCGCCGTGTACTATTGCGCCAGAGATAGAGGCGGCGCCGTGT
CCTACTTCGACGTGTGGGGACAGGGCACACTGGTCACCGTGTCTTCTGGCGGAGG
CGGCAGCGGCGGCGGCGGCTCTGGCGGCGGCGGATCTGACATCCAGATGACACA
GTCCCCTAGCAGCCTGTCTGCCAGCGTGGGAGATAGAGTGACCATCACCTGTAG
AGCCAGCCAGGACGTGTCCTCTTATCTGGCCTGGTACCAGCAAAAGCCCGGCAA
AGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTCGAGAGCGGCGTGCCCAGC
AGATTCAGCGGAAGCGGCAGCGGAACAGACTTTACCCTGACAATCAGCTCCCTG
CAGCCAGAGGACTTCGCTACATACTACTGCCAGCAGTACAATAGCCTGCCTTACA
CATTTGGCCAGGGCACCAAGGTGGAAATCAAGCGGACC SEQ ID NO: 769
[00810] Construct pJAQ500 [CD8a Signal Peptide]-[CD117 scFv 2D 1 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGATATTGTGATGACCCAGAGCCATAAGTTCATGAGCACCAGCGTGG
GCGATAGAGTGTCCATCACCTGCAAGGCCTCTCAGGACGTGTCTACAACCGTGGC
CTGGTACCAGCAGAAACCTGGCCAGAGCCCTAAGCTGCTGATCTACTCTGCCAGC
TACAGATATACCGGCGTGCCCGACAGATTCACAGGCAGCGGCTCCGGCACAGAC
TTCACCTTCACCATCAGCAGCGTGCAGGCCGAAGATCTGGCCGTTTACTACTGCC
AGCAACACTACAGCACACCTCCAACATTCGGCGGCGGCACCAAGCTGGAAATCA
AAGGCGGTGGAGGCAGCGGAGGCGGAGGCTCTGGCGGCGGCGGCAGCCAAGTG
CAACTCCAGCAGAGTGATGCCGAGCTGGTGAAGCCTGGAGCTTCTGTGAAGATC
AGCTGCAAAGCTTCTGGCTACACCTTTACCGACCACGCCATCCACTGGGTCAAGC
AGCGGCCCGAGCAGGGCCTGGAATGGATCGGCTGTATCTCCCCTGGAAATGGCG
ACATCAAGTACAACGAGAAGTTTAAGGGCAAGGCTACACTGAGCGCCGACAAAA
GCTCTAGCACCGCCTACATGCAGCTGAACAGCCTGACAAGCGAGGACAGCGCCG
TGTATTTCTGCAAGCGGTGGGACTACTTCGACTACTGGGGCCAGGGAACCACCCT
GACCGTGTCCAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTG
GAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGG
CATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAG
GCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTG
ATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCC
ATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCT
GAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAA
GCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAG
AATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCAC
TGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGAT
TCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCAT
CCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTG
GAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCAT
CAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCC
TGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCT
GGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGC
TCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAA
TACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAA
TGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGG
CACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAG
GATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCAT
CTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGC
AACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCC
AATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTT
TTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCA
TCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGA
GATGAACCGACTTGGAAAG SEQ ID NO: 770
[00811] Construct pJAQ501 [CD8a Signal Peptide]- [CD 117 scFv 2D2 Targeting
CTAGACCTCAAGTGCAGCTGCAGCAGAGCGACGCCGAGCTGGTGAAGCCCGGAG
CCTCCGTGAAGATCTCCTGCAAGGCTAGCGGCTACACCTTCACCGACCATGCCAT
CCACTGGGTGAAACAGCGGCCTGAGCAGGGCCTGGAATGGATCGGATGTATCAG
CCCCGGCAACGGCGACATCAAATACAATGAGAAGTTCAAGGGCAAGGCTACACT
GTCTGCCGACAAGAGCAGCAGCACCGCCTACATGCAGCTGAACAGCCTCACCAG
CGAGGACAGCGCCGTTTACTTCTGCAAGCGGTGGGACTACTTTGATTATTGGGGA
CAAGGCACCACCCTGACAGTGAGCTCTGGCGGAGGTGGCTCTGGAGGCGGTGGA
TCTGGTGGTGGCGGATCAGATATTGTGATGACCCAGAGCCACAAGTTCATGAGC
ACAAGCGTCGGAGATAGAGTGTCTATCACATGCAAAGCTTCTCAGGACGTGTCC
ACCACCGTGGCCTGGTATCAGCAGAAACCTGGCCAGTCTCCTAAGCTGCTGATCT
ACAGCGCCAGCTACAGATACACAGGCGTGCCAGACAGATTCACCGGCTCTGGTA
GCGGCACAGACTTCACCTTCACCATCTCTAGCGTGCAGGCCGAAGATCTGGCCGT
GTACTACTGCCAGCAACACTACAGCACCCCTCCTACCTTTGGCGGAGGCACAAA
GCTGGAAATCAAGAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTG
GAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGG
CATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAG
GCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTG
ATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCC
ATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCT
GAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAA
GCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAG
AATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCAC
TGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGAT
TCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCAT
CCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTG
GAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCAT
CAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCC
TGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTA
AGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCT
GGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGC
TCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAA
TACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAA
TGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGG
CACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAG
GATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCAT
CTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGC
AACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCC
AATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTT
TTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCA
TCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGA
GATGAACCGACTTGGAAAG SEQ ID NO: 771
[00812] Construct pJAQ508 [CD8a Signal Peptide]-[CD117 scFv AHI Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAACCTGGCGCTGAACTGGTCAAGCCCGGCG
CCAGCGTGAAAATGAGCTGCAAGGCCAGCGGCTACACATTTACCAGCTATAATA
TGCACTGGGTGAAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGTGATCT
ACAGCGGCAACGGCGACACCAGCTACAACCAGAAATTCAAGGGCAAGGCCACA
CTGACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATTAACAGCCTGACC
TCTGAGGATAGCGCCGTTTACTACTGCGCCCGGGAAAGAGATACAAGATTTGGA
AACTGGGGACAGGGAACACTGGTGACCGTGTCTGCCGGCGGAGGTGGCTCTGGA
GGCGGTGGATCTGGTGGTGGCGGATCAAACATCGTGCTGACCCAGAGCCCCGCT
TCTCTGGCCGTGTCCCTGGGCCTGCGGGCTACAATCAGCTGCAGAGCCAGCGAG
AGCGTGGACATCTACGGCAATTCCTTCATGCACTGGTACCAGCAGAAGCCTGGA
CAGCCTCCAAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGAGTGCCT
GCCAGGTTCAGCGGCTCTGGCTCTAGAACAGACTTCACCCTGACCATCGACCCCG
TGGAGGCCGACGACGCCGCCACCTACTATTGTCAGCAGAACAACGAGGACCCTT
ACACCTTCGGCGGCGGAACCAAGCTGGAGATCAAGAAGTTCACCATAGTTTTTCC ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCG TCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCA AAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTC CAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACAT TCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAA CGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGC AACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTG GTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGC AGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATA AGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTC AGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTA ACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGC ATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCT CTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCA TCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATT ATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCC
AGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACC
ATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTG
CTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAG
CGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATG
GAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGG
TATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGA
TACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGG
AAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGSEQ ID NO: 772
[00813] Construct pJAQ509 [CD8a Signal Peptide]- [CD 117 scFv AH2 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAATATCGTGCTGACACAGAGCCCAGCTAGCCTGGCTGTGTCTCTGGG
CCTGAGAGCCACAATCAGCTGTAGAGCTTCTGAGTCCGTGGACATCTACGGCAAT
AGCTTCATGCACTGGTACCAGCAGAAGCCTGGACAGCCCCCCAAGCTGCTGATCT
ATCTGGCCTCCAACCTGGAAAGCGGAGTGCCTGCCCGGTTCAGCGGCTCCGGCTC
TAGAACCGACTTCACCCTGACCATTGACCCCGTGGAAGCCGACGACGCCGCCAC
CTACTACTGCCAGCAGAACAACGAGGATCCTTACACCTTTGGCGGAGGGACCAA
GCTGGAAATCAAGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGG
ATCACAGGTGCAGCTGCAGCAACCTGGCGCCGAGCTGGTTAAACCTGGTGCTAG
CGTGAAGATGAGCTGCAAGGCCAGCGGCTACACCTTCACCAGCTACAACATGCA
CTGGGTCAAACAGACACCTGGCCAGGGCCTGGAGTGGATCGGCGTGATCTACAG
CGGCAACGGCGATACCTCTTATAACCAGAAATTTAAGGGCAAGGCCACACTCAC
AGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATCAACAGCCTGACAAGCGA
GGACAGCGCCGTGTACTACTGCGCCAGGGAGCGGGACACCAGATTCGGCAACTG
GGGACAAGGCACCCTGGTGACCGTGTCTGCCAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 773
[00814] Construct pJAQ512 [CD8a Signal Peptide]-[CD117 scFv 58 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGCTCGAGTCCGGCGGCGGACTGGTGCAGCCCGGCG
GATCTCTGAGACTGTCTTGCGCCGCTAGCGGCTTCACCTTTAGCAACTACGCCAT
GAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCAGCGCTATCTC
CGGCAGCGGAGGCTCAACATACTACGCCGACAGCGTTAAGGGAAGATTCACCAT
CAGCCGGGACAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGC
CGAGGACACCGCCGTGTACTATTGTGCCAAGGGCCCTCCTACATACCACACCAAT
TACTATTACATGGACGTGTGGGGCAAAGGCACAACAGTGACCGTGAGCAGCGGC
GGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATG
ACCCAGAGCCCTAGCTCTGTGTCCGCCTCTGTGGGAGATAGAGTGACAATCACCT
GCAGAGCCAGCCAGGGCATCAGCAGCTGGCTGGCCTGGTACCAGCAAAAGCCCG
GCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGCGTGCC
CAGCAGATTCAGCGGTAGCGGCAGCGGCACCGACTTCACACTGACCATTAGCTC
CCTGCAGCCTGAGGATTTCGCCACATACTACTGCCAGCAGACCAACTCTTTTCCA
TACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAGAAGTTCACCATAGTTTTTC
CACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCC
GTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTC
AAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCT
TCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACAC
ATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACA
AACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATAT
GCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGC
TGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAAT
GCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTA
TAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCT
CAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGT
AACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAG
CATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATC
TCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCC
ATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGAT
TATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTC
CAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCAC
CATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATT
GCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAA
GCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAAT
GGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATG
GTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCC
TCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTG
ATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTG
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCT
TGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAG
ACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 774
[00815] Construct pJAQ513 [CD8a Signal Peptide]-[CD117 scFv 61 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGCTGGAAAGCGGAGGCGGCCTGGTGCAGCCTGGCG
GCTCTCTGCGGCTGTCTTGCGCCGCTAGCGGCTTCACATTTAGCAGCTACGTGAT
GATCTGGGTTAGACAGGCCCCTGGAAAAGGACTGGAGTGGGTCTCCTCTATCAG
CGGCGATAGCGTCACCACCTACTATGCCGACAGCGTGAAGGGCAGATTTACAAT
TAGCAGAGATAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGC
CGAGGACACCGCCGTGTACTACTGCGCCAAGGGCCCTCCAACCTACCACACAAA
CTACTACTACATGGACGTGTGGGGCAAAGGCACCACAGTGACCGTGTCCAGCGG
CGGCGGAGGCTCTGGAGGCGGCGGCAGCGGCGGAGGAGGCAGCGACATCCAGA
TGACCCAGAGCCCTAGCTCCGTGTCCGCCTCTGTGGGCGACAGAGTGACAATCAC
CTGCAGAGCCAGCCAGGGTATCAGCTCTTGGCTGGCCTGGTACCAGCAAAAGCC
TGGCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGAGTG
CCCAGCCGGTTCAGCGGCAGCGGCAGCGGCACTGATTTCACCCTGACAATCTCTT
CCCTCCAGCCCGAGGACTTCGCCACCTACTATTGTCAGCAGACCAATAGCTTCCC
CTACACCTTCGGCGGCGGCACAAAGGTGGAAATCAAGAAGTTCACCATAGTTTTT
CCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCC
CGTCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGT
CAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGC
TTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACA
CATTCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAAC
AAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGAT
ATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGT
GCTGGTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAA
ATGCAGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGAC
TATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCT
TCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAA
GTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCA
AGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGG
ATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGC
TCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTG
GATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCT
CTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTT
CACCATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGAT
ATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAG
AAGCGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCA
ATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACA
TGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACAT
CCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGG
TGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGT
TGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATT
CTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAA
AGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 775
[00816] Construct pJAQ514 [CD8a Signal Peptide]-[CD117 scFv 67 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTTCAGCCCGGCG
GAAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACGCCGACA
TGGACTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGGCCGCACCA
GAAACAAGGCCGGCTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGAT
TCACAATTTCTAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAATTCCCT
GAAGACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTACTGGAT
CGACTTCGACCTGTGGGGCAGAGGCACACTGGTGACAGTGTCCTCCGGCGGAGG
TGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATGACCCA
GAGCCCCAGCAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCACATGCAG
AGCCTCCCAGTCTATCAGCAGCTACCTGAACTGGTACCAGCAGAAGCCCGGCAA
AGCCCCTAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCGGCGTGCCTAGC
CGGTTCAGCGGCAGCGGCAGCGGTACAGACTTTACCCTGACCATCAGCTCCCTGC
AGCCTGAGGATTTCGCCACCTACTATTGTCAGCAAAGCTACATCGCCCCATACAC
CTTTGGCGGCGGAACCAAGGTGGAAATCAAGAAGTTCACCATAGTTTTTCCACAC
AACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAA
GCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAAT
GCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAA
ATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCC
ATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACG
AAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAA
CTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGT
TGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAG
CAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAG
GTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAG
AGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACT
ACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATT
GGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTT
TGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCT
CAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATT
CCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGT
GGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATA
ATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTG
CTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGG
AACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAG
TTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTAT
GTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCAC
ATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATAC
TGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAA
AGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 776
[00817] Construct pJAQ515 [CD8a Signal Peptide]- [CD 117 scFv 70 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGGCTGGTGCAGCCTGGCG
GCAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACTACGCCAT
GAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGCCGTGATCAG
CGAGAACGGCTCCGATACCTACTACGCCGATTCTGTTAAGGGCAGATTCACCATT
AGCCGCGACGACAGCAAGAACACCCTGTACCTGCAAATGAACAGCCTGAGGGCC
GAGGACACCGCCGTGTACTATTGCGCCAGAGATAGAGGCGGCGCCGTGTCCTAC
TTCGACGTGTGGGGACAGGGCACACTGGTCACCGTGTCTTCTGGCGGAGGCGGC
AGCGGCGGCGGCGGCTCTGGCGGCGGCGGATCTGACATCCAGATGACACAGTCC
CCTAGCAGCCTGTCTGCCAGCGTGGGAGATAGAGTGACCATCACCTGTAGAGCC
AGCCAGGACGTGTCCTCTTATCTGGCCTGGTACCAGCAAAAGCCCGGCAAAGCC
CCTAAGCTGCTGATCTACGCTGCTTCTAGCCTCGAGAGCGGCGTGCCCAGCAGAT
TCAGCGGAAGCGGCAGCGGAACAGACTTTACCCTGACAATCAGCTCCCTGCAGC
CAGAGGACTTCGCTACATACTACTGCCAGCAGTACAATAGCCTGCCTTACACATT
TGGCCAGGGCACCAAGGTGGAAATCAAGCGGACCAAGTTCACCATAGTTTTTCC
ACACAACCAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCG
TCAAGCTCAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCA
AAATGCCCCAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTC
CAAATGGGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACAT
TCCATCCGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAA
CGAAACAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGC
AACTGTGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTG
GTTGATGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGC
AGCAATTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATA
AGGTCAAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTC
AGAGGACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTA
ACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGC
ATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCT
CTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCA
TCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATT
ATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCC
AGTGGATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACC
ATAATCAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTG
CTGCTCCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAG
CGGAACTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATG
GAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGG
TATGTTGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCT
CACATTCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGA
TACTGGGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGG
AAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGSEQ ID NO: 777
[00818] Construct pJAQ528 [CD8a Signal Peptide]- [CD 117 scFv 54 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTCCAGCTGGTGCAAAGTGGAGCAGAAGTCAAGAAACCCGGAA
GCTCAGTCAAAGTGTCTTGCAAAGCTAGCGGAGGCACGTTCTCAAGTTATGCCAT
ATCCTGGGTGCGCCAAGCGCCCGGCCAAGGCTTGGAATGGATGGGTGGTATAAT
ACCGATTTTTGGGACAGCGAATTATGCACAGAAGTTTCAAGGTAGAGTGACGATT
ACGGCGGATGAAAGTACATCCACGGCGTACATGGAGCTGTCCAGTCTGCGGTCA
GAAGACACAGCCGTATATTACTGCGCGCGAGGAGGGCTCGATACGGACGAATTT
GATCTGTGGGGGCGGGGGACCTTGGTCACAGTAAGTAGCGGGGGAGGAGGCTCT
GGCGGTGGCGGTTCAGGTGGAGGAGGATCCGACATTCAGATGACTCAATCCCCT
TCCTCCCTGAGTGCCTCCGTCGGGGACAGAGTAACGATTACCTGTAGGGCCAGCC
AAAGTATTAACAGCTACCTGAATTGGTATCAGCAGAAGCCCGGCAAAGCCCCGA
AGCTCTTGATATACGCCGCGTCCTCCTTGCAAAGTGGGGTGCCGTCTAGATTCAG
CGGTAGCGGTAGTGGAACGGATTTTACGCTTACTATATCTAGTCTTCAACCGGAG
GATTTTGCTACTTATTATTGTCAACAAGGAGTGTCCGATATCACGTTTGGCGGTG
GGACAAAGGTGGAAATTAAAAAGTTCACCATAGTTTTTCCACACAACCAAAAAG
GAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTT
AAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAG
TCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACT
ACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCT
TCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAA
CTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGA
TGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATAC
ACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATA
TGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGC
TATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGA
GCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTAT
GAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGA
CTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCA
GATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGT
GGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAA
GAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCT
ATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTAC
CCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTC
TCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGAT
GACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACC
AGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCG
ATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGC
TGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCA
AAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGC
CTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGG
TATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 778
[00819] Construct pJAQ529 [CD8a Signal Peptide]-[CD117 scFv 55 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTTCAGTTGGTTCAGTCCGGCGCTGAAGTTAAAAAGCCCGGAA
GCAGTGTAAAGGTCTCCTGCAAGGCCAGTGGCGGGACATTCCGAATTTACGCCA
TCTCATGGGTCCGACAGGCTCCAGGACAAGGACTTGAGTGGATGGGTGGTATTA
TACCAGACTTCGGGGTTGCCAATTACGCACAAAAATTCCAGGGACGAGTAACTA
TAACTGCGGATGAATCAACCTCTACGGCTTATATGGAGCTCTCATCCTTGCGGTC
AGAAGACACGGCCGTGTATTATTGTGCAAGGGGCGGACTCGACACCGATGAGTT
TGATCTTTGGGGCAGAGGTACTCTGGTGACTGTTAGTAGCGGGGGTGGAGGCTCT
GGCGGAGGGGGAAGTGGCGGAGGAGGGAGCGACATCCAAATGACTCAATCACC
TAGCTCACTTAGCGCAAGCGTTGGCGACCGCGTCACTATTACCTGTCGCGCGTCA
CAATCTATCAACTCATATCTGAATTGGTATCAACAAAAGCCTGGTAAGGCCCCTA
AGCTTCTTATTTATGCAGCCAGTAGCCTTCAATCCGGCGTCCCAAGTCGATTCTCC
GGGAGTGGAAGTGGTACAGATTTTACCCTGACCATAAGCAGTTTGCAGCCGGAA
GACTTTGCTACCTATTATTGCCAACAGGGGGTCTCCGATATTACTTTCGGGGGAG
GCACCAAAGTGGAAATCAAGAAGTTCACCATAGTTTTTCCACACAACCAAAAAG
GAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTT
AAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAG
TCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACT
ACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCT
TCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAA
CTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGA
TGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATAC
ACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATA
TGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGC
TATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGA
GCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTAT
GAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGA
CTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCA
GATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGT
GGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAA
GAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCT
ATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTAC
CCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTC
TCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGAT
GACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACC
AGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCG
ATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGC
TGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCA
AAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGC
CTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGG
TATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 779
[00820] Construct pJAQ530 [CD8a Signal Peptide]-[CD117 scFv 56 Targeting
CTAGACCTCAGGTGCAGTTGGTGCAGAGTGGTGCAGAGGTAAAGAAACCAGGCA
GCAGTGTAAAGGTCTCCTGCAAAGCTAGTGGAGGGACTTTCTCTCTCTATGCCAT
AAGTTGGGTTCGCCAGGCGCCGGGACAAGGACTCGAATGGATGGGAGGAATCAT
TCCGGCGTTCGGGACAGCCAATTATGCACAGAAATTCCAAGGTAGGGTAACTAT
TACTGCCGATGAGTCAACGTCTACCGCCTATATGGAACTCTCATCCCTTCGAAGC
GAGGACACCGCTGTATACTACTGTGCACGCGGAGGATTGGATACCGATGAATTC
GATCTCTGGGGAAGAGGAACGCTTGTCACGGTAAGCAGTGGCGGTGGCGGGTCT
GGAGGCGGAGGAAGCGGCGGCGGGGGGTCAGACATACAAATGACCCAGAGTCC
ATCAAGTCTGAGTGCTAGTGTAGGAGATCGCGTAACCATTACATGCCGCGCCTCT
CAATCTATCAACTCCTACTTGAACTGGTATCAGCAGAAACCAGGAAAGGCTCCA
AAGTTGTTGATTTATGCAGCTTCTAGTCTCCAGTCAGGAGTACCTTCTCGGTTCTC
CGGATCTGGTAGCGGAACAGACTTCACATTGACCATAAGTAGCTTGCAGCCAGA
AGACTTTGCAACGTATTACTGCCAACAAGGCGTGAGTGACATCACGTTCGGCGG
CGGAACAAAGGTAGAGATTAAAAAGTTCACCATAGTTTTTCCACACAACCAAAA
AGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGAT
TTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAG
AGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCA
CTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATC
CTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGG
AACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACG
GATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAAT
ACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACA
TATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGG
GCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGA
GAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCT
TATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTC
AGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAG
CCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTC
AGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGC
CAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTC
AGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATG
GTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAAT
CCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTG
GGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAG
GACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGAC
TCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAG
ACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTA
TCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTA
TTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAG
TTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATAC
AGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 780
[00821] Construct pJAQ531 [CD8a Signal Peptide]-[CD117 scFv 57 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTCCAACTTGTACAATCTGGTGCGGAGGTCAAGAAACCGGGTA
GCTCCGTTAAGGTCTCATGCAAAGCAAGCGGTGGCACTTTCAGTTTGTATGCGAT
CTCTTGGGTGCGGCAAGCGCCAGGACAAGGTCTGGAATGGATGGGTGGGATAAT
ACCTCATTTTGGACTCGCGAATTATGCACAAAAGTTTCAAGGTAGAGTTACAATA
ACCGCGGATGAAAGTACCTCCACCGCATACATGGAGTTGTCAAGCCTTAGGAGT
GAGGACACAGCCGTTTATTACTGTGCCCGAGGCGGATTGGACACTGATGAATTTG
ACTTGTGGGGGAGAGGCACACTCGTAACAGTCAGTAGTGGGGGAGGCGGCTCCG
GAGGCGGCGGTTCTGGCGGCGGAGGTTCCGATATTCAAATGACCCAGAGTCCAA
GTAGTCTTTCCGCATCCGTAGGTGACAGAGTGACTATAACATGCAGGGCATCACA
ATCCATCAACTCTTATCTGAACTGGTACCAACAAAAACCAGGTAAAGCTCCTAAG
CTGCTCATATATGCAGCAAGTTCCCTCCAGAGCGGAGTCCCCTCTCGGTTTTCTG
GTTCCGGAAGCGGAACAGATTTTACGCTCACTATAAGTAGCCTTCAACCTGAGGA
CTTCGCAACATATTACTGTCAACAAGGCGTTTCTGACATCACCTTCGGGGGCGGC
ACCAAGGTCGAGATAAAAAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGA
AACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAA
ATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTC
ACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTAC
TTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTC
ACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACT
TGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATG
CCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACAC
AGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATG
CCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTA
TGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGC
TATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 781
[00822] Construct pJAQ538 [CD90 scFvl Targeting Domain]-[VSV-G mut del SP
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAA
CTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATT
GGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACA
AGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTG
TGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACT
CCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGG
CTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCG
AAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGG
AGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCC
CACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGT
GATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTAT
CATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAA
CTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCC
CATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATT
CCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGAT
GTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAA
CCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCT
TGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTA
AAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAA
GAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACT
GGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTT
CAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTT
CATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTT
CGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAA
TCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCT
TTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAG SEQ ID NO: 782
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCAAGTTCACCATAGTTTTTCCACACAACCAAA
AAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGA
TTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAG
AGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCA
CTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATC
CTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGG
AACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACG
GATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAAT
ACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACA
TATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGG
GCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGA
GAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCT
TATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTC
AGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAG
CCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTC
AGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGC
CAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTC
AGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATG
GTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAAT
CCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTG
GGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAG
GACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGAC
TCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAG
ACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTA
TCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTA
TTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAG
TTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATAC
AGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 783
[00824] Construct pJAQ540 [CD8a Signal Peptide]- [CD 117 scFv 2D2 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAGAGCGACGCCGAGCTGGTGAAGCCCGGAG
CCTCCGTGAAGATCTCCTGCAAGGCTAGCGGCTACACCTTCACCGACCATGCCAT
CCACTGGGTGAAACAGCGGCCTGAGCAGGGCCTGGAATGGATCGGATGTATCAG
CCCCGGCAACGGCGACATCAAATACAATGAGAAGTTCAAGGGCAAGGCTACACT
GTCTGCCGACAAGAGCAGCAGCACCGCCTACATGCAGCTGAACAGCCTCACCAG
CGAGGACAGCGCCGTTTACTTCTGCAAGCGGTGGGACTACTTTGATTATTGGGGA
CAAGGCACCACCCTGACAGTGAGCTCTGGCGGAGGTGGCTCTGGAGGCGGTGGA
TCTGGTGGTGGCGGATCAGATATTGTGATGACCCAGAGCCACAAGTTCATGAGC
ACAAGCGTCGGAGATAGAGTGTCTATCACATGCAAAGCTTCTCAGGACGTGTCC
ACCACCGTGGCCTGGTATCAGCAGAAACCTGGCCAGTCTCCTAAGCTGCTGATCT
ACAGCGCCAGCTACAGATACACAGGCGTGCCAGACAGATTCACCGGCTCTGGTA
GCGGCACAGACTTCACCTTCACCATCTCTAGCGTGCAGGCCGAAGATCTGGCCGT
GTACTACTGCCAGCAACACTACAGCACCCCTCCTACCTTTGGCGGAGGCACAAA
GCTGGAAATCAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACT
ATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTCTTTTTTCTT
TATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTT
GCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGA
ACCGACTTGGAAAG SEQ ID NO: 784
[00825] Construct pJAQ541 [CD8a Signal Peptide]-[CD117 scFv 4F1 Targeting
CTAGACCTGACATCGTGATGACCCAGAGCCACAAGTTCATGAGCACCAGCGTGG
GCGATAGAGTGTCCATCACATGCAAGGCCAGCCAGGACGTGTCTACAACCGTGG
CCTGGTACCAGCAGAAACCTGGCCAAAGCCCCAAGCTGCTGATCTACTCCGCCTC
TTACCGGTACACCGGCGTGCCTGACCGGTTCACCGGCAGCGGCTCTGGCACCGAC
TTCACCTTCACCATCAGCAGCGTCCAGGCCGAGGACCTGGCCGTGTACTACTGCC
AGCAGCACTACTCTACCCCTCCAACCTTTGGCGGAGGAACAAAGCTGGAAATCA
AGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGAGGTGC
AGCTGCAGGAGAGCGGTCCTAGCCTCGTGAAGCCTTCTCAGACCCTGAGCCTGA
CCTGTAGCGTGACCGGCGACAGCATCACCAGCGGATATTGGAATTGGATCAGAA
AGTTCCCCGGCAACAAGCTGGAATACATGGGCTACATCAACTACAGCGGCAGCA
CGTACTACAACCCCAGCCTGAAAAGCCAGATCAGCATTACCAGAGATACATCTA
AGAACCAGTACTATCTGCAACTGAACAGCGTTACAACAGAGGATGCTGCTACAT
ACTATTGCGCCAGAGGCGGAAATTACTTTGCCATGGACTACTGGGGCCAGGGCA
CCTCCGTGACAGTGTCCAGCACTACAACTCCAGCACCCAGACCCCCTACACCTGC
TCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTCT
TTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAG SEQ ID NO: 785
[00826] Construct pJAQ542 [CD8a Signal Peptide]- [CD 117 scFv 4F2 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAAGTGCAGCTGCAGGAGAGCGGACCTAGCCTGGTGAAGCCTAGCC
AGACCCTGAGCCTGACCTGCAGCGTCACAGGCGACAGCATCACCAGCGGCTACT
GGAACTGGATCAGAAAGTTCCCTGGCAACAAGCTCGAGTACATGGGCTACATCA
ACTACAGCGGCTCCACCTACTACAACCCCAGCCTGAAGTCCCAAATCAGCATTAC
CAGAGATACCAGCAAGAATCAGTACTATCTGCAACTGAACAGCGTGACAACCGA
GGACGCCGCTACATACTATTGCGCCAGAGGCGGCAATTACTTCGCCATGGACTAC
TGGGGCCAGGGCACCAGCGTGACAGTGTCTAGCGGCGGCGGCGGCTCTGGCGGT
GGCGGAAGCGGCGGCGGAGGAAGTGATATCGTGATGACCCAGAGCCACAAGTTT
ATGAGCACATCTGTGGGCGACAGAGTGTCCATCACATGTAAAGCTTCTCAGGAC
GTGTCCACCACCGTGGCCTGGTACCAGCAGAAACCTGGCCAGTCCCCAAAGCTG
CTGATCTACAGCGCCAGCTACCGGTACACCGGCGTTCCTGACCGGTTCACAGGAT
CTGGATCTGGCACAGATTTCACCTTTACCATCAGCAGCGTGCAGGCCGAGGACCT
GGCCGTGTACTATTGCCAGCAGCACTACTCTACACCCCCCACCTTCGGCGGAGGC
ACCAAGCTGGAAATCAAGACTACAACTCCAGCACCCAGACCCCCTACACCTGCT
CCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTCTT
TTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATC
CATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATA
GAGATGAACCGACTTGGAAAG SEQ ID NO: 786
[00827] Construct pJAQ548 [CD8a Signal Peptide]-[CD117 scFv AHI Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAACCTGGCGCTGAACTGGTCAAGCCCGGCG
CCAGCGTGAAAATGAGCTGCAAGGCCAGCGGCTACACATTTACCAGCTATAATA
TGCACTGGGTGAAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGTGATCT
ACAGCGGCAACGGCGACACCAGCTACAACCAGAAATTCAAGGGCAAGGCCACA
CTGACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATTAACAGCCTGACC
TCTGAGGATAGCGCCGTTTACTACTGCGCCCGGGAAAGAGATACAAGATTTGGA
AACTGGGGACAGGGAACACTGGTGACCGTGTCTGCCGGCGGAGGTGGCTCTGGA
GGCGGTGGATCTGGTGGTGGCGGATCAAACATCGTGCTGACCCAGAGCCCCGCT
TCTCTGGCCGTGTCCCTGGGCCTGCGGGCTACAATCAGCTGCAGAGCCAGCGAG
AGCGTGGACATCTACGGCAATTCCTTCATGCACTGGTACCAGCAGAAGCCTGGA
CAGCCTCCAAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGAGTGCCT
GCCAGGTTCAGCGGCTCTGGCTCTAGAACAGACTTCACCCTGACCATCGACCCCG
TGGAGGCCGACGACGCCGCCACCTACTATTGTCAGCAGAACAACGAGGACCCTT
ACACCTTCGGCGGCGGAACCAAGCTGGAGATCAAGACTACAACTCCAGCACCCA
GACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGA
AGCCTGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGT
TCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 787
[00828] Construct pJAQ550 [CD8a Signal Peptide]-[CD117 scFv 58 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGCTCGAGTCCGGCGGCGGACTGGTGCAGCCCGGCG
GATCTCTGAGACTGTCTTGCGCCGCTAGCGGCTTCACCTTTAGCAACTACGCCAT
GAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCAGCGCTATCTC
CGGCAGCGGAGGCTCAACATACTACGCCGACAGCGTTAAGGGAAGATTCACCAT
CAGCCGGGACAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGC
CGAGGACACCGCCGTGTACTATTGTGCCAAGGGCCCTCCTACATACCACACCAAT
TACTATTACATGGACGTGTGGGGCAAAGGCACAACAGTGACCGTGAGCAGCGGC
GGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATG
ACCCAGAGCCCTAGCTCTGTGTCCGCCTCTGTGGGAGATAGAGTGACAATCACCT
GCAGAGCCAGCCAGGGCATCAGCAGCTGGCTGGCCTGGTACCAGCAAAAGCCCG
GCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGCGTGCC
CAGCAGATTCAGCGGTAGCGGCAGCGGCACCGACTTCACACTGACCATTAGCTC
CCTGCAGCCTGAGGATTTCGCCACATACTACTGCCAGCAGACCAACTCTTTTCCA
TACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAGACTACAACTCCAGCACCC
AGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTG
AAGCCTGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTG
GTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGAC
AGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 788
[00829] Construct pJAQ551 [CD8a Signal Peptide]-[CD117 scFv 61 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGCTGGAAAGCGGAGGCGGCCTGGTGCAGCCTGGCG
GCTCTCTGCGGCTGTCTTGCGCCGCTAGCGGCTTCACATTTAGCAGCTACGTGAT
GATCTGGGTTAGACAGGCCCCTGGAAAAGGACTGGAGTGGGTCTCCTCTATCAG
CGGCGATAGCGTCACCACCTACTATGCCGACAGCGTGAAGGGCAGATTTACAAT
TAGCAGAGATAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGC
CGAGGACACCGCCGTGTACTACTGCGCCAAGGGCCCTCCAACCTACCACACAAA
CTACTACTACATGGACGTGTGGGGCAAAGGCACCACAGTGACCGTGTCCAGCGG
CGGCGGAGGCTCTGGAGGCGGCGGCAGCGGCGGAGGAGGCAGCGACATCCAGA
TGACCCAGAGCCCTAGCTCCGTGTCCGCCTCTGTGGGCGACAGAGTGACAATCAC
CTGCAGAGCCAGCCAGGGTATCAGCTCTTGGCTGGCCTGGTACCAGCAAAAGCC
TGGCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGAGTG
CCCAGCCGGTTCAGCGGCAGCGGCAGCGGCACTGATTTCACCCTGACAATCTCTT
CCCTCCAGCCCGAGGACTTCGCCACCTACTATTGTCAGCAGACCAATAGCTTCCC
CTACACCTTCGGCGGCGGCACAAAGGTGGAAATCAAGACTACAACTCCAGCACC
CAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCT
GAAGCCTGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTT
GGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGA
CAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGSEQ ID NO: 789
[00830] Construct pJAQ552 [CD8a Signal Peptide]- [CD 117 scFv 70 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGGCTGGTGCAGCCTGGCG
GCAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACTACGCCAT
GAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGCCGTGATCAG
CGAGAACGGCTCCGATACCTACTACGCCGATTCTGTTAAGGGCAGATTCACCATT
AGCCGCGACGACAGCAAGAACACCCTGTACCTGCAAATGAACAGCCTGAGGGCC
GAGGACACCGCCGTGTACTATTGCGCCAGAGATAGAGGCGGCGCCGTGTCCTAC
TTCGACGTGTGGGGACAGGGCACACTGGTCACCGTGTCTTCTGGCGGAGGCGGC
AGCGGCGGCGGCGGCTCTGGCGGCGGCGGATCTGACATCCAGATGACACAGTCC
CCTAGCAGCCTGTCTGCCAGCGTGGGAGATAGAGTGACCATCACCTGTAGAGCC
AGCCAGGACGTGTCCTCTTATCTGGCCTGGTACCAGCAAAAGCCCGGCAAAGCC
CCTAAGCTGCTGATCTACGCTGCTTCTAGCCTCGAGAGCGGCGTGCCCAGCAGAT
TCAGCGGAAGCGGCAGCGGAACAGACTTTACCCTGACAATCAGCTCCCTGCAGC
CAGAGGACTTCGCTACATACTACTGCCAGCAGTACAATAGCCTGCCTTACACATT
TGGCCAGGGCACCAAGGTGGAAATCAAGCGGACCACTACAACTCCAGCACCCAG
ACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAA
GCCTGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTT
CTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAG
ATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 790
[00831] Construct pJAQ561 [CD8a Signal Peptide]- [CD 117 scFv 54 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTCCAGCTGGTGCAAAGTGGAGCAGAAGTCAAGAAACCCGGAA
GCTCAGTCAAAGTGTCTTGCAAAGCTAGCGGAGGCACGTTCTCAAGTTATGCCAT
ATCCTGGGTGCGCCAAGCGCCCGGCCAAGGCTTGGAATGGATGGGTGGTATAAT
ACCGATTTTTGGGACAGCGAATTATGCACAGAAGTTTCAAGGTAGAGTGACGATT
ACGGCGGATGAAAGTACATCCACGGCGTACATGGAGCTGTCCAGTCTGCGGTCA
GAAGACACAGCCGTATATTACTGCGCGCGAGGAGGGCTCGATACGGACGAATTT
GATCTGTGGGGGCGGGGGACCTTGGTCACAGTAAGTAGCGGGGGAGGAGGCTCT
GGCGGTGGCGGTTCAGGTGGAGGAGGATCCGACATTCAGATGACTCAATCCCCT
TCCTCCCTGAGTGCCTCCGTCGGGGACAGAGTAACGATTACCTGTAGGGCCAGCC
AAAGTATTAACAGCTACCTGAATTGGTATCAGCAGAAGCCCGGCAAAGCCCCGA
AGCTCTTGATATACGCCGCGTCCTCCTTGCAAAGTGGGGTGCCGTCTAGATTCAG
CGGTAGCGGTAGTGGAACGGATTTTACGCTTACTATATCTAGTCTTCAACCGGAG
GATTTTGCTACTTATTATTGTCAACAAGGAGTGTCCGATATCACGTTTGGCGGTG
GGACAAAGGTGGAAATTAAAACTACAACTCCAGCACCCAGACCCCCTACACCTG
CTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTC
TTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAG SEQ ID NO: 791
[00832] Construct pJAQ562 [CD8a Signal Peptide]-[CD117 scFv 56 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAGGTGCAGTTGGTGCAGAGTGGTGCAGAGGTAAAGAAACCAGGCA
GCAGTGTAAAGGTCTCCTGCAAAGCTAGTGGAGGGACTTTCTCTCTCTATGCCAT
AAGTTGGGTTCGCCAGGCGCCGGGACAAGGACTCGAATGGATGGGAGGAATCAT
TCCGGCGTTCGGGACAGCCAATTATGCACAGAAATTCCAAGGTAGGGTAACTAT
TACTGCCGATGAGTCAACGTCTACCGCCTATATGGAACTCTCATCCCTTCGAAGC
GAGGACACCGCTGTATACTACTGTGCACGCGGAGGATTGGATACCGATGAATTC
GATCTCTGGGGAAGAGGAACGCTTGTCACGGTAAGCAGTGGCGGTGGCGGGTCT
GGAGGCGGAGGAAGCGGCGGCGGGGGGTCAGACATACAAATGACCCAGAGTCC
ATCAAGTCTGAGTGCTAGTGTAGGAGATCGCGTAACCATTACATGCCGCGCCTCT
CAATCTATCAACTCCTACTTGAACTGGTATCAGCAGAAACCAGGAAAGGCTCCA
AAGTTGTTGATTTATGCAGCTTCTAGTCTCCAGTCAGGAGTACCTTCTCGGTTCTC
CGGATCTGGTAGCGGAACAGACTTCACATTGACCATAAGTAGCTTGCAGCCAGA
AGACTTTGCAACGTATTACTGCCAACAAGGCGTGAGTGACATCACGTTCGGCGG
CGGAACAAAGGTAGAGATTAAAACTACAACTCCAGCACCCAGACCCCCTACACC
TGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 792
[00833] Construct pJAQ567 [CD8a.2 Signal Peptide] -[SCF soluble 2 Targeting
Domain] -[GGGGSx3 Linker] -[TPO- 145 Targeting Domain] -[GGGGSx3 Linker] -[FLT3L
ATGGCTTTGCCTGTTACAGCTCTGCTGCTGCCCCTGGCTCTGCTTCTGCATGCTGC
TAGACCTGAGGGCATCTGCCGGAACAGAGTGACCAACAACGTGAAGGACGTGAC
CAAGCTGGTGGCCAACCTGCCTAAGGACTACATGATCACCCTGAAATACGTGCC
CGGCATGGACGTGCTGCCTAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCT
GAGCGACAGCCTGACCGACCTGCTGGACAAGTTCAGCAACATCAGCGAGGGCCT
GAGCAACTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTGGA
ATGCGTGAAAGAGAACAGCAGCAAGGACCTGAAGAAGTCCTTCAAGAGCCCCG
AGCCTCGGCTGTTCACCCCTGAGGAATTCTTCCGGATCTTCAACCGGTCCATCGA
CGCCTTCAAGGACTTCGTGGTGGCCAGCGAGACAAGCGACTGTGTGGTTTCTGGT
GGCGGAGGATCTGGCGGAGGTGGAAGCGGCGGAGGCGGATCTTGCGATCTGAG
AGTGCTGAGCAAGCTGCTGAGAGACAGCCACGTGCTGCACAGCAGACTGAGCCA
GTGTCCTGAAGTGCACCCTCTGCCTACACCTGTGCTGCTGCCTGCTGTGGATTTCA
GCCTCGGCGAGTGGAAAACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTG
GGAGCCGTGACACTGCTTCTGGAAGGCGTGATGGCTGCCAGAGGACAGCTGGGA
CCTACATGTCTGTCTAGCCTGCTGGGCCAGCTGTCTGGACAAGTTCGACTGCTGC
TGGGAGCCCTGCAATCTCTGCTGGGAACACAGCTGCCTCCACAGGGCAGAACAA
CAGCCCACAAGGACCCCAACGCCATCTTCCTGAGCTTCCAGCACCTCCTGAGAGG
CAAAGTGCGGTTCCTGATGCTCGTCGGCGGCAGCACACTTTGTGGTGGCGGAGG
ATCTGGCGGAGGTGGAAGCGGCGGAGGCGGATCTGACTGCAGCTTTCAGCACAG
CCCCATCAGCAGCGACTTCGCCGTGAAGATCAGAGAGCTGAGCGACTACCTGCT
GCAGGACTACCCTGTGACCGTGGCCAGCAATCTGCAGGACGAAGAACTGTGTGG
TGGCCTGTGGCGACTGGTGCTGGCTCAGAGATGGATGGAACGGCTGAAAACAGT
GGCCGGCAGCAAGATGCAGGGCCTGCTGGAAAGAGTGAACACCGAGATCCACTT
CGTGACCAAGTGCGCCTTCCAGCCTCCTCCAAGCTGCCTGAGATTCGTGCAGACC
AACATCAGCAGACTGCTGCAAGAGACAAGCGAGCAGCTGGTGGCCCTGAAGCCT
TGGATCACCAGACAGAACTTCAGCCGGTGCCTGGAACTGCAGTGTGCGGCCGCA
ATTGAAGTTATGTATCCTCCTCCTTACCTAGACAATGAGAAGAGCAATGGAACCA
TTATCCATGTGAAAGGGAAACACCTTTGTCCAAGTCCCCTATTTCCCGGACCTTC
TAAGCCCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCA
AGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAG SEQ ID NO: 793
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGACATCGTGCTGAGCCAGAGCCCAGCTATCATG
AGCGCCAGCCCTGGCGAGAAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTG
TCTTACATGTACTGGTACCAGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCT
ACCGGACCTCTAATCTGGCCTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAG
CGGAACCAGCTACAGCCTGACAATCAGCAGCATGGAAGCCGAGGATGCCGCTAC
CTACTACTGCCAGCAGTACCACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAG
CTGGAACTGAAAAGCTCCGGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAG
CTCTAGAAGCAGCCTGGAAGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAA
GCCTGGAGAAACCGTGAAGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGA
TTACAGCATGAAGTGGGTCAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGG
CTGGATTAACACCGAGACCGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAG
ATTCGCCTTCAGCCTCGAGACATCTGCTAGCACCGCCTACCTGCAGATCAACAAC
CTGAAGAACGAGGACACCGCCACATACTTCTGCGCCACCGACTATGGCGATTAC
TTCGACTACTGGGGCCAGGGAACAACACTGACCGTGTCCTCC SEQ ID NO: 794
[00835] Construct pJAQ569 [Nipah G mut trunc TM]-[CXCL12 Targeting Domain]
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGC
TGACCGCGCTCTGCCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCC
CATGCCGATTCTTCGAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAAT
TCTCAACACTCCAAACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAAC
AGACAAGTGTGCATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAA
GCTTTAAACAAG SEQ ID NO: 795
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGGGCATCTGCAGAAATCGGGTGACCAACAAC
GTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACC
CTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAG
ATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAAC
ATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGG
ACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTT
TCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAA
CCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGC
GTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAG
CCATTCATGCTGCCTCCTGTGGCCGCC SEQ ID NO: 796
[00837] Construct pJAQ571 [Nipah G mut trunc TM]-[TPO-157 Targeting Domain]
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAACTGACCGAGCTGCTGCTGGTCGTGATGCTGC
TGCTCACCGCCAGACTGACCCTGAGCAGCCCCGCCCCTCCTGCCTGCGATCTGCG
GGTGCTGTCTAAACTGCTGCGGGACAGCCACGTGCTGCATTCTAGACTGAGCCAG
TGTCCTGAGGTGCACCCCCTGCCCACCCCTGTGCTGCTGCCCGCTGTGGACTTCA
GCCTGGGCGAGTGGAAGACCCAAATGGAAGAGACAAAGGCCCAAGACATCCTG
GGCGCCGTGACCCTGCTGCTGGAAGGCGTGATGGCCGCTAGAGGCCAGCTGGGC
CCTACATGCCTGTCCAGCCTCCTGGGACAGCTGTCCGGCCAGGTGCGGCTGCTGC
TTGGAGCCCTGCAGAGCCTGCTGGGCACACAGCTGCCACCTCAGGGCAGAACCA
CAGCCCACAAGGATCCTAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGAGA
SEQ ID NO: 797
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGCTGACCGAGCTGCTGCTGGTCGTTATGCTGC
TGCTTACAGCCAGACTGACACTGTCCAGCCCTGCCCCTCCAGCATGCGACCTGAG
GGTGCTGAGCAAGCTGCTGAGAGATAGCCACGTGCTGCACTCTAGACTGTCTCA
GTGCCCCGAGGTGCACCCTCTGCCCACCCCTGTGCTGCTCCCCGCCGTGGACTTC
AGCCTGGGCGAGTGGAAGACCCAGATGGAAGAAACCAAGGCCCAGGATATCCT
GGGCGCTGTGACCCTGCTGCTGGAAGGCGTGATGGCCGCTAGAGGACAACTGGG
ACCTACCTGTCTGAGCAGCCTGCTGGGCCAGCTGTCCGGCCAAGTGCGGCTGCTG
CTGGGCGCCCTGCAGAGCCTGCTCGGCACACAGCTGCCTCCTCAGGGCAGAACC
ACCGCCCATAAGGACCCCAACGCCATCTTCCTGAGCTTTCAGCACCTGCTGCGGG
GCAAAGTGCGGTTCCTGATGCTGGTGGGCGGATCTACACTG SEQ ID NO: 798
[00839] Construct pJAQ575 [Nipah G mut trunc TM]-[CD117 scFv 58 Targeting Domain]
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGGTGCAGCTGCTCGAGTCCGGCGGCGGACTG
GTGCAGCCCGGCGGATCTCTGAGACTGTCTTGCGCCGCTAGCGGCTTCACCTTTA
GCAACTACGCCATGAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGG
TCAGCGCTATCTCCGGCAGCGGAGGCTCAACATACTACGCCGACAGCGTTAAGG
GAAGATTCACCATCAGCCGGGACAACAGCAAGAACACCCTGTACCTGCAGATGA
ACAGCCTGCGGGCCGAGGACACCGCCGTGTACTATTGTGCCAAGGGCCCTCCTA
CATACCACACCAATTACTATTACATGGACGTGTGGGGCAAAGGCACAACAGTGA
CCGTGAGCAGCGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGAT
CAGATATCCAGATGACCCAGAGCCCTAGCTCTGTGTCCGCCTCTGTGGGAGATAG
AGTGACAATCACCTGCAGAGCCAGCCAGGGCATCAGCAGCTGGCTGGCCTGGTA
CCAGCAAAAGCCCGGCAAGGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTG
CAAAGCGGCGTGCCCAGCAGATTCAGCGGTAGCGGCAGCGGCACCGACTTCACA
CTGACCATTAGCTCCCTGCAGCCTGAGGATTTCGCCACATACTACTGCCAGCAGA
CCAACTCTTTTCCATACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAG
SEQ ID NO: 799
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTCAAGTTCAGTTGGTTCAGTCCGGCGCTGAAGTTA
AAAAGCCCGGAAGCAGTGTAAAGGTCTCCTGCAAGGCCAGTGGCGGGACATTCC
GAATTTACGCCATCTCATGGGTCCGACAGGCTCCAGGACAAGGACTTGAGTGGA
TGGGTGGTATTATACCAGACTTCGGGGTTGCCAATTACGCACAAAAATTCCAGGG
ACGAGTAACTATAACTGCGGATGAATCAACCTCTACGGCTTATATGGAGCTCTCA
TCCTTGCGGTCAGAAGACACGGCCGTGTATTATTGTGCAAGGGGCGGACTCGAC
ACCGATGAGTTTGATCTTTGGGGCAGAGGTACTCTGGTGACTGTTAGTAGCGGGG
GTGGAGGCTCTGGCGGAGGGGGAAGTGGCGGAGGAGGGAGCGACATCCAAATG
ACTCAATCACCTAGCTCACTTAGCGCAAGCGTTGGCGACCGCGTCACTATTACCT
GTCGCGCGTCACAATCTATCAACTCATATCTGAATTGGTATCAACAAAAGCCTGG
TAAGGCCCCTAAGCTTCTTATTTATGCAGCCAGTAGCCTTCAATCCGGCGTCCCA
AGTCGATTCTCCGGGAGTGGAAGTGGTACAGATTTTACCCTGACCATAAGCAGTT
TGCAGCCGGAAGACTTTGCTACCTATTATTGCCAACAGGGGGTCTCCGATATTAC
TTTCGGGGGAGGCACCAAAGTGGAAATCAAG SEQ ID NO: 800
[00841] Construct pJAQ579 [Nipah G mut trunc TM]-[AdF35 Genscript Codon
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAAT
CCTGTGTACCCCTACGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCG
GCTTCATCAGCCCTAATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAA
GTGCCTGACCCCTCTCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGG
AGGACTGACCGTGGACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCA
CCGCCCCTATCACCAAGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCC
TGGAAACCCAGAACAACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCA
ACAACGGAGATATCTGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCA
ACCCTCCACCTAATTGCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGC
TGACACTCGTGCTGGTTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGT
CGGCGTGTCCGATACAGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCA
GCTGAGACTGTATTTCGACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTG
AAAATCCCCCTGAAAAACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGC
AGCAAGGCCTTCATGCCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGG
ACAGCGAGAACTACATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAA
GCCTGTTCCCCCTGAACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCA
ACGTGGCTTACGCCATCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTG
AGTCTAATATCGCCACACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAA
GATGACAAC SEQ ID NO: 801
[00842] Construct pJAQ580 [Nipah G mut trunc TM]-[CD117 scFv AHI Targeting Domain]
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTCAAGTGCAGCTGCAGCAACCTGGCGCTGAACTG
GTCAAGCCCGGCGCCAGCGTGAAAATGAGCTGCAAGGCCAGCGGCTACACATTT
ACCAGCTATAATATGCACTGGGTGAAACAGACCCCTGGCCAGGGCCTCGAGTGG
ATCGGCGTGATCTACAGCGGCAACGGCGACACCAGCTACAACCAGAAATTCAAG
GGCAAGGCCACACTGACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATT
AACAGCCTGACCTCTGAGGATAGCGCCGTTTACTACTGCGCCCGGGAAAGAGAT
ACAAGATTTGGAAACTGGGGACAGGGAACACTGGTGACCGTGTCTGCCGGCGGA
GGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAAACATCGTGCTGACC
CAGAGCCCCGCTTCTCTGGCCGTGTCCCTGGGCCTGCGGGCTACAATCAGCTGCA
GAGCCAGCGAGAGCGTGGACATCTACGGCAATTCCTTCATGCACTGGTACCAGC
AGAAGCCTGGACAGCCTCCAAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAA
GCGGAGTGCCTGCCAGGTTCAGCGGCTCTGGCTCTAGAACAGACTTCACCCTGAC
CATCGACCCCGTGGAGGCCGACGACGCCGCCACCTACTATTGTCAGCAGAACAA
CGAGGACCCTTACACCTTCGGCGGCGGAACCAAGCTGGAGATCAAG SEQ ID NO: 802
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGCCTG
GTGCAGCCTGGAGGCAGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTTT
CTGATCACTACATGGATTGGGTGCGGCAGGCCCCAGGAAAAGGCCTGGAATGGG
TCGGACGGACCAGAAACAAGGCCTCTTCTTATACAACCGAGTACGCTGCTTCTGT
GAAGGGCAGGTTCACAATTAGCCGGGACGACAGCAAGAACAGCCTGTACCTGCA
GATGAACAGCCTGAAGACCGAGGATACCGCCGTGTACTATTGCGCCAGAGAGCC
TAAATACTGGATCGACTTCGACCTGTGGGGCAGAGGCACCCTGGTTACAGTGTCC
AGCGGCGGTGGCGGCAGCGGCGGCGGAGGCAGCGGAGGCGGAGGCAGCGACAT
CCAGATGACACAGAGCCCTAGCAGCCTCTCCGCCAGCGTGGGAGATAGAGTGAC
AATCACATGTAGAGCCTCCCAGTCTATCAGCTCTTACCTGAATTGGTACCAGCAA
AAGCCCGGCAAGGCCCCTAAGCTGCTGATCTACGCCGCCAGCAGCCTGCAAAGC
GGCGTGCCCAGCAGATTCTCCGGCTCCGGCTCTGGCACCGACTTCACCCTGACCA
TCAGCTCCCTGCAGCCCGAGGACTTTGCCACCTACTACTGCCAGCAGAGCTACAT
CGCCCCTTACACCTTCGGCGGCGGCACCAAGGTGGAAATCAAG SEQ ID NO: 803
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTG
GTTCAGCCCGGCGGAAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCA
GCGACGCCGACATGGACTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGG
TCGGCCGCACCAGAAACAAGGCCGGCTCTTATACAACCGAGTACGCTGCTTCTGT
GAAGGGCAGATTCACAATTTCTAGAGATGACAGCAAGAACAGCCTGTACCTGCA
AATGAATTCCCTGAAGACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCC
TAAGTACTGGATCGACTTCGACCTGTGGGGCAGAGGCACACTGGTGACAGTGTC
CTCCGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATAT
CCAGATGACCCAGAGCCCCAGCAGCCTCAGCGCCAGCGTGGGAGATAGAGTGAC
CATCACATGCAGAGCCTCCCAGTCTATCAGCAGCTACCTGAACTGGTACCAGCAG
AAGCCCGGCAAAGCCCCTAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCG
GCGTGCCTAGCCGGTTCAGCGGCAGCGGCAGCGGTACAGACTTTACCCTGACCA
TCAGCTCCCTGCAGCCTGAGGATTTCGCCACCTACTATTGTCAGCAAAGCTACAT
CGCCCCATACACCTTTGGCGGCGGAACCAAGGTGGAAATCAAG SEQ ID NO: 804
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGGCTG
GTGCAGCCTGGCGGCAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCA
GCGACTACGCCATGAGCTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGG
TCGCCGTGATCAGCGAGAACGGCTCCGATACCTACTACGCCGATTCTGTTAAGGG
CAGATTCACCATTAGCCGCGACGACAGCAAGAACACCCTGTACCTGCAAATGAA
CAGCCTGAGGGCCGAGGACACCGCCGTGTACTATTGCGCCAGAGATAGAGGCGG
CGCCGTGTCCTACTTCGACGTGTGGGGACAGGGCACACTGGTCACCGTGTCTTCT
GGCGGAGGCGGCAGCGGCGGCGGCGGCTCTGGCGGCGGCGGATCTGACATCCAG
ATGACACAGTCCCCTAGCAGCCTGTCTGCCAGCGTGGGAGATAGAGTGACCATC
ACCTGTAGAGCCAGCCAGGACGTGTCCTCTTATCTGGCCTGGTACCAGCAAAAGC
CCGGCAAAGCCCCTAAGCTGCTGATCTACGCTGCTTCTAGCCTCGAGAGCGGCGT
GCCCAGCAGATTCAGCGGAAGCGGCAGCGGAACAGACTTTACCCTGACAATCAG
CTCCCTGCAGCCAGAGGACTTCGCTACATACTACTGCCAGCAGTACAATAGCCTG
CCTTACACATTTGGCCAGGGCACCAAGGTGGAAATCAAGCGGACC SEQ ID
NO: 805
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTAAAAAAACCCAGACCTGGATCCTGACATGCATC
TACCTCCAACTGCTCCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAA
ATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCA
AGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCC
ACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCT
GGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAA
GCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAA
GGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGA
ATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCC
TCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCA
GAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAG
AAACGACAGCAGCAGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCA
GCCTGCACTGGGCCGCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTT
CGCCTTCGGCGCTCTGTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGT
GGAAAACATCCAGATTAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGA
AGGAACGGGAATTTCAGGAGGTG SEQ ID NO: 806
[00847] Construct pJAQ588 [Nipah G mut trunc TM]-[CALR-ins5 Targeting Domain]
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTCTGCTTAGCGTGCCTCTGCTGCTGGGCCTGCTGG
GCCTGGCCGTGGCCGAACCCGCCGTGTACTTCAAGGAACAGTTCCTCGACGGCG
ATGGATGGACATCTAGATGGATCGAGTCTAAGCATAAGAGCGATTTCGGCAAGT
TTGTGCTGAGCTCCGGCAAGTTCTACGGCGACGAGGAAAAAGATAAGGGCCTGC
AGACCAGCCAAGACGCCAGATTCTACGCTCTGAGCGCCAGCTTCGAGCCCTTCTC
CAACAAGGGCCAGACCCTGGTCGTGCAGTTTACAGTGAAGCACGAGCAGAACAT
CGATTGCGGCGGAGGCTACGTGAAGCTGTTCCCCAACTCTCTGGATCAGACAGAT
ATGCACGGCGACAGCGAGTACAACATCATGTTCGGCCCTGACATCTGTGGCCCC
GGCACAAAGAAAGTGCACGTGATCTTTAACTACAAAGGAAAAAACGTGCTGATC
AACAAAGACATCAGATGCAAGGACGACGAGTTCACCCACCTGTACACCCTGATT
GTGCGGCCTGATAATACCTACGAGGTGAAGATCGATAACAGCCAGGTCGAGAGC
GGCAGCCTGGAAGACGACTGGGATTTCCTGCCTCCTAAGAAGATCAAGGACCCC
GATGCTAGCAAGCCCGAGGACTGGGACGAGAGAGCCAAGATTGACGACCCTACA
GACTCCAAGCCTGAGGACTGGGACAAGCCCGAGCACATCCCTGATCCTGATGCT
AAAAAGCCTGAGGACTGGGACGAGGAAATGGACGGCGAATGGGAGCCTCCAGT
GATCCAGAATCCTGAATACAAGGGCGAATGGAAGCCTAGGCAGATCGACAACCC
AGACTACAAGGGCACCTGGATCCACCCTGAGATCGACAATCCTGAGTATTCTCCC
GACCCCAGCATCTACGCCTATGATAACTTTGGAGTTCTGGGACTGGACCTGTGGC
AGGTGAAGTCTGGAACCATCTTCGACAACTTCCTGATCACTAACGACGAGGCCTA
CGCCGAGGAATTCGGCAACGAGACCTGGGGCGTGACCAAGGCCGCCGAGAAAC
AGATGAAAGACAAGCAGGACGAAGAACAGCGGCTGAAGGAAGAAGAGGAAGA
TAAGAAAAGAAAGGAAGAAGAGGAGGCTGAGGATAATTGTAGACGGATGATGA
GAACCAAGATGCGCATGCGGAGAATGAGAAGAACCAGAAGAAAGATGCGGCGG
AAGATGAGCCCTGCCAGACCGCGGACAAGCTGCCGGGAAGCCTGCCTGCAAGGC
TGGACCGAGGCC SEQ ID NO: 807
[00848] Construct pJAQ590 [Nipah G mut trunc TM]-[CD117 scFv AH2 Targeting
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTAATATCGTGCTGACACAGAGCCCAGCTAGCCTG
GCTGTGTCTCTGGGCCTGAGAGCCACAATCAGCTGTAGAGCTTCTGAGTCCGTGG
ACATCTACGGCAATAGCTTCATGCACTGGTACCAGCAGAAGCCTGGACAGCCCC
CCAAGCTGCTGATCTATCTGGCCTCCAACCTGGAAAGCGGAGTGCCTGCCCGGTT
CAGCGGCTCCGGCTCTAGAACCGACTTCACCCTGACCATTGACCCCGTGGAAGCC
GACGACGCCGCCACCTACTACTGCCAGCAGAACAACGAGGATCCTTACACCTTT
GGCGGAGGGACCAAGCTGGAAATCAAGGGCGGAGGTGGCTCTGGAGGCGGTGG
ATCTGGTGGTGGCGGATCACAGGTGCAGCTGCAGCAACCTGGCGCCGAGCTGGT
TAAACCTGGTGCTAGCGTGAAGATGAGCTGCAAGGCCAGCGGCTACACCTTCAC
CAGCTACAACATGCACTGGGTCAAACAGACACCTGGCCAGGGCCTGGAGTGGAT
CGGCGTGATCTACAGCGGCAACGGCGATACCTCTTATAACCAGAAATTTAAGGG
CAAGGCCACACTCACAGCCGATAAGTCCAGCAGCACCGCCTACATGCAGATCAA
CAGCCTGACAAGCGAGGACAGCGCCGTGTACTACTGCGCCAGGGAGCGGGACAC
CAGATTCGGCAACTGGGGACAAGGCACCCTGGTGACCGTGTCTGCC SEQ ID NO: 808
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAAGTGCAGCTGCAGGAGAGCGGACCTAGCCTG
GTGAAGCCTAGCCAGACCCTGAGCCTGACCTGCAGCGTCACAGGCGACAGCATC
ACCAGCGGCTACTGGAACTGGATCAGAAAGTTCCCTGGCAACAAGCTCGAGTAC
ATGGGCTACATCAACTACAGCGGCTCCACCTACTACAACCCCAGCCTGAAGTCCC
AAATCAGCATTACCAGAGATACCAGCAAGAATCAGTACTATCTGCAACTGAACA
GCGTGACAACCGAGGACGCCGCTACATACTATTGCGCCAGAGGCGGCAATTACT
TCGCCATGGACTACTGGGGCCAGGGCACCAGCGTGACAGTGTCTAGCGGCGGCG
GCGGCTCTGGCGGTGGCGGAAGCGGCGGCGGAGGAAGTGATATCGTGATGACCC
AGAGCCACAAGTTTATGAGCACATCTGTGGGCGACAGAGTGTCCATCACATGTA
AAGCTTCTCAGGACGTGTCCACCACCGTGGCCTGGTACCAGCAGAAACCTGGCC
AGTCCCCAAAGCTGCTGATCTACAGCGCCAGCTACCGGTACACCGGCGTTCCTGA
CCGGTTCACAGGATCTGGATCTGGCACAGATTTCACCTTTACCATCAGCAGCGTG
CAGGCCGAGGACCTGGCCGTGTACTATTGCCAGCAGCACTACTCTACACCCCCCA
CCTTCGGCGGAGGCACCAAGCTGGAAATCAAG SEQ ID NO: 809
[00850] Construct pJAQ595 [CD8a Signal Peptide]-[CD117 scFv 4F1 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGACATCGTGATGACCCAGAGCCACAAGTTCATGAGCACCAGCGTGG
GCGATAGAGTGTCCATCACATGCAAGGCCAGCCAGGACGTGTCTACAACCGTGG
CCTGGTACCAGCAGAAACCTGGCCAAAGCCCCAAGCTGCTGATCTACTCCGCCTC
TTACCGGTACACCGGCGTGCCTGACCGGTTCACCGGCAGCGGCTCTGGCACCGAC
TTCACCTTCACCATCAGCAGCGTCCAGGCCGAGGACCTGGCCGTGTACTACTGCC
AGCAGCACTACTCTACCCCTCCAACCTTTGGCGGAGGAACAAAGCTGGAAATCA
AGGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGAGGTGC
AGCTGCAGGAGAGCGGTCCTAGCCTCGTGAAGCCTTCTCAGACCCTGAGCCTGA
CCTGTAGCGTGACCGGCGACAGCATCACCAGCGGATATTGGAATTGGATCAGAA
AGTTCCCCGGCAACAAGCTGGAATACATGGGCTACATCAACTACAGCGGCAGCA
CGTACTACAACCCCAGCCTGAAAAGCCAGATCAGCATTACCAGAGATACATCTA
AGAACCAGTACTATCTGCAACTGAACAGCGTTACAACAGAGGATGCTGCTACAT
ACTATTGCGCCAGAGGCGGAAATTACTTTGCCATGGACTACTGGGGCCAGGGCA
CCTCCGTGACAGTGTCCAGCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGG
AAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTA
AATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGT
CACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTA
CTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTT
CACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAAC
TTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGAT
GCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACA
CAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATAT
GCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCT
ATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAG
CTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 810
[00851] Construct pJAQ596 [CD8a Signal Peptide]- [CD 117 scFv 4F2 Targeting Domain]-[VSV-G mut del SP TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAAGTGCAGCTGCAGGAGAGCGGACCTAGCCTGGTGAAGCCTAGCC
AGACCCTGAGCCTGACCTGCAGCGTCACAGGCGACAGCATCACCAGCGGCTACT
GGAACTGGATCAGAAAGTTCCCTGGCAACAAGCTCGAGTACATGGGCTACATCA
ACTACAGCGGCTCCACCTACTACAACCCCAGCCTGAAGTCCCAAATCAGCATTAC
CAGAGATACCAGCAAGAATCAGTACTATCTGCAACTGAACAGCGTGACAACCGA
GGACGCCGCTACATACTATTGCGCCAGAGGCGGCAATTACTTCGCCATGGACTAC
TGGGGCCAGGGCACCAGCGTGACAGTGTCTAGCGGCGGCGGCGGCTCTGGCGGT
GGCGGAAGCGGCGGCGGAGGAAGTGATATCGTGATGACCCAGAGCCACAAGTTT
ATGAGCACATCTGTGGGCGACAGAGTGTCCATCACATGTAAAGCTTCTCAGGAC
GTGTCCACCACCGTGGCCTGGTACCAGCAGAAACCTGGCCAGTCCCCAAAGCTG
CTGATCTACAGCGCCAGCTACCGGTACACCGGCGTTCCTGACCGGTTCACAGGAT
CTGGATCTGGCACAGATTTCACCTTTACCATCAGCAGCGTGCAGGCCGAGGACCT
GGCCGTGTACTATTGCCAGCAGCACTACTCTACACCCCCCACCTTCGGCGGAGGC
ACCAAGCTGGAAATCAAGAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGA
AACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAA
ATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTC
ACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTAC
TTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTC
ACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACT
TGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATG
CCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACAC
AGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATG
CCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTA
TGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGC
TATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATG
AAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGAC
TCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAG
ATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTG
GATGTAAGTCTAATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAG
AAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTA
TCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACC
CTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCT
CAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATG
ACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCA
GTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGA
TCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCT
GCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAA
AAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 811
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCC
TTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAA
TAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAG
ACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTAT
GGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAAT
GCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCC
CTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCA
GGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCA
CAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTA
CAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTC
CATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGA
GGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTG
CAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTC
GAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAG
GGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGA
CGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAG
AGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCA
GGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCA
GATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGAT
CAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGA
CGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCT
TTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGG
CTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGA
TGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTA
GAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGG
GTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAAT
TAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTG
GAAAG SEQ ID NO: 812
[00853] Construct pJAQ602 [CD8a.2 Signal Peptide] -[SCF soluble 2 Targeting
Domain] -[GGGGSx3 Linker] -[TPO- 145 Targeting Domain] -[GGGGSx3 Linker] -[FLT3L Targeting Domain]- [VS V-G mut del SP TM]
ATGGCTTTGCCTGTTACAGCTCTGCTGCTGCCCCTGGCTCTGCTTCTGCATGCTGC
TAGACCTGAGGGCATCTGCCGGAACAGAGTGACCAACAACGTGAAGGACGTGAC
CAAGCTGGTGGCCAACCTGCCTAAGGACTACATGATCACCCTGAAATACGTGCC
CGGCATGGACGTGCTGCCTAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCT
GAGCGACAGCCTGACCGACCTGCTGGACAAGTTCAGCAACATCAGCGAGGGCCT
GAGCAACTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTGGA
ATGCGTGAAAGAGAACAGCAGCAAGGACCTGAAGAAGTCCTTCAAGAGCCCCG
AGCCTCGGCTGTTCACCCCTGAGGAATTCTTCCGGATCTTCAACCGGTCCATCGA
CGCCTTCAAGGACTTCGTGGTGGCCAGCGAGACAAGCGACTGTGTGGTTTCTGGT
GGCGGAGGATCTGGCGGAGGTGGAAGCGGCGGAGGCGGATCTTGCGATCTGAG
AGTGCTGAGCAAGCTGCTGAGAGACAGCCACGTGCTGCACAGCAGACTGAGCCA
GTGTCCTGAAGTGCACCCTCTGCCTACACCTGTGCTGCTGCCTGCTGTGGATTTCA
GCCTCGGCGAGTGGAAAACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTG
GGAGCCGTGACACTGCTTCTGGAAGGCGTGATGGCTGCCAGAGGACAGCTGGGA
CCTACATGTCTGTCTAGCCTGCTGGGCCAGCTGTCTGGACAAGTTCGACTGCTGC
TGGGAGCCCTGCAATCTCTGCTGGGAACACAGCTGCCTCCACAGGGCAGAACAA
CAGCCCACAAGGACCCCAACGCCATCTTCCTGAGCTTCCAGCACCTCCTGAGAGG
CAAAGTGCGGTTCCTGATGCTCGTCGGCGGCAGCACACTTTGTGGTGGCGGAGG
ATCTGGCGGAGGTGGAAGCGGCGGAGGCGGATCTGACTGCAGCTTTCAGCACAG
CCCCATCAGCAGCGACTTCGCCGTGAAGATCAGAGAGCTGAGCGACTACCTGCT
GCAGGACTACCCTGTGACCGTGGCCAGCAATCTGCAGGACGAAGAACTGTGTGG
TGGCCTGTGGCGACTGGTGCTGGCTCAGAGATGGATGGAACGGCTGAAAACAGT
GGCCGGCAGCAAGATGCAGGGCCTGCTGGAAAGAGTGAACACCGAGATCCACTT
CGTGACCAAGTGCGCCTTCCAGCCTCCTCCAAGCTGCCTGAGATTCGTGCAGACC
AACATCAGCAGACTGCTGCAAGAGACAAGCGAGCAGCTGGTGGCCCTGAAGCCT
TGGATCACCAGACAGAACTTCAGCCGGTGCCTGGAACTGCAGTGTGCGGCCGCA
ATTGAAGTTATGTATCCTCCTCCTTACCTAGACAATGAGAAGAGCAATGGAACCA
TTATCCATGTGAAAGGGAAACACCTTTGTCCAAGTCCCCTATTTCCCGGACCTTC
TAAGCCCAAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAA
TGTTCCTTCTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATG
ACTTAATAGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTC
AAGCAGACGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCG
CTGGTATGGACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTA
GAACAATGCAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCC
AGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTG
ATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGG
TTGATTCACAGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCA
TAACTCTACAACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAAC
CTCATTTCCATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGG
GAAAGGAGGGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCA
AGGCCTGCAAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTG
TCTGGTTCGAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATG
CCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTA
ATTCAGGACGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCA
AAATCAGAGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAA
AAACCCAGGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTT
GAGACCAGATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCG
GAATGATCAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCAT
ATGAAGACGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATA
AGTTTCCTTTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGC
TCAAAGGCTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTC
CTGATGATGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGA
GCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTA
TCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGC
ATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAAC
CGACTTGGAAAG SEQ ID NO: 813
[00854] Construct pJAQ603 [CD8a Signal Peptide]-[CD117 scFv 67 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTTCAGCCCGGCG
GAAGCCTGCGGCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACGCCGACA
TGGACTGGGTGCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGGCCGCACCA
GAAACAAGGCCGGCTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGAT
TCACAATTTCTAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAATTCCCT
GAAGACCGAGGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTACTGGAT
CGACTTCGACCTGTGGGGCAGAGGCACACTGGTGACAGTGTCCTCCGGCGGAGG
TGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATGACCCA
GAGCCCCAGCAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCACATGCAG
AGCCTCCCAGTCTATCAGCAGCTACCTGAACTGGTACCAGCAGAAGCCCGGCAA
AGCCCCTAAGCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCGGCGTGCCTAGC
CGGTTCAGCGGCAGCGGCAGCGGTACAGACTTTACCCTGACCATCAGCTCCCTGC
AGCCTGAGGATTTCGCCACCTACTATTGTCAGCAAAGCTACATCGCCCCATACAC
CTTTGGCGGCGGAACCAAGGTGGAAATCAAGACTACAACTCCAGCACCCAGACC
CCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCC
TGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTC
CGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTT
ATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 814
[00855] Construct pJAQ606 [CD8a Signal Peptide]-[CD117 scFv 55 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTTCAGTTGGTTCAGTCCGGCGCTGAAGTTAAAAAGCCCGGAA
GCAGTGTAAAGGTCTCCTGCAAGGCCAGTGGCGGGACATTCCGAATTTACGCCA
TCTCATGGGTCCGACAGGCTCCAGGACAAGGACTTGAGTGGATGGGTGGTATTA
TACCAGACTTCGGGGTTGCCAATTACGCACAAAAATTCCAGGGACGAGTAACTA
TAACTGCGGATGAATCAACCTCTACGGCTTATATGGAGCTCTCATCCTTGCGGTC
AGAAGACACGGCCGTGTATTATTGTGCAAGGGGCGGACTCGACACCGATGAGTT
TGATCTTTGGGGCAGAGGTACTCTGGTGACTGTTAGTAGCGGGGGTGGAGGCTCT
GGCGGAGGGGGAAGTGGCGGAGGAGGGAGCGACATCCAAATGACTCAATCACC
TAGCTCACTTAGCGCAAGCGTTGGCGACCGCGTCACTATTACCTGTCGCGCGTCA
CAATCTATCAACTCATATCTGAATTGGTATCAACAAAAGCCTGGTAAGGCCCCTA
AGCTTCTTATTTATGCAGCCAGTAGCCTTCAATCCGGCGTCCCAAGTCGATTCTCC
GGGAGTGGAAGTGGTACAGATTTTACCCTGACCATAAGCAGTTTGCAGCCGGAA
GACTTTGCTACCTATTATTGCCAACAGGGGGTCTCCGATATTACTTTCGGGGGAG
GCACCAAAGTGGAAATCAAGACTACAACTCCAGCACCCAGACCCCCTACACCTG
CTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTC
TTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAG SEQ ID NO: 815
[00856] Construct pJAQ608 [CD133 scFv 1 Targeting Domain]-[CD8 trunc Hinge]- [VSVG TM tail TM]
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTCTTTTTTCTTTATCATAGGGT
TAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTA
AAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGA
AAG SEQ ID NO: 816
[00857] Construct pJAQ609 [Nipah G mut trunc TM]-[SCF soluble Targeting Domain]
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTGAGGGCATCTGCAGAAATCGGGTGACCAACAAC
GTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACC
CTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAG
ATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAAC
ATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGG
ACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTT
TCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAA
CCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGC
GTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAG
CCATTCATGCTGCCTCCTGTGGCCGCC SEQ ID NO: 817
ATGAAGAAAATCAACGAAGGCCTGCTGGACTCCAAGATCCTGAGCGCCTTTAAC
ACCGTGATCGCCCTGCTGGGCAGCATCGTGATCATCGTGATGAACATCATGATCA
TCCAGAACTACACACGGTCCACCGACAACCAGGCTGTGATCAAGGACGCCCTGC
AGGGCATTCAGCAGCAAATCAAGGGCCTGGCTGATAAGATCGGAACAGAGATCG
GTCCAAAGGTGTCCCTGATCGACACCAGCAGCACAATCACTATCCCCGCCAACAT
CGGACTCCTGGGCAGCAAGATCAGCCAGTCTACAGCCAGCATCAATGAGAACGT
GAACGAAAAGTGCAAGTTCACCCTGCCTCCCCTGAAGATCCACGAGTGCAACAT
CAGCTGCCCTAATCCCCTGCCCTTCCGGGAATACAGACCCCAGACCGAGGGCGTC
TCCAACCTGGTGGGTCTGCCTAACAACATCTGTCTGCAGAAGACAAGCAACCAG
ATCCTGAAACCTAAGCTGATCTCCTACACCCTGCCAGTGGTGGGACAGTCCGGCA
CCTGCATCACCGATCCTCTGCTGGCCATGGATGAGGGTTATTTCGCCTACAGCCA
TCTGGAACGAATCGGCTCTTGTAGCAGAGGCGTGTCCAAGCAGCGCATCATTGG
CGTGGGCGAAGTGCTGGACCGGGGCGATGAGGTGCCAAGCCTGTTCATGACCAA
CGTGTGGACCCCTCCTAACCCTAATACCGTGTATCACTGCAGCGCTGTGTATAAC
AACGAGTTCTACTACGTGCTGTGCGCCGTGTCTACAGTGGGCGATCCTATCCTGA
ACAGCACCTACTGGTCCGGCAGCCTGATGATGACAAGACTGGCCGTGAAGCCCA
AAAGCAACGGCGGAGGCTACAACCAGCACCAGCTCGCCCTGAGAAGCATTGAGA
AGGGCAGATATGACAAGGTGATGCCTTACGGCCCCAGTGGCATCAAACAGGGAG
ACACACTGTACTTCCCCGCCGTGGGCTTCCTGGTTAGAACAGAATTCAAGTACAA
CGACAGCAACTGTCCCATCACCAAGTGCCAGTACAGCAAGCCTGAGAACTGCAG
ACTGAGCATGGGCATCCGGCCTAATAGCCACTACATCCTTAGAAGCGGACTGCTC
AAATACAACCTGAGCGACGGCGAGAACCCTAAGGTCGTGTTCATCGAGATCTCT
GACCAGAGGCTGTCTATCGGAAGCCCTAGCAAAATCTACGACAGCCTGGGACAA
CCTGTGTTTTACCAGGCCAGCTTCAGCTGGGACACCATGATCAAGTTCGGCGACG
TGCTGACCGTTAATCCTCTGGTCGTGAACTGGCGGAACAACACCGTGATCTCTAG
ACCCGGCCAATCTCAGTGTCCTAGATTCAACACCTGTCCTGCCATCTGCGCCGAG
GGCGTGTACAATGACGCCTTCCTGATCGACAGAATTAACTGGATATCTGCCGGCG
TGTTCCTGGACAGCAATGCCACCGCCGCTAATCCTGTGTTTACAGTGTTCAAAGA
TAATGAAATCCTGTACCGGGCACAACTGGCCAGTGAAGATACAAACGCCCAGAA
AACCATCACCAACTGCTTCCTGCTGAAGAACAAGATCTGGTGCATCAGCCTGGTC
GAGATCTACGATACAGGCGACAACGTGATCAGACCAAAGCTGTTTGCCGTCAAG
ATTCCAGAGCAGTGCACCAGTCAAGTGCAGCTGCAGCAGAGCGACGCCGAGCTG
GTGAAGCCCGGAGCCTCCGTGAAGATCTCCTGCAAGGCTAGCGGCTACACCTTC
ACCGACCATGCCATCCACTGGGTGAAACAGCGGCCTGAGCAGGGCCTGGAATGG
ATCGGATGTATCAGCCCCGGCAACGGCGACATCAAATACAATGAGAAGTTCAAG
GGCAAGGCTACACTGTCTGCCGACAAGAGCAGCAGCACCGCCTACATGCAGCTG
AACAGCCTCACCAGCGAGGACAGCGCCGTTTACTTCTGCAAGCGGTGGGACTAC
TTTGATTATTGGGGACAAGGCACCACCCTGACAGTGAGCTCTGGCGGAGGTGGC
TCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAGATATTGTGATGACCCAGAGC
CACAAGTTCATGAGCACAAGCGTCGGAGATAGAGTGTCTATCACATGCAAAGCT
TCTCAGGACGTGTCCACCACCGTGGCCTGGTATCAGCAGAAACCTGGCCAGTCTC
CTAAGCTGCTGATCTACAGCGCCAGCTACAGATACACAGGCGTGCCAGACAGAT
TCACCGGCTCTGGTAGCGGCACAGACTTCACCTTCACCATCTCTAGCGTGCAGGC
CGAAGATCTGGCCGTGTACTACTGCCAGCAACACTACAGCACCCCTCCTACCTTT GGCGGAGGCACAAAGCTGGAAATCAAG SEQ ID NO: 818
[00859] Construct pJAQ614 [CD8a Signal Peptide]-[CD117 scFv 2D 1 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGATATTGTGATGACCCAGAGCCATAAGTTCATGAGCACCAGCGTGG
GCGATAGAGTGTCCATCACCTGCAAGGCCTCTCAGGACGTGTCTACAACCGTGGC
CTGGTACCAGCAGAAACCTGGCCAGAGCCCTAAGCTGCTGATCTACTCTGCCAGC
TACAGATATACCGGCGTGCCCGACAGATTCACAGGCAGCGGCTCCGGCACAGAC
TTCACCTTCACCATCAGCAGCGTGCAGGCCGAAGATCTGGCCGTTTACTACTGCC
AGCAACACTACAGCACACCTCCAACATTCGGCGGCGGCACCAAGCTGGAAATCA
AAGGCGGTGGAGGCAGCGGAGGCGGAGGCTCTGGCGGCGGCGGCAGCCAAGTG
CAACTCCAGCAGAGTGATGCCGAGCTGGTGAAGCCTGGAGCTTCTGTGAAGATC
AGCTGCAAAGCTTCTGGCTACACCTTTACCGACCACGCCATCCACTGGGTCAAGC
AGCGGCCCGAGCAGGGCCTGGAATGGATCGGCTGTATCTCCCCTGGAAATGGCG
ACATCAAGTACAACGAGAAGTTTAAGGGCAAGGCTACACTGAGCGCCGACAAAA
GCTCTAGCACCGCCTACATGCAGCTGAACAGCCTGACAAGCGAGGACAGCGCCG
TGTATTTCTGCAAGCGGTGGGACTACTTCGACTACTGGGGCCAGGGAACCACCCT
GACCGTGTCCAGCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACT
ATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGCCTCTTTTTTCTT
TATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTT
GCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGA
ACCGACTTGGAAAGTAA SEQ ID NO: 819
[00860] Construct pJAQ615 [CD8a Signal Peptide]-[CD117 SRI scFv Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTCAAGTGCAGCTGCAGCAGCCTGGAGCCGAGCTGGTGAAACCTGGCG
CCAGCGTGAAGATGAGCTGCAAGGCCTCCGGTTATACATTCACCTCCTACAACAT
GCACTGGGTCAAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGTGATCTA
CAGCGGCAACGGAGATACCAGCTACAACCAGAAATTCAAGGGCAAGGCCACCCT
GACCGCCGACAAGTCCAGCAGCACCGCCTACATGCAGATCAACAGCCTGACCAG
CGAGGATAGCGCCGTGTACTATTGCGCCAGAGAGCGGGACACCAGATTTGGAAA
TTGGGGCCAAGGCACCCTGGTTACAGTGTCTGCCGCTAAGACCACCGGCGGAGG
TGGCTCTGGAGGCGGTGGATCTGGTGGTGGCGGATCAATCGTGCTGACACAGAG
CCCTGCTTCTCTGGCCGTGTCCCTGGGCCTGCGGGCCACAATTAGCTGTAGAGCC
TCTGAGAGCGTGGACATCTACGGCAATAGCTTCATGCACTGGTACCAGCAAAAG
CCTGGCCAGCCCCCCAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGC
GTGCCAGCTAGGTTCAGCGGAAGCGGCTCTAGAACCGACTTCACACTGACCATC
GACCCTGTGGAAGCCGATGACGCCGCCACATACTACTGCCAGCAGAACAACGAG
GACCCCTACACCTTTGGCGGCGGAACAAAGCTGGAAATCAAGACTACAACTCCA
GCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGC
GCCCTGAAGCCTGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTA
TTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGA
AAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 820
[00861] Construct pJAQ616 [CD8a Signal Peptide]-[CD117 scFv 66 Targeting
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAGGTGCAGCTGGTGGAAAGCGGCGGCGGCCTGGTGCAGCCTGGAG
GCAGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTTTCTGATCACTACAT
GGATTGGGTGCGGCAGGCCCCAGGAAAAGGCCTGGAATGGGTCGGACGGACCA
GAAACAAGGCCTCTTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGGTT
CACAATTAGCCGGGACGACAGCAAGAACAGCCTGTACCTGCAGATGAACAGCCT
GAAGACCGAGGATACCGCCGTGTACTATTGCGCCAGAGAGCCTAAATACTGGAT
CGACTTCGACCTGTGGGGCAGAGGCACCCTGGTTACAGTGTCCAGCGGCGGTGG
CGGCAGCGGCGGCGGAGGCAGCGGAGGCGGAGGCAGCGACATCCAGATGACAC
AGAGCCCTAGCAGCCTCTCCGCCAGCGTGGGAGATAGAGTGACAATCACATGTA
GAGCCTCCCAGTCTATCAGCTCTTACCTGAATTGGTACCAGCAAAAGCCCGGCAA
GGCCCCTAAGCTGCTGATCTACGCCGCCAGCAGCCTGCAAAGCGGCGTGCCCAG
CAGATTCTCCGGCTCCGGCTCTGGCACCGACTTCACCCTGACCATCAGCTCCCTG
CAGCCCGAGGACTTTGCCACCTACTACTGCCAGCAGAGCTACATCGCCCCTTACA
CCTTCGGCGGCGGCACCAAGGTGGAAATCAAGACTACAACTCCAGCACCCAGAC
CCCCTACACCTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGC
CTGTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCT
CCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATT
TATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 821
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATTGC
CTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGG
TATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 822
[00863] Construct pJAQ633 [VSV-G Signal Peptide] -[CD90 scFv 2 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
GGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGCGTACG
CTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACTGGGTT
AAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCAGTGAT
TCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGTCGATA
AATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGATTCTGC
CGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAATACTGG
GGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCGGTGGCGGCAGCGGTGGCGGC
GGCAGCGGCGGTGGTGGCAGCGATATTCAGATGACTCAAACAACATCTAGCCTC
TCCGCTTCCCTGGGCGACCGGGTGACGATTTCTTGCAGAGCCTCCCAGGACATCA
GCAATTATCTTAACTGGTACCAGCAGAAACCAGATGGTACGTTTAAACTCCTGAT
CTACTACACCAGTAGGTTGCACTCTGGAGTCCCCAGCCGCTTCAGTGGCGGCGGA
TCAGGGACAGACTACAGCCTTACCATCAGTAATCTGGAAAAGGAAGACATCGCT
ACCTACTTCTGTCAGCAGGGGAACACCTTGCCCCGGACGTTCGGAGGAGGCACT
CGACTGGAAGTGAAAGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGT
AGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACT
ATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAG
AAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC
SEQ ID NO: 823
[00864] Construct pJAQ634 [VSV-G Signal Peptide] -[CD90 scFv 2 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
GGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGCGTACG
CTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACTGGGTT
AAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCAGTGAT
TCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGTCGATA
AATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGATTCTGC
CGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAATACTGG
GGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCGGTGGCGGCAGCGGTGGCGGC
GGCAGCGGCGGTGGTGGCAGCGATATTCAGATGACTCAAACAACATCTAGCCTC
TCCGCTTCCCTGGGCGACCGGGTGACGATTTCTTGCAGAGCCTCCCAGGACATCA
GCAATTATCTTAACTGGTACCAGCAGAAACCAGATGGTACGTTTAAACTCCTGAT
CTACTACACCAGTAGGTTGCACTCTGGAGTCCCCAGCCGCTTCAGTGGCGGCGGA
TCAGGGACAGACTACAGCCTTACCATCAGTAATCTGGAAAAGGAAGACATCGCT
ACCTACTTCTGTCAGCAGGGGAACACCTTGCCCCGGACGTTCGGAGGAGGCACT
CGACTGGAAGTGAAAAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAA
TCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCT
TTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 824
[00865] Construct pJAQ635 [VSV-G Signal Peptide] -[CD 133 scFv 1 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGC
CGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGCAGCCT
GAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGAGCTGG
GTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCAGAACC
GGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCAGCCGG
GACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCGAGGAT
ACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGTGCCAG
GGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGTGGGCG
ACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCTGAACT
GGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGCTTCTG
ATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACCGATTT
TACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATTGTCAG
CAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAATCGGT
ACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTG
CCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTG
GTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAG
ACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 825
[00866] Construct pJAQ636 [VSV-G Signal Peptide] -[CD 133 scFv 1 Targeting
CGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGCAGCCT
GAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGAGCTGG
GTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCAGAACC
GGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCAGCCGG
GACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCGAGGAT
ACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGTGCCAG
GGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGTGGGCG
ACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCTGAACT
GGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGCTTCTG
ATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACCGATTT
TACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATTGTCAG
CAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAATCAGC
GGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAGAA
GGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTT
AATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAA
AGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAA
AGGTC SEQ ID NO: 826
[00867] Construct pJAQ637 [VSV-G Signal Peptide] -[CD 133 scFv 2 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
CATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAGAAGGT
GACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACCAGCAA
AAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGCCTCTG
GCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTGACAA
TCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTACCACA
GCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCCGGCG
GTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGAAGTG
AAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGAAGAT
CTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGTCAAC
CAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGACCGGC
GAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGAGACA
TCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACACCGCC
ACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAGGGAA
CAACACTGACCGTGTCCTCCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTT
CAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTG
GACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACC
AAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC
SEQ ID NO: 827
[00868] Construct pJAQ638 [VSV-G Signal Peptide] -[CD 133 scFv 2 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
CATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAGAAGGT
GACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACCAGCAA
AAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGCCTCTG
GCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTGACAA
TCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTACCACA
GCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCCGGCG
GTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGAAGTG
AAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGAAGAT
CTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGTCAAC
CAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGACCGGC
GAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGAGACA
TCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACACCGCC
ACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAGGGAA
CAACACTGACCGTGTCCTCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTA
CCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGC
CTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGG
TATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 828
[00869] Construct pJAQ639 [VSV-G Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
CGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGAC
GGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCAT
GTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCC
TTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGA
AGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGGGTACCAATC
CAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTT
TTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCC
ATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAG
AGATGAACCGACTTGGAAAGGTC SEQ ID NO: 829
[00870] Construct pJAQ640 [VSV-G Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
CGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCTCAGCGAC
GGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGAAAGCCAT
GTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCAAACTGTGCCC
TTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGCATTGACCCGA
AGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAGCGGTGGGA
GCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGT
TCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATT
GGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACAC
CAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC
SEQ ID NO: 830
[00871] Construct pJAQ641 [VSV-G Signal Peptide] -[AdF35 Genscript Codon
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAC
CAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGA
GAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTT
ACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCA
CAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCG
ACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACC
ACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGT
GCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGG
ACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGT
GGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGG
AGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCA
GATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGT
GGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGC
AGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACC
ACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGC
ATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCA
TCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCG
AGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCA
CATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACGGTACCAATCCAAT
CGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCT
TTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTT
TGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATG
AACCGACTTGGAAAGGTC SEQ ID NO: 831
[00872] Construct pJAQ642 [VSV-G Signal Peptide] -[AdF35 Genscript Codon
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAC
CAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTACGAGGACGA
GAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCTAATGGCTTT
ACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTCTCACCACCA
CAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGGACGACACCG
ACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCAAGAACAACC
ACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAACAACAAGCTGT
GCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATCTGTATCAAGG
ACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATTGCCAGATCGT
GGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGGTTAAGAACGG
AGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATACAGTGAACCA
GATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTCGACTCCAGT
GGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAAAACAAGAGC
AGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATGCCTAGCACC
ACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTACATCCACGGC
ATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGAACATTAGCA
TCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCATCCAGTTCG
AGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCACACTGACCA
CATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGGTGGGAGCGG
CGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAG
TAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGAC
TATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAG
AAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC
SEQ ID NO: 832
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTG
GTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTG
AAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACC
TGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGA
GCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAG
TATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTC
AGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTC
ATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATA
GAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCC
TGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGG
GTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTAT
TGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGT
TGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACA
GACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 833
[00874] Construct pJAQ644 [VSV-G Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.2 Linker] -[ VS VGss TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTG
GTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTG
AAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACC
TGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGA
GCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAG
TATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTC
AGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTC
ATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATA
GAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCC
TGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGA
GCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAG
AAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGG
TTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATT
AAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGG
AAAGGTC SEQ ID NO: 834
[00875] Construct pJAQ645 [VSV-G Signal Peptide]-[SCF soluble Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACA
GCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAG
AGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGT
TCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGA
CTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCT
GAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGC
TCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTC
CGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTT
ATACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 835
[00876] Construct pJAQ646 [VSV-G Signal Peptide]-[SCF soluble Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGGTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGTTCAGCAACATTTCTGAAGGCCTGAGCAATTACA
GCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAAG
AGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTGT
TCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGGA
CTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCCT
GAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTT
GTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAGGTC SEQ ID NO: 836
[00877] Construct pJAQ647 [VSV-G Signal Peptide]-[SCF mutant (V49L/F63L)
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGG
TGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGA
AGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCT
GGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAG
CCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGT
ATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCA
GCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCA
TGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAG
AAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCT
GCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGG
GTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTAT
TGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGT
TGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACA
GACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 837
[00878] Construct pJAQ648 [VSV-G Signal Peptide]-[SCF mutant (V49L/F63L)
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGG
TGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGA
AGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCT
GGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAG
CCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGT
ATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCA
GCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCA
TGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAG
AAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCT
GCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGA
GCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAG
AAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGG
TTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATT
AAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGG
AAAGGTC SEQ ID NO: 838
[00879] Construct pJAQ649 [VSV-G Signal Peptide]-[SCF soluble mutant
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTAC
AGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAA
GAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTG
TTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGG
ACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCC
TGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGC
TCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTC
CGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTT
ATACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 839
[00880] Construct pJAQ650 [VSV-G Signal Peptide]-[SCF soluble mutant
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTAC
AGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGAAA
GAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTG
TTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGG
ACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCC
TGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTT
GTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAGGTC SEQ ID NO: 840
[00881] Construct pJAQ651 [VSV-G Signal Peptide]-[SCF mutant (V49L/F63L/K91E) Targeting Domain] -[VSVGss TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGG
TGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGA
AGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCT
GGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAG
CCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGT
ATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCA
GCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCA
TGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAG
AAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCT
GCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGG
GTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTAT
TGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGT
TGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACA
GACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 841
[00882] Construct pJAQ652 [VSV-G Signal Peptide]-[SCF soluble mutant (V49L/F63L/K91E) Targeting Domain] -[VSVGss TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTAC
AGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAG
GAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTG
TTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGG
ACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCC
TGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGC
TCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTC
CGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTT
ATACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 842
[00883] Construct pJAQ653 [VSV-G Signal Peptide]-[SCF soluble mutant
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTAC
AGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAG
GAGAACAGCTCCAAGGACCTGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTG
TTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGG
ACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCC
TGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTT
GTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAGGTC SEQ ID NO: 843
[00884] Construct pJAQ654 [VSV-G Signal Peptide]-[SCF mutant
(V49L/F63L/K91E/I98R) Targeting Domain]-[VSVGss TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGG
TGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGA
AGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCT
GGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCGGAAAAAGTCTTTCAAGAG
CCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGT
ATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCA
GCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCA
TGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAG
AAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCT
GCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGG
GTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTAT
TGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGT
TGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACA
GACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 844
[00885] Construct pJAQ655 [VSV-G Signal Peptide]-[SCF mutant
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCAA
AAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCTGTTTAAC
CCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAG
GACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCACCCTGAAG
TACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGG
TGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGA
AGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTGGACGACCT
GGTTGAGTGCGTGGAGGAGAACAGCTCCAAGGACCGGAAAAAGTCTTTCAAGAG
CCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGT
ATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCA
GCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCA
TGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGCTCTAATAG
AAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCTATGGCCCT
GCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTATTGGAAG
AAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAACGAGGA
AGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGGAGGTGA
GCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAG
AAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGG
TTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATT
AAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGG
AAAGGTC SEQ ID NO: 845
[00886] Construct pJAQ656 [VSV-G Signal Peptide]-[SCF soluble mutant
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGGCATCTGCAGAAATCGGGTGACCAACAACGTGAAGGACGTGACAAAGCTGGT
GGCTAATCTGCCCAAGGACTACATGATCACCCTGAAGTACGTGCCTGGCATGGA
CGTGCTGCCCAGCCACTGTTGGATCAGCGAGATGCTGGTGCAGCTGAGCGATTCT
CTGACAGATCTGCTGGACAAGCTGAGCAACATTTCTGAAGGCCTGAGCAATTAC
AGCATCATCGACAAGCTGGTCAACATCGTGGACGACCTGGTTGAGTGCGTGGAG
GAGAACAGCTCCAAGGACCGGAAAAAGTCTTTCAAGAGCCCCGAGCCAAGACTG
TTCACCCCTGAGGAATTCTTCAGAATCTTCAACCGGAGTATCGACGCCTTTAAGG
ACTTCGTGGTGGCCTCTGAGACATCTGATTGCGTGGTCAGCAGCACCCTGTCCCC
TGAAAAGGATAGCAGAGTGTCCGTGACCAAGCCATTCATGCTGCCTCCTGTGGCC
GCCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTT
GTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAGGTC SEQ ID NO: 846
[00887] Construct pJAQ659 [VSV-G Signal Peptide] -[TPO- 171 Targeting Domain] -
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GCTGACCGAGCTGCTGCTGGTCGTTATGCTGCTGCTTACAGCCAGACTGACACTG
TCCAGCCCTGCCCCTCCAGCATGCGACCTGAGGGTGCTGAGCAAGCTGCTGAGA
GATAGCCACGTGCTGCACTCTAGACTGTCTCAGTGCCCCGAGGTGCACCCTCTGC
CCACCCCTGTGCTGCTCCCCGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCA
GATGGAAGAAACCAAGGCCCAGGATATCCTGGGCGCTGTGACCCTGCTGCTGGA
AGGCGTGATGGCCGCTAGAGGACAACTGGGACCTACCTGTCTGAGCAGCCTGCT
GGGCCAGCTGTCCGGCCAAGTGCGGCTGCTGCTGGGCGCCCTGCAGAGCCTGCT
CGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCATAAGGACCCCAACGC
CATCTTCCTGAGCTTTCAGCACCTGCTGCGGGGCAAAGTGCGGTTCCTGATGCTG
GTGGGCGGATCTACACTGGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCA
GTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGA
CTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAA
GAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC
SEQ ID NO: 847
[00888] Construct pJAQ660 [VSV-G Signal Peptide]- [CD 117 scFv 54 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTCCAGCTGGTGCAAAGTGGAGCAGAAGTCAAGAAACCCGGAAGCTCAGTCAA
AGTGTCTTGCAAAGCTAGCGGAGGCACGTTCTCAAGTTATGCCATATCCTGGGTG
CGCCAAGCGCCCGGCCAAGGCTTGGAATGGATGGGTGGTATAATACCGATTTTT
GGGACAGCGAATTATGCACAGAAGTTTCAAGGTAGAGTGACGATTACGGCGGAT
GAAAGTACATCCACGGCGTACATGGAGCTGTCCAGTCTGCGGTCAGAAGACACA
GCCGTATATTACTGCGCGCGAGGAGGGCTCGATACGGACGAATTTGATCTGTGG
GGGCGGGGGACCTTGGTCACAGTAAGTAGCGGGGGAGGAGGCTCTGGCGGTGGC
GGTTCAGGTGGAGGAGGATCCGACATTCAGATGACTCAATCCCCTTCCTCCCTGA
GTGCCTCCGTCGGGGACAGAGTAACGATTACCTGTAGGGCCAGCCAAAGTATTA
ACAGCTACCTGAATTGGTATCAGCAGAAGCCCGGCAAAGCCCCGAAGCTCTTGA
TATACGCCGCGTCCTCCTTGCAAAGTGGGGTGCCGTCTAGATTCAGCGGTAGCGG
TAGTGGAACGGATTTTACGCTTACTATATCTAGTCTTCAACCGGAGGATTTTGCT
ACTTATTATTGTCAACAAGGAGTGTCCGATATCACGTTTGGCGGTGGGACAAAGG
TGGAAATTAAAGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTG
GAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCT
TGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAG
ACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 848
[00889] Construct pJAQ661 [VSV-G Signal Peptide]- [CD 117 scFv 57 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTCCAACTTGTACAATCTGGTGCGGAGGTCAAGAAACCGGGTAGCTCCGTTAA
GGTCTCATGCAAAGCAAGCGGTGGCACTTTCAGTTTGTATGCGATCTCTTGGGTG
CGGCAAGCGCCAGGACAAGGTCTGGAATGGATGGGTGGGATAATACCTCATTTT
GGACTCGCGAATTATGCACAAAAGTTTCAAGGTAGAGTTACAATAACCGCGGAT
GAAAGTACCTCCACCGCATACATGGAGTTGTCAAGCCTTAGGAGTGAGGACACA
GCCGTTTATTACTGTGCCCGAGGCGGATTGGACACTGATGAATTTGACTTGTGGG
GGAGAGGCACACTCGTAACAGTCAGTAGTGGGGGAGGCGGCTCCGGAGGCGGC
GGTTCTGGCGGCGGAGGTTCCGATATTCAAATGACCCAGAGTCCAAGTAGTCTTT
CCGCATCCGTAGGTGACAGAGTGACTATAACATGCAGGGCATCACAATCCATCA
ACTCTTATCTGAACTGGTACCAACAAAAACCAGGTAAAGCTCCTAAGCTGCTCAT
ATATGCAGCAAGTTCCCTCCAGAGCGGAGTCCCCTCTCGGTTTTCTGGTTCCGGA
AGCGGAACAGATTTTACGCTCACTATAAGTAGCCTTCAACCTGAGGACTTCGCAA
CATATTACTGTCAACAAGGCGTTTCTGACATCACCTTCGGGGGCGGCACCAAGGT
CGAGATAAAAAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAA
TCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTC
TTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCT
TTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGAT
GAACCGACTTGGAAAGGTC SEQ ID NO: 849
[00890] Construct pJAQ662 [VSV-G Signal Peptide]- [CD 117 scFv 67 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTTCAGCCCGGCGGAAGCCTGCG
GCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACGCCGACATGGACTGGGT
GCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGGCCGCACCAGAAACAAGG
CCGGCTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGATTCACAATTTC
TAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAATTCCCTGAAGACCGA
GGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTACTGGATCGACTTCGA
CCTGTGGGGCAGAGGCACACTGGTGACAGTGTCCTCCGGCGGAGGTGGCTCTGG
AGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATGACCCAGAGCCCCAG
CAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCACATGCAGAGCCTCCCA
GTCTATCAGCAGCTACCTGAACTGGTACCAGCAGAAGCCCGGCAAAGCCCCTAA
GCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCGGCGTGCCTAGCCGGTTCAGC
GGCAGCGGCAGCGGTACAGACTTTACCCTGACCATCAGCTCCCTGCAGCCTGAG
GATTTCGCCACCTACTATTGTCAGCAAAGCTACATCGCCCCATACACCTTTGGCG
GCGGAACCAAGGTGGAAATCAAGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGC
GGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTA
TTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAG
TTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATAC
AGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 850
[00891] Construct pJAQ664 [VSV-G Signal Peptide]-[TPO-157 Targeting Domain]-
ACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACCGCCAGACTGACCCTG
AGCAGCCCCGCCCCTCCTGCCTGCGATCTGCGGGTGCTGTCTAAACTGCTGCGGG
ACAGCCACGTGCTGCATTCTAGACTGAGCCAGTGTCCTGAGGTGCACCCCCTGCC
CACCCCTGTGCTGCTGCCCGCTGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAA
ATGGAAGAGACAAAGGCCCAAGACATCCTGGGCGCCGTGACCCTGCTGCTGGAA
GGCGTGATGGCCGCTAGAGGCCAGCTGGGCCCTACATGCCTGTCCAGCCTCCTGG
GACAGCTGTCCGGCCAGGTGCGGCTGCTGCTTGGAGCCCTGCAGAGCCTGCTGG
GCACACAGCTGCCACCTCAGGGCAGAACCACAGCCCACAAGGATCCTAACGCCA
TCTTCCTGAGCTTTCAGCACCTGCTGAGAAGCGGTGGGAGCGGCGGGAGCGGTG
GGAGCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAA
GCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTC
TCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGAT
TTATACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 851
[00892] Construct pJAQ665 [VSV-G Signal Peptide] -[TPO- 163 Targeting Domain]-
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
ACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACAGCCCGCCTGACACTG
AGCAGCCCTGCCCCTCCAGCCTGCGATCTGAGAGTGCTGAGCAAACTGCTGAGA
GATAGCCACGTGCTGCACAGCAGACTGTCTCAGTGCCCCGAGGTGCACCCCCTGC
CCACCCCTGTGCTGCTGCCTGCCGTGGACTTCAGCCTGGGAGAGTGGAAGACCCA
AATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCTGCTGCTGGA
AGGCGTGATGGCCGCTAGAGGCCAGCTGGGACCTACCTGTCTGTCCAGCCTGCTT
GGCCAGCTCTCCGGCCAAGTGCGGCTGCTGCTGGGAGCTCTGCAGAGCCTGCTG
GGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCATAAGGACCCCAACGCC
ATCTTCCTGTCTTTTCAGCACCTGCTGCGGGGCAAGGTGCGGTTCCTGGGTACCA
ATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTC
TTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTAT
CCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACAT
AGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 852
[00893] Construct pJAQ666 [VSV-G Signal Peptide]- [CD 117 scFv 55 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTTCAGTTGGTTCAGTCCGGCGCTGAAGTTAAAAAGCCCGGAAGCAGTGTAAA
GGTCTCCTGCAAGGCCAGTGGCGGGACATTCCGAATTTACGCCATCTCATGGGTC
CGACAGGCTCCAGGACAAGGACTTGAGTGGATGGGTGGTATTATACCAGACTTC
GGGGTTGCCAATTACGCACAAAAATTCCAGGGACGAGTAACTATAACTGCGGAT
GAATCAACCTCTACGGCTTATATGGAGCTCTCATCCTTGCGGTCAGAAGACACGG
CCGTGTATTATTGTGCAAGGGGCGGACTCGACACCGATGAGTTTGATCTTTGGGG
CAGAGGTACTCTGGTGACTGTTAGTAGCGGGGGTGGAGGCTCTGGCGGAGGGGG
AAGTGGCGGAGGAGGGAGCGACATCCAAATGACTCAATCACCTAGCTCACTTAG
CGCAAGCGTTGGCGACCGCGTCACTATTACCTGTCGCGCGTCACAATCTATCAAC
TCATATCTGAATTGGTATCAACAAAAGCCTGGTAAGGCCCCTAAGCTTCTTATTT
ATGCAGCCAGTAGCCTTCAATCCGGCGTCCCAAGTCGATTCTCCGGGAGTGGAA
GTGGTACAGATTTTACCCTGACCATAAGCAGTTTGCAGCCGGAAGACTTTGCTAC
CTATTATTGCCAACAGGGGGTCTCCGATATTACTTTCGGGGGAGGCACCAAAGTG
GAAATCAAGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAAT
CGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCT
TTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTT
TGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATG
AACCGACTTGGAAAGGTC SEQ ID NO: 945
[00894] Construct pJAQ683 [VSV-G Signal Peptide]- [CD 117 scFv 4k94 Targeting Domain]-[VSVG TM tail TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTGAGGT
GCAGCTGGTCGAGAGCGGAGGCGGCCTGGTGCAGCCAGGCGGATCTCTGAGACT
GAGCTGCGCCGCCTCTGGCTTCAATATCAGCAGCTACAGCATGCACTGGGTGCGG
CAGGCCCCTGGCAAAGGCCTGGAATGGGTCGCCAGCATCTATCCTTACAGCGGC
TACACCTACTACGCCGACAGCGTGAAGGGCAGATTCACAATTAGCGCCGATACC
AGCAAGAACACCGCTTACCTGCAGATGAACAGCCTGCGGGCCGAGGACACCGCC
GTGTACTACTGCGCCAGATACGTGTACCACGCCCTGGACTACTGGGGCCAGGGC
ACACTGGTGACCGTGTCCAGCGGCGGCGGCGGATCTGGAGGCGGCGGTTCCGGA
GGAGGCGGCAGCGACATCCAGATGACCCAGTCTCCTAGCTCCCTGTCTGCTAGCG
TGGGCGACAGGGTGACCATCACCTGTAGAGCCAGCCAGAGCGTGTCTAGCGCTG
TTGCTTGGTATCAGCAAAAACCTGGCAAGGCCCCTAAGCTGCTGATCTACTCCGC
CAGTTCTCTGTACTCCGGCGTGCCCAGCCGGTTCAGCGGCTCTAGAAGCGGAACA
GATTTTACCCTGACCATCAGCAGCCTCCAGCCCGAGGATTTCGCCACATACTATT
GCCAGCAGTGGGCCGTGCACAGCCTGATCACATTCGGCCAAGGCACCAAGGTGG
AAATCAAGACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAA
GCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTC
TCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGAT
TTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 853
[00895] Construct pJAQ737 [VSV-G Signal Peptide]-[TPO-157 Targeting Domain]-
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
ACTGACCGAGCTGCTGCTGGTCGTGATGCTGCTGCTCACCGCCAGACTGACCCTG
AGCAGCCCCGCCCCTCCTGCCTGCGATCTGCGGGTGCTGTCTAAACTGCTGCGGG
ACAGCCACGTGCTGCATTCTAGACTGAGCCAGTGTCCTGAGGTGCACCCCCTGCC
CACCCCTGTGCTGCTGCCCGCTGTGGACTTCAGCCTGGGCGAGTGGAAGACCCAA
ATGGAAGAGACAAAGGCCCAAGACATCCTGGGCGCCGTGACCCTGCTGCTGGAA
GGCGTGATGGCCGCTAGAGGCCAGCTGGGCCCTACATGCCTGTCCAGCCTCCTGG
GACAGCTGTCCGGCCAGGTGCGGCTGCTGCTTGGAGCCCTGCAGAGCCTGCTGG
GCACACAGCTGCCACCTCAGGGCAGAACCACAGCCCACAAGGATCCTAACGCCA
TCTTCCTGAGCTTTCAGCACCTGCTGAGAGGTACCAATCCAATCGAGCTTGTAGA
AGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGT
TAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTA
AAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGA
AAGGTC SEQ ID NO: 854
[00896] Construct pJAQ738 [VSV-G Signal Peptide] -[TPO- 163 Targeting Domain]-
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GCTGACCGAGCTGCTGCTGGTCGTTATGCTGCTGCTTACAGCCAGACTGACACTG
TCCAGCCCTGCCCCTCCAGCATGCGACCTGAGGGTGCTGAGCAAGCTGCTGAGA
GATAGCCACGTGCTGCACTCTAGACTGTCTCAGTGCCCCGAGGTGCACCCTCTGC
CCACCCCTGTGCTGCTCCCCGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCA
GATGGAAGAAACCAAGGCCCAGGATATCCTGGGCGCTGTGACCCTGCTGCTGGA
AGGCGTGATGGCCGCTAGAGGACAACTGGGACCTACCTGTCTGAGCAGCCTGCT
GGGCCAGCTGTCCGGCCAAGTGCGGCTGCTGCTGGGCGCCCTGCAGAGCCTGCT
CGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCATAAGGACCCCAACGC
CATCTTCCTGAGCTTTCAGCACCTGCTGCGGGGCAAAGTGCGGTTCCTGAGCGGT
GGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTTGTAGAAGGT
TGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAAT
CATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGC
ACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAG
GTC SEQ ID NO: 855
[00897] Construct pJAQ739 [VSV-G Signal Peptide] -[TPO- 171 Targeting Domain] - [SGGSx3.2 Linker] -[ VS VGss TM]
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GCTGACCGAGCTGCTGCTGGTCGTTATGCTGCTGCTTACAGCCAGACTGACACTG
TCCAGCCCTGCCCCTCCAGCATGCGACCTGAGGGTGCTGAGCAAGCTGCTGAGA
GATAGCCACGTGCTGCACTCTAGACTGTCTCAGTGCCCCGAGGTGCACCCTCTGC
CCACCCCTGTGCTGCTCCCCGCCGTGGACTTCAGCCTGGGCGAGTGGAAGACCCA
GATGGAAGAAACCAAGGCCCAGGATATCCTGGGCGCTGTGACCCTGCTGCTGGA
AGGCGTGATGGCCGCTAGAGGACAACTGGGACCTACCTGTCTGAGCAGCCTGCT
GGGCCAGCTGTCCGGCCAAGTGCGGCTGCTGCTGGGCGCCCTGCAGAGCCTGCT
CGGCACACAGCTGCCTCCTCAGGGCAGAACCACCGCCCATAAGGACCCCAACGC
CATCTTCCTGAGCTTTCAGCACCTGCTGCGGGGCAAAGTGCGGTTCCTGATGCTG
GTGGGCGGATCTACACTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTAC
CAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCC
TCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGT
ATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGAC
ATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 856
[00898] Construct pJAQ740 [VSV-G Signal Peptide]- [CD 117 scFv 2D1 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
TATTGTGATGACCCAGAGCCATAAGTTCATGAGCACCAGCGTGGGCGATAGAGT
GTCCATCACCTGCAAGGCCTCTCAGGACGTGTCTACAACCGTGGCCTGGTACCAG
CAGAAACCTGGCCAGAGCCCTAAGCTGCTGATCTACTCTGCCAGCTACAGATATA
CCGGCGTGCCCGACAGATTCACAGGCAGCGGCTCCGGCACAGACTTCACCTTCA
CCATCAGCAGCGTGCAGGCCGAAGATCTGGCCGTTTACTACTGCCAGCAACACT
ACAGCACACCTCCAACATTCGGCGGCGGCACCAAGCTGGAAATCAAAGGCGGTG
GAGGCAGCGGAGGCGGAGGCTCTGGCGGCGGCGGCAGCCAAGTGCAACTCCAG
CAGAGTGATGCCGAGCTGGTGAAGCCTGGAGCTTCTGTGAAGATCAGCTGCAAA
GCTTCTGGCTACACCTTTACCGACCACGCCATCCACTGGGTCAAGCAGCGGCCCG
AGCAGGGCCTGGAATGGATCGGCTGTATCTCCCCTGGAAATGGCGACATCAAGT
ACAACGAGAAGTTTAAGGGCAAGGCTACACTGAGCGCCGACAAAAGCTCTAGCA
CCGCCTACATGCAGCTGAACAGCCTGACAAGCGAGGACAGCGCCGTGTATTTCT
GCAAGCGGTGGGACTACTTCGACTACTGGGGCCAGGGAACCACCCTGACCGTGT
CCAGCAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAG
CTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTAT
CATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCA
TTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACC
GACTTGGAAAGGTC SEQ ID NO: 857
[00899] Construct pJAQ741 [VSV-G Signal Peptide]- [CD 117 scFv 2D2 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTGCAGCTGCAGCAGAGCGACGCCGAGCTGGTGAAGCCCGGAGCCTCCGTGAA
GATCTCCTGCAAGGCTAGCGGCTACACCTTCACCGACCATGCCATCCACTGGGTG
AAACAGCGGCCTGAGCAGGGCCTGGAATGGATCGGATGTATCAGCCCCGGCAAC
GGCGACATCAAATACAATGAGAAGTTCAAGGGCAAGGCTACACTGTCTGCCGAC
AAGAGCAGCAGCACCGCCTACATGCAGCTGAACAGCCTCACCAGCGAGGACAGC
GCCGTTTACTTCTGCAAGCGGTGGGACTACTTTGATTATTGGGGACAAGGCACCA
CCCTGACAGTGAGCTCTGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTG
GCGGATCAGATATTGTGATGACCCAGAGCCACAAGTTCATGAGCACAAGCGTCG
GAGATAGAGTGTCTATCACATGCAAAGCTTCTCAGGACGTGTCCACCACCGTGGC
CTGGTATCAGCAGAAACCTGGCCAGTCTCCTAAGCTGCTGATCTACAGCGCCAGC
TACAGATACACAGGCGTGCCAGACAGATTCACCGGCTCTGGTAGCGGCACAGAC
TTCACCTTCACCATCTCTAGCGTGCAGGCCGAAGATCTGGCCGTGTACTACTGCC
AGCAACACTACAGCACCCCTCCTACCTTTGGCGGAGGCACAAAGCTGGAAATCA
AGGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCT
CTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCC
GAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTA
TACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 858
[00900] Construct pJAQ742 [VSV-G Signal Peptide]- [CD 117 scFv 2D2 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTGCAGCTGCAGCAGAGCGACGCCGAGCTGGTGAAGCCCGGAGCCTCCGTGAA
GATCTCCTGCAAGGCTAGCGGCTACACCTTCACCGACCATGCCATCCACTGGGTG
AAACAGCGGCCTGAGCAGGGCCTGGAATGGATCGGATGTATCAGCCCCGGCAAC
GGCGACATCAAATACAATGAGAAGTTCAAGGGCAAGGCTACACTGTCTGCCGAC
AAGAGCAGCAGCACCGCCTACATGCAGCTGAACAGCCTCACCAGCGAGGACAGC
GCCGTTTACTTCTGCAAGCGGTGGGACTACTTTGATTATTGGGGACAAGGCACCA
CCCTGACAGTGAGCTCTGGCGGAGGTGGCTCTGGAGGCGGTGGATCTGGTGGTG
GCGGATCAGATATTGTGATGACCCAGAGCCACAAGTTCATGAGCACAAGCGTCG
GAGATAGAGTGTCTATCACATGCAAAGCTTCTCAGGACGTGTCCACCACCGTGGC
CTGGTATCAGCAGAAACCTGGCCAGTCTCCTAAGCTGCTGATCTACAGCGCCAGC
TACAGATACACAGGCGTGCCAGACAGATTCACCGGCTCTGGTAGCGGCACAGAC
TTCACCTTCACCATCTCTAGCGTGCAGGCCGAAGATCTGGCCGTGTACTACTGCC
AGCAACACTACAGCACCCCTCCTACCTTTGGCGGAGGCACAAAGCTGGAAATCA
AGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCAATCGAGCTT
GTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCAT
AGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTA
AATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGAC
TTGGAAAGGTC SEQ ID NO: 859
[00901] Construct pJAQ749 [VSV-G Signal Peptide]- [CD 117 SRI scFv Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTGCAGCTGCAGCAGCCTGGAGCCGAGCTGGTGAAACCTGGCGCCAGCGTGAA
GATGAGCTGCAAGGCCTCCGGTTATACATTCACCTCCTACAACATGCACTGGGTC
AAACAGACCCCTGGCCAGGGCCTCGAGTGGATCGGCGTGATCTACAGCGGCAAC
GGAGATACCAGCTACAACCAGAAATTCAAGGGCAAGGCCACCCTGACCGCCGAC
AAGTCCAGCAGCACCGCCTACATGCAGATCAACAGCCTGACCAGCGAGGATAGC
GCCGTGTACTATTGCGCCAGAGAGCGGGACACCAGATTTGGAAATTGGGGCCAA
GGCACCCTGGTTACAGTGTCTGCCGCTAAGACCACCGGCGGAGGTGGCTCTGGA
GGCGGTGGATCTGGTGGTGGCGGATCAATCGTGCTGACACAGAGCCCTGCTTCTC
TGGCCGTGTCCCTGGGCCTGCGGGCCACAATTAGCTGTAGAGCCTCTGAGAGCGT
GGACATCTACGGCAATAGCTTCATGCACTGGTACCAGCAAAAGCCTGGCCAGCC
CCCCAAGCTGCTGATCTACCTGGCTAGCAACCTGGAAAGCGGCGTGCCAGCTAG
GTTCAGCGGAAGCGGCTCTAGAACCGACTTCACACTGACCATCGACCCTGTGGA
AGCCGATGACGCCGCCACATACTACTGCCAGCAGAACAACGAGGACCCCTACAC
CTTTGGCGGCGGAACAAAGCTGGAAATCAAGAGCGGTGGGAGCGGCGGGAGCG
GTGGGAGCGGTACCAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGA
AAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTG
GTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGAC
AGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGTC SEQ ID NO: 860
[00902] Construct pJAQ750 [VSV-G Signal Peptide]- [CD 117 scFv 54 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCCA
AGTCCAGCTGGTGCAAAGTGGAGCAGAAGTCAAGAAACCCGGAAGCTCAGTCAA
AGTGTCTTGCAAAGCTAGCGGAGGCACGTTCTCAAGTTATGCCATATCCTGGGTG
CGCCAAGCGCCCGGCCAAGGCTTGGAATGGATGGGTGGTATAATACCGATTTTT
GGGACAGCGAATTATGCACAGAAGTTTCAAGGTAGAGTGACGATTACGGCGGAT
GAAAGTACATCCACGGCGTACATGGAGCTGTCCAGTCTGCGGTCAGAAGACACA
GCCGTATATTACTGCGCGCGAGGAGGGCTCGATACGGACGAATTTGATCTGTGG
GGGCGGGGGACCTTGGTCACAGTAAGTAGCGGGGGAGGAGGCTCTGGCGGTGGC
GGTTCAGGTGGAGGAGGATCCGACATTCAGATGACTCAATCCCCTTCCTCCCTGA
GTGCCTCCGTCGGGGACAGAGTAACGATTACCTGTAGGGCCAGCCAAAGTATTA
ACAGCTACCTGAATTGGTATCAGCAGAAGCCCGGCAAAGCCCCGAAGCTCTTGA
TATACGCCGCGTCCTCCTTGCAAAGTGGGGTGCCGTCTAGATTCAGCGGTAGCGG
TAGTGGAACGGATTTTACGCTTACTATATCTAGTCTTCAACCGGAGGATTTTGCT
ACTTATTATTGTCAACAAGGAGTGTCCGATATCACGTTTGGCGGTGGGACAAAGG
TGGAAATTAAAAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCGGTACCAATCCA
ATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTT
CTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATC
TTTGCATTAAATTAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGA
TGAACCGACTTGGAAAGGTC SEQ ID NO: 861
[00903] Construct pJAQ751 [VSV-G Signal Peptide]- [CD 117 scFv 61 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGTGCAGCTGCTGGAAAGCGGAGGCGGCCTGGTGCAGCCTGGCGGCTCTCTGCG
GCTGTCTTGCGCCGCTAGCGGCTTCACATTTAGCAGCTACGTGATGATCTGGGTT
AGACAGGCCCCTGGAAAAGGACTGGAGTGGGTCTCCTCTATCAGCGGCGATAGC
GTCACCACCTACTATGCCGACAGCGTGAAGGGCAGATTTACAATTAGCAGAGAT
AACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCGAGGACACC
GCCGTGTACTACTGCGCCAAGGGCCCTCCAACCTACCACACAAACTACTACTACA
TGGACGTGTGGGGCAAAGGCACCACAGTGACCGTGTCCAGCGGCGGCGGAGGCT
CTGGAGGCGGCGGCAGCGGCGGAGGAGGCAGCGACATCCAGATGACCCAGAGC
CCTAGCTCCGTGTCCGCCTCTGTGGGCGACAGAGTGACAATCACCTGCAGAGCCA
GCCAGGGTATCAGCTCTTGGCTGGCCTGGTACCAGCAAAAGCCTGGCAAGGCCC
CTAAGCTGCTGATCTACGCTGCTTCTAGCCTGCAAAGCGGAGTGCCCAGCCGGTT
CAGCGGCAGCGGCAGCGGCACTGATTTCACCCTGACAATCTCTTCCCTCCAGCCC
GAGGACTTCGCCACCTACTATTGTCAGCAGACCAATAGCTTCCCCTACACCTTCG
GCGGCGGCACAAAGGTGGAAATCAAGGGTACCAATCCAATCGAGCTTGTAGAAG
GTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTA
ATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAA
GCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAA
GGTC SEQ ID NO: 862
[00904] Construct pJAQ752 [VSV-G Signal Peptide]- [CD 117 scFv 67 Targeting
ATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGCGGTACCGA
GGTGCAGCTGGTGGAAAGCGGCGGAGGCCTGGTTCAGCCCGGCGGAAGCCTGCG
GCTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCGACGCCGACATGGACTGGGT
GCGGCAGGCCCCTGGAAAAGGCCTGGAATGGGTCGGCCGCACCAGAAACAAGG
CCGGCTCTTATACAACCGAGTACGCTGCTTCTGTGAAGGGCAGATTCACAATTTC
TAGAGATGACAGCAAGAACAGCCTGTACCTGCAAATGAATTCCCTGAAGACCGA
GGACACCGCCGTGTACTACTGCGCCAGAGAGCCTAAGTACTGGATCGACTTCGA
CCTGTGGGGCAGAGGCACACTGGTGACAGTGTCCTCCGGCGGAGGTGGCTCTGG
AGGCGGTGGATCTGGTGGTGGCGGATCAGATATCCAGATGACCCAGAGCCCCAG
CAGCCTCAGCGCCAGCGTGGGAGATAGAGTGACCATCACATGCAGAGCCTCCCA
GTCTATCAGCAGCTACCTGAACTGGTACCAGCAGAAGCCCGGCAAAGCCCCTAA
GCTGCTGATCTACGCCGCTTCTTCTCTGCAGAGCGGCGTGCCTAGCCGGTTCAGC
GGCAGCGGCAGCGGTACAGACTTTACCCTGACCATCAGCTCCCTGCAGCCTGAG
GATTTCGCCACCTACTATTGTCAGCAAAGCTACATCGCCCCATACACCTTTGGCG
GCGGAACCAAGGTGGAAATCAAGGGTACCAATCCAATCGAGCTTGTAGAAGGTT
GGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATC
ATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCA
CACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTGGAAAGGT
C SEQ ID NO: 863
[00905] Construct pJAQ782 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [SGGSx3.1 Linker]-[CD8a trunc Hinge]-[CD162 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCGTGTGCACC
GTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTGTGCGGAAC
SEQ ID NO: 864
[00906] Construct pJAQ783 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [SGGSx3.1 Linker]-[CD8a trunc Hinge]-[CD62L TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTT
ATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGG
SEQ ID NO: 865
[00907] Construct pJAQ784 [CD8a Signal Peptide] -[CXCL 12 Targeting Domain]- [SGGSx3.1 Linker]-[CD8a trunc Hinge]-[ICAM1 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTG
CCTCAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTC
GAAAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCA
AACTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGC
ATTGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAG
AGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCA
CCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCT
GTATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCT
GAGCACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTG
SEQ ID NO: 866
[00908] Construct pJAQ785 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTGGC
ATGCTGCCTGTGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCC
TGCTGCTGCTGTGGCGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 867
[00909] Construct pJAQ786 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTCCT
CTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCCTGGCTTTTATCAT
CTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGCGG SEQ ID
NO: 868
[00910] Construct pJAQ787 [CD8a Signal Peptide] -[AdF35 Genscript Codon
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTACCAAAAGAGTGCGGCTGTCTGATAGCTTCAATCCTGTGTACCCCTA
CGAGGACGAGAGCACCTCCCAGCACCCCTTCTACAACCCCGGCTTCATCAGCCCT
AATGGCTTTACCCAAAGCCCAGATGGCGTGCTGACCCTGAAGTGCCTGACCCCTC
TCACCACCACAGGCGGCTCCCTGCAACTGAAGGTGGGCGGAGGACTGACCGTGG
ACGACACCGACGGCACACTGCAGGAGAACATCAGAGCCACCGCCCCTATCACCA
AGAACAACCACAGCGTGGAACTGAGCATCGGCAACGGCCTGGAAACCCAGAAC
AACAAGCTGTGCGCCAAGCTGGGCAATGGCCTGAAGTTCAACAACGGAGATATC
TGTATCAAGGACTCTATCAACACCCTGTGGACCGGAATCAACCCTCCACCTAATT
GCCAGATCGTGGAAAACACCAATACCAACGACGGCAAGCTGACACTCGTGCTGG
TTAAGAACGGAGGCCTGGTCAACGGCTACGTGTCCCTGGTCGGCGTGTCCGATAC
AGTGAACCAGATGTTCACACAGAAGACCGCTAATATTCAGCTGAGACTGTATTTC
GACTCCAGTGGCAACCTGCTGACAGAGGAATCTGACCTGAAAATCCCCCTGAAA
AACAAGAGCAGCACCGCCACATCTGAGACAGTGGCCAGCAGCAAGGCCTTCATG
CCTAGCACCACAGCTTATCCTTTTAACACCACCACACGGGACAGCGAGAACTAC
ATCCACGGCATCTGCTACTACATGACCAGCTACGACAGAAGCCTGTTCCCCCTGA
ACATTAGCATCATGCTGAACAGCAGGATGATCAGCAGCAACGTGGCTTACGCCA
TCCAGTTCGAGTGGAACCTGAACGCCAGCGAGAGCCCTGAGTCTAATATCGCCA
CACTGACCACATCTCCTTTTTTCTTCAGCTACATCACCGAAGATGACAACAGCGG
TGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCTAC
ACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAAC
GTGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATCATCATTGGAACAA
TCTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAGCGGAGAGGCCCTC
TG SEQ ID NO: 869
[00911] Construct pJAQ788 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a trunc Hinge]-[CD162 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTC
GTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCT
GTGCGGAAC SEQ ID NO: 870
[00912] Construct pJAQ789 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a trunc Hinge]-[CD49d.2 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCT
GCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAA
GTCC SEQ ID NO: 871
[00913] Construct pJAQ790 [CD8a Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a trunc Hinge]-[CD62L TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCT
CCTGTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAA
CAACGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGAT
CACCCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGC
GAGATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGC
AACATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATC
GTGGACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAG
TCTTTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCT
TCAACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGA
TTGCGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGAC
CAAGCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGC
AGCTCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCC
GCTATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCT
GTATTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGAT
TAACGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTC
AGGAGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCC
CCCAGACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGC
CCGAGGCCTGTCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGG
CCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAA
GCGG SEQ ID NO: 872
[00914] Construct pJAQ791 [CD8a Signal Peptide]-[TPO Genscript Optimized
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTGAACTTACAGAACTGCTGCTGGTCGTGATGCTGCTGCTGACCGCCAG
GCTGACCCTGTCCAGCCCGGCTCCTCCAGCCTGCGACCTGCGGGTGCTGAGCAAG
CTGCTGAGAGATAGCCACGTGCTGCACTCCAGACTGTCTCAATGTCCTGAGGTGC
ACCCTCTGCCTACCCCTGTGCTGCTCCCTGCCGTGGACTTCAGCCTGGGCGAGTG
GAAGACCCAGATGGAAGAGACAAAGGCCCAGGACATCCTGGGCGCCGTGACCCT
GCTGCTTGAGGGCGTGATGGCCGCTCGGGGCCAGCTGGGACCTACCTGCCTGTCC
AGCCTGCTCGGACAGCTGAGTGGACAGGTGCGCCTGCTGCTGGGCGCCCTGCAG
AGCCTGCTGGGGACCCAACTCCCACCTCAGGGCAGAACAACCGCACATAAGGAC
CCCAACGCCATTTTCCTGAGCTTCCAGCACCTGCTGCGGGGCAAGGTGCGGTTTC
TGATGCTGGTGGGCGGCTCCACCCTGTGCGTGCGGAGAGCCCCTCCTACCACCGC
CGTGCCCAGCCGGACATCTCTGGTTCTCACCCTGAACGAGCTGCCTAATAGAACG
AGCGGCCTGCTGGAAACCAACTTCACCGCCAGCGCCAGAACCACAGGCTCTGGT
CTGCTGAAATGGCAGCAGGGCTTCAGAGCTAAAATCCCCGGCCTGCTGAACCAG
ACATCTAGAAGCCTTGATCAGATCCCTGGCTACCTGAACAGAATCCACGAGCTGC
TGAACGGCACCAGAGGCCTCTTCCCCGGACCCTCTAGAAGAACCCTGGGAGCTC
CTGATATCAGCAGCGGCACAAGCGACACCGGCAGCCTGCCACCTAACCTGCAAC
CTGGATATAGCCCCAGCCCCACTCACCCCCCCACAGGCCAGTACACCCTGTTTCC
TCTGCCTCCTACACTGCCAACACCCGTGGTCCAGCTGCACCCCCTGCTGCCTGAC
CCTAGCGCCCCTACCCCAACCCCCACCTCTCCTCTGCTGAATACCAGCTACACAC
ACAGCCAGAACCTGTCTCAGGAGGGCAGCGGTGGGAGCGGCGGGAGCGGCGGT
AGCACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCTACCATCGCCAGCC
AGCCTCTGTCCCTGCGGCCCGAGGCCTGTCTGCTGGCTATCCTGATCCTGGCCCT
GGTCGCCACAATCTTCTTCGTGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGA
AAGGGCCACATGTACCCTGTGCGGAAC SEQ ID NO: 873
[00915] Construct pJAQ792 [B2M Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker]-[CD49d.2 TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCA
GACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGA
GGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGAC
ATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGG
TGATCACCCTGTACTGCAGCGGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCT
GCTGGGCCTGATCGTGCTGCTGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTC
TTCAAAAAACAGTACAAGTCC SEQ ID NO: 874
[00916] Construct pJAQ793 [B2M Signal Peptide]-[SCF full Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge] -[SGGSxl Linker] -[HLA-DRA TM]
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGGTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGTTCAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCA
GACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGA
GGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGAC
ATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGG
TGATCACCCTGTACTGCAGCGGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGA
CCGTGAGCCTGGTCGGCATCATCATTGGAACAATCTTCATCATCAAGGGCCTGAG
AAAGAGCAACGCCGCTGAGCGGAGAGGCCCTCTG SEQ ID NO: 875
[00917] Construct pJAQ794 [B2M Signal Peptide]-[SCF mutant (V49L/F63L)
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAAAAAAACCCAGACCTGGATCCTGACATGCATCTACCTCCAACTGCTCCT
GTTTAACCCTCTGGTGAAGACCGAGGGCATCTGCAGAAATCGGGTGACCAACAA
CGTGAAGGACGTGACAAAGCTGGTGGCTAATCTGCCCAAGGACTACATGATCAC
CCTGAAGTACGTGCCTGGCATGGACGTGCTGCCCAGCCACTGTTGGATCAGCGA
GATGCTGGTGCAGCTGAGCGATTCTCTGACAGATCTGCTGGACAAGCTGAGCAA
CATTTCTGAAGGCCTGAGCAATTACAGCATCATCGACAAGCTGGTCAACATCGTG
GACGACCTGGTTGAGTGCGTGAAAGAGAACAGCTCCAAGGACCTGAAAAAGTCT
TTCAAGAGCCCCGAGCCAAGACTGTTCACCCCTGAGGAATTCTTCAGAATCTTCA
ACCGGAGTATCGACGCCTTTAAGGACTTCGTGGTGGCCTCTGAGACATCTGATTG
CGTGGTCAGCAGCACCCTGTCCCCTGAAAAGGATAGCAGAGTGTCCGTGACCAA
GCCATTCATGCTGCCTCCTGTGGCCGCCAGCTCCCTTAGAAACGACAGCAGCAGC
TCTAATAGAAAGGCCAAGAACCCCCCTGGAGATAGCAGCCTGCACTGGGCCGCT
ATGGCCCTGCCTGCCCTGTTCAGCCTGATCATCGGCTTCGCCTTCGGCGCTCTGTA
TTGGAAGAAAAGACAGCCTAGCCTGACCAGGGCCGTGGAAAACATCCAGATTAA
CGAGGAAGATAACGAGATCAGCATGCTGCAGGAGAAGGAACGGGAATTTCAGG
AGGTGAGCGGTGGGAGCGGCGGGAGCGGTGGGAGCATGAAGTGCCTTTTGTACT
TAGCCTTTTTATTCATTGGGGTGAATTGCAAGTTCACCATAGTTTTTCCACACAAC
CAAAAAGGAAACTGGAAAAATGTTCCTTCTAATTACCATTATTGCCCGTCAAGCT
CAGATTTAAATTGGCATAATGACTTAATAGGCACAGCCTTACAAGTCAAAATGCC
CAAGAGTCACAAGGCTATTCAAGCAGACGGTTGGATGTGTCATGCTTCCAAATG
GGTCACTACTTGTGATTTCCGCTGGTATGGACCGAAGTATATAACACATTCCATC
CGATCCTTCACTCCATCTGTAGAACAATGCAAGGAAAGCATTGAACAAACGAAA
CAAGGAACTTGGCTGAATCCAGGCTTCCCTCCTCAAAGTTGTGGATATGCAACTG
TGACGGATGCCGAAGCAGTGATTGTCCAGGTGACTCCTCACCATGTGCTGGTTGA
TGAATACACAGGAGAATGGGTTGATTCACAGTTCATCAACGGAAAATGCAGCAA
TTACATATGCCCCACTGTCCATAACTCTACAACCTGGCATTCTGACTATAAGGTC
AAAGGGCTATGTGATTCTAACCTCATTTCCATGGACATCACCTTCTTCTCAGAGG
ACGGAGAGCTATCATCCCTGGGAAAGGAGGGCACAGGGTTCAGAAGTAACTACT
TTGCTTATGAAACTGGAGGCAAGGCCTGCAAAATGCAATACTGCAAGCATTGGG
GAGTCAGACTCCCATCAGGTGTCTGGTTCGAGATGGCTGATAAGGATCTCTTTGC
TGCAGCCAGATTCCCTGAATGCCCAGAAGGGTCAAGTATCTCTGCTCCATCTCAG
ACCTCAGTGGATGTAAGTCTAATTCAGGACGTTGAGAGGATCCTGGATTATTCCC
TCTGCCAAGAAACCTGGAGCAAAATCAGAGCGGGTCTTCCAATCTCTCCAGTGG
ATCTCAGCTATCTTGCTCCTAAAAACCCAGGAACCGGTCCTGCTTTCACCATAAT
CAATGGTACCCTAAAATACTTTGAGACCAGATACATCAGAGTCGATATTGCTGCT
CCAATCCTCTCAAGAATGGTCGGAATGATCAGTGGAACTACCACAGAAAGGGAA
CTGTGGGATGACTGGGCACCATATGAAGACGTGGAAATTGGACCCAATGGAGTT
CTGAGGACCAGTTCAGGATATAAGTTTCCTTTATACATGATTGGACATGGTATGT
TGGACTCCGATCTTCATCTTAGCTCAAAGGCTCAGGTGTTCGAACATCCTCACAT
TCAAGACGCTGCTTCGCAACTTCCTGATGATGAGAGTTTATTTTTTGGTGATACTG
GGCTATCCAAAAATCCAATCGAGCTTGTAGAAGGTTGGTTCAGTAGTTGGAAAA
GCTCTATTGCCTCTTTTTTCTTTATCATAGGGTTAATCATTGGACTATTCTTGGTTC
TCCGAGTTGGTATCCATCTTTGCATTAAATTAAAGCACACCAAGAAAAGACAGAT
TTATACAGACATAGAGATGAACCGACTTGGAAAG SEQ ID NO: 876
[00918] Construct pJAQ795 [B2M Signal Peptide] -[CXCL 12 Targeting Domain]-
ATGAGCAGAAGCGTGGCCCTGGCCGTGCTGGCTCTGCTGTCTCTGTCCGGCCTGG
AGGCCAACGCCAAGGTCGTGGTCGTGCTGGTCCTCGTGCTGACCGCGCTCTGCCT
CAGCGACGGGAAGCCCGTCAGCCTGAGCTACAGATGCCCATGCCGATTCTTCGA
AAGCCATGTTGCCAGAGCCAACGTCAAGCATCTCAAAATTCTCAACACTCCAAA
CTGTGCCCTTCAGATTGTAGCCCGGCTGAAGAACAACAACAGACAAGTGTGCAT
TGACCCGAAGCTAAAGTGGATTCAGGAGTACCTGGAGAAAGCTTTAAACAAGAG
CGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACC
TACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGT
AGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACA
TCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCAC
CCTGTACTGCAGCGGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACC
GCCTTCAGCGGCCTGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGC
AAGAAATCTAAGCGG SEQ ID NO: 877
[00919] Construct pJAQ796 [CD90 scFvl Targeting Domain] -[CD 8 a trunc Hinge] - [CD28 TM]
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTTTCTGGGTCCTGG
TTGTGGTGGGCGGAGTGCTGGCCTGCTACAGCCTGCTGGTGACCGTGGCCTTTAT
CATTTTCTGGGTG SEQ ID NO: 878
[00920] Construct pJAQ797 [CD90 scFvl Targeting Domain] -[CD 8 a trunc Hinge] - [CD43 TM]
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTGGCATGCTGCCTG
TGGCTGTGCTGGTGGCCCTGCTCGCCGTGATCGTGCTGGTCGCCCTGCTGCTGCT
GTGGCGGAGAAGACAGAAGAGACGGACC SEQ ID NO: 879
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCATCGTGATCATCTCTAGCAGCCTGCTGCTGGGCCTGATCGTGCTGC
TGCTGATCAGCTACGTGATGTGGAAGGCCGGCCTCTTCAAAAAACAGTACAAGT
CC SEQ ID NO: 880
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCCCTCTGTTCATCCCCGTGGCCGTGATGGTGACCGCCTTCAGCGGCC
TGGCTTTTATCATCTGGCTGGCCAGAAGACTGAAGAAGGGCAAGAAATCTAAGC
GG SEQ ID NO: 881
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCCTGCTGGCTATCCTGATCCTGGCCCTGGTCGCCACAATCTTCTTCG
TGTGCACCGTGGTGCTGGCCGTGAGACTGAGCAGAAAGGGCCACATGTACCCTG
TGCGGAAC SEQ ID NO: 882
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCATCGTGGGCATCATCGCCGGACTGGTGCTGTTCGGCGCCGTCATCA
CCGGCGCTGTGGTGGCCGCCGTGATGTGGCGGAGAAAGTCTAGCGACAGAAAGG GC SEQ ID NO: 883
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCAACGTGGTGTGCGCCCTGGGCCTGACCGTGAGCCTGGTCGGCATC
ATCATTGGAACAATCTTCATCATCAAGGGCCTGAGAAAGAGCAACGCCGCTGAG
CGGAGAGGCCCTCTG SEQ ID NO: 884
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCATCGTGATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACA
GCCGGCCTGAGCACCTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGG
CTG SEQ ID NO: 885
[00927] Construct pJAQ804 [CD90 scEvl Targeting Domain]-[CD8a Hinge]-
ATGCAGGTGCAGCTGCTTCAGCCAGGGGCAGAACTTGTACGGCCCGGCGCAAGC
GTACGCTTGTCCTGCAAAACGAGTGGATATACGTTTACCTCCTACTGGATCAACT
GGGTTAAACAGAGACCGGGTCAAGGTCTTGAGTGGATCGGTAAGATTTTCCCCA
GTGATTCCCACACTAACTATAATCAAAAATTTAAGGATAAAGCTACGTTGACGGT
CGATAAATCATCTTCCACCGCGTATATGCAACTGATATCTCCGACCAGTGAGGAT
TCTGCCGTTTACTATTGCACAAGAGATTTCGACACGCAGTTCTACGCTATGGAAT
ACTGGGGTCAGGGGACTTCTGTAACGGTAAGCTCTGGCAGCGATAGCAACGCGG
GCCATGCGAGCGCGGGCAACACCAGCCAAATTGTCCTGACACAAAGCCCTACAA
TAATGAGTGCATCACCGGGACAAAAGGTTACAATTAACTGCTCTGCGATTAGTA
GCGTGAATTACATGCACTGGTATCAGCAGAAGCCCGGTTCTTCACCTAAACTTTG
GATATATGCTACTAGTAAGCTGACCCTCGGAGTACCGGCTCGTTTTAGTGGAAGT
GGATCAGGGACCAGTTACAGCTTGACGGTTAATTCAATGGTTACAGAAGATGCT
ACTTCCTATTTTTGCCACCAGTGGTCTTCTTATCCTCCTACATTCGGGGCTGGAAC
TAAATTGGAGTTGAAGACCACAACCCCTGCCCCCAGACCACCTACACCTGCTCCT
ACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTAGACCCGCTGCTG
CCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACATCTGGGCCCCTCT
GGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACCCTGTACTGCAGC
GGTGGGAGCTACCTGTACGTGTTGAGCGGCATCGGCGGACTGCTGCTGCTGCTCC
TGATCTTCATCGTGCTGTACAAGGTGGGCTTTTTCAAAAGAAACCTGAAG
SEQ ID NO: 886
[00928] Construct pJAQ805 [CD133 scFv 1 Targeting Domain]-[CD8 trunc Hinge]-
ATGGCCGAGGTGCAGCTGCTGGAAAGCGGCGGAGGCCTGGTGCAGCCTGGCGGC
AGCCTGAGACTGAGCTGCGCCGCTAGCGGCTTCACCTTCAGCTCCTACGCCATGA
GCTGGGTTAGACAGGCCCCTGGCAAGGGCCTCGAGTGGGTCAGCGCCATCAGCA
GAACCGGCGGCGTGACCAGATACGCCGACAGCGTGAAGGGCAGATTCACCATCA
GCCGGGACAACTCAAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCG
AGGATACAGCCGTGTACTACTGCGCCAAGCGGACCAGGCGGTTCGACTACTGGT
GCCAGGGCACCCTGGTGACAGTGTCCAGCAGCCCCAGCTCCCTGTCTGCTTCTGT
GGGCGACAGAGTGACCATCACCTGCAGAGCCAGCCAGAGCATCAGCAGCTACCT
GAACTGGTACCAGCAGAAACCTGGAAAAGCCCCTAAGCTGCTGATCTACAGCGC
TTCTGATCTGCAATCCGGCGTGCCATCTAGATTTTCTGGCAGCGGATCTGGAACC
GATTTTACACTGACCATTTCCAGCCTGCAGCCCGAGGACTTCGCCACCTACTATT
GTCAGCAAACAGCTAATTCTCCTAGCACATTCGGCCAGGGAACAAAGGTGGAAA
TCACTACAACTCCAGCACCCAGACCCCCTACACCTGCTCCAACTATCGCAAGTCA
GCCCCTGTCACTGCGCCCTGAAGCCTGTATCGTGATCATCACCGTGGTCGCCGCC
GCTGTGATCATGGGCACAGCCGGCCTGAGCACCTACCTGTACAACAGACAGAGA
AAGATCAAGAAATACCGGCTG SEQ ID NO: 887
[00929] Construct pJAQ806 [CD133 scFv 2 Targeting Domain]-[CD8 trunc Hinge]- [ICAM1 TM]
ATGGACATCGTGCTGAGCCAGAGCCCAGCTATCATGAGCGCCAGCCCTGGCGAG
AAGGTGACCATCAGCTGCAGCGCTAGCTCCAGCGTGTCTTACATGTACTGGTACC
AGCAAAAGCCCGGCTCTTCTCCAAAGCCCTGGATCTACCGGACCTCTAATCTGGC
CTCTGGCGTGCCCGCCAGATTTTCTGGCAGCGGCAGCGGAACCAGCTACAGCCTG
ACAATCAGCAGCATGGAAGCCGAGGATGCCGCTACCTACTACTGCCAGCAGTAC
CACAGCTACCCTCCTACCTTCGGCGCCGGCACAAAGCTGGAACTGAAAAGCTCC
GGCGGTGGAGGCAGCGGAGGCGGCGGCGGCGGAAGCTCTAGAAGCAGCCTGGA
AGTGAAACTGGTGGAAAGCGGCCCTGAGCTGAAGAAGCCTGGAGAAACCGTGA
AGATCTCCTGTAAAGCCAGCGGCTATACATTTACCGATTACAGCATGAAGTGGGT
CAACCAGGCCCCTGGCAAGGGCCTGAAGTGGATGGGCTGGATTAACACCGAGAC
CGGCGAGCCTAGCTACGCCGACGACTTCAAGGGCAGATTCGCCTTCAGCCTCGA
GACATCTGCTAGCACCGCCTACCTGCAGATCAACAACCTGAAGAACGAGGACAC
CGCCACATACTTCTGCGCCACCGACTATGGCGATTACTTCGACTACTGGGGCCAG
GGAACAACACTGACCGTGTCCTCCACTACAACTCCAGCACCCAGACCCCCTACAC
CTGCTCCAACTATCGCAAGTCAGCCCCTGTCACTGCGCCCTGAAGCCTGTATCGT
GATCATCACCGTGGTCGCCGCCGCTGTGATCATGGGCACAGCCGGCCTGAGCAC
CTACCTGTACAACAGACAGAGAAAGATCAAGAAATACCGGCTG SEQ ID NO: 888
[00930] Construct pPHl [CD8a Signal Peptide] -[Z34C peptide Targeting Domain]- [SGGSx3.1 Linker]-[CD8a Hinge]-[CD28 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTATGTTCAACATGCAGTGTCAGCGGAGATTCTACGAGGCCCTGCACGA
CCCTAATCTGAACGAGGAACAGAGAAACGCCAAGATCAAGAGCATCAGAGATG
ACTGCAGCGGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCA
GACCACCTACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGA
GGCCTGTAGACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGAC
ATCTACATCTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGG
TGATCACCCTGTACTGCAGCTTCTGGGTCCTGGTTGTGGTGGGCGGAGTGCTGGC
CTGCTACAGCCTGCTGGTGACCGTGGCCTTTATCATTTTCTGGGTG SEQ ID
NO: 889
[00931] Construct pPH2 [CD8a Signal Peptide] -[Z34C peptide Targeting Domain]- [SGGSxl Linker]-[IgG4 Fc CH3 Hinge]-[CD28 TM]
ATGGCCCTGCCTGTGACCGCCCTGCTGCTCCCCCTGGCCCTGCTGCTGCACGCCG
CTAGACCTATGTTCAACATGCAGTGTCAGCGGAGATTCTACGAGGCCCTGCACGA
CCCTAATCTGAACGAGGAACAGAGAAACGCCAAGATCAAGAGCATCAGAGATG
ACTGCAGCGGTGGGAGCGGCGGGAGCCCCGGCCAACCTCGGGAACCCCAGGTGT
ACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTCACAT
GTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGCAACG
GCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGATGGCA
GCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAGGGCA
ATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACACAGA
AATCTCTGAGCCTGTCTCTGGGCAAGTCTTTTTGGGTCCTGGTCGTGGTGGGCGG
AGTTCTGGCCTGCTACAGCCTGCTGGTGACAGTGGCCTTCATCATCTTCTGGGTG
SEQ ID NO: 890
[00932] Construct pPH3 [Z34C peptide Targeting Domain]-[SGGSx3.1 Linker]-[CD8a
ATGTTCAACATGCAGTGTCAGCGGAGATTCTACGAGGCCCTGCACGACCCTAATC
TGAACGAGGAACAGAGAAACGCCAAGATCAAGAGCATCAGAGATGACTGCAGC
GGTGGGAGCGGCGGGAGCGGCGGTAGCACCACAACCCCTGCCCCCAGACCACCT
ACACCTGCTCCTACCATCGCCAGCCAGCCTCTGTCCCTGCGGCCCGAGGCCTGTA
GACCCGCTGCTGCCGTGCACACAAGAGGCCTGGATTTCGCCTGCGACATCTACAT
CTGGGCCCCTCTGGCCGGCACCTGCGGCGTGCTGCTGCTCTCTCTGGTGATCACC
CTGTACTGCAGCTTCTGGGTCCTGGTTGTGGTGGGCGGAGTGCTGGCCTGCTACA
GCCTGCTGGTGACCGTGGCCTTTATCATTTTCTGGGTG SEQ ID NO: 891
[00933] Construct pPH4 [Z34C peptide Targeting Domain]-[SGGSx3.1 Linker]-[IgG4
ATGTTCAACATGCAGTGTCAGCGGAGATTCTACGAGGCCCTGCACGACCCTAATC
TGAACGAGGAACAGAGAAACGCCAAGATCAAGAGCATCAGAGATGACTGCAGC
GGTGGGAGCGGCGGGAGCGGCGGTAGCCCCGGCCAACCTCGGGAACCCCAGGT
GTACACCCTGCCTCCTAGCCAGGAGGAAATGACCAAGAACCAGGTGTCCCTCAC
ATGTCTGGTGAAGGGATTCTACCCCAGCGACATCGCCGTGGAATGGGAGAGCAA
CGGCCAGCCTGAGAACAACTACAAGACCACCCCTCCAGTGCTGGACAGCGATGG
CAGCTTCTTTCTGTATAGCAGACTGACCGTGGACAAGTCCAGATGGCAGGAGGG
CAATGTGTTCAGCTGCAGCGTGATGCACGAGGCTCTGCACAACCACTACACACA
GAAATCTCTGAGCCTGTCTCTGGGCAAGTCTTTTTGGGTCCTGGTCGTGGTGGGC
GGAGTTCTGGCCTGCTACAGCCTGCTGGTGACAGTGGCCTTCATCATCTTCTGGG
TG SEQ ID NO: 892
Linkers
[00934] The fusion proteins (e.g., first and second fusion proteins) described herein may include one or more linkers. As defined above, the term “linker,” as used herein, refers to a chemical group or a molecule linking two molecules or moieties, e.g., a binding domain and a cleavage domain of a nuclease. In some embodiments, a linker joins one or more domains of a fusion protein disclosed herein (e.g., a linker joins a targeting domain to a stalk domain or a stalk domain to a transmembrane domain, etc.).
[00935] Typically, the linker is positioned between, or flanked by, two groups, molecules, or other moieties and connected to each one via a covalent bond, thus connecting the two. In some embodiments, the linker is an amino acid or a plurality of amino acids (e.g., a peptide or protein). In some embodiments, the linker is an organic molecule, group, polymer, or chemical moiety. In some embodiments, the linker is 5-100 amino acids in length, for example, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 30-35, 35-40, 40-45, 45-50, 50-60, 60-70, 70-80, 80-90, 90-100, 100-150, or 150-200 amino acids in length. Longer or shorter linkers are also contemplated.
[00936] The linker may be as simple as a covalent bond, or it may be a polymeric linker many atoms in length. In certain embodiments, the linker is a polypeptide, or amino acidbased. In other embodiments, the linker is not peptide-like. In certain embodiments, the linker is a covalent bond (e.g., a carbon-carbon bond, disulfide bond, carbon-heteroatom bond, etc.). In certain embodiments, the linker is a carbon-nitrogen bond of an amide linkage. In certain embodiments, the linker is a cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic or heteroaliphatic linker. In certain embodiments, the linker is polymeric (e.g., polyethylene, polyethylene glycol, polyamide, polyester, etc.). In certain embodiments, the linker comprises a monomer, dimer, or polymer of aminoalkanoic acid. In certain embodiments, the linker comprises an aminoalkanoic acid (e.g., glycine, ethanoic acid, alanine, beta- alanine, 3-aminopropanoic acid, 4- aminobutanoic acid, 5-pentanoic acid, etc.). In certain embodiments, the linker comprises a monomer, dimer, or polymer of aminohexanoic acid (Ahx). In certain embodiments, the linker is based on a carbocyclic moiety (e.g., cyclopentane, cyclohexane). In other embodiments, the linker comprises a polyethylene glycol moiety (PEG). In other embodiments, the linker comprises amino acids.
In certain embodiments, the linker comprises a peptide. In certain embodiments, the linker comprises an aryl or heteroaryl moiety. In certain embodiments, the linker is based on a phenyl ring. The linker may include functionalized moieties to facilitate attachment of a nucleophile (e.g., thiol, amino) from the peptide to the linker. Any electrophile may be used as part of the linker. Exemplary electrophiles include, but are not limited to, activated esters, activated amides, Michael acceptors, alkyl halides, aryl halides, acyl halides, and isothiocyanates.
[00937] In some other embodiments, the linker comprises the amino acid sequence (GGGGS)n (SEQ ID NO: 309), (G)n (SEQ ID NO: 310), (EAAAK)n (SEQ ID NO: 311), (GGS)n (SEQ ID NO: 312), (SGGS)n (SEQ ID NO: 313), (XP)n (SEQ ID NO: 314), or any combination thereof, wherein n is independently an integer between 1 and 30, and wherein X is any amino acid. In some embodiments, the linker comprises the amino acid sequence (GGS)n (SEQ ID NO: 312), wherein n is 1, 3, or 7. In some embodiments, the linker comprises the amino acid sequence SGSETPGTSESATPES (SEQ ID NO: 315). In some embodiments, the linker comprises the amino acid sequence SGGSSGGSSGSETPGTSESATPESSGGSSGGS (SEQ ID NO: 316). In some embodiments, the linker comprises the amino acid sequence SGGSGGSGGS (SEQ ID NO: 317). In some embodiments, the linker comprises the amino acid sequence SGGS (SEQ ID NO: 318). In some embodiments, the linker comprises the amino acid sequence SGGSGGS (SEQ ID NO: 319). In other embodiments, the linker comprises the amino acid sequence
SGGSSGGSSGSETPGTSESATPESAGSYPYDVPDYAGSAAPAAKKKKLDGSGSGGSS GGS (SEQ ID NO: 320, 60AA). In some embodiments, the linker comprises the amino acid sequence GGS, GGSGGS (SEQ ID NO: 322), GGSGGSGGS (SEQ ID NO: 323), SGGSSGGSSGSETPGTSESATPESSGGSSGGSS (SEQ ID NO: 324), SGSETPGTSESATPES (SEQ ID NO: 325), or SGGSSGGSSGSETPGTSESATPESAGSYPYDVPDYAGSAAPAAKKKKLDGSGSGGSS GG S (SEQ ID NO: 326). In some embodiments, the linker comprises the amino acid sequence GGGGSVP (SEQ ID NO: 327). In some embodiments, the linker comprises the amino acid sequence GGGGSAK (SEQ ID NO: 328). In some embodiments, the linker comprises the amino acid sequence VSGGGGS (SEQ ID NO: 329). In some embodiments, the linker comprises a single amino acid. In some embodiments, the linker comprises the amino acid serine (S).
[00938] In certain embodiments, linkers may be used to link any of the fusion protein domains disclosed herein.
[00939] In some embodiments, a linker is a non-cleavable linker. In some embodiments, the non-cleavable linker is flexible. In some embodiments, a linker is a cleavable linker (e.g., a linker that can be split or cut by any means). A cleavable linker may be an amino acid sequence. In some embodiments, the linker between the targeting domain and the stalk domain of the fusion proteins comprises a cleavable linker. A cleavable linker may comprise a self-cleaving peptide (e.g., a 2A peptide such as EGRGSLLTCGDVEENPGP (SEQ ID NO: 330), ATNFSLLKQAGDVEENPGP (SEQ ID NO: 331), QCTNYALLKLAGDVESNPGP (SEQ ID NO: 332), or VKQTLNFDLLKLAGDVESNPGP (SEQ ID NO: 333). In some embodiments, a cleavable linker comprises a protease cleavage site that is cut after being contacted by a protease. For example, the present disclosure contemplates the use of cleavable linkers comprising a protease cleavage site of amino acid sequences
TSTLLMENSS (SEQ ID NO: 334), PRSSLYPALTP (SEQ ID NO: 335), VQALVLTQ (SEQ ID NO: 336), PLQVLTLNIERR (SEQ ID NO: 337), or an amino acid sequence at least 90% identical to any one of SEQ ID NO:s: 1-4. In certain embodiments, a cleavable linker comprises an MMLV protease cleavage site of an FMLV protease cleavage site. In certain embodiments, the fusion proteins and BE-VLPs described herein comprise the cleavable linker TSTLLMENSS (SEQ ID NO: 338) joining one or more NES and a napDNAbp. In some embodiments, the linker is cleaved upon delivery of the BE-VLP/fusion protein to a target cell, releasing a free base editor that is capable of translocating into the nucleus of the target cell.
[00940] The protease cleavage site may be any known in the art, or any sequence yet to be discovered, so long as the corresponding protease may be co-packaged in the eVLPs to allow for post-maturation cleavage within the mature eVLP particles. Such cleavage sites and their corresponding proteases include but are not limited to: (a) granzyme A, which recognizes and cleaves a sequence comprising ASPRAGGK (SEQ ID NO:339), (b) granzyme B, which recognizes and cleaves a sequence comprising YEADSLEE (SEQ ID NO: 340), (c) granzyme K, which recognizes and cleaves a sequence comprising YQYRAL (SEQ ID NO: 341), (d) Cathepsin D, which recognizes and cleaves a sequence comprising LGVLIV (SEQ ID NO: 342). Many other combinations of specific proteases and protease cleavage sites may be used in connection with the present disclosure by co-packing a specific protease during the eVLP manufacture process. Such proteases can include, without limitation, Arg-C proteinase, Asp-
N Endopeptidase, Caspase 1, Caspase 2, Caspase 3, Caspase 4, Caspase 5, Caspase 7, Caspase 8, Caspase 9, Caspase 10, Chymotrypsin, Clostripain, Enterokinase, Factor Xa, Glutamyl endopeptidase, Granzyme B, Neutrophil elastase, Pepsin, Prolyl-endopeptidase, Proteinase K, Staphylococcal peptidase I, Thermolysin, Thrombin, and Trypsin. Any protease paired with its cognate recognition sequence may be used in the present disclosure proteasesensitive linkers, including any serine protease, cysteine protease, aspartic protease, threonine protease, glutamic protease, metalloprotease, or asparagine peptide lyase (which constitute major classifications of known proteases). The specific protease cleavage sites for said enzymes are well-known in the art and may be utilized in the linkers herein to provide protease-susceptible linkers. eVLP complexes
[00941] Additional aspects of the present disclosure relate to eVLP complexes. In some embodiments, eVLP complexes comprises (i) a fusion protein comprising a transmembrane domain and a targeting domain and (ii) an antibody domain. In some embodiments, the fusion protein further comprises a stalk domain. In some embodiments the fusion proteins comprise at least one of the following non-limiting structures in either the N-C or C-N orientation:
(1) N-term-[targeting domain] -[optional linker]-[stalk domain] -[optional linker]- [transmembrane domain] -C-term;
(2) C-term- [targeting domain] -[optional linker] -[stalk domain] -[optional linker]- [transmembrane domain] -N-term;
(3) N-term-[targeting domain] -[optional linker] -[transmembrane domain] -C-term; and
(4) C-term- [targeting domain] -[optional linker] -[transmembrane domain] -N-term.
[00942] In some embodiments, the targeting domain binds (e.g., non-covalently) to a second targeting domain, which in turn, binds to a target receptor on a target cell (e.g,. HSBC cell). For example, in certain embodiments, the fusion protein comprises a targeting domain comprising an IgG binding peptide configured to bind to an IgG antibody (e.g., second targeting domain). Thus, in some embodiments, the fusion protein comprises the following non-limiting structure in either the N-C or C-N direction, although, other structures and orientations are also contemplated in other embodiments.
(1) [IgG binding peptide] -[optional linker]-[IgG4 Fc CH3]- [optional linker] -[CD28] The IgG binding peptide may be configured to bind to any known domain of the IgG antibody,
according to certain embodiments. For instance, in some embodiments, the IgG peptide binds to the Fc region of the IgG antibody. In other embodiments, the IgG peptide binds to the Fab region of the IgG antibody. In other embodiments still, the IgG peptide binds to the Fv region. In some embodiments, the IgG peptide does not bind to the Fv region, as this is likely to reduce the affinity of the antibody for the target receptor on the target cell. In some embodiments, the IgG peptide binds to any subclass of IgG antibodies, including, for example, IgGl, IgG2, IgG3, and IgG4. Non-limiting exemplary embodiments of possible IgG binding peptides for use in any of the fusion proteins disclosed herein include: [00943] CGYWRSEWGLC (SEQ ID NO: 200) [00944] CTGFWEREWGLC (SEQ ID NO: 201) [00945] CLYWPRLWGLC (SEQ ID NO: 202) [00946] CTGYWPKAWGLC (SEQ ID NO: 203) [00947] CYWAWRWGLLGC (SEQ ID NO: 204) [00948] CGYWADVWOIHC (SEQ ID NO: 205) [00949] GCGYWRSEWGLCG (SEQ ID NO: 206) [00950] GCTGFWEREWGLCG (SEQ ID NO: 207) [00951] GCTGYWPKAWGLCG (SEQ ID NO: 208) [00952] GCGYWRSOWGLCG (SEQ ID NO: 209) [00953] GCTGYWPRAWGLCG (SEQ ID NO: 210)
[00954] YDPxTGTWRS[VL] x is any naturally occurring amino acid (SEQ ID NO: 211) [00955] YDPRTGTWRSSIAYGGG (SEQ ID NO: 212)
[00956] YDPGTGTWRSYLRFGGG (SEQ ID NO: 213) [00957] YDPYTGTWRSSIWVLSG (SEQ ID NO: 214) [00958] YDPGTGTWRSWLSFNVG (SEQ ID NO: 215) [00959] YDPWTGTWRSFIWGGGG. (SEQ ID NO: 216) [00960] YDPRTGTWLLYASRLLG (SEQ ID NO: 217) [00961] YDPVTGTWTSSIASWMG (SEQ ID NO: 218) [00962] YDPRTGTWRRSSLSYSG (SEQ ID NO: 219) [00963] R[Q/R/S]xx[G/S]YDPRTGTWRSSIAYGG (SEQ ID NO: 220) [00964] GVVRQWSGYDPRTGTWRSSIAYGGG (SEQ ID NO: 221) [00965] AGSRRAHGYDPRTGTWRSSIAYGGG (SEQ ID NO: 222) [00966] ASVRSWSSYDPRTGTWRSSIAYGGG (SEQ ID NO: 223) [00967] SWRRRGSSYDPRTGTWRSSIAYGGG (SEQ ID NO: 224)
[00968] TGRGRSARYDPRTGTWRSSIAYGGG (SEQ ID NO: 225)
[00969] HWVNGRSGYDPRTGTWRSSIAYGGG (SEQ ID NO: 226)
[00970] ERWITWSGYDPRTGTWRSSIAYGGG (SEQ ID NO: 227)
[00971] GSWRWRGYDPRTGTWRSSIAYGGG (SEQ ID NO: 228)
[00972] GAVYRRSFYDPRTGTWRSSIAYRGG (SEQ ID NO: 229)
[00973] GVVRQWSGXXXXXXXXRSSIAYGG (SEQ ID NO: 230)
[00974] GVVRQWSGGGGSGGGGRSSIAYGGG (SEQ ID NO: 231)
[00975] RSSIAYGGG (SEQ ID NO: 232)
[00976] DAAWHLGELVWATYYDPETGTWxPDWxxM (SEQ ID NO: 233)
[00977] DAAWHLGELVWATYYDPETGTWQPDWLYMTTR (SEQ ID NO: 234)
[00978] DAAWHLGELVWATYYDPETGTWAPDWRLMQGQ (SEQ ID NO: 235)
[00979] DAAWHLGELVWATYYDPETGTWLPDWQTMAQK (SEQ ID NO: 236)
[00980] DAAWHLGELVWATYYDPETGTWEPDWQRMLGQ (SEQ ID NO: 237)
[00981] DAAWHLGELVWATYYDPETGTWQPDWRAMSGR (SEQ ID NO: 238)
[00982] DAAWHLGELVWATYYDPETGTWRPDWKWMSTH (SEQ ID NO: 239)
[00983] DAAWHLGELVWATYYDPETGTWEPDWKLMQRP (SEQ ID NO: 240)
[00984] DAAWHLGELVWATYYDPETGTWQPDWDIMAGH (SEQ ID NO: 241)
[00985] DAAWHLGELVWATYYDPETGTWLPDWDVMVRQ (SEQ ID NO: 242)
[00986] DAAWHLGELVWATYYDPETGTWVPDWERMKQH (SEQ ID NO: 243)
[00987] DAAWHLGELVWATYYDPETGTWEPDWSKMRPQ (SEQ ID NO: 244)
[00988] DAAWHLGELVWATYYDPETGTWRPDWAVMATP (SEQ ID NO: 245)
[00989] DAAWHLGELVWATYYDPETGTWKPDWRMMGVP (SEQ ID NO: 246)
[00990] DAAWHLGELVWATYYDPETGTWLPDWDYMSSK (SEQ ID NO: 247)
[00991] DAAWHLGELVWATYYDPETGTWMPDWDRMLRR (SEQ ID NO: 248)
[00992] DAAWHLGELVWATYYDPETGTWTPDWNAMSQR (SEQ ID NO: 249)
[00993] DAAWHLGELVWATYYDPETGTWQPDWKRMTSR (SEQ ID NO: 250)
[00994] DAAWHLGELVWATYYDPETGTWQPDWGRMNSK (SEQ ID NO: 251)
[00995] DAAWHLGELVWATYYDPETGTWAPDWNRMRDFNRSFREV (SEQ ID NO: 252)
[00996] DAAWHLGELVWATYYDPETGTWVPDWDAMSSR (SEQ ID NO: 253)
[00997] DAAWHLGELVWATYYDPETGTWIPDWTRMQTW (SEQ ID NO: 254)
[00998] DAAWHLGELVWATYYDPETGTWKPDWQRMKLH (SEQ ID NO: 255)
[00999] DAAWHLGELVWATYYDPETGTWLPDWSQMRPQ (SEQ ID NO: 256)
[001000] DAAWHLGELVWATYYDPETGTWLPDWDTMTPR (SEQ ID NO: 257)
[001001] DAAWHLGELVWATYYDPETGTWQPDWSVMKSL (SEQ ID NO: 258)
[001002] DAAWHLGELVWATYYDPETGTWVPDWDTMH (SEQ ID NO: 259)
[001003] DAAWHLGELVWATYYDPETGTWIPDWRAMSQF (SEQ ID NO: 260)
[001004] DAAWHLGELVWATYYDPETGTWLPDWNLMGQH (SEQ ID NO: 261)
[001005] DAAWHLGELVWATYYDPETGTWRPDWARMEPM (SEQ ID NO: 262)
[001006] DAAWHLGELVWATYYDPETGTWKPDWQVMSPVSNRSFREV (SEQ ID
NO: 263)
[001007] DAAWHLGELVWATYYDPETGTWQPDWEIMRPF (SEQ ID NO: 264)
[001008] EAWHLGELVWATYYDPETGTWRPDWSRMSGR (SEQ ID NO: 265)
[001009] [R/S/G] [A/G/V]xYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR MLGQ (SEQ ID NO: 266)
[001010] GPGISAFSPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDW
QRMLGQ (SEQ ID NO: 267)
[001011] VISLGSDRGVYDPETGTWYDAAWHLGELVWATYYDPET
GTWEPDWQRMLGQ (SEQ ID NO: 268)
[001012] IMSVDGSSARYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 269)
[001013] VDLRAHGGAVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 270)
[001014] WSRFSSRSVAYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 271)
[001015] GNPSDSASAWYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 272)
[001016] SNFVRSPSAWYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 273)
[001017] IPYGFPGRGEYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQRM
LGQ (SEQ ID NO: 274)
[001018] GPYNIPDSAVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 275)
[001019] WPLNAPSSAFYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 276)
[001020] VPPRFSSSAQYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 277)
[001021] FLVGLHAGAVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 278)
[001022] WRVDHSSAVYDPETGTWYDAAWHLGELVWATYYDPETTWEPDWQRM
LGQ (SEQ ID NO: 279)
[001023] WMEFYPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQ
RMLGQ (SEQ ID NO: 280)
[001024] DGVGPGSRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 281)
[001025] FVSSLPNSAMYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 282)
[001026] GRAFSGSRRWYDPETGTWYDAAWHLGELVWATYYDPETGTWAPDWRL
MQGQ (SEQ ID NO: 283)
[001027] VMATEWRGVYDPETGTWYDATWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 284)
[001028] MMVRPPRLGVYDPEPGTWYDATWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 285)
[001029] ERHLVSDYLHYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 286)
[001030] FSDLDSFGVSYDPETGTWYDAAWHRGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 287)
[001031] LFDNKLKHASYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 288)
[001032] GSCKFSSSCHYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQR
MLGQ (SEQ ID NO: 289)
[001033] LIPPGGISPWYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDWQRM
LGQ (SEQ ID NO: 290)
[001034] LNDFLTPTAWYDPETGTWYDAAWHLGELVWATYYDPETGTWLPDWQT
MAQK (SEQ ID NO: 291)
[001035] GVVRRWSGYDPRTGTWRSSIAYGGG (SEQ ID NO: 292)
[001036] GVVRQAQSGYDPRTGTWRSSIAYGGG (SEQ ID NO: 293)
[001037] GVVRQWAGYDPRTGTWRSSIAYGGG (SEQ ID NO: 294)
[001038] GVVRQWSGYDPRTGTWASSIAYGGG (SEQ ID NO: 295) [001039] GVVRQWSGYDPRTGTWRASIAYGGG (SEQ ID NO: 296) [001040] GVVRQWSGYDPRTGTWRSAIAYGGG (SEQ ID NO: 297) [001041] GVVRQWSGYDPRTGTWRSSAAYGGG (SEQ ID NO: 298) [001042] GPGISAFSPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEADWQRML GQ (SEQ ID NO: 299)
[001043] GPGISAFSPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPAWQRML GQ (SEQ ID NO: 300)
[001044] GPGISAFSPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDA QRMLGQ (SEQ ID NO: 301)
[001045] GPGISAFSPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDW QAMLGQ (SEQ ID NO: 302)
[001046] GPGISAFSPGRGVYDPETGTWYDAAWHLGELVWATYYDPETGTWEPDW QRALGQ (SEQ ID NO: 303)
[001047] IgGBP cyclic peptide: DCAWHLGELVWCT (SEQ ID NO: 304)
[001048] Z33 peptide: FNMQQQRRFYEALHDPNLNEEQRNAKIKSIRDD (SEQ ID NO: 305
[001049] NKFRGKYK (SEQ ID NO: 306)
[001050] NARKFYKG (SEQ ID NO: 307)
[001051] In some embodiments, an IgG binding peptide comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5%, or 100% identical to the amino acid sequence of any SEQ ID NO:s: 200-307.
[001052] Additionally, or alternatively, fusion proteins of the present disclosure may comprise targeting domains comprising peptides that bind antibody classes other than, or in addition to, IgG antibodies. For example, in some embodiments, the targeting domain comprises IgA binding peptides (e.g., IgAl and IgA2). In some embodiments, the targeting domain comprises IgD binding peptides (e.g., IgDl and IgD2). In some embodiments, the targeting domain comprises IgE binding peptides. In some embodiments, the targeting domain comprises IgM binding peptides. The targeting domain may bind to any antibody domain, e.g., Fc domain, Fv domain, or Fab domain of any known antibody (e.g., IgG, IgA, IgE, IgM, IgD and their respective subclasses).
[001053] As described above, in some embodiments, the fusion proteins disclosed herein comprise a targeting domain that binds to a second targeting domain (e.g., an antibody domain), which in turn, is capable of binding to a specific receptor on a target cell (e.g., HSPC cells). In some embodiments, the second targeting domain is an antibody domain. Any known, or yet to be discovered antibody domain (or fragment thereof), capable of binding to any known, or yet to be discovered cell surface receptor (or fragment thereof) may be used as the second targeting domain. In some embodiments, the antibody domain is configured to bind to an HSPC cell surface receptor. Exemplary embodiments of possible antibodies for use herein, include but are not limited to, anti-CDl 10 antibodies or fragments thereof, anti-c-kit (e.g., CD 117) antibodies or fragments thereof, anti-CXCR4 antibodies or fragments thereof, anti-CD46 antibodies or fragments thereof, anti-Scal antibodies or fragments thereof, or anti-CDl 50 (e.g., SLAM1) antibodies or fragments thereof.
[001054] In some embodiments, the antibody domain binds to one or more of the following antigens (e.g., cell surface receptors) with the following sequences:
[001055] CD 117 (human)
[001056] MRGARGAWDLLCVLLVLLRGQTATSQPSASPGEPSPPSIHPAQSELIVEAG DTLSLTCIDPDFVRWTFKTYFNEMVENKKNEWIQEKAEATRTGTYTCSNSNGLTSSI YVFVRDPAKLFLVGLPLFGKEDSDALVRCPLTDPQVSNYSLIECDGKSLPTDLTFVPN PKAGITIKNVKRAYHRLCVRCAAQRDGTWLHSDKFTLKVRAAIKAIPVVSVPETSHL LKKGDTFTVVCTIKDVSTSVNSMWLKMNPQPQHIAQVKHNSWHRGDFNYERQETL TISSARVDDSGVFMCYANNTFGSANVTTTLKVVEKGFINISPVKNTTVFVTDGENVD LVVEYEAYPKPEHQQWIYMNRTSANKGKDYVKSDNKSNIRYVNQLRLTRLKGTEG GTYTFLVSNSDASASVTFNVYVNTKPEILTYDRLINGMLQCVAEGFPEPTIDWYFCTG AEQRCTTPVSPVDVQVQNVSVSPFGKLVVQSSIDSSVFRHNGTVECKASNDVGKSSA FFNFAFKGNNKEQIQAHTLFTPLLIGFVVAAGAMGIIVMVLTYKYLQKPMYEVQWK VVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSD AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTVGGPTLVITE YCCYGDLLNFLRRKRDSFIFSKQEEQAEAALYKNLLHSTEPSCDSSNEYMDMKPGVS YVVPTKTDKRRSARIDSYIERDVTPAIMEDDELALDLDDLLSFSYQVAKGMAFLASK NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFSC VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMVSPEHAPAEMY
DVMKTCWDADPLKRPTFKQVVQLIEKQISDSTKHIYSNLANCNPNPENPVVVDHSV
RVNSVGSSASSTQPLLVHEDA (SEQ ID NO: 381)
[001057] CD 117 (mouse)
[001058] MRGARGAWDLLCVLLVLLRGQTATSQPSASPGEPSPPSIHPAQSELIVEAG DTLSLTCIDPDFVRWTFKTYFNEMVENKKNEWIQEKAEATRTGTYTCSNSNGLTSSI
YVFVRDPAKLFLVGLPLFGKEDSDALVRCPLTDPQVSNYSLIECDGKSLPTDLTFVPN PKAGITIKNVKRAYHRLCVRCAAQRDGTWLHSDKFTLKVRAAIKAIPVVSVPETSHL LKKGDTFTVVCTIKDVSTSVNSMWLKMNPQPQHIAQVKHNSWHRGDFNYERQETL TISSARVDDSGVFMCYANNTFGSANVTTTLKVVEKGFINISPVKNTTVFVTDGENVD
LVVEYEAYPKPEHQQWIYMNRTSANKGKDYVKSDNKSNIRYVNQLRLTRLKGTEG GTYTFLVSNSDASASVTFNVYVNTKPEILTYDRLINGMLQCVAEGFPEPTIDWYFCTG
AEQRCTTPVSPVDVQVQNVSVSPFGKLVVQSSIDSSVFRHNGTVECKASNDVGKSSA FFNFAFKGNNKEQIQAHTLFTPLLIGFVVAAGAMGIIVMVLTYKYLQKPMYEVQWK VVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSD AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTVGGPTLVITE
YCCYGDLLNFLRRKRDSFIFSKQEEQAEAALYKNLLHSTEPSCDSSNEYMDMKPGVS YVVPTKTDKRRSARIDSYIERDVTPAIMEDDELALDLDDLLSFSYQVAKGMAFLASK NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFSC VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMVSPEHAPAEMY
DVMKTCWDADPLKRPTFKQVVQLIEKQISDSTKHIYSNLANCNPNPENPVVVDHSV RVNSVGSSASSTQPLLVHEDA (SEQ ID NO: 396)
[001059] CXCR4 (human)
[001060] MSIPLPLLQIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIF LTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYF
GNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWI PALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIII SKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKW ISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVST
ESESSSFHSS (SEQ ID NO: 382)
[001061] CXCR4 (mouse)
[001062] MEPISVSIYTSDNYSEEVGSGDYDSNKEPCFRDENVHFNRIFLPTIYFIIFLT GIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAMADWYFGK
FLCKAVHIIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKAVYVGVWIPA LLLTIPDFIFADVSQGDISQGDDRYICDRLYPDSLWMVVFQFQHIMVGLVLPGIVILSC YCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYVGISIDSFILLGVIKQGCDFESI VHKWISITEALAFFHCCLNPILYAFLGAKFKSSAQHALNSMSRGSSLKILSKGKRGGH
SSVSTESESSSFHSS (SEQ ID NO: 398)
[001063] CD46 (Human)
[001064] NO:MEPPGRRECPFPSWRFPGLLLAAMVLLLYSFSDACEEPPTFEAMELIG
KPKPYYEIGERVDYKCKKGYFYIPPLATHTICDRNHTWLPVSDDACYRETCPYIRDPL
NGQAVPANGTYEFGYQMHFICNEGYYLIGEEILYCELKGSVAIWSGKPPICEKVLCTP PPKIKNGKHTFSEVEVFEYLDAVTYSCDPAPGPDPFSLIGESTIYCGDNSVWSRAAPE CKVVKCRFPVVENGKQISGFGKKFYYKATVMFECDKGFYLDGSDTIVCDSNSTWDP PVPKCLKGPRPTYKPPVSNYPGYPKPEEGILDSLDVWVIAVIVIAIGKQMVELNMPLT
RLNQPLQQSREAE (SEQ ID NO: 383)
[001065] CD46 (mouse)
[001066] MTAAPLMPDSTHPCRRRKSYTFFWCSLGVYAEALLFLLSHLSDACELPRP FEAMELKGTPKLFYAVGEKIEYKCKKGYLYLSPYLMIATCEPNHTWVPISDAGCIKV
QCTMLQDPSFGKVYYIDGSFSWGARAKFTCMEGYYVVGMSVLHCVLKGDDEAYW NGYPPHCEKIYCLPPPKIKNGTHTLTDINVFKYHEAVSYSCDPTPGPDKFSLVGTSMIF
CAGHNTWSNSPPECKVVKCPNPVLQNGRLISGAGEIFSYQSTVMFECLQGFYMEGSS MVICSANNSWEPSIPKCLKGPRPTHPTKPPVYNYTGYPSPREGIFSQELDAWIIALIVIT SIVGVFILCLIVLRCFEHRKKTNVSAAR (SEQ ID NO: 401)
[001067] CD110 (MPL) (Human):
[001068] MPSWALFMVTSCLLLAPQNLAQVSSQDVSLLASDSEPLKCFSRTFEDLTC FWDEEEAAPSGTYQLLYAYPREKPRACPLSSQSMPHFGTRYVCQFPDQEEVRLFFPL
HLWVKNVFLNQTRTQRVLFVDSVGLPAPPSIIKAMGGSQPGELQISWEEPAPEISDFL RYELRYGPRDPKNSTGPTVIQLIATETCCPALQRPHSASALDQSPCAQPTMPWQDGP KQTSPSREASALTAEGGSCLISGLQPGNSYWLQLRSEPDGISLGGSWGSWSLPVTVDL
PGDAVALGLQCFTLDLKNVTCQWQQQDHASSQGFFYHSRARCCPRDRYPIWENCEE
EEKTNPGLQTPQFSRCHFKSRNDSIIHILVEVTTAPGTVHSYLGSPFWIHQAVRLPTPN
LHWREISSGHLELEWQHPSSWAAQETCYQLRYTGEGHQDWKVLEPPLGARGGTLEL
RPRSRYRLQLRARLNGPTYQGPWSSWSDPTRVETATETAWISLVTALHLVLGLSAVL
GLLLLRWQFPAHYRRLRHALWPSLPDLHRVLGQYLRDTAALSPPKATVSDTCEEVE
PSLLEILPKSSERTPLPLCSSQAQMDYRRLQPSCLGTMPLSVCPPMAESGSCCTTHIAN
HSYLPLSYWQQP (SEQ ID NO: 399)
[001069] CD110 (MPL) (Mouse):
[001070] MPSWALFMVTSCLLLALPNQAQVTSQDVFLLALGTEPLNCFSQTFEDLTC
FWDEEEAAPSGTYQLLYAYRGEKPRACPLYSQSVPTFGTRYVCQFPAQDEVRLFFPL
HLWVKNVSLNQTLIQRVLFVDSVGLPAPPRVIKARGGSQPGELQIHWEAPAPEISDFL
RHELRYGPTDSSNATAPSVIQLLSTETCCPTLWMPNPVPVLDQPPCVHPTASQPHGPA
PFLTVKGGSCLVSGLQAGKSYWLQLRSQPDGVSLRGSWGPWSFPVTVDLPGDAVTI
GLQCFTLDLKMVTCQWQQQDRTSSQGFFRHSRTRCCPTDRDPTWEKCEEEEPRPGS
QPALVSRCHFKSRNDSVIHILVEVTTAQGAVHSYLGSPFWIHQAVLLPTPSLHWREVS
SGRLELEWQHQSSWAAQETCYQLRYTGEGREDWKVLEPSLGARGGTLELRPRARY
SLQLRARLNGPTYQGPWSAWSPPARVSTGSETAWITLVTALLLVLSLSALLGLLLLK
WQFPAHYRRLRHALWPSLPDLHRVLGQYLRDTAALSPSKATVTDSCEEVEPSLLEIL
PKSSESTPLPLCPSQPQMDYRGLQPCLRTMPLSVCPPMAETGSCCTTHIANHSYLPLS
YWQQP (SEQ ID NO: 400)
[001071] Seal (mouse)
[001072] MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVG
DEIRLLCTDPGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIY
VFVRDPAKLFLVDRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPD
PKAGIMIKSVKRAYHRLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYL
LREGEEFTVTCTIKDVSSSVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISS
ARVNDSGVFMCYANNTFGSANVTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVE
YEAFPKPEHQQWIYMNRTFTDKWEDYPKSENESNIRYVSELHLTRLKGTEGGTYTFL
VSNSDVNAAIAFNVYVNTKPEILTYDRLVNGMLQCVAAGFPEPTIDWYFCPGTEQRC
SASVLPVDVQTLNSSGPPFGKLVVQSSIDSSAFKHNGTVECKAYNDVGKTSAYFNFA
FKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIVMILTYKYLQKPMYEVQWKVVEEIN
GNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV
AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD
LLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNEYMDMKPGVSYVVPT
KADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR
DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF
ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT
CWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSVGST
ASSSQPLLVHDDV (SEQ ID NO: 384)
[001073] CD150 (human)
[001074] MDPKGLLSLTFVLFLSLAFGASYGTGGRMMNCPKILRQLGSKVLLPLTYE
RINKSMNKSIHIVVTMAKSLENSVENKIVSLDPSEAGPPRYLGDRYKFYLENLTLGIR
ESRKEDEGWYLMTLEKNVSVQRFCLQLRLYEQVSTPEIKVLNKTQENGTCTLILGCT
VEKGDHVAYSWSEKAGTHPLNPANSSHLLSLTLGPQHADNIYICTVSNPISNNSQTFS
PWPGCRTDPSETKPWAVYAGLLGGVIMILIMVVILQLRRRGKTNHYQTTVEKKSLTI
YAQVQKPGPLQKKLDSFPAQDPCTTIYVAATEPVPESVQETNSITVYASVTLPES(SE
Q ID NO: 385)
[001075] CD150 (mouse)
[001076] MDPKGSLSWRILLFLSLAFELSYGTGGGVMDCPVILQKLGQDTWLPLTNE
HQINKSVNKSVRILVTMATSPGSKSNKKIVSFDLSKGSYPDHLEDGYHFQSKNLSLKI
LGNRRESEGWYLVSVEENVSVQQFCKQLKLYEQVSPPEIKVLNKTQENENGTCSLLL
ACTVKKGDHVTYSWSDEAGTHLLSRANRSHLLHITLSNQHQDSIYNCTASNPVSSIS
RTFNLSSQACKQESSSESSPWMQYTLVPLGVVIIFILVFTAIIMMKRQGKSNHCQPPVE
EKSLTIYAQVQKSGPQEKKLHDALTDQDPCTTIYVAATEPAPESVQEPNPTTVYASV
TLPES (SEQ ID NO: 397)
[001077] CD90 (human)
[001078] MNLAISIALLLTVLQVSRGQKVTSLTACLVDQSLRLDCRHENTSSSPIQYE
FSLTRETKKHVLFGTVGVPEHTYRSRTNFTSKYNMKVLYLSAFTSKDEGTYTCALHH
SGHSPPISSQNVTVLRDKLVKCEGISLLAQNTSWLLLLLLSLSLLQATDFMSL (SEQ
ID NO: 402)
[001079] CD90 (Mouse):
MNPAISVALLLSVLQVSRGQKVTSLTACLVNQNLRLDCRHENNTKDNSIQHEFSLTR EKRKHVLSGTLGIPEHTYRSRVTLSNQPYIKVLTLANFTTKDEGDYFCELQVSGANP MSSNKSISVYRDKLVKCGGISLLVQNTSWMLLLLLSLSLLQALDFISL (SEQ ID NO: 403)
[001080] In some embodiments, the target antigen (e.g., cell surface receptor) comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 380-385 and 396-403.
[001081] Other second targeting domains are also contemplated herein, in other embodiments. For example, in some embodiments, the second targeting domain comprises a bivalent molecule (e.g., protein, nucleic acid, carbohydrate, glycoprotein, etc.) comprising a first domain and a second domain. In some embodiments, the first domain of the bivalent molecule binds to a targeting domain of an eVEP fusion protein and a second domain of the bivalent protein binds to a target receptor on a target cell. eVEPs comprising at least one conjugation domain.
[001082] A second strategy, as contemplated herein, for enhancing the selective tropism of eVEPs is to chemically conjugate a desired targeting domain to the surface of the eVLP (e.g., via the envelope glycoprotein). It will be appreciated that although general methods are known in the art for chemically conjugating any of the targeting domains disclosed herein to the surfaces of the contemplated eVLPs, bio-orthogonal click chemistries are uniquely able to perform such reactions with high selectivity and specificity, both in vitro and in vivo.
Without wishing to be bound by any particular theory, it is believed that this high degree of selectively and specificity is because bio-orthogonal click chemistries use chemical functionalities not found in nature. While many types of bio-orthogonal click chemistries are known in the art, the most common reaction performed in biological systems include the copper (I)-catalyzed azide-alkyne cycloaddition reaction and the strain-promoted azidealkyne cycloaddition reaction. The former reaction is the classic click reaction between an azide and an alkyne to form a 5-membered heteroatom ring (e.g., the 1, 2, 3-triazole ring). This reaction is catalyzed by copper, which is toxic and may limit in vivo application of such
reactions. The latter reaction remedies this by using a strained alkyne which is capable of reacting with the azide in the absence of the copper catalyst.
[001083] Therefore, in some embodiments, eVLPs of the present disclosure comprise at least one conjugation domain capable of forming a bond with a desired targeting domain. In a first set of embodiments, the conjugation domain is a subdomain of a transmembrane domain. In a second set of embodiments, the conjugation domain is a subdomain of a viral envelope glycoprotein domain. In third set of embodiments, the conjugation domain is a subdomain of a stalk domain. In other embodiments, multiple conjugation subdomains are possible within the eVLPs (e.g., the conjugation domain is a subdomain of the transmembrane domain and the envelope glycoprotein domain).
[001084] In some embodiments, the conjugation domain comprises one or more reactive groups capable of forming a bond with a desired targeting domain comprising a second reactive group (e.g., -COOH + -NH2 or -N3 +-C=C-, etc.) In some embodiments, the reactive group is a chemical group that is naturally occurring in biological systems (e.g., -SH, -NH2, -COOH groups, etc.). In other embodiments, the chemical group is a chemical group that is not naturally occurring in biological systems (e.g., -N3, -C=C-, etc.). The person of ordinary skill may use any method suitable for conjugating a desired targeting domain to the surface of the eVLP, such as those disclosed by G. Hermanson in “Bioconjugate Techniques” 3rd edition, 2013, which is herein incorporated by reference in its entirety.
[001085] In one set of embodiments, the conjugation domain comprises a reactive group comprising one or more azido functionalities. In other embodiments, the conjugation domain comprises a reactive group. In some embodiments, the reactive groups is a click chemistry handle (e.g., one or more alkyne or strained alkyne functionalities). In other embodiments, the targeting domain comprises a second reactive group. In some embodiments, the second reactive group comprises a click chemistry handle (e.g., one or more azido functionalities). In some embodiments, the second reactive group comprises one or more alkyne or strained alkyne functionalities. In certain embodiments, the first reactive group is configured to react with the second reactive group via a click reaction.
[001086] In certain embodiments, the click chemistry handle comprises an alkene. In certain embodiments, the click chemistry handle comprises a diene. In certain embodiments, the click chemistry handle comprises a dienophile. In certain embodiments, the click chemistry handle comprises a thiol. In certain embodiments, the click chemistry handle comprises a nitrile oxide. In certain embodiments, the click chemistry handle comprises a
tetrazine. In certain embodiments, the click chemistry handle comprises an alkyne. In certain embodiments, the click chemistry handle comprises a terminal alkyne. In certain embodiments, the click chemistry handle comprises a strained alkyne. In certain embodiments, the click chemistry handle comprises an optionally substituted cyclooctyne. In certain embodiments, the click chemistry handle comprises a substituted cyclooctyne. In some embodiments, the click chemistry handle can react to form covalent bonds in the presence of a metal catalyst (e.g., copper (II)). In some embodiments, the click chemistry handle comprises a strained alkyne and can react to form covalent bonds in the presence of a metal catalyst (e.g., copper (II)). In some embodiments, the click chemistry handle comprises an optionally substituted cyclooctyne and can react to form covalent bonds in the presence of a metal catalyst (e.g., copper (II)). In some embodiments, the click chemistry handle comprises a substituted cyclooctyne and can react to form covalent bonds in the presence of a metal catalyst (e.g., copper (II)). In some embodiments, the click chemistry handle can react to form covalent bonds in the absence of a metal catalyst. In some embodiments, the click chemistry handle comprises a strained alkyne and can react to form covalent bonds in the absence of a metal catalyst. In some embodiments, the click chemistry handle comprises an optionally substituted cyclooctyne and can react to form covalent bonds in the absence of a metal catalyst. In some embodiments, the click chemistry handle comprises a substituted cyclooctyne and can react to form covalent bonds in the absence of a metal catalyst. In certain embodiments, the click chemistry handle comprises dibenzoazacyclooctyne (DIB AC or DBCO), biarylazacyclooctynone (BARAC), dibenzocyclooctyne (DIBO), difluorinated cyclooctyne (DIFO), bicyclononyne (BCN), dimethoxyazacyclooctyne (DIMAC), monofluorinated cyclooctyne (MOFO), cyclooctyne (OCT), and/or aryl-less cyclooctyne (ALO). In other embodiments, the click chemistry handle comprises an envelope glycoprotein with one or more dienophilic strained alkene functionalities (e.g., cyclopropane glycoengineering to react with tetrazzini-conjugated antibody)
[001087] In some embodiments, the conjugation domain comprises one or more N- azidoacetylglucosamine (GlcNAz)or an acetylated variant thereof. In certain embodiments, the conjugation domain comprises one or more N-azidoacetylmannosamine (ManNAz) or an acetylated variant thereof. In other embodiments, the conjugation domain comprises is one or more N-azidoacetylgalactosamine (GalNAz) or an acetylated variant thereof. In other embodiments still, the conjugation domain comprises one or more6-azidofucose (6AzFuc) or an acetylated variant thereof. In some embodiments, the conjugation domain comprises one
or moreN-azidoacetylneuraminic acid (SiaNAz) or an acetylated variant thereof. In one set of embodiments, the conjugation domain comprises one or more N-(4-pentynoyl mannosamine) (ManNAl) or an acetylated variant thereof. In some embodiments, the conjugation domain comprises one or more N-(4-pentynoyl galactosamine) (GalNAl) or an acetylated variant thereof. In other embodiments, the conjugation domain comprises one or more N-(4-pentynoyl glucosamine) (GlcNAl) or an acetylated variant thereof. In some embodiments, the conjugation domain comprises one or more N-(4-pentynoyl neuraminic acid) (SiaNAl) or an acetylated variant thereof. In other embodiments still, the conjugation domain comprises one or more 6-alkynyl fucose or an acetylated variant thereof.
[001088] In some embodiments, the targeting domain comprises a second reactive group comprising a click reagent. In some embodiments, the click reagent comprises an azide functionality. Exemplary embodiments of azide containing compounds that may be incorporated into a targeting domain, include but are not limited to, 3-azido-l-propanamine, 3-azido-l -propanol, l l-azido-3,6,9-trioaundecan-lamine, 4-azidoaniline hydrochloride, and l-azido-4-chlorobenzne, among others. In some embodiments, click reagent comprises an alkyne or strained alkyne functionality. Exemplary embodiments of strained alkyne containing compounds that may be incorporated into a targeting domain include, but are not limited to, difluorocyclooctyne (DIFO), dibenzocyclooctyne (DIBO), Dibenzo-aza- cyclooctyne (DIABC), dibenzocyclooctyne (DBCO), biarylazacyclooctyneones (BARAC), tetramethylthiacycloheptyne (TMTH), and bicyclo[6.1.0]non-3yne (BCN).
[001089] In some embodiments, the targeting domain is any targeting domain within any fusion protein disclosed herein. In other embodiments, the targeting domain is an aptamer. In some embodiments, the aptamer comprises one or more azides. In other embodiments, the aptamer comprises one or more alkynes or strained alkynes. In some embodiments, the aptamer is conjugated to an eVLP comprising one or more azide functional groups. In other embodiments, the aptamer is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. In some embodiments, the aptamer has a nucleic acid sequence GGCGCUCCGACCUUAGUCUCUGCAAGAUAAACCGUGCUAUUGACCACCCUCAA CACACUUAUUUAAUGUAUUGAACGGACCUACGAACCGUGUAGCACAGCAGA (SEQ ID NO: X). In some embodiments, the aptamer has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: X. In some embodiments, the aptamer
directs the eVLP to EGFR+ cells; however, other aptamer sequences directed to other receptors are also contemplated herein, in other embodiments.
[001090] In some embodiments, the targeting domain is a lectin. In some embodiments, the lectin comprises one or more azides. In other embodiments, the lectin comprises one or more alkynes or strained alkynes. In some embodiments, the lectin is conjugated to an eVLP comprising one or more azide functional groups. In other embodiments, the lectin is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. Non-limiting examples of lectins include, but are not limited to, Concanavalin A (e.g., ConA), Lentil lectin (e.g., LCH), Snowdrop lectin (e.g., GNA), Ricin (e.g., RCA), Peanut agglutinin (e.g., PNA), Jacalin (e.g, AIL), Hairy vetch lectin (e.g., VVL), Wheat germ agglutinin (e.g., WGA), Elderberry lectin (e.g., SNA), e.g., Maackia amurensis leukoagglutinin (e.g., MAL), Maackia amurensis hemagglutinin (e.g., MAH), Ulex europaeus agglutin (e.g., UEA), and Aleuria aurantia lectin (e.g., AAL). In some embodiments, lectin- conjugated eVLPs may be used to target aberrant glycans on cancer cells.
[001091] In some embodiments, the targeting domain is a glycan. In some embodiments, the glycan comprises one or more azides. In other embodiments, the glycan comprises one or more alkynes or strained alkynes. In some embodiments, the glycan is conjugated to an eVLP comprising one or more azide functional groups. In other embodiments, the glycan is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. In some embodiments, glycan-conjugated eVLPs enhance transduction efficency into cancer cells, e.g., due to the Warburg effect and increased metabolic need for glycans.
[001092] In some embodiments, the targeting domain is a hyaluronic acid. In some embodiments, the hyaluronic acid comprises one or more azides. In other embodiments, the hyaluronic acid comprises one or more alkynes or strained alkynes. In some embodiments, the hyaluronic acid is conjugated to an eVLP comprising one or more azide functional groups. In other embodiments, the hyaluronic acid is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. In some embodiments, hyaluronic acid- conjugated eVLPs enhance binding to CD44+ cells, which is an art recognized biomarker of cancer.
[001093] In some embodiments, the targeting domain is an antibody. In some embodiments, the antibody comprises one or more azides. In other embodiments, the antibody comprises one or more alkynes or strained alkynes. In some embodiments, the antibody is conjugated to an eVLP comprising one or more azide functional groups. In other
embodiments, the antibody is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. Any class or subclass of antibody may serve as the targeting domain. For example, in some embodiments, the targeting domain comprises IgG, IgA, IgM, IgE, and IgD. Further, the antibody may be configured to bind to any known receptor on any desired target cell, according to certain embodiments (e.g., anti-CD117, anti- CD5 antibody, anti-CDUO antibody, anti-ckit antibody, anti-CXCR4 antibody, and anti- CD46 antibody, etc.). In some embodiments, eVLPs comprise more than one type of antibody (e.g,. via by performing first bio-orthogonal click reactions using a first antibody followed by a second bio-orthogonal click reaction using a second antibody). Non-limiting examples of antibodies contemplated herein include antibodies directed against CD34, CD150, Sca-1, Flk2, CD201, and CD120.
[001094] In some embodiments, the targeting domain is protein. In some embodiments, the protein comprises one or more azides. In other embodiments, the protein comprises one or more alkynes or strained alkynes. In some embodiments, the protein is conjugated to an eVLP comprising one or more azide functional groups. In other embodiments, the protein is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. Non-limiting examples of proteins contemplated herein include SCF, TPO, AdF35, and CXCL12.
[001095] In some embodiments, the targeting domain is small molecule. In some embodiments, the small molecule comprises one or more azides. In other embodiments, the small molecule comprises one or more alkynes or strained alkynes. In some embodiments, the small molecule is conjugated to an eVLP comprising one or more azide functional groups. In other embodiments, the small molecule is conjugated to an eVLP comprising one or more alkyne or strained alkyne functional groups. Non-limiting exemplary embodiments of small molecules contemplated herein include fluorophores, bisphosphonates, Risendronate, eltrombopag, avatrombopag, plerixafor, LY2510924, TC14012, and CTCE- 9908.
[001096] In some embodiments, the small molecule is an imagining agent and the eVLP is an imaging agent-conjugated eVLP (e.g., a fluorophore-conjugated eVLP). In some embodiments, the imaging agent is a fluorophore. In some embodiments, the imaging agent is a IR dye. In other embodiments, the imaging agent is a dye, e.g., a fluoroscopic dye. In some embodiments, imaging agent-conjugated eVLPs enable in vivo imaging of the distribution of the eVLPs (e.g., biodistribution between the various organs).
[001097] Those skilled in the art will understand that the eVLPs contemplated herein may comprise one or more targeting domains disclosed herein. For example, in some embodiments, eVLPs may be conjugated to an aptamer and a lectin. In other embodiments, the eVLP may be conjugated to a glycan, an aptamer, and an imaging agent. Other combinations are also possible in other embodiments. For example, in some embodiments, the eVLP may comprise one or more targeting domains as part of a one or more fusion proteins. Such eVLP constructs may be further modified with additional targeting domains using one or more bio-orthogonal click reactions.
Additional VLP Components
[001098] In various embodiments, the eVLPs disclosed herein are formed via supra- molecular assembly comprising (a) an envelope comprising (i) a lipid membrane (e.g., singlelayer or bi-layer membrane) and a (ii) viral envelope glycoprotein and (b) a multi -protein core region enclosed by the envelope and comprising (i) a Gag protein, (ii) a Gag-Pro-Pol protein, and (iii) a Gag-cargo fusion protein (e.g., a second fusion protein) comprising a Gag protein fused to a cargo protein (e.g., a napDNAbp, base editor, or prime editor) via a cleavable linker (e.g., a protease-cleavable linker). The gag protein comprises, among other components, a viral nucleocapsid protein. In various embodiments, the cargo protein is a napDNAbp (e.g., Cas9). In other embodiments, the cargo protein is a base editor. In other embodiments, the cargo protein is a prime editor. In various other embodiments, the multiprotein core region of the eVLPs further comprises one or more guide RNA molecules (e.g., comprising a unique barcode sequence as described herein) which are complexed with the napDNAbp, base editor, or prime editor to form a ribonucleoprotein (RNP). In various embodiments, the eVLPs are prepared in a producer cell that is transiently transformed with plasmid DNA that encodes the various protein and nucleic acid (gRNA) components of the eVLPs. Without being bound by theory, the components self-assemble at the cell membrane and bud out in accordance with the naturally occurring mechanism of budding (e.g., retroviral budding or the budding mechanism of other envelope viruses) in order to release from the cell fully-matured eVLPs. Once formed, the Gag-Pro-Pol cleaves the protease-sensitive linker of the Gag-cargo (i.e., [Gag] -[cleav able linker] -[cargo], wherein the cargo may in some embodiments be base editor RNP, prime editor RNP, or a napDNAbp RNP), thereby releasing the RNP or other cargo molecule within the eVLP. Thus, in various embodiments, the present disclosure also provides eVLPs in which the cargo has been cleaved off of the gag protein and released within the eVLP. For example, the present disclosure provides eVLPs
comprising a group- specific antigen (gag) protease (pro) polyprotein, a cargo protein, and a second fusion protein comprising a gag nucleocapsid protein and a nuclear export sequence (NES), encapsulated by a lipid membrane and a viral envelope glycoprotein. In some embodiments, the present disclosure provides eVLPs comprising a mixture of cleaved and uncleaved products (z.e., a mixture of cargo proteins that have been cleaved from the gag protein and that have not yet been cleaved from the gag protein). In some embodiments, the cargo is fused to one or more additional domains such as one or more NLS.
[001099] Once the eVLP is administered to a recipient cell and taken up by said recipient cell, the contents of the eVLP are released. Once in the cell, the cargo may translocate to the nucleus of the cell (in particular, where NLSs are included on the cargo), where DNA editing may occur at target sites specified by a guide RNA. In some embodiments, the Gag-cargo fusion further comprises one or more nuclear export signals at one or more locations along the length of the fusion polypeptide protein which may be joined by a cleavable linker such that during eVLP assembly in the producer cell, the Gag-cargo fusions (due to presence of competing NLS signals) do not accumulate in the nucleus of the producer cells but instead are available in the cytoplasm to undergo the eVLP assembly process at the cell membrane. Once inside the matured eVLPs following release from the producer cell, the NES may be cleaved by Gag-Pro-Pol thereby separating the cargo from the NES. Upon delivery to a recipient cell, therefore, the cargo will not comprise an NES element, which may otherwise prohibit the transport of the cargo into the nucleus and hinder gene editing activity.
[001100] In some embodiments, the eVLPs comprise a gag-cargo:gag-pro-pol stoichiometry of 25% gag-cargo : 75% gag-pro-pol. In some embodiments, the ratio of gag- pro-polyprotein to gag-cargo is approximately 10:1, approximately 9:1, approximately 8:1, approximately 7:1, approximately 6:1, approximately 5:1, approximately 4:1, approximately 3:1, approximately 2:1, approximately 1.5:1, approximately 1:1, or approximately 0.5:1. [001101] Accordingly, in some embodiments, the eVLPs of the present disclosure comprise (a) an envelope, and (b) a multi-protein core, wherein the envelope comprises a lipid membrane (e.g., a lipid mono- or bi-layer membrane) and a viral envelope glycoprotein, and wherein the multi-protein core comprises a Gag (e.g., a retroviral Gag), a group-specific antigen (gag) protease (pro) polyprotein (z.e., “Gag-Pro-Pol”), and a second fusion protein comprising a Gag-cargo (e.g., Gag-napDNAbp, Gag-base editor, or Gag-prime editor). In various embodiments, the Gag-cargo may comprise a ribonucleoprotein cargo, e.g., a napDNAbp, base editor, or prime editor complexed with a guide RNA. In still further
embodiments, the Gag-cargo may comprise one or more NLS sequences and/or one or more NES sequences to regulate the cellular location of the cargo in a cell. An NLS sequence will facilitate the transport of the cargo into the cell’s nucleus to facilitate editing. An NES will do the opposite, i.e., transport the cargo out from the nucleus, and/or prevent the transport of the cargo into the nucleus. In certain embodiments, the NES may be coupled to the second fusion protein by a cleavable linker (e.g., a protease linker) such that during assembly in a producer cell, the NES signal operates to keep the cargo in the cytoplasm and available for the packaging process. However, once matured eVLPs are budded out or released from a producer cell in a mature form, the cleavable linker joining the NES may be cleaved, thereby removing the association of NES with the cargo. Thus, without an NES, the cargo will translocate to the nucleus with its NLS sequences, thereby facilitating editing. Various napDNAbps may be used in the systems of the present disclosure. In some embodiments, the napDNAbp is a Cas9 protein (e.g., a Cas9 nickase, dead Cas9 (dCas9), or another Cas9 variant). In some embodiments, the Cas9 protein is bound to a guide RNA (gRNA). The second fusion protein may further comprise other protein domains, such as effector domains. In some embodiments, the second fusion protein comprises a deaminase domain (e.g., an adenosine deaminase domain or a cytosine deaminase domain). In certain embodiments, the second fusion protein comprises a base editor, such as ABE8e, or any of the other base editors described herein or known in the art. In certain embodiments, the second fusion protein comprises a polymerase (e.g., a reverse transcriptase). In certain embodiments, the second fusion protein comprises a prime editor as described herein, or any prime editor known in the art.
[001102] In some embodiments, the second fusion protein comprises more than one NES (e.g., two NES, three NES, four NES, five NES, six NES, seven NES, eight NES, nine NES, or ten or more NES). In certain embodiments, the second fusion protein further comprises a nuclear localization sequence (NLS), or more than one NLS (e.g., two NLS, three NLS, four NLS, five NLS, six NLS, seven NLS, eight NLS, nine NLS, or ten or more NLS). In certain embodiments, the second fusion protein may comprise at least one NES and one NLS. In certain embodiments, the second fusion protein comprises at least one more NES than NLS (e.g., three NES and one or two NLS).
[001103] The Gag-cargo fusion proteins described herein (e.g., the second fusion protein) comprise one or more cleavable linkers. In one embodiment, the Gag-cargo fusion proteins comprise a cleavable linker joining the Gag to the cargo, such that once the Gag-cargo fusion
has been packaged in mature VLPs (which will also contain the Gag-Pro-Pol), the protease activity can cleave the Gag-cargo cleavable linker, thereby releasing the cargo. In some embodiments, a cleavable linker may also be provided in such a location such that when the cleavable linker is cleaved (e.g., by the Gag-Pro-Pol protein), the NES is separated away from the cargo protein. Such an arrangement of the second fusion protein allows the second fusion protein to be exported from the nucleus of a producing cell during VLP production, and the NES can later be cleaved from the second fusion protein after delivery to a target cell, or prior to delivery to the target cell but after packaging into the VLP, releasing the cargo and allowing it to enter the nucleus of the target cell. In some embodiments, the cleavable linker comprises a protease cleavage site (e.g., a Moloney murine leukemia virus (MMLV) protease cleavage site or a Friend murine leukemia virus (FMLV) protease cleavage site). Various protease cleavage sites can be used in any of the second fusion proteins of the present disclosure. In certain embodiments, the protease cleavage site comprises the amino acid sequence TSTLLMENSS (SEQ ID NO: X), PRSSLYPALTP (SEQ ID NO: X), VQALVLTQ (SEQ ID NO: X), PLQVLTLNIERR (SEQ ID NO: X), or an amino acid sequence at least 90% identical to any one of SEQ ID NO:s: X-X. In some embodiments, the protease cleavage site comprises the amino acid sequence of any one of SEQ ID NO:s: X-X comprising one mutation, two mutations, three mutations, four mutations, five mutations, or more than five mutations relative to one of SEQ ID NO:s: X-X. In some embodiments, the cleavable linker of the second fusion protein is cleaved by the protease of the gag-pro polyprotein. In certain embodiments, the cleavable linker of the second fusion protein is not cleaved by the protease of the gag-pro polyprotein until the eVLP has been assembled and delivered into a target cell. In some embodiments, the gag-pro polyprotein of the VLPs described herein comprises an MMLV gag-pro polyprotein or an FMLV gag-pro polyprotein. In some embodiments, the gag nucleocapsid protein of the second fusion protein in the eVLPs described herein comprises an MMLV gag nucleocapsid protein or an FMLV gag nucleocapsid protein.
[001104] In certain embodiments, the fusion protein comprises the following non-limiting structures:
[001105] [gag nucleocapsid protein variant]-[lx-3x NES]-[cleavable linker] -[cargo], wherein ]-[ comprises an optional linker (e.g., an amino acid linker, or any of the linkers provided herein); or
[001106] [1 x-3x NES]-[gag nucleocapsid protein variant] -[cleav able linker]-[cargo], wherein ]-[ comprises an optional linker (e.g., an amino acid linker, or any of the linkers provided herein).
[001107] In embodiments in which the cleavable linker has been cleaved by the protease within the eVLP, the eVLP may comprise a fusion protein comprising the structure [gag nucleocapsid protein]- [lx-3x NES], and a free cargo protein.
[001108] In some embodiments, any of the constructs above comprise 3x NES.
[001109] The eVLPs provided by the present disclosure comprise an outer encapsulation layer (or envelope layer) comprising a viral envelope glycoprotein. Any viral envelope glycoprotein described herein, or known in the art, may be used in the eVLPs of the present disclosure. In some embodiments, the viral envelope glycoprotein is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein. In certain embodiments, the viral envelope glycoprotein is a retroviral envelope glycoprotein. In some embodiments, the viral envelope glycoprotein is a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein. In some embodiments, the viral envelope glycoprotein targets the system to a particular cell type (e.g., immune cells, neural cells, retinal pigment epithelium cells, etc.). For example, using different envelope glycoproteins in the eVLPs described herein may alter their cellular tropism, allowing the eVLPs to be targeted to specific cell types. In some embodiments, the viral envelope glycoprotein is a VSVG protein, and the VSVG protein targets the system to retinal pigment epithelium (RPE) cells. In some embodiments, the viral envelope glycoprotein is an HIV-1 envelope glycoprotein, and the HIV-1 envelope glycoprotein targets the system to CD4+ cells. In some embodiments, the viral envelope glycoprotein is a FuG-B2 envelope glycoprotein, and the FuG-B2 envelope glycoprotein targets the system to neurons. [001110] As discussed elsewhere herein, current v4 eVLPs comprise the envelope glycoprotein VSVG, which initiates receptor- mediated endocytosis through the ubiquitously expressed LDL receptor protein (LDLR). While this permits imparts eVLPs with a broad tropism (e.g, the ability to infect many different cell types), in some embodiments, it hinders production of eVLPs with selective tropism (e.g, targeted delivery to specific cell types). Thus, in some embodiments, the envelope glycoprotein comprises a mutated envelope glycoprotein, wherein the mutated glycoprotein has impaired binding affinity for its natural
receptor but retains its fusogenic activity. In some embodiments, the eVLPs disclosed herein comprise one or more mutated envelope glycoproteins. In some embodiments, the one or more mutated envelope glycoproteins comprise VSVG. Exemplary embodiments of various mutant VSVG protein contemplated herein include:
[001111] VSVGmut amino acid sequence (K47Q/R354A, del 1-16):
KFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTALQVKMPQSHKAIQADG WMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESIEQTKQGTWENPGFPPQS CGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGKCSNYICPTVHNSTTWHS DYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYFAYETGGKACKMQYCK HWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTSVDVSLIQDVERILDYSL CQETWSKIRAGLPISPVDLSYLAPKNPGTGPAFTIINGTLKYFETRYIRVDIAAPILSRM VGMISGTTTEAELWDDWAPYEDVEIGPNGVLRTSSGYKFPLYMIGHGMLDSDLHLS SKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLII GLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ ID NO: 230)
[001112] VSVGmut amino acid sequence (K47Q/R354A):
MKCLLYLAFLFIGVNCKFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTA LQVKMPQSHKAIQADGWMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESI EQTKQGTWLNPGFPPQSCGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGK CSNYICPTVHNSTTWHSDYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYF
AYETGGKACKMQYCKHWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTS VDVSLIQDVERILDYSLCQETWSKIRAGLPISPVDLSYLAPKNPGTGPAFTIINGTLKY FETRYIRVDIAAPILSRMVGMISGTTTEAELWDDWAPYEDVEIGPNGVLRTSSGYKFP LYMIGHGMLDSDLHLSSKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEG WFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ ID NO: 231)
[001113] VSVG amino acid sequence:
MKCLLYLAFLFIGVNCKFTIVFPHNQKGNWKNVPSNYHYCPSSSDLNWHNDLIGTA LQVKMPKSHKAIQADGWMCHASKWVTTCDFRWYGPKYITHSIRSFTPSVEQCKESI EQTKQGTWLNPGFPPQSCGYATVTDAEAVIVQVTPHHVLVDEYTGEWVDSQFINGK CSNYICPTVHNSTTWHSDYKVKGLCDSNLISMDITFFSEDGELSSLGKEGTGFRSNYF
AYETGGKACKMQYCKHWGVRLPSGVWFEMADKDLFAAARFPECPEGSSISAPSQTS
VDVSEIQDVERIEDYSECQETWSKIRAGEPISPVDESYEAPKNPGTGPAFTIINGTEKY FETRYIRVDIAAPILSRMVGMISGTTTERELWDDWAPYEDVEIGPNGVLRTSSGYKFP LYMIGHGMLDSDLHLSSKAQVFEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEG WFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIEMNRLGK (SEQ ID NO: 232)
[001114] In some embodiments, the mutant VSVG protein comprises an amino acid sequence that is at least 80%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any SEQ ID NO:s: 230-232.
[001115] It will be appreciated that general methods are known in the art for producing viral vector particles, which generally contain coding nucleic acids of interest, and may also be used for producing the virus-derived particles according to the present invention, which do not contain coding nucleic acids of interest but instead are designed to deliver a protein cargo. [001116] Conventional viral vector particles encompass retroviral, lentiviral, adenoviral, and adeno-associated viral vector particles that are well known in the art. For a review of various viral vector particles that may be used, the one skilled in the art may notably refer to Kushnir et al. (2012, Vaccine, Vol. 31: 58-83), Zeltons (2013, Mol Biotechnol, Vol. 53: 92- 107), Eudwig et al. (2007, Curr Opin Biotechnol, Vol. 18(no 6): 537-55) and Naskalaska et al. (2015, Vol. 64 (no 1): 3-13). Further, references to various methods using virus-derived particles for delivering proteins to cells are found by the one skilled in the art in the article of Maetzig et al. (2012, Current Gene Therapy, Vol. 12: 389-409), as well as the article of Kaczmarczyk et al. (2011, Proc Natl Acad Sci USA, Vol. 108 (no 41): 16998-17003).
[001117] Generally, a virus-like particle that is used according to the present disclosure, which virus-like particle may also be termed “virus-derived particle,” is formed by one or more virus-derived structural protein(s) and/or one more virus-derived envelope protein.
[001118] A virus-like particle that is used according to the present invention is replication incompetent in a host cell wherein it has entered.
[001119] In preferred embodiments, a virus-like particle is formed by one or more retrovirus-derived structural protein(s) and optionally one or more virus-derived envelope protein(s).
[001120] In preferred embodiments, the virus-derived structural protein is a retroviral Gag protein or a peptide fragment thereof. As it is known in the art, Gag and Gag/pol precursors are expressed from full length genomic RNA as polyproteins, which require proteolytic cleavage, mediated by the retroviral protease (PR), to acquire a functional conformation.
Further, Gag, which is structurally conserved among the retroviruses, is composed of at least three protein units: matrix protein (MA), capsid protein (CA) and nucleocapsid protein (NC), whereas Pol consists of the retroviral protease, (PR), the retrotranscriptase (RT), and the integrase (IN).
[001121] In some embodiments, a virus-derived particle comprises a retroviral Gag protein but does not comprise a Pol protein.
[001122] As it is known in the art, the host range of retroviral vector, including lentiviral vectors, may be expanded or altered by a process known as pseudotyping. Pseudotyped lentiviral vectors consist of viral vector particles bearing glycoproteins derived from other enveloped viruses. Such pseudotyped viral vector particles possess the tropism of the virus from which the glycoprotein is derived.
[001123] In some embodiments, a virus-like particle is a pseudotyped virus-like particle comprising one or more viral structural protein(s) or viral envelope protein(s) imparting a tropism to the said virus-like particle for certain eukaryotic cells. A pseudotyped virus-like particle as described herein may comprise, as the viral protein used for pseudotyping, a viral envelope protein selected in a group comprising VSVG protein, Measles virus HA protein, Measles virus F protein, Influenza virus HA protein, Moloney virus MLV-A protein, Moloney virus MLV-E protein, Baboon Endogenous retrovirus (BAEV) envelope protein, Ebola virus glycoprotein, and foamy virus envelope protein, or a combination of two or more of these viral envelope proteins.
[001124] A well-known illustration of pseudotyping viral vector particles consists of the pseudotyping of viral vector particles with the vesicular stomatitis virus glycoprotein (VSVG). For the pseudotyping of viral vector particles, one skilled in the art may notably refer to Yee et al. (1994, Proc Natl Acad Sci, USA, Vol. 91: 9564-9568) Cronin et al. (2005, Curr Gene Ther, Vol. 5(no 4): 387-398), which are incorporated herein by reference.
[001125] For producing virus-like particles, and more precisely VSVG pseudotyped viruslike particles, for delivering protein(s) of interest into target cells, one skilled in the art may refer to Mangeot et al. (2011, Molecular Therapy, Vol. 19 (no 9): 1656-1666).
[001126] In some embodiments, a virus-like particle further comprises a viral envelope protein, wherein either (i) the said viral envelope protein originates from the same virus as the viral structural protein, e.g., originates from the same virus as the viral Gag protein, or (ii) the said viral envelope protein originates from a virus distinct from the virus from which
originates the viral structural protein, e.g., originates from a virus distinct from the virus from which originates the viral Gag protein.
[001127] As is readily understood by one skilled in the art, a virus-like particle that is used according to the disclosure may be selected in a group comprising Moloney murine leukemia virus-derived vector particles, Bovine immunodeficiency virus-derived particles, Simian immunodeficiency virus-derived vector particles, Feline immunodeficiency virus-derived vector particles, Human immunodeficiency virus-derived vector particles, Equine infection anemia virus-derived vector particles, Caprine arthritis encephalitis virus-derived vector particle, Baboon endogenous virus-derived vector particles, Rabies virus-derived vector particles, Influenza virus-derived vector particles, Norovirus-derived vector particles, Respiratory syncytial virus-derived vector particles, Hepatitis A virus-derived vector particles, Hepatitis B virus-derived vector particles, Hepatitis E virus-derived vector particles, Newcastle disease virus-derived vector particles, Norwalk virus-derived vector particles, Parvovirus-derived vector particles, Papillomavirus-derived vector particles, Yeast retrotransposon-derived vector particles, Measles virus-derived vector particles, and bacteriophage-derived vector particles.
[001128] In particular, a virus-like particle that is used according to the invention is a retrovirus-derived particle. Such retrovirus may be selected among Moloney murine leukemia virus, Bovine immunodeficiency virus, Simian immunodeficiency virus, Feline immunodeficiency virus, Human immunodeficiency virus, Equine infection anemia virus, and Caprine arthritis encephalitis virus.
[001129] In another embodiment, a virus-like particle that is used according to the disclosure is a lentivirus-derived particle. Lentiviruses belong to the retroviruses family, and have the unique ability of being able to infect non-dividing cells.
[001130] Such lentivirus may be selected among Bovine immunodeficiency virus, Simian immunodeficiency virus, Feline immunodeficiency virus, Human immunodeficiency virus, Equine infection anemia virus, and Caprine arthritis encephalitis virus.
[001131] For preparing Moloney murine leukemia virus-derived vector particles, one skilled in the art may refer to the methods disclosed by Sharma et al. (1997, Proc Natl Acad Sci USA, Vol. 94: 10803+- 10808), Guibingua et al. (2002, Molecular Therapy, Vol. 5(no 5): 538-546), which are incorporated herein by reference. Moloney murine leukemia virus- derived (MLV-derived) vector particles may be selected in a group comprising MLV-A- derived vector particles and MLV-E-derived vector particles.
[001132] For preparing Bovine Immunodeficiency virus-derived vector particles, one skilled in the art may refer to the methods disclosed by Rasmussen et al. (1990, Virology, Vol. 178(no 2): 435-451), which is incorporated herein by reference.
[001133] For preparing Simian immunodeficiency virus-derived vector particles, including VSVG pseudotyped SIV virus-derived particles, one skilled in the art may notably refer to the methods disclosed by Mangeot et al. (2000, Journal of Virology, Vol. 71(no 18): 8307- 8315), Negre et al. (2000, Gene Therapy, Vol. 7: 1613-1623) Mangeot et al. (2004, Nucleic Acids Research, Vol. 32 (no 12), el02), which are incorporated herein by reference.
[001134] For preparing Feline Immunodeficiency virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Saenz et al. (2012, Cold Spring Harb Protoc, (1): 71-76; 2012, Cold Spring Harb Protoc, (1): 124-125; 2012, Cold Spring Harb Protoc, (1): 118-123), which are incorporated herein by reference.
[001135] For preparing Human immunodeficiency virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Jalaguier et al. (2011, PlosOne, Vol. 6(no 11), e28314), Cervera et al. (J Biotechnol, Vol. 166(no 4): 152-165), Tang et al. (2012, Journal of Virology, Vol. 86(no 14): 7662-7676), which are incorporated herein by reference.
[001136] For preparing Equine infection anemia virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Olsen (1998, Gene Ther, Vol. 5(no 11): 1481-1487), which are incorporated herein by reference.
[001137] For preparing Caprine arthritis encephalitis virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Mselli-Lakhal et al. (2006, J Virol Methods, Vol. 136(no 1-2): 177-184), which are incorporated herein by reference.
[001138] For preparing Baboon endogenous virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Girard-Gagnepain et al. (2014, Blood, Vol. 124(no 8): 1221-1231), which is incorporated herein by reference.
[001139] For preparing Rabies virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Kang et al. (2015, Viruses, Vol. 7: 1134-1152, doi:10.3390/v7031134), Fontana et al. (2014, Vaccine, Vol. 32(no 24): 2799-27804) or to the PCT application published under no WO 2012/0618, which is incorporated herein by reference.
[001140] For preparing Influenza virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Quan et al. (2012, Virology, Vol. 430: 127-135)
and to Latham et al. (2001, Journal of Virology, Vol. 75(no 13): 6154-6155), which is incorporated herein by reference.
[001141] For preparing Norovirus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Tome-Amat et al., (2014, Microbial Cell Factories, Vol. 13: 134-142), which is incorporated herein by reference.
[001142] For preparing Respiratory syncytial virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Walpita et al. (2015, PlosOne, DOI: 10.1371 /journal. pone.0130755), which is incorporated herein by reference.
[001143] For preparing Hepatitis B virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Hong et al. (2013, Vol. 87(no 12): 6615-6624), which is incorporated herein by reference.
[001144] For preparing Hepatitis E virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Li et al. (1997, Journal of Virology, Vol. 71(no 10): 7207-7213), which is incorporated herein by reference.
[001145] For preparing Newcastle disease virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Murawski et al. (2010, Journal of Virology, Vol. 84(no 2): 1110-1123), which is incorporated herein by reference.
[001146] For preparing Norwalk virus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Herb st- Kralovetz et al. (2010, Expert Rev Vaccines, Vol. 9(no 3): 299-307), which is incorporated herein by reference.
[001147] For preparing Parvovirus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Ogasawara et al. (2006, In Vivo, Vol. 20: 319-324), which is incorporated herein by reference.
[001148] For preparing Papillomavirus-derived vector particles, one skilled in the art may notably refer to the methods disclosed by Wang et al. (2013, Expert Rev Vaccines, Vol. 12(no 2): doi:10.1586/erv.l2.151), which is incorporated herein by reference.
[001149] A virus-like particle that is used herein comprises a Gag protein, and most preferably a Gag protein originating from a virus selected from a group consisting of Rous Sarcoma Virus (RSV), Feline Immunodeficiency Virus (FIV), Simian Immunodeficiency Virus (SIV), Moloney Leukemia Virus (MLV), and Human Immunodeficiency Viruses (HIV-1 and HIV-2), especially Human Immunodeficiency Virus of type 1 (HIV-1).
[001150] In some embodiments, a virus-like particle may also comprise one or more viral envelope protein(s). The presence of one or more viral envelope protein(s) may impart to the
said virus-derived particle a more specific tropism for the cells which are targeted, as it is known in the art. The one or more viral envelope protein(s) may be selected from a group consisting of envelope proteins from retroviruses, envelope proteins from non-retroviral viruses, and chimeras of these viral envelope proteins with other peptides or proteins. An example of a non-lentiviral envelope glycoprotein of interest is the lymphocytic choriomeningitis virus (LCMV) strain WE54 envelope glycoprotein. These envelope glycoproteins increase the range of cells that can be transduced with retroviral derived vectors.
Polynucleotides encoding eVLPs
[001151] Aspects of the disclosure also relate to one or more polynucleotides that encode for the eVLPs disclosed herein. Additionally, the one or more polynucleotides disclosed herein may also encode any cargo encapsulated within the eVLPs, for example, a base editor or a primer editor. Thus, in some embodiments, the one or more polynucleotides comprises a first nucleic acid sequence encoding a first fusion protein. The fusion protein may be any fusion protein contemplated herein. In some embodiments, the fusion protein comprises a transmembrane domain, a targeting domain, and optionally, a stalk domain.
[001152] In some embodiments, the one or more polynucleotides comprises a second nucleic acid sequence encoding a viral envelope glycoprotein. Any suitable viral envelope glycoprotein known to one of ordinary skill may be used herein. In some embodiments, the viral envelope glycoprotein is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein. In some embodiments, the viral envelope glycoprotein is a retroviral envelope glycoprotein. Any suitable retroviral envelope glycoprotein known to the artisan of ordinary skill may be used herein, for example, vesicular stomatitis virus G protein (VSVG), baboon retroviral envelope glycoprotein (BaEVRless), FuG-B2 envelope glycoprotein, HIV-1 viral envelope glycoprotein, or ecotropic murine leukemia virus (MLV) envelope glycoprotein.
[001153] In some embodiments, the one or more polynucleotides comprises a third nucleic acid sequence encoding a mutant viral envelope glycoprotein. Any suitable mutant viral envelope glycoprotein known to one of ordinary skill may be used herein. In some embodiments, the mutated viral envelope glycoprotein is mutated version of an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein. In some embodiments, the mutated viral envelope glycoprotein is a mutated version of a retroviral envelope glycoprotein. Any
suitable mutated retroviral envelope glycoprotein known to the artisan of ordinary skill may be used herein, for example, mutated vesicular stomatitis virus G protein (VSVG TM), a mutated version of baboon retroviral envelope glycoprotein (BaEVRless), a mutated version of FuG-B2 envelope glycoprotein, a mutated version of HIV- 1 viral envelope glycoprotein, or a mutated version of ecotropic murine leukemia virus (MLV) envelope glycoprotein. [001154] In some embodiments, the one or more polynucleotides comprises a fourth nucleic acid sequence encoding a group- specific (gag) protease (pro) polyprotein. Any suitable gag- pro polyprotein known to one of ordinary skill in the art may be used herein. In certain embodiments, the gag-pro-polyprotein comprises an MMLV gag-pro polyprotein. In other embodiments, the gag-pro-polyprotein comprises a FMLV gag-pro polyprotein. Other gag- pro-polyproteins are contemplated in other embodiments.
[001155] In some embodiments, the one or more polynucleotides further comprise a fifth nucleic acid sequence that encodes for a desired cargo to be delivered to a target cell, for example, a base editor or prime editor. Thus, in some embodiments, the fourth nucleic acid sequence encodes a second fusion protein (e.g., base editor or prime editor). In certain embodiments, the second fusion protein comprises a group specific antigen (gag) nucleocapsid protein. Any suitable gag nucleocapsid protein known to one of ordinary skill may be used herein. The gag nucleocapsid protein, according to some embodiments, comprises an MMFV gag nucleocapsid protein. According to other embodiments, the gag nucleocapsid protein comprises a FMFV gag nucleocapsid protein. In certain embodiments, the second fusion protein comprises a nucleic acid programmable DNA binding protein (napDNAbp). Any suitable napDNAbp known to one of ordinary skill may be used herein. In certain embodiments, the second fusion protein comprises a cleavable linker. Any suitable cleavable linker known to one of ordinary skill may be used herein. In certain embodiments, the second fusion protein comprises a nuclear export sequence. Any suitable nuclear export sequence known to one of ordinary skill may be used herein. Combinations are also possible in some embodiments, for example, in some cases, the second fusion protein comprises a group specific antigen (gag) nucleocapsid protein, a nucleic acid programable DNA binding protein, a cleavable linker, and a nuclear export sequence.
[001156] In some embodiments, the second fusion protein further comprises one or more editing domains. Exemplary editing domains include, but are not limited to, polymerases, recombinases, integrases, adenine oxides, guanine oxidases, guanine methyltransferases, transglycosylases, adenosine methyltransferases, glycosylases, and thymine alkyltransferases.
[001157] In some embodiments, the one or more polynucleotides further comprise a sixth nucleic acid sequence that encodes for a single guide RNA (e.g., sgRNA or simply guide RNA, gRNA). As discussed elsewhere herein, gRNAs are a particular type of guide nucleic acid that associates with a napDNAbp, directing the napDNAbp to a specific sequence in a target DNA molecule that includes complementarity to the protospacer sequence of the guide RNA. Any suitable gRNA known to the artisan of ordinary skill may be used herein.
[001158] The one or more polynucleotides may comprise any suitable number polynucleotides, according to certain embodiments. For example, in one set of embodiments, the one or more polynucleotides comprise at least one polynucleotide, at least two polynucleotides, at least three polynucleotides, at least four polynucleotides, at least five polynucleotides, at least six polynucleotides, at least seven polynucleotides, at least eight polynucleotides, at least nine polynucleotides, or at least ten polynucleotides.
[001159] In some embodiments, the one or more polynucleotides may comprise at least 1 nucleic acid sequence, at least 2 nucleic acid sequences, at least 3 nucleic acid sequences, at least 4 nucleic acid sequences, at least 5 nucleic acid sequences, at least 6 nucleic acid sequences, at least 7 nucleic acid sequences, at least 8 nucleic acid sequences, at least 9 nucleic acid sequences, or at least 10 nucleic acid sequences.
[001160] In some embodiments, the one or more polynucleotides comprises (i) a first nucleic acid sequence encoding a first fusion protein, wherein the first fusion protein comprises: (1) a transmembrane domain, (2) optionally, a stalk domain, and (3) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
[001161] In some embodiments, the one or more polynucleotides comprises (i) a first nucleic acid sequence encoding a first fusion protein, wherein the first fusion protein comprises:(l) a transmembrane domain; (2) optionally, a stalk domain, and (3) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
[001162] In some embodiments, one or more vectors comprise one or more polynucleotides disclosed herein. In some embodiments, the one or more polynucleotides are on different vectors. For example, in one set of embodiments, a first vector comprises a first polynucleotide, a second vector comprises a second polynucleotide, a third vector comprises a third polynucleotide, a fourth vector comprises a fourth polynucleotide, and a fifth vector comprises a fifth polynucleotide. In other embodiments, the one or more polynucleotides are
on the same vector. For example, certain embodiments, a first vector comprises a first polynucleotide, a second polynucleotide, a third polynucleotide, a fourth polynucleotide, and a fifth polynucleotide. Other combinations are also possible in other embodiments.
[001163] In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 109 ([TPO]- [optional linker] -[VS VGTM]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 112 [SCFK9iEmon°]-[optional linker] -[ VS VGmut]. In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 133 [ADF35]- [optional linker] -[VS VGTM]. In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 92 [SCF]- [optional linker] -[ VS VG]. In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 123 ([SCF]-[optional linker] -[IgG4]- [CD 62]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 113 ([SCF] -[optional linker] -[CD 8a] -[CD43]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 115 ([SCF]-[optional linker]-[CD8a]-[CD62]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 117 ([SCF] -[optional linker] -[CD 8 a]- [HL A- A2]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 118 ([SCF] -[optional linker]- [CD8a]-[HLA-DRA]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at
least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 120 ([SCF]- [optional linker]-[CD8a]-[LFA-l]). In some embodiments, the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 197 [Z peptide] -[optional linker]-[IgG4 Fc CH3]- [optional linker]-[CD28].
[001164] Non-limiting examples of the one or more vectors comprising one or more polynucleotides comprising one or more nucleic acid sequences are provided below.
Vectors comprising polynucleotides encoding core VLP elements
GACGTCGCTAGCTGTACAAAAAAGCAGGCTTTAAAGGAACCAATTCAGTCGACT
GGATCCGGTACCAAGGTCGGGCAGGAAGAGGGCCTATTTCCCATGATTCCTTCAT
ATTTGCATATACGATACAAGGCTGTTAGAGAGATAATTAGAATTAATTTGACTGT
AAACACAAAGATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTGG
GTAGTTTGCAGTTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAA
CTTGAAAGTATTTCGATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACAC
CGTTTATCACAGGCTCCAGGAAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAA
GGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTTAAGC
TTGGGCCGCTCGAGGTACCTCTCTACATATGACATGTGAGCAAAAGGCCAGCAA
AAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGC
CCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCG
ACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTC
CTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGC
GTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTC
GCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTT
ATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTG
GCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACA
GAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTA
TCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATC
CGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATT
ACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTG
ACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAA
AAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTA
AAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCA
CCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGT
GTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGAT
ACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGC
CGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCT
ATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCA
ACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGC
TTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTG
TGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGG
CCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATG
CCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAG
AATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATAC
CGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGG
CGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTC
GTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCA
AAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATG
TTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATT
GTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGG
TTCCGCGCACATTTCCCCGAAAAGTGCCACCT (SEQ ID NO: 1)
[001166] In some embodiments, the sgRNA has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequences of SEQ ID NO: 1.
ATAAATCAATATTGGCTATTGGCCATTGCATACGTTGTATCCATATCATAATATGT
ACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGACT
AGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGT
TCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCC
CCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACT
TTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTAC
ATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATG
GCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAG
TACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACAT
CAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATT
GACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTC
GTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGG
TCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCATCC
ACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGCGGCCCC
AAGCTTGGGCATCGTTCTGTGTTGTCTCTGTCTGACTGTGTTTCTGTATTTGTCTG
AAAATATGGGCCAGACTGTTACCACTCCCTTAAGTTTGACCTTAGGTCACTGGAA
AGATGTCGAGCGGATCGCTCACAACCAGTCGGTAGATGTCAAGAAGAGACGTTG
GGTTACCTTCTGCTCTGCAGAATGGCCAACCTTTAACGTCGGATGGCCGCGAGAC
GGCACCTTTAACCGAGACCTCATCACCCAGGTTAAGATCAAGGTCTTTTCACCTG
GCCCGCATGGACACCCAGACCAGGTCCCCTACATCGTGACCTGGGAAGCCTTGG
CTTTTGACCCCCCTCCCTGGGTCAAGCCCTTTGTACACCCTAAGCCTCCGCCTCCT
CTTCCTCCATCCGCCCCGTCTCTCCCCCTTGAACCTCCTCGTTCGACCCCGCCTCG
ATCCTCCCTTTATCCAGCCCTCACTCCTTCTCTAGGCGCCAAACCTAAACCTCAAG
TTCTTTCTGACAGTGGGGGGCCGCTCATCGACCTACTTACAGAAGACCCCCCGCC
TTATAGGGACCCAAGACCACCCCCTTCCGACAGGGACGGAAATGGTGGAGAAGC
GACCCCTGCGGGAGAGGCACCGGACCCCTCCCCAATGGCATCTCGCCTACGTGG
GAGACGGGAGCCCCCTGTGGCCGACTCCACTACCTCGCAGGCATTCCCCCTCCGC
GCAGGAGGAAACGGACAGCTTCAATACTGGCCGTTCTCCTCTTCTGACCTTTACA
ACTGGAAAAATAATAACCCTTCTTTTTCTGAAGATCCAGGTAAACTGACAGCTCT
GATCGAGTCTGTCCTCATCACCCATCAGCCCACCTGGGACGACTGTCAGCAGCTG
TTGGGGACTCTGCTGACCGGAGAAGAAAAACAACGGGTGCTCTTAGAGGCTAGA
AAGGCGGTGCGGGGCGATGATGGGCGCCCCACTCAACTGCCCAATGAAGTCGAT
GCCGCTTTTCCCCTCGAGCGCCCAGACTGGGATTACACCACCCAGGCAGGTAGG
AACCACCTAGTCCACTATCGCCAGTTGCTCCTAGCGGGTCTCCAAAACGCGGGCA
GAAGCCCCACCAATTTGGCCAAGGTAAAAGGAATAACACAAGGGCCCAATGAGT
CTCCCTCGGCCTTCCTAGAGAGACTTAAGGAAGCCTATCGCAGGTACACTCCTTA
TGACCCTGAGGACCCAGGGCAAGAAACTAATGTGTCTATGTCTTTCATTTGGCAG
TCTGCCCCAGACATTGGGAGAAAGTTAGAGAGGTTAGAAGATTTAAAAAACAAG
ACGCTTGGAGATTTGGTTAGAGAGGCAGAAAAGATCTTTAATAAACGAGAAACC
CCGGAAGAAAGAGAGGAACGTATCAGGAGAGAAACAGAGGAAAAAGAAGAAC
GCCGTAGGACAGAGGATGAGCAGAAAGAGAAAGAAAGAGATCGTAGGAGACAT
AGAGAGATGAGCAAGCTATTGGCCACTGTCGTTAGTGGACAGAAACAGGATAGA
CAGGGAGGAGAACGAAGGAGGTCCCAACTCGATCGCGACCAGTGTGCCTACTGC
AAAGAAAAGGGGCACTGGGCTAAAGATTGTCCCAAGAAACCACGAGGACCTCG
GGGACCAAGACCCCAGACCTCCCTCCTGACCCTAGATGACTAGGGAGGTCAGGG
TCAGGAGCCCCCCCCTGAACCCAGGATAACCCTCAAAGTCGGGGGGCAACCCGT
CACCTTCCTGGTAGATACTGGGGCCCAACACTCCGTGCTGACCCAAAATCCTGGA
CCCCTAAGTGATAAGTCTGCCTGGGTCCAAGGGGCTACTGGAGGAAAGCGGTAT
CGCTGGACCACGGATCGCAAAGTACATCTAGCTACCGGTAAGGTCACCCACTCTT
TCCTCCATGTACCAGACTGTCCCTATCCTCTGTTAGGAAGAGATTTGCTGACTAA
ACTAAAAGCCCAAATCCACTTTGAGGGATCAGGAGCTCAGGTTATGGGACCAAT
GGGGCAGCCCCTGCAAGTGTTGACCCTAAATATAGAAGATGAGTATCGGCTACA
TGAGACCTCAAAAGAGCCAGATGTTTCTCTAGGGTCCACATGGCTGTCTGATTTT
CCTCAGGCCTGGGCGGAAACCGGGGGCATGGGACTGGCAGTTCGCCAAGCTCCT
CTGATCATACCTCTGAAAGCAACCTCTACCCCCGTGTCCATAAAACAATACCCCA
TGTCACAAGAAGCCAGACTGGGGATCAAGCCCCACATACAGAGACTGTTGGACC
AGGGAATACTGGTACCCTGCCAGTCCCCCTGGAACACGCCCCTGCTACCCGTTAA
GAAACCAGGGACTAATGATTATAGGCCTGTCCAGGATCTGAGAGAAGTCAACAA
GCGGGTGGAAGACATCCACCCCACCGTGCCCAACCCTTACAACCTCTTGAGCGG
GCTCCCACCGTCCCACCAGTGGTACACTGTGCTTGATTTAAAGGATGCCTTTTTCT
GCCTGAGACTCCACCCCACCAGTCAGCCTCTCTTCGCCTTTGAGTGGAGAGATCC
AGAGATGGGAATCTCAGGACAATTGACCTGGACCAGACTCCCACAGGGTTTCAA
AAACAGTCCCACCCTGTTTGATGAGGCACTGCACAGAGACCTAGCAGACTTCCG
GATCCAGCACCCAGACTTGATCCTGCTACAGTACGTGGATGACTTACTGCTGGCC
GCCACTTCTGAGCTAGACTGCCAACAAGGTACTCGGGCCCTGTTACAAACCCTAG
GGAACCTCGGGTATCGGGCCTCGGCCAAGAAAGCCCAAATTTGCCAGAAACAGG
TCAAGTATCTGGGGTATCTTCTAAAAGAGGGTCAGAGATGGCTGACTGAGGCCA
GAAAAGAGACTGTGATGGGGCAGCCTACTCCGAAGACCCCTCGACAACTAAGGG
AGTTCCTAGGGACGGCAGGCTTCTGTCGCCTCTGGATCCCTGGGTTTGCAGAAAT
GGCAGCCCCCTTGTACCCTCTCACCAAAACGGGGACTCTGTTTAATTGGGGCCCA
GACCAACAAAAGGCCTATCAAGAAATCAAGCAAGCTCTTCTAACTGCCCCAGCC
CTGGGGTTGCCAGATTTGACTAAGCCCTTTGAACTCTTTGTCGACGAGAAGCAGG
GCTACGCCAAAGGTGTCCTAACGCAAAAACTGGGACCTTGGCGTCGGCCGGTGG
CCTACCTGTCCAAAAAGCTAGACCCAGTAGCAGCTGGGTGGCCCCCTTGCCTACG
GATGGTAGCAGCCATTGCCGTACTGACAAAGGATGCAGGCAAGCTAACCATGGG
ACAGCCACTAGTCATTCTGGCCCCCCATGCAGTAGAGGCACTAGTCAAACAACC
CCCCGACCGCTGGCTTTCCAACGCCCGGATGACTCACTATCAGGCCTTGCTTTTG
GACACGGACCGGGTCCAGTTCGGACCGGTGGTAGCCCTGAACCCGGCTACGCTG
CTCCCACTGCCTGAGGAAGGGCTGCAACACAACTGCCTTGATATCCTGGCCGAA
GCCCACGGAACCCGACCCGACCTAACGGACCAGCCGCTCCCAGACGCCGACCAC
ACCTGGTACACGGATGGAAGCAGTCTCTTACAAGAGGGACAGCGTAAGGCGGGA
GCTGCGGTGACCACCGAGACCGAGGTAATCTGGGCTAAAGCCCTGCCAGCCGGG
ACATCCGCTCAGCGGGCTGAACTGATAGCACTCACCCAGGCCCTAAAGATGGCA
GAAGGTAAGAAGCTAAATGTTTATACTGATAGCCGTTATGCTTTTGCTACTGCCC
ATATCCATGGAGAAATATACAGAAGGCGTGGGTTGCTCACATCAGAAGGCAAAG
AGATCAAAAATAAAGACGAGATCTTGGCCCTACTAAAAGCCCTCTTTCTGCCCAA
AAGACTTAGCATAATCCATTGTCCAGGACATCAAAAGGGACACAGCGCCGAGGC
TAGAGGCAACCGGATGGCTGACCAAGCGGCCCGAAAGGCAGCCATCACAGAGA
CTCCAGACACCTCTACCCTCCTCATAGAAAATTCATCACCCTACACCTCAGAACA
TTTTCATTACACAGTGACTGATATAAAGGACCTAACCAAGTTGGGGGCCATTTAT
GATAAAACAAAGAAGTATTGGGTCTACCAAGGAAAACCTGTGATGCCTGACCAG
TTTACTTTTGAATTATTAGACTTTCTTCATCAGCTGACTCACCTCAGCTTCTCAAA
AATGAAGGCTCTCCTAGAGAGAAGCCACAGTCCCTACTACATGCTGAACCGGGA
TCGAACACTCAAAAATATCACTGAGACCTGCAAAGCTTGTGCACAAGTCAACGC
CAGCAAGTCTGCCGTTAAACAGGGAACTAGGGTCCGCGGGCATCGGCCCGGCAC
TCATTGGGAGATCGATTTCACCGAGATAAAGCCCGGATTGTATGGCTATAAATAT
CTTCTAGTTTTTATAGATACCTTTTCTGGCTGGATAGAAGCCTTCCCAACCAAGA
AAGAAACCGCCAAGGTCGTAACCAAGAAGCTACTAGAGGAGATCTTCCCCAGGT
TCGGCATGCCTCAGGTATTGGGAACTGACAATGGGCCTGCCTTCGTCTCCAAGGT
GAGTCAGACAGTGGCCGATCTGTTGGGGATTGATTGGAAATTACATTGTGCATAC
AGACCCCAAAGCTCAGGCCAGGTAGAAAGAATGAATAGAACCATCAAGGAGAC
TTTAACTAAATTAACGCTTGCAACTGGCTCTAGAGACTGGGTGCTCCTACTCCCC
TTAGCCCTGTACCGAGCCCGCAACACGCCGGGCCCCCATGGCCTCACCCCATATG
AGATCTTATATGGGGCACCCCCGCCCCTTGTAAACTTCCCTGACCCTGACATGAC
AAGAGTTACTAACAGCCCCTCTCTCCAAGCTCACTTACAGGCTCTCTACTTAGTC
CAGCACGAAGTCTGGAGACCTCTGGCGGCAGCCTACCAAGAACAACTGGACCGA
CCGGTGGTACCTCACCCTTACCGAGTCGGCGACACAGTGTGGGTCCGCCGACACC
AGACTAAGAACCTAGAACCTCGCTGGAAAGGACCTTACACAGTCCTGCTGACCA
CCCCCACCGCCCTCAAAGTAGACGGCATCGCAGCTTGGATACACGCCGCCCACG
TGAAGGCTGCCGACCCCGGGGGTGGACCATCCTCTAGACTGACATGGCGCGTTC
AACGCTCTCAAAACCCCTTAAAAATAAGGTTGACGCGTCAACCCGCGAGGCCCC
CTAATCCCCTTAATTCTTCTGATGCTCAGAGGGGTCAGTATCGAATTCCTGCAGC
CCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCC
TCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATA
AAATGAGGAAATTGCATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGT
GGGGTGGGGCAGGACAGCAAGGGGGAGGATTGGGAAGACAATAGCAGGCATGC
TGGGGATGCGGTGGGCTCTATGGCTTCTGAGGCGGAAAGAACCAGCTGGGGCTC
GATCCTCTAGAGCGGCCGCCACCGCGGTGGAGCTCCAATTCGCCCTATAGTGAGT
CGTATTACAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGG
CGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAAT
AGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGC
GAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACG
CGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTT
CCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGC
TCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGA
TTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCT
TTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAA
CACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCG
GCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACA
AAATATTAACGCTTACAATTTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACC
CCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATA
ACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACA
TTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCA
CCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGT
GGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCC
GAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTAT
TATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCA
GAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCAT
GACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGC
CAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCAC
AACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAA
GCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACG
TTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAA
TAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCC
GGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGT
ATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACA CGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATA GGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATAC TTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTT TTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTC AGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTA ATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGG ATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGAT ACCAAATACTGTTCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCT GTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCA GTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATA AGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGC GAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCA CGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGA ACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGT CCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGG GGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGC CTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGA TAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACC GAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACC GCCTCTCCCCGCGCGTTGGCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCC GACTGGAAAGCGGGCAGTGAGCGCAACGCAATTAATGTGAGTTAGCTCACTCAT TAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGT GAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGATTACGCCAAGCT CGAAATTAACCCTCACTAAAGGGAACAAAAGCTGGTACCGGGCCCCCCCTCGAG ATCCGGCCATTAGCCATATTATTCATTGGTTATATAGC (SEQ ID NO: 2)
[001168] In some embodiments, the MLV-gag-pro-pol protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequences of SEQ ID NO:s. 2.
ATGGGCCAGACTGTTACCACTCCCTTAAGTTTGACCTTAGGTCACTGGAAAGATG
TCGAGCGGATCGCTCACAACCAGTCGGTAGATGTCAAGAAGAGACGTTGGGTTA
CCTTCTGCTCTGCAGAATGGCCAACCTTTAACGTCGGATGGCCGCGAGACGGCAC
CTTTAACCGAGACCTCATCACCCAGGTTAAGATCAAGGTCTTTTCACCTGGCCCG
CATGGACACCCAGACCAGGTCCCCTACATCGTGACCTGGGAAGCCTTGGCTTTTG
ACCCCCCTCCCTGGGTCAAGCCCTTTGTACACCCTAAGCCTCCGCCTCCTCTTCCT
CCATCCGCCCCGTCTCTCCCCCTTGAACCTCCTCGTTCGACCCCGCCTCGATCCTC
CCTTTATCCAGCCCTCACTCCTTCTCTAGGCGCCAAACCTAAACCTCAAGTTCTTT
CTGACAGTGGGGGGCCGCTCATCGACCTACTTACAGAAGACCCCCCGCCTTATAG
GGACCCAAGACCACCCCCTTCCGACAGGGACGGAAATGGTGGAGAAGCGACCCC
TGCGGGAGAGGCACCGGACCCCTCCCCAATGGCATCTCGCCTACGTGGGAGACG
GGAGCCCCCTGTGGCCGACTCCACTACCTCGCAGGCATTCCCCCTCCGCGCAGGA
GGAAACGGACAGCTTCAATACTGGCCGTTCTCCTCTTCTGACCTTTACAACTGGA
AAAATAATAACCCTTCTTTTTCTGAAGATCCAGGTAAACTGACAGCTCTGATCGA
GTCTGTCCTCATCACCCATCAGCCCACCTGGGACGACTGTCAGCAGCTGTTGGGG
ACTCTGCTGACCGGAGAAGAAAAACAACGGGTGCTCTTAGAGGCTAGAAAGGCG
GTGCGGGGCGATGATGGGCGCCCCACTCAACTGCCCAATGAAGTCGATGCCGCT
TTTCCCCTCGAGCGCCCAGACTGGGATTACACCACCCAGGCAGGTAGGAACCAC
CTAGTCCACTATCGCCAGTTGCTCCTAGCGGGTCTCCAAAACGCGGGCAGAAGCC
CCACCAATTTGGCCAAGGTAAAAGGAATAACACAAGGGCCCAATGAGTCTCCCT
CGGCCTTCCTAGAGAGACTTAAGGAAGCCTATCGCAGGTACACTCCTTATGACCC
TGAGGACCCAGGGCAAGAAACTAATGTGTCTATGTCTTTCATTTGGCAGTCTGCC
CCAGACATTGGGAGAAAGTTAGAGAGGTTAGAAGATTTAAAAAACAAGACGCTT
GGAGATTTGGTTAGAGAGGCAGAAAAGATCTTTAATAAACGAGAAACCCCGGAA
GAAAGAGAGGAACGTATCAGGAGAGAAACAGAGGAAAAAGAAGAACGCCGTA
GGACAGAGGATGAGCAGAAAGAGAAAGAAAGAGATCGTAGGAGACATAGAGA
GATGAGCAAGCTATTGGCCACTGTCGTTAGTGGACAGAAACAGGATAGACAGGG
AGGAGAACGAAGGAGGTCCCAACTCGATCGCGACCAGTGTGCCTACTGCAAAGA
AAAGGGGCACTGGGCTAAAGATTGTCCCAAGAAACCACGAGGACCTCGGGGACC
AAGACCCCAGACCTCCCTCCTGACCCTAGATGACTCTGGCGGCTCACTTCAACTG
CCTCCACTTGAAAGACTGACACTGGGATCATTACAATTACCTCCTTTAGAACGAT
TAACACTCGGTTCACTACAGCTTCCGCCTCTTGAGAGATTGACATTAACGTCCAC
GCTGCTAATGGAGAACTCGTCTGGAGATTACAAAGACGATGACGATAAGAAACG
GACAGCCGACGGAAGCGAGTTCGAGTCACCAAAGAAGAAGCGGAAAGTCTCTG
AGGTGGAGTTTTCCCACGAGTACTGGATGAGACATGCCCTGACCCTGGCCAAGA
GGGCACGGGATGAGAGGGAGGTGCCTGTGGGAGCCGTGCTGGTGCTGAACAATA
GAGTGATCGGCGAGGGCTGGAACAGAGCCATCGGCCTGCACGACCCAACAGCCC
ATGCCGAAATTATGGCCCTGAGACAGGGCGGCCTGGTCATGCAGAACTACAGAC
TGATTGACGCCACCCTGTACGTGACATTCGAGCCTTGCGTGATGTGCGCCGGCGC
CATGATCCACTCTAGGATCGGCCGCGTGGTGTTTGGCGTGAGGAACTCAAAAAG
AGGCGCCGCAGGCTCCCTGATGAACGTGCTGAACTACCCCGGCATGAATCACCG
CGTCGAAATTACCGAGGGAATCCTGGCAGATGAATGTGCCGCCCTGCTGTGCGA
TTTCTATCGGATGCCTAGACAGGTGTTCAATGCTCAGAAGAAGGCCCAGAGCTCC
ATCAACTCCGGAGGATCTAGCGGAGGCTCCTCTGGCTCTGAGACACCTGGCACA
AGCGAGAGCGCAACACCTGAAAGCAGCGGGGGCAGCAGCGGGGGGTCAGACAA
GAAGTACAGCATCGGCCTGGCCATCGGCACCAACTCTGTGGGCTGGGCCGTGAT
CACCGACGAGTACAAGGTGCCCAGCAAGAAATTCAAGGTGCTGGGCAACACCGA
CCGGCACAGCATCAAGAAGAACCTGATCGGAGCCCTGCTGTTCGACAGCGGCGA
AACAGCCGAGGCCACCCGGCTGAAGAGAACCGCCAGAAGAAGATACACCAGAC
GGAAGAACCGGATCTGCTATCTGCAAGAGATCTTCAGCAACGAGATGGCCAAGG
TGGACGACAGCTTCTTCCACAGACTGGAAGAGTCCTTCCTGGTGGAAGAGGATA
AGAAGCACGAGCGGCACCCCATCTTCGGCAACATCGTGGACGAGGTGGCCTACC
ACGAGAAGTACCCCACCATCTACCACCTGAGAAAGAAACTGGTGGACAGCACCG
ACAAGGCCGACCTGCGGCTGATCTATCTGGCCCTGGCCCACATGATCAAGTTCCG
GGGCCACTTCCTGATCGAGGGCGACCTGAACCCCGACAACAGCGACGTGGACAA
GCTGTTCATCCAGCTGGTGCAGACCTACAACCAGCTGTTCGAGGAAAACCCCATC
AACGCCAGCGGCGTGGACGCCAAGGCCATCCTGTCTGCCAGACTGAGCAAGAGC
AGACGGCTGGAAAATCTGATCGCCCAGCTGCCCGGCGAGAAGAAGAATGGCCTG
TTCGGAAACCTGATTGCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACT
TCGACCTGGCCGAGGATGCCAAACTGCAGCTGAGCAAGGACACCTACGACGACG
ACCTGGACAACCTGCTGGCCCAGATCGGCGACCAGTACGCCGACCTGTTTCTGGC
CGCCAAGAACCTGTCCGACGCCATCCTGCTGAGCGACATCCTGAGAGTGAACAC
CGAGATCACCAAGGCCCCCCTGAGCGCCTCTATGATCAAGAGATACGACGAGCA
CCACCAGGACCTGACCCTGCTGAAAGCTCTCGTGCGGCAGCAGCTGCCTGAGAA
GTACAAAGAGATTTTCTTCGACCAGAGCAAGAACGGCTACGCCGGCTACATTGA
CGGCGGAGCCAGCCAGGAAGAGTTCTACAAGTTCATCAAGCCCATCCTGGAAAA
GATGGACGGCACCGAGGAACTGCTCGTGAAGCTGAACAGAGAGGACCTGCTGCG
GAAGCAGCGGACCTTCGACAACGGCAGCATCCCCCACCAGATCCACCTGGGAGA
GCTGCACGCCATTCTGCGGCGGCAGGAAGATTTTTACCCATTCCTGAAGGACAAC
CGGGAAAAGATCGAGAAGATCCTGACCTTCCGCATCCCCTACTACGTGGGCCCTC
TGGCCAGGGGAAACAGCAGATTCGCCTGGATGACCAGAAAGAGCGAGGAAACC
ATCACCCCCTGGAACTTCGAGGAAGTGGTGGACAAGGGCGCTTCCGCCCAGAGC
TTCATCGAGCGGATGACCAACTTCGATAAGAACCTGCCCAACGAGAAGGTGCTG
CCCAAGCACAGCCTGCTGTACGAGTACTTCACCGTGTATAACGAGCTGACCAAA
GTGAAATACGTGACCGAGGGAATGAGAAAGCCCGCCTTCCTGAGCGGCGAGCAG
AAAAAGGCCATCGTGGACCTGCTGTTCAAGACCAACCGGAAAGTGACCGTGAAG
CAGCTGAAAGAGGACTACTTCAAGAAAATCGAGTGCTTCGACTCCGTGGAAATC
TCCGGCGTGGAAGATCGGTTCAACGCCTCCCTGGGCACATACCACGATCTGCTGA
AAATTATCAAGGACAAGGACTTCCTGGACAATGAGGAAAACGAGGACATTCTGG
AAGATATCGTGCTGACCCTGACACTGTTTGAGGACAGAGAGATGATCGAGGAAC
GGCTGAAAACCTATGCCCACCTGTTCGACGACAAAGTGATGAAGCAGCTGAAGC
GGCGGAGATACACCGGCTGGGGCAGGCTGAGCCGGAAGCTGATCAACGGCATCC
GGGACAAGCAGTCCGGCAAGACAATCCTGGATTTCCTGAAGTCCGACGGCTTCG
CCAACAGAAACTTCATGCAGCTGATCCACGACGACAGCCTGACCTTTAAAGAGG
ACATCCAGAAAGCCCAGGTGTCCGGCCAGGGCGATAGCCTGCACGAGCACATTG
CCAATCTGGCCGGCAGCCCCGCCATTAAGAAGGGCATCCTGCAGACAGTGAAGG
TGGTGGACGAGCTCGTGAAAGTGATGGGCCGGCACAAGCCCGAGAACATCGTGA
TCGAAATGGCCAGAGAGAACCAGACCACCCAGAAGGGACAGAAGAACAGCCGC
GAGAGAATGAAGCGGATCGAAGAGGGCATCAAAGAGCTGGGCAGCCAGATCCT
GAAAGAACACCCCGTGGAAAACACCCAGCTGCAGAACGAGAAGCTGTACCTGTA
CTACCTGCAGAATGGGCGGGATATGTACGTGGACCAGGAACTGGACATCAACCG
GCTGTCCGACTACGATGTGGACCATATCGTGCCTCAGAGCTTTCTGAAGGACGAC
TCCATCGACAACAAGGTGCTGACCAGAAGCGACAAGAACCGGGGCAAGAGCGA
CAACGTGCCCTCCGAAGAGGTCGTGAAGAAGATGAAGAACTACTGGCGGCAGCT
GCTGAACGCCAAGCTGATTACCCAGAGAAAGTTCGACAATCTGACCAAGGCCGA
GAGAGGCGGCCTGAGCGAACTGGATAAGGCCGGCTTCATCAAGAGACAGCTGGT
GGAAACCCGGCAGATCACAAAGCACGTGGCACAGATCCTGGACTCCCGGATGAA
CACTAAGTACGACGAGAATGACAAGCTGATCCGGGAAGTGAAAGTGATCACCCT
GAAGTCCAAGCTGGTGTCCGATTTCCGGAAGGATTTCCAGTTTTACAAAGTGCGC
GAGATCAACAACTACCACCACGCCCACGACGCCTACCTGAACGCCGTCGTGGGA
ACCGCCCTGATCAAAAAGTACCCTAAGCTGGAAAGCGAGTTTGTGTACGGCGAC
TACAAGGTGTACGACGTGCGGAAGATGATCGCCAAGAGCGAGCAGGAAATCGG
CAAGGCTACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTTTTCAAGACC
GAGATTACCCTGGCCAACGGCGAGATCCGGAAGCGGCCTCTGATCGAGACAAAC
GGCGAAACCGGGGAGATCGTGTGGGATAAGGGCCGGGATTTTGCCACCGTGCGG
AAAGTGCTGAGCATGCCCCAAGTGAATATCGTGAAAAAGACCGAGGTGCAGACA
GGCGGCTTCAGCAAAGAGTCTATCCTGCCCAAGAGGAACAGCGATAAGCTGATC
GCCAGAAAGAAGGACTGGGACCCTAAGAAGTACGGCGGCTTCGACAGCCCCACC
GTGGCCTATTCTGTGCTGGTGGTGGCCAAAGTGGAAAAGGGCAAGTCCAAGAAA
CTGAAGAGTGTGAAAGAGCTGCTGGGGATCACCATCATGGAAAGAAGCAGCTTC
GAGAAGAATCCCATCGACTTTCTGGAAGCCAAGGGCTACAAAGAAGTGAAAAAG
GACCTGATCATCAAGCTGCCTAAGTACTCCCTGTTCGAGCTGGAAAACGGCCGG
AAGAGAATGCTGGCCTCTGCCGGCGAACTGCAGAAGGGAAACGAACTGGCCCTG
CCCTCCAAATATGTGAACTTCCTGTACCTGGCCAGCCACTATGAGAAGCTGAAGG
GCTCCCCCGAGGATAATGAGCAGAAACAGCTGTTTGTGGAACAGCACAAGCACT
ACCTGGACGAGATCATCGAGCAGATCAGCGAGTTCTCCAAGAGAGTGATCCTGG
CCGACGCTAATCTGGACAAAGTGCTGTCCGCCTACAACAAGCACCGGGATAAGC
CCATCAGAGAGCAGGCCGAGAATATCATCCACCTGTTTACCCTGACCAATCTGGG
AGCCCCTGCCGCCTTCAAGTACTTTGACACCACCATCGACCGGAAGAGGTACACC
AGCACCAAAGAGGTGCTGGACGCCACCCTGATCCACCAGAGCATCACCGGCCTG
TACGAGACACGGATCGACCTGTCTCAGCTGGGAGGTGACTCTGGCGGCTCAAAA
AGAACCGCCGACGGCAGCGAATTCGAGCCCAAGAAGAAGAGGAAAGTCTGAGA
TCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTG
ACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGTGTGTTGGAATTTTTT
GTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACATCAGAA
TGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAAC
AAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATT
CCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTTTTTATATTTTGTTTT
GTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAGA
TTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAG
ATCCCTCGACGGATCGGCCGCAATTCGTAACCATGTCATAGCTGTTTCCTGTGTG
AAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTG
TAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCA
CTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCC
AACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCAC
TGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAG
GCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGA
GCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTT
TTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAG
AGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGC
TCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTT
TCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTT
CGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCC
CGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTAT
GTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGA
AGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAG
TTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGT
TTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGAT
CTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTG
GTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAA
GTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATG
CTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTG
CCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCC
CAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCA
ATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCC
GCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAG
TTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTC
GTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACA
TGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTG
TCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAA
TTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAA
CCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTC
AATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGG
AAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGT
TCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAG
CGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAA
GGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAG
CATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAA
AATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTG
TAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTT
TTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACC
GAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAAC
GTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTA
CGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAA
ATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGA
ACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG
GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCG
CCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGG
CGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCT
GCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAA
ACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTC
CACCGCGGTGGCGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCAT
ATCATAATATGTACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACAT
TGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCC
CATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACC
GCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACG
CCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCC
ACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAA
TGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTT
CCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGT
TTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAG
TCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGAC
TTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTG
TACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGACGCCATCCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAG
CCTCCGGTCGACCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGT
TCTTTCTTTTTCGCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAG
GGTGTTGTTTAGAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAA
TTTTGTTTCTTTCACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTT
CATTTTCTGTAACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAAT
TCACTTTTGTTTATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAG
GCAATCAGGGTATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTAT
AATTAAATGATAAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAAT
ATTCTTATTGGTAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATG
GTTACAATGATATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCG
GGCCCCTCTGCTAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAA
CGTGCTGGTTGTTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGAGGGCCGG ATCCGAATTCCTGTATTTGTCTGAAAAC (SEQ ID NO: 3)
[001170] In some embodiments, the MLV gag-cargo protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequences of SEQ ID NO:s. 3.
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGC
AAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTT
CTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAAT
AGGCACAGCCTTACAAGTCAAAATGCCCAAGAGTCACAAGGCTATTCAAGCAGA
CGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATG
GACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATG
CAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCC
TCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAG
GTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCAC
AGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTAC
AACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCC
ATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAG
GGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGC
AAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTC
GAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAG
GGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGA
CGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAG
AGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCA
GGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCA
GATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGAT
CAGTGGAACTACCACAGAAAGGGAACTGTGGGATGACTGGGCACCATATGAAGA
CGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCT
TTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGG
CTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGA
TGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTA
GAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGG
GTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAAT
TAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTG
GAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTT
GTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAA
AAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCA
GGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCA
CAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAG
CCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGT
GTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCAT TTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGC TGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGC CCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTT TTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACAT GTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCC TCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATA GCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCC GGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTA ATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGC ATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 4)
[001172] In some embodiments, the VSVG envelope glycoprotein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequences of SEQ ID NO:s. 4.
GAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCG
CTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACG
GTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCC
AGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
TCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAA
ACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCG
CTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGG
GAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGT
CGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGC
GCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGC
CACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTG
CTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATT
TGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCT
TGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGC
AGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGG
GGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATT
ATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCA
ATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTG
AGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA
ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAG
CCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATC
CAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTT
TGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGG
TATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCC
ATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTA
AGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTAC
TGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCA
TTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGG
ATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTC
TTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAA
CCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGG
GTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAG
GGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAA
TAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTAAATTGTAAGCGTTAAT
ATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATA
GGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTT
GAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAAC
GTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCA
CCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTA
AAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGA
AAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGC
GGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGG
CGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCG
GGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATT
AAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAG
TGAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGAGCTCCACCGCGGTGG
CGGCCGCTCTAGAGAGCTTGGCCCATTGCATACGTTGTATCCATATCATAATATG
TACATTTATATTGGCTCATGTCCAACATTACCGCCATGTTGACATTGATTATTGAC
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAG
TTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACC
CCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGAC
TTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTA
CATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAAT
GGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCA
GTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTAC
ATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCA
TTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATG
TCGTAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGA
GGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCAT
CCACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGTCGA
CCGATCCTGAGAACTTCAGGGTGAGTTTGGGGACCCTTGATTGTTCTTTCTTTTTC
GCTATTGTAAAATTCATGTTATATGGAGGGGGCAAAGTTTTCAGGGTGTTGTTTA
GAATGGGAAGATGTCCCTTGTATCACCATGGACCCTCATGATAATTTTGTTTCTTT
CACTTTCTACTCTGTTGACAACCATTGTCTCCTCTTATTTTCTTTTCATTTTCTGTA
ACTTTTTCGTTAAACTTTAGCTTGCATTTGTAACGAATTTTTAAATTCACTTTTGTT
TATTTGTCAGATTGTAAGTACTTTCTCTAATCACTTTTTTTTCAAGGCAATCAGGG
TATATTATATTGTACTTCAGCACAGTTTTAGAGAACAATTGTTATAATTAAATGAT
AAGGTAGAATATTTCTGCATATAAATTCTGGCTGGCGTGGAAATATTCTTATTGG
TAGAAACAACTACACCCTGGTCATCATCCTGCCTTTCTCTTTATGGTTACAATGAT
ATACACTGTTTGAGATGAGGATAAAATACTCTGAGTCCAAACCGGGCCCCTCTGC
TAACCATGTTCATGCCTTCTTCTCTTTCCTACAGCTCCTGGGCAACGTGCTGGTTG
TTGTGCTGTCTCATCATTTTGGCAAAGAATTCCTCGACGGATCCCTCGAGGAATT
CTGACACTATGAAGTGCCTTTTGTACTTAGCCTTTTTATTCATTGGGGTGAATTGC
AAGTTCACCATAGTTTTTCCACACAACCAAAAAGGAAACTGGAAAAATGTTCCTT
CTAATTACCATTATTGCCCGTCAAGCTCAGATTTAAATTGGCATAATGACTTAAT
AGGCACAGCCTTACAAGTCAAAATGCCCCAGAGTCACAAGGCTATTCAAGCAGA
CGGTTGGATGTGTCATGCTTCCAAATGGGTCACTACTTGTGATTTCCGCTGGTATG
GACCGAAGTATATAACACATTCCATCCGATCCTTCACTCCATCTGTAGAACAATG
CAAGGAAAGCATTGAACAAACGAAACAAGGAACTTGGCTGAATCCAGGCTTCCC
TCCTCAAAGTTGTGGATATGCAACTGTGACGGATGCCGAAGCAGTGATTGTCCAG
GTGACTCCTCACCATGTGCTGGTTGATGAATACACAGGAGAATGGGTTGATTCAC
AGTTCATCAACGGAAAATGCAGCAATTACATATGCCCCACTGTCCATAACTCTAC
AACCTGGCATTCTGACTATAAGGTCAAAGGGCTATGTGATTCTAACCTCATTTCC
ATGGACATCACCTTCTTCTCAGAGGACGGAGAGCTATCATCCCTGGGAAAGGAG
GGCACAGGGTTCAGAAGTAACTACTTTGCTTATGAAACTGGAGGCAAGGCCTGC
AAAATGCAATACTGCAAGCATTGGGGAGTCAGACTCCCATCAGGTGTCTGGTTC
GAGATGGCTGATAAGGATCTCTTTGCTGCAGCCAGATTCCCTGAATGCCCAGAAG
GGTCAAGTATCTCTGCTCCATCTCAGACCTCAGTGGATGTAAGTCTAATTCAGGA
CGTTGAGAGGATCTTGGATTATTCCCTCTGCCAAGAAACCTGGAGCAAAATCAG
AGCGGGTCTTCCAATCTCTCCAGTGGATCTCAGCTATCTTGCTCCTAAAAACCCA
GGAACCGGTCCTGCTTTCACCATAATCAATGGTACCCTAAAATACTTTGAGACCA
GATACATCAGAGTCGATATTGCTGCTCCAATCCTCTCAAGAATGGTCGGAATGAT
CAGTGGAACTACCACAGAAGCGGAACTGTGGGATGACTGGGCACCATATGAAGA
CGTGGAAATTGGACCCAATGGAGTTCTGAGGACCAGTTCAGGATATAAGTTTCCT
TTATACATGATTGGACATGGTATGTTGGACTCCGATCTTCATCTTAGCTCAAAGG
CTCAGGTGTTCGAACATCCTCACATTCAAGACGCTGCTTCGCAACTTCCTGATGA
TGAGAGTTTATTTTTTGGTGATACTGGGCTATCCAAAAATCCAATCGAGCTTGTA
GAAGGTTGGTTCAGTAGTTGGAAAAGCTCTATTGCCTCTTTTTTCTTTATCATAGG
GTTAATCATTGGACTATTCTTGGTTCTCCGAGTTGGTATCCATCTTTGCATTAAAT
TAAAGCACACCAAGAAAAGACAGATTTATACAGACATAGAGATGAACCGACTTG
GAAAGTAACTCAAATCCTGCACAACAGATTCTTCATGTTTGGACCAAATCAACTT
GTGATACCATGCTCAAAGAGGCCTCAATTATATTTGAGTTTTTAATTTTTATGAAA
AAAAAAAAAAAAAACGGAATTCCTCGAGGGATCCGTCGAGGAATTCACTCCTCA
GGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCA CAAATACCACTGAGATCTTTTTCCCTCTGCCAAAAATTATGGGGACATCATGAAG CCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTTTCATTGCAATAGT GTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCAT TTAAAACATCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGC TGGCTGCCATGAACAAAGGTTGGCTATAAAGAGGTCATCAGTATATGAAACAGC CCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGATTTTT TTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACAT GTTTTACTAGCCAGATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCC TCTTCTCTTATGGAGATCCCTCGACGGATCGGCCGCAATTCGTAATCATGTCATA GCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCC GGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTA ATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGC
ATTAATGAATCGGCCAACGCGCGGGGA (SEQ ID NO: 5)
[001174] In some embodiments, the VSVG mutant has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequences of SEQ ID NO:s. 5.
Methods and uses thereof
[001175] Other aspects of the disclosure relate to one or more methods. In some embodiments, the methods are directed toward delivering any of the viral-like particle disclosed herein to a target cell comprising preparing any one of (1) the viral-like particles disclosed herein, (2) the one or more polynucleotides disclosed herein, (3) the one or more vectors disclosed herein or (4) the cells disclosed herein, and contacting a target cell with one or more of said compositions
[001176] Other aspects of the present disclosure relate to methods of preparing the eVLPs disclosed herein. Any suitable method for producing the eVLPs of the present disclosure may be used by the skilled artisan. For example, in some embodiments, methods for producing the presently described eVLPs comprise transfecting, transducing, electroporating, or otherwise inserting into a producer cell one or more polynucleotides that together encode all the components of the eVLPs (e.g., any of the pluralities of polynucleotides described herein). In some embodiments, the polynucleotides which are transfected, transduced, electroporated, or otherwise inserted into a producer cell comprise: (i) a first polynucleotide
comprising a nucleic acid sequence encoding a viral envelope glycoprotein; (ii) a second polynucleotide comprising a nucleic acid sequence encoding a group -specific antigen (gag) protease (pro) polyprotein; (iii) a third polynucleotide comprising a nucleic acid sequence encoding a fusion protein, wherein the fusion protein comprises: (a) a group- specific antigen (gag) nucleocapsid protein; (b) a nucleic acid programmable DNA binding protein (napDNAbp); (c) a cleavable linker; and (d) a nuclear export sequence (NES); and (iv) a fourth polynucleotide comprising a nucleic acid sequence encoding a guide RNA (gRNA), wherein the gRNA binds to the napDNAbp of the fusion protein encoded by the third polynucleotide.
[001177] In some embodiments, once the producer cell expresses the polynucleotides, the various components of the eVLPs self-assemble spontaneously within the producer cells. Assembly of the eVLPs relies on multimerization of the gag polyproteins encoded on the polynucleotides as described above. The gag polyproteins (some of which are fused to a gene editing agent, such as a Cas9 protein, a base editor, or a prime editor) multimerize at the cell membrane of a producer cell and are subsequently released into the producer cell supernatant spontaneously. Thus, eVLPs may be produced by transient transfection of producer cells (for example, Gesicle Producer 293T cells) as described in the Examples herein. All of the polynucleotides required for production of the eVLPs may be transfected into the producer cells simultaneously, or each polynucleotide needed may be transfected one at a time. In some embodiments, a single polynucleotide encodes all the components needed to produce the eVLPs described herein. Pollowing transfection and incubation of the producer cells (e.g., for about 2 hours, about 3 hours, about 4 hours, about 5 hours, about 6 hours, about 7 hours, about 8 hours, about 9 hours, about 10 hours, about 15 hours, about 24 hours, about 36 hours, about 48 hours, or more than 48 hours), producer cell supernatant may be harvested, and eVLPs may be purified therefrom.
[001178] Any cell capable of expressing a foreign polynucleotide may be used to produce the eVLPs described herein. Lor example, the present disclosure contemplates the use of any of the cells listed in the Kits and Cells section herein for production of the eVLPs, or any other cell known in the art capable of expressing a foreign polynucleotide. In some embodiments, the producer cells are HEK Gesicle produce cells. In some embodiments, the producer cells are immune cells. In other embodiments, the cells are neural cells. In other embodiments still the cells are retinal pigment epithelium cells. .
[001179] Overview of an embodiment of the manufacture of eVLPs comprising gene editing cargo in a producer cell using a set of expression plasmids which encode the various self-assembling components of the eVLPs: (a) plasmid encoding a Gag-BE fusion protein (e.g., a retroviral Gag, MMLV-Gag-BE fusion protein); (b) plasmid encoding a Gag-Pro-Pol protein (e.g., a retroviral proteins, such as a MMLV protease precursor); (c) a plasmid encoding a BE sgRNA; and (d) a plasmid encoding an envelope glycoprotein (e.g., the spike glycoprotein of the vesicular stomatitis virus (VSV-G)). The plasmids are transiently cotransfected into the producer cell and the encoded protein and sgRNA products are encoded. In some embodiments, such as the fourth-generation eVLPs described herein, the inventors found an optimized stoichiometry ratio of Gag-cargo fusion to Gag-Pro-Pol fusion protein which balances the amount of Gag-cargo available to be packaged into VLPs with the amount of retrovirus protease (the “Pro” in the Gag-Pro-Pol fusion) required for VLP maturation. In one embodiment, the optimized ratio of Gag-cargo fusion to Gag-Pro-Pol fusion protein is achieved by the appropriate ratio of plasmids encoding each component which are transiently delivered to the producer cells. In one embodiment, to modulate the stoichiometry of the Gag-cargo fusion to Gag-Pro-Pol fusion, the ratio of the plasmid encoding Gag-cargo (e.g., Gag-3 xNES-ABE8e) to wild-type MMLV gag-pro-pol plasmids transfected for VLP production was varied.
[001180] Other methods are directed to methods of editing a nucleic acid molecule in a target cell using any of the eVLPs disclosed herein. In some embodiments the methods comprise contacting the target cell with any of the eVLPs, polynucleotides, vectors, and/or cells disclosed herein, wherein the eVLPs encapsulate a gene editor (e.g., base editor or prime editor), and wherein upon transduction the gene editor installs one or more modifications to the nucleic acid molecule at a target site. The eVLPs disclosed herein may be used to edit any suitable nucleic acid in any suitable target cell known to an artisan of ordinary skill in the art. In some embodiments, the target cell is a mammalian cell (e.g., a human cell). In certain embodiments, the target cell is a human cell. However, other target cells are possible other embodiments. Lor example, in some embodiments, the target cell is a plant cell.
[001181] In some embodiments, the target cell is in a subject (e.g., a human). In certain embodiments, the subject is a human. However, the subject may be any mammalian species, such as dog, cat, sheep, cow, camel, horse, goat, and the like, according to some embodiments.
[001182] As described in more detail above, the methods, according to some embodiments, install one or more modifications to the nucleic acid molecule at a target site. Without wishing to be bound by theory, it is believed that installation of the one or more modifications to the nucleic acid molecule are associated with reducing, relieving, or preventing the symptoms of a disease or disorder. Any disease or disorder capable of being treated using the methods disclosed herein are herein contemplated. For example, in some embodiments, the disease or disorder is a central nervous system (CNS) disease or disorder. In other embodiments, the disease or disorder is a liver disease or disorder. In other embodiments still, the disease or disorder is an ocular disease or disorder.
[001183] In other embodiments, the methods comprise treating a disease by gene editing using the eVLPs disclosed herein. In some embodiments, the methods comprise contacting a target cell any of the eVLPs, polynucleotides, vectors, and/or cells disclosed herein, wherein the eVLPs encapsulate a gene editor (e.g., base editor or prime editor), and wherein upon transduction the gene editor installs one or more modifications to the nucleic acid molecule at a target site, and wherein the one or more modifications are associated with reducing, relieving, or preventing the symptoms of a disease or disorder. In some embodiments, the disease or disorder is a central nervous system (CNS) disease or disorder. In other embodiments, the disease or disorder is a liver disease or disorder. In other embodiments still, the disease or disorder is an ocular disease or disorder.
[001184] In other embodiments, the methods are directed toward treating a disease comprising contacting a target cell with the eVLPs, polynucleotides, and/or vectors disclsosed herein. In some embodiments, the cargo encapsulated within the eVLPs is a therapeutic intended to reduce, relieve, cure or prevent the symptoms of a disease or disorder.
Pharmaceutical compositions
[001185] Other aspects of the present disclosure relate to pharmaceutical compositions comprising any of the VLPs, nucleocapsid protein variants, polynucleotides, and vectors provided herein. The term “pharmaceutical composition,” as used herein, refers to a composition formulated for pharmaceutical use. In some embodiments, the pharmaceutical composition further comprises a pharmaceutically acceptable carrier. In some embodiments, the pharmaceutical composition comprises additional agents (e.g., for specific delivery, increasing half-life, or other therapeutic compounds).
[001186] As used here, the term “pharmaceutically-acceptable carrier” means a pharmaceutically-acceptable material, composition or vehicle, such as a liquid or solid filler,
diluent, excipient, manufacturing aid (e.g., lubricant, talc magnesium, calcium or zinc stearate, or steric acid), or solvent encapsulating material, involved in carrying or transporting the compound from one site (e.g., the delivery site) of the body, to another site (e.g., organ, tissue or portion of the body). A pharmaceutically acceptable carrier is “acceptable” in the sense of being compatible with the other ingredients of the formulation and not injurious to the tissue of the subject (e.g., physiologically compatible, sterile, physiologic pH, etc.). Some examples of materials which can serve as pharmaceutically-acceptable carriers include: (1) sugars, such as lactose, glucose and sucrose; (2) starches, such as corn starch and potato starch; (3) cellulose, and its derivatives, such as sodium carboxymethyl cellulose, methylcellulose, ethyl cellulose, microcrystalline cellulose and cellulose acetate; (4) powdered tragacanth; (5) malt; (6) gelatin; (7) lubricating agents, such as magnesium stearate, sodium lauryl sulfate and talc; (8) excipients, such as cocoa butter and suppository waxes; (9) oils, such as peanut oil, cottonseed oil, safflower oil, sesame oil, olive oil, corn oil and soybean oil; (10) glycols, such as propylene glycol; (11) polyols, such as glycerin, sorbitol, mannitol and polyethylene glycol (PEG); (12) esters, such as ethyl oleate and ethyl laurate; (13) agar; (14) buffering agents, such as magnesium hydroxide and aluminum hydroxide; (15) alginic acid; (16) pyrogen-free water; (17) isotonic saline; (18) Ringer's solution; (19) ethyl alcohol; (20) pH buffered solutions; (21) polyesters, polycarbonates and/or poly anhydrides; (22) bulking agents, such as polypeptides and amino acids; (23) serum component, such as serum albumin, HDL and LDL; (22) C2-C12 alcohols, such as ethanol; and (23) other non-toxic compatible substances employed in pharmaceutical formulations. Wetting agents, coloring agents, release agents, coating agents, sweetening agents, flavoring agents, perfuming agents, preservatives, and antioxidants can also be present in the formulation. The terms such as “excipient”, “carrier”, “pharmaceutically acceptable carrier” or the like are used interchangeably herein.
[001187] In some embodiments, the pharmaceutical composition is formulated for delivery to a subject, e.g., for delivering a gene editing agent using a VLP. Suitable routes of administrating the pharmaceutical composition described herein include, without limitation: topical, subcutaneous, transdermal, intradermal, intralesional, intraarticular, intraperitoneal, intravesical, transmucosal, gingival, intradental, intracochlear, transtympanic, intraorgan, epidural, intrathecal, intramuscular, intravenous, intravascular, intraosseus, periocular, intratumoral, intracerebral, and intracerebroventricular administration.
[001188] In some embodiments, the pharmaceutical composition described herein is administered locally to a diseased site (e.g., tumor site). In some embodiments, the pharmaceutical composition described herein is administered to a subject by injection, by means of a catheter, by means of a suppository, or by means of an implant, the implant being of a porous, non-porous, or gelatinous material, including a membrane, such as a sialastic membrane, or a fiber.
[001189] In another aspect, an article of manufacture containing VLPs and/or other materials useful for the treatment of the diseases is provided. In some embodiments, the article of manufacture comprises a container and a label. Suitable containers include, for example, bottles, vials, syringes, and test tubes. The containers may be formed from a variety of materials such as glass or plastic. In some embodiments, the container holds a composition that is effective for treating a disease and may have a sterile access port. For example, the container may be an intravenous solution bag or a vial having a stopper pierce-able by a hypodermic injection needle. The active agent in the composition is a compound of the invention. In some embodiments, the label on or associated with the container indicates that the composition is used for treating the disease of choice. The article of manufacture may further comprise a second container comprising a pharmaceutically-acceptable buffer, such as phosphate-buffered saline, Ringer's solution, or dextrose solution. It may further include other materials desirable from a commercial and user standpoint, including other buffers, diluents, filters, needles, syringes, and package inserts with instructions for use.
Kits and cells
[001190] The VLPs, libraries, nucleocapsid protein variants, polynucleotides, and vectors of the present disclosure may be assembled into kits. In some embodiments, the kit comprises polynucleotides for expression and assembly of the VLPs described herein. In other embodiments, the kit comprises VLP libraries as described herein.
[001191] The kits described herein may include one or more containers housing components for performing the methods described herein, and optionally instructions for use. Any of the kits described herein may further comprise components needed for producing or delivering VLPs as described herein. Each component of the kits, where applicable, may be provided in liquid form (e.g., in solution) or in solid form, (e.g., a dry powder). In certain cases, some of the components may be reconstitutable or otherwise processible (e.g., to an active form), for example, by the addition of a suitable solvent or other species (for example, water), which may or may not be provided with the kit.
[001192] In some embodiments, the kits may optionally include instructions and/or promotion for use of the components provided. As used herein, “instructions” can define a component of instruction and/or promotion, and typically involve written instructions on or associated with packaging of the disclosure. Instructions also can include any oral or electronic instructions provided in any manner such that a user will clearly recognize that the instructions are to be associated with the kit, for example, audiovisual (e.g., videotape, DVD, etc.), Internet, and/or web-based communications, etc. The written instructions may be in a form prescribed by a governmental agency regulating the manufacture, use, or sale of pharmaceuticals or biological products, which can also reflect approval by the agency of manufacture, use or sale for animal administration. As used herein, “promoted” includes all methods of doing business including methods of education, hospital and other clinical instruction, scientific inquiry, drug discovery or development, academic research, pharmaceutical industry activity including pharmaceutical sales, and any advertising or other promotional activity including written, oral and electronic communication of any form, associated with the disclosure. Additionally, the kits may include other components depending on the specific application, as described herein.
[001193] The kits may contain any one or more of the components described herein in one or more containers. The components may be prepared sterilely, packaged in a syringe, and shipped refrigerated. Alternatively, they may be housed in a vial or other container for storage. A second container may have other components prepared sterilely. Alternatively, the kits may include the active agents premixed and shipped in a vial, tube, or other container. [001194] The kits may have a variety of forms, such as a blister pouch, a shrink-wrapped pouch, a vacuum sealable pouch, a sealable thermoformed tray, or a similar pouch or tray form, with the accessories loosely packed within the pouch, one or more tubes, containers, a box, or a bag. The kits may be sterilized after the accessories are added, thereby allowing the individual accessories in the container to be otherwise unwrapped. The kits can be sterilized using any appropriate sterilization techniques, such as radiation sterilization, heat sterilization, or other sterilization methods known in the art. The kits may also include other components, depending on the specific application, for example, containers, cell media, salts, buffers, reagents, syringes, needles, a fabric, such as gauze, for applying or removing a disinfecting agent, disposable gloves, a support for the agents prior to administration, etc. Some aspects of this disclosure provide kits comprising a nucleic acid construct comprising a nucleotide sequence encoding the various components of the VLPs described herein (e.g.,
including, but not limited to, the cargo, gag proteins, gRNAs, and viral envelope glycoproteins). In some embodiments, the nucleotide sequence(s) comprises a heterologous promoter (or more than a single promoter) that drives expression of the VLP system components. In some embodiments, the kit comprises a VLP library, or a library of cells comprising a VLP library.
[001195] Other aspects of this disclosure provide kits comprising one or more nucleic acid constructs encoding the various components of the VLPs described herein. In some embodiments, the nucleotide sequence comprises a heterologous promoter that drives expression of the VLP system components.
[001196] Cells that may contain any of the VLPs, libraries, nucleocapsid protein variants, polynucleotides, and vectors described herein include prokaryotic cells and eukaryotic cells. In various aspects relating to the production of VLPs, the disclosure provides for any suitable cells for use as a VLP-producer cell line, i.e., the cell line that in various embodiments becomes transiently transformed with the plasmids encoding the protein and nucleic acid components of the VLPs. In various other aspects relating to applications of VLPs, the disclosure provides for any suitable target or recipient cells, e.g., a diseased cell or tissue in a subject in need of treatment by way of base editing or prime editing as delivered by a VLP. The methods described herein may be used to deliver a cargo such as a base editor or prime editor into a eukaryotic cell (e.g., a mammalian cell, such as a human cell). In some embodiments, the cell is in vitro e.g., cultured cell). In some embodiments, the cell is in vivo (e.g., in a subject such as a human subject). In some embodiments, the cell is ex vivo (e.g., isolated from a subject and may be administered back to the same or a different subject).
[001197] Examples of cell lines include, but are not limited to, C8161, CCRF-CEM, MOLT, mIMCD-3, NHDF, HeLa-S3, Huhl, Huh4, Huh7, HUVEC, HASMC, HEKn, HEKa, MiaPaCell, Panel, PC-3, TF1, CTLL-2, C1R, Rat6, CV1, RPTE, A10, T24, J82, A375, ARH-77, Calul, SW480, SW620, SKOV3, SK-UT, CaCo2, P388D1, SEM-K2, WEHI-231, HB56, TIB55, Jurkat, J45.01, LRMB, Bcl-1, BC-3, IC21, DLD2, Raw264.7, NRK, NRK- 52E, MRC5, MEF, Hep G2, HeLa B, HeLa T4, COS, COS-1, COS-6, COS-M6A, BS-C-1 monkey kidney epithelial, BALB/3T3 mouse embryo fibroblast, 3T3 Swiss, 3T3-L1, 132-d5 human fetal fibroblasts; 10.1 mouse fibroblasts, 293-T, 3T3, 721, 9L, A2780, A2780ADR, A2780cis, A 172, A20, A253, A431, A-549, ALC, B16, B35, BCP-1 cells, BEAS-2B, bEnd.3, BHK-21, BR 293. BxPC3. C3H-10T1/2, C6/36, Cal-27, CHO, CHO-7, CHO-IR, CHO-K1, CHO-K2, CHO-T, CHO Dhfr
COR-L23/R23, COS-7, COV-434, CML Tl, CMT, CT26, D17, DH82, DU145, DuCaP, EL4, EM2, EM3, EMT6/AR1, EMT6/AR10.0, FM3, H1299, H69, HB54, HB55, HCA2, HEK-293, HeLa, Hepalclc7, HL-60, HMEC, HT-29, Jurkat, JY cells, K562 cells, Ku812, KCL22, KG1, KYO1, LNCap, Ma-Mel 1-48, MC-38, MCF-7, MCF-10A, MDA-MB-231, MDA-MB-468, MDA-MB-435, MDCK II, MDCK 11, MOR/0.2R, MONO-MAC 6, MEDIA, MyEnd, NCI-H69/CPR, NCI-H69/LX10, NCI-H69/LX20, NCI-H69/LX4, NIH-3T3, NALM-1, NW- 145, OPCN/OPCT cell lines, Peer, PNT-1A/PNT 2, RenCa, RIN-5F, RMA/RMAS, Saos-2 cells, Sf-9, SkBr3, T2, T-47D, T84, THP1 cell line, U373, U87, U937, VCaP, Vero cells, WM39, WT-49, X63, YAC-1, YAR, and transgenic varieties thereof. Other cells contemplated herein include primary cells (e.g., isolated directly from tissue) and/or primary cell lines. Exemplary primary cells include immune cells, neural cells, or retinal pigment epithelium cells.
[001198] The function and advantage of these and other embodiments of the present invention will be more fully understood from the Examples below. The following Examples are intended to illustrate the benefits of the present invention and to describe particular embodiments, but are not intended to exemplify the full scope of the invention. Accordingly, it will be understood that the Examples are not meant to limit the scope of the invention.
EXAMPLES
Example 1, Cloning
[001199] All plasmids used in herein were cloned using USER cloning. Plasmid DNA was PCR-amplified using PhusionUGreen Multiplex PCR Master Mix (Thermo Fisher Scientific). Maehl (Thermo Fisher Scientific) and Stbl3 (New England Biolabs) chemically competent E. coli were used for plasmid propagation.
Example 2, Cell culture conditions
[001200] Gesicle Producer 293T cells (Takara; 632617) were maintained in DMEM + GlutaMAX (Life Technologies) supplemented with 10% (v/v) fetal bovine serum. Primary human CD34 cells were maintained in serum- free X-VIVO-15 media (Lonza) and supplemented with lOOng/mL recombinant human SCF (R&D Systems; 255-SC/CF) or 1 microM 740Y-P (R&D Systems; 1983), TPO (R&D Systems; 299-TP/CF), and Flt3 (R&D Systems; 308-FK/CF). Cells were cultured at 37°C with 5% carbon dioxide and were confirmed to be negative for mycoplasma by testing with Myco Alert (Lonza Biologies).
Example 3. BE-eVLP production and purification
[001201] BE-eVLPs were produced by transient transfection of Gesicle Producer 293T cells. Gesicle cells were seeded in T-75 flasks (Coming) at a density of 5xl06 cells per flask. After 20-24 h, cells were transfected using the jetPRIME transfection reagent (Polyplus) according to the manufacturer’s protocols. For producing v4 BE-eVLPs, a mixture of plasmids expressing VSVG (400 ng), MMLVgag-pro-pol (3,375 ng), MMLVgag-3xNES- ABE8e (1,125 ng), and an sgRNA (4,400 ng) were co-transfected per T-75 flask. For producing targeted BE-eVLPs, rather than 400 ng of VSVG, 300 ng of VSVGmut or VSVG plus 900 ng of the targeting protein construct were transfected. For azido-eVLPs, producer cells supernatant was injected with a final concentration of 50 mM N- Azidoacetylmannosamine-tetraacylated (Ac4ManNAz) (Sigma Aldrich; 900917) ten minutes prior to plasmid transfection.
[001202] 40-48 h post-transfection, producer cell supernatant was harvested and centrifuged for 5 min at 500 g to remove cell debris. The clarified eVLP-containing supernatant was filtered through a 0.45-mm PVDF filter. For azido-eVLPs the clarified supernatant was reacted with lOOmg/mL of specified cell-targeting DBCO-conjugated antibody or 20mM DBCO-conjugated small molecule and reacted for 1 h (37 °C). The supernatant was concentrated 1000-3000-fold by ultracentrifugation using a cushion of 20% (w/v) sucrose in PBS. Ultracentrifugation was performed at 26,000 rpm for 2 h (4°C) using an SW28 rotor in an Optima XPN Ultracentrifuge (Beckman Coulter). Following ultracentrifugation, BE-eVLP pellets were resuspended in cold PBS (pH 7.4) and centrifuged at 1,000 g for 5 min to remove debris. BE-eVLPs were frozen at a rate of -l°C/min and stored at -80°C. BE-eVLPs were thawed on ice immediately prior to use.
[001203]
Example 4, BE-eVLP transduction in CD34+ cell culture and genomic DNA isolation [001204] Cryopreserved primary human CD34+ cells were thawed rapidly and plated at a density of 1E6 cells/mL and a volume of 50 microL per well in 96-well plates. Subsequently, BE-eVLPs were added directly to the culture media in each well at an multiplicity of infection of between 2E5-2E6 VLP/cell. 12 hrs post-transduction, cells were diluted with 100 microL of X-VIVO-15 media plus cytokines. Cells were again diluted with 100 microL of media and transferred into 48 well plates 48 h post transduction. After a total time course of 96 hrs, cells were briefly washed once with PBS and lysed in 50 microL of lysis buffer (lOmM Tris-HCl pH 8.0, 0.05% SDS, 25 microg/mL Proteinase K (Thermo Fisher
Scientific)) at 37 °C for 1 hr followed by heat inactivation of Proteinase K at 80 °C for 30 min.
Example 5. BE-eVLP transduction in CD34+/HEK293T cell culture
[001205] HEK293T cells were seeded in a 48-well plate (Coming) at 1.2xl05 cells per well in 250 microL DMEM supplemented with 10% fetal bovine serum. 20-24 hr after seeding, cryopreserved human CD34+ cells were thawed and resuspended in at 3xl05 cells/mL of X- VIVO-15 media plus cytokines. Then, DMEM was aspirated from HEK293T cells, cells were washed briefly with PBS, and 100 microL of the CD34+ cell suspension was added to each treatment well of the 96-well plate. The eVLPs were added directly to each well. 12 hrs posttransduction, cells were diluted with 150 microL of X- VIVO- 15 media plus cytokines. Cells were again diluted with an additional 150 microL of media 48 hr post transduction.
[001206] 72 hr post-transduction, cells were washed, reacted with an antibody cocktail of anti-hCD34 (Biolegend; clone 581; cat 34511) and anti-hCD51 (Biolegend; clone NKI-M9; cat 327916) to separate CD34+ cells from HEK293T cells (CD51+) by FACS. The genomic DNA of the separated cells were isolated as described above.
Example 6. High-throughput sequencing of genomic DNA
[001207] Following genomic DNA isolation, 1 microL of the isolated DNA (1-10 nanog) was used as input for the first of two PCR reactions. Genomic loci were amplified in PCR1 using PhusionU polymerase (Thermo Fisher Scientific). PCR1 primers for the BCL11A genomic locus are:
[001208] PCR1 was performed as follows: 95 °C for 3 min; 30-32 cycles of 95 °C for 15 s, 61 °C for 20 s, and 72 °C for 30 s; 72 °C for 2 min. PCR1 products were confirmed on a 1.5% agarose gel. ImicroL PCR1 was used as input for PCR2 to install the Illumina barcodes. PCR2 was conducted for 9 cycles using Phusion HS II kit (Life Technologies). Following
PCR2, samples were pooled and gel purified in a 1% agarose gel using a Qiaquick Gel Extraction Kit (Qiagen). Library concentration was determined by Qubit High-Sensitivity Assay Kit (Thermo Fisher Scientific). Samples were sequenced on an Illumina Miseq instrument (paired-end read, read 1: 250-300 cycles, read 2: 0 cycles) using an illumine Miseq 300 v2 Kit (Illumina).
Example 7, High-throughput sequencing data analysis
[001209] Sequencing reads were demultiplexed using the MiSeq Reporter software (Illumina) and were analyzed using CRISPResso2 (Clementet al., 2019) as previously described (Doman et al., 2020). Batch analysis mode (one batch for each unique amplicon and sgRNA combination analyzed) was used in all cases. Reads were filtered by minimum average quality score (Q > 30) prior to analysis. Base editing efficiencies are reported as the percentage of sequencing reads containing a given base conversion at a specific position. Prism 9 (GraphPad) was used to generate dot plots and bar plots.
Example 8. BE-eVLP protein content quantification
[001210] For protein quantification, BE-eVLPs were lysed in Laemmli sample buffer as described above. The concentration of BE protein in purified BE-eVLPs was quantified using the FastScan™ Cas9 (S. pyogenes) ELISA kit (Cell Signaling Technology; 29666C) according to the manufacturer’s protocols. Recombinant Cas9 (.S'. pyogenes) nuclease protein (New England Biolabs; M0386) was used to generate the standard curve for quantification. A copy number of 50 molecules of BE per eVLP was used to determine eVLP titers.
Example 9. Prime editing eVLP production
[001211] eVLPs were produced as previously described. Gesicle 293T cells were plated at a density of 5E6 cells per flask in 10 ml of DMEM + 10% FBS media in T75 flask (Corning, 353136). A total of 18-24 h after seeding, a mixture of plasmids was transfected to producer cells with jetPRIME transfection reagent (Polyplus) following the manufacturer’s protocol. For production of v3 PE-eVLPs, plasmids expressing VSV-G (400 ng), wild-type MMLV Gag-Pol (2,813 ng), Gag-MCP-Pol (1,125 ng), Gag-PE (563 ng) and MS2-guide RNA (4,400 ng MS2-epegRNA for v3 PE2-eVLP, 3520 ng MS2-epegRNA and 880 ng MS2- ngRNA for v3 PE3-eVLP) were co-transfected to each T75 flask. For production of v3b PE- eVLPs, plasmids expressing VSV-G (400 ng), wild-type MMLV Gag-Pol (2,813 ng), Gag- COM-Pol (2,000 ng), Gag-P3-Pol (422 ng), P4-PE (422 ng) and COM-gRNAs (4,400 ng COM-epegRNA for v3b PE2-eVLP, 3,520 ng COM-epegRNA and 880 ng COM-ngRNA for
v3b PE3-eVLP) were co-transfected to each T75 flask. A total of 40-48 h after transfection, supernatants were collected, centrifuged at 500g for 5 min and the supernatant was filtered through 0.45-pm PVDF filter. eVLPs were concentrated using a 20% (w/v) sucrose cushion solution via ultracentrifugation at 26,000 rpm for 2 h at 4 °C using an SW28 rotor in an Optima XPN Ultracentrifuge (Beckman Coulter). Following ultracentrifugation, eVLP pellets were resuspended in cold PBS solution. For short-term storage, eVLPs were stored at 4 °C for up to 1 week. For long-term storage, eVLPs were stored at -80 °C and thawed on ice immediately before use. Repeated freeze-thaw was avoided.
[001212] It is noted that PE efficiencies are typically much lower in the eVLP format. A similar edit is described in An et al. (see below) in which editing saturates at 30% in HEK293T cells. Such a drop from HEK293T cells to CD34+ cells is commonly seen for other edits as HEK293T cells are easier to genome edit.
Example 10, Barcoded lentiviral dictionary screens for targeted ligands
[001213] HEK clone 17 cells were seeded in 96-well plates at a density of 30k cells/well. After 20-24 hours cells were transfected with the following plasmid mixture: 20 ng Env., 60 ng targeting ligand, 40 ng psPAX2 lentiviral packaging plasmid, and 36 ng lentiviral genome encoding both a NNNNNNNNNNNNNNNNNNNN barcode and the CMV-EGFP-P2A- PuroR gene. Plasmids were prepared using PlasmidPlus Midi and Mini kits (Qiagen). Plasmids were mixed with 0.5 pF FuGENE 6 (Promega) to a final volume of 10 pL, incubated 10 min at room temperature, and added to each well.
[001214] 48 hours post-transfection, virus-containing supernatant was harvested and concentrated 1000-3000x by ultracentrifugation with a 20% sucrose cushion. Target cells were then transduced at a dose of 2-10 pL of virus into 100k cells. 5 days post-transduction, target cells were stained with relevant antibodies and sorted for GFP-positivity. The gDNA from GFP-positive cells was extracted using QIAamp DNA Mini kit (Qiagen) according to manufacturer’s protocol. Viral RNA was extracted from concentrated virus using the NucleoSpin kit (Macherey-Nagel) according to manufacturer’s protocol and reverse- transcribed using SuperScript IV (Thermo Fisher). All cell gDNA and 1 pL of viral cDNA was used as input for PCR reactions and DNA was sequenced by Illumina High-throughput sequencing using methods known in the art.
Example 11, Barcoded Lentiviral Screening protocol
[001215] HEK clone 17 cells were seeded in 96-well plates at a density of 30k cells/well.
After 20-24 hours cells were transfected with the following plasmid mixture: 20 ng Env., 60
ng targeting ligand, 40 ng psPAX2 lentiviral packaging plasmid, and 36 ng lentiviral genome encoding both a NNNNNNNNNNNNNNNNNNNN barcode and the CMV-EGFP-P2A- PuroR gene. Plasmids were prepared using PlasmidPlus Midi and Mini kits (Qiagen).
Plasmids were mixed with 0.5 pL FuGENE 6 (Promega) to a final volume of 10 uL, incubated 10 min, and added to each well.
[001216] 48 hours post-transfection, virus-containing supernatant was harvested and concentrated 1000-3000x by ultracentrifugation with a 20% sucrose cushion. Target cells were then transduced at a dose of 2-10uL of virus into 100k cells. 5 days post-transduction, target cells were stained with relevant antibodies and sorted for GFP-positivity. The gDNA from GFP-positive cells was extracted using QIAamp DNA Mini kit (Qiagen) according to manufacturer’s protocol. Viral RNA was extracted from concentrated virus using the NucleoSpin kit (Macherey-Nagel) according to manufacturer’s protocol and reverse- transcribed using SuperScript IV (Thermo FisherScientific). All cell gDNA and 1 mL of viral cDNA was used as input for Genomic loci were amplified in PCR1 using NEBNext polymerase (New England Biolabs)). PCR1 primers for the BCL11A genomic locus are:
[001217] PCR1 was performed as follows: 98°C for 3 min; 15-30 cycles of 98°C for 15 s, 61°C for 20 s, and 72°C for 30 s; 72°C for 2 min. PCR1 was performed on qPCR to avoid overamplification. PCR1 products were confirmed on a 1.5% agarose gel. luL PCR1 was used as input for PCR2 to install the Illumina barcodes. PCR2 was conducted for 9 cycles using NEBNext polymerase (New England Biolabs). Following PCR2, samples were pooled and gel purified in a 1% agarose gel using a Qiaquick Gel Extraction Kit (Qiagen). Library concentration was determined by Qubit High-Sensitivity Assay Kit (Thermo Fisher
Scientific). Samples were sequenced on an Illumina Miseq instrument (paired-end read, read 1: 250-300 cycles, read 2: 0 cycles) using an illumine Miseq 300 v2 Kit (Illumina).
Example 12, Targeted ligands for CD34+ cells identified from an exemplary lentiviral screen comprising VSVG and/or VSVG mutant fusogens..
[001218] The results from the screen are shown graphically in FIGs. 14B and 14D.
[001219] The corresponding tabular data for all reads, normalized to cDNA representation, is shown below for the targeting ligands (note that NA in Targeting ligand 2 represents a lentivirus with a single targeting ligand). Viruses low in cDNA reads (maximum barcode cDNA reads <100) were filtered by setting their gDNA read counts to zero.
[001220] The corresponding tabular data for mean and median reads, normalized to cDNA representation, for the positive control (VSVG) and negative control (VSVGmut), respectively is shown below:
Example 13. Targeted ligands for CD34+ cells identified from lentiviral screens comprising Cocal mutant fusogens.
[001221] The results from the screen are shown graphically in FIGs. 18A and 18B.
[001222] The corresponding tabular data for all reads, normalized to cDNA representation, is shown below for the targeting ligands (note that NA in Targeting ligand 2 represents a lentivirus with a single targeting ligand):
[001223] The corresponding tabular data for mean and median reads, normalized to cDNA representation, for the positive control (Cocal) and negative control (Cocalmut), respectively is shown below:
Example 14, Targeted ligands for CD34+ cells identified from a second exemplary lentiviral screen comprising VSVG and/or VSVG mutant fusogens.
[001224] The results from the screen are shown graphically in FIGs. 19A and 19B.
[001225] The tabular data for all reads, normalized to cDNA representation, is shown below for the targeting ligands (note that NA in Targeting ligand 2 represents a lentivirus with a single targeting ligand):
REFERENCES
[001226] Li, C. et al. Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors. Mol Ther - Methods Clin Dev 24, 127-141 (2022).
[001227] Gutierrez- Guerrero, A., Cosset, F.-L. & Verhoeyen, E. Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy. Viruses 12, 1016 (2020).
[001228] Girard-Gagnepain, A. et al. Baboon envelope pseudotyped LVs outperform VSVG-LVs for gene transfer into early-cytokine-stimulated and resting HSCs. Blood 124, 1221-1231 (2014).
[001229] Cheng, H., Zheng, Z. & Cheng, T. New paradigms on hematopoietic stem cell differentiation. Protein Cell 11, 34-44 (2020).
[001230] Araki, M. et al. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood 127, 1307-1316 (2016).
[001231] Verhoeyen, E. et al. Novel lentiviral vectors displaying “early-acting cytokines” selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. Blood 106, 3386-3395 (2005).
[001232] Fielding, A. K., Maurice, M., Morling, F. J., Cosset, F. L. & Russell, S. J. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood 91, 1802-9 (1998).
[001233] Cosset, F. L. et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 69, 6314-6322 (1995).
[001234] Ho, C. C. M. et al. Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling. Cell 168, 1041-1052. el8 (2017).
[001235] Takematsu, E. et al. Transmembrane stem cell factor protein therapeutics enhance revascularization in ischemia without mast cell activation. Nat Commun 13, 2497 (2022).
[001236] Fujiwara, K. et al. Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold. Cells 9, 1182 (2020).
[001237] Schafer, D. et al. A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes. Front Immunol 11, 1704 (2020).
[001238] Yu, B. et al. Engineered cell entry links receptor biology with single-cell genomics. Cell 185, 4904-4920.e22 (2022).
[001239] Frietze, K. M., Peabody, D. S. & Chackerian, B. Engineering virus-like particles as vaccine platforms. Curr Opin Virol 18, 44-49 (2016).
[001240] Sockolosky, J. T., Kivimae, S. & Szoka, F. C. Fusion of a Short Peptide that Binds Immunoglobulin G to a Recombinant Protein Substantially Increases Its Plasma Half- Life in Mice. Pios One 9, el02566 (2014).
[001241] Sugita, T. et al. Screening of peptide ligands that bind to the Fc region of IgG using peptide array and its application to affinity purification of antibody. Biochem Eng J 79, 33-40 (2013).
[001242] Lee, J. H., Engler, J. A., Coll, J. F. & Moore, B. A. Receptor mediated uptake of peptides that bind the human transferrin receptor. European Journal of Biochemistry (2001).
[001243] Guerrerio, A. L. & Berg, J. M. Design of Single-Stranded Nucleic Acid Binding Peptides Based on Nucleocapsid CCHC-Box Zinc-Binding Domains. J Am Chem Soc 132, 9638-9643 (2010).
[001244] Li, N., Larson, T., Nguyen, H. H., Sokolov, K. V. & Ellington, A. D. Directed evolution of gold nanoparticle delivery to cells. Chem Commun 46, 392-394 (2009).
[001245] Czechowicz, A., Palchaudhuri, R., Scheck, A. et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nat Commun 10, 617 (2019). https://doi.org/10.1038/s41467-018-08201-x
[001246] Costa, M.J., Kudaravalli, J., Ma, JT. et al. Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates. Sci Rep 9, 2443 (2019). https://doi.org/10.1038/s41598-019-38745-x
[001247] Dobson, C.S., Reich, A.N., Gaglione, S. et al. Antigen identification and high- throughput interaction mapping by reprogramming viral entry. Nat Methods 19, 449-460 (2022). https://doi.org/10.1038/s41592-022-01436-z
[001248] Pisani, A.; Donno, R.; Gennari, A.; Cibecchini, G.; Catalano, F.; Marotta, R.; Pompa, P.P.; Tirelli, N.; Bardi, G. CXCL12-PLGA/Pluronic Nanoparticle Internalization Abrogates CXCR4-Mediated Cell Migration. Nanomaterials 2020, 10, 2304. http s ://doi . org/ 10.3390/nano 10112304
[001249] Guo, F., Wang, Y., Liu, J. et al. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene 35, 816-826 (2016). https://doi.org/10.1038/onc.2015.139
[001250] Humbert, O. et al. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells. Mol. Ther. 24, 1237-1246 (2016).
[001251] Thomas, J., Burkmueller, K., Kanestrom, G., Radtke, S. & Kiem, H.-P. CD90- Targeted Cocal-Pseudotyped Lentivirus As a Robust Platform for Human HSC Gene Therapy. Blood 142, 2254 (2023).
[001252] Strebinger, D. et al. Cell type-specific delivery by modular envelope design. Nat. Commun. 14, 5141 (2023).
[001253] Banskota, Raguram et al., Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250-265 (2022).
EQUIVALENTS AND SCOPE
[001254] In the claims articles such as “a,” “an,” and “the” may mean one or more than one unless indicated to the contrary or otherwise evident from the context. Claims or descriptions that include “or” between one or more members of a group are considered satisfied if one, more than one, or all of the group members are present in, employed in, or otherwise relevant to a given product or process unless indicated to the contrary or otherwise evident from the context. The invention includes embodiments in which exactly one member of the group is present in, employed in, or otherwise relevant to a given product or process. The invention includes embodiments in which more than one, or all of the group members are present in, employed in, or otherwise relevant to a given product or process.
[001255] Furthermore, the invention encompasses all variations, combinations, and permutations in which one or more limitations, elements, clauses, and descriptive terms from
one or more of the listed claims is introduced into another claim. For example, any claim that is dependent on another claim may be modified to include one or more limitations found in any other claim that is dependent on the same base claim. Where elements are presented as lists, e.g., in Markush group format, each subgroup of the elements is also disclosed, and any element(s) may be removed from the group. It should it be understood that, in general, where the invention, or aspects of the invention, is/are referred to as comprising particular elements and/or features, certain embodiments of the invention or aspects of the invention consist, or consist essentially of, such elements and/or features. For purposes of simplicity, those embodiments have not been specifically set forth in haec verba herein. It is also noted that the terms “comprising” and “containing” are intended to be open and permits the inclusion of additional elements or steps. Where ranges are given, endpoints are included. Furthermore, unless otherwise indicated or otherwise evident from the context and understanding of one of ordinary skill in the art, values that are expressed as ranges can assume any specific value or sub-range within the stated ranges in different embodiments of the invention, to the tenth of the unit of the lower limit of the range, unless the context clearly dictates otherwise.
[001256] This application refers to various issued patents, published patent applications, journal articles, and other publications, all of which are incorporated herein by reference. If there is a conflict between any of the incorporated references and the instant specification, the specification shall control. In addition, any particular embodiment of the present invention that falls within the prior art may be explicitly excluded from any one or more of the claims. Because such embodiments are deemed to be known to one of ordinary skill in the art, they may be excluded even if the exclusion is not set forth explicitly herein. Any particular embodiment of the invention may be excluded from any claim, for any reason, whether or not related to the existence of prior art.
[001257] Those skilled in the art will recognize or be able to ascertain using no more than routine experimentation many equivalents to the specific embodiments described herein. The scope of the present embodiments described herein is not intended to be limited to the above Description, but rather is as set forth in the appended claims. Those of ordinary skill in the art will appreciate that various changes and modifications to this description may be made without departing from the spirit or scope of the present invention, as defined in the following claims.
Claims
1. A virus-like particle comprising: a fusion protein, wherein the fusion protein comprises:
(i) a transmembrane domain; and
(ii) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
2. The virus-like particle of claim 1, wherein the transmembrane domain is selected from the group consisting of CD28, CD43, CD49d, CD62L, CD 162, HLA-A2, HLA-DRA, ICAM1, LFA-1, mCD3z, mCD4, mCD8a, hCD8a, hCD8a, and VSVG-TM.
3. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5%, or 100% identical to the amino acid sequence of SEQ ID NO: 371 (LFA-1).
4. The virus-like particle of claim 1 wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5%, or 100% identical to the amino acid sequence of SEQ ID NO: 369 (HLA-DRA).
5. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 368 (HLA-A2).
6. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least
99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 366 (CD62L).
7. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 364 (CD43).
8. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 376 (VSVGTM).
9. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 377 (VSVGTM ASP).
10. The virus-like particle of claim 1, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any one of SEQ ID NOs.: 363-376 or 493.
11. The virus-like particle of claim 1, wherein the targeting domain is selected from the group consisting of CALR-del52, CALR-ins5, CXCL12, AdF35, mSCF soluble, mSCF soluble (V49L/F63L), SCF, SCF mutant (V49L/F63L/K91E/I98R), SCF mutant (V49L/F63L/K91E), SCF mutant (V49L/F63L), SCF soluble, SCF soluble mutant (V49L/F63L/K91E/I98R), SCF soluble mutant (V49E/F63E/K91E), SCF soluble mutant (V49E/F63E), TPO-157, TPO-163, TPO-171, TPO, CXCE11, CXCE4, CXCE14, 53E11 a- hCD8 DARPin, CD8 51.1-Xencor-H1E1 scFv, 53F6 a-hCD8 DARPin, 53F6 a-hCD8 DARPin, 63A4 a-hCD8 DARPin, Acapatamab CD, Acapatamab Vh-Vk, Acapatamab Vh-Vl, CD3 DARPin-C7vl4, CD3 DARPin-C7vl l8, CD3 DARPin-C7vl l9, CD3 DARPin-C7vl22, CD3 DARPin-C7vl27, scFv-CD3-l, scFv-CD3-2, scFv-CD3-3, scFv-CD3-4, scFv-CD4-l,
scFv-CD4-2, Sana CD19 scFv FMC63 G4S linker, Sana CD22 scFv m971-L7, CD28 scFv, hCD117 scFv Ab54 CA3079215A1, hCD117 scFv Ab55 CA3079215A1, hCD117 scFv Ab56 CA3079215A1, hCD117 scFv Ab57 CA3079215A1, hCD117 scFv Ab61 CA3079215A1, hCD117 scFv Ab66 CA3079215A1, hCD117 scFv Ab67 CA3079215A1, hCD117 scFv Ab68 CA3079215A1, hCD117 scFv Ab69 CA3079215A1, USPTO 6,054,297 genentech hCD117 scFv, Sana CD8 scFv form 1, Sana CD8 scFv form 2, Sana CD8 scFv form 3, Sana CD8 scFv form 4, Sana CD8 scFv form 5, Sana CD8 scFv form 6, Sana CD8 scFv form 7, Sana CD8 scFv form 8, Sana CD8 scFv form 9, Sana CD8 scFv form 10, Sana CD8 VHH form 1, Sana CD8 VHH form 2, and Sana CD8 VHH form 3.
12. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5%, or 100% identical to the amino acid sequence of SEQ ID NO: 359 (TPO).
13. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 358 (TPO- 171).
14. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 357 (TPO- 163).
15. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 356 (TPO- 157).
16. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 347 (mSCF soluble).
17. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 348 (SCF).
18. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 349 (SCF mutant (V49L/F63L/K91E/I98R).
19. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 350 (SCF mutant (V49L/F63L/K91E)).
20. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 351 (SCF mutant (V49L/F63L).
21. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 352 (SCF soluble).
22. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 353 (SCF soluble mutant (V49L/F63L/K91E/I98R).
23. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 354 (SCF soluble mutant (V49L/F63L/K91E).
24. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 355 (SCF soluble mutant (V49L/F63L).
25. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 346 (AdF35).
26. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 345 (CXCL12).
27. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 360 (CXCL11).
28. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 361 (CXCL4).
29. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 362 (CXCL14).
30. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least
99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 344 (CALR-ins5).
31. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 343 (CALR-del52).
32. The virus-like particle of claim 1, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of any one of SEQ ID NOs: 343-362, 387, 900-944, 504-522, or 527-533.
33. The virus-like particle of claim 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein] -[TPO]- [optional linker] -[VS VGTM].
34. The virus-like particle of any one of claims 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein]- [SCFK9iEmono]- [optional linker] -[ VS VGmut].
35. The virus-like particle of any one of claims 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein]- [ADF35]- [optional linker] -[VS VGTM].
36. The virus-like particle of any one of claims 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein]- [SCF]- [optional linker] -[ VS VG].
37. The virus-like particle of any one of claim 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein]- [SCF(V49L/F63L)]-[optional linker]-[VSVG TM].
38. The virus like particle of any one of claims 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein]- [SCF V49L/F63L/K9 IE] -[optional linker]- [VS VGmutA SP].
39. The virus like particle of any one of claim 1-32, wherein the fusion protein comprises the structure:
[VSVG Signal Peptide]-[SCF soluble]-[SGGSGGSGGS linker]-[VSVG TM],
40. The virus like particle of any one of claim 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein] -[CXCL 12] -[optional linker] -[ VS VGmut del SP].
41. The virus like particle of any one of claim 1-32, wherein the fusion protein comprises the structure:
[VSVG Signal Peptide]-[SCF soluble (V49L/F63L/K91E/I98R)]-[SGGSGGSGGS linker]-[VSVG TM],
42. The virus like particle of any one of claim 1-32, wherein the fusion protein comprises the structure:
[optional signaling protein]- [SCF soluble] -[optional linker] -[VS VGmut del SP].
43. The virus-like particle of any one of claims 1-42, further comprising a first linker that connects (i) and (ii), wherein the first linker is selected from the group consisting of SEQ ID NO:s. 309-342.
44. The virus-like particle of any one of claims 1-43, further comprising a second fusion protein comprising a transmembrane domain, a targeting domain, and optionally, a stalk domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
45. The virus-like particle of claim 44, wherein a targeting domain of the second fusion protein is different than the targeting domain of the first fusion protein.
46. A virus-like particle comprising a fusion protein, wherein the fusion protein comprises:
(i) a transmembrane domain;
(ii) a stalk domain; and
(iii) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
47. The virus-like particle of claim 46, wherein the transmembrane domain is selected from the group consisting of CD28, CD43, CD49d, CD62L, CD 162, HLA-A2, HLA-DRA, ICAM1, LFA-1, mCD3z, mCD4, mCD8a, hCD8a, hCD8a, and VSVG-TM.
48. The virus-like particle of claim 46, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 363-376 or 493.
49. The virus-like particle of claim 46, wherein the targeting domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 343- 362, 387, 900-944, 504-522, or 527-533.
50. The virus-like particle of claim 46, wherein the targeting domain is selected from the group consisting of CALR-del52, CALR-ins5, CXCL12, AdF35, mSCF soluble, SCF, SCF mutant (V49L/F63L/K91E/I98R), SCF mutant (V49E/F63E/K91E), SCF mutant (V49E/F63E), SCF soluble, SCF soluble mutant (V49E/F63E/K91E/I98R), SCF soluble mutant (V49E/F63E/K91E), SCF soluble mutant (V49E/F63E), TPO-157, TPO-163, TPO- 171, TPO, CXCE11, CXCE4, CXCE14, 53E11 a-hCD8 DARPin, CD8 51.1-Xencor-H1E1 scFv, 53F6 a-hCD8 DARPin, 53F6 a-hCD8 DARPin, 63A4 a-hCD8 DARPin, Acapatamab CD, Acapatamab Vh-Vk, Acapatamab Vh-Vl, CD3 DARPin-C7vl4, CD3 DARPin-C7vl l8, CD3 DARPin-C7vl l9, CD3 DARPin-C7vl22, CD3 DARPin-C7vl27, scFv-CD3-l, scFv- CD3-2, scFv-CD3-3, scFv-CD3-4, scFv-CD4-l, scFv-CD4-2, Sana CD19 scFv FMC63 G4S linker, Sana CD22 scFv m971-E7, CD28 scFv, hCD117 scFv Ab54 CA3079215A1, hCD117
scFv Ab55 CA3079215A1, hCD117 scFv Ab56 CA3079215A1, hCD117 scFv Ab57 CA3079215A1, hCD117 scFv Ab61 CA3079215A1, hCD117 scFv Ab66 CA3079215A1, hCD117 scFv Ab67 CA3079215A1, hCD117 scFv Ab68 CA3079215A1, hCD117 scFv Ab69 CA3079215A1, USPTO 6,054,297 genentech hCD117 scFv, Sana CD8 scFv form 1, Sana CD8 scFv form 2, Sana CD8 scFv form 3, Sana CD8 scFv form 4, Sana CD8 scFv form 5, Sana CD8 scFv form 6, Sana CD8 scFv form 7, Sana CD8 scFv form 8, Sana CD8 scFv form 9, Sana CD8 scFv form 10, Sana CD8 VHH form 1, Sana CD8 VHH form 2, and Sana CD8 VHH form 3.
51. The virus-like particle of claim 46 wherein the stalk domain is selected from the group consisting of hCD8a-l, hCD8a-2, h!gG4-CH3, mCD3z, mCD4, mCD8a-l, mCD8a-2, hCD8a’, mCD28, hCD8, Siglec-4:12, IgGl-CH3, IgG4-CH2CH3, IgGl-CH2CH3, IgGl-1, IgGl-2, IgG2, IgG3, and IgG4.
52. The virus-like particle of claim 46, wherein stalk domain is selected from the group consisting of hCD8a-l, hCD8a-2, h!gG4-CH3, mCD3z, mCD4, mCD8a-l, mCD8a-2, hCD8a’, mCD28, hCD8, Siglec-4:12, IgGl-CH3, IgG4-CH2CH3, IgGl-CH2CH3, IgGl-1, IgGl-2, IgG2, IgG3, and IgG4.
53. The virus-like particle of claim 46, wherein the stalk domain is selected from the group consisting of mmIgG2_l, mmIgG2_2, and mmIgG2_3.
54. The virus-like particle of claim 46, wherein the stalk domain is selected from the group consisting of IgG3_l, IgG3_2, IgG3_3, IgG3_4, IgG3_5, IgG3_6, IgGl_3, IgGl_4, IgG3_7, IgG2_l, and IgGl_3.
55. The virus-like particle of claim 46, wherein the stalk domain is selected from the group consisting of IgAl_l, IgAl_2, IgAl_3, IgAl_4, IgA2_l, IgA2_2, IgA2_3, and IgA2_4.
56. The virus-like particle of claim 46, wherein the stalk domain is selected from the group consisting of IgD_l, IgD_2, IgD_3, IgD_4, IgE, IgM_l, IgM_2, IgM_3, and IgGl_4.
57. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NOs.: 29-47. or SEQ ID NO: 404.
58. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 48-57.
59. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 58-60.
60. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 61-71.
61. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 72-79.
62. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 80-88.
63. The virus-like particle of claim 46, wherein the stalk domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 502-503, 894, or 896-899.
64. The virus-like particle of claim 46, wherein the stalk domain comprises IgG4.
65. The virus-like particle of claim 46, wherein the stalk domain comprises CD8a.
66. The virus-like particle of claim 46-65, wherein the fusion protein comprises a structure selected from the group consisting of [SCF]- [optional linker] -[IgG4]- [optional linker] -[CD62], [SCF] -[optional linker] -[CD8]- [optional linker] -[CD43], [SCF] -[optional linker] -[CD8]- [optional linker] -[CD62], [SCF] -[optional linker] -[CD8]- [optional linker]- [HLA-A2], [SCF] -[optional linker] -[CD8]- [optional linker] -[HLA-DRA], and [SCF]- [optional linker] -[CD8]- [optional linker]-[LFA-l].
67. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide]- [CD 117 scFv 67]-[CD8a trunc stalk]-[ICAMl TM],
68. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide]-[SCF]-[CD8a trunc stalk]-[CD62 TM],
69. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[B2M Signal Peptide]-[SCF]-[CD8a trunc stalk]-[CD49 TM],
70. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide]-[TPO]-[CD8a trunc stalk]-[ICAMl TM],
71. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide] -[AdF35]-[CD8a trunc stalk]-[CD62 TM],
72. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[B2M Signal Peptide]-[SCF]-[CD8 trunc stalk]-[LFAl TM],
73. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide] -[CXCL 12] -[CD 8 a trunc stalk]-[ICAMl TM],
74. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide] -[CXCL 12] -[CD 8 a trunc stalk]-[HLA A2 TM],
75. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD90 scFv]-[CD8a trunc stalk]-[ICAMl TM],
76. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide] -[CXCL 12] -[CD 8 a trunc stalk]-[CD49 TM],
77. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD8 Signal Peptide]- [CXCL 12] -[ CD8a trunc stalk]-[LFAl TM],
78. The virus like particle of any one of claims 46-65, wherein the fusion protein comprises the structure:
[CD90 scFv]-[CD8a trunc stalk]-[LFAl TM],
79. The virus-like particle of claim 46-78, wherein a first linker connects (i) and (ii) and is selected from the group consisting of SEQ ID NOs.: 309-342.
80. The virus-like particle of claim 46-79, wherein a second linker connects (ii) and (iii) and is selected from the group consisting of SEQ ID NOs:. 309-342.
81. The virus-like particle of any one of claims 46-80, further comprising a second fusion protein comprising a transmembrane domain, a targeting domain, and optionally, a stalk
domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
82. The virus-like particle of claim 81, wherein a targeting domain of the second fusion protein is different than the targeting domain of the first fusion protein.
83. A virus-like particle comprising:
(a) a fusion protein, wherein the fusion protein comprises:
(i) a transmembrane domain; and
(ii) a targeting domain; and
(b) an antibody domain, wherein the targeting domain of the fusion protein binds to the antibody domain to form a virus-like particle-antibody complex, and wherein the targeting domain is not an envelope glycoprotein, an antibody, or an antibody fragment.
84. A virus-like particle comprising:
(a) a fusion protein, wherein the fusion protein comprises:
(i) a transmembrane domain;
(ii) a stalk domain; and
(iii) a targeting domain; and
(b) an antibody domain, wherein the targeting domain binds to the antibody domain to form a virus-like particle-antibody complex, and wherein the targeting domain is not an envelope glycoprotein, an antibody, or an antibody fragment.
85. The virus-like particle of claim 84, wherein the stalk domain is IgG4 or CD8a.
86. The virus-like particle of claims 83 or 84, wherein the transmembrane domain is selected from the group consisting of CD28, CD43, CD49d, CD62L, CD 162, HLA-A2, HLA-DRA, ICAM1, LFA-1, mCD3z, mCD4, mCD8a, hCD8a, and VSVG-TM.
87. The virus-like particle of claim 83 or 84, wherein the transmembrane domain comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s: 363-376 or 493.
88. The virus-like particle of claims of claim 83 or 84, wherein the targeting domain binds to the antibody domain to form the virus-like particle complex.
89. The virus-like particle claims of claim 83 or 84, wherein the targeting domain comprises an IgG-binding peptide.
90. The virus-like particle of claim 89, wherein the IgG-binding peptide has an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to any one of the amino acid sequences of SEQ ID NO:s. 200- 307.
91. The virus-like particle of claim 89 or 90, wherein the IgG-binding peptide binds to one or more IgG protein domains of an IgG antibody.
92. The virus-like particle of 91, wherein the IgG antibody further binds to an antigen on a target cell.
93. The virus-like particle of claim 92, wherein the antigen on the target cell comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 384 (Seal).
94. The virus-like particle of claim 92, wherein the antigen on the target cell comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 381 or 396CD117).
95. The virus-like particle of claim 92, wherein the antigen on the target cell comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO:385 or 397 (CD150).
96. The virus-like particle of claim 92, wherein the antigen on the target cell comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO:382 or 398 (CXCR4).
97. The virus-like particle of claim 92, wherein the antigen on the target cell comprises an amino acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO:383 or 401 (CD46).
98. The virus-like particle of claims 83-97, wherein the fusion protein comprises the structure selected from the group consisting of: [targeting domain] -[optional linker] -[stalk domain] -[optional linker] -[transmembrane domain] or [Z peptide] -[optional linker] -[IgG4 Fc CH3]- [optional linker]-[CD28].
99. A virus-like particle comprising at least one conjugation domain.
100. The virus-like particle of claim 99, further comprising a targeting domain linked to a transmembrane domain or a viral envelope glycoprotein domain via the conjugation domain.
101. The virus-like particle of claim 100, wherein the targeting domain is selected from the group consisting of antibodies, nucleic acids, aptamers, fluorophores, glycoproteins, proteins, peptides, and small molecules.
102. The virus-like particle of claim 100 or 101, wherein the targeting domain comprises a click chemistry handle.
103. The virus-like particle of claim 102, wherein the click chemistry handle is selected from the group consisting of azides, dibenzoazacyclooctyne (DIB AC or DBCO), biarylazacyclooctynone (BARAC), dibenzocyclooctyne (DIBO), difluorinated cyclooctyne (DIFO), bicyclononyne (BCN), dimethoxyazacyclooctyne (DIMAC), monofluorinated cyclooctyne (MOFO), cyclooctyne (OCT), and/or aryl-less cyclooctyne (ALO).
104. The virus-like particle of any one of claims 100-103, wherein the linkage between the targeting domain and the transmembrane domain or envelope glycoprotein domain comprises a 1,2,3-triazole ring.
105. The virus-like particle of any one of claims 99-104, wherein the conjugation domain is selected from the group consisting of one or more N-azidoacetylglucosamine (GlcNAz) or an acetylated variant thereof, one or more N-azidoacetylmannosamine (ManNAz) or an acetylated variant thereof, one or more N-azidoacetylgalactosamine (GalNAz) or an acetylated variant thereof, one or more 6-azidofucose (6AzFuc) or an acetylated variant thereof, one or more N-azidoacetylneuraminic acid (SiaNAz) or an acetylated variant thereof, one or more N-(4-pentynoyl mannosamine) (ManNAl) or an acetylated variant thereof, one or more N-(4-pentynoyl galactosamine) (GalNAl) or an acetylated variant thereof, one or more N-(4-pentynoyl glucosamine) (GlcNAl) or an acetylated variant thereof, one or more N- (4-pentynoyl neuraminic acid) (SiaNAl) or an acetylated variant thereof and one or more 6- alkynyl fucose or an acetylated variant thereof.
106. The virus-like particle of claim 1, 38, 83-84 or 99, further comprising a viral envelope glycoprotein and/or a mutated version thereof.
107. The virus-like particle of claim 106, wherein the viral envelope glycoprotein and/or mutated version thereof is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein.
108. The virus-like particle of claim 106, wherein the viral envelope glycoprotein and/or a mutated version thereof is a retroviral envelope glycoprotein.
109. The virus-like particle of claim 106, wherein the viral envelope glycoprotein and/or a mutated version thereof is a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 viral envelope glycoprotein, a Cocal virus envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein.
110. The virus-like particle of claim 106-109, wherein the mutated viral envelope glycoprotein retains its fusogenic activity.
111. The virus-like particle of claim 106- 110, wherein the mutated viral envelope glycoprotein does not bind to its native ligand.
112. The virus-like particle of claim 1, 38, 83-84 or 99, further comprising a group- specific antigen (gag) protease (pro) polyprotein.
113. The virus-like particle of claim 112, wherein the gag-pro polyprotein comprises an MMLV gag-pro polyprotein or an FMLV gag-pro polyprotein.
114. The virus-like particle of claim 1, 38, 83-84 or 99, further comprising a second fusion protein comprising a group specific antigen (gag) nucleocapsid protein, cargo protein, a cleavable linker, and a nuclear export sequence.
115. The virus like particle of claim 114, wherein the second fusion protein further comprises a domain selected from the group consisting of polymerases, recombinases, integrases, adenine oxides, guanine oxidases, guanine methyltransferases, transglycosylases, adenosine methyltransferases, glycosylases, and thymine alkyltransferases.
116. The virus-like particle of claim 114, wherein the gag nucleocapsid protein comprises an MMLV gag nucleocapsid protein or an FMLV gag nucleocapsid protein.
117. A cell comprising the virus-like particle of any one of claims 1-116.
118. One or more polynucleotides comprising
(i) a first nucleic acid sequence encoding a first fusion protein, wherein the first fusion protein comprises:
(1) a transmembrane domain;
(2) optionally, a stalk domain, and
(3) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment.
119. The one or more polynucleotides of claim 118, further comprising a second nucleic acid sequence encoding a viral envelope glycoprotein.
120. The one or more polynucleotides of claim 119, wherein the viral envelope glycoprotein is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein.
121. The one or more polynucleotides of claim 119, wherein the viral envelope glycoprotein is a retroviral envelope glycoprotein.
122. The one or more polynucleotides of claim 119, wherein the viral envelope glycoprotein is a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 viral envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein.
123. The one or more polynucleotides of claim 118-122, further comprising a third nucleic acid sequence encoding a mutated viral envelope glycoprotein.
124. The one or more polynucleotides of claim 123, wherein the mutated viral envelope glycoprotein retains its fusogenic activity.
125. The one or more polynucleotides of claim 123 or 124, wherein the mutated viral envelope glycoprotein does not bind to its native ligand.
126. The one or more polynucleotides of any one of claims 123-125, wherein the mutated viral envelope glycoprotein is a mutated version of an adenoviral envelope glycoprotein, an
adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein.
127. The one or more polynucleotides of any one of claims 123-125, wherein the mutated viral envelope glycoprotein is a mutated version of a retroviral envelope glycoprotein.
128. The one or more polynucleotides of any one of claims 123-125, wherein the mutated viral envelope glycoprotein is a mutated version of a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 viral envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein.
129. The one or more polynucleotides of claim 118-128, further comprising a fourth nucleic acid sequence encoding a group-specific antigen (gag) protease (pro) polyprotein.
130. The one or more polynucleotides of claim 129, wherein the gag-pro polyprotein comprises an MMLV gag-pro polyprotein or an FMLV gag-pro polyprotein.
131. The one or more polynucleotides of any one of claims 118-130, further comprising a fifth nucleic acid sequence encoding a second fusion protein comprising a group specific antigen (gag) nucleocapsid protein, a cargo protein, a cleavable linker, and a nuclear export sequence.
132. The one or more polynucleotides of claim 131, wherein the cargo protein is a base editor or a prime editor.
133. The one or more polynucleotides of claim 131 or 132, wherein the second fusion protein further comprises a domain selected from the group consisting of polymerases, recombinases, integrases, adenine oxides, guanine oxidases, guanine methyltransferases, transglycosylases, adenosine methyltransferases, glycosylases, and thymine alkyltransferases.
134. The one or more polynucleotides of claim 131-133, wherein the gag nucleocapsid protein comprises an MMLV gag nucleocapsid protein or an FMLV gag nucleocapsid protein.
135. The one or more polynucleotides of any one of claims 118-134, further comprising a sixth nucleic acid sequence encoding a third fusion protein, wherein the third fusion protein comprises:
(1) a transmembrane domain;
(2) optionally, a stalk domain; and
(3) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment;
136. The one or more polynucleotides of any one of claims 118-135, wherein the first nucleic acid sequence encoding the first fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 601 (pJAQ222), and wherein the sixth nucleic acid sequence encoding the third fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 602 (pJAQ223).
137. The one or more polynucleotides of any one of claims 118-135, wherein the first nucleic acid sequence encoding the first fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 597 (pJAQ218), and wherein the sixth nucleic acid sequence encoding the third fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 601 (pJAQ222).
138. The one or more polynucleotides of any one of claims 118-135, wherein the first nucleic acid sequence encoding the first fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 671 (pJAQ300), and wherein the sixth nucleic acid sequence encoding the third fusion protein has a nucleic acid sequence that is at
least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 713 (pJAQ342).
139. The one or more polynucleotides of any one of claims 118-135, wherein the first nucleic acid sequence encoding the first fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 671 (pJAQ300), and wherein the sixth nucleic acid sequence encoding the third fusion protein has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 718 (pJAQ347).
140. One or more vectors comprising the one or more polynucleotides of any one of claims 118-139.
141. The one or more vectors of claim 140, wherein each of the first, second, third, fourth, fifth, and sixth polynucleotides are on separate vectors.
142. The one or more vectors of claim 140, wherein one or more of the first, second, third, fourth, fifth, or sixth polynucleotides are on the same vector.
143. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 109 ([TPO]- [optional linker] -[ VS VGTM]).
144. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 112 [SCFK9 iEmono]- [optional linker] -[VS VGmut].
145. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at
least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 133 [ADF35]- [optional linker] -[ VS VG™].
146. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 92 [SCF]- [optional linker] -[ VS VG],
147. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 123 ([SCF]-[optional linker] -[IgG4]- [CD 62]).
148. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 113 ([SCF]-[optional linker]-[CD8a]-[CD43]).
149. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 115 ([SCF]-[optional linker] -[CD 8 a] -[CD 62]).
150. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 117 ([SCF]-[optional linker] -[CD 8 a] -[HL A- A2]).
151. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 118 ([SCF]-[optional linker]-[CD8a]-[HLA-DRA]).
152. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 120 ([SCF]-[optional linker] -[CD8a]-[LFAl]).
153. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 197 [Z peptide] -[optional linker]-[IgG4 Fc CH3]- [optional linker]-[CD28].
154. The one or more vectors of any one of claims 140-142, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 534-945.
155. A cell comprising the virus-like particles of any one of claims 1-116, the one or more polynucleotides of any one of claims 118-139, or the one or more vectors of any one of claims 140-154.
156. One or more polynucleotides comprising
(i) a first nucleic acid sequence encoding a first fusion protein, wherein the first fusion protein comprises:
(1) a transmembrane domain;
(2) optionally, a stalk domain;
(3) a targeting domain, wherein the targeting domain is not a viral envelope glycoprotein, an antibody, or an antibody fragment;
(ii) a second nucleic acid sequence encoding a viral envelope glycoprotein; and
(iii) a third nucleic acid sequence encoding a group- specific antigen (gag) protease (pro) polyprotein.
157. The one or more polynucleotides of claim 156, further comprising a fourth nucleic acid sequence encoding a second fusion protein comprising group specific antigen (gag) nucleocapsid protein, a cargo protein, a cleavable linker, and a nuclear export sequence.
158. The one or more polynucleotides of claim 157, wherein the cargo protein is a base editor or a prime editor.
159. The one or more polynucleotides of claim 157 or 158, wherein the second fusion protein further comprises a domain selected from the group consisting of polymerases, recombinases, integrases, adenine oxides, guanine oxidases, guanine methyltransferases, transglycosylases, adenosine methyltransferases, glycosylases, and thymine alkyltransferases.
160. The one or more polynucleotides of any one of claims 156-159, wherein the gag nucleocapsid protein comprises an MMLV gag nucleocapsid protein or an FMLV gag nucleocapsid protein.
161. The one or more polynucleotides of any one of claims 156-160, wherein the gag-pro polyprotein comprises an MMLV gag-pro polyprotein or an FMLV gag-pro polyprotein.
162. The one or more polynucleotides of any one of claims 156-161, wherein the viral envelope glycoprotein is an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein.
163. The one or more polynucleotides of any one of claims 156-161, wherein the viral envelope glycoprotein is a retroviral envelope glycoprotein.
164. The one or more polynucleotides of any one of claims 156-161, wherein the viral envelope glycoprotein is a vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 viral envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein.
165. The one or more polynucleotides of claim 156-164, further comprising a fifth nucleic acid sequence encoding a mutated viral envelope glycoprotein.
166. The one or more polynucleotides of claim 165, wherein the mutated viral envelope glycoprotein retains its fusogenic activity.
167. The one or more polynucleotides of claim 165 or 166, wherein the mutated viral envelope glycoprotein does not bind to its native ligand.
168. The one or more polynucleotides of any one of claims 165-167, wherein the mutated viral envelope glycoprotein is a mutated version of an adenoviral envelope glycoprotein, an adeno-associated viral envelope glycoprotein, a retroviral envelope glycoprotein, or a lentiviral envelope glycoprotein.
169. The one or more polynucleotides of any one of claims 165-167, wherein the mutated viral envelope glycoprotein is a mutated version of a retroviral envelope glycoprotein.
170. The one or more polynucleotides of any one of claims 165-167, wherein the mutated viral envelope glycoprotein is a mutated version of vesicular stomatitis virus G protein (VSVG), a baboon retroviral envelope glycoprotein (BaEVRless), a FuG-B2 envelope glycoprotein, an HIV-1 viral envelope glycoprotein, or an ecotropic murine leukemia virus (MLV) envelope glycoprotein.
171. One or more vectors comprising the one or more polynucleotides of any one of claims 156-170.
172. The one or more vectors of claim 171, wherein each of the first, second, third, fourth, fifth, and sixth polynucleotides are on separate vectors.
173. The one or more vectors of claim 171, wherein one or more of the first, second, third, fourth, fifth and sixth polynucleotides are on the same vector.
174. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 109 ([TPO]- [optional linker] -[VS VGTM]).
175. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 112 [SCFK9 iEmono]- [optional linker] -[VS VGmut].
176. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 133 [ADF35]- [optional linker] -[VS VGTM].
177. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 92 [SCF]- [optional linker] -[ VS VG],
178. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 123 ([SCF]-[optional linker] -[IgG4]- [CD 62]).
179. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 113 ([SCF]-[optional linker]-[CD8a]-[CD43]).
180. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at
least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 115 ([SCF]-[optional linker] -[CD 8 a] -[CD 62]).
181. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 117 ([SCF]-[optional linker] -[CD 8 a] -[HL A- A2]).
182. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 118 ([SCF]-[optional linker]-[CD8a]-[HLA-DRA]).
183. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the nucleic acid sequence of SEQ ID NO: 120 ([SCF]-[optional linker] -[CD8a]-[LFAl]).
184. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 197 [Z peptide] -[optional linker]-[IgG4 Fc CH3]- [optional linker]-[CD28].
185. The one or more vectors of any one of claims 171-173, wherein the one or more polynucleotides has a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 534-945.
186. A cell comprising the virus-like particles of any one of claims 1-116, the one or more polynucleotides of any one of claims 118-139 or 156-170, or the one or more vectors of any one of claims 140-154 or 171-185.
187. A method of delivering a viral-like particle to a target cell comprising preparing the viral-like particles of any one of claims 1-116, the polynucleotides of any one of claims 118- 139 or 156-170, the vectors of any one of claims 140-154 or 171-185, or the cells of claims
117, 155 or 186 and contacting a target cell with one or more of said compositions.
188. The method of claim 187, wherein the cell type is selected from the group consisting of hematopoietic stem and progenitor cells (HPSCs), immune cells, neural cells, or retinal pigment epithelium cells.
189. The method of claim 187 or 188, wherein the targeting domain of the fusion protein targets the eVLP to a particular cell type.
190. The method of any one of claims 187-189, wherein the viral envelope glycoprotein does not target the eVLP to a particular cell type.
191. The method of any one of claim 187-190, wherein the mutated viral envelope glycoprotein retains fusogenic activity.
192. The method of any one of claims 187-191, wherein the mutated viral envelope has a reduced affinity for its native receptor.
193. A method of preparing a virus-like particle comprising transfecting the polynucleotides of any one of claims 118-139 or 156-170, the vectors of any one of claims 140-154 or 171-185 into a producer cell.
194. The method of claim 193, wherein the producer cell is selected from the group consisting of Gesicle 293T cells, HEK 293T, 293G, 293SF, 293FT, 293TN, Eent-X 293T, and inducible custom cell lines with lentivirally integrated VEP genes.
195. A method for editing a nucleic acid molecule in a target cell comprising contacting the target cell with the virus-like particle of any one of claims 118-139 or 156-170, the vectors of any one of claims 140-154 or 171-185, or the cells of claims 117, 155 or 186, thereby installing one or more modification to the nucleic acid molecule at a target site.
196. The method of claim 195, wherein the cell is a mammalian cell.
197. The method of claim 195 or 196, wherein the cell is a human cell.
198. The method of any one of claims 195-197, wherein the cell is in a subject.
199. The method of claim 198, wherein the subject is a human.
200. The method of claim 198, wherein the subject is a non-human.
201. The method of claim 195, wherein the cell is a plant cell.
202. The method of any one of claims 195-201, wherein the one or more modifications to the nucleic acid molecule are associated with reducing, relieving, or preventing the symptoms of a disease or disorder.
203. The method of any one of claims 195-202, wherein the disease or disorder is a CNS disorder, liver disorder, or ocular disorder.
204. A method of treating a disease, comprising, contacting a target cell with the virus-like particle of any one of claims 1-116, the polynucleotides of any one of claims 118-139 or 156- 170, the vectors of any one of claims 140-154 or 171-185, or the cells of claims 117, 155 or 186 wherein contacting the target cells results in reducing, relieving, curing or preventing the symptoms of a disease or disorder.
205. A method of treating a disease by editing a nucleic acid molecule in a target cell, comprising, contacting the target cell with the virus-like particle of any one of claims 1-116, the polynucleotides of any one of claims 118-139 or 156-170, the vectors of any one of claims 140-154 or 171-185, or the cells of claims 117, 155 or 186, wherein the edits introduce one or more modifications to the nucleic acid molecule and, wherein the one or more modifications are associated with reducing, relieving, or preventing the symptoms of a disease or disorder.
206. The method of claim 205, wherein the disease or disorder is selected from the group consisting of CNS disorders, liver disorders and ocular disorders.
207. A pharmaceutical composition comprising the virus-like particle of any one of claims 1-116, the polynucleotides of any one of claims 118-139 or 156-170, the vectors of any one of claims 140-154 or 171-185, or the cells of claims 117, 155 or 186, and a pharmaceutical excipient.
208. The virus-like particle of claim 114, wherein the cargo protein is a base editor or a prime editor.
209. The method of any one of claims 187-194, wherein the method is performed in vivo or in vitro.
210. A fusion protein comprising a nucleic acid sequence that is at least 80%, at least 85%, at least 90%, at least 95%, at least 98%, at least 99%, at least 99.5%, or at least 100% identical to the nucleic acid sequence of any one of SEQ ID NOs: 89-199 or 534-892.
211. A polynucleotide encoding the fusion protein of claim 210.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363506823P | 2023-06-07 | 2023-06-07 | |
| US63/506,823 | 2023-06-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2024254346A1 true WO2024254346A1 (en) | 2024-12-12 |
| WO2024254346A8 WO2024254346A8 (en) | 2025-10-02 |
Family
ID=91758903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2024/032867 Pending WO2024254346A1 (en) | 2023-06-07 | 2024-06-06 | Engineered viral like particles (evlps) for the selective transduction of target cells |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2024254346A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001038547A2 (en) | 1999-11-24 | 2001-05-31 | Mcs Micro Carrier Systems Gmbh | Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| US20150166980A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Fusions of cas9 domains and nucleic acid-editing domains |
| WO2016164305A1 (en) * | 2015-04-06 | 2016-10-13 | Subdomain, Llc | De novo binding domain containing polypeptides and uses thereof |
| WO2017070633A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Evolved cas9 proteins for gene editing |
| WO2017182585A1 (en) * | 2016-04-21 | 2017-10-26 | Ecole Normale Superieure De Lyon | Methods for selectively modulating the activity of distinct subtypes of cells |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| WO2019023680A1 (en) | 2017-07-28 | 2019-01-31 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| CA3079215A1 (en) | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+ cells |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| WO2020191239A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2021231505A1 (en) * | 2020-05-11 | 2021-11-18 | Abintus Bio, Inc. | Vectors and methods for in vivo transduction |
| WO2022013872A1 (en) * | 2020-07-14 | 2022-01-20 | Ichilov Tech Ltd. | Pseudotyped viruses configured to express car in t-cells |
| CA3219487A1 (en) * | 2021-05-28 | 2022-12-01 | Richard C. Mulligan | Lipid particles containing a truncated baboon endogenous retrovirus (baev) envelope glycoprotein and related methods and uses |
-
2024
- 2024-06-06 WO PCT/US2024/032867 patent/WO2024254346A1/en active Pending
Patent Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001038547A2 (en) | 1999-11-24 | 2001-05-31 | Mcs Micro Carrier Systems Gmbh | Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| US20150166980A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Fusions of cas9 domains and nucleic acid-editing domains |
| US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
| US10077453B2 (en) | 2014-07-30 | 2018-09-18 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
| WO2016164305A1 (en) * | 2015-04-06 | 2016-10-13 | Subdomain, Llc | De novo binding domain containing polypeptides and uses thereof |
| WO2017070633A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Evolved cas9 proteins for gene editing |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| US20170121693A1 (en) | 2015-10-23 | 2017-05-04 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2017182585A1 (en) * | 2016-04-21 | 2017-10-26 | Ecole Normale Superieure De Lyon | Methods for selectively modulating the activity of distinct subtypes of cells |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| US20180073012A1 (en) | 2016-08-03 | 2018-03-15 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| WO2018176009A1 (en) | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| WO2019023680A1 (en) | 2017-07-28 | 2019-01-31 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| CA3079215A1 (en) | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+ cells |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| WO2020191239A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2021231505A1 (en) * | 2020-05-11 | 2021-11-18 | Abintus Bio, Inc. | Vectors and methods for in vivo transduction |
| WO2022013872A1 (en) * | 2020-07-14 | 2022-01-20 | Ichilov Tech Ltd. | Pseudotyped viruses configured to express car in t-cells |
| CA3219487A1 (en) * | 2021-05-28 | 2022-12-01 | Richard C. Mulligan | Lipid particles containing a truncated baboon endogenous retrovirus (baev) envelope glycoprotein and related methods and uses |
Non-Patent Citations (26)
| Title |
|---|
| "The Cambridge Dictionary of Science and Technology", 1988 |
| ANZALONE, A. V. ET AL.: "Search-and-replace genome editing without double-strand breaks or donor DNA", NATURE, vol. 576, 2019, pages 149 - 157, XP055980447, DOI: 10.1038/s41586-019-1711-4 |
| AUTIERIAGRAWAL, J. BIOL. CHEM., vol. 273, 1998, pages 14731 - 37 |
| BANSKOTA, RAGURAM ET AL., CELL, vol. 185, 2022, pages 250 - 265 |
| BECERHOOGENBOOMSCHUBERT: "Click Chemistry beyond Metal-Catalyzed Cycloaddition", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 48, 2009, pages 4900 - 4908, XP055215368, DOI: 10.1002/anie.200900755 |
| CHYLINSKIRHUNCHARPENTIER: "The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems", RNA BIOLOGY, vol. 10, no. 5, 2013, pages 726 - 737, XP055116068, DOI: 10.4161/rna.24321 |
| EVANS, AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 60, 2007, pages 384 - 395 |
| FERRETTIMCSHAN W.M.AJDIC D.J.SAVIC D.J.SAVIC G.LYON K.PRIMEAUX C.SEZATE S.SUVOROV A.N.KENTON S.: "Complete genome sequence of an M1 strain of Streptococcus pyogenes", PROC. NATL. ACAD. SCI. U.S.A., vol. 98, 2001, pages 4658 - 4663 |
| FUNG, H. Y. J. ET AL.: "Structural determinants of nuclear export signal orientation in binding to exportin CRM1", ELIFE, vol. 4, 2015, pages e10034 |
| HALEMARHAM: "The Harper Collins Dictionary of Biology", 1991, SPRINGER VERLAG |
| JINEK M.CHYLINSKI K.FONFARA I.HAUER M.DOUDNA J.A.CHARPENTIER E.: "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", SCIENCE, vol. 337, 2012, pages 816 - 821, XP055229606, DOI: 10.1126/science.1225829 |
| JOGLEKAR ALOK V. ET AL: "Pseudotyped Lentiviral Vectors: One Vector, Many Guises", HUMAN GENE THERAPY METHODS, vol. 28, no. 6, 1 December 2017 (2017-12-01), pages 291 - 301, XP055890845, ISSN: 1946-6536, Retrieved from the Internet <URL:https://authors.library.caltech.edu/81197/1/hgtb.2017.084.pdf> DOI: 10.1089/hgtb.2017.084 * |
| KOBLAN ET AL., NAT. BIOTECHNOL., vol. 36, no. 9, 2018, pages 843 - 846 |
| KOLBFINNSHARPLESS, ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 40, 2001, pages 2004 - 2021 |
| KOSUGI, S. ET AL.: "Nuclear Export Signal Consensus Sequences Defined Using a Localization-based Yeast Selection System", TRAFFIC, vol. 9, no. 12, 2008, pages 2053 - 2062 |
| MAGIN ET AL., VIROLOGY, vol. 274, 2000, pages 11 - 16 |
| MAKAROVA ET AL.: "C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector", SCIENCE, vol. 353, no. 6299, 2016, XP055407082, DOI: 10.1126/science.aaf5573 |
| MOEDE ET AL., FEBS LETT., vol. 461, 1999, pages 229 - 34 |
| QI ET AL.: "Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression", CELL, vol. 152, no. 5, 2013, pages 1173 - 83, XP055346792, DOI: 10.1016/j.cell.2013.02.022 |
| REESLIU: "Base editing: precision chemistry on the genome and transcriptome of living cells", NAT. REV. GENET., vol. 19, no. 12, 2018, pages 770 - 788 |
| SINGLETON ET AL.: "Dictionary of Microbiology and Molecular Biology", 1994 |
| TINLAND ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 89, 1992, pages 7442 - 46 |
| VOGEL J.CHARPENTIER E.: "CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III", NATURE, vol. 471, 2011, pages 602 - 607, XP055308803, DOI: 10.1038/nature09886 |
| XU, D. ET AL.: "Sequence and structural analyses of nuclear export signals in the NESdb database", MOL BIOL. CELL, vol. 23, no. 18, 2012, pages 3677 - 3693 |
| XU, D. ET AL.: "Sequence and structural analyses of nuclear export signals in the NESdb database", MOL. BIOL. CELL, vol. 23, no. 18, 2012, pages 3677 - 3693 |
| ZHANG XIAN-YANG ET AL: "Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus", RETROVIROLOGY, vol. 7, no. 1, 1 December 2010 (2010-12-01), GB, XP093202217, ISSN: 1742-4690, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823649/pdf/1742-4690-7-3.pdf> DOI: 10.1186/1742-4690-7-3 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024254346A8 (en) | 2025-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250034549A1 (en) | Compositions and methods for efficient in vivo delivery | |
| US20250382334A1 (en) | Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same | |
| US20250064979A1 (en) | Self-assembling virus-like particles for delivery of prime editors and methods of making and using same | |
| CN117642420A (en) | Lipid particles containing truncated baboon endogenous retrovirus (BaEV) envelope glycoproteins and related methods and uses | |
| WO2024215652A2 (en) | Directed evolution of engineered virus-like particles (evlps) | |
| US20250136950A1 (en) | Compositions and methods for efficient in vivo delivery | |
| EP3822346A1 (en) | Use of engineered packaging cell lines for producing recombinant virus particles | |
| KR20230044420A (en) | Methods and compositions for producing viral fusosomes | |
| WO2024254346A1 (en) | Engineered viral like particles (evlps) for the selective transduction of target cells | |
| US20240141382A1 (en) | Gene editing components, systems, and methods of use | |
| JP2023550381A (en) | Vectors, systems and methods for eukaryotic gene editing | |
| WO2024064838A1 (en) | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof | |
| CA3215435A1 (en) | Genetic modification of hepatocytes | |
| WO2025185623A1 (en) | Virus-like particles for gene editing | |
| US20250019691A1 (en) | Rna export for measurement and manipulation of cells | |
| WO2025184529A1 (en) | Viral particles with fusogen display and related compositions and methods | |
| US20250236852A1 (en) | Large serine recombinases, systems and uses thereof | |
| Rousseau | Engineering Virus-Like Particles for the Delivery of Genome Editing Enzymes | |
| Fichter | Development of Novel Transient Delivery Systems for Gene Therapy | |
| WO2025064678A2 (en) | Prime editing-mediated readthrough of frameshift mutations (perf) | |
| WO2024243340A1 (en) | Tandem fusogens and related lipid particles | |
| WO2024119157A1 (en) | Lipid particles with cofusogens and methods of producing and using the same | |
| WO2024254518A2 (en) | Compositions of lipid delivery particles and method of use thereof | |
| JP2025188163A (en) | Methods and compositions for producing viral fusosomes | |
| KR20250155074A (en) | Genome editing compositions and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24737622 Country of ref document: EP Kind code of ref document: A1 |